From 09aa9c2c6b9ccddfe2e100b463ac86c3fbd6ae97 Mon Sep 17 00:00:00 2001
From: Frank Knoll <Knoll_Frank@web.de>
Date: Fri, 26 Jul 2024 23:42:07 +0200
Subject: [PATCH 01/16] starting Drugs for Pathologies

---
 src/HowBadIsMyBatch.ipynb      | 131 ++++++++++++++++++++++++++++++++-
 src/data/1000-pathologies.xlsx | Bin 0 -> 237633 bytes
 2 files changed, 129 insertions(+), 2 deletions(-)
 create mode 100644 src/data/1000-pathologies.xlsx

diff --git a/src/HowBadIsMyBatch.ipynb b/src/HowBadIsMyBatch.ipynb
index 55350529c27..383ea805f87 100644
--- a/src/HowBadIsMyBatch.ipynb
+++ b/src/HowBadIsMyBatch.ipynb
@@ -608,9 +608,136 @@
   },
   {
    "cell_type": "markdown",
-   "id": "439c055f",
+   "id": "be72f509",
    "metadata": {},
-   "source": []
+   "source": [
+    "# Drugs for Pathologies"
+   ]
+  },
+  {
+   "cell_type": "code",
+   "execution_count": null,
+   "id": "c8190125",
+   "metadata": {},
+   "outputs": [],
+   "source": [
+    "import pandas as pd\n",
+    "import os"
+   ]
+  },
+  {
+   "cell_type": "code",
+   "execution_count": null,
+   "id": "a416e3b7",
+   "metadata": {},
+   "outputs": [],
+   "source": [
+    "drugs4Pathologies  = pd.read_excel(\n",
+    "        io = 'data/1000-pathologies.xlsx',\n",
+    "        converters = {\n",
+    "            'PATHOLOGY': lambda text: text.strip(),\n",
+    "            'DRUG': lambda text: text.strip() })\n",
+    "drugs4Pathologies"
+   ]
+  },
+  {
+   "cell_type": "code",
+   "execution_count": null,
+   "id": "492230af",
+   "metadata": {},
+   "outputs": [],
+   "source": [
+    "def drugsTable2drugDescr(drugsTable):\n",
+    "    drugDescr = drugsTable.to_dict('list')\n",
+    "    del drugDescr['PATHOLOGY']\n",
+    "    return drugDescr"
+   ]
+  },
+  {
+   "cell_type": "code",
+   "execution_count": null,
+   "id": "1c0166e6",
+   "metadata": {},
+   "outputs": [],
+   "source": [
+    "drugDescrByPathology = drugs4Pathologies.groupby('PATHOLOGY').apply(drugsTable2drugDescr)\n",
+    "drugDescrByPathology"
+   ]
+  },
+  {
+   "cell_type": "code",
+   "execution_count": null,
+   "id": "f7e83e81",
+   "metadata": {},
+   "outputs": [],
+   "source": [
+    "drugDescrByPathology['bone cancer']"
+   ]
+  },
+  {
+   "cell_type": "code",
+   "execution_count": null,
+   "id": "0d0b6909",
+   "metadata": {},
+   "outputs": [],
+   "source": [
+    "drugs4Pathologies[drugs4Pathologies['PATHOLOGY'] == 'bone cancer']"
+   ]
+  },
+  {
+   "cell_type": "code",
+   "execution_count": null,
+   "id": "4444d234",
+   "metadata": {},
+   "outputs": [],
+   "source": [
+    "import shutil\n",
+    "from IOUtils import IOUtils\n",
+    "\n",
+    "def saveDrugDescriptionsForPathologies(drugDescrByPathology, directory):\n",
+    "    shutil.rmtree(directory, ignore_errors = True)\n",
+    "    filenameByPathology = {}\n",
+    "    i = 0\n",
+    "    for pathology, drugDescr in drugDescrByPathology.items():\n",
+    "        i += 1\n",
+    "        filenameByPathology[pathology] = f'{i}'\n",
+    "        drugDescr['PATHOLOGY'] = pathology\n",
+    "        IOUtils.saveDictAsJson(drugDescr, f'{directory}/{i}.json')\n",
+    "    return filenameByPathology    \n"
+   ]
+  },
+  {
+   "cell_type": "code",
+   "execution_count": null,
+   "id": "5bd7d025",
+   "metadata": {},
+   "outputs": [],
+   "source": [
+    "webAppBaseDir = os.path.normpath(os.getcwd() + '/../docs/DrugsForPathologies')\n",
+    "webAppBaseDir"
+   ]
+  },
+  {
+   "cell_type": "code",
+   "execution_count": null,
+   "id": "7652a551",
+   "metadata": {},
+   "outputs": [],
+   "source": [
+    "filenameByPathology = saveDrugDescriptionsForPathologies(\n",
+    "    drugDescrByPathology = drugDescrByPathology,\n",
+    "    directory = os.path.normpath(webAppBaseDir + '/data/DrugDescriptionsForPathologies'))\n"
+   ]
+  },
+  {
+   "cell_type": "code",
+   "execution_count": null,
+   "id": "013ffd05",
+   "metadata": {},
+   "outputs": [],
+   "source": [
+    "filenameByPathology"
+   ]
   }
  ],
  "metadata": {
diff --git a/src/data/1000-pathologies.xlsx b/src/data/1000-pathologies.xlsx
new file mode 100644
index 0000000000000000000000000000000000000000..639c4524e4d3655b2df666e26ddcb9889138ac1a
GIT binary patch
literal 237633
zcmaI72Q=L8^DmzGkg!Tbc8L}x!Rn$%ZyV7&(L*dtwCDs$#HvA}?~1lqy+rRmAxN-#
zTZABb@16f!zQ23#?|<*PH_pl7>|~yqdFGjUy=FpN?H@w$4Ps*A8<c^k&u{#<Kcv9-
zmTquIcYeO>zl&qPX|@TFg>1cv;5ridB}bfzZBT#Kz#{zM-$%~$RpD9RKkObV-J>Fl
zDsPK^9r*UrI%itlnP*ynUCkogz&M<siT!0j?)UD?*S`FsI80#2U2$by7ey|&7%kQP
zo>}>>>^B~tR6)yo8fpVKmtL;h+>n+Fbu%~c7QD0xTMRZ{|48-P&JZ*Hmas8c!|9cX
zvkDV~pN!C)5o;Wa*AG?oEdN~bMk;c62*`ID9#GdkvlUN4OD6D4<8Bhm;^q(Pp_*ux
zi}>!9<m7wxb&GDU*88_`ja0z`b{=mu9tJ#9-%N)v3R$W~nxvg~FW%EuyG@Kl3!^uI
zAoLR4xS{=j4bvS!!pD){+r{mbwTsIuJ|8E?D7{Iy2?5H0EhC?Oie^_%fn+ifpIFp1
zd-l%?$I`D6Jigg%auOFuCGaoUA({P~*-gvq_+Rr2xVpq?q5IsG5ys+V$+x-2klJU-
z0dJn&7Fsm^Q}A1tI}A_6(_q|WnpXM5#)L`Auhg-J>$~mjnP_RoqE{ZhHkh+2|4FR<
zVY3t2cB|oy=W4Q`pnOaB%;%wH0#_e0yLJDR4V-+vg=7r7`SbJmq^fXYabnJ=?QxMm
zJJ^$+SC~{+l+fD))w9AK!8E354ORSO?z&33D8tizwlj(+y2@s%ix38uFSqAq7VZ#7
z#jC)7;3XaqeOce~c_s1P)aiSq;g1DAF_W(3%qJFwcXhxgEvyY*+IOTXn)c2g>1S#^
z&VravPibwQJ^~dX-VY5pPMtZ+uXBII^L$b6QB3<)^C1HND8nvCfZF_SXls6)U4~yV
zjQqq!!cB5bORMgEeUg=0LT^J5mt-n4G7SkqJ?gM!fxg&`_`z~0Fzl?kM?)O4doMs=
ziN)~=EmU?Th<P;FE2@QW$-zaAl_R!|nYfjjruTRNBU!2&i{5<uQzfEDj)OUuZILl5
z3?Fkegh2OT2bfJlv*hnPb9}gywPW+ic_^Me$uZXVG|po|n`U24;*y#?;L(xxCST>G
zdr$Qe!=H)QyPU;m-oxh>_X;hq^F|mQV|I4)#tqkh{$F`R{-3;Y_waRuyI*I`hKYI1
zkT^JC#`5k7W2|Uue}-@v@2Z0(rO7Q4lAYh|&h)e6pXUX6TLLdWmwNe!qA1qAGQx#b
zHV>qaj*lfg*HkPvR96GoFnr=EnFD(_e1qXq{NsKhGG_c~8lR2Sdfe2XJQS+r5b;a6
z{5<TY_4ACJWl)c}C@nK8enf4iw1S-T^~D#XV9vgXNGi1h=xCrhNzk6j?Sx^b+wy;s
zYF|J##;eWZ%MS&c;kpCM>S;~qsoXDx<<pQUduBQ(kpip&ut4-Nxg5GkeC>6~Cy{KG
z3*1>mJ^}5@B5kgjk9E_R%yw3RP*EW>s>yXvHs6h=c7<*F4ddDJj5lla^ugrRRjUm|
zB49^MmPcnTrYt!0-8U4HzgRJXcc57^yP`8Dw%2T*k~-c?@jmOTXK^4k6++Xz+og3a
z(?$gp$z1BBFDC+W4@`bvApAYA-l2zB$9P8ftY(yrbOb~gO&&-Dy(rN9Ap7rnIVy5>
zAvV%XqoF$e<uJOj@!way0vFo2e$Ws)qjx`Krff8sJ-#Sg^<l)pQ%kl|VR}9`{t*rO
ztnlZ5m_C0Kx@T$7*`Yqw!y8^|5*VuLo)!OtIA=>_wbOuKIpbgN!pWg@)a`@BK|#?P
z>U`gS4PZy4CGzS-rfuoipYK;hct?vKDU;8T@TsulCi|0z2y4ij$Z6Weh>E$re>Dc|
zck5B3MDdrbTCu6;p=ypg;9UCmg|Fc2!+g)3skkkh?h>83;b>q>hJpr+<T1PJq(4n#
zQ&^2MKO|l{duHqRuL(;S<c2JL)mGfo&abveqd@H-$>bLQ)OoVF|Bo*aO2tPrJw9&0
z_$%rQBxUEx*YGPl!AsW@XPUhap6C0+@N;L+l#@?=5A$WKL@wSwqThxse=C3&kl$U(
znaDPB^1n0k;A~+BgZD+)>Rn)Ct4_aoC&+JA3=HL$N7^pQ3Nb-ZYcKa`Qqh4G4)o{L
zlf}PTh0FX-y)S9~3canC<*FB|Gs<5a{%m0sSb~R79%dDOct=ULEkl&vkg?1Rb-U$+
zWagRle#}o{&F<aK@CW_idy{K>(?f+ABN{5E;PDNlMUU`L?+c7iP|x1H_k$^VvRkJ%
z=giCAo`JV6t?xDu<i1?`W5>}<(|l<vMo+(5kUJ6mXKzu51@|i@v@=Zx?{o*8RTU~V
zaeLwYeYwY8AI;M^$C;XniQH2pr1b=BK^^-e0qdySr@_0m1J<6kZ|FL$?!!J|_Uhuk
zF%0rX1l>^hP`g45jp^MND4rb%;r_EJ@vdXP1oYkyWW+kG_x#ny>oshQxL1s5eCO$u
zZ^pz|nIz@0cu97$gFJ<)3|g``bN6?bO+3aB;G3&TryenPgw<LFqJKSLoVTS6`J~+U
zbo`&k{S3@nh*8Mpz}ckB%v#{p9iEkz>moz?sy2;_@Wu_IhySl41AO>Dnv**M4)<{9
z|4&E%`@`ews`IzEN5yo5S_LR!M}e^9Ce$c0OnBpIuyanJoO-VPSKm)c11(}1q@;Xi
zy#Zfl4RLKf>zXW@y&$OX&5uQH7dBPz+`Y}VGV+Z^!fjD*kD}vZc)T6K0@y!CVLDMZ
zHh+5KaJ|2SK69qaXC<w2iOgc5)%TlewfU2aHi&|&`QLkLX<e255>Stz(ELS)-=8O9
z_eF931MiO~biFi`dHPd`QXr<Sz5bNw+HaG(Q^Q=qD=<)C|L;xt{{P|k|MIvo)jV$M
z2P$>zf}7o^#b!Y)BN;{RLeMXvP%TzuF4^imT&CPc`SU>>L%@2ex94ZPT$+117yt7*
z8t(jKN<`Yzn<szHZ0FA2UY?zK&s-eL&ga&|Fa`QpS)^I`A8pU(c8a;ko}Yx$T<vU4
z%4+a8pY5L<go>5UNC)~H&$i1xkZC$zV!G-+di&=5I7zETO3MFo)BoL_^gy4T?xnt#
z%gvEOE!m6R?aPDQq?i^NfAOoIeKAZkEtme6=}cGWt3#zsOcpJ5=Q&4P7Wg5~X1}Y`
zjZhlP=<S9W=}w>XlcgG2X`UF_i^I#=wk7`CC&$~H2TOY~S1U<1ErDFhXJ;uT^Gzqm
zr!Grx9Zq~HWaoAlw9;biq!_m@CevkP0{zZU_PWy_%)GrAIJSJ!f-Zc!be8THSawt@
zd$~|!d9~vI+p_PfR<<eN=x|S#Pj)_%silSCd`2elXm8Rxok`~Ms8eidrn|3nCcsbp
z3SU}!b-vvh+IO|Hw$LYgbvECUDhqvkzS_BE8F0}p8+f(2@uW4^^30owDe!W({jEsL
zSwQ99IiY#-)y3hgOFG5XMFS9~ODD;zu$HDb7x@f3yR%!e%>jF%HB1kB(*rM$C&%tw
zjm^*O&NsZ3wtL-N8~t|sEmLo1!X26Bi#`4&rrkStWZwqL{8<`%dph6N5SlI{+xX<N
z>FQ*1$$Kg8e1~c4YX5li<c7<Gz`%>ihCVIX))S8yrtYP;(pTSQ8;`f+mmBt2nBE3R
zzyf`aHdic9=Ni(}#;?3&0{4Ln?(6J4dV9Wd(BQ7Q=pk{wb@lpW?RZ5G^Va7grgMhx
ztN+DN?p9m+1E#Cp{ehv^T3Ri+-7RyRvzC^!0p87*VE*Pe0hjxwcPs<Z?TlAPNiC<p
za<9BkQomfSpBNo_{GNZy--6z78~E~e(lSmwcl+&h^T~Pl9e!-mH(V~F&0TeA=4XqH
z6kFhB=CAHOu`}7emdM?oWBW`k-_JusTVxs~_mY^Fj`1hQmY1HT1w&WI7f%MYlCG}6
zn+;<vfqth40n*D_Edi(J$Cqn;2MaX&-IHQ24`hA}S@fP<9?bN~E}Y2D1lFD}<pLLf
z9@MMz_Q^+5{?xZ!OOt7XfzmmU+{(Rf%9abxUt@apOL}Q(TE3Uk?UG*x-%95g<*M^X
zogC(pS!&S^b8d7~HeYbgkLf-2>{@}V&RoW?tZ~Lk<h)(sH(D>`pGn~FLye_d0v2|5
zwgepQxa9{t*-0uL*{kE5d49FKQb;D-PIKPneZ2cmf6LZ+U!cUyQ1SNAf{E<ag4UAO
z)#?1onbF&TQ<4^{t6ik)?bczXONHZqtX^4LwT^u63N8&VrYvm^+&*i&UD~@NZHFke
zLF6WFrr06)WuJ+kuiq3rSNQ(VU6wX}rFu%HW}EvPgpUPn&OfRMf^XtMy9^7nAGlP-
zBvieHRF!qu!v=M3tPm!xw|<ni`qXp3k)83@3Z4Avfc$BSydQ{)uV$U|oo_2M>M=?4
zMWHqGvl#i)r=P6$$pxp#1hqd25z-z<e2LPaY;8@}*gStr$?<Y%eKvH0;1(U-`ws5+
zA=`t2Yf|$#sfP>pzftioI}?6>yyF8GeED0z^gHv*hd+c*yVS+v)W1BEX}HHm$!gY2
zDijiHb1Ti&w3S)!;SYO{PeV9n4hkxQANSt+Iwk)i3pGhr`<6mdX28(<J-9EOL@1RG
z)ti+ryN6S^>jiIm_%4=i|M_iECJ;|x_J&)C!X;Vg=@T)GaPI8O{UMw{3#$Rz_3NKf
z^#k*oOPj~q-)QGGzN_iG@~OM-ji==YOa(fyNlpj$Y}k-<&<hx6rA-BPD98T(Si#bh
zT=bhY+N#FRL2I-!mT^;Qu^LQU&HBN_CV02U;~Qw<+ftka<)Vs-jfsU#NaW`_r>7w!
z#GQD2*>EsPXC{H5hZ=;^0m~vS$SW&2Mz|tlc`+Gc^ZYZJM66ZaS8+3Q!arn-oIE6Z
zkJJQtH3Y|`R%B?Fopb~pRc{&mEc<o*`{Avw;S&;AjSh=`JZE^UJt~&ASaq?Qn>LZn
zKh3T!@g9K;jz%6A&Zir~Ly=8J8)wfMSGTC{t+HP&M4QOoh$z21s&vW8EPQDoKt2D+
zMIunQ(--$;b1$c*STp3;PmCmOb?WaqdrWCl8LOSval9#!9lNYmxs4V!N6WTW7Bxu#
zAJ5>Si?`Y%S+tS9)t#(zi+{zy>iuS(jV?Av*Q-_)Kgk6*&JieeG!DSNYlGfQ<#+f}
zY)8CxBay7Dnykx0DDP}o#+g1I{-HJWX?3g5;=SlBLWrIJDrwj%lZ|FIT=Nk9<ku1v
z+`atnL%3(T_;3v-+oLtN`5jqDGw8>xdi(-fS1oN_#J656n@5X*bMoHkOgRMpaBYPP
za{7IQO`gqP!I%m<Nd=WO%itjehj!h9zy9umJoecyf@uSf8q|6MRilENQo%!MQh3zB
zc3sp+cMKl1hx*W_j)WP1u{9wQ8LCO=>8j@GvZ%;A3+|$8&n#EY%(UYsBgx&QzUj-r
zT1?RT24}01<*1gmzC9QRkC}UBoXtRSUc8<DBPKxSo!~K{2@&id*3R}$6`S56THSX~
zFyKtv7%Q${%~^EEuKQ5vB~|3R)^JuxGqT?0C&sZGvn~=@AG&Fp2-Vad&Rq85a!}v<
zsG%9OD@2Fqg3={AB{FnXGjy4|=bh~@mnrHLM6-c%4^suwpHZ>pRk&fcNh8o{4EFJ_
z?BnT6bfQHfgy1olQ4X*4;J&Xgxy0sEg1JqOLFm{Z)LSEK(@o5ik#6C6*7n!fRKZ6;
z_z@T-WQ<kDBb^dFN~~F=R1w3V29}7|YiHZlmB+s$LJ(Pvh0jwrB`Vat0(qvts#MHm
z;07P^*>HeCnJ_tuB~3!bG3ZI$tCP5fMXe*B=?01bw<0a!maSkJnD8-7TWAz(<O}^6
zzy7mo{U>=1$C#CtX65><_6+9|$<N<4es_PbOT8|X$k2LTKEdD{|H?O>ep9EUEsNm|
zSTj?c?OE<nPfXygUwUV>pn~7FeFL!?jI#MzjMKwQ5{_LYDHtm*N$q_P?iW9@21*H9
zU$;C&x$&ah#%xw)!o9}hU#7STKZE@8Nek6i*YL@*Ao}iY<i<JX#`zYPvnfch&B(Wa
z&ta%qt+?Uqm}^F8^HtdiLWz#&h}-3j+if#F^$%6?73E|A!TEW@jbw>uS|2A!P~K8y
zT`*-`2=(4Qq4>OuNw|}nBXt&&ZpX7j%B3NmM@4zC=jX;b<Hjl5$h;tF))na`6R*cV
zak75$Q!yX3A~-!~GtDJFFu3+J-{1Y$kZbNPqvirWzbqoDiA!yk@Q^i6sp*^m^UU|A
zes{t7c0v4BKNr8>nYLcj^2S~`ojdh6yk6LIPZLPeu>)JfE^otb+eVl7c!FKSE}|$6
z{)45G_{Z;O)(}eRl4tq;YWe4`IlGLi3&#0Urv)?x!B)Hkg5ha~H7Vz5pQQ&9RZeC#
z0-M{i8=tcv*%x3&)9T@%U#(OT|I5##!@qv=AXyjifvg4Rtjzb8)%fGd?y*Jf@<xH$
zM7TT<`Y)msV*2FuQ&<lZ_=6(EKQw`eX{2xO=JoI92{f`oB&4{)s&pz3Q3st`;v8kf
zT}tcsEQny_7w^ruD$Tgayz~2Kb>;UDXWKZ-ZXoeb%?>JwdqXN%UR>zEmKi|1=@#_s
z7PxBUZ$3U?lK99KMlH*5cw01M*;Vk(-T0mC{2<I>xEvqEgbxx@bBv@&0=4F7>wR#|
z*ZX*!N0l5i{-y~8;&7>!lYp2=Ktk5^m;3Yol|Y(G{bBat`m9dU^>kWKp^{*5K0=AB
zQi+R<CcmFWS3W*pJ3GiVTZy+hXg6FCPP~Nu2c?fd>ECzO&1}miNCESHCTo4`I);JC
zRT?S??C*1Y25ReViN;3|2_>$wXS1uF3`(XJ=zE%{Bt2mv!tZBY>`1fqGIR8-e9XB#
zmi1qxw#sW$C<Nuv7|7icu{NM&SN&^XsP}O@MQVgK3cRWhmefqXM{$Sxy>zimn?B@e
zVIS)g1IH%@3>GO7jG7R9{x&KtYxQ^AQXgwx7&npO%~?v3Se^Dno%Y$n9P3aWn3cY`
zQWWMxjD$bYA4F8;JJ)*t*k|pD&)R1L0>8FpV+1%E(w@#f6DqkhCQK;nsR9wFYk!vF
zs+Qui*vo5h^c~IA(LsPUbCh%(BZN74q1_+!<Yz(g&!`}#RFF_L{q;|IKd2xGjwfs~
z)D7>b-?yVwFM=@IDi~`u%$#d@gmoLqhs<)NSzFg95p-1iYj?pGyM-^*zo#Ye#y)LN
zeA+%s2QkhP*B^zN6(>EM?9*#_7;r)Kw1I_W`JA+MXY%mlMqRZd7e!4z^e`>M438y{
zJ~1%vQvO5Tj(QfuWu=#UkJ_yInF7RA0TN1T0DhyTUCyIFo|%$0VGy)ggh9se8GXHs
zC^4Wa7^f-__MZ%YRGs>-(mhg$bA3Wwo|F!TK+q@UIg!ndZ#7$N{%~x*uo*UX+&4%N
zj%tP2KH)^QHWUO2=nRmC>E(s%b5-ecksIYds$S2MGtSwbPK-nBOIm%?lKX=VdR(b5
z_*pF{Q7s3Et;+g@^5=53*@E3K!--V;O*9Ma{!%2jUd~YE>pSG@(^<r-T2IQT#+!qd
zV%>GwI44MSbe@x$L6j7Sl>`$^1QSBK^{r8JK=&wnmlXGj(_|u-dCE-pv3Rhmjcz_%
z*S=OIhayhZQCD2MFZ?3ZOU#1MW;>)omH4(!xDr>D5*Im5{xFMfI1Dt|=|+_rz|o~Y
zoV9Grr61{x&DQSJT2%_=)?d}m`wl|N|9Le0Bkh?6k*zOpi$rqfY#{4<Ro?fiZA4t2
z#QN6nTcw}4QxSN2seE~M_j&8$n!$remjWA|e7MfgcKPtIl}_Ba4*{<O6*Vj}htS4e
zCH-AleU-)|9X&M+cGf&lFH}i`N9Qh^165#f9X|njXOjPZ{WFg8ylVxnk!T4X2db?P
z3X$mH-lg&7O5%ta;v5QC)@8VqgM;s|@KhF-A_hI4wXMPKYkjdJyi7w`DnmnAQa#O1
zm7mY1JLLKqEurLK{ke67+?VR`!)+77VA4awZ~Zjsj~pCShK0>ASc-7;b4*#_7mfwx
zdtQn>1f(JUmfHHG)9ixzKq!Yq;_CbE6|`lui*ovt7^lTwy?AdaH_XL(|4SVDSr#_&
zsYaWK!)kwCxClu3w=Y$Q(%M5Jo9&WDP#BZe9~~f;&pKP=3fi*R51~`>{8|d1{Ka*K
zf`8lYfH+xnb4kvKs>9VC98iES*;tA=^mw-Gib7ia#S805Oxc+mgtD5-`JVmo@L-;=
z&tr$p{ydZjXieRh+LK)wmJPEKqNq2NCt`TzD3m`urJL{TBki!Mop0<o8_FfZ{SSsC
zA%ox`6BNd-Ya5$i$ELUEib6};IM||Eqbm1!{C4x4xtKph$rT2<PRYip;&>C#rTN3=
ziK@MfTq2Q4>ljs>btX7LgUH6dy)MX=3eKK@HsunzGvj7`eM+M<je!I8nUZ#bmR#f8
zq<4tUOO%a+^Uq;_4eaLL=?@AN+8FElAx(-@ZH~XWKy;SbK(6x8gZ(qwlvU&ozY30#
zRixsX22{5Ks$vCuaraZErv1%XQ=V#+zJqiAu#{QOB1Hn)IH!MMk7r_shqfhyfTZOe
zf^kcz!fwJX-}l)0o_nYoZe6$bmvb8O;<vQxT}rNXuKV=~u?jd|B)YRDyhbt8)({$>
zB~=*Jy<*r!=@ia&-;Cx-oGgy_tzhmff#;Kj;%B7#aMe;V>3ofTUmB10Iyt>OP~`r>
zO#YHbVGQ&14*!C*XR`kL0-qJ9T#l*}CCtrtb6;l1x=4DSucD{FDmLT9_R>PsMi%00
z_Ta_n<%L|1S%Y(16&0Q8IksjnPfO;}upqZPokdRlmtC(i>lhC|($(-(L<d|a5<})(
zT+RimX&U!hrgYkaH|6fQtVw%{8@?|nj$Lue;}|(nHf7<9NXa)VhDL5UPHHj^IyKiH
z2{(EGrf+!QYszqsX^2m|PPz>4N5dh=Zoz6s37g4sK6knj^CZ3L-o$p&ZjU;-g9OPT
zYKPdAGUjU4kJIZ_dZ9k1w`?`rAnR^jlRM?XR!K^H+R|0Z4VP*kv*mSb8?8er@YU))
zUqX_q_;MRldAsjhzyLKr!j<c+Lp>fq!&qsFx=RnGt3IxuL+F?sL*pQMAnKeVxsfva
zG{i;092RAQXA5y?+8Ab;#-^io0&V@yd&<&horeK6Qq<-(L35Hp@0ROD9Br}owziEZ
z)B_<QM_X~{E~0{-o>WB8)7P`XEx85{qE*c$J;Q1^0hwgfgU3QVw&H|8hzdeM<6=cn
zzhaCOn5f&@7Hw_Y5s6y4E7WEk!k^SjRPZpXp*RC!-*El0i7nd1w!|JEFs<w2SJ_jR
zIMAL<>e+;Ru5)W<thVc=PUX4{cE!flhv+&S1LbkF{vTZU^dYx37kMId2O<E0A{%VJ
zjcsEr>H(XOb&Z^3+Ye-cDUY}bR^ZA&UfA>1c!&B>M~@G^khG}nc*l<lx6A_4C@&jb
z@a9f=m!eMjx^-s^Gk%B9cD$XexoXc6WT31z_#!@PfG|0uOyDaQv7~Ly_00`G7HU-R
zdIDFjUe);KNQMceq$i?=>12Hk%9CkU40TN5vkfi9UuRNvBK%`w*`mUT=+iD{DD|zI
z1Kh!0h`v!#&z|Z2uP2kr-J)0wB&G6YmLZ?MbRjIMIK%bsaRIX*=OhIq#;G8=Dbw0J
zEKx%p#%=Ki$zR@$EKnm94rPY6^)f@htl_<uKRFF`tdr9>C|2{l<TBkk<@S60CUaGi
zfZ_%<(l?EgCceE1SDh-6J*hAFCQH{V)C2!Rzh2=df`47Xz!Df<gCZh75w!CCatfsw
z5KZWrhQ|G3F%cDn6l)9m(K~0ZYLYk4fY`E<syRXQEPuWC5PZ}2bMq4~H>%5U<G1GG
z3z$`;*aN-ftg4FL7gDWN>+tFo_+d!WFBbDr!Gw}+LBE9;nX4EcCz&FFdx*zTQgpqi
zj(@Yo?l9!bFP3ROv5HpQGNUgtD2QT)c6f2KvO7hJ?ozcTRpR^PzR;U2Gp|sehW#Fp
zbe8ugNI{9@r&CbGA<pR2{m8Frcx+l7eNMRxQ}J545Xbt*>8FNy^^0=e=CIES#9_Bc
zqZfKa7JA5&gvQwHG=I=G$z^Ge)QAtNSwL*1C|(#LeR=ww{u+aDuFa_9lXq9>UnYkm
z3zi5FSRHNg{pXPHn``5JW<z~buCngtfs4WE1Cx~?gN66Q7^n#khS|B&oyV?()6Ti}
zOC8@6cZFV8&|{i{-VbRuL9L7thQ82Ui%z#iwA*4xH)<_bh~v-4=@O&7)1SQq1yyix
zF*Iq%pxb#7?YtP$fLe1C;+Xn4O{|x9N(<W>(@kzG{g>-b2y($GmtsZqR}Z<j(Aa{l
zW-V>g_iXK|l-VGE*nrtq0rbo0-%QZ!nR0#XZf?C8oIJ3m4l<Z=`6}kDlbp+__2*mJ
z^jF}O|H3BK%~~whH};V5x0$}+(+|+tB{qW6Sk_`fKgYs(-8Fdk+NyfI?NKx)Aw;ca
zd47a)KY?IN8c@piNWDS1_@S6K;mzIMjoX4#7l5B>^K%b~-uqgZu|v)Jt2g>trmzVo
zvs+@#U&<evXTocL>hS5O@<o9O+iOg34)A`fNH_rmcBDTxt93W_3r?wX13G5r5be}V
z!tc46y>9oJET)(&c9!z(nOiI(lV;~RXbMVLt=nJdJeL!)fV7)>Z(bKG^vO=~$L4Na
zqpOf(Rv)rp5#)O4pc4<@f`FZVHz|g?rnoJ3iV2<aN$$1wZex0o1)WBfGnK7WO;(yZ
z=gqy>sZ}W?+nhDvy@I0g3n|{O(-x3dqYr@g_Oia{V09iV2g3Cmi#geeifZm2Xmk}W
zn*5_+aC7hUnfw6#AXsVbNa_sba*ASV>FMz%LDK|<tR|2eyiGZ2?glsia5kX4<6+$I
zuh-vt%x0U}-5(?%{6*;}vfx$hxN<eL=Syf_a!G3$-hVP*dZxd!QXnwLczLjrS(uzY
z-YqlZ<@*xz_q4mfm?m-3?Vm^!M1;xxmSG-`a1%;Q$eaEpg^?I;I$>fElVM@dI6Fa#
z2?A|$-^C%bdpJlygdt#2!2qAO42OV7_hm$2v%g<XW-8We7?IAK^Lo^oP?jwI90@|0
z|Je!3K<Ix}jbQKmFAXhspDhbkF{_g^Db;C@h;X(-c%y6KBL&cjhaRC6v!WWjAH}Nr
z;STc2berobq(nr7f!J_f>etf!1yHH^YQ<2G6byAoq{%W>6|)jK$1S(a)o|yD2m`B|
zl4*vpaIOU*ph@K0TQy>ld>W(*LsIr8FKSe+|78|Er5r2Ccs5M%A6NMuGS!BIC`F3?
z03r8U^La`1KJ`vVmid97ZEunjudowubWPPb{FTl)o%2RI5cO2MO`3aOq+e@jyomPX
zEiY-umbAaB_ex?c<Ii0ue!h(6FppFyTW&Xsm`i(n^L3@8!&iHU*Nyq@e0q_s!)1F9
zfh1e*&yd#+u^7*Qu4hjGt=?I0WX{JR(!78gSzyH`2;?bCTlX8_If+ekM=bR|EHrT}
zFkvWl_^LL7(H1$c0jj*vKYzXj&7~$2D)HSl9=6sSp7YU(G{;aQ^Je3?XbMD)Hm7Kk
zJDZ*wstowBl;^i&^V@f@)D7yqAiXyHrdeLWrxz=Xy&$3Rq%4x2U5dWX=DecjywToO
z;|mTtwRD?TC{lwX&Otv;`Pnt3A<;m$`E>*M@5iX|xo5uE?;9(D=FKwtCxCG&%A!@{
z!d2qa!`4apFe``Sgg#`DgCvsMKf2WH>y`|xJC-^nHnBs^WHq+((IfJ;Pj%X!;YrS*
zAk6DuT%7gJ_ef0~KqhpST59G&iNP5}RF&CWFFf=p!7hAIX0(tN4<ervVejAfa+Rv`
z5h3rV47S7qS|;B}3=d5Z1oja5Jtz?!l-NOP^7nIcm)JV(Du!)A)%Q5F&y?T?4u4Zq
zUTvO;*OSDADkx;~@{hvEp0#*YGxXyFzd}rHN80#+?$E%XkFuJ1bYgIpm8348{zcxL
znvt;bZh-uKI#~DLBT7gnQa9`V8VLhTIWz|!nXy<j;-WHq8j#<;6473XC3t*l>qdFS
zqjj>}8u!fAHR>}NpiTNql*D2bCWJhm)vVarH>T(C$*Q&Xxso^l@PfE$<hc&D_d8Qa
zd$Cyf0guQ5kNHr=89>dF(%3TXYRg%G#Gsycg>^o(thFAy8<BV|<49L(r<atbq0raA
z3!Ec=<Chx|vO&C<sujVJSdq_ZHze|;p^w~qHMT<Khw-B)DZ@{r_2=$_k5)io^$P6&
z5jkGP53||DeG)Q*C6XGLJD5GE0Yjb`seG1E=dsh%>&5Q4iF*FTKl($qWC0vv??%T#
z+%?C3QHarg3?R(lNskKq#uN>6XHgQdHvE=Z-s;JRJ4Y~`5TjJ$hzht+3ffjQN~|Kk
zyNBJ%Hczik`=EB^JE;MY9b?}F;v<2rYzjJ1H0lTt=wqL?^ZB-*V9>`^at?~H6e)#H
z>3ab;SF0hLQgVV1xK*c@l&%59tYX~^y8JN571jE=vw(Rw)NYZ|>AzcQN9>;IklXGz
zhY^_fVJrLhxZUjD8h&`V!ruSDadoglWto=Z9B_s^3Hy!a=K$TRf%UP)DA4|Him^F8
zXqmj6VzaOKB)rZD)cnvq{WLJxdA*S<Ox@a6B_$<RG$yICPHoVZ#Xeb?Pv29v-8-Kz
zqWt`piTq9@t_LkDCgSv<)ZRS_i&Ge)vY+6ocK=gepK)w(ivR<f=!q4*K7$|lJR7Gl
z=sNqBPv2bk`{gCf3d5wNJ-*lgw6|Z_9NfI+J5g`r2_7EuBadEWLG#bXDkR2dAUxwZ
zx;s%+jMwRb3!ozh*E(4C?<Z0NOUGgT5@@qCEe4f>x^Q$p#Y;7Rd%d|^VSG%>cOQo=
zc#3Vbs>?vo*Ba=7`OffD`xU<a-t$unb`{$~3<FCFzm}cB@jjmE8OQb=L0;#?<&69Y
z_oNJ*LVp<_kQn6V?QQD%eLnMc@;l#Kd;CPj4jdm`JpcmHXPap^ei}<^&^NISRd=fF
zQ=Ez>SF{zasDs-c3OD+DJz2mxk{Z}W+8XBh-4Cfcf?0jGc$oo3yG&*NC04&?H=>gC
zyt29fkc~|M*S{w^E>aGSn9iu=0(F8U-G5Xs0E(t?e7WmC3~On7(}8kr@PNt^Mq9A^
z>{`NuxCU+qNb~{{#75(^e91t-*2Kh_u+WJS9eD=ceB*<=N|KH5uF-U*0&Y73=+vfZ
zUqfwmlC#*>c3=2+vOOu33GyiYi8t>6{g*9bKXAx;iGeC;gaxLEd4D?fiPB`O&>K2F
zJ3v6`+So|ISTQsIv0VV8-DbH18;C_4Fv(Z8jR4#s8i7RP@@$a>9HeF8FLj>(yEI$?
zW#Dy@1fD;e-BQEQvB#S~McSVAP&;Hn3ia0?)li<<trrGh-dQ}*MtLPGa%bBsx;Z5W
zAzmTehX9Fq!<oPiS@@pAO`WGxZDTj0>{)Hwn2O?)6auiv695&&Snw9_SU&Q>i1C%6
zv&hk2j(y|8jJS{9!b1y)r{Z**bih5@sT1%(^<xblL}1`BAq|*NTT+I(CjM@*w(xKP
z@OU4`1eHM}7Ke;r19D?!nJ8=~YA3|Do(xx(X*~4@z)^Ih+4q{1p1zLWoGWZy-f#ej
zD1oydns&<`+dV|~2HpOP12Fb?(9t>K-tQC94-e-J+=M6VHpW@zvBjvJYTNPA^`E*O
zj<2X60zif1`^ha9$EbJ(xk|QwDHzM0R?)Q6Yd+Vkr|1=R>8@EGJv$F{BG1tP%ojiN
zw_lF;h*&k~)$%xUnNf>Qa0$>9L`U&YO|n;aDSj@Iz9vTXwjFC|D|0=3d5Q757(mZ-
z+YE{#F^D(pzR(9EWko1#5o)L0_W7uOHP0*R1{a_bq!7ps4AT!Ew?aDST=ApoL!;|H
zrWKB_Sk1btpXyZuIOSp3^k^2;KW4jt+3c!$qd%?K$pp>lVxP#X0q;(<-H9Rsgzgci
ztW(2`r#x&7z!tv%cGc?Shi0@?tys6`GCLHG#1R7ZkC1j+gC=|y_tF5|V&{-cu_J1L
zv(T$LBctXiL`N9q(SZ~InnsqfqAafyS`y?__5wfXI5fB}qSnxji33ui9FiC!6ar}S
z;1QkY1Z4u3iFM(bL^(~M7^j#22CucZ>@Ft_$eFbAXW^VWrkOo_$FGu6^3jxsuw-+#
zZ36=iq};YL4nXfwWM@4=WNq<}0;pf^?`mKikdkQIX^P$`7v|={eabP`G0f65hgtQl
z6fjR<e1KtqC@(I$MtBl#Z}^-}vkT~>Syv=)Z%5Agw{EZ)A!$R;x}7Dxp4F~6cr_N{
z`HU)BN6NyIf!5MACB+V%c;b}+j-ekPaU2?%@-cEZFIfyOoNW=IDG0njKp2fdEb7P!
z=dV2<G1D8F+J@NweQWyUzW{*;6#bsuP)9{mh>}t9OC5I&9rt+{&NCc+4-;~b1h^8`
z)%23U{W;<}1a{WCbzMet>vq^g#un@~edso4(WIVLMjoHRGKYpRozS?KTJ9QJ?(>EA
zCEY_`wuKq!78FMKSWZ15Nv;wIgYn>;i@yy4j*ChX8Do2;`Gf9odPzaPlW&RJ!M;}C
z%>e9NQSrA}=hf|C7VDL8Bsy*O>t=bTZA94GM0RE~i7KH`L`v*p$B|4upNczB?I(W&
zW`1mMBbv3e`Ii8*g1qirLjzMj%I@aTi@{m52SA`=PVM~14lv^M%gDPRwddZ`UaOR@
zdIMA23D?me<N=e{kOKvdVDT1*{J@$6<U94Zpha}hVkaqji%OWEki2`YPTK%c3CCiV
zH=DR3I69=b(JowQrcy+++CZbWu>VgBAi=8SNQ)t&1HIG{n43F)?;XA9f|xkp7y_=I
zpNIUFDWIjE!~f+rMnLoh(E#sQMfM3c`-DE$E7TE4AX4Qv7ki+2-Nur*%NtuDS)tAg
zM?Ch;oc5O?*}qsO`IPrs2g;gLNDZ`-hPt|8uRDC4MUxn6!hEWQXDWr?wheB6a!tzi
zWw9SW`%G#e#;em^lJTAFLk1$`TLtC>AVu^MUZIEvG90O5Te%e<Sa_!Yx%vy+4*DNl
zkH54{0a0<$8#*V~Xi#i4Ph3RiWU>Oe_|Tl;IS(ju>enOal%vaE@Sw9NrnEsZ>*b54
zNeiKY1Fko`<GqS(mEtF%j=#TN{vWSAD<y*`7Z4UeojeB230+%hx*I{7W~xfG=z1$~
zGGDP-LyuHUePeQozFvu!Sf}l2omt*#v?{-`;qy77cR{VRl}@3Du8Kp$tx?ULfG#!%
z`7k;xP;#{xU8^0ul^x#bgEdxfjaK##R|=R7DI{TuGVPDOfW)mI{+FDLAjSS(AZ#|z
z`mfDeq;1l?9=;}&X(4Vv1p5R&5s*e0S{FxP=$&6^kZNd<wuyN+0`%8()?Qq&3t5nk
zIL0Q!tnTK%GJ@?m-+T|@6^8JB<j+R(DU-GixNf)uEZj6BO<CUR!({<8dWgITk(rOM
z@`vzxJTak+4)Fz=YK^X;u>8*9S?pXcEvX3tWOCn9nbbUlIyiH7F$e(c5ASP2`9N8y
z83UcE{4+9O07(aksFIpTPzPgXb(_udxG2Azn1f;61b`9ulZbeQiFiM{c#!=^hmQ=v
ze{SggbAl01`tB-Uq?T1P0?_Q=*v$5ws><;kgbtLBLK7&)b5F=S2;sGRPqpKnY~&*~
z<Rj;4u<d+`k*)nwv?ltS?f3{fTBAWi*gWz_5Oqorb>|inRRb9>NU@DTgAWWIgql|Q
zKD4Y+=!cpfR*dggh&SUOdy$xcgF>QGfhw&SmUKwmwZmwnZFVEt5%JX?@!G%U<+@-c
zl#D!y6G$TRS}E##$*-px`33w#aRB4=Nr|BDbfKqe0P})iZE^tP<ba5U68D7PMw=`=
zT`A9L$L6%}BvLo<@PgFZJZ<W<jXG~eVqBkn<qBhOXO%Q@lrUk~LVWEWz_<#VEyM#!
z5u|t4oWav1rK2NmGyS)*4b1t#B7s;UF|+h*?wJL6BEOdR7>3duFt{c}$*XeQqf&f&
zz&a@lHjAjO)8ZQ*2|C6=rvv5X{C}0FwqsLscDxen*Lg@J+oS*s2ksrB`9P%NzSUfy
zv!EKri6IRQS+)5K9?uhFs=$zn-@uIukxSzUky-Ty^83PSMRxi5cJ}8EmBTr9D$B-?
zq}3D}eg099-`R8`z`RkgmQ>S_RGZ)6@x&Wbd4&kw1Sr<fpq#w+KJ^Qt>+w<|+BvbK
z!FbiJ;?WdYWEs$(mO)}s7GPVR=6x@N`!2aD<2c<R+~D!<f60tx0V9UNh3{2`XoiQ>
zw1(}zjSyf=2DFa<#gDelr2sqI6OGhKdiqN)3tMYx_`hc5V6$>|q7&;GcuADoj6VQR
zs5?5{p<v>vqPhIei;s|v<GVI*GzK;+O!ZcED<6T$jTC_De(?Cg$M7S)JvpNy<1B=6
zzph^YppX2280W0I6Hv<-=5x^#_|Fv(I%Rx$W)3z}W1ie;Rj^X!K3#LN1Tb);79%hQ
zQ~TyR$<G?Sn9P*^m2Zz2@=;8wCv&0-q5j#=ZiR@JR(KIje>CzfFV)^!B?TQT8kJO;
zuQtfeVqdE&3$(G#-9gXyY|SemP!h=T8V|164;>dX=JIK!1n15=TJ!1uDpl7L3&N=G
z7C`BE)Oj5A^oFrJ7*WsgiAPH0Gki&;26w(LBOM~=dTAKKgC!Ue{{X{R!YTbK`^Ewd
z^8!&4gEssG0Osb}y#@Irs9tdrwbSscO$^6Z+MjQp=_O@r0KLe9nWmsQeOD-oGqh&g
zKu7Au3&j+42*A}U^SiJ85Dx=bL%M?h5G15yl8-pzlp!6ZSgoO$(m^wT<x@-v&a|SJ
z2dc^t`~s5P7TaEM2Y3kC8X77o9l%j+_Hmzt8Hj<$H1??3*G(t6Q^dbe=6+5$T2$nJ
z<41|fR`*UZ(6$Ge(MWtRkG;Fz;Nq)TuXI$(e^^%S6E7enU<I0zj55|5V1!=jh;Se3
zU!3jkU*wZdL1tL3T;o#9*IHp2{n^0(BvDP=aCDx)OZk&eOtINj0Mzz7z>tzCwyVEF
zdwgCi*P1&{0wWFQp}xi024s)9pD3wx+h;xC5L+!bc4*Ob(XMtpPb7W{T;Y4n$Ksxp
zglp~YuLa&z7rAVwQf3s0aupDGg`XNO_dR9@1QKwqUHvs~nI+W`{1F(GfafDnVydIF
z1l}JQVpBRM#o`oxZZEI_)4#HX;%&mE#qjU)j1=8q06gzH`QiO>-3mVTEdkBuCZeRg
zZQ)};XQ73eJ|_l^<rQDsB8i{!DEDoQ!<lP}l5(`Y;-x7l5S@cM>41xEfSG|2FFk%r
zP|%ys*#_A3^i*qmRwHbH>9X0^&t5voioO;L-^xa8L(_(e0g@9+bIp^U8Hv+wwq19p
z(%<6pI{Q?rzR-xoFGZ)s7)A?`2B5Q;u)v?+0>Jag&2-xc!AjD1nB#IbZh$5^h8~Gp
zXyQK?_X`${0T+Bvz#m@_^?=jlHJ~B>KN<x8YM8YVk}%F(wdQ}|2qb`Jvw_YrT?ViN
zSgEe;Nevn6{%eO1ZFLv$INe_i=amYqzBPli&&Hwv9#z}cKzBV?Gs>ggv;xL}cZ3{Y
z=swSGdJI8ADpH>WPnHXL(^)*eKFADUpgmtm4Uj1aQYmEqS&;bs(E)GZhP!c7_CC04
zI_81=Vx?>Z^!|HoMkUYFLgGGxT2W>H;dI{ri_^_`qe%@G<l(nr1AZz*JI~)w6`kfq
zkACzP8d|V@T1)GE`+8lpnE~bbQ3}E!$Rknq5hz-ITdZ2oM@k`om_BfVNMNfU4kI4t
zlb0bd#pne<hkrGsh2{@>JXTOv((cDDz`NS44N<lxNZH=}$_28U1U4SolVD*Xi+=T_
z3|ea8iC$n-sLMZ53=q^O;VB;wf!TIwD-|IP6`^@HoQDeVz56pDW;Fbo;#?6IMsoi1
za77^vMWK0eoChu1O3}S`krS90v1Uho2X{<Hb49q2IwG+42;0U?6rZAyBcifTmv7jh
z)Eo>iTWnU1D2K}nX~+wW5pM8pU;vP5(;c+vI&=us)z=~Eb_ISRL=RxEtBdS_&DG?N
zpY8L$UN232d0HxOTsee@-(;&0y2_Fi+G_9?Na$845So@B5kjPa><)TL{|l(`Uw6oj
zgoWK|75ZJrHUU&UD+<9y8wqzuu(wtfAu2@-fKi+H!$?Z-NH5`sg^vJ^LOAIStoy(!
ziV$2ThQf3ffV0w~&%G@lJ>@SoiqEa__`6KZ!0!av8u#lrD)f_a218QA%;xWcM}{Fv
zskwg*IYlvU*(F}6Be~DXEMoywm(+bSXs{)h<vP+E<<VE=Xjg4-=hc{MTrC7CDHHMl
z8i}9D$E`YrM#Lv>=HYoDRq>(+J<(%A-G10|h+jw?6zFP3sHfIJtt1}|<d5sC{)%k$
zMAry)dtuArlJgdn+<!jiIugR7dO;Y^SV@ntYEC;Z|AU_LFZl={2}K^$td6#+Lm40}
z;NUgYzoXUOb)P2{=5Dsey?G;bawEKh{i5GNLhs2HtSG#F@LubmT!#AAePk=l18tG%
zR&SpINj8FnM8d2{H2e(Wvr-Sd0W3V!Kjow7ZXU7-6y_zMiClznTtMPyXM?hTurjEj
zU#X($`Rz;81{u`ooXmAH>M7*=gym^h{S3i;6951KR($_ML44-G_o#cMUE0mpT$b^T
z0l50Y>3Ygyk8p0xtm9L3@9IYgFUG&oX^6rsqu7}z+~C)dBEm({2#>KLG>Pdf9DzXT
zQzx(x!hOWqq3b_^)e)uh|2zRelx|ICc@k!V!ty$|f!)$;qZcrD4Ve2p1n0?#zDFeN
zF$&bcM72H9Ai?7(O9)cU^zX1SURcax&@3tY35$KAdTV$A&A}=!RhGHA2yBS7?|Nke
zFut_KdMR8uE1gUTP_gI8oT#$}Vz$zZ7ryy4PkqJKVX<{P=*4<r9Epaa9e|umEdujM
zBHAF734RQc=vNYGrY*#Ob}>^Ed^81`QNjw^W|7*Vn8_eJ#XSwhJ>Zdf)1qlYItIER
z2;l~1fl$Tw1`o)@Sn*z~KvNkw_fg&h*c>v;>gu|eb3Q#XgAF`0lFz=I2EmCzaCc_v
zc7TfH2;jUXVSxAQ4gg5hFqoT;-M(Y0BI^X3b+Qw^2r#UQtbuN8kiJo;tMmv)AjZ_O
zWcP)5$>jAZdV}XaDtqR!iwW5S>p?U`g31-7L71cSF2w=4p8x0oesS_|m39^W!U4>?
z2vBwRv|ik+Spr4)T>)?b*h~q_P7nGg<@j3J*V>r_o!m}N&jP%Nc=$L#0Bz-i1qKtm
zxR@H@8MwX0bGpDK0GaP_=5mh~?xe~yL}339R`~;X=|=Qb8>A6u?ZcVJ;T;i+0Br8y
zHd)rKWCoL4?gBHyI~jSce9#Gunf$&&8skI-xdx1M9^fFHCX}hs;(5TlHN_br`4~B1
zi!8)!8<qX#*BInZ1a&=_ml)P2od?|M*ZZM`e)m_ZGoZUO|3*`zqp3TR1{9LAh`fZS
zrJ;F5w(@5602buW0$BV%{{r>qL{x<L<5*>Xj=g;RAcL>Tr>%7CPSC%3i*;QeW~G7c
zm|~-b7U}%|U|cEuz-o(z;lV4N_?((!PLSl$-`oRN2{b2D1LO~?^N@sM-Oysnry;^V
zs1;z(*Q-D@b;m0cV7vA&`f2eqfI2h#C<0W-^a)p(-Tkyo068g>&NKcO+agT{+{lH@
zK$KoS^882==Jjsof0Hn>;nPpxHCbcjL=QnI#pa2;D*OK%{y!!JGPhf(GNrmTkG-br
z!)rF)a%?*m+rERQZV=`LX(+M*UFP05%rT}+j{X~Wgi)H(Xyy2DrMShAbrKeqX+KVz
zMru$9`E?(REEF_S8PMkW?+PMx={A1?=wOD{$3gwYXL`?(Z$5RFHfoU?YLWB2yk5p8
z;KUGeE5J?Xj`<MH$T{}iC<80LaMENLuPBT+nx<-;%|R!OuG$mem7mr37w;o!KisP+
zY~`We0g~^}qzAAp8nI3)gv~mnd9Z?7TD`7dI=9|v0mRWu;s3XhiXSekV+Ziv-E9i8
zAVDb@JCuj%Z#Ck4^}4aBozFN@VYJNtAq}Wr>3GnfUGQ$HuIz)PuVwAnvi6-;>V{xm
zkX4&zKTz7uI<!Q;!em3=G(2$wSa!9BmD*VFhD<S8zS?*!rRbMxAY{&D;}#Xrh|z}9
zh&kHw@AZl3`oxYklhwhhM;_!x(SH=oFSz(4<|1<5JxAW_HgV`Oq2qs*uQnR{NyPu<
zH5^vaC5_JTnJ|;{*L$|^kiX(!??3r+)vfB08F}dsGib7HhT{nJMLe(E71NCyS67Xx
zlhF&z<wRGA%DVA)9%&uGudQScO;9<-eJw|aa$3|VRQpwRvp;)wspTQSzh61$XJWi%
z5APa^*cO(AzwvPJcf{*Hdl98kO@z!3JIl1#sgE@rRWm`wRw}66yHoOspO4`l*!ze$
z><-^SQLUfh=$bKVu!42}W4CAIcv6SE4I!l6T~be#d$?k5)!4Yy4zAi4(J#~xbiO=%
z9NKeHK%ls>tP7?=Um-14>H`f&&x}#K6$-MXU+Or83!*M)2qEKJ2HHjX)Lq7}7mA9K
zDg@c=U_WVXsUu9VKRCRxHCgY<Oso2F5o@-dO(`RsVuh`^_3&Kf+>rk9!>8JrFFqDR
zKZ3b_71cW%zICgx1bKJixPFn*_r+*lh~Ip}1>zXu3LDVH6%+#h9zDV-QmBA){O4<y
zUfay$J5iM2-scUEkP2EkDF$P>RX?#pJ!eB?3Vy*<Ik$s_@92z#O!?9*qCCCt>^)$=
zpW)b=aq3_N*I~9*E4Dz|-ro&I9>s4qFn0InU{Ap-+XD`vvz#TbuATyDI{xw1K>llj
z$bndEyBkC-CI!ZxBSj@f6%skN26?FCc+S*0ye`4nLt6iN(8q)sRmsAV)R6-(!`$_v
z2xRnngElhtwS>C1<M1Qq@ixmvNb&#l0OMgxS_K$bN-G&c>{t_Zix2kN=zn*?Vgrbg
z2WN9o`5sYHFeUGGghogCJskC%NA<@7QXJznj&`~r&#i>0<?#o4NB>CAijLtXPV0?R
z+$x@m&8ubRo6ul?5W&6AEkUhk)jBwIp{-LBx{6cel`2jEGOC{+$)@stb|F9ov^Duu
z>{Urh)q(RUcB+U|tWDTiFKSmuohIICB!Cmho%W(S>(S9j;}oh2EJg9t@&dhw*j7UL
z7|NVVp&VSX7-4*-(&Kilb%M0X{a%#s8THJN=N0%T=*`O|Zh0%#BAp&IH*k1z73bqu
zsy)ZUx;YWQl-#(ubh`=RNs?1{_CaG+<<-+&6Y&WmIzlh!m$1~_)&r>-j*3HS^5@Y5
zUDL8C#F(jZN_jau$d=)4_$X7mCN2#``Z>3gxThqlk!d-h<Q3ehDWQs!`&Db#x^;b)
z-n>yn7NM@S4>w^9Ubh>a3qPr7v^i{AkgeDl-u^Q|;~W}-u!2XFcdPIdu}s`PrQg_&
z3-_vv4{&*MxA=Jvf;$YjBf0enIv5_7n-sK8IN#QYIVj?Jn`nwZO1w7!;;xVmiqS-o
zm??2jk?Ufi4bCf87I;6+MA`16R6xsT-c&N=R+e7Y&V&mJQ^sVV5Js&jdTxU;-?W)A
z)l}jh6`Wvm0}erKY#Zu`YpTkBq}KiWd2{s6o9=J~C;a?lIDt`gvWoUp`qd3nrWUY~
zQ$s88&QJVofm3knfRsNHg?GX!=c+>(Pa<wb|1cb<k3}Yu%c5+OUR~Sy6T~~8rIs+E
z)2E~Vub_?!9*()Q-!-~der~)82h6bHE`Tp*|H@BK;(&sj9z$#rj;t&O{B!~RIoJ9D
zD-f7pnO4|aY8&8$flLjZxv$80a@i<+$bl|3Hk&8R#8|#oJ`YSsqyjoq0VBtpG7^Z!
zx?26XN%ah=5paa|bS6vmozNPBGa=&Yy_#KzPoZ*;NlTKE>EG9r(xx~cldAUIFV*Gq
z2c}U3^+CtK2fKsT;8smZNKSrIjG=7|LR><`|D9`cIHsR}TQ{C}MXHC})TpOb%eva>
zD*WmUk=qDZfl9r<)qiZ{=)DRBr3UlCtdc30;olC*%ci?q<CBQ|XekV~`tQ?$zU9t2
zbj;ZzVVZ)s{ES_jc#4k71s34)20fqn;RX29@A-M}a=dm;!V;~i%^s7kwezTl8&g`_
zs__6XGU?GOJVKX$>Mj3E|74?Tz=;EEYV3EOupnB$KVA-IByD#~CagN{ZU&=>(8jJf
zo+7ad0l2MvLN{fxKt<#HuwQ$QZSDj=a>Fa?$AxyOzqw>&w~=6=%gL61R+*3~LP|oU
zw{I?z9lHOb4h*Lel<A3c^4Q=hsi_c$+vyDVth0XtQacGWBP5U4SW9XIV{*_iBi#Q-
z)wjnp`Tqa+u9QPM$f1<Z4#Q9mg$|AtGpEgAV?<8F3OPhk$rPeuhB=QpjG=9oLsTo}
z%;q>tMJcDH6ou69n)mnf`F+3tc|7jRb>G)@U)SsPJiM-Z<I5yejy>bNu7uy<aQQ)<
z#(Q6o(u--WFk#>d9Z&~>>jcHePQfbK3lA@J$|SGfdfZ<6w9i8yS&Vkl49q9kvWu*e
z#Y+I|^~2CTO@5Ykk9120bX2|Jl5EDD*2>$ELoN-wyB7t$Ckk&uT#b3*TQXvQnG~d(
z54DfmI4;84tWl`q^s)2PTP3&AG8N>UmkWGZ>_Ef5wb1J+JCuaVkz$-bYHB#Yb@vDM
zpJOd8k`k|FeD;3@4ZeZ93^k&1LKtORDQBOMJ<iqerLFP0p&kfn*4fj&YOYS*<5Bua
zh!9zPjzbFjB}>b2=$fkPNB|~r-1(NLEaoT-yeN1A%HA_xSKNY$czG}_kxhRBv%7j}
zXN!8hClQ1%k`$x(<(8ev76V;1nRd3%HO!tK!3Sb}+H@Jrx1C%<mZFExupPJjTkg6k
z8RW~s^A-nPsHl(ub(#}HhvJjqAFnZ|AU|~cVn8w5Q%X~0Aa(x~w>ve!7u%Feff&Nt
zyS0Wg<Ln$9`$S|<FRn&II%Q|RY>sM~5l5rlPr?wfM6++5`{J&I`n!JW3^h-dEG>tL
z^XxgP6@J(zG6iA|L+UiknO!;Cs31ThnLEE^6hBa3P_K_7g1k-QGLHPXSEN<wd-9L1
z$DZS-Ma9DyPr*hQ>f%NnhaoNzCw+2Wz{wu3|2*oOEFCv-{6<Zq?bcdVua6;uyiJ;C
z6#w2Lk(oNZPD-BY8_Op}A9ojLD1HRfztoUI9MZ&fB2tJ`e&>%T34Bht+1p>85f^>O
zurdbD%)~-0v2-I8(Hm5J_RcGt^xW45GP0)!A8O*qXb-S{JYD9Kx4rX(LT?X0z58GV
zxfBk2E|s59e_j7^poXi2;L_Ewk&$~I%t4jMWfrszMTFQz73aQ)@W=`X8EDzAp#W`6
zA>IgKx?`QbHBFe+O`q`hQj<NBc<lZ&D$T=f-m{e$OT-v=%!oiGj2UW@fBEIXb6YKU
zpw7#vJxyd=Eo}@v(+i?P@BDIlGD?)x>PQQWJLmPt?_u_VjovVMuv6ZNA(^wP=sy;m
zm?^xPG~7##s5f$0A0Ul7;u2C??c}t5CoysHPn*|D8hO>8Wx_FIk*^N|TexG#ndJT2
z!P2^)WjD&4P$okBcrwf<ZoTyFIy<Vj>#W%B%au<$Y1nZxwnFk;5JdfYuhz<QH?hV<
z7EQAVXTr(+s?_es;=cxfq9#ehO5D^%0JHOp{Apy<kUfLt+vF`8zIX(`N;>Z(%?;d4
z0u$&fnWv=k<$=`pA_@gpMZwKLaXX1hWC~?Wy=bdsaFCXgic3JFbljuiv&MW^WB#BM
zNAIBDA=E*?AMfCmmR6aNlQK?HPyN^PXElaF!uY2#6+BBZ&V+0B%!E5@@D<!cMcmuc
zc<i>)F63c7)sauCBdnN*AM_}G+4ee}(7+$mz@L+OiQ=p`k&wh{k$)Swaaa&@ewp9W
zZHw3Ns{?~4P#Se-*srgeAM6SbYuG<6Qv-&xY(Jtmfz4K-@Ln)dtdn1?lfEh9?cN2#
z#jJhbS|)emvLJB2nPOMf1PJXX1I@R{nH`RH`Tpc%3yA()y&*1ZfyjcRM$W=I_MiW%
zB&)S)HtD3|<1uOf&mp3jsjT``R&@q5+L9Y?iDo@l$d&iq{R^|xxpu}%!<?7G1!!pM
zOI5L8CJDPjC>9WOLW}hcbTxjkrBe!iy>-YiVG@|5>CEWpI}iS+5A&oV#6>2{;ca=1
z;C8ff?D!R!4Ig8}AG$VjdIH<%Ebt3(2jO2iL`^KfLd5CJ<nOAQ3+~-NO`Fz-pTfD%
zf%}vSelP>~*MW(R-TmVbF*6tcR9ZyrZMlDAh5w2Tb<q%UafLt?AZr6>8bQ*3zHU%Y
z%u<J8D@~_R1yxkRi~}y;z7|tP!rToF^=}P-9DmKS^U`p=bc=?%;VE3ie{aL?n{E9*
z+3$>J(!y-;x{hihEvFDS3Y{AMS10n>q5?Ac6$KtkPp89-uS0wL!iV}6^G^yg&R#_1
zu_SC56IlR7&t}rT<t4IjwTXK&b(o{NO#0hiaY?8PX8CgItCDrQCS?cKZPau%4yF~|
zoQ+fl6U&nw>S>QUqxM5Pod$}B>Nw?NmvaM18}Snov5z+Y8Qu0Had3e_Z@%j|>8pw!
z^BsRA<G{R|E>=1o@<>_LO<Zk1zx#JgjT5`7IDH}2Q3b2&aS$7Rdze%HXfUnrja~4b
z;}kLVS6d`Cn9OlB8g&_qCzeRb5`ADB!K~GWvYuVF?5yg3Dve)A1Jgeqc8XT%zTiBG
zRdpM~p42I^3Or$`*mB1SvY$>Vl^N=5kFrtwp#z>(XYml!gcc6I_N3^O{n<5<je5TJ
z|K_wxxmpuD#5Zv}#%Afgx$^ItGWYG2wmdy;c|8P+oy)gk&Om9sTqKjt9sW@wTI<=f
z$DB9Mp{T6fhy*dm72IPv3SC%Q9)vG_<b-&b=Tj<e(;{fgdvzTW7!XdISiMjkhrv|L
zgwd?0&@v*rh8|Zz_|v{%rBrtBKB+;PPV29oo<?J;1HvqasJ*%?|C}+<-72EhaX>{w
z0g>U!`cXT*jK<6bgtZS*zv^a>fH*SJ(Y-ZC{Ka@b%&oI|YVHomGVN%LCg@?1`an1D
ziapjT`NdJ=gb$JZwKbbcxqZ|bY*<t20K}$(-FJ1@IfuM>`<ephIlGM5Vh2lfm?Etz
zgK40MbvQ4-b=_RQmQ>B7+{DE2-te{n<HM>@S_9E>$OWBCXR4}qrR0NceHr1>rZ3}I
zui%X7+~*y3reDo%h&ydV1clrQ2Hsc)XZbzTj$@AMbP4|t*Nj~g=S2KRR+Q5O%K~he
zWgoRyhZRxjX?*zcA2IRQHExNXGo6<3imH-<g$bqs1?%7^f852%ZUf^(DZ&n<(l%J(
zCj`WAK!(Y3>m4B!=pOW&O&xlf_`3C!)cTbV!FQc5cygcEaY<@eTvKr^#3BGhIZ_SS
z)Xi7JMZEdjFyeHC{Lc+dbTCp{22)QF3qLP^e+ui#xj11=Sf6y#0fo88xR{(e=xPx#
zqez2Wpm(OeI&4Eyy>%2b;2j4HyPaG9?^WUfEWH2e?6<N~@>Rdun<pB3Rj^&@-~qWK
zgks%C`pE)|Z0bXgFK6wpUlQ}k0b#St0bJ#b5Xia|zpw9<RK1e#&?M9!!EQF}`kAkz
zioPO413|hLVjf_^33LD){J|a(XWLsVf22i{e@Qg4!xX@EN-gAE0JY=r@5c#;vPS1(
zR1=$6A}{^0eqFjuR`Y|wk}WhbQ${V=-5);Z_Ryx+C-}8c&zr%F1M&)R`4h213REQM
z-$hG*XPpe2nw4;}+wuB<MZ0yvsor-%ck-?3Is`)CAB4{>{2oyHsxYl-7;;o+#8G<D
z=k2zI#G#!`0mHSo`Ekx&CsBElY=r-=X7X}{in?Lb5pQ4FeUma(rM`UM`aB_#s_NCg
z7h<TJ5_0^WtaL_i)KB|ipZkxW2s1^gA814tHmb4JX*>-^`&E(M36QCEwmo4rzhOV<
z=(Dg*(OO3;#XR_fbERh)Ej}0UE!#%E!a7q%zTAnLm`NB}L}~Z~D)UjztgHLczTD-=
zZdbc-lED4}CiSOQwcjZV{^^bxzctQvL=s+TsJk_M>0_$N9SM=(lbg)<#2n*jI57b>
zA<HEC+&4M}Hs8gTi)z*ujN6Scdn-92AZ1*P+c_Z!#&}@E@6UmthkcQ7K9L=s1hdP8
z-Y9UYt187$Kz}`b{5zt~_$q0%3&ikHHN&a0vJ1+0G|hQa_&bqw$*L0k0!g++2Pz6@
zbV!0-v=iS63aQ@Kt*7fU??jr<sG^;#{X8r=v9>zQh}r%VA@u!J1Q7k}uLrd>>+A|D
zC>C+zvZE{{5UH|p#k}1aAcnh#jBSQrfLvIJWgk*J(aVXQ@f%Y<w?cXRg-|3i<`<s2
zGTE=CS9_R+u=DGTwn*HjsQ|4@ksUNdXNE8j?Cq*LYGB}f_M&J8;p$P*QB!6=<NY+s
zx!TvmvM07z+hrKcN4F1;`vn|8_i;`n|K22z4w8hbYYN}X!zwKu!*&BOV;(K%;Da2k
zewkgT#x;K=4%ISi-g4OliU^o6sjuMWzE*c@Ais%MicB4cWu(fwT1a%ju;87<sTq8`
z5`GYzB#U~gDlTCm^U|-}@3{lBu9+ZPDlEBRT<!z=_|~R5S7VQg{8+8rJy<`EF0<}!
z?>M2*+`}(Co6RZT?{q6Sk=-C7auh9(4wZyzTo(KSIFiZkojsciwt|7;^$x(NW-y7d
zt7oTCp$qC&Lx2+b+T~u9TuC0E)mC>tEhBq%I)UAL<FAmAgv$;&fg9wSd-$^8U7YfR
z+XLO42&Ya@fK?S9zJ@is$8ACu)o=<=ALq0>wr0Tvll=vo#xE*KZ(Zd}<KJEt>KX%#
zI=7y2LY{e{uVLr$#MF${Nf1}ZX$SUh<=J<W)qI1Sa#|qzNtWFO%?}M^Xg0Zt^g|&K
z(G70^wnsa4jz=9$LU_vJGf}V4fVbqKrG2YKTpJ;Gu|bD1NkX~0pH4#f$l|laqPP3J
zg6uIKyLv|CTQp2NsVa-I;6p6wR2S1$%d|V+-l??(A-zdloX$}qp+dUUX~!8l-aZzY
zS-1mHq5iw(`AyGDi+2gk1nQj5)BqoBQx*lH4P$rC{%!}WeUJCKs#0>$$@hxY|6xqO
zzfOZKLznUKNs0r|==hNlZ&lUdE6N&?P%ju1Rz;*Npot|+bulPI?PQ8|R(eq@k)Znl
z<|fYJwx<SoW24*D;V6`pqtA*3$hv=qp<$}xYOQPk4uMq>C=2#PATNkP7~0Ap^ULUU
zI+pEu#hSLiOSC4sD#K=S)#3UmDQm~~jR}WZOi#<m1V!B=XF@5nt7&cFO#})A0<&y?
z-)IpQR7?Ou;63+5_VRr*Wmr`jWnqA>GvQ^Sj;+*sd!(BtJLfWBw2^TkcKkL>c<Tvp
z>(XL%2?!(iCfKA(Ng1&PvC+?66HQoIjzo-F#~BoFZp-EGgmiBYZ&n7t^<#6pnlh!+
zXY*!ZcAZ2t5d-a*sa2PNGESufrgGG!%rs9mQ>?uz<;jt_Z@3bow^PS_6tu&n!;IBW
zzq?b#Q1|r1UqmtSCL|C8ANiGJcn^UFnjP#8vpROi>?SVQ0m%~GYAToRN^NhLSzCUc
z^ERG~ux(Y_wI4!T)W^MgtR?l5V$?v^{yafZ`9kQ_Va$?HZkK&fnOUMvnOV8rrww%f
zG+mUdE$EH6a0kq@i(cUq*+lX#^f?5G?#s5kT=@*n7}FomJEaN~FD@N$!?A`-L_p1D
zFDbDp+2(uu2g(oD$~q@YyS}McwYpG0+|v8=c9T@N2((&`slE|@#L75nk~3I779jI7
z$!WoxsSyoPA31#(K&|;OMV!l1K_JMh*N<DGUuL!E%1b@s+gbyGZ5z0qfBed=yujmt
z94t^6@bjcrVybMgI<EAUuUsij?H){K<4eZi{^|6p3cxXPeffkETtD;fhDHP3Eq}9d
znq_5iMZcxZZTOQ|A*ou%C-VuVH~^N_UvkR7y@>z*Oh#7ko6q(^-_KXq@&*+Uo_9Pw
zivJ!5$s1*0iCy1aU8A+Pqe#W&+EZcnnepc@9|By)KRZOXdG|~1*)N7Wk!-O|iS%n4
zfY;+^8b(-e2Urj%{-pop$LoOB|6X`h-H!<7cl+Oeww|?Rblalkur3SN^azJ|#S**t
zqVRpL{64Ek;x-rd{9F_hfAM)uv+rg>FW3GB(dtP%@5H!Fw~u>oDY>`G)p+*KW6q%7
z&>(Ap#e(xjlmaDRhlTlH9dRaZm(I8^e)m4q9CyVW=k5;Ymzv?^$niTV2HwO|E`^3N
z8L$?Bi4HRO@2xR>42C~6Gjf^|(AcZHH+{I=Zb&MkQ0&sm`+MGa5q00E`)AW@Dgsxc
zy!oXBoLsw)+<QQ1^Tt}c%GXQm&+#odYV~QB$r`O?MMsC>^64y$dKB|UKbWy0&3D_`
zf?qM)lh193;&BmpoV#Y=3ZX_oWyRO$U_!aCc>{^`4~;P6KsLQ^D12yWaiN)IvoxY{
zJsFx9;o$PY<reZH%hUS^gHk1^suIkA{<*c7N%`*kQ~iGR;YY5i&i1Iu-9Cm7uJS0Y
z6jW6TX1sCvskN9^`R<$<f>=sdi!?Y}RuFWlYfVmb;SV_tFG5`SEz_^t58ifOZ525j
zJMOs`DERFoU)o2S-3AvSD1Lh7H;zn;Rt`N_wQ>Yc$S8TB5siz8rd9r|JvI?wUKzu5
zCxb0Fs<2<zIQSjm<^g{^+0oTbZN{8tm4Mzs_SvQ&WR$(86X$FL{SF>@a!EpxRu}I$
zxCfnejCp8_r0?}`|6N|e0rv}Rd+LvfocbS!#T}`Jh;lTu>(X!rN}sjdF;@q~?cd_!
zAKsXpQLD;NUkKRWLCBXG^9}EQ4=k952}5J&y_SOY<1@r4N7qwoGa09ekW*?VJ+te;
z^%K_5w2W<^|EUL|O{LJbC$YlUyD2aI-v;w>MToQewVGv|J+m-&yT<;HMbo-_TY?HX
z^_7B3tciO(%w7fY2M@NokK^DFr=5@`V|VW2i}^#Hm5=rvtdZPIwn*G?^k0YPvaEf{
z$I83O*zlsafQC$Mw%idbRW0(*K{N>!+*MiSKJQ%GSxL2&Z}xSVl(xR64|F2e=pwDX
z6~Aq5ng<3L4Q@Ttggl2r-xDMj!lzBcZOeLz{CJbNXMtlMVhWs|RFMbrr3Df4j|U*;
z75<}#-)>1qrwcAdg4|-gHKX{eT?LXktqRDJUzjC_YOiy>pK8l|H5GCT?<GgZh%>x9
z*Yw2y(iP&Vktreo0N;Ji#FVn7vb9tar|kQwYW`u-3N-5kv<%tjFAXf^*SOCQuf!%9
zD&5v-D^!~Uob4{gy<#SsX1#=#X?~UFMYUCL)LBI$-*ZnIKgX-#XbmjKAwHl)wNy*&
z^`D93a)znmszEl5<eI>rnnFvXwxK!2u{4k-?!st{0ZswR-1>v)rE_W-Fpq@nYBfBq
zf$cct)HhA2aj=7buzTj99=(O79;&)!6s8G3h%s;p%capGSb7tI@DqFXoYX@*j<M~H
z730-Zs&-(dS)asRTr>l5mcyj&di#zI^gs7~a}iS0j=va74;Y%;97UN~M!UG%2OydU
z%?uyL_n>#Cc$a$Hm<LDRy{XmL>le^fTg!SoI6|Q5K6=afavz|$lXZ)u!C<D1zfn}~
zh3;{n)l&y!>}%g;`S>BIgK^YH0_SXhr9&!Jk~_BVcZot@IYnE2(Kqt<G!Fs~FzFlK
z+>ikEc1DG(s*nGjvUh&pwkbJf(Dhuv-yo*@-3Ut#$yR4y<J-9F0-iM@FOjdu8j*FT
zU;ZR?G#c^-|BPXuKA0nv=sF-j*xvK6<!}CiMAC;Eq!sfp|B}ZuIs!R5AfZZ*h9er?
z0Ck)kK8LV9dDPDMJTYd_^-RFuuMGF|;g&t5>BH=vEdTAEn&4S@)K!W~W9}qaUUhkS
zg8Uom;lK0mtTcT%^Fq*n!m*~W0mygh&K9ai4c(fhz1{cz+^{Mc@vALvW!tG0e30*K
zCE~-%pvDnF|F5Bxu~@bV{pS;DpAHj1C%Fqh0{{Lt?TI-!y4!H3-}zz9<u}&JUjpvb
z17m4kQ{*UWnD;f!VsU@?qC{JFE2{LBM^*HPaQ{|y4`?}?nrrby+S{g~QJ8H?eOEs3
zPiMM|M!f0<p@BDS>|7c@k-uwPRh+@hAkVh9frZVBiecSwT;csp*~wEq!`P{pD}TnQ
z?Mv%v899}ZjPXR8`slU=@nLP|>i4w5)%L(IzyT7IFlQv2-nUM!-o#%$Yxg|Q<_e^}
zn=dp`db$^T=2b^PBc6Q^J$DoUgznA5`bW(R|5O|>Y>&=#V&>%t@+WlH*pWl{tJjXX
z=er)o`i-}GWKQml_4Dw3VWTuMF~AVACx;FN>~_!OL$bOM)$w~9%nKJ+jH-h$h7ui*
z0nb~S3%cE_eQkRuKuZZ`FO<v+&)<NwSG~HHsmy=hj&gQ0Tr(LQ3}4*d6Bn*)xI0KS
z@O7e+IdAOcs!??)Mqi>Mz!&g^Vzt@MFCoIkirf8JO>MTPWmh#?aQC@M0a?U}!=7I+
z9L^Fr;W8GJD}TpXL;)q8Ar<~pWsB!kAW~d#>SND~+z0(^R6i-XIWEHg>H<3WluV1Z
zt#pf%rY^LOBumtc_$~B1Ccufo#EFzPjj2;IvUCAF)S~lC)>D8$sspedOX$~N%<~R-
zozsmv6?-3%Ej&CJH^eg7y`R1b`2$%tMymGR!}nU?D8K;c*B2S`U@y(WqpKSQ4C#vM
zwf)(Ec5XHl0InUHUJ=}Bh_FBqu7)VPLVE{dXZ$_F6b08_CwQ4FO5OpFss6AKlg3`(
z<LI#K^Q-mV&^o$oMh17BAS|K?R|yLB-}}vTG@0%B;+P+PZ1(<2VcylEnSkKPqfj6^
zNjJn_=>zZf?nNI^_kOfQrT^L?Z)gMP!s$O<z&`^8P9>!$tAM>(`+h7vNp2r7t!J>o
zkr1dg7A;Nk@nzq)<`u4gTOZ4pkoSOW@qVzjZ%Lq&zHtJ@+yhGlZ^b$q=p~H(yg%1y
zz%We>Qv_6O-@K5DfwJSR*GgY`i&dTz4K#i26nRu7sF-Z-#2Jq=PeLThI;?DOz5;RR
zN_<nUqMp_)jc<A;WKc4I38u;d_d(p4QQZb2c~R1bYtr!-F`AJ_Q)E^AfI!y(gx+Aw
zUb6rG^~Omiy)Vz-BaALyfr!S+Li{+w|Id^yT{|K0ydzhB@1bGU-{m!TJy$7OjW7SM
z<(xvw#5GPc;O<W>R7j@;6M(MLR5Q`rrP2G{6HSZ{+4ZDW_+q2=p>SdOywBgaU^ht!
z0+pK(9wM-x6D?X0qMu)zE|b}uLoAVomWRm8Y8`oG!bzc9n~UtwfSj&JGC!&U7swI@
zJeK~Db5BCkruW7^k1eQMk2VUrYi0<m%B3urGj)X3_q$n3VgA1YY<>W)CwZ!KVnFLd
zW|?1`1L!_Q*u5P`&u}#YXvC7yZ=~^V2Qr?>(kTUsPQBbHW1-7LDDY@LngI8i9W1W-
zYMgO0Qg=&>lnk^!kvOP^CJ9U8yZ%7;10;GpG}=L0&X5XR!e!oy@=ih285kml7?(fx
zEX_JuO>Q=&7U3~=(P`3k-v3@k3eoi(Y(@bJ*GH3!aN+SlR#0*8bvGU>fJ8#fU}s=e
z`4bBr3f~F&-pf26!;L_eFKU4Se4@v1{8$^v%8DUk&UDPIs@p7~O7d}wreUG}IgmTX
z;H0pgkky3{G5Q@d6Y4f?D8~iuR+Majg5cT*r1YL`s^TF;h%Yal@x-lro{-~x&^LSs
zpya`k`gMrlg9*#U?~gUSIoYq~F~pgVI@bZF7+>UV^~Q_G+X24$;Qi(NPHD%7KJw^r
zNoe(P=1Ffqlnm#W|8_@3S-fZ<<BD$vxo%Xmk3*mFi)<>IfSl`S=lp^rM&$(-$Wrz(
z60RfZTZ@r-M-_QuA(03)2?R&VSB|c7UuNac37JLT6Y-C#p3R0NtN{-aaVP+t$7QPP
zbX^(%I_~c-ep?#?d_zoK#Rqn-qpE0PA%$4F7n)=sKlH%o5%=hLW&$E4JG#_O+;sEw
znpIQ6q8+crwfE}{9N&2PZF0DSp!p8ME(^Fd9<7a>e!Zc7)<Ovjo;6b9XyDmdlQ8bY
z+9Pj`$KO}D<tqN6sPSLUkRK?BNPNa8&~VIJuhJLyttCy7)+7mk#&@?2@~=tm{~{J=
zUHG$!LfZ+w+v=ET;zC#$c%N{-E1W+VFrr7n?$O2VyiYS&mwcc0K>r8FK{{Sy4-|I=
z3g}#aa5kL@AK(-`%igZm=<y3F-97OD7%WI85Ib>AWE>(9SVkXSTgf#4I=g*lFV65e
z%<gxpU9X-~FKZ!|1s59u4%V#e7<ior_q`S?uDgN3h;!__*NmbLo}Qxbo{7Mff_PSf
zz&rfU81O~+x4`VK^X<F!oVr;HAuM<suS8bg)6HWi*IaievL@SJ!@N-X5vN0MsAF-#
zjb#(bt5Wsb{tokl^SF;+N`9#UF+Rx8bz?QUv8sR4quV>e$GlIJu@E1As3`?*Y=J*r
zlNeZy)~xF40s+FBrKWuQ_-s2%3#Or>Zq_7?w_{r?^D)Z&Aw%Bj39rVWV}{<*!dk3v
z5KwIOtqklY1Kt+{Uh|W_KOhxxsQV6njmLyxy_lY1MY(5%p7WGf<BZqJa{K@Mf1~@<
zWWOK%x}s>}c!7!+48q4i_(L$>X+>{Cih8hEpY=mky!O5I5_`IrkeRqg*8u-_`|s#9
zo^1IH*oL~?1?pMb*@ut=r|W;ve}c4}|0IzAXXoFaZPr*`6;W><uNIdi@p5B}pn1I~
zok<_9rAIfV3lNShHMJsr(KOHM5My5R=Zx50P)c9~1ypm<k12YaOLqk6nU%gWF~~@j
zP&cbuZ@25yPVuJ7Iyc9`YoHp8e#lX8q<V!@?lIZGcv$qz<dODd27A^Mka?l4?>N|q
z$_inS-`x8qK4V$AAbw976jkEZiBDA4g*Xm&pt4dK<d0j%UCbbz-P1XV<2kW6zYanP
zjPZ8Vl0|n+X&FMuH)69^O#wJD>+nvF1r<9QK;~;e1&>x%Mlg;|_~0)Q>#U#lmLB6v
z00bWHYS&7<<mh@_ZDzF6svc!0qP-<Jsir(IdK&5ctLAt~gFKf)l5y&4kJ42`GP=4Q
z|2{^1fc>M$Fv%a$-wjF(FV-EwzbM`Zq=o?B31!2T+@%_mQ;4ZVY8FNr#9gb6+8<--
zqdzo6cxu4!Y8U!lZ+pa7t-RG(xxB-5K<sMU<)x;cV(J<UspM)(Gsnfzn0Io;_Pu5-
z2V~c**$}`$P^?ozPNLLGcYp2I_m0!3u!YJ$#lBCaH5Ne0`j5^(4*>_?XF=@R=&cq6
z-0L5O+%77pqFY73vOJF9al7<Zf&m3B)652A9v`-dgr2SoWlT4qR@=H_J_k5X`KY>%
z`Gniea>_XkUth^cFB`cf(&27v!o>&*bJ;gNyo4<i?qd@w^k8w0Ppr*7nt$3$+nlZZ
z!I)k~Vdi|(V?c{q?S0A4Q^*sx^GL#}`DObDS0}hV)EVEfrhJFxtaf4yi&y>>$k4Zw
zG(MHG*MGXMiN`HAMgXkkKGZuMWm<uVcf=Qdi>tS+X!rPV!KyVwJ~_cYC%P4wRueM@
zz}NB%Yv)jdbXMqq63egO?{3ek3WnUxJ*uWaYe;b%GDPQwFje<L*&M3hvPU_>ZuZfE
z1D7%?Lz&YCfZ&(~AW{b7ig@iGfJn>tRPMLIi*V!-7uuS=fXp+Gt178oaA1Nc2KOU5
z03Gc^=JPLC!8blLIw@tXeG>9;T7AhN@XtpG<+>jJtVcq*v)*d_o6IijM@|HRWeC`8
z7^i`e<zwh<`&uPrR~`=7ca;gs#3LK!I7jE~cRBujCj{LCwXB$*sBCVnQfTt$T{?x%
zw~E|u;RCa4UBzLnrKL4_;$px|L_sa&VgP$s>K;w3YlLTd{=$v3P1nzecB=kbYZ4GJ
zL!-e_E;|Q(I=s)7{>iGIl=hVS;g%@w8r!FW>q=*_+(t$SOx=Sx)(wya$F>;+S6N-i
zG8`0<nT4)7fd(!vPxsK^`Yt=WeM)^m<hQxZO5R|N7tDgX0Yi4(TDcrfpd7G5iI^kQ
z>U!W7%Y}tUCxRx863?n1kPj}Z)$JK+_pPr5xV<OPP}eIUBNnX3SCXvVv*l$Mo<7VV
zYsoAb-FTr8b8Jk*i3OlATc({zqlfvct6s>UvR@vhN-+*U5hBE>ZpYIdxk8wG9nToc
z>9J0h4LIYUO8@>qe7s1)W6ge%6ZSxsVf!>*16uGtJy3y2pj~nkr|;C?_C0YBQ9F-n
zh6uax!&AL0{B!01rU-u5lY3>1K+&AgpCM!1oP_)V?SVbvRFC)|cbAjOezi}8XFMz{
z+uKOHPLvQ51CF?{sT>!~h#)U8`8U$_?bvoHhT&$gQbcAU=q2?vA85U7qR(*~fRN-2
z`1Zr)HJQD+7M_a^p~5xY!vWK>W_?r#>F}$^fl6a8!RneUuXBEM3hsg0xCIVI^pB=y
z)ta@{t8;DpbCBBxTlSHIRkuV(3Yq=gk*|H3mz*{IJuLgzn?o;ngqGfm{f4|I@(MFd
zdT(Eo9R6kVwPRbWs__fWvL)A{qV6xgUCEU<-*WkaF>k9zM(o!x31sbiDxeSB=l`7)
zl$dZAr>p!`NsPV>Qq<*w3X!1!c9fF@qDnTdf)~9NlnCl}x(Sf3qLM8hZHhUbYZ8aA
zL`O$}&>2(D!QI}v+2J_sM4oAIB;$1zMm%Zp??OzO)3d62{K6;Ml1`}T6^0V1-06kR
zTG>f&r8G$6KM>c1(n}sqjd)0e1bZ~-O-N~csZ_15d7(;VTfjjVf0v+IXyp(~i-I%u
z%f`e4Uu>^rP>R!qw!uyf^D*fLp-^Gz;;f1DupEhfptrYTr2HU8HM^ju#Mt;c#C9mQ
zBEX}mN~AD=we8CdL*26y7zux6`68LkZWpVpjGU*hfw$s1G&mmRlEfa|bxGP=*YG#M
zU4whS+HWT)*t;&<>+#RSlBy^z3q)BwB_R+`89VXbI@w+O-ph@6#5!Qk{k;W})mTHG
z>`+EO`K!*3Do|eC1U7jlUV4mr_I~D}odg^w0>lAVr~dIMyCjo-vpSRh%A*Ro%fWGB
zs_j**X6ZQlpyC2^U>QXTDF|RYy|dvzK(t9T&vB}#+3xIw*tLj0Eewi1<56dl*ga;=
z?4EEHvtoodU+p77+FinAT&p#?pD{U&a;^5Yo6Kr;oZQ_&2>1Ve`}Ld5g5JilRO#R9
z+#d1_@Qm`!$9xaDF7F;p5BK{Gd)1j)P#J*{H!&aA{BAiI#;AMSMGn$_SQ(_9Lmep(
zwv-F7lwtAu-hi=U8DOlS7Frh6Lg#Q9DnB|61c3Raq^zolOOS_)v~r~W2<s9}VKb6Y
z_-?d){H9g7XQRBem=luuVhm>2|IW-DRz;>vK+S;%3_k5fI>r4s*}uI?SV>~?;UUcK
zkgF;>L<UN80(8btNT^`*K&xzJ2UZoVSC-p|7Y`yADh>g*VhTgV6XObbS(RX-Mou<%
z&mwnq+to|stxdQ6upCNfGTpdbLb2jO><I!L@ge`1i1P)%p6IruZ#)WF(TT&2GKV1&
ziE(6JQ4`SDWGsg9<htcYuOc9Uj}4E4P$)7Rg+|X|vF&}S;3E&BZ_1Be*t$Ee>syi1
zNa6uB8XW?K(jGH)ys;KY&TQ%%Aedg_Kw!aQrRtdZkZ{}UU};@&8sys07h#9#5ERU0
zFsM7aG=6jUmrVvTGMrXtJKI__2Ur!AvOp!4AfaLojNDpbyv>fz&r2MCS=0dPGbxHg
z-1#V22ZBh%Q+QIqtQ?!m<%o+*0!JgcHIzAPfOebni)`o6!D*fOq4IC(9TUatJ5IcF
zv%5O#V}K4<fL2E^PfqxuPLR?Eix55|J47zr8Y3(M>-lOYfjMglYTCFlQ*F7aO!XsO
zc_HC|S7Dw#DJpm`4=M<uGSJ3EV#ed>-*34-NnbwY$}{k0UKBqq9dqLwB3|iV0Rv|J
zTjGZ=0K21r=QPCumesG@1;6@JA4yyXh{1e@igK&=L6v3Qbu8Q6ojcusV&jXij<z|f
za@!;Fyc$s9qw3WW4D~lwUTSYT!NKHQ`JvXY2&F+|&jvfA@S;JW-~<Xiu>e1mA6VFa
zD7=B!fd4xd?F2Agk$2eCQLkWObam>Q57Aw@0e<4<@86fX9pM61y2y>T1K*~J`~Lp5
z_~|-#Yoq>#>=e{!nCE$iD;?*JmA*!Uykgw-v6pGN@V%bfy^)~tYr}a~U{s+Jzc3rW
za7p%Amkxj3C7=AFBKy_M3cTnuJ^g_smCG*ua~V+|Bu&pq%<%Va__h0`M2u1?%88o)
zBGpOWmizIpQ>x!UH@ml+9c3tS!FM}!IBWIV8P$O^sjRZAQnG@XZ|tP0W9<bovhgvp
zgL0hpYhCyZ8SG7;j?xcRl~XzOV_mgk(Is1B2~%SUFmw;g-u0rS)xS|ls>I7z;ZhS}
zyX9>ccTU6<D!nNz#4p6lmTZCEENn9_NT2>QZvN4l{bxl!Ei&Yp7j-hGT<Klmf2s${
zO4`f>cIBt*y1w9pr9L;|wChDX7JtpGP)IlLRLKrD0%yN=U6s<EJ_qXDcY2qNvd8ln
z9OmlL)sN9-N^c9R@CyyHC85xpRlIXkWyrt3M=WS*HC<IkO?T<;az7<>r?z@S)!%*o
zwnE%F6<f(W1-)+>c4Hx=W}{tqOt;%r=+UtPmTWvr7U<tO^xE?*C8fR32WRg_NqMgv
z(0D?yBAs)nJ%OyPa~l{ZP|Y1`{an6-9`Yr#9gnQLlAYV}L==2&BO$|oUSS#SIu{V!
zK15z7%`RU@Qm<jm8%IA`WX`f8chvIY31CQ9?=;H}t)O$}Ys;EtCz$Uo!@jjATu}Dd
z^HPE^YV!fi%-h08Eeo$?OYcFckIeP+o9svPoAyqc5(bslrP6JX?n$QZNi)$<pyY$U
z!`UlkNOzyd1EjQ?(U>=2R#vJbpCWh8*$$0IVUiFHvJOMV_20_~OZ{BT<(uC*?QQ0n
zd6Y$a_%l;X(oC38PeWpo7GI7O*+<`}oo=?Aa@}ea&iVyjBfqesW#V&L^gEy)hUr=e
z%8);qQ`0&HA9Ko+R9xzwx|fMXl=%loW1!aMXru$5Idn2MuFcrrtd014BbKS^AFSe!
zZ7QQc>|m<?97pjK%Y_@Qhy0DElt}B^eq6G*ftlLCW==ujk?2D<J2zX`yzjJD$T7oi
zIAg^9nu+9aZT}M!jW~gfA-nQFA1w0G!^h1wxx^kp4={B48BDhxE+J2`SKH9$Dw2BR
zp#^-s3a*a=vtUwvuw_2j=*JgH_Kc1GKFa0b?%KzWRj(sxWRU-Ry@{mg!0>zh`me)u
zM$;uJ{fyJKMpKB22h!Se8UEmNq$sqek44KpHbqil!F-da(&sxn6*tqQiVYtsh0%3F
z>CCrnsRp~fC9HiSkSA0JZj4N4u4|xNK1O|I!J76G*eLNA78u3WXL+${JdNri`_Y|P
zr;?oWQ&(0DL!a8F32fWA%hM=(#iBrmHu9+LcQD0wDk&BPKdw8FKi+&Q2cE$a^~a+9
zkJ6h;`%Pm$4~~sSpE12gUc|4P2*qr)^L&D;Ro_;tUOhywM4ug_5^>9V9q;X162Dnw
zc7$`s4t4V3tzU#ovjOEc=Ytx(H?Md+Z8v_)g!bs4-72T*i7G20PlPYh&o{Cu*Sl6*
z+({64I|ys@+RI5d=OvE*Z1s>;%H^l-RI#g*LP5zpOh-I(FZ|r*k<X@&kBF$xh>I0e
zwvTG|7aR72D&oF*LWy@-0Z%p)tfvO<l?{Ywwr1>)+LBb_omAow44s$CwCYM(?pn8;
zp0w}W<~KL?+Z!A+ViY-ErIXP6Na#Op{eS$tGLO}6De-aFK1Yf9{l*}Ht9J#wahcjh
zp{i%sfglr&`)6au&ry~W(4%uQT0bfKwq%|v9tVr|ZDGa4LKU&p6?(gZ*OCgF5VuED
zjJ>T+?m7@1GSENY+ut6AP(zeBKI;$6;M$dcX&dlH7=cgnX~cRhmXwvI7nY_k<T;j{
zq!}%BeyIybQuDvlefQ<XO~995-lV_2@kTgSCX@b_+fJa!)abY@8mJCLoZ+{xSPYj)
z&=RCJYf!P?WmxZ~l5_}M&DM;eed`>h!6<Z8%+}iX^&~o#CXe1Nk4C+F?+nV@ZWf~U
zoB~Vd&Q#m8I9_*ek_zV?Io2^g)^Sh*oh8LI3DeoZG>I+YvF){wiZ&3;D*o5S^@8N^
zlCK~FT<`b8o{R31^|GNm99J{_k6Q50amIdUaPu=4e<5w#XHZn5sff&W)QYgCBqtrB
zuXezfwSNo*%>=dY^+r=!o7PP|DDZTQ_jDZmsY`?$RXgCrN?QWg!ziZfC$qbCr4)J8
ztn`Oj6V(&R$?qOBc_WvX{yI>52EjMYmw!G*s)+H;_kZ;a|MDxQT>0%6<(+dOhAYjW
z7~q00>z~;&WJY%Guzmvl??yRe`j?-0QsB8u#HYkY-cL|`BXT?q;RRAs!=hJ1n$~5>
zFNZ8UL6gw`--Ii2oRPc{ywlja)Ae3KsWg-2_lcx1aGoloLf8daM3?b>1YDmk*3sC`
zYRkHEo_Bl%WPp@6>NlVfj5%PqNVI4h-U>ld=jv;VURw;`*yOQCZWlv_DcmGt=s#!;
zzjvSlN^WD<rE@Vz>i+Nv+cWHN)C*JTlTBp5Q5&VviR2W};=G)6m+FjNxizQQz=FWo
z=__Z?Vt+S**Bw6B;ok9+{}&9p?!Dil3JvV~KBZE%or<81oq_t@V(`3y8L*MHAzLt3
zR29;v?fG8aKaX7EPxOYdy^1E+QeVlZ!E93YG2P82KBe9uddci<Bz-*6IT!Adk))+e
zYtUTyG!sw#1RTvXDAMv8a2S~VW(P)p=9;1YSwiQOl-Fkk_mYHgKmSWj<@FH6l?(oh
z-zUomQ|Gs59k9}Sd#>Fv%B{>I0$g9}URfKIRaf(;`<4q+Bk+$l?9dLUCz+=kRRb=m
z1YByWtcRek90*{6A3{R9Gog#C5mJxmLRkAfS)w5z<9zKMdK2Y-1=0Mef5_|pJQ(#I
zWc*M0gv?Ogu>lYO8a~B0d>Wh~Wpi~)8<ehPIZeKX@X}QD(>G`;wo$3|h1B{5>ZcN9
z*F$QX*=<CVWk}+PMW)(UG{S1+n_F2z1bBu>V*yCw-#`*q9R@o$OZ_W)Ln-60sGMDh
z#)L4@hjl?OhyMms-%t>+xN`wK=-qx}xnk>Z<^jtyt^NIPdi#GzA-*F@K0WUbOqv9J
zC>-&n<i+XxIyqzF+Fsq({PAk$4*63?{=-EuqgRdl1GPbnXqLsw+2zD}>)%XKQP}mQ
zfwaGY<UZ#g(>`#rjwJI2jMW9+jZkbyQJU|j-g;h9zEoJgw4ked#@l}%n9*hc7i=y)
zYUJg{)prfv(RleW>3IcpsgSw^MqG;Qx=rPIvcX-vu=jVK5lidR(j@D+4(Oce*LmvJ
z_nS}>sZzmP`T_##&Xm&)7qIkgI`*kFaJt`s^tX-kXEJ$HijuFgBeloTirq)ni7xaQ
zgVS?|4L;&YL3c=>h5|^N;kSc~`-+_&+piw4+$!GNU3OR_^z3wLrU7~_6cj}U>9or3
z?OGfJaL=AWTT-^`?%seg;~o672It623o^Rf5;u*p!&A6onDXW#BynYjZ0)rzDyOzj
z2|*2!1$9pYQ}*t|=reBM44AV&0mg~Xjd&KUqyzkq5l?%w1$sy(E}H*gQ{pBb`_sWe
zDp=EuH^(&ADJC1p*)7r{p4#sG(%Z|*-y*ob&s9rD)JYPTmL^aecse$L-$V$kh}_|Q
zZfQk0DB)3*5?q1bc8%G+<SWPb?7c~>EtjtO+k7SL!c9{4tle*Wc(ds_{-EK=rj$)f
z)FK@Hpd)3uZO>A_h$U54&JE^&D%)U0FBFLSMY#8%9|D)z-E5cK*--+2iL<Y-`x?S6
zje6>w_O%z-69Y`4f1#zzGh*0}e!cKm=X3)7aF_Xm?vs~P{rR?_1(^j;7%3sMrtArl
zW&#*%t8ph0uR(s_=HL);<JeS{Q!UPNK+mBT?nDj@{hg(kyMf4LNUKzPFT%ZXd)h}>
zZi6gP$WxHF$^D5fB<UD#D?$D53s@U-sicG@2?s?{HvCd6oH8QqT!d4Tcu3Vhc3;gm
z5pcmz-6tg@_ESfin@KF2@{z3rIxFY*rB9DKG=$$u?Xwn5J*DGb)&?TL$})Q7w70)u
zKi7-#2tXm$yzVA~;7`+6`$PVXi6f__Yonu~xO}PFTr+q{Sj2P`;X6n4dqa?nis8fS
z0IGbk?OR*`_rQ*9C6ze5SLkogBZNvReulZ4P0bEhkyzVwaqiXN<VcC20J~W5uE-u!
z$72oT#MNW0E6qFebfTUj)8=fsi=ZT4cuZyFgWac~aA#!6=qDrn#@kbP!s#de*p*(;
zfXK2zjaX0UWJSL*u6&|Vy|J^SK19wlJa}<c_*%g^mTEhG=}BB^DrxK1_t=n{Eq2|D
z*{<iO&fNxMWP+10Lmy6iV-1~2rz}A3I`fU9WUNtoUqc}hIz}xKn8GDybfH#Q^g1|0
zVHt!=8)%mPW@@YQ2BTw*+mT$hEtd_BKxC#e*DdG>#<v~7MiF&AP=?tz>CM6a&ICIO
zE`cD)8ubOvy$1XCyHUJr!N<&?*dNawU=pS<i5V!=3WdIza*iJ!grxqxE@iR7@_0jm
z5O(@`l=*oyk?|07iC%$9X|yBtZ)j@#N%BX-e-0!&ia@uBKz|?cyTOn?akGGOfMZf!
z1ih}1ek^U%@~|qg@`$^czMxNX+Sg;!*CTod^k%;C696zguOX>>ES@r7ZOw#@d=<@n
zVhrHxyuw=j^*_>*^CISbn;se|+z<Jp?D5umud5kv`t_;_yg|t1B(VQ%l;nySGxnpv
zTtsfrN5|KU=4nUlP;@a7j<&a#9c3zU!S8{_E)p)}G(aj^t#2f49Tzo(!#yKmdL{|D
zpt1Q_=8oU$N%`i^=NHra58ae#vqrkc$*ka_pZ4zw+KWcJUdHZFms}rjPdY_<Uxs{V
zsMObBggpl_I;L*sz&wFu*12&GsmPm2B>LFE0U$aa-72@iHaz_Eq4V+hvP9WCiLyg#
z=#A#L{fs$*rJZ)=F{*Y7k~PI@M{d%!=hkQ*6smDXMVKL`Vkx{Bl917mpY+_6f`h0$
z_oj>_dxs=DG{hMvl$iJG81euJ_^Xrtp;GL-+wlwQtWvV-+^KC5li1*<(iVtK(tGS8
zJPe>e!|loIEK>?i&yyX@lT6K%&Ok=?OG*HX-<T6>a-8ZQVh9P6nn)t3+~Rr|i_liv
zyc*p=t#yI<WN6%+tDi^ch~}nDHG?A9a7O3U*|nkm0!Q+?W}S2FndcLg*6%Gp3BKV$
zwt%cZu!^=7-UBu>R4hC}S>VU|5{8_XyS=WRx8bG+xj0FuJeN`k%=K_$$*lUVT%P0Y
zBKxO=LpQmvi5iL=>i@lXyw|SW?cnUmL5s}ClI3!CTr*OC54X36`>!+ptS7PT^7?P|
zE8CRq+#>dGw0ym>mZ8IBFq`B5r}vZzFo!*LvQeUp$4~BZgB*Iew&1@{!4OeIqn^qL
zfLtWpzkXDe4K$s`%cTVkba8vTxXb%qZ@lD4j;pw&)Nu`f3HR!8AEUNMgpE_yy%rPd
zk`wByM|^L5zm;v&eZVE1QDB&=RF*&Gc-#oPd7sf@40x5itrP0B%a^SV_&%VuXIUKv
z5pBQTs=aM{)LZihI07InZQ&|D*j0JvM$b(=YNp6Fm2ogshcK&~^h~SN4M!I46nhfm
zJ&E9)?xv%CevCv^??Bpa)<2JEqRMuS`*cMJ3WPbis25$P+8r|)1>RcPqE1~_Pr$nT
z`DWyWp*4Ay0+_%0$2O`@WZ7C(v8{Hi<A8cAFCl$;pT%f`h)V8(&F6p8Tm5~&?`lUj
zWq~eQ9lO+9zYU~MC#5z_%GHeOop!x?^lGR>_q=WQe3X920pIP_?Wo?>b;p<*?UsMj
zYT&*yH$%dEhSy|)C?e1>H=VkD)uAUA^Bu6+Ym(7C&0A?T<kxNM6nzIqH3wcAN(&Ea
z&Jzl}rF60`bsq3r+&^}teIGP<$B`J~K+k+{&;0VAS0^WYcmKBPvFUv8>%Qoz?9n({
zF>$C}11xVL*7J*uUQ)N&joxJ1chNz+E@R(sF+!j0$pU86(F*cJ;eV<EZj*UELXD}T
zy&IMXe#ffu=`(z0^a6N_kA^>(^yb%(tRm3|ZPM1GZ;_q2FChOUg*cwDJGLzpZ1>B%
zNobV2>AxiF$7~NdN>L4AP0p!GT4xzXE~BOwQqvb!42Td1wF3Xe4}kUlt!sNGLBJS?
z?kMI^%hL<X(-%q{ORQ)&%cshzBGii^C7&&v`&ZR((gR$-$oX>>645A4e{aiv@w=pb
ztEgwR*+g!dis3WYjctTWb{1-;7HZ(wla&Sfphe$ixpp@T8_LGcnUvc`QyRz36=+)&
zXqA_P)DbC;&p4q^J56A(ndxF$k9o~y5=V1ARaE`GRs6l1%F-crY6tuqvM$}49{O_d
z!i47|hr*;9ucsq`QLo?E06t&h@7+Ei?$GD;>4}l9<XP}@tgBu(t1J>6;j}GqTIKQD
zW8VJe@Gk68T5tT43+M8t;g}n@t1&Hf>jyFpwa4sh=WAUDnlCQ}JWHQ;$LYNXdqtA&
zF6z1HK6c2`+9A47dGw2N+LsXUflUBuz5K(yz*N<GpW8(KvC)7$+xztxoORev&AlVQ
zUr1VH&EQ)LDv&>w^C@L#GkfM8&SvIrZ*T|L`AEP-Kz*f9$#F~7HEeQ$eAg}5u;CKa
zQ#n|ap)dfp+_#iK+I8sTT0oIr!dN9AH2ORAc;C{sKGQT@<4~*3!d|=rK`)QidePF;
zkE^m@B|M((Fv-kVx<WpHIm%jl){AS;dLb|*)|0X<N6bBZ*b;62)n1C$ivF1fK1l(d
z!k!G5qP34)lFJ4GWd6ZG%y|oXyYoA+J`=)=vEUvh!h4_xn3%1n%8~CxR9|1teTjQ(
z?cy4Tzo3@=Gf7wM{(qnLNF|HK2S0RN9+P-h&)e9_l5G~r<BbbJY1OB}M$%!Yw5z!d
zBO1qC%bVfGi?@~3&kv-Q9oe(Jxqnafo_3OpW<ZJ;{DT9EPnk!QH@`mXC8;u6vkQXN
zj4oFiEv%|vX!vw~NCz`eiy2u`8>sl2A@DFrkjM@s-pQP8y0(T9hu=h9yy6u|s*&ew
zU?kJ0G0*iL<lW_MdoBUd7yTi8lvkey_hcWw*mrec_@fRJ5C&i4nt)y#cB<e&(^t=s
z_3bd-Z(EbQXvg)=y(;+zN>jOCk>xRmxXmo<m$QqLa`qunJ;EmGT{I`XbM2rBUBFeu
zK(r;5rmQQGFJK7_{V=`bp?Z(s^4<^_`ayaqeLDyua_E-abP&sX4DA1D5H>9$%5ayO
zSoILxl>*%2&L3boq0_{-dk)%akY`g_09=ROY5z2+mYr>{x4B&j^CW%x^Fi;tEh_xS
zS9To1|CIBmD=Y)*6A;rrbn+JoqXx3m>#a}HAlXo(V=7m}bkBt9K7Bjzn@|xMq}%vn
z)UI4(TbORalfcP%f)ydsLH7(&_o*AWPK~tHrNOV3Rkn#cl97kkagRQ)C|)WoURp@~
zRC=WAc5xeIbNV#wBMEAk3N@0ViIet=liW4^@&GSyaW9W4l~~&Hy~bX0pG!gL`I}Ls
ztz!PZF@C-=O}UYD?Jh@wdQ97FvT`B)MjJppi_`8`kGf<xx>FN?&h>AbWT11UF&xwe
z_QVbEwhg&^$k^Z4P0+bb(D~QP_XhobtB{^M7^X=sf(+)pKRV?3Sn*Vj3eOoR5<z!D
zJ`HtbDeLzIIdpR~1ox_te@oRrNf2fe%^xUa&IxCUn&n>Ylh<#>aL|RZ;sFZGw&<7L
zR4{w!OVWYH#nm-=m4ura2t2Ht7I@r&Q9Q?xT-l9->39x)*J#ds(xW%Pz?J#(qfYV9
z_vp9{Xixn)t?I4%gnQ5=v-|E?i<j3hvX@m@fSVD)9X9T}>d>1y`ezxS-6YC3%}Or>
z2(>AHuCHnFxEV>@Vbi{#f!>eBWkMEtJ6?jHaCenU`FO<xVa|^Sbjpc|v*hSG=;(7Q
zOhzk{0~JjOSKpWuR7Xk@S&}k1muf#g0sOv}Uz_YcKxP?w4cYo0Z?V@zFEp;YhYOK?
zFNd{|!h-9Ml%x;?T>v|8mOz$XS_h-=JY$z_eGf;)@@@NA`8oodLCg(d9OCL^HSvsS
zq4d2fy!@#{mfa0Egil+7o6*H(bD5GlU7JFX?MM}Y`cI3TcV2s(pS;P);ePXkvrSR_
z!Hy9<#ehAnq*I<?%s+jr!*mLY8-E^Zx84M#$T&l0ZFCb&fMBt1(|9(;V7pax=|$(5
zJ(u2U%i0YrisNshC;eBVocN`#xXn%sj23{t_mRL!(W-7bXw>F-La6Z}K_^rJg31E?
zyhsr&gKZQY&2`=`SAkN99CqkmEG!eum<u_Rf*Cx+a<-<VlUJUXruBJt*OeVCY~xZD
zowdyy93lx=Ayf(u1T?sLmP(p`?AKw3W8}9G(o@#9TLY_ls5aViD7;q}_vxK+&Bq_r
zAm@+v8bt~s-V6*b7SaSWIB-s-Rv{1$3a4#1rH$rUvr}^f=7hY{3-<6Qrr?waA8@+>
z!(mdc%SiyxCH)$DJ5*-+*QF{%tU;xKl_(Uy)C+e<VD|CZQ_F?af}N5#+ca|J?CAVn
zp>6_>-Dvu+5XuA~-L?Cc7SRN^t|)udY}&4p8~0`ajI<oTP$FAm1uZK#A9%mc@aC{)
zQku#Nt3fo??{*Y=R}|WL4(rk0xBe<A(AyQlk3B5ECCA1<Yn{@{^c&5AjVF<{HEsiJ
z0#(FTSHH8=zGOIH=A&}3%R~4NQNH&bwlJTH1KT{%!*Y1NXtu^bTWq!Yl?l0V7L60;
zgg(sf*k$ytWpI-KkM^PUzeszh5#@jCnN2>*9-Kc%UCr92h(Cql5f81DV`(V{{u9?_
zFbFh=Yp{|w0I}xC5)cJ><Ph6-h#iHI0IrD9P^iG)_C-7AQ@GS8FS`!&%t~g%8vG9!
zQ+8h|x?Xx6db4_J{^`2r#fjO3VddcLSyuE8S)6-6AfeApu@W;BsFj7wP4R36F|afy
zV52=^HC{dS4R^UQ^a8GIJXdxQ<^sO%V8m7Gll+GoFmGTWcE#@6o^@%P(g5JQerH5>
zD8MC$%MumQ!|?Z&hbo=2F>33TxOcMNjt1RI16;;I$Yt7MYug4n>C@R)C!UM6^Y8N{
zAWP%P{(-^&kE$<^hw^Lxw=|}Vt$Y}gwS^L6DP<?LktGVn%*YlIA=?<yWT{akqO!GE
zLiP}5?6MPC#$@03b!M2c{Ej}~=XpK9e|mX!pSkbroco;Xy58^ib<Ta?<q;vj{<JL~
z#M<mTsbxkAB;PoxyM~nq3+gMt)N%<c;O}d>lMwy=AQU-&*6xc^W5#HW#JTxnaFeo!
z5}8@`K;NO{@B^y+X;xD{Dt4}%s@D_r^kqTN5fl7h_2v;FqyDrBUd-9!o^>ky_k!s9
z^LW?Ggz)IkxWBoi^CQC7`qQR(w6h1>gVeHLW<p1U3SdfzXD9B&7F~=1kPZ}Nf6<FN
zH^?IS^p^c2bc!8iA|%EOuLh_d<G<Afrce2`JH0-y9}LN>nB~7%byE4tq(ti?^&B{Q
z@%^)~Xnvp>Bt#b-j841zT(|$k0TGncyQV+NT4nAMnJM)jQ&PcUE@=m3UZ*@~lI%QV
z9m5h+c-`ahNl)8rd@`Iswnt?D3#2>}zz~5AIk#AwMLv3npZJxTk_vu38TR#WuEBFo
zc{S^%Lrl#5;4U`xlnI@)U;keJ_wL%~Z}`Bki{1AxK47f!hvmd)*PE*PI;#5fi)U|;
zELl|FeExl=r{lP@<7xCz@pWt6rq_!54rBwI!~^uH<dZ9kgPk(LzD^f3jlK7N;l+e`
z&Dy(++q?Xg^-VqAYPEaa%|1Ypce7PJMBd<qOIhp1{x44Z-J#@4x-nw*R^@qgZQY?R
zAmk40pX2bKhbuBk_mrHTqsiRrIC1Ar!YNW_T<XWTR0{HKTE*F~ajw+O=+8F^zpjt7
z7?-*5iD6RzP7dVTK8$73S^)<#?e3(#g6tz`id_-p^5tjQx8H`{e%l8J#mTYu1q$zO
zG`f4eza0=9{jyN@lWt3av!#f$B@%U^#q`eGTP;d5*BvrGkjxp^V!CTz2St;fW#4%l
zb_diATPAfC7~DCfc>Y~ct070yGuN_}XR@bmHDx=z4Rd(g_rWqrp^(GDA?~th?A*`0
zcUe>pkr%+%6{X%)wViSBlXBRSlxKWMTw9BYx92HLsb%Spk$uO~Jp0^BYj)nC?JRfO
z+1v|-YW5C-tp;2+Ic9NTgO?a5n%h%Q2bwNe+?Hw4`MYa1>+MPM(pKg5@4p5vzGA2F
z-7!I?xTr7G=wCa%6a4=Ezn0#X`FvlyW#O_YkV+1By%GX=xP?p0iEuV6Zt`Q?BpAt_
z7AdQYxaVsQGnb0auf36S{Rz2>C;S!Pva|aNKHXva#owu*o>CBGFndWPWkIuBFDfTn
z_KbtQl!HAXo{vwlnZM2;^0rKhRq>696W8atn4ZV+Q3@0`3JQi=Uib^@Wg#7)m7g!|
zEWBucde{Na3pW|~h%#$!Hg0VOJ7ceOe0w1nl6B94maBYbqh&(IxVWAwarH}fMojF-
zm{`iq+h)yDmi@jc4OiGj%U`nxs=U9gvG7eufBe4&Jq4d`ULK8(Y2vUod3{|aktqhZ
z>g_<XG?A9pk(QqSmYor6QtE8)e@{19C4O*x`^0t3I&+u#yX%&M*DWm(_V(ACUtE9p
zZAgS~?oE%9NmcZq&5Xo#BYHpz2-<IBDR*wC6=i3<C8c&;389-?_9}7)t()Lgyp+i`
zPyXfyt<C<5(xwi#!Kq)_^Cse^W}WhJ#Rq={+f11ieR_EN^1~@2@ofvK60>`B8An+@
zr>df6p=p~(Dp+|wGUXcAT@NoZ)$_rrE7K}TDRCE+cFU&?Iwzc|5E>e5lp`#~Q^=bL
zzez1G2_6W)QbQenLT~EdwQJrUR(F&L<-el(3k&WSX$y-DZ+cw>N8M25cb$JyD2T|-
z*a3HHFgC^a4vJ)RBl=J6y{SIS>(JP=y1>~prB+b7x7+RUlHt?wF5%Y1LX!DUoyVp{
zy%L5E=pv@!?q~HA^kJ8p7V9POpd+_GkSEbG(D}=E$RgenQws?VAp#W}x-+0jLrd&_
z6NTGf-@MBmucrH1tBMB4t2=F7VrOHQFW<c&wCYi^|CI2aC701{-wa}~?)#3{j6H5y
z&UY%(=j}}@b}xKb^Jv;{6Z4UNiuVC`Z@r7;Bcr+vfs+mAY=7-vU-kI4e?3B*;_`9k
zV;MKI|77*)2i{36r>|OA<?gkeSkMr|JT#;x0QxpcG&4EmpqvQn=5Wb}G>(LCnuDA@
zbqfud(;6xMTxK1CS-Z>CWeAv);gh_;e~h`ATV*Y^ul8o2GZR|1p!``I`%{T&*X5YL
z*Ag7T-P=bJHn__ZZ-39Ts%f`^v+tBTzXpwY)Ke@Vrigvmf%~B*7~O{UD)Ccc%Io!B
zR^GslvzR5;f@v+Pl&uP$Qz5M^kw|BH!#T5cFG_wUNoYQa5wxV-sopH$WmK#am^Vxu
zVe+J&>w?KEOO$*Zi26yK))>KX1w>xDJxm@EY7hQok2z8G{EuwQ5YHRMh9$NKwj!#@
zjG%R8ca0a8iEeS9lSH#c-=uaQQFhbRm91Ntds_Z+Am(Q~xJ>|8LgdZc(`38ZRovs_
zq324Er`=VTV-v@1{K((<k^E)Z=xFfnpyw&OSfceSUu@pP6HyOc>bw-q>RinASicKK
ze(!jq#ZbF1YPWEUp+w@Gs;2wA2fgXeXAw($wvG-6bP3pHZJ3^p=)kR3TNR|^^6jhH
zJiTix@$x&**2S=aXR*7i6m?BWtVnM&pRlyrxtlc$5cFCpDtz`&2y}4Wc5q#^Q(ZG1
zlQf5+L#97|KGOU<i1dvQL5#o5Q9S*#cv=&U32djTkwnxQ^7`9E8oVS<37I0pNg)cH
zza7+y)%Tdm>z>8aUrW<X-ILC>7dIStaO?wE<1$Ci^v|4W%@O~=c1lIr&_ijxpSZ^)
z64wu2`SPCOkbeSh2TgC~Pj7MiCMB<{<tD`~EY1AHQFt}vZffDvo6i}q{DYhLUP%hq
z6!Qx-TvNN6<jSTZlHFp+RioWXdR~E-ZxcAy5h>j9BqeWp`dCNzoJylWcB`zE=HWMw
z#o_nl%!0<Z^2c38-78)m%e~qlwDG99U4gq7>&)kTfN4e3p!mRLxkeJ4v-bqyrL`L)
zXx??gKMEYfekw75+&Jo0$JBbJ4G0LWLg7P7`~=r6!`QtgWnTGn9(T^Giex|8@Ty{J
zCCgMJ>K2|xu{kS>;D@NpzsOfN#B6!g%P;h;qIZHm4)X^om-jT+n|DW4ZxrXxx{AsX
zUK(&KuyyOJ$Q1qh%3Sd4yobWxBXKrvg^VGk+k{2d%#zo0+KqW<I#m9wq6f7eB-421
z-KIYyz+!YKxGwmUjdEz_tO`Fw>^SbGHL@Mzb|@#Fx67C(omzv*9~5+P6Cw{$@r$vV
zjRJNZ-i)2)>Vb&KtDEE1{=C1sPNTiQH-*G3BzGCR*4dKDf%$~WZ~?nWiQA<0&iL=u
z3Ti7(RS7$Br2^f~-E74rFJ0Xj_0(Mn+bH#B3;T|iUj*)6qsu{|T7yQ@Gr`e|W=At$
z`kuuw5Ct^o;pGv3p4FV3>B;Q~===wxB09Ig@Ap9kS=&Mx*L+3whj#H3J9;%EzA<?!
zNoNm(G0c5Bqr(xu(O?}h8%E}OTM{YbwwD^Vj!<B0`W$g<tzuAh(l>9Zx-hq%SDyZb
ziGyzElUIRt@nay~(%^!)36q91en@H^SU6K{?V}0deyZ9&;tm%`l|q?qzW;x-p}<R`
z+`aZ3^Wx0woj1AT7ZeAKT^nqh$WLBZR5l76i&VJ%^Gz%ROh8tdh@U}CLr=qJE2g+!
zl|%{yo04eo!?-b%x=i1-5n=A$$}e^;(i0MAds$nP&IevF6I$zErBYs%bSMvTy@F;@
zyxrA=TAm9SK$%mA8@PX;QoCJ&C5$b4z9_+sHHC_E_v%4kS_JuFUi5_sylhDEWmtfp
zzbNTAJ;e0_+Qz54*!<}zXZ+wx+NJB$Prc<pmwjyrqan(*Ftl%Rp1)fB=@93-D%Z|1
zy}0h`i$N11`4b_OX!z6#M9>6juM%|P>&%22y1<k7CS3q(Tp@S6A`iJ*lQ0G`R<r2)
zCq=8Ih1s-G*>SI4mY76bW4VeH&_`Mz{A>)t-y$))IA_ZsS2rfl;t?NlHXX=Cq<|`N
zvuSlVgXsu(M#cmrivv6(RxMVo%0+Xx9^M_Uy;@_jS_7T)wP{~vxhQh>94Feo{^6Ft
z#I#*cZG9h3Qt%ui;yfZC#Z|G@56RR~sCxVucP}^VFGG&xgK1*Z>8p^%b4`P2*G}6W
znCSf>4$mBT6~)eT2|6Ffq5PU%c{|k90OrsAJ5;Thuo6sdlS{`idl|JmJ;@u2d3^6+
z9;dT-P<1$SF}$G|uF**pobo~hEs@M#K^5P)sVE+>dZtJ4Quf^mUJc1#t>-@H-k>~*
zH~Zb)hcdf@FJG97Oc-8J8w^Px%nushXnnL0u*y34;gKO-;%f4--E}lpPq6i9=|NG!
zASamCfknLSB3`sV@npLn>cDd0jtdwJacKF2q30vJ5V8!D<CQHC0up|X!8JQ;1*cmP
zPq&)VX1RMyII5349(n3&N#w!3R({H;&u7$gdp&AUrs0i8-mpFr&Cd0miBUig<;?yN
z=#J3d9kbXSgH9mYn@|U~3h%~<aQABZdk?4cDl0qE?iuK?QSi1Dyr^;I#q_|}*8_M!
ztyA7|5wH9#r2_oCnm*P~AA@Ei+AUFL^RUi(!H-gK*VQH6cE9q&EA_|fIEMOm9c*`l
zX!Xj=_z|pk&-yAFyPT^2VoX=|j(H^yPFt`J@v0sXsI@(ou&KwR+3zOamCwF0g`;4-
zJAz>HzR}f;v3^Duv;y&(MykCkn(g+j&#m;pcV*=*HhE<(JR%JeeV{9@p)2lfax`r@
zNl`Fsqsh;fyC?EHJ(fct`&2F7sV*hJDLY`6wK?wUme@Uu0>{15NT}jTwKjn>zRo>b
zv(G$O$ojTqebGFEZZY(5)?#(v-KVE+7&})jIA_34Ta-s>QMxQBT~IRw@SAl-=kb>f
z9N*WzW2)1}@uR7T>4zCg6Z!M0+@(l~K3r4}B}GR%c#ed7ZdiB!i}7{G1>SJvQ9P0!
zG;{KZ`c;9q^S@w`Z|7&9siTV@ZC$#aK6Jzvc@zV#PoG><3%5{5kbV@5R|n2d9BA#m
zjQE0fYYYRvUmrA>I2o<h=)2SzazMzvhW&6=g6md=01hg60`c-B0;{!l<eJE{>}bah
z8&#3a<lwMg{}F|AtV~l2r%w3bzMqbiK|HBiTT7U<&r=Im#t|*$K^!Zzeck0&!Vw+!
zGdfPwnAGAK9XA`KzN68e;#U4oiqQcYOG{!9-dnV&ym}zzXJ(vco~nM5DZwB!J$BAu
z`rUjUNBpsmft+%jf_8{Vd&Cnh>RQ5reSebP^aaJucY|hhT@E(;l%k{2)s(e<${O^J
z%6h`Qy}P>9O-HHu>N54JW9L|S(v}GvIdMO8;y^6-Yo`>HiFn<$ivnLnWF{VbSnhg+
z5C!vo5DF|v_}Ks~(AG~<BpNiNE5ZfepSQUnSyeGuxPB=@#KE1Y=1tsYo^J7MkL%ge
zx}p#}X12xC9Uj|dIRSO%6%j)12CYsikGD7nbUMX<<e=FnQ+a<dy-Dy=PQ22N4)Ajc
z*kWynn~p%#Dq~bklRtt;iLY8CAgpI#@ry{JP$s9}*?>vOQO0NHAFYQ_;-lSHei)xL
z9L7AGy~`~ne3tznN)U$H3R;O(9+egg=u|ZO-QiJ$KW#LTuwdmS5A}pY0&*j;xdACf
z=2HQ=8Ozn_dckcMZS>Bgz1Q}DFP?`rA_ZHJTR{u4$|UI%m;qK}txmhW0^T3!;rnou
zVb}yqjd??jxrXr{Y0nySG-tBm-G7cK&p3#4of>5VPVnE`SJ9dimiaOkzna23FUB90
zFwh(h>I(eGl4jnJ27XJH_DnNx+(2gseM*#xNDBY8AY}7iJ{&2C2Tz`fRsJP?#{c${
z$gnw4BgQO7!7(y|z=IQP4|CQLDF-d)`P|i2gZ7hbD5+f!cv+*ZnHUJV^A>lEy5164
z4deN9vD_I*=AO?HqZ5#s?@~oiPF1XF9r~UaBGt(wM^HGYPWw(QqG3CR6>}`&@^@<0
zMY6kja$PBPJ9~Fjg%myMa+QCCyl5Xd{Rzw1Vb4?dDTIuy#528um;WrzMe=IHC(WAh
z+Lfe8LOC-zJFI=0*sD5BQ+F%~J(@gtc+EHOp?f=>{e)o}4N>PksIpc+5Fa)M8sYaF
z-D6wrR!5w1aPEDtu+SuNQi>SwkUh}1<DiJl#SYUFngr$o%4U7)>9Pg_=d>7J(cyCB
ztN!~zxRbFfG^EL+;42!EJtPTRdIg=o)Jt`%@q$TwlCnKtxdf1m|2l&RfEhaQOdsDo
zOkZ2bisx)u=FuOB!Sh>_17E^+ff<Z_GonMM3>mjUlHykT)JAaIi2cOX>bz|Fzji#?
zw<CVTC@ogHR}~t7mP-41WvpKJ1`^~Q8Bg|{TA&I^U6n5=g0)#jFTXV!hD&<n%sgcq
zi%xVR2xYhVWd|*>vd>KY(;3V%_lTKq{wK_`!Z2P5#bfXDvP>wmssH6-2exYWPr{CJ
z1~vHaKMdxn>|v{LQuV(MjrxQ8e)5NI4d{TQ`8yC8o*ZtRsBJ=j3A6lhAaGG@`;W!;
zA81`i+w)}8RbKK%k=B3SZBU>I3G43S4vwtLq0XivSpdb*e<)KtQv%D<Z`YSqddOrQ
zae!{YPM6zm4(?}1>z<-=nim`c4cidiQOwsJA9P9HTRZ6??%?ydbbqyF2QIPBO;7#q
z_)52DOuDOCT!=UoU&qwGSbTEo(!=xw?f=h=7L>~3?C+lF!N+U5tt7Tom^`L|1fJ9Q
z-{)|>S94|U0f}=7T&<-D$$gna>bP@$T`>JeKK%!GM)C(!O=t@p&0ZVa<!9~iGGXUJ
zIZvT*myZr`pY;GLZEq)R`tfM`#;EtqnQb5JmK2l{j#l?g7R4m*1<|&Ym)G-r@QHTd
zrS7@sz2TDdV0L)HRLCp5e}j@S+JE*`+<i5nQXu2#6*YFZGWF+nn3s>F7-Y6Z4PUBt
z@(FKf_|o@V>_-P@&z(l_RLV&PGW)AhuE#-zXm5RdQ9PwjX5B>HEz6M_7NSLnK%3yr
z5am_aiNLa3|7dL&h&&QAlr^c~DQqE>f2PM^S7ER^MC)^u@#+Krk_p^PX@u*YQx8j8
z=3w%ImL5J9qJ_)g7K{*O8f-4G=lbC4y;=`H#EM+Eyw=Q5F~ezaOss|@YOjW62j)qK
zYwe}fOI78o_s6idD*d*;TK$=03LdZygS8@B-=Ub+3u9-;>l?28gA{l%s|NpMb`6;k
z*-s<pRWWK3Xpj{RRo-Ra{85?A+RQ`U4!WO4^q70$0rN0eHlo!M#WdeNTga`XQ6D4k
ze(QrZ6Yk74rg<2VQV;2c_t4*~JJP1>LvbgR-j3HBki~xAVvb4v3CkC=r7XXifBK5Z
zsD~`Udv@gRKi2&5Y}7YjTVg@`HLtv7l65%Abr%dq6qbUA{YGTcZ5mSo{lAlNFU7Mq
znTuy99@n^(?+%(^8;R6<$N>BnL(Z;KgYaOj`f_6TONlD<I|ETRH&_&LMjvG*hBZm$
zR%DySUG6ye?OmS9f&R45F^39sm;OFr5)X?(WUkpX8ZQ;Tx%CPzl&tQ$aexEaXvX_H
zyqfyS4f7~?QSZBYM7)d9H<hQ0vwFtQNHY5i;$ekqW=DS?p;U|ZX->o;yDV<;J;gWw
zkv-cod%-1&deuURpwAVGIHLv*KZr6Lt&O_1S%BPQpmo53Hb)M_^@xZm^t#4Virz4N
zjAb70jEz^cNFJ<LL%KAk&b~~lBaK$WZx)dRtLdNIuuj30RONYnXKdRpmoP#}16yXu
zX5g(X+pu9`hz@AFKrE`->`GWYDW@Uqv4^((r8$QcIM6UiZ9+CSoh<eVqi8dF<M=I5
z?+b|sdL1#Nk#Heu#|V@M)P_7e&Ss=&fm-{9kjW#SbHpCX?r8sU5$WRPfJLyfIZ6dT
z4cDeeBY+7TsminZa=+`_eN~Yzf0}+<(&}PAX$A&WyP;U-^@)^JNN?O!HX@ip()s)o
z&*_G@>zGJvgv?5mMiuH5F29<yrM4kt<SNfO23~7JkX`e^)U!xw<1M`hJ&y`^%`=J7
z+Kom$aSGl}Ro>D!o-f=Bi-a@CuO!h$<A>sJe?n$-^!rp6Rqb>oFiuKQN%TLf_iQC)
zD&A_(rleetci<R`3s}~NRUm?CkRQp*)w>GX)71_21rN`#vS9?YNUB4?21V*O1R{^f
z(F+xH{H~$WpY%~Fon|1BCdg_Z={79fW1oPXZGnA3;5JMe+>5ve?kW`d-X_e1lpbup
z5}#P;xxWH)1N?&5?2R>E_&rS1PpifH<BmNNpFR3YqaA7DzTW_W^$XsxkNUR(+ic;t
zamjn$Up-dCv>VV^QVFr5imqTGYR>^>p#QlXy4!y50a?;xEqP%ql6A2q1xxB9R%kI4
z?u*uQ>?9hSwDp&KJuRJf!EPjM_HZ;udmMJU1(txot(!E=1)S?SoAqUK4f2q41esFF
zTN+~%XvMbJ0^}sfK%6#1%Be>~g)^agdZh8ZO<s&CJ5m6R-5GYN14|f3F{$$^;(jae
zd+e(NXZ%h(UX$bPqyHGVmO!!3)3`{A`{>gxLe&(+p)^v^Smxe1?7TEAI~T0~;5(wn
z!p;~cW?dWRtAbqQ&=XBB;m795PL1JFmSTbShTH6IUcvEB7Wkb~-X90k2WH0?(g%fm
ze=hv@`txM|Td?mBYibRyP|w+^oX!x$QTT@G%`EfMp1t4*mE@&*zEaO>q)>o_156Zt
zQ?98n=zkhi(ML)xgU60}4YE4y>04c`j{nBeY#uNv4U5TbJ&j_X{5&mSwFGnSt+MyO
zD^*MymjO#bp3!R#mcqM2qQZsF)Sxem?i>Q8dkGMa&?J+1rdw58FO~!BgV$q~r=^YO
zaI?&M=f73m6U^hB5@ligtcJ?u1~0Inir$<+;VaOvKvh|)l{@)JIH<mo{eu3G@xSKX
zPr~<JWuHy(W@BP|S)>(g3C|;r-9=fWv5(v7XI`%Urs##N9pgB~;?gaoaoBV^Yb2n@
zhgep%HJ7k{D}I{gikY;*P|=<YsLePtafzM3neSOHy~Z5)lSE$P^=_*X?X<3A92`ut
z{pDW(&nTAjH-b!Nf!?>DMx`oZ>DP0NKXkXW1Mnxgbbn6^TSr{&fi##mZB9t!K!wT>
z8~i;`q2vlSYZ{Y-;29rr+AxbnADpiump)_;_eGst#(n8wM1LCvKBvOXCPEVZo7*t{
zVco4f;@sbU#Ab6}Vw=ZtMzFuV{gD-Sk=*}SoJ}(@C7{QgSf;ggMk?9*`>tR9#}xKy
zlJwQ1GICm53+dJo+8w=k%4tTsIs76DGW|KGdduZ*$LhVb=IqltoE@_4h&qLAIW2l7
z0{b|4<5rXgyJaeZ{Ip^9-gp-?fZa^B{j=lu#i2vy*yRVXiriqDb}Og9+Nhj6>oSgh
z5dFcLf1i(R95k_RY@-p2s~AWBW`OX;y;0zEV&l#nLQ@}OR>Ni`a)N2+hZzGb%MV7d
zG4j62-)<j6D3v~b_MkL~EU_WY3SU(FQeI0>z^*@lwdMwInY5z=y+=BMCFAMk%|X>7
zY{qoMhv>kz3zfxH+ehO?^|GfNJHU9Ie;c>p_l)<)-go$eMt6hGr2Goi>`1V(i?tX>
z!OG4afS-2cIZtNtl3**m9MskA!1*P2tE-RyDvEXXGjO>ni+NvDcW6gKN+5q$nI1o=
zvLjXv+F)CW)bEgizNw<zuT*<X!nkj~&8S$VlcWcytSQ6=C-eXXp7OWP0|~VA?`K)`
zIm*5Z-wgeQSm}m_9XNk4k2rM~br+3wZKuD#lT5Ih@cmlpD$VNP$OX~^I_I<8t(p=9
z4-sp)>3x6sSzEjCl*fQ|D{nqpXdMunKS<@D%c6Wxn^Z_mNynjKt`H61S3bukKS4hR
zz4;Xmw;k{)#jPz8*A`(hZpo%Z>sW-jwe>>g{YBUmimBveyr5QsI>Fn=A{ls52FoOQ
zI>t?MvitgP!*n`Y>!SPXd%GBum8A>~`(Zj2(p%DDIm~rjZLvCPygu~F#7%H`@|#Ob
zA@Se0{!aB-GW_bWh9p+?YO=8R<BI;sbbiCSl-VQ=gX3(oWbA(~mtRjd*wsL`{(g7<
zp3Cy@2xh>AY<draJ~Whc2o7@*620%$uikrNdbn!g>`T~b--v1|9q`QX{vi!VjB0<9
zjIJoc;mqZ{n`~TPj>=I8!U1kHtQ%?s!$??O>>O~yD1m@#z~vvq{6_kvEZ}A3h=b>e
zD-=cpZ71<b$7VG>;xV#Hhx3Du%9~(0@|!2(C*8)mH?H|^ez>tod%Vn01)9!a_hL!d
zQPmmBoY}+%@mh`UB@N@`d}++ywaKRu+SG-2JDLb3**_ET<?4pZ7|YVb#j^>=Y8C=#
z_cNiK*^u1f3xwt6ghQ4$jL2ak&R(IXK3(}kO~oYCS-z}P%`_sNC#+E3%!W{(tfIbf
zq+L0kH9H%@2s@f==k!C&z|BGOdZc1NhQ>Yf^_srr2SYTUcHQjv&_g=%vdynLo{vx~
zXZMa4KK)h$)3J8j{Lr=~+1IkQSECs&Xcl?zc2D={Jootuy~j}sHXjTnBn*_!0_*c0
z_>a!hZtV9@;&yj8eq6-4D9TyrfYE`LheDBvU9Cm7O*FPWXDK8%*=rd^h|#7=IrgY0
z9@;gw6;0>?QNy+GYvQKgn1m>>pR#ZN@=jJvHBHK%qD~U@PZ<^bPD%`ixE5V8;Jr;2
z+I2WG6j(rb60^cq3_av#JpAU_g(!7l-k^9Fw<D<qCBX}>#06KFof|8ua8F>bq8}Cd
zR=vN}AxZ{T=e5NaBQnM?#y0%h<TwczVdIPk>bYFGY<JXNpvv-?5i2*TimEhBErt}A
zyk699miuNZsjl9?89q>c!D!+LK^E<S=hE9jgJrtp3iEP1K8TCA@xmuv#pdM?ea*6~
zDtgDO$suCDLTIBAT!WWgCooa@bP<kFOx`2QQ-p+Pv*ApivbX;T_c$(;4^bJ9_upuf
zg}u@Hb6|$SguTrco?CSVOKd*cAVX_Pz*3drA-;UZeed=t?wS$E#hc5nvKizK)Ntd#
zlmT-%;z?yOn1g_4Td4j`feH<OM@v*K7K^T4Iy=A>2|Qao7I6NRW&3U9YfB9ieOA%q
z3S3A5ujA#R*)jhZYZ{B@=VENMA0eWaoa&gTiu)g?jMujwHIz7Ia6u-#3u47I4kNCH
zKpNmv5r|G<&aOi%=y6RqrvqXJxvk>YG4q;c$@y*pHh^eV9*3a=jQ!c&|KyPH#|$T;
z)qDNL`Mp?vLFa9$v52$AM7i_;<`^TyT0ow7T()OYxU_L5n@b_$>t91BVU@!zTl<D~
z7a8u1!q840xpU90I`x+i6?%C3m?ak=ur|RPA<DBbF|2<_FOGAWV=MQOggN>fN52F2
z$G@ou2DRD5*!{Ju7r#zq8cH9R6>$l-<i5?z#;L1CLg9d0iNManKmyo$4J9^<OV(UD
zC(LFT-`*e&DrKLfXxtm#s$rRidA7qFx6r8(d>Sv~2b6DZF?E|Hih|VO0>Dn2H3_Sb
zvJ~b^p&vH9%p`3-$e3D3RL`*_AU50KAmSx>5)ZbgOX`WZEIcxuK5p>7@_85S(Sb=k
zajhQG44;lc)L1X51T0sFnrCpmKH*YmZVzC-ee++$vtAErhfgOUp03ZfHFGQFKxVX)
zqJ9A6d}edsYofNsSSInF&G4_y(9^gzQthIoZ5f6+<{?tIlQ1)nv`WD|GNeh&h@5lM
z>%55RU()5c^Cq}!xZ+?A9NUM7Ss~hgAP@9)uNrbIIY19fr;!twv^!i5bl{28^$-f-
z;<VrEIn2t3bm!Y6L(XHx2+Y~BdtAjb5~auuYlN&jXyAX?irY{@*IgZRxczy2qNcYv
zq~(G;Vb@J*43Yz%wn9YD0~ktCCrHG~&FHhSJ7*j=L(ntf@C;;vDdAvdI!;%_WqX=a
zu=X2=v%glgEypJ~_Ln|P7t!_{`DrZa?N{DXL9?&S<c+tOx(#K+6#pi3LJ{D66Xs6N
zOdsgcH!jA_iJ(6abms0E#JL?ZLu_Tn@n<04n-UIWrkfrYbqUaY%q=Kaj`0#tO^T~p
zk6!k33Z70??$96cQ%RkyZh*V~BJm$w^3Uaeq>#6>l&5ijnA!zMXV2oeD(b?+b`br&
zpXCfQb?Xa;KlM@QN3OXdcI+^F851#6E{Nd8lY^rM==&<};dx(rOjEqlHNb!U_YUam
z_(dIMq>GDl@OKEhjKUTpJA5P@xu%DZ;US!p^gpC)^fOSie`Q2lABI+8#7Oy?1kF&M
z6dp$W_p-8jKML;Vm8g;(<@nHg&lmvV*;Ghc+>`+#c$TCH{fU2B@ANH!g{|I+F85Nv
z0I`)82aiW4DH1r+(tSQ@^!Kx5Y5E3PhLmsCo*3guio<raz|;_LruAM5T=&1j*3?<|
zj<^3@kh?!~MjrG&b7P7>$(&H3MN#-FGQnZ0JbEqkp7o!_Z%L9k$hiZht|fbVORwf}
z)DQ$n91Lop+PD>`ySGD!^f8&Mx&}Y{#>1)$IWpt0JuNUZ#2diLr}z(`<3IibRSaYL
z{8qdwoBprELm~mA4J23jA4v`dna~?dReJZw4z%tXm8<S&-GquNssc&m83$Z`X2>{H
zTLuN3U@^2-hN+No;xE=F#=$p{r-lKkPxI~}a6BdmQ-_1_DzUusz9(_3U=YO-@!io)
zn__ly8f2}2ivCS~NEYm3G*lDQS^xDgZrOgAw#G8tGJ)aArzc@oUd0`~l+XLruudtS
zohg3luH6b@fq}Ff!Gr`D9ha3$)e{~26iQ9@eb7(^zRPv2DI_7$+uO%1&SNz;7kD#;
z^Z*Fg66wthcp>fSpEI7f6r)zhB2BqZiv`rfi3M7l%?T@j_9Z1Yf%JwJl86GypgwH>
zotfosW}1UZ`_7cWlIa+^EP_zF>>^o~(CF%}5-oTBHA}I109hL5lG{o`nve^1(jw!I
zl3$OOs<{6W@vq>)fehw_8^%6(F;<x@?Tqmc>D77pL1U#Hdh>pq7~J-#d?|9(I`^zQ
zL1Efo&zgG*3y&(~Oj8k0?=h`HJ7xgRc$m`6(kJbiV_rou%fN$!<udP(kGCWF0>vF7
zbq0ld!WPPrmd1n96aLq9(xe4OOxXHxN=!BAmmJf3Bd*K^<^d#Wm|bqvf_8)ZxQG`P
z-gVLUIPRYs_IJNc6xqnq#Kj(nqOvq8$-%0cnqr&LbxqBh!0eFRiPtn3=Hs)<rRSK#
zOOYr0a1o=;>Z%i~Ak+OpfyBu%mDm&1qe};6Q<u5sJ*lp_vU!B-#Zcv1b&gI4i;r7J
z?#v(R-nsC}3+!)Sx`m?68I{p;hu~i@QSw%$j;g({0H>fTC>N!^E!QSsmrE}&hc_Zm
zf@nWlrhZ>O8~v#G$+#{DbuRd+Nhsg{UcW^>n&6dbhbeX((KUP+T*gCo>7fGe;DFkk
zV;Rjl5x}GP4=tr5@6uyL^N9i8YJqQU){Q%E=@xI;=Cg>D9!Rfw6J5;dJJA7S0;r}T
zwq9|gIweLb*mGzD!k1`)8}_kwNG?$4Zp}aF)HeGHGc5rkfhAF^T7v6KF1^bfeifDY
zhREKxM5<o|PUyq$SGP1?!&0z8q|cdP0i0$G^zq+Eeds2#4M1hWIA1MWF6c%mEi&W8
zB{(Z`w}$%oeNi9QiEKlTCGEh1ZpPCcLlz$(FNnuw5fzVyqt@$lWq2x;Bm-~M=aOKd
zpbgx!Ob{wyHLoAfb;L<5unk^WthGImuz8+GQ`Kk&5MIG-g5x0z@8!{D<D{zX_ill%
z!CT*z*B_t*JNY{A-+^s!9_}kT2obn?jg|I*$oLLf>YMtL8_XaL0QyG9U!iqDH^;&n
zh>KitY;%19ln1cixouxjtQ1_9qtHLA=!YlJ9@}&epjc(+ZuRy7<o=<M$kuEAn|>5r
zWr)ZrpL#5x_L3O^W+VVM#`6z6d;6;BDT*n<?dLNxSmG+h?4z%4uClH_AZ~q!O!ZCe
z<2aJeK|oPe-fmNRoY?4k69XhGs^(9CuiA->Mc7d_nlg?2wc2#h4SKgwB2a=&hb5?M
zm?+%pMr(6Jp#vESTZ`zx+u<N7d-82$2{x8uA}B|8!t5s@xmbqL04*}cF1ed1T+~5r
z0Bd)b)%+xLYmy~!xaR-@8!RDWwSA^F9I>hvD3f_|HQmKm@}7{@WnI8xb(Ju>N)S;*
z;V&J?Mh2izBPfn;VK!$weGc|J&;kL_|HJ^H-WIh*g*2Do)&Nfx%}rJHxrl-G9IjHj
zSZ^q>Jr}&XNL*cnMYuu7KS$YImt62!I)~+LxWWQIZC^DK%h6oIXf8n*6NO_UZ-!D0
z2P^t}em&iBdj!BJXYkWF$R={{!iN<jVqEcF)}DmTiu!ed_SNe4daf(W3+M>m{LFG4
zt=U&QTsb9-oDzgPLD(u%BDAG<RGclOaPXF-?MhOReA0V4i=m}E$Zc?H0AshkQgRzz
zn|bL-U`BpiXAazOLN^-Gpqr}sTXJI5O=)77R<Vy>-m!r*dd*6@RrSK(IM0W~5B8Ss
zJO7@FO$wvuFTQzq&PXS;*6)M*c%X!&b0FApT|xUukFx%SM^z&HhliDU3tl9N$YC<_
zSM1F1N_t!?mt7gRJHDku5id`JR|XDm5Gz52RXpj_BmpWUQ>R2qYP=<^gcpS(>>m?=
zDU-uK`wzM%*o;|`%1Y2%{3X%)P~Ljm=6&9ap%pMJ%lLhCbRzqcWDf)I3Fb1o90F?f
zT26J&ezkyFt90|*w<7;e(vrE_@6z!s$-d|MMFF34j5saz0CeKqqQNlxEfk(7nHh<?
z{EkZTX_x3<Xm1EfC}sf=%(0I;*0)UFf5?P^sfs;(tGdC$4*y0j<0kK^%R9j!MI9#d
zZw@I<V?NN6M7{-PtfDUd>3)vR<DLyk_{I&QX??|3Ly3$W(Y1Y3={)g^Ie<BN=em2v
zYm`*~8NXx@2NyaxJOvvr*4ivq9wnP?ZZI))IQNK;!_{qWPso0;<KAMW9AXrg$m9`R
z+o?+5)m`uVNv(UPX=17%%>rMH71>DS01}zMaY#uLBNXBC`o=`q(GJP}bw5cD6YhzT
zpH2-a{vUGv$t*qOs}%1xi(5vQoxws-^Ybqkw;5m#5@i#_{RfThL#<IIHuV}Bx^~_o
z_reK|_w$DerK|r^^n+ynnW4*NQ1PrKJwpCMb%O?M@Ef%C)xFBiTCb4pn*gsZy24!C
zj+1c_JyeN{6s1R4`tx||@$s-(<PKX}$yOQ|h`%*fp|53B=EkZGQgtHL4qM={yjG3%
z_p=W8{G?oC5aIlrNU`DWFE~1~$kYsYzCL#a(`Rz})&|$=n5__-IdJ|`q*xy=yoX}<
zb_2*R@AaqUc#27FX)yW61g0E#Kp(&-wfp!)u(p-o__fv*nwV{T!zZ%ahRsp=M&yb;
z;%pQ_s{oWNEL?lD3jB9()VZd_gAPAPGh^Jphlxxz@PJVm>=`0xg+%$C3>PY1pjZIa
zLk7Na7S}v`UiO(@xz&$-7Rd*oj4hUnfFGVz2MkVi1E;}YxtKv*vlgkNY+sl7PXl|7
z_Vj7Eh)b(LlHE+_@9@#WFY^o?%3($WoL>ONH2yifXY)ndl5c)K^-JNxbA5l_i#Gm;
ze}&DNQWFtp-HA-?fF@YyQ%&9V%@_5NGpbv#SApO3uJ{A6NCR;_1YnV>Eh$@f4fW$|
z05=M9Egg>c5heiMK`+<doj9V3vKk3EoWLFZY9gR48b1;sZ^@~7I0E7w8{DG8N5MVT
zzB0T$#<Gq_2mW);sxe)7gj=Z?H8Z4+R?&VZ6+3@$431sJ!(Id&t^*ZmtI}W~evzar
zjOqZSi!p?5?xXdsddL*KdRxl&%=)Z?>?Ir70Y!F64>H{4EHCtA^uZ}Ob{((zZdh}m
zF5Ghp-m~4DmKAX@^Kys6p-&I}j)2-rn%*#DjAa?`IRx)v6ug4^=B*Bw%1$yBYDU3t
zt`M0P@&D>f(?y7zU%8WP&$MelKTx{YCf^hD^;E`u>A@v9mWGG@0niC`fK~|m1N1Jp
zpazZ?8R?maaE^klxqBble1o^@mDllhfp<ioi#;e;H}aE!yXfzR#CzB38CT9^p{!B@
zU;j2*VtbNjgLuXN$m^96hKspSRRVs~Ka3Oxbc<AkOcYVKD_u}BmY6+$N5sXdj&y$I
z`5*qr;U^xADfxswR+b#z>SCGJp9qLjyqH`M=J0wUp1}Jfg_rA4;X~hlgOgJ*^<<aE
zRlyu|SmNY?^o<cYQM6D(`~i;kcPCef6ByK;5$y8{?n}3qTfBKlKw%L#a)U}fd{Z8W
zm`V{;3#OeMW^_G$fs$CpC43x9hd<Nok55kI0o_^T*oMjbzt`T5Mg%$qZ=O7&dG%eL
z5nS+j*##S3(NfNbxtF<AUL5I1tt|qrsZy5;RnFS6m&!g>nx&0cJK++RtT}VEC;WeY
zA8t{P(D`~Ic=Oi9LlCP_MU^1ZjeTV>220Tg%HV4{U|@2)xoY<HsI=dU7i-Wz)E;p&
zpmWEm^#D#)o|6nbRM#Q0qKRDiITgd3&txqSRNcZ-hu9j6gNLJ%cq=)^9H%`*5!CU_
zQQcON>WZkY3wmtREyVRnNP8TB*|iCV_iGx(oK*56<Vd;YJl%R8Y~wA&)yd?D<za(v
z`mSM<Mb2ly?x6HheDBN*UvkT3XfZ>Mdng=4{TB}j*2Wu_{|c<==RrPIml)Z-JLcqf
zp!CLo2M|JW)Rzc^94L>0YU`wSJWK*iJMmD_8-BU_=BL<29R30h<Ot?n0JlOKo6+Xr
zXLe+0At%$+RU<|BdZp{b!hMp9LMS9U;9UfFbg1;vGiq&ToO*K7!BX`rfSr!VzSiC<
z_*byHsnKW=n@bvc0l-FB$L*Vjb?6NUHh#&f0x&cPplPkxAJJ$OaK@_eQmPyHZ5!j$
zO7AylRU<?NQ2(`35VuMi{0{C=Qc&cS(AZSB(!#j-Qt%6c(Pa*}Yw_9cc>Hx#zI_P@
zj0D)uENg3;&uW;{11;uxX(A;S<iL$|G28D%_C>g!x=i(R?;5Ye;0vO~vS@5Q&{a~}
z&8M<+Gbpz%Cfxz*j({Ax^Y9hXG<`fvuX(_KgeT_t!f{J5yY*XFj+s)pMC|VK_Y?=Q
zG?)jBOT!{^TLn=j<DWkphrCyM?8+Q3D>GAQwh2moRzq^n@(>jy1N1_2Ys3>-0@+MW
z4t0k>jJ@4k|N67JSV*S%lv!@j9BF7A*xzf|7_Xu_s?B!%8C1|JcQeNvgn)OR1eP4=
zXGhpMml_`Xnxax@%+jgKeU{AMK6oxxxkuWV+)efnammmiudP4tXIocc#yROi{`dFm
zD&GzRo#B~F7D@7+2fh|;c`parW7xt6q&3?Aar;K*dt}If=`Ce)A@MBJn|sud_}JKe
z;yo+Z|8ekKk8)3z@kk;0CBT(;>*QpZN@e=X#zL&}OfUU~M2~Z2I|(Z37`_()z2jh<
zN<7VIOt|MGT9&o{r&^b3(dH7CZgr{OnqwDnoc|_yuhWJ5A6<?Db1W$f#<kX?Ov-ZS
z6OEyriJ^^zamxv0LSk}c&NLz^_PMfA1QkgPUnWNGWyVd~$%-gG9OiP+({zFVK(<6r
z!u6bV4QuVO_lbgm67Yp5`GB9Y+x^Q=QRi4lS)K*v+EjFv+bvDJDu+9B4(VxENWTO5
zFtFa18j>r^LsXFr;Ct3lEF_9h%4sdSd_y2R+NL=DGDn#?b}$R(mD@gx4CzX84cA1v
zSX7W;vmhe0iW{$FLHB#`K(lE`^NvN4GU>q?4Chjxv)BC7w-lZ?;lW)jk6C*j5a+%_
zGW)=b24#OT$>2p#<}YzDv$5*U>}Tf{Q+JVf(SEM&Yey}TgcZCi`UUcdQcSqhM*DI6
zDsuf~u1r*glB6H!3GSswPVS>B+kcqZ;J1#a3F0Qt53db8jYhJz6z(|#e%WHLkMf8W
zi*vB7dOCQPAW(=~27NRI(Gie6Y@e>2#?4fpm*r%Cbl8CVqH+>e{H;sw^k0={;X9<D
z4{TX*h*HOd(m?c;_LjVtC#}1mH_e?#Q3hCg9;Eok$bS{7kgICTmP!t<h7@U$rau2=
zFgqT=)N+HT0W^S%T4ncWwT(z|+4v6}lFA4@$3vLHBkzj&bLvJagqDf?A(JwWq^t4=
zxprC~j9=6M`2#m#d$8KpZqOcFl+P`~pkbj3vh_>4{>70`);!4VN7U{muK9aI*g-OU
zW{9ioio6c5WQ>u|`J#K=5sBfh)J0F_<TP>I$|7-P5%$atI{G<k^pr;Vq$eO;B5FQ!
zSSPHU=nivgKnIk&0TF1NT)hdZv53y~BLL&8YYEmK*0in~{oe-D5pL<_n<MrgU)`1{
z;$$w7^o^b!FM^?=lVt2987?)fkseTfW|(UpFYJuzglNV4pAQ63ide!RmLOIL*mjyX
zMcw)Bp!P2hNG_Y)<&5Ve(7@T*M&WEX+BX2`u#5!CqBB-ipo!~~LmvjH_0E6J>j9R-
zapCSTv5HPro+tOvz3Ho;Rkw-`y^{N`@oD5Gb8iWww*(XuVB6{5--$c=j8N}V=iHie
zn2}-@VQLj$|8uhTwzv6qSKl%yWb@fopN0x~zUAzI3L#6WS3u3vLuKo$B>&MtljMl7
zeXf3(z7I`orPfHIAAyVghDj_k6tEDr@uq_|K;)sM<_?z-|H337yoSo&5U$kfcQ6XJ
z3O8xY!~*QmSP3fP_7RZt@WY=<!U%`Jt%>x=()&LpP}`3-YK+%`L}I&(T?cUNUHr#h
z$9WOpLdeaZPCRq6RWMOWS=XTmmJh@c15u2>mUL=h(13V(bk~x<`5DRZ9qjb2d2TQ$
z&L}z^ySRUs2yI5umHFz>C&Mb;QF&r8`)#?|nQf4l<*Wc>;rqrm2|P1$M5y(z1O?7M
zR<7GAF@EbRG4_IReH)M`j^=bQJo;dG0M?O7ED)lhZQH3A7Ih!CP}gNAUM#)?8E*%P
zuX2OJ7~5AVl)L3M4p)NWs$*JLtGKnV&g3OKWOrTIZnLWZ`H`z3T`5X~jQ6YPUpY&@
zGy6PV<jTorrI`K7j*6|WlK*Q0w%0^{*681ynSCHAXCcL!s$a?(<F+2_b~hz}oUrDa
z5>RZi0{ZRuQU79<SM))XoBBKZ>iLSR=Aq$AC+0oS^Kk9W1>!hJ<3H(Rx#jMjBt%6g
zwsZf!vd}VAtVJzWCXrKGp_;xzt>(X^#}0PuBci&(t0_vulwwFuN!yR1v>fwqzTg#Q
z_N=5aNfr%Z#fwRvfqx4W%1UH939g1Tr5?iITLs|3hgiI&cXbV>Z}O&&7ixfTor@u}
z43ekz6{hZQA727WzL<&QE#GzRI<)`a@(u$x({8fs$F&YT=V5X_J9y0>;yeH%?-yig
z78xb(gM^X_*WgK4XTNy)7}`cL9x9}IZ}b-P;Cqi=xF!cbKicnuo1abaB;>nV^TnV^
zr@~R(j;jrGyhuO|clY26rnm5b78vX-B4g5~0qs{jzT=z!OUA2&B`-x%@L*vxNH;|b
zmcb3CArv(ZK{cagSHHY`N3!g?;Y9Hb2Iq5_e_SsV5O@F<Wh_Br)msJajNFh<^74=K
z7hen}f019kB-_vVulha?gGC@RR&7AhuYb!jj`PQfa_@_;^;K$<@^0J>2ZeQoZrD-D
zdBznCT>BfhZ76%Pi~z`_WMfCaF<;s8`pWT7g?!cK)4wtl<h(|NKm<2?5A%r|ABuQz
z(*heN$Js_<#FY?84cu%~?jDbZYa%vJoUc6fi3Hnv^dTICO#lV>kX4p(m}djLYSX0z
zR4a_HwIb*IB;vfNJU0ILwf|x!x#<ArgpRinfEzOH&Ec;*XM2$^<1lUw@?UL6dut;)
z2r5+2(y4qP!OFx#JdO8_CSZ*>QW3II#EX*H!(Te~*)iK@Ds)j-_HJ_d=C~JL>c6#O
zp1tsDI=UMakIn8}e5U>SsMI@+jbM5>b`%fLWBVc0fziS#_lkbsOU%sxud7-uT{3{X
zA9g{|i{bEo<N<Qw(e3H_-QFGH+1&$!K&<6uyZVGG5s%!sfsoBu){|3zAuxwg$ylfk
zTsW>F*uCrj$&4bAf!w%-kTnJh%@sjYMEZc&vvTke>sPN%<T+r3e%Fgi!5jYkn~hqb
z0}e+-M&BOC74`s4GN{arSwKd1q!#^%xuI{b&7q=dQ$j%09^|}6iZ_Oyi4rSOSw705
zAbu|E4b#S0hVdhq7<n&`E|!O5X(4aq7k5vw5Alfw{DKpUv^I|%6tzo0>!yp)uz5DG
zw;@?}BT7HMPF#|m<7*bpZc*N9j^md?u}pqWuyMz8oyEv?J7?Tru7YG(usT$3{40`m
zu}tcx1jHyr%ss2kICS=9Z*!HNaFJoZ!`{!oD&YgvofPb$qR4xpqcSSj*FZLmv6f|Z
zD1U(1mGiX;qMRJ2cP*ouSN6fa&dZLRa<E2sLv(l#qw{C(04C7F=kM$XMRT-N<z@X5
ztg+BF<58TjeHA)H`yadiR;so6p`IQQC7hjcPa2#86WZNhSnl1n-@i3v|5tH$0-G0g
zd=__QYgxrdJhh#63HYJ)Q~*z=5)i@bBvdAVo3Td6L+6BbIa0M=3dA752n60FKA~h?
zNDnx4J%D;*8O+x4Lx*+lN>-dn;Q^Cz_2ls88q0VKI^guxI>GA!-n;Xl{O0T@vU?RD
zrteQkJjb<i)oi>nqb3ei8?lXkj{n#Yw}DOg$j2MNEr%&5g~SZ<5dN)ztk9w<%!t@?
z@M);N-uIbM3$Vwn+5|<Hb1iEe@hABJ-G-u23R;}hU>Ji{dFH$Kedfy@@;$KgU;`VF
z5s=2CEh8Y8iFgpq$>8v`Xw(UUc?eg9Smo<S{Vl#3Y=L<pa7!lbot;i@WOY!S2yM3f
zaUTP!#TR5jnGd#^xH1W;iPPScvX|PZF2<hH!BK#?_Ul^AL$YHYVS$W9qA`LlAmK@C
z|5C0ac#bP)^!O`>=bb<8!v!M%K7Z*KylOAEU$Ez(&o+)bBZ@AbpTERjwxB450@5@h
zW53?7IlfHg@e`@6)bH7!tDciH+Y?U8k_%4)m#xegG6&rHyLIBHp(~g~NN9eQ)v+q2
z`$Q&#Wyeip>&AU-^KZ?V)Ot1h=b#Mxi*f8$fE>tU>hNG*l_qY+LdMLe>T;ttXAP}B
zmUlhY7nBp|xh9%ciG|eVZjPDrhoj!{R$dx|F2i^<=VbxKDrUsD#U74Ytp~8CQb95h
zQpfGE%*RuPmSj(8<SU={62Cld4D&^;5^~S35EZ7ekcy6+yOD6k8?x^eW<P==s9teU
z5vfD{o_n?vh*elf5jVRr#BlhQK<^=|5U0c-SMSKZeSu?myP0KO+H=bM_x8lqHZYkU
zSbi8|!o8G8DT<-*&qqpZa`v()-^cx;xXktHyYI4%N@AI7`yd?dzrenu7j9VlU`nj=
zymTk|&~ZWb8?(=>B}OLh{J_f(uAChSsQ+)(TLy&`nglZPRGIBHW;mMfN<1-I`YH+}
zKEN}oNMiY}V=aB2pRsr^JmV+9=E)M?1;TJ9BH(fGN{{krmRJB)qiwu?_tfzqlR93X
zyuX4yZSLu{#K-NlGn+})*TDR1E>Jm-?sD{!-*-5-hG}yw!&xI3>e=07_`G7fw|@=L
zB^u;PAaYV^EGN4kfP`J=UzLfy_=<SeqW#@<P#zl~JkKsDhe>Y-D?$3l{z`}=lxb1V
zG>X_~7sM@+KyhoUY<|w`U>NlU2`|s68{RK`Y(ef^qwe;o3fh618B)uwk~j0Z)=Rpr
z8eiZy^9q<q^Lq}*k;Y?LVwivOn~}wuW*~0c-}gQFhS#~yT@nYj(3)fWvS9C3q)SEg
zvUB1V`7VMMpE!=N@LHOs2X{Ta3i*{qocRv<)Tgx}HkS4&Zc(=eWReT$78Y<;{i-bV
zO_Y!?a$P-FW~G8H33O-LUR4N0?p4?9Bxw9%^pALuq^!SR_HzxMKEI;&0&H(0zW_z%
zI(6~#TVl^RMAONaIL&gmGW+;rs7EtIQnNE9Sw%spGq*3xW->rrKFKa(Cr6n2fV}G-
zklXeS$=Y40BMH2tYVl(XZ{9cOc^>S02aZpD0lyx=baR2C&-$yd7sRT5<u5YSAPDBt
z=p}=`hn%{(Tc7&)!;v3&370=XJM!OK7XRD@YS~OYgd@rJUyNql^}zFOU*notn$YjL
zFY}YS5AnT65fclS=)lQ43~vmubU*M+>#N#W(BA+Ir#uf5?k>Z6_H{M%{Jp;>GWN3P
zb~OL*y9sw+jjJ4i_?(jyjcy$7wcXQyFTxt#r1rY!0Gs_TKMS?~hx5B?gHwCC;Xe&>
zqh@DqUb9Fpfr_6Dt8~|<pla!V2?EJ|#j;y5n(uP)jIGtjgN|@9=skKGla!W_BcwZv
zINNh5&Ae$t?B02GWm3MTMJ3_ucb=M!E8J3dkCq<IZ0k2CsAyBpd<A=X3-62^)HxXf
z@)J4VsL>Z1gMYHc{CnWw`o@{(B6bGn)vd+N%kBp+!I|as?#^kvd-LYDdF^*VWt&Ty
zQO|6NoZ!?^`B<NK$-YC0RXCialO}o7`}$@N*vCO!?m0v>Zvy-@h0t?!U>8j|JAYf<
zCQAMvs#j#;)4z-2z;G5QPLelxkdLdUg5A4!N55sqC$4!*Kz{a0Zz3t!T*DQ@bs|(S
zYng8*J9oq}1rzk^+OaAZajJ8MlHD+M?f^N<4#T5x?$IUq|D)>5<DvZ8{|$!hB73&_
zWGT#$tYuAQDau-8$d<}diNY8&gBFxRrjSuW$Pz`CS%hTInq8K%?+i0${Lc71&-42J
z{_@8h=RWtj&$+JaeJ$_H$lmzfkM2n56$FbnZMu--rY(T^7X%3wwVcZN%SUqGI0zcd
z{4q!v94mvl{TML_JmDl&njhXgM{A-m+ECxaJ?K)V)zk*+ix(q?mP4aQ(D4!_=S9V3
z=Y{W5w58T4pO@(Aht=~pMHV!wO9({!N?xw6m!1HN9HfHxE!<QsTDmz((?6>LOhbBk
zl_BoKvTwuTvy|m;o>GgZp8@D8uO<{BmzECxaQbZR|8iKiV9?c8Lf$GQ@o^`Ag+Pz@
zJoo4-m9Shxy!(#_uKh#wbE)GW4+v@m2KQ~BZqbTy<?G3wKgt}k${gZl4}vbs!%kw&
zZ#n;Y9Q!<C8}E6Y#sS{^Zt&-T2S@~MWK{P>=?z2)jYh+6Eck7D1;TyGQ5Whk>Cz$0
zx4#(y-kzQYR`mFCYtg_7GWbfJ#!WVY2UflbU>#$gASl2hrPMQDTmrk*fBqqzOkD_`
z(fUVa2Kg{*CipL?{|c@F&l+VuOGty)?<ba5yZ7O(U7v%E(OIUX$IW_pD)zH3ZCp&@
z5kg#;$YSc;O=Io(J5Sza)AhyaZcmhztYJ?mbB@w#*_U`cM#RQgGTwMslthS`BAO$~
zp%O|p*XF?P(MH4+?jyuOMwQ}LP|kD%RfOZ@4|p`_2B{SKluW}cA>A>QX!Ru?P-c-@
zO~c;HcOG_9P#HiwD_#rTt_KSR{#q+gJEIVRuCq@52ft;0Q}Oms{+v_$yGlxB^Un8+
z5#h!=wYV*)2$7X1j>YVxw2w7zSU~qV<`H=tvlQ-*S&LTx%VRU!<w}#9E5%Clj$P}N
ze^KY#LpA-ZPHPh*AQr+<f6ukpEOb4Yjo;`o(0y%+bIr9%8fawuyr0%2rl5onw<X}4
z%4dFVfKPjR`5UK(kK*Q=o!bc-I*8?T*v@3Q?v4*FKIwZJEMd*uY@?yl$!L3D*P8Vs
z--fX;GNnd`OgXgm<`moZUvg#Kf=eTvTp5yEb8yzk$_Fkevi`C{pf~CuayV8v2!>g_
z*oY4cby{s;{Csdu{N#6|eu;yQ%&n{xQ=E2XAAT2SOeyPUG*In7F=ip&oT6`b+;1G(
z9|WWRZ@_O!gJajhW(GhO9v<f9rwe)Cn_^x)1ZA9kI2IpvKx6uiOxxEI1J5}!=bhhB
zHP*E7p&mECHo|f}SFIQ@mV87Al`{;RC~legt1RBJr8#S$u23AY9uK<!C+urD3!J^=
z;5$*DhHgAFJlN<(dl#%Ho0Gb^KMqE15K|OKuur_h^=yeQEP*>WohhPJJ9befZ}pU2
zYDrP}3hlTaa7DaOx7!ZVXp6rWdp!N?SzM4*`Xls;8JsXJg-ElRiggP=pdmiWBjcGn
zqI$E(PY2{w322RRo(VfRb)!Pd7lazDM<|y5=?&E|<8*7zdn35Zr_QxSqF=DQ?@b|5
zUx3mW%*K25Im^Hk*b&rik716%Jda0@cw$}0%!h6iC09unwDxNgHOV`jxa}hvhQmu%
znpj&!nvmFw;b6VzmK~N!B*u#XlrM(<UY%y?iK6o0@K18E&HJ$L5841S3$URc2u3IS
zwx!2v$~neZI;1a~xX!9HZu02_S@`Q|UF^=0|NU;nSZA%1n!EFy%Z2k!>cWKK{#ZTA
z3>F+fMvB4~LUN7B?x;Dva9Z12D=sKZqC!qA|4pM;RcX)(r_@qdq%VdgTODF07pav3
z?sCt;0!_x{7XAI5!*4+~?B)jSeD2nJb-Jag*xImDc^$G}3&Zv`;ocdx+x-M5rexXV
zgP(_!G`%Ca3Vl1OP6iZ+>8F1`J7fa$UN#(jwI@@HP!CM{Vb5j|F`qIn#8#E4dH+&p
z<qh>kV{Vvp>^2j2r??m?-*;f9J?$4(M`Q~|xjVP5>yD(3KE{pctO6PnB&}I^9`>vs
z5%WQ9vpfO?U+d!ZV`cZQ;=Fe#CDZkV@$M(^3=CsRo!;Cr=Ud~CD)!g^HX`>xPIO^A
zLs;Fps!}qKub)EPp)0=u!i@`5Qu_FT_i2f|>P-?lXu!rB{OWikVsi>+oj^RPfRdPO
zUmThj*z}N?F|ra9XYtMP;aF-WP^P#>QodKiOos*9TzvGN=9G5|mCp)-BUo^OW3HL7
zF$FBrl+EQe+=ds3HuR<#|8*<cSB(2@&hfB2dDZl@JZ(Hhv75e%+w#h#i44~^+I)D|
z1AQR7GtW2Fw~QVDX`s!*S+Hm3%&qeK3HG9>6QnY6*bF|2>|DLa@w=I@tO~qAuu~1q
zxMkIU!YfOvBj1^)%%g|0yRNTHtb3J2uBsANRfUrRBy0)Lq@p|rSjV*Qs50j@^2l`9
zA<)1C8Wpe-9k6Y_6)|TnBTRrcAv>Zfax;GX)5KN+I6*|9Cp;5s>QidGF!QP&pUQLR
zRlk^`P{nGZ&Y`CSyDXmokCO3*C}QI!S6(>?TD($50UDC0_8X!J$E#HI1xqdN9`Y*s
zy=PZwgGpvo-9nQ}UXPrS$WIq(5^o9#{mSDmpZie7Ei5)5teJh#nY5|og`2w8t~xK!
z8?a5<<`}~)Ea+`d%zv2yf&(Nqs|r5}=b4tNFQ_c<x4i~5mng4c_}J}Y?b8|At)~Tg
zV&>;YG&0-DBY}Ji{M7#P9EEevLF^|#yH3KpeD#DdvQY{&Enp=*;MG_-kB%&qugxce
zNGCJwKXJ79H)ON{r>`6`7KWUQItq>+r$iCFUieAxv9tlUzicfQ&5x5#g@>Q8OI(>f
zHmYa5?Eo;Dc;(53q8^6Z)rL<)`U&}ZE)s@qdB68oyYW%DDg2ldD7NS=@4q_@R{Ng!
z>NOS)={M`{l~0|GsSXHgFIQ(d2Gn}l{C;=#mH(AKKOK-BV<ns2TaMZINB}cPp6pYf
zbMB!!gg!Oz*0PXzx?qNrW^qZn`LHPFX5!{>K>Aq39FF#JEFxIC8W?nDT!s-gQ(daO
zRQRyM74nY5=uR)!pYo@#M)UrptiPR-I_}r_T0Lo7^ICNGS%(BdPYU54X8ofFa~b_7
z<`{0sj8xZSMnfF5(~(EQ1{?O?Wb>nNS%7pGL8MHeO{>6W%5u|a4n1U&uan1-xBgKM
znGbf1ea88FR)GD?v0!Q~m_;D<%_5u1uk!ZCxX-EifX4_qH>i+A{h~fMnA@F``bH|5
zT6U2Kt`o$OWbj?;+~^<6Q7vQe^UUDb2!~Eir7>g)io8-s#`20+Cus)~T0;nam^D9-
zw(^TNa|lV=O22E?2Li_(s$i%?qPO@cH;T2q5wtH{1Lg6)qa1&!V`;M-cb#r+Oc+^l
z%%?r-XEOxqO`bMVetwzY*Fw{(C=}RC*6z@xUDFlBde|6|EhVA?)}jMa<-!MX%YH}0
zySWJHA3v95f^OZ|&#k1i;U^cK3JV{!uBABNj8*?Vh%f1SJp{hH%9mR~a^A$X(-ss}
zEjXc7o3NlbLHqdVdt3mv@Pg8spA8Xf>>Wu)nw|Eoa|>Gl89Ks%6Q{I>kAJP-tDoU!
z_(fXw5!p=7i2QSu&n{riJ|GnzI*6O~^Wfapnw^RIE?#-!w;xEI-H)C2BTOfAy>)Cj
zT@*P@&Nj=u8$#9K;8hEOSX`})oEAZ>H(9@>IPZV<*flfe0=?!~&_!%vJOpcbimPjJ
ziS@N(c<V7?&7wG8SNYbi^4pm=(yqw3ZJxmhgPIfLl_y2_rxfdHAHUzXTH&_ev|Hg8
znHW0{>DwaPp6qP9Y_$9YcHav#maI-b_RoE4n4{71i$Z0<myl@zTsmVSh~*}048_@c
z1ve%lQY|;pO?fz1i>=yb!Cu;j1kn(TV>tPkFnduPm+M6`Ew#ko?!YvmY~rOr-Sj>-
z<m(vTCywFu$Aq7Rnu#n0geH8_bH(JjUQ~?@KDKJadr%<PEyT8nX}PNwSru2mefeG4
z^rFBUPw|p#<?;M=xAYqx+eLn0foc|Qy>?W%?s~CxBB5uEai=)^ow-W!X$9Ht^PzQa
zP|iZf@V<QEE4ulWGJjm`H^;_-y*2_3jvPXZr#)wHdg)#ibHk(%WQTHj)#QEo4$^+;
zQ$Zq*x4mPtd9UQEnIx%A9Q`l+$Rm6Q@Zm??Bv6;<J+B@W&TiJhyET|WC-Om|8<$y4
zUIUn5l|D5V4Qcan6yWrj4L9m%8vrL!8N{m<&mrt*CX#xnj60Rih?xVj)$p-PocG;H
zJ>ggIg=5Gb3PCTk*s+JE<0V4$L@fYWcC#tefgO&!Ykc5jlUziP7*Q`XxioL<c4J4g
zFCq&_n5rLw8u9Dh31r$>jzC=zb=*<$5kmR^F>job(shcK_vuURlv?Buza$W2+WZE<
zSPNmhhwG0cXKPX3Hh9xf0*2QAeci}v)6ANox#0U@ETSibs7I#H;%WBxh@Ob|z~Y-d
z>yr`51Er2luZ`K<fNtj(?tCm-Y6bv@6GQmQ7*^rj_Ae-U(d5A4UfDzvNVIQwNR1kz
zx5n%sw}BOG(<q0!QbH(Uq|00C)?ysY_jS?V3IP1lG)kosb^v}+^3rKkB%-u?>fhEI
z)UFFb-UcPFWDdk#r8px-Lx_|Rey@VXlv~aKIwI9Ny{&O0vS*VnQ0Sm`zmN)+k`I>h
z(8OWGa)3L;gWiB$Y}~JSc-guRqo!d1Or2w>xjC8{bDAk$dqZb+fVM{Qkq<AcOH)oC
zIN3ZKF${?8{_`B(MW2viu=AGZLao_uU$nM7#PRIY002J#^(_GKW2$c2Z+%v2^w+Z!
z32f@8JkA{0+5AAg2RQdo2s!{hNhNuRPr_PYhLEH6JNrsu$->GX%#e63k3L#&AEkyl
zg@kEq`<v4PvIVhbMHi0TO6CiH>#4uU2CVTtTwpYn|KhgIRP$yGFzKm<73ZxD<#FpT
z48~V2VJ?io^WEe<c*6Qb_VjssL%;78Ul}z84+|d07ALV;wZB5<YWX1Owd@-_xe*Da
zd5A9*%#wij4O(#c7TV3_UdpSAYl;9r_9`s!xZ&g?AyB~=+2gX}ZY;iCmv2A%@#Wyf
z<pCB5FM%b7i&fl)Mcy-yPA+tbR68GPjP38QZF-FBE-|!81$LJ^h5_vcSvRi@K0A;7
zq59YzRfy^ji?GfLD%nrk#VmmVyU=yReXlAFK5vEGttt6&#=srY%?_VYqZ;`&5g5^2
zRIzir^H&zyzui+EFD4)C{`Jx<tnRTTOdq@I*|sU;!q>~Opznqoi$otxz{IQ}i%*E*
z3mm=dme6j>19bBt?>TozEO0_7h%4aS<b<=b-0`u)2Z8nEJgXKwxN4*paHT^*Z5IDg
z08BLJmWIbZ4-&*Y&BN|i5v^W4wfo#v&*4TU2w$iR@;Hp)Iy1^X!7d!<iAmCUjW=lD
zZ)Kx)*)YMmto<c?5EF93F10iOa~llPFmAehei@b%Ful*qNcyiiE@(L8(FgqLV$!s;
zTbdjCxk|?u+1&>f{>Qps;=x(C_S2m&3M#Gn7+08n_`2Kr3HXH$(mBa<%BIpCp@R%J
zx|CSnN0QgClW(7O$&&WTh$98!MwcK+aCurL(O=}fP!+P;qx^M2Q&t)8C9oW45Ns3d
zd~sRmFK^fX{<dnUe7AqbPPY1`$h#9Um)0jZCB>0^al)GL7aW(Gy4h|>UD|v|b2O8J
zTSzDkvw{QSH42$v=Zu?-OwuTe97xOolH{1?)(ZAc=CFyu{>1aS`Q!l{5)voO4u8RN
zsU>K~I&3YVFaV2A6DgJ6QM}ZlDMn_z-NP|QJ{g|VeNHELrMWrf0OLfC<Dm*y>Dg)^
zSFc?lFy3=fQ_k%wdG`=`H&d>=<Sb%@vUzmz>o3qu>#Yj$dMx7c&@+?lqxhCXUjfp$
z>l2UsQSwVzT{>cyY5!9!g@<6zX&0M-!NU`QDkeNU#}gUl+rzG;ud%WRKk1$98<trS
z2Q+eJ*UA4>wm@XO>gSVV6)zPhSjt8G5F=`4vf$3`D0zwyucuank8#4Jd=)~Yojotn
zV(lo-)eYO8O;N~2NZJvzW)%ndfxxrQxNuue#fVMG?Tgi2@YO#RMfhT<?~OMs^CHyA
z0U1qKqHb`x1wQ3ey553fdY^VW+1D(we^R=4J|#Z_mv*Y3N6P?WB~^3$9OG8lQcs{?
zH-Y}1Ycqvo0hUQ8Yp`9|?3Zb0Q=g86SmgI}O~STUQxqE!GD*aORj~zCdGI}8d>uk#
zS~~4)P90SkL#M>Mn+q`OV&ci`s8>%=UlhYp6|TEMx|}%v@-r5u9JFQveQF6Y!eF#z
zCiE~oFU<l`nfkKu4@=_jBZ?janki()rvTJ8ZNdPc<Rpy^RP7zLZ$AyfoW_l;_|wzl
zW-Jb4cfCe;SJ`))v5b_S-O1_=Fon5ApG4%$dGhHQ=`XT-K<Z@XatbFMmcM)Cdiam-
z-48dtNpc?1WeZ2JJ6;IJD*JXbb~VMG@%HN2qJX#LtIz8DD+Jf`-2RO93GBcCFh#8r
zM?+x(R768(2De*`s7=kyhwxVdp@+P~?i9w{@BpaN8csTSJyL?#rs#cjiT?sLH6zmO
zSEC~Dh@>2<KZSVGn6ZlA@k%D%qR0YQAuXnWc(CzD7zkKD%m8QG8?pP6i(1Y*J8DAB
z5m;lz8u~q+Fj6sTik!hbfKZ&nDb55`>o=yxP@t45lo-0~Cce+HVkw=g6;>Wry+Wdk
zj?!OpB@?5E+6M+Q9?qR1l9JHTXYQFa*vNIC*Tv6!e+P=Rkw8@y=0@>+kd5Xo-zMMw
z06iMId3M35V49UpDfgv{TtqA^qM3cg`QM|*$L|B{ZvHTSRy>M#Jg5Ezv@T$!KH!yH
z1kYo@7BpT?9$96LHVg||Flyl!Hh7NtG63xkSm_CPg^yr9qF}b1{05ZhZ@f*He;`-h
ze|17w{p*WaU<Lb(?(8kL<=GvFHEh^WK*16ua@3&y*6;PxPe#PYkiY_M6s``CUjk_{
zwVb~;T=00G(GkvTHXCf*y<%?2*Z^cR`<!zlRmr2WPry~&6B!+`!_u<(X!UVg9I0Be
z;QW9X@g8RD<3AAz>v`kl#=`;cP160FAlcs#ES--WI|w~}gnK4G0*)-adjx1gue-W_
z7|-cZB6Sx)m}DORK|TBy0AcyGD*~uj{?8n!h^a}IFtj?(@z)vo*I7|#RBt-`m~KX4
zlB4A0hv=K6LqQMOK(g%GN5a}i;j{qhAc9DmK--y*noC`xhWwLS`oc6%D_f2kXXK2t
z;<?c$ojLEO9CA0wtJmIZUD*1`W|bmpG&2lmp4op9j}lT)BYmyZBXINK+$j6<C56<k
zq|DHLFkTx1U=O%wQW9V`g-!bKi*wD@p+j?e@KD^fnAdVDfEQqZ*pJ(L1gCoby1kNX
z(U@=QLYiR$&nwp!o0Da`cY&FT-E0j=cZ)doT9*CeAIAm#5Fn|P_=qS_=au@#$XIxs
zyR)3yS$;l&!1vzTbi|G-s*k)22xz~i-Rn!#5qGo1jRdcgU#Dr0?tB68Epyu#RQ@mf
zkK~Tz!1zdVo|3Y85?HDqf$AsR9bmeFjq`1arT?u0XE$LsThX2Bs$ijgN;`qrnnLu$
z?D#365;QhK2PQgb-|kfjZ|<X^ouX`yZ23wapC0`)2awmURyQc6UI$q{JUed3`HS7!
zNpIS6d>h?RsR5`#cG@7vLVzue*8G9t*HOQXG2;kSuXX1f>&=V(%6A}eO(ZZCA32C;
z_0NmU9~l7d@@xDG5v=8yw2trni@QL1q#?P66uRkOjJbwvSU)R#Mi1Ax1+fM88*BkX
z)S(aDpEd&2Usxqjs*H4A)h6IO;RE61)z3;$mjt!f!e4vdd?GSkX(=Q>47)#8sDhk~
z>VOsh>=A%3K`Y99kEFtH>I22EOOtU@xbG&hPBIZjjO7N(12qJ}mh`Q=-%x_86mN+-
zDLA=Fl#xtCb0tiFEPBDzbP}91U+_6adMrUt7jGSMQh4Mhae&M!M))@PHKDS9b%dOz
z8kZ5*&(i_E>fKHIVk;Z6MlL4WPB65dM-w%0@i6B#O$QOU&X$c4G`0xih2ef_ETR&$
zf*rOPku5|8T(1#<55@;+y#Fi1UE#KJwRmR|^RFY9^J;M}k3&^`v7r;CnZxf)q*=vN
zFxE1ZsbQATUKq}o#sVsn=*pstq^0SLF&6mY8iV~<p36K=ZY!$AR>dTZ>*#0|!5DFo
z>A9?)gXi#@8f<3m8ai$?K%vaese<Kq!qdALV@m?PMR)EUPJ&mN-Z=y=5sN5-rI{U~
zf@O8OJ_)D>Bkt0BQ)S?gxVqEIejQ3~sQPkX@-t@fbo)<+$Ev}ZnIUHylIAP^2rGYn
z!M*B;+|C!CEaGoM*l%0H7fLa7bdq59B4?7MIdm<b2`DC9XYt$iM<KQM3PjZIl%E&l
zyw=-ioi%36v5-&L?BN=4<osNex2gJNA`o1RmsiVtB6Y;SnTekS^fN$u=o!<F`T{m0
z`dT2eWm)N)xOK&4ad?FUM=ncj1^0j>av@*XA~Lz`*`;hDxr1T3-DO<IH6ojX)uw-l
z^A>${i|Ek?FR*j;l`Qo9d3<nQ7bB2PysK-9(vhQc2>I;FU*+rbUZ5e;$56>T&pw^m
z?P`tVZcT-%c^=_cBOGaA$Py$A_y!zFdd84r%5qS?a)WBOf9}3#m7U}*H=X{VOoiV+
zi)C{dh0L*Y7BH<Q-Lbb)c#*cvpVsnmboNscw@KXmPFFdHTt`Dl0B1yn-`&;Wy6r(9
zwA)<evW1>*^4>ukNQCUc1PD_DtH&WPLaR$6KFSZ?dGzCt;-%LmN8R>9EU~DirKGrp
zbJ2zZecmp&zBe)4hFMj9NmH@9$J7<Cp~TuQ!M6kbItn@bL6m6>=rK(8Y=-pXQXmYD
zMrw1Ui5@VPw<tQiW#iXW2xVMtus-)nCE=0-kIEOJPrzeD=PHUr3Eb0t{`TzUBgHgO
zA4C({Vww&1tiKDU;y2`DS%thQm#nkaPqs5-I?%u{B!UI3`M@V`x00@tz=CRZdX3oE
zwXJu~d~l07q%|N6Il2ST&w)>`Wm}M6OJrluKg9Yr8ks-X0A84?-trnk05jUf{fZm)
z_ONzuO8Re5duYffVPMq_A|~=xo#izVF9@SE-|sW=V&IOob@s5+Qh2Ab5w4fM{B6wK
zVP=luZNd*+qzUWBjmGbbZs<3}Z<xIOzWc~I=$Nb_ziTt34z{%yTasIOmuA0nv|yYy
zC}>uNvlep|nz7?sS-TG(L3RX@9eORE3biM4AB$r-u7|BTHesYT$2SQWT4Vk)MamyB
z1sp<LlZgLQK48nojCin}N;~6pQ4wNcZ4l0kc<j`&ukc{U#jZ1WqIe4(ZlPMxLwUBr
z%M-V(xA!6*wCE)Y5~MUL`5a{#xJse_rmBWtz0Tr22T??cS8EtCFfag)cA|~9dE`*`
zPf*&M9xxIbhb&3kaj$ed@PB_lis~6L2j6X%#u=+ytLd4$Z4B`Ao>HHL@irkMw_%%n
zUk!0H)F{eoho3-HKlS$>&Syj~_3eF=<1O^={ygp8U8%lSFOt!2Bqol`zyzRfW9aq9
zwAk)V-zpm>K4^^e)#tca`7{<E@zas0V@w~%Q|mK-z_fcmV*Kd9gtBRT(hu6+f^$Wn
z)^p8@arVG4)P7kSFnG^)FMg43nTZRpWpy%V--!L+fIMn)ii6`}>8Y-GUebIuQCPWA
zyah)6Bc_N$9MmM{0%b|Pg(^n%*h9Li4m`dz7wd-nSx(T&92evK2s5b{sJwdUfn;?u
zr0czgO=t8L(^LL8RyYmDuZOVvo8Nl}9LHYoFJI@3T4dT!K4&d?Iu`yjgrGy-9>=el
zDQy{7Sw=}pClx}lA<-t4A9sxW04Y&DSA!U5JPfmP*=$g@AnfVJ7mHf_O&+EDve-ql
zf8$x$N-<-~x(c`t&Z|dzB7Z2wB&s_d!7iI2wmR8=TViWd@I#!#kjJ4XHyoeAuO4Q5
z9}vq<NC_Xc6b^^+QC%;M9xLWbF`C3b6NOK|gIZ)vuzyJjAG8#{1>+lV#aPPBFMk62
z=Jl#c#=TOPJxNVP2<N(b9){e#K-u$mWIJxOeU+m1fwT|(tFx!MnUvk2?w%_<h2uQT
z_^#rCOTsQqEUoELGqZe3((@o#l7Q^76t;u$<+)z!$uIVL-uQbgn)eibS?(KfbMMg>
zXc}*H;%AT8pVB?})zB$NELi3*+NslhA?ky*qD{?YzUymzD3`sp^|OEMYlsI={um3@
zD|iXNz7H>e?SuYu-BUAzme<1)G-PJ5(1X)&+I;0&Mm!#9yqCu=9zjq#*@rE2K@9%Q
zG@$P~`7<Y^R#4nA{qWN?BnrXTduBl&@n$SsBHj93o84sTUunw2<AZ^fD98{i{YsQ?
zn?yB?Hj<)vA8`iM`pj5_3|4(IbQzuS{azs37=3FOmA3OhQ1ic`nz&U?<E}Wd8u34W
zsH58V--wjPn=7JlF#u&UV@9*#5(@$*OtQ4rpRF6sY(0jgbs4iAP}aK+qft{7rx9o9
z*aZ9Cto=7p#f$xxmGKbqnv~z)G(C!m^MeS+4@QKq)Zuq@<A&}L-@!59+U&BWv#IpA
zJxNqQFR=$?6t@rxyQRXTjFUr#3TmTHqo(<>x+J_OU((gf2tELAY2a;9uXdi9fMGX>
zfD8y(ZFVT&=g4nMJFPb8H=X}`pa99!BCG;WgkI|PL<di{0=*TS;NJ@I{=SlSuK#=|
zaHJ<8`C0&yPXtIl3vHwF!!8%wsyjYk->>Kq{5}GN?#p24W_B)@bFA{y&?7cjSA15A
z`*m5g`as5LqM;4-K8PE9at+__qVQ<U<j}dx@Al1(G?-8{j2>`TTn{5!GjytK!}g}Z
zG_&t_ImfPiUC1~Lw6d(YVBlHy6YUb+mA`&FxNaH<whjWXny_b}yhIj0bH>&_F!Mo1
zWf8;)o$%ur$gLyShmgH6JZh7eB=rjX)31aQfBBV8^`yEVA4tL_?0hXeTfqG~rjaRG
zksxrXZ4w(CUu@{&XcavX5ed~<;uNpZFxn@E*q6d(Qjs7yQ1zH`(k0}y)BCVYn$&y`
zF9>n^-2={vJJh`xg^-$XQlR{iESx>pOltw-%k;0{T1@)idxyMt=`PIeuNu=JL&feG
zb6>vN;jcL_(6jJu(1pKlnnl1ZbpJLp3BW$^6&}O$K`y%B=)U(0(58?;3vPJo$m0WP
z0<I)hu~F8(43*`Sr<FyX=!6vu(Oj{PVHe6xXt}bG;<s#&IzcZ2@m{Xb4UxcfeB_?p
za0-8P@R<D;-s7N-1Sf#B0W)7EK{^42xS_ZU9PQvRTmr_2eFJyx8SCR^Xbc0AZ5byr
z8L%-Gklw*r`C{i{lO0!C>LxJ3h^Wnbp>iDOpBT-&`N_RmPTefOP)tmo2fmVHjCBGf
zb?)W>dC^jKpPEMg>ZCxFLA(fi;081>T`uw%mz-HVYp!K{vgD}+o(&^4cKws<r`w*&
zfzTY&%DIPOEzFHH!#Y4);PavH?;_!AP@Pv*w-0SPHp*X5AoZkxA?$@pXu&cIyxm`b
zu@N1W?;zsyT5Ly#JAv7)OcSlRP)rh06$EBQOCWb3^mgfA8h;&$72Roh&A?9TQviC7
zoyX-TtGwrD(!uV}j(Ve<MZ7?J9hJP%h)3rap$DU`jm1dj$_M13`x%44BOCU+Nf;$3
zCaRMalQxW~lq@t4T{{(+I);`CmHX$T3~nL%AK(?iybbUsO@1)kkB#ZzI~m9vVZ%Ap
z!6xsuLApho088EZ<qC_C6P>@E*|n{CUgAGv*#9%8fRZ)rL?nLDr$+V{Ms{rjf$;B$
zz2`&~$l&}!fyNK5wx>hb)vA?z@<eBE__Og0h4Tz4IE}@K?laDZdRJKiwc*S=*zl39
zge4IJDP0KL^YL?6oVOwQ*+8^yjA%{Zolq$^klgSvwYk&W)Of89Vrw5jXAD0qwH(dp
z|3U@{8wr{F&f)yMS)iK~rb~hDCp;e@RYv5Sw}v%>`_pQ*<W<Qp=+GkfSWn-BjXoGo
zA5@qgjiEZ8@WQcrOn_yi_&C9idH=OYKiBWoy62Z*By&+6ZFV&$Sxw#WkZhxeiZ1(2
zasJ2IynMKTV2W}HUppq;QiKPFMBs0>q-^fw%>rTBM%ChNE+>r083^SVftJj*=-5G*
z^TE-$?j^FC>ErMar>G+wZeOay_Rva%7ltMhWO(lK@H6jUqMavn?r^0A-A>!N-NAmv
zX!l7G$_v8~={9V9FyHo&^=fMDMm*cs`rzN`kIcf}Z0>n27)|W7W7km$r3139fv}Fx
zm))E9RotNQTh|G7U*Xw8tk8?BmWdb!VA^1}!Oc2OJIT3>LtQXfG>}H4ROTEANHaTB
zB{wnwT&3Fjvt}Pv&(MZs8;^+du{lK+{^11pO|^K(6HV;qvF%`$_rbAqe`JHMKNY>#
zp`Mp|X5D@H@IE1@a4r>LHO4WlkW&NrBZr1-iNp1IW==P?RaP-`2T}kkV4cIWJG?OZ
z=<Qgnf1`ubzcfS%@PLJJuiPkB_&XcsmOh5Q*TFXTOS8j*a^e>ctH7i~#kN54zQ3Q3
z-FMqKReWKYq&JODK563^l*}&BU=DE{8|HN?wvXC_%EAT0R>l0U-J(C>H@8NBxld#H
zqsb<^;QmEeJuG|;csadB+2+^<3a~OxWVX!SE1A`bVy-fcs&IZO`1OOicyv!6SR~sV
zp2MMo^fvTTW~Jg;4uQ!RenzJxy4uj(qE1Mj0>jH=u#d0j@KA?hqhCEmHqf&6QM6Op
zsS}FV;Da@o|DqcJB6}eDH8H`!I}s~>iK85=CSIrM1t)C+ssb(!Cr-X%45Zeb#ND@n
zzRsrbw*b_28otA@Iv^l(QF?CDb|h}@>pbB!EWILJN3itUxOG-p?-epj{>{j#jYJ5e
zEpdm@hK>s;M7?<519G>{TVB2<C>m6|-~E#d!zd%6irAk(ECLwlAh$$Qq?yd5)Lh6|
zy#?TyL3hU4(<?#Y60s<P36cEnqhtyVJKkNmbC*77qP51=Wx5Pl6F%*ws;%y&s+lV1
zZ;``afE*bvy@D4NJq`z~>w*pqJiOr%+*(vk2mtdOd?F!fbWd@&fl9Zy|B|aKf%6O|
z0)%TEX-#vq0gw)u8D~#>F(Px<gZ}5~L6ls}%YD`ic&k%-5iPZKi<S(+N;ewrG_C%r
zL|W^M`2cvk3w`5ZW4iSln;7-UiouLgttR(Tl9`bo5FPv&ifoDBs9MaIkyL<lgze0p
zR#W{VwF=UYZuBu9NzY)eNz$7%ZS+oR4k`Y|N9Uhh<!4T#faX8=BXiMAAO&*64ZZr-
z8mO-i6u?;$Ex0ZQOWZjD1aA@YH!T{h>1otKJK7Uu$|C655Uxf1Ht~-)>8+>}(~-Q~
z3bTR}jsBd~#cuaY)d2%~txNm3+W`EbEN~W3q5lmY34Y2$lzjREpoc>*<Is4JHor2`
zi`|AemXE;UBOpBjmttOL$iRWu{*`-<rF7$ukDS1{<8>b_qqHc(9YclM0Uy(oh~n2g
zV?paGwzfGjyvfF`;@z;VSux;nHv(=fdphIJas$hUQjspKdMobaB~uOx4}liVwI~L9
zUPjXT&6dG^Fbvec|Jz8#sZVErmj{ZOpqBz*9HSP$15G9p(*O}PEx!_N4crM9WPORU
zB6=#{1I#A0+u)UGIN;v6|MGX1tMdB9*$KmsPcnAUyHfZ(ckC{7bhnm$muDI!s5Q*t
zF7^#5-PX&YYlqyw+?+mr<1;LOF9^aGC(H|f3%Sv9k<TXkH*l>u>a5oo<8El#Y-SQA
z^SE@WRFFc4I1S9n%q80tiT!04&ip;t_%Ybv+Yj+u5@v#=X&$#Uxyb!c!D|fz8S8x`
zE|jDJ<Qq11=?msb$t!y%-d?2TEsIGLoC@VG*w5b4YtP>>U%7PJ%K4@t(>nyf+OF9;
zkhk=JpZ*}{D@0{s7l>3SuVC@5XBR=3?9aTuTiRIUerdrwXE^PCJ{|K5-FgQ1J6k7!
z&5`&AP8AYYJm+?rD=NvJ^_yi_g?}OH_*~^H_<h`mv|ME@`xyl51Upxp5;{S{j^%eU
z#6M?kO0dfx!Xzy^SWE|m0vNUiV`ju?fEa$4?m*b&5zJ0)*>Zoa(TG@|f?Y@;>L{U}
zgXAgOd4WE9!NsOPeEUnp1%~E~&@MCTyz`!GHHBje_ESV~)3c2ccohy$d{Kehn3Rop
zlYaHV38%!M)qnHJu1A{l!DqJSq~^4v)+qw;Dv6-ghsKR#s2>!NShw4W-#xNQ%uB^T
zUYzf0<t1fJ&7HOi7y#am76MB)7b}hf3jZlB*rAbvFY|FO=C7L+Uw(|Er`%>9%K(t{
z2FW&NvkKygN}mJpqWpa3!)PuZo9ob)8*O{A`M+~KXEAwq@erij_GBaZrGeX*l|MiZ
z1C`Uo4z<E^<7^=J?y8YptZPKx6tgTyL>ae?Mg9mOX_6sbcs7Nj>?RXNn8gcK{}>2j
z8^ZB+tg^XGO|qWI&S<lF0RUb!uaNjWa1-lv-N=&vwr#Xe;z^_=aOJH^!_Nnj*!h(b
z=XOuJ5Itiu3@dxlCNZq|biD_MM1?1Lg>d0qEyDl6vFw-HB#uUgHUmEhjCYvjh?Tw(
zx|2uM&`$WyCLOjri6RCOG_bqwVC#C1Y;w~23irE*%A~?+yW>oi0{Gb3AuV!|IN;X#
z)Xq$4^6F+t844!)4<#C&7ufY$CjJXyBz6RBW4@s}Ag_&g=eN4q)caR;_Lt^d1ra`5
zkS1u|LFA=ARQ@Kitmn1SKy^I~N|&;`idMb_eOLNlOh^tTu5plojY0FKr>`qvsr_9m
zpuRZqxiKBY)*fJ}UN(kSmwRBw9uYFQsXKDs^ySkQiiCfiEvxJ+&2kaqK(2q9D+M-_
z7&)&C^Oy$~>J@o*;2AK%`36!zeqSbxsWYxj!TKRTfC(pcGH_iQUeOQ>4?T{hdyO(y
ztv4yo$^ruj4qE9_C&1oxuKTZzg)-Hj!#jimiSt#X8t(JW8q*Ox6{C3pf1qs}#+SJP
zWgxr7aaSX{C<4TU-V?oS=%O};Rri0%7SJwtmE4IkyY9)+LI?+uE8ESzXiYPos)~;Y
zKJynu&qPj-Hbq{3cJg`WI~32O(ec<(4db1c#w*T7JL@JGsk!4Zim!HTjynKwzu+9c
z;H+?cR3jJ3b6qyB$?5v9oU73XfmK${i{q#5Fpu|^s&HMvgSsW+e`*LUUrgwIf`+WC
z7z+_+rhIlSLwk-23q6{69&OIuRqcOi&{q_CmYsF?kwl$<g3f81&#eRpwaHI@0oBr0
z9vo}2|8kiqw!&U)8@I^a)T>E{*Ia#~<b;UaGD85Kl$F@TaWUhadBc%X_iwQW_)A#5
z%M<;xNQF{>J7ACO{`Mv6A#)ISHturs0ThRGL5JVl_v~vDLr%r=a7Wy}w0%fPHtuYk
zaBG^_HJh&-+%LucTUOVZwR}X-pl0TGJpGqSkUWQ_4!(>#*=XwpEZi5peB^+^sn~SD
z6C_lreS%<e&&wF6cj6-GpXa)I4@S=lBW@ggw`knZF)J}2o#ZpouyEpj0+|vtA)_=r
zV>K4`gHlsQq6kqzzZ(K)&TyjSm5-sSTDOg#sA}J}nYA1X{}BQx?6-yVWG4&SIDMpF
z=v|3EbifS~_Y6KPXYpT#dm%~LsDg$RcPX{!D>K~uaB));X3^lDql1;{=twA;m6`8X
zJlcAM7U#+<(_zVzcIx>?kR6k3*cZKe#Ll4ca&micOGdn;BdPMHfVgHSEA$zl>evNs
z5ixfoxS|CP#pFwOn+e%1VQT8vuC>Wnecf*>W&VFxz^ko){V$UBY<}o@vD-fu^+z9F
z{`^1>@Y9A6s`2FG@78>qBx1sEG`+eJzPTG8t2@mjXJyhRhXi4-Y9p$K#b~B{{yP14
z83k@iUz}@x-CU2avEDeNG9SoL!P2}&>8qGah%*#y?oYa%l}1Yd8hYGa^7w<S7~aJc
zB&8Yf%)Fy{@m(H<nfMrGucRlGTnls)QBpo=Al;iYp9-izA|zS`E;+0n3!eCW>({TE
z50_ZQak4g{sBvv3!^D3Em^iG(b`&RPh6#Up!h&VvKMl(9BS5BfHEBoVwX7$vt-*qL
zL8-fklvK4EK8jO7BOGLqG0ESX0dxGj4daFz$V<(JQd*TUuH_akWj??B89E<xwDO+)
zZ;rZxKVq5PDdu#yLE(y4LRCOrP^~4$Ml*pr1)WW~NSE`nCuZ3OeX6_?qsmK~9)XbT
zb~GL#HuuWeFyoH@Ot4N|#hm&Sq2=#VM=mfJ<Ia_hNSkya(Vr|uc%hkSr}5QL`z*O%
zXCgwf^jh%S(f9*Vy#M71!EYEhdLn!I+Zy6QYgsADK=;z)@&1!#(~d?vPhenzEfFC@
zn&~=XBIcBCZer5o52|9<0xJZR2B|wi%+h60vPKbEHQ;{5Pcd$^$-*jFlgbLX1+6w!
z@W}c;z}`sX_5~dN1DwKkJa(&NEJxgzFL699`_<(R$`SX<`9PrAO9=SXk3JadjU+2e
zzXil=<Bs7g$9R}^exO%fM33mJwirGyn?crKd4=}rc-;MF@b5sdFslK<zk65o2wboc
z71YCZ@`E(Y%(0xoCTLmF)_^16`IBFG7w2B=Q~dE8xNvS`DFSMD`vy+f1d3eWD=6#%
zQ<(3_P34WB4N-Iu`FzXLO3VZFjW|k582C4Y!&6rDV)J5CF0xYI(fvw}pJ=5Zc2Vc;
z`bQTsEpG{MuT$(-4J<C#z-p_fxTVuHZ}L>IT{*>7YBrF=q(ooJ2i)ryLJ{x3A*t62
zZI-dhk0PN;i7XsMl*nG@8=%-pXJ)>oxS3ppzAH@+0!)X4i)SpFrmP=sDAQ&g#c~np
zcEr3{M|YtJs53VGQ0*8+KxyGh;a&i#lC(3MwQVmxEpf|t`qt2|%om?a9_fTVT?mE`
zHx%JfJ$=MVqutpohJ6pwFztzXG{*H)`kL6CdeI91I-!Hy{>*+Wk@wInz2=Yt&0gW`
zGDjQzL5(m_XFuK(kGqG<c?al^ISY6W7GKbFi@qBX+}71!{QLIP^$~ogYH;-ZwZCNh
zRuRqON=YZ8K@qxWDQzFMHNL7vXkAJwKj)}Y-H|Ze_Ey=Ps_oHVA#H$up)Es<+!u0T
zD(;Zd;C6t&)52`=q1ySfGAU*0ZpQfy<*GwqA{YitWO3OHKDV>1tyO*R-i#H_A2a^&
zaYnc;;CO)c7PUK%&FSZu#8gRRF0e)1&8C^za#(F@K6(-VE+AK+Kbb_`c)%5o{A<_P
zvEf@(a7s$6_rh=U>_eH}I{~vZxdxtnkh#9U(#sp^w(|LGv!3nRC)8v-k7vO9TS)Dg
zlxWGZWgzeV@-YYOH(jvy5veIr7i+}9`7VPzRC`7YfOLj16j){xZnB-hksdEqrRxRD
zfDfx5vdH<4v_&=*Zub<mr;dVUUW)08*o>_0FJ6gPS$GsRQ%^qqbIzn@kLPY}ghFlm
zknmyCXO8AG5%d1lh17qnM2EFKK)@^;?EPLR8LKOZ$cc#1JAdQj2k%fF6s%Cx$QRds
zXm@)Z4BxB!w~|CezIszh-f3t+jaOpWTKorxt^QMTQ%s_;Zom1+NAIgxNiW!M8kUXB
zae3t1^Gs>DVxL<WxxA*Bw8`541{uxht1$ksfjnq5KDqiQR<{QBytp-DVDGjqMMDW<
zjT9yC>CLQisM2fR#;*y3W#^y5`{`kNfPBJ{P;9i#sw_KI&?Gi_eWSnP_JjOrq45{P
z9#s;h$4xT$0gF>T3>4uSjh{6(ompy@S=E)&W>*!XyEckAsk4dtmCk?%br9&$&`q&M
zhSK%VhRzUOsT1eYH*fD3UH`*d7gX_A8;I{ggp(TzJr6h;D>Ga_uQfDKN^7>JP5k>L
z@}l}TTDvX+*{~Z8Wr#I`46a<-Ov{wEmO=KFBM>W?6iEPkMEVzEc_F~r4JFkt8&z%G
z+Af;j9`h=jmkX4tTCAP1pe$(@6I;uPerUR%Cn`z(SH`LBFs)m^I6lq&<|%2l7>^e(
z_@lK<Y^4wvfP*yM(g885o2((dRk}uKZ;0QmyB80^4WFrb-kCw*;|*Nn3v_mi9L$3F
z+bm&KcjB9np*IiQP93(Z+>fPC{X2m6g9YW|vH(uXH3znCuc0$yU%%-~thZaV#p9mp
z(y{@WA#E_?6LGZZekVigv*FD1Fw=L>f0;E#5AAYXx!%;&U%KC#$!$7YPS1)UCa-2u
z{cP5{l0Hn?`ux~m-p}8eYRE4tjz^{zAqQC(1{FRBynCCG&CB<?LzV>>q&xb^7?czM
zPK*Ygtbo)c0-r^Mq<T=O%>L{d!LP~hruimL_p*L;mcotxNgV|}9KM*Z4dPc7*(yf5
zD~ev-EII#O?Co}YX~44sqdS?qskHptST=tG+hPWB^7lsi@!Lyqidn|O)sLzQ3q?oN
zJktxY898}1SdK*k$D*OHTik9r-J~f|w8FG6r!Xy~`j4@yU`194=frp8MmKa-0Gjp}
z7J47t<t8_DWqOIJwogf7Eo{>BAD|3QWif4+Pk=0ym2XJ#L?9=hUDt^FlfS_og#8Kf
z2jPjaji*F)cb8i?+-VvWFeT2#M2(7k-r6q>{AXGG)Woh;J#AF9La~M<kcU&qNMq%|
zj3lzO1^UYE;mnVv;XnR)!}Ft9R>Cv7@m6Zxo2PT%Hq!$UV^Op$;YAz%?uGdDypZKt
zmVUOY5MB+ABSXj|L#Ru&h%2|OB!3s4*>@hVuZeCF@8$U_=M&^VInS{Pj%O3$z#>l;
zcuuYKQFLWZiFMpMU?ZNmWJJdBy983M2JY_EF9N~x#OZ2>7Aien^3CMLuX*LiJU{%N
zRq;#7t)g0QOKRc97E{Mo61f;{&J(x;WK%Ois-J+;s&UF8w_<tjq+n$kIrKvq`n$Ez
zmgTcGbzk(uEBFho_if)v$@VI%v73&}w@<dpO>aUJ?r$mFSAml~I@tx_#=~QVpruTq
z2Fqc6d64KNa57xrWW*|odGgo<^cX%x1K`>&O8cHwax*KRj>II8clk$mpF-<N9-X`V
z%Z87{o5DL4kn)cBgZprWDFT9|Z(<}5G>eQ<q`9dBq~*)n@~vMLLcP%AZZ^Ff+!uIc
z<su%!BEDk`I@sz#@M}L@ujzMde7i<<k_ek}ra;#j99#F&a?g^J4c|%N-1WLg%<Ge`
zQSUM+l*e{`a0MJm6eDIItTla6+$j1Fr+nAE*s&_0?eB?Y72w)50L_1rF@qn$cnXas
zu}uN1Z@c-+^$@LFL*F|T_(+o{f5+n%9)&ZF({e%uo>TMfrf<{5&oHw3qjRV516@$@
zv<vS9x<(2A;aPlbbohyEl$9ys792d}s@#Gsi`BydA?UHVeVt;+nOGiv$eAR-9T-Ef
zX`J=FQxCe;&NuFVZz8nUr0TZu2J9`cx&nCxBdCW?gxoOWE@rjX80ILF$L_Vc!sH=N
z&jE67YSzwety|%Pvm5w2=nb|bZJT+9(!HDusR$Rhh})ezhtgTg*vi@(UP)_SZGxmM
zc%Tk*Ts^aY5=LDW6Kh1IB@uI1Q#NV`wY9$7@C`F?Gd}xOnB#NLzEv^gb}Y{%>_QX5
zZo4_ubXrPk_thY@E_%p+v`YKhX6@rWjZcr|S%+PiMcC0TH&^tfwEV@$)^Z2-{l5IB
zVu3CNm=>o13(8Kt`F5-vD)`Sxf3dtMZTTu_P=yu1xgxfK9;dCQh&Cc#ClT3042{0K
zV2+20C}cpyo=9&+94?n0IF?|<k_gKA&@9>J5UZn+6506*Hd;E+ed1PzY!-duT<frH
zYKrJI;&nGMi>io)02@%?xO6(}VtctsOQ1u?OV>9{ogxBPwIOMKh~)C8ccq$){;IIR
zrf|4jspYUpxx>W^-{!!Hio3nmBxP|p{r(mBb`4qS#=)x~`IA{hh5C^~EE^MaV=i)4
z(W4cZ!9~tjJz2atO^0^eB{gt})xBn1r~mkr6Bsv#0vYM9qCwm?+Ee>L-;2eZ!k5C2
z5UYDEil@f`Prz3H=2GcJq)HF}XQJR><_FPYJ}q@gptAl$7ztEX^N2g&*>`&GPKN@k
z(u2a*zLOy&_Suwhz|}Y#@wgi>9&B_un~ZiZ!^On^a1N=3kcJwgTU}M@K`ydo0jLLP
zy4NSeeR|)18a|kL6E8*ixn2VikK@S}=z1E*JDY;sXa<~*iPVcta2AERwKQ{j&~u3R
zP;yL0c5@u>Y6^0@8GQRh5V1Ro3Oqb4B{hyc{4KISqCeHpsyucNSpa@|q7`_XuFt4S
z*S0{@D!(h$f`j;~eZ{%4U;n>HXhQ5vvmy9_1PJcla;kDXNRgoZNfAq;YrJB%_~E3S
z^0fc#<ac}7#Gm#y!$9yf?K7}xb-}>^2lP!6(aOuPRpPZ~ex<A%<jW~8Y&r1CfpY}|
zC5_6c%Tob{fZ9SeL*g0-z4YwUfV%myt-Yg3Yv!4USq~r_XoJ6TfgB&PXCS0`JWfh^
zdb?#TqCW({Gx};4%}bnS9>AM$LjS~u3GbB(kUwHf1CC}d^k%a8!ZAD&Vdf|f&3h0$
z1-dbn3ZXm8&Hl%}*g;(%x&WEOX7)iP4FI)aiz^a&SY&=32Tb}T<Q~H!Ku%4Xo5I=Z
zV(=4TN5@Tg8`y>4BR~HScNi~Vlgw%BDMbnG<Wei`)7Kk!{dtjkfHrQA<b?Z*EI?tL
zAH|~=eR9sex}y8Jfcw`4f#bP|l^(!~PsGe}>SC$JEjI5<YuLp+^yImfoVD-k0R{~K
zs@xhZ!Sr!6xf!QO0Ql{YFA+I-^ZJbXMc;!BN<uCj1DFF(F>abg8h?po9%@#n?`R4+
z?6NZL@}8Nn2aWz+Vs{}=^2}I)Y+!2ghE&N_SSW}ofKE=wcq9#YUdv8ei7||0UF0{q
zq{B&LWwJKGs3l-L0{}kDO39y&czx#xrAzECbOTfZyKO#PIKw@#e5?YoF<hi3zII7*
zxTv$(8VPeeI^_$Ig8!;x;pVS&v?0#sBd)@KzrT=&h{njS``b^qMLlkbB&(h@>d)_g
z!(>}&EmDIM^?W0e&s6`?g#bDG@qyn5XbZu9QJHDHdm+H{H}Vr_9gXQK!CJTOQ^yvC
zNEqqp;Nu)?)T21W#{VX0qy7w&Xj|^TO5stz>@dpD5#U`+oE-!W#!&Y<8ApG~-a<Mg
z7*3yIZy7mq_b}8HcdQYyF$I`Zh<eH>k;(Sp{B%C4&+H=-HZ5H}8a7`L6HM^%@B1e%
zI+E#QYQ5YSeDrl;b@TPH+Ltz2R)C6cBy9CSkANv6L@rQgjEUR>oP7?g-c=<3Y*6x4
zRunow`MbOP46(XQ(cewKJ<+1q7W_!tKd$}DJ~?mB>qF;$I9xpYIq5sGKgrN_jYdni
zRZgV*P)ToyU*e%%I@2QaqWbv@1mWqd?PlFlJBqqxk3tde9`(xG?tfk1Ur}=D+Nk)W
z{<{v^C>+v*X&?DSpcq|-Ekz8IM%(eeiram{8ZovHH17O0Df}hdDOK_h)>RLXCfgDX
zcV}d0DN^dzuMiUr+8os{XM{qkNJdr-<wK8tpkFXQ&fXIrZqd&)+K%+;tko7<#x=w{
zUw1esm{@z%c6mavSDOLKsGd2rkM4V5L6y{AbpNGc{;eV96K|f^g~gHE@Tx0J#+-H<
zV<!i7e>9-(<a=bil(V{=_leI+cQXYO*%r_BUtR=9RU!;*lp)=e7IAn&dG6*APQ6;q
z=r6(Z3I83G%!8YKjYqC{Jlc*&mFn((+le^*S9#@T+5_0PZ&tRK$C4qfZ<ZUj%H<50
ztfBdct+Vw@VkZ2Ff5hBsV~1mJb_?GATz|99)9&X1U_y%BUao=dd;<>}H(%h<9J1|e
zLi^t=jveFq`t6I%Fkoy%)c@;th(>9KG0wCkj)-;8x(nGpy!J~lwHmmZ@ItknxjQwm
z@DW;V76p2At3P@Ue2V~^0eHf(V07@|;9q>xdtQMRo(wS}TsZ<#XYKFj|EpLbL4Dy-
zf7>f5WtuB+leL5PqRS7Kc)%mNX~9k6+(ADV6|Xi*cP`Y*`kXBXPOR_1N3~VG9c{kG
zbH51Nz<d1iyuofXE(k1C<US&j0tIXoe`{b?p$L+zHJ?NilKkd$O~T;&ye3&rXEVMz
zkIf!fxGTLjiwdp$MSl4T2#K4z_hF{0)~4CBnclnuV&Mxs8GQu!2PEWk`xkdj|8;MP
znD#X3(olWeVj~nz97`SDe6TjC&>HaWb;j_AlTzAhQ|o^P;Jz!B+g<DNCFmVL!j4}C
z$n3tv&??yOKNHu$_x0AMMJ3PIefhjp9f@~fH`_q&Kn6fs0MwKj#!GONAGFtALGxU^
z;<~lw*?5_$ELba$I}SwRsIG{nq}<7lAVn;<oZFo{$)Ev7tJGdz_~y#XcJO<$h6rQw
z&bx;A!Q|yT4lRq&VNfXDBo~<qiyZu}Z?GEy;KPl`=Q3Wen^}vz>pdG|*MN%u&kPbU
z=JoN+-RXZI@AJ({@lf@v%*3uMv{qR~+Y~0ZqBdz^LOO#v$VZ9(6DFsOchPy8<|^GH
z>l2m?43WE=B7wB~U4KV`KR}`hb!Rfu{o9~XL(0`gzn^M?0h3SYKI=ii*Rq5j{4Qn4
zTug@&W`O>Q94=aQ`L?{m+521H<h+VWt>q;8gd&3x@z<(J-xq&M9I561E2Fe08Az{(
zqmO<(r#zhntfG8FV(Sr$i82+o`)#zJ23LLsENs^@?N0ko3KgV<ER%*QV4A}SFpXWu
zKbXp}GE?WAxU;9NsP)e==i{aS38Wke+}--Rx33!J`1Ht7E&p4uO8+th6NQbnQLoib
z1Q(Nr%SlKybP?b(TM?TSNqsxW@dM6io`+WcXVnJo1_E7fOgmHo6C@)qv4`A%^dvX%
zFM6+43BJoPx~>?VV9Xu@sJ@|xDy*N3@kbj?rw;l~$G*&EN$g4nG#zMtr?ExnF#?H|
zV$L&^DY%ahuYX`m$#Ysbnxc_==;RN4B*3GMJO=_Z>`3WNk-?@5w}zZJx?gL#eQ`pr
zJp}EM809oZIVya-8Em@6s~zh_SHGd$gUc%4RK&Ix*etsfjCX?(0Gd!ktY$|usfvf+
zN}edJUI$dY(^l*j9B|NtX61L)XbFk_)SRMEqW?dx-aU}%|9v0d!8V6ErkoNTNoCH8
zoGO(F9fXoiIi!RN6~<=hfKq58hYAU?a#l8{<ec+4l*lo{#x|SZV|u+_pZE9oPk-dO
z=lOX*?(4p<`?`MqCWc2fA~OqMN}ON1!7mJaSABRMd_iAebp2gja}avWG)h)SFG)oQ
z$M}Zd?y}}|a6PmPzc&WEpzB+6d{USM^DQGwaNNQpnmEaI{2%O+8uTTNC7&8(t$o0_
zE9V~eetrBsIrS^D`zzQY!|X?hq1zVz!_a-Ht*~3xE~3dU^VFORO@w;qRbGVuJZGl}
ze!n7b4J|+^eGQMAbGZZjTxZ;y6V>fp2uyh@Q(mZPE?$d9YO=Z=FRI+T^Fr^(=otMG
zFTj)YUFKZ`Cin}CslRJ%4#LcTz0?vO#okb+go<}CyeBEmfd0O{^85DQOpbia@7th#
z9q<4o+g8{x+we<8X4B)M9kXNb!MXWw7*%iD{>dQm6Tyu4dUCFxjvPXwpGh0P#UAsf
zO?(70_5hf0ww0!Mem@pnsC;|#*4xJ9eK_yh9U&}JEa%6UH+U|m<!wAjO5sMQFT7Fx
z3CSlzhW;8Z0|9zqxNMn#<y*{Os{$8Evr%(^lw1iu=2hcdHL)HnSf3G7Qc67jZvD^x
za85RTgBp0yf;!~w@z|wi3`iOFy9bG@1ZkWpbQ*P(+Z+#59WZwQzn}X#2~<>vIX_^_
z5i!4|UQQ@U&1-p}cO5bntiZF|9bHG9k57X`v{TnUgTj##2NSYZpCl_RM{e@h5>}J`
zj*7Lsc?CEP&IR2dvOk+GN3^m9-VAU5_6N1cHFM%r-3IciFIZ(U!8eHifFkSIhg!>~
zx*8CYuxl!=68#(K-<yNJ#K|%&Y?<`jO~BQse>Mr!lT?|WHMo#dFt#}uwnH$;yJj&?
zJwQBQ!-Rs*b{O*TS3-OFE56_4K=AX1Aoq5TL`jMRx`Xn5bc5edpaF<lZGJJ>J;*Da
zK{61>*4on`yCjTf{mpP51y4jBLdVb7Xt~bQezLLWM}pnk*Cd!Jo-#W@5GzHE_&9%!
z8r)@DvmTiM7K3M)p)5uSYRdafUXPRIb8l>wa&nf$F+wWWGjD{2kfhp472GyNXL%{#
zm{Bhjku#AXqul%TI4-!p7}yST+tWBZDMo5BN8TlPbLC5}C@|&JpIfbeN1%;Ogl3q*
zEvz}D=dor<`})~T)tW=y-wsraOkiPf3o0}NfsEfJtVV=ZDbtQ@$BhIEcqhu!gSG=r
zN|1HAVquFgfu<OV_{o`++!vaCNz~^8XY`>bq?%<U)!2gZQp&jGvlVDT{td4+Hm~L*
z=77}xQ-O}2n@Cg>6+Vs-iC2<WBf<O2Q$f>aIxhDoB!<D2Q;#P<F@XSSnY$(kH7h|J
z5*k|XAd~CfJDWTZHkk6bLqgG8&Y&fg&}Uom$r!qr26MGGo-l7p^Se3t>(KmHh3{i%
z;Z(|-Cza6rIRaA&wVFO~X(0{ndeb;=7A?Zx5eXqB-$+%wELJfigmY9R+&vA^<X3FE
zQKtsga(59_lS%d8j$FiQNaMg5AqI>Qx`Q!7u}98s);jEL->t62EYGw~bJ<QeQ2KPl
z1>bGwYV;~JHPoH$C4CU^)(9OriuN<soWO#%Hl~$!@NKY+6}R#bDfFbSCS(A|)y8?3
zo<(vRsoXdO%XSw%kHD?m-3_zRm*v0)osM;Xi=4caOMq?~hBU(9dt;Dx6_D>0XNi~b
z-geSzR~k`*{?CQ@aeok$y<!y_y9r@@*0&=cs$BT?{g-G-^lbUO?#)Dlg~h+GkP8w1
z%nY@6gkasKI^uEDof+m3a=9<m{d(5_?*LL10>xy5GS2&nl=b{2<T`sVWpIu>)#uXA
z5iCh55B%xTD;5DL*!Qm&X?SZQF=z_y#{kwI7wpo`73@vHue5|ex4dxQzEtquUTFUI
z3n@JBY&uYBq-nejMl5|52?b?~XBHz`qTU~8yFjrunRt}0&PLjSdcbq7ibKduwkblz
zZ)qA8^@?&STr(s=eFFREe|Et5oGdJNd$Mp1K|$xaSerFV59Y1>whg{X!?I?x*K_}w
z-Aka!+znr4K#ztCOZ#a21veZsPSBn)GkSJv5aZ4qsQR0Q3yfCCQyy)%K+(=d)214+
z7rn;<l45Cs3vQwZ0Km}ISh^2pb9c&H&nuIbZHC!Xu(|A*A=^r}#~ruo+Fkqi9fuZG
zF2K~TjApG5AF*N>oNl4Zr`al3Qr;0?2+I|#_y)_U?Poz^Jp<0QQm3wAFSau5l?wAh
z7=7H|;4I6aI%H@J>_>CF>JODGSb8B4z^CfH#m5y`nfJyOhz2o7_NV-o5C@ami#Ef|
zDcG;<m=@bErt=q$NALWM$?N?%HAMyGm2dFxK!H)yQ8Cc>^ok09$~SM&;q)*!-j2j2
z&I*-_lSrpG#^$jaY^9Vz<BBTS;1;3aRvms%^tUQ>Z-u)Dm<#l#PU&G+Sb^np^rQ`2
zX{GAUf2MSGRLiJKVJ0KH7Aao$V#u|+jHD%CB((I4x78Ul(sCaPR1WQW$rra(=>#ZF
z9Bp#cT;oBTZ2b4>#eQBBCDw%PlRGG<dGSYr#!~p9I_vokK!aQF)a2oLof_$aub#yz
z!g7vHZADM9b%?jLp}LKCE@!R?0|XIFUGK!a0Neq=WslyKy<UJTB^~QWNjwnXTf<u&
za=Br7Uu`*#AlcNKNHNg7spBE3GkJ7}1^em)iO<|{R^&yd5Z0)E*vsXhQm~h2lU<Se
zQ15(0*B^Z7bsImjKu7Z{FHmO$tvDk|p&^-DtmW}=_Z|N8oG5_NCok@@&^LS#5^1yc
z_muxOmzJz_B8GY&kF^V_mls4RPl~Pla~zOcgFc!|&O-6DJ55)I`sDV<nsTwdr}8fC
z^vq{1fK|W1i{M0rhMU3BID)B;=1{M6q(On-Rx%DWC=B%f0MK)5o{kBmjxK^btWM(g
z4HxD+9d0^}0IeN*tHPx+SCNt6%4OO-^JNOJ9xb!_)$zqGP&wtE)!y1P<nOmV!@Lv%
zlMaNUQxsSWyf)S!D(a#OpDbG-53RTO<{Aj?r;r>WAew++N$sLz2;9E+o4^aL`&Jdy
z(0Vkq!midT1_5b^d1e`}QKoV3&j5V~Lr(4-w#W^5FeUI-|Hn)@fUBCpiO#II$|_f9
zCO_pnjS5yjsw|B*Us682Q9RjYo#JPg8sv1E1M>;!2jM~3DuomFNi4=>zL*4%KrqNB
z8$k8Tq5%t%pn+)cQogaW`YpC8r+o1KTMmLk8(D8HIkj_Pv0RUDOpjhlo2#3s!~N_2
zOcf{VJp#C(N?qFQA}1N#470o27dt@zhGj6D878EjbsV~jBRy;_wJ;t4Iwb5Ov$=r^
z_RLBsj~?(wH4ZAo5F3t)=Pq3b6YgI4fnQdvaw<R^9}K@e85l`ZnAr#4RInAU&Y2uA
zX6pcrAVh!h$*aT2ez!M&Kzu0PrRbvkt8yA<2x{_^1A&tRn~o3b?8eI-PcgXc4+<bp
z>4w5pGgm@D9q<3$;4FLQ?T37)*XoD&AidkD{GK&FxHjFcFEiJGu@yMY*@3fck&mW#
zbv#zhI)tq%W?sgu@8j1%;IDyA`-gQV1LgLoyt@iQOmaDfT~r?3sF(LxZJ-CdJ_`95
z&`z2h*p==DpUiLe0(Ue;>$>R<j~<h(P@W&3*J8TY1x5To+R}9&T8ife@b9o+Z^q|{
zdQ7SMvY)a1B9qsb`CW|3WX;C>E+(=2_FzGB>NH)eg!5y9G~cXNKXdqZ_Au3$!!V-{
zm~f~|KU)&nZMv#8OXsb5qcNRc%Uxbr>-hntE-w^4|2w!_-6f3uBVqB9XFO{PBnwH*
zSt@f@NY8K?bgjBpi!ig|z28%@8NNuu$H0-O!J^6JL6LPVftjb_+t>W)wC09IP|>cq
zv$^Q1|5oNN)4XL8=vEW0zJQbc5AleZ#1GDo*QyGBdjUr?79O-mo4{{l;mZho3Ofz?
zJB!E=>+H*{JUHW2C#3Fvu1uyQ@}CW4OJb1y4;O-?<ZNZJ^NL>!@vw|hpZo1QZ;?PF
zLts$q_=u&%@vR-E!DZUT)o*E;Uu++k%jg*q^Ep1CC<5k(OEB{lNe5dWWv%4hz_)~T
zh913Dm7gQ6B?L*=jG(>+1uB4hxVNL%OzQ5ju!R9);G0X@@~sioWGPkp<U^vl)iK|#
z3RK7zA-;J<Xj-%lB)fdas7G(~kkc<E$GR}g#21umpU7iStpFO|2RC)Di99tHJin7t
z^>z4V|FiEeByl5zBX1Kn|Lrls1P&gD?RJi<K(m>s0{1Dk167$%Po`wN!=U&_z6*`K
zH-?Bx7@x35s8#zjtuN@$G%g*ocvC*YLvcTDul%^Zx+93@b7DpD&+BL~1L;HEJc8FN
zxvy60!XCFG#a6D046i;yASy^rj{#|?vFImwU3(8cVlY2O3w1FR2J2id$luY+5$*4x
zT_$qn(}E=nrm%%yBtZ<AhQ0qKR2u!#3t)-csefAr^LD8O6quNOCuo;?#MjvNm!+4R
zGG9Oad$R(H-VK+WpWn#a<VzZCOBSJP)9J6_GKkO@M3SRx)eP*{I+TEoT5Vb}r;%>7
z!?vG=(w4S_=<2ST7n44!*65V)OjOgCWKU+Qj!y*O97c#Y+Tq*prgFuO&g;kzTH3Yh
zhY674ZUN>hm9G{7IIcU@p7KpK9%$DVDKkLDQ`IN(N6e6@NGiM*u`l&TJM^_4PI!v&
z<mlZ)wcaGsxdLLlK;<x?-{cW)5Mi}uh{!C$#v}Swh#)_Q#jyC64N8K~q{SuGSc1}0
zo!lR3u%p(-<-ZtFQ5&!D2$#B=gjY&3Xf+m6T1p!CLaTxwnOP0Af$Rj^_HC~ML#u*1
zn%jD@OS2eN3IJ5Wr)I6f+j*(bu)8?woZDAFP=+vd`di8WuhnGxQeaor{;!w|Js+b7
zUb>5@1^6*|Df|Cnu2qz248N~Ifc1|<P0255Puk6zc-OFQgOzUf$6O`I9)rYRzWg!F
zuz^td{&wn;i6stSUko^JtoAhe&O)k(P^Vipw~Hen?coGT|9S(sc>NW5-<5=UySQ<J
zYvGNDdj!HZrBY8wrvV~X;Iz4r3cx%p344W4`$mqW;6X4CJ1o^mm~?3#=5>vM_&g)s
zY}VX+Ni=ub|JGr())j&H>-4fGA;)A2FwA~3pb#Z=Qu+GbL@kqr**EsA9I^-tH8kIj
zoHVB{r6bzOyV5bI`m7SwC1Mvn+NKVnE$3T7Yw2IIUVGZ&PG2fa7$b0A>*cXWYIS!q
zhVxB;A=_L!f=X^()@hbz88~szoi=GKs-8b&A<OovnK?AJUgBPE|I63Y5N35Yw;a)Q
zc)ITdmVZ;iVVFZ*Yek$f>nR3**W|0)(aDZX&9m&05Sp%TjsWg8zgo#al9~Y{dA;9p
zm&kDGG(2u!__)7D^GZtjBKHvbQ8_U47(@4y@w1IW1(??iliDmiBj{cJsZpaF`kBl_
zzX@#>gvmMVUy(>eH@S@^B5eO|j?!})WKYZYN3KJoUa%H{>6Ga-x}6MEAb}b9YcS%h
zj0aTgKTkRKAEP5EQm9^6sp0i9(Ylq`(LbbAn^lp38W3n!AY1${dT%W;wR3~q?tL2x
zwlV`cD^e@iqiduzr{59ZvJT4W_!SagK#Du86al$U83%fO80(5iL4NgY7_#I$qghxq
ztNixpp(fR8ue6bOP?6rX=I~DyP)$7`!cD@CG&Jby8a9c2xa4gqsBG6vgt=m&i!ek}
zCPD0j%7~K{6I@GB|IE7xsY{hbQbYGEFUb7FuorAW+tP%&N8;uwra1!vB28d);YN}g
zJ{nBE&BK1%1}^Ur8q7;&19o>1C4NupH45D<UUiHR(jkKQnYZ%K@4=iVcN-d|>Kt4a
zCMw-&L;O(1<Wc4@!7jwrjj=#qD)&yS-236diJksO0Atq|+Avhb;N`PkU<=O10w7T}
zW920gbZc#@8iF1aRSr1ZyG|Zp#UZ9_t$EZyqf+bw$jz53`CTiVM}NCEO??MxY7=!i
z4l!ig%2sqO8HcKR1l=0_2-)JQyxLcuD)%0OhyACOZ}Nu(M$WH9K{?Mg1||+!o~MI?
z(SFNzo?S1e0Y=}G86>9pR^f%OGVYojx(oW7BK33-SR3751~KpocC7)%*^?P8rq#qr
z)2|acd6S4bude@o!OswAoUHAku5}@}wo075tToe;;M{g`!vVDSR;lmq8IMVmrW++G
zEJ3^A(-qjMoOdyTc1{yY-xeKTa#5Nd(EQ?N(0^s!%pD<g-L5FBfKI2u&-ofRNaqNv
zDx&sQSSjMXU!Fyva;WfbgovGzJS7Ak)F%)O=u^6?4r1{5LBiebu4}~x@*vMK$6Zt;
z`ksbmpBNE|dn+iyPky{1<73K(&h<9UzdOi+Pu-u(zcH%U^C%o-zu(nlajlonn!vI#
zL|-Cbx0yhW3Q>S{ZO`WR{0m&EOQ{6oKEp6j6p6;ebA-?oOIcicdy0YDT^-NC^d8OA
zgvt`DRGxTH-Wr(dAg*<pt!1}z&16V<eearu)cc~SG94SLHvY_GE!cu)=sFTycKPxd
zu*e!a=Bwfp7y^<O8}k%{yW(iG(~Aor?|l$EJV<eP7F4RMol9~lwTR#HblZuc`r+2w
zH9SMr6by%#P+p=_FS*?T(Rz*8xByeX`v~BPF4j7p@cIjZe*3SqZ(}6NCAVUdl#e+?
z-|f}CRn)-*Pt@I(Q<V2Lo0o?_JxY&R7*3QUJNjEcEII79N!*p)0TA{rzi(b_)+aXa
zP;Pr6RU3q<u5NM{@AsXrYgWkEn#~44YHRQi4<c>UC<vN5m;``{urr8!1D!V)L13KX
zIWX0xEK_@KpQ!b7=mt5^xyGVF@Rj8}too`TofP@*vuI2bfJvf#bn5K1(i}T!@&d@W
z1!c;uiXILP_AcxWSPAXRcs9UPJ8AzJQ0PuF7k~Ukf2(Ql7$=3Vp|95~THKoi*~JOV
zLa;&e%3pXG`F3o>p$tb$@age&M!O4UhUatxPo&Vzz%N-5a4z7nt20~1`Y6G>1#qkr
z8DHBY;a9Npg&1J`VBCL9CYv!?7p|*ayDjlZsOj6o;^}jvkZ!5Kb$(tn{Z!3W{KtJ?
zLH0@BR2B$tdRE|>rg(Y2e1z?2HxfV$e5{d?A5=!+x1P-RiWPdFI^Z2TnMUQI!GGv?
zThh^Sh6WZ3wMY9pum%-AbY!%kFQi9^IvtkcFh_n?N95TD>tPAyEs!ABV;b1VN;#Q_
zL|Ki0T~pO|2SA;_4lVHR<z3@i&C3Q4Lc$Owj`J4*a;oLsp~x<v#FTeer>WrXREwCm
zzo|fwY#KTj*v(`B`;n@&>9Dsl7%z{&r|Hor;*)QD5$%Yqq=(G;e^=^Zzq4IPn@0E=
zl($ZtjJk&OkA5k3rP$cB2B@X*&hfgCgV*7nn8w}1gCkq@a=u4JtyL7N9Rhsl*ewrP
z8D-JBSVj@zL-ETQle+Sm{|p5hAB|;6AcEgECAzc!tfly{pE-NgZM6RqqneQ(U0l!~
zC2(BAmJ!0T?-4v-_0w~D!+ZYAHzC79)O9*y>$0ND{^2(lA9{KO#rawwEksXAq!%VB
zTt)Xu0XpIeOb~G4tB$EiOguCEHnbh>=+e9QY_`a{4mpn$38?mHa%uHuRcrN(TnC6N
zdD1eiplIxH)K;GN>&$P2mLb24-*W0M#mv`;^6Dft85_%*E1w`^LezyYM1zzy69i$y
z^X4Kx%n;y)()yaHcH#6b;m-IE7`zj42?1z8_UV{j?Iup;_-z>^nsVU6LZAk613H@e
z2h1fR+NF-OJeHe`M0Ja+2)AVpHV5U2)a>=$hDb4trjD3n?I@LC3+2mkRM^K%=#;km
zCqhQDO1H85pP75Ihk@BC@cTI4j@o)`YVy^zw>ax=|6ym;rS?DHk62{S8g)kBTzUs`
zIO_3k;GswF!#@P4@qkQiAoOutluomD9rLD6teek1dGT1|+^;?UdcSJN+b`SEAi2|p
zn9#o9h-;~}fPfkS*z8Z~r<$(fP37JU^)9LC&dM7*q>GPs8Djb7BB;xs5kpe-Y-Lvv
zdvq6;QHjH@HWC#-RYPKU4tM`L$Nt1ie(+cD@hyE{x*$CTBTV~CX*yZI-DtA<3InR@
zE2a`g4`oD_CWR|?b;#B3;^H`Kkz?QuG-1EW!`~n>Oxq0`><aTL^iJ`eV!yJL*&kre
zd=Rhdbg(rZ<Z)nw&*Xk76ZTSCUsUt%!|ykFn_SQoL+&R1I~9WYj0st(Jdk<(b9_Ji
zNeRDP55c4X7u2Q;%GRsx=8NXIpdtaFbQ`04c<X-LDY-A=8FD=W>o%ysR_4&30WIe%
zW3Q5mJZET(vrtn0fg^93JJo1E6S3!UK?2P{lu8pnKMVHa7Xd`LKVnC!eI&>g?5A@)
zgQJ~G;7xk8*q8j6O={M+DElE0A9+g2NZ8S(mHP9qky0U;Oso#HkJ?cwk~C}Wr<QRo
z8IuVfKs0{V93*Kk8Gv9vB7oYpVP>?iKMk%v>;G7^0};vBP7a(j2kF;KkbZSGoauQW
zF~g{IH>^m@t9T%dXBo4fu4lPB*ONdm5<ZhJxqGV%#gJVK>=0Y%hog40*VEiXfU)xO
zvC`gsO8v7W0pyEcq~{ve3F^nO3+tx3p+IQ*u$0v7$lc3}Uj(Uv1-mn4s*_V)(GBFl
zu|}a-%<BdBTKhQB{<fiBtzEbGMZhimvMp;y?)&~{6^qrwW-yY<`pDnWTQ;{r_g1wV
z;3(+{CM@u|+$AoJk=w~8teN7g!Ia&GS4I!TTVe<w_W9-#*I#u^G<EefOXGOT?AiB5
zy`OgEwWH$q;q;z_NJOGr$oOB4LN732bPU~s+9@rQYhSDpsE9OgFg7F2i)y*f?7=#w
z1~StZfaSzI;_`>{=fgt0E0(IHUimzGQMvNL3mCip86(${D_3Tc+qk&JZM$-+p-Mf+
zlOijZV6hl>0~u5^gWd+p#C~<u{%F)28!@!oGM<6^!lRJ|j`E1Jp%|JZ)uIX&BP3=x
z`zA78wVGE-op-?k6RGcwm@o`!zVb%C1v#fW0PUFR+pq+N6hkrWD%(x`*t@%d-zvuL
z3t*!R&5}P#i|~!zA9)aejwGc<{UHa6-hqfHtKSl|QujR@{g{FW5-ek&`R4vgr;D80
zw5>1KQRm|jRkqeEip~??FBL~JP>DC&RB53m0pkAgBGQP^yp{FCn0zNif44~4=g_C%
z;po<50_w${$k>bhG~{~3{9wEy2qLD1frC#QwUzp!e3@-*+2CSXlSb^+29AT&r8q>p
ztu;&0O?j^1F!0*ArRKc}$b}UbS=B5pJQ3Bd1w=Rd5j>(?^il>jX`W7cXz}rDprUKQ
z+>7Ir*G+kGxtO{TL+88(C-n~4Cr?LM1KMk+M=%knN|NEg^ovIw0p4dUK#+1qCppYK
z2?IgvhH->GG++3UWd=|>q5il4ZU`RyUgO;KYpPY4suN*3{)E2v<&qXFO(f4jw+lGv
zwz0HEv%00|Lt}D@x1agYVQQHIkQ2kBf(^F#v23B(JSwP7_Y@qy#XfOcdqPq~Z9)we
zo9v#63+&RRmQ}1wnU7}AmHC~!`svah6_N4O%_3@SDi#i|Q6GD8B#@rIXya{YH<RPD
zyhUp#OtpV^UA=UqG!EZY41Ud;GM~=&u_ASqa=wqBFp<{a?})A3s_kq|o!W!tm@&C+
zTBW?>H`w|lIDj$VwlT|!BhRgBeZG{1{IMBcnSzaGUkNlj6K<(`@-|E5dh_HC5w+fv
z>G%3}zPVOW8_T-_9hQoULRwA(*(uARt34#?!RE-yJ1=87QXhFwbKNXTMGvfhEj=%1
zDD9Rhxj^~Z5EkpWnfnsNl*w$Nw7gd!WGLdj{nFaEB<EH`kx?mxkZogv-M0AYYeG4B
zFX`@eQ4jT<$_6vl-#h|Jl&R=w`LaBs>>*DoqY%;GW6f4{?xJ3`lAaOO5q|B>l~S8j
z4AMXXv(~0O=6KJhc<kXtQhe8H*|*)_6g*USwr@mN;0iY=>#sP#wZp;7a$y87T+Xx6
zo@T5padB(($@N8gf9GXu;ha2XcMr(S4zIIe%PuB@k3+=X2p>9WIV?0Ko2l+R%<2z`
zqK0>)wr1090!qihcl*gaaSY;mTNtRgbvnZ*uThr@5$!#WC$R8I(n1ST=h)V2ofOL-
z1X#Z3NFY#aFREbnoBz5t73iJ$@@@Lg20L~AHvK0dG22D8c|ij>UCyR2X!nkjA|A?W
z-+0gNN8R#sV;n)te%6krj+<jIc)J}A*o_yS(l5^Ng+_UvE|wn?`I$9qdvjZnJ&K0(
z08APh)p(U<{%2YxNM2;p$F~qYfG5-+XxgBzzeq)1JzmNl?~#hf2D=9(>8uvS7Ll@T
z;_IPgr;Tt*?&<c*)iSRjJdsH!kN3Qcc=Jdm$r7-K6@$)G5R#n=eqyxW5m>BZ5GQ@b
zx2yzuD17SVK+&A>-rlU|G3s|>{`c2it13-o{W{qf9Z(Ch8l?TX18Q!Xx=cq5^<e$6
zs5w%=OTC$|rus_zqs{$p%pGZBeFvchC~wmd<2~2}tnFg9wd7Fcs>j?blKRU0ZbXOB
z{~le;D4+@0E--DnKku)YFhxdnMw+bFf*~0&;1s+&=;G(RelsB4zj%nEIs|{#l}ikv
zTFDpWvHN?ZX6STse~%4YMT<S_(*_Ggf4rk+2LZwJk8jV)kDfWX;bkvs-O6}|*@u1N
z{oqBKk5!SX`k6bjLH)TyV5(JJ2Ox^jFoDA~riyd#RL5+mT;efj`<>gG^jHsKo1Pf8
z#=pN7@Mn7Y`W#yq>w-S%pfj)-0K|#0ZE*GL!jD8dqHUHlfPzCXc9|NyXjA8tA$n9u
zOlvmBG`?vsf5`nVI{54T;9)v7_{{cP+4p6R9p=R#=ZuQE=&@g{3Cp-`_4DaFP8rg}
zqThzPLI;LSoW#7R=f)b#Qv5G3E~H&wxv5w@hT)gp&)!|mdnw|mG=))w2`HJg_R`L{
zHtOp3)HQt2aPpUw-VF*ZUMwJRxBQNGx?wrpJxdcmqfTx(VE<k}dLZPSlb9QueG#rb
zK9hi5W$}D!n{5wdGqnxg-MYN!ebqcn<mZo!lT{C5ED1e?D3gy2DO%7lmv>>U){}3|
z8+CPPnf~hAZk$Y1kjN;MR=673CslEs2=P=V$S!8UdY7)&$R*kWi?CMW;P7OjiXyOY
z8Uvy?znX7@&ETFBK)R%G!9&m6!&@V7$^%Ym9!kHlEdyIAyw`hi9~gEa%AHqCv)I&|
zeyX~;x%zFc8zf^ac?Fc}|L5<a=ywN;Rpokhb;|?KN14RGXg(-Tg2In@FPeH^Pz;fK
zkoxVx+M@TF1}r7@edWo3&pL+<qRlVr*a}QDiYh=1OvQ^1Zn`sabjxv*Y!p}cJlz>C
z-l@4Wv=3RNbebXE2;SWWDxas&4)5&(X|X0ST0!5>=4RP<)3*rja9m*g3<sa7?lKH3
zMr<m1f;io9l^A@cdt;d}V>%6pj|_G%Z95T|d~P(DqV7HnFGg%Bd4f9K-rBR+_~;G0
z`lP_s2&t;2O9uku`x!`y5~f7SzUYdm9nq)58@^&1XGL|Rn*F~*oESNb2a-{;BZR~`
z(20X1ZyFyzP;r-r*{4=kdcZ|q3j)`M3U1PZN#o{))%L1Y7$dJ>sYar18O<M3@V6F&
z{0hVJQKVD)1>0?bGn4ROeBm6?iHJfj7&pkW$}4`HBAf~KJ2io`K)I#jdih6)mCF_L
zF(_{0ht;{^z>OOI;5oP?l^sIG7k-XW$S9JpfRq02VafRTa~(eI%M@dMD}AvJxciZ|
zM6{rEAOa029;vWHwONF=pbsFCu#K8HdCt<a)lfWtxgLaVu>Rpz>Y;001fmGPddJaJ
zKd+L~-A1!>X1%WPgEFLIpxdw_A-(B1&RAfttfnO4JP^t|U?{C&JnPefj@`GboVPqJ
z(<l{dFcu&|Z%n;NUW9MFUWJCs606W8PXv#*6#{hHi9DTlei;>GIyYY~u~sPH3ftHt
zzxP4BLFi2$#>xX^8?I@m(a8f<n^KeXf&C43OeS<vOGIJU)?*af!~mF-2o?u|YT>fh
zcJUDur#HoJV!KR_C|&B8`NK<lhoq$LV2{j^V!PNsch!JA!}P#_+^VtVc$kt=OVIW_
zsN5|;lT_`6MgG;KM=VBIe-c>km5^F$k*}I58eNZ%?9YhbQf(YXS8t=)Z14ppKd{t*
z<iD=07bQIb^~As97)O}AdSJpun_-2SFKa(}GLvWdvVd+0j~5j(OS?Y>7BQCgh0P$h
zbnwdy5sud?0={0gc!jGLU|6`MV)cjlVuW*0^oNG?-PDTEz6(z+)0R}@MZq$f$eRfH
zlg>2NroqOg-196|iTlOS@+XXm*^KUP@TsKX*QYtCowQ6=kH?v6aHYOlcamOC3t2pW
zn|v1Na7X;59y#`7x3SNBv7{`cG!InF=(RqGebo3@=R4>rEx2I*xnl$NG;>-pSRkiG
z#{}5xZ0|b`RQiJIZD|F@9Eq%yb31q0&>Xg2?rrS2ro~TcR!+sq{y!iH49X7dsb`=x
z-)tN?8QyMn!Q+lzd@Xv295`n#^a=BF*`#R-FT;2(;ZWbY6n^4|^E(!Bj<W|jO(eJv
z0I5kNDAb^pAauXia_qcIH!4y?Bb1w^{|}~-B475r8M3~6xuacVCI+&pKz!$=XpMiz
zG(vv>FTE9)ffVpkx(}IpY0RLjWVTc(x~S3C5&1Z|byd+to0el><K^M_h-4Z#^6;B5
z5bk={#n(>`{1=HeW#R2H?IrKsHy*xlL%gWZHBRYL>W)-=eGeF4XKP%=#()sX>fE@B
zHgvn4AzCx@vJiZJ_qJ%<!2*6Trgy1v0th>62er*+S`58m_Ym9@l>_4+HOSOpfa4Na
zF+r(3dNLfvFB92vZg|W6Q>VlYgij+E8>!4O#5lPPoMZ2wj@+BNI@5(iT9yvEdKWUj
z^tFeAhyCL32*_)eNlWYW29}WX)Y_|Yl=S91kQ3Q_{~Ujw8aV_!3735vq^C6DIbWdU
z!t48-DwA`;+SK%SfI_1TsK|aZEKFL7IvImfu7z0mpG~^&Zq+5KoiXzf>o^i5^9_tr
zEl)Ep6d3g`vEpFcHSNBUuV>!SKxN+))d9W*0CEM(&_zSSg}5`FxM0d%BT+{;ijlOI
zW70~aB2N?jlQCDL0mOivDgOKVqnfu?H=-|))Ee&;{vw-j|5nQ5$P2b-xg*bB%O#F|
z_4M9cXEX5d_Yn)h<KXMOsY+do10`lh78bgezw9t4suSGjlMIcYwY|M9T}TG8l()jN
z1tUav-v);*SsfdLRk_Yd7>VWU!<0_@Kkww#P-gS?QfLc+QRFc1wtN`WE`+qcn}*Mt
zNI!#;Y*zoP_J8uB!E{$E14}<$X}hVoY2qRheHzK$L*>LF7`EWEIkm1jy|JG`daPjg
zs%4bWE^`!0-$Pxm)jMWkPtm6tNMJrVZg56A?(NWqUD96uL7UWQKN7Lb`c>{J`%}<G
zAwS<=U#sJuccgzk#J*d$Bq04_>Gi$03<F-Q<ISyXY&Eoat`{`rclPC@l(I9h_$6IE
z@z<whKIN^fJL^K{s$-oxzB>998THOo`(N3pRxS~xEDcyO5A(pFI>V;bu%RT2F_uwn
z8aDJ|{yV%$b_IOloBpHgAjYaAZI~a*lYq$gfy-<o5DRw=0mYL|ww0_bFR%-`4aG20
zCd**<5=gdVS|&f=3T;b8195mBWXJ}PA%yN!XFV(6azE~%aDiwEjJ<=<cMs$$wKIT^
zl!^z|OqVl6Fk+e)XGG>SmYAWoGFyN+#gYw{H3gf@R>a4vZ(bl3vISd|_Pj>j6n^-S
z2b})z*nRgvPOxS}!d7-Ho!6?WV?pu<Y<i4&B@A0Bj};qG<9PnipiuI4NM>K(5HbFn
z!9k{z8je5*69QW?6zW5O70$d<YKoiWBBe2zLYcXDBr^6$Z_LSKb=ykWVNIt=vEM^e
zW|zP_{pl9pQP{?pVj3lY5C1=qs8%>fv}Hz%Ld6V}ju~6hO5Rkvw+eUWF{gSqWnzKK
zd8!R30dEdoC8<c?I>_EbL<r7Wv9)3~!7J!Gk*Tc(8aqu^x@NM<7YV{fBeGgyFtlZ<
zt~YJ`BfvvJ!ruURjtNrPDV*SkWG8F^{P9inl)ApDHc$(CfoEP5`kD7~)ucr+*m|yg
zgkK@H3-+vn3n7tZX7ZSfo=v^j!)$=^Qx#q)yW@h}is}wTN3@PcZg~@TUwA2x$?5^$
zL%`c$;e<~W2E|b<zpA>`;d?8VL7-B*&=a`6`|?;?#zK$BJD{$!xF-udLX$nvS6Y|7
zc_DHXkn|L0vvquoX3q?ac%oR0$}RGn2cYPNB0|Vkng79kk>6cW0Td8t6?zCFH91F<
zj}xN_Ozq)S7Ho0)N>IX$djayP$(f|LeY<v{F12=o`|)W`5&w-$r5dyJP5}5{tXI+b
zigu;<uA-~xix*&;JvH!~E%+-_PesAmqL?*#XK*qBnPdw&iV6V|XeKLVm_R&n-d7UT
z+B|PjW`QMZ;-R89@gg-Nub_Z`8D0Ln(GjZ{Anzio5w6ckHNt)gN~Rp;!`+jY@K3f>
z)mw2~#^+(?%O6q6T5fcMN&aH68dt)0!3Kv@x(;l<K{0QyTq*Mc2l?X*O2g-)Fja9!
z<;y<$1T3u?dtS5NX8gjF=}V#hzJSGAPxiI3K8#1kC1-WZ7fsGUZYd(=b{bdO=<_0I
z02WL6)zijSbota_Wjn8bz2iEA?++0d-7%<i^K(%L73mQP$P85DHN7cdn8QK|6F;h4
z81yi!BsvhY6QBblKHezQOfEblFJ<%maO7ryeYQ;`YML}MhMP|cH8Ct&h<2?mfi=!D
zYlrcdlDV#zxp?7KfE3h8$OcKL;F3}?<8$!>9WKDdr**~na$PPeBX4-QVs1D#diFFk
z<zAwzoQCsY=O@dp<|(0lFS$ofJc~4Jm41JX80_{+XxlEKwEJB!8<^MC<Tu((uDDV}
zm(r#AE!jv*@TIL$kwI%2;h)^=T1QRCZ|Z7)9ZQ=CQ@iN6tKr;&BOE|$6&#C&NAS)^
zCL4Axz`l-)>sUSXIaKXJXYjUk-D4m(ceY(?@0pwCVLw3`*-yP2IG}X8GaR&Yi*Tbq
z@6}(b1@YVO8wSteK3d<%{#)Ka*fNN*&k=zP+-0$FA^-UBoGD$Nr4xIKhsX|vPp^6q
zzk*}!$<hgt{sf#r&Ky2BnaFiL%*9XgaMacg-=O*L+keG;wyM%$TlsBsEj|khkY^ZC
zUTn@q8c3>R7BXs4%Q1t!FCr57omgYrPZXsYc8V>GvxkZ*mUR{k1ZDI-UirQd)vO7#
z$L;dSW~sn4q>#Y?Y+zT45LLx5=S><~2TXM-Ai>BCjfKWE+q^1BW$>B~4aNJcslss}
zV{J)h7|n5UuD1@`-X{oMw7n0>&yQQL#;-HK7^hh}WsRbjkkha0HM~s{?`?3sum{{&
zP=H$}pOJ@(iOcSdp!9XKEkUYkWKhJZUwDO=^ZqE_Cq|o1U%9Rr1pcRXoG25H?rkAG
z-|X~3f&LOymKF!V7&W7PRY%QecINJ7qemsEONr%iBhD7K54V71)E4L>u&!geyhs;m
zxN9!U_YxZ;a8>B|G6n0h`|rV@fZKymr&qw+pn>e7WL=##sh-82ng^d=+&7gbS8{ZQ
zIaRP_A<Q?7@nx%bS>^9b`7FtE0x<?Que3%XQ&NF+AzJWr-t%mTFJdiKjU*=O7!_dQ
zPKiYqc3Gez|84?iTvJ(QE^W;x1Mrj-*}86@Ehy<D=;lj4>B<BqVtBO*wkUKZDEd7Z
zO{y7CxXN0)ZaXMilhX?HM(NSuK1Skag+Ng~b)EUpW=RCm+UQCd1sy+|bw^|8*bQE(
zk_=i%EZ7N9LTh&uJ@#8vyF8$1&mhqbA_w&#eWOC!r2;2~K;az_RT_5S6Eq5zI?Xlt
z^Y`UhrOi;M0XC@puS;~<hMH->=jkzo3yC&k`Xr$3NV+nyUaN^G?-CafXF;1N&dQGi
zPNMeIfH>XQgQOx=F_ST}j$s$W5G_)zpwm?L#p-bFhM=+$0SC$+KP4ke%&iq1D9|i^
z1{<_7wZ=1B+}4)Cc`^@oPD?ysuO+!W)%5Oa`N~U`9`U*~7lOpgMQ@&)i|}Jnzye2p
zbMM6c2(_!NqaI01>jhrsXT-P^sP%vujL+3<(n(VO#RQNqk<X_9oz@s|-=gvK2ypYM
zXK9&JQcfCDP90YIbaCXhWaG(0r~WFagAomE7M73R;dx(IC%9MfvYsUWD54}K96crV
z_t&pj?%(le=@I_q;V6!+`aYZ*7TJ(YEa3seb*!^30VIWARtpZ#MxFHf@J<8B(Is6=
zO>NQqJ4XVeM*w1iMrMkie5tzT)>aqv$g3?2+tE{MTL4P94bT#2TbV+Q#qT#lH^tL_
z3l*^mB+vVyl}{b`m=V;~&xi%7Q(Q&YINBBcJdiVDiimL)N4JEoj&Gsy@KiSTymtxa
zCCk0etjo&bI_O3?t4UOh9FerP4tw&y4ITUPyel8UH-<Hoe+KO^_q*S2@9-Zd2|TgO
z-iC6GAlTGoPn>*E<NLAu#<oofBGLl?5{p2`<%J1*CdnJz>FRx*;c%pIzc@)8{y$(Q
z)?{_*M1x#n(h(^`C}|eJsT#<fIdwT5F$7xkSlArN<tty}U53zI#iNK70-&Ve>z4sz
ziY?)fZHul4^;zYnPV-WJ(&1TSck!dJS#v5Q9nnt)mD|f*R6dT3#1)0|x`)K2HXtJI
z&Fe~zB3j6Q&s{m~q;;%-tFRsASFu&ih$(W^ocbpnQA=(GeFkl6n*2pi563;{Mu8da
zOG1d0Oels~MFzz@7fHkB{bzKguCE2$T0CM;)`t$@N+1?)^)itdb}d;-8hdm!rtzAW
zXYR+I!Uzjpt%*dm^vngg%kc908}?5($)wJw$f{6}w4i+_W|BYkkrct6Q;Gx;ND5%A
z6%9d!H1tIS(sgc$(O}NadDUuPQSguUysXBGBLfeF1OwKt$f&-a15yiK`Z>O?Vh3jH
zEqjp>Qlai`=a8d~)IVe3QrcDk+M|l-<7LjORv`5GkbSv&Od_`EbBnh3<xXIr3+^*m
zrLWQr^}xv0L>m8uv1bIun(xJa4)|bNsjFj%1u}S<uEZJX9eeH+lRM#ZwC4Irw(175
z(=B=>s8Ye3gwSfQp@&+p6680<YtFDL{UmX%w<5M=d~O6JJT@{OknoPeL!-MOAMx*i
z;NjQkw`yk(bG_C}+(0ZC#uE#cy?F{TQ`E=-J(oJ~rxGO)r9o&uJ{i>FFR4=D&j1O=
zQ4dE%V$=qd&nCas-$^j(Ih(pPZEFmT$RoHAVb92dc4wh`3U2TAsTD2rgi3wr7r^-?
zvOyW$br>82wHG5#F(ygrOMp`TNez{~qwwO5c8PG+zE@EIRDxpLULgjj!CZ82YtIJ%
z$C96hpy94%O;$7lp>Khgna1PA_X-`Me3Gnuwe5I0OVFd+G)WWg+C#QXn+c9uf3AqV
zLXwnEXDbc~W)7SV^YoykFQRU?<$9&8?jP7ODN9jz`#XVx5vF89{W3QyU-fubtt7_R
zI&?m0n=9E7Tr5y-%v<F~1@S7qF6~Cr&nFZ7E`EhrV0Ld6biK813G<<X+hES#<4xAr
z+P}v+SZyyHIf|H(05tR9&t#y5#ho%|W&_QN6CeT}yww^B9Z222&FTC{he}S?T#zr3
z-9`RwThH;Sa+v&JD8CPq-}xZc@`uXbnRag)tDQ6Tu{(L=U|#<-Db!7Yhh%6z`x}5D
z>g?aPQYBdYWKdi}Kvg!{Qt91u(VwsO*&h_oH$S_+!MH7`^W(u#yC1~2IxVEFPxujB
zy)<~`2s#`+Pn`+?eI-0Sec6Uiy-sTB23r+6L)7-{S2{hledDJ*){reISM8k3f4h3O
z#C?;k@3E|^Q$`1dZz+;r?vuoc`+M2^yOX$2z*cMSnzw+3&6(-W%uOZl`eBb^N`)DA
z3Z54Iw`pa#>Aa`xQ|;b`q>CRxFVOO6_8$S#vW&99w4(_(3lr>1T(x;>BnWJ!H?@KY
zDJ<8#g?unRe~+Znr8dJ^-lM`o24GN+9fasxBv(w4eG9J{sCNyCR*52nG|J1aU>7-g
z`{rp!xyQDW)=WrWkz6-jQ_-4{Ubun9n<imC3KQ15i66IpoqH^&HG56buhn#;n%y#A
zL(%#55@8Rm$aqb55*U@q8(!Z%$i<!USF4BYH7?zcE234eFO8f+1fvH?MY)vpo8$>o
z-@9++pAn@9i+qH;>Q=6&ZS=f-t+b=8W4p7t^+_=x&elSGF@&~Ew94D_?Z#^fdBN9-
z+(I&|C-sYx1G1x{XGU*{7*A(y*uC*7a;hhgeod$|uly_xX_`U_{$|`YBm4|?xojIs
z(&D=@YrVU191HqCC)4vP=_$eon;9+##5y(x`ae60Zs-Xdy9WA<FBjYuR*(MT;4%qO
z2LlAEE2S;=RS0QcZY>|5cEqLz$opDp{%##X2>#KZS?)W!33Z8b3>ND;Sji{@1~tT4
z--7Z~nZsBs=|}qfvVjX?9g*KBQhy)zrIi03aKz#Q<gbe!3hEh2kC~l(rh@ZMlTfCV
zixl<X2d0HQ@?OuH)Xf2a(!RgYpkky<IW_gyIaJ>?b%u_($I)xp5^B+WaVfv2^2ba)
z(DwbPgWrabAx-&W=`2{+bf$mw`z*)zoO=LAh03Z1L-z*0orWTn%=AhemoMgFyvrZu
zN@=_Jmh<_3m){|hH3!XK`v7{<v-9BT)bWn-q30As(K*hb>}qPv%w)fqlS+VbWuY5y
zmHqGB&kc|gk$U_IomvWYF8ha2cA*=3<s<XhwLM^^I5tX(cZv~p=DVulB0OpAX|Cn0
zZ0p_xnV!xCA`QdERFIKBS!`}Tx^22%*LBlFQ?vU*MM?Gbk2`*ph%)N$vJ#t_%gww#
z%2>|$8=(dOMTE*M#_kK1p~4<_$Sk7dE&~V=%%QUJYvbARm7D_NR8(`sXN|AM7KTJH
zUSR+2Z!hNCdM^eYmi(hfSDV(Tc4>84WavTc1RW*2-LDz!fvdwyS|3V3TCU8@$?Yz9
zu-U1ys0BzrcW>t<lQy(f`adA#9Gx_P_4M#xE?A9L+udd)o?ke@t6_YcBGZDf9A2ZQ
zp|v+=2&l`>60PD5RD!o5ygnohFX<-!nM+(xjipr%x(JVEH2nzmFcBxu>icio#o^C|
z{=XOVw)joXmv6nFOkr3<mATOP$!^q1`z~-fCz;D#;BvHGN*gD}GYYq{Z3YxPl3!F3
zUdAVTRotuB;2|qUxfkfp%K4{+e<CjTg;W7t6^2SuhP#?iS*4vls^h(Gc1>KoJ`otL
z{%y!pG-pm!7ymBDWb^$8St<9;mS2c!Wz6gWLncg}vxbvr0&am`j_I?Xo}ODg(`&=j
z?!*iaeqZLbqQ?d{DG!G?ptc_N`ify=fk))smnUuK9|)=K-QcRf$pH?Ei4kBwt2&ZK
z{O3Q<d9~`12S)BFcpMie7ZM?cmiiw9De70S+#<w6F({3+dRNT}eR4j7ojxyV+3VVP
z$+BkY2q^YlX8cus>sP4BVJt7>yW_qJf3oyi+hJku{-FJ8BoCLf0eo810g}}+e%u1T
z>DqBRt`TU2yT@!$w^Q@yEtYFV2yXGqHBhDw9w0lW-neDd(kW7l%l(s4`0E~6pg7>R
z1<SEOXP&!!+xb~Ye_|pz1XpL>BvPt$I#z>!WLyYm$1|{{oM-^^rUS1P0IVI>7M4-7
zd-nR?WWfOf6gdp3hQZNS08LpI*A2^+OC;a%u|uMZUK83)4iMHQz+pTI@aXrfl%*l?
z@EpIlF*R^{5%A+1^$8rrFt-ZE7P=BF_P!rm1YZVaoF&+{aCsy7=m+hfD;t6daw4uE
zB#r9qK4S(>0H@rH$k|I@h|*DCaQFoE{n+^=%wBIQp#=p-0Vku5>gqhsx6d=*p{AvL
z`z5MhWddXbY5xJJc2Eny;6K#6nlN<)sOj#wxd2khzw|XlJTx7!G$tGS`KM}ue#9vm
zXAun~sWY;2Wj%IEV~s~+46SwDp3VC*w^i)A*c#qlquqNRfj;pN_CKd_fV7Bc7w>J(
z?<GnXKz3Q^rv3e^syFq1%bVTDe5thE(+&sPb5lfQ2z}>2Z`dubv28zgDG3a$gDp^7
zJ91NWh-IaBcW-!hkT^hH;+MT8t92i{^ckZnMmzq)?M+qi7SF5=g!5ndf4F%)JRo+h
z>;pRXk+k@_=@VGBcPze+>{@-ARQemFM_UTSkxm6>hpa%&iSsHi=+E+FCLYu~a(rRp
zj8z?jl3TZKO)93L%dxnURJrfkF444!My!J(P#OnLD$I_jWPU_~e_E)T-Xx?q<B@#j
z>MJk6fMc3!7(IM$$*RmmN7=pFa(<_0wttHF&D37;B@B>jmzu!t;Ji+C`uf<>O-<(t
zpM^tPqZxnxt<?4G3mys5%%{-PP0oZOVinhWQD=jNW~LCj#-jM}6`+^hCRMQ#1L0<S
zDGDflM#D<%0iEJE?b#n_e%@p~Xn<F)y_ySlCjymnqr?VK{W%xuu@7JuqjMMK?^oVM
zrOp_wX<Hwz18U|46<~y1AuN*nCcl*Lwsx<xNKJ@AmftocqDf!|!(@;_3GxsdgzW**
zsh>{;FLdh5^T$+QRl1ZF{GX=RA)q@CyplfJ7aI*8tZy~M)a)EknLT3BSS-PhTR^Do
z>t&lO6T~$6ajkO3UY-v{r}!WPOM)K2(m|}^rx5PEBH;mFYf&Q$RD*ALXuqYLn%#u+
z_CqO0&+swGfoyZ25cP!9*U$*4m5&?Bl;SG7msBp)oaGSOk#4+j{I`|#99Wc&+xleh
zAg-9CLx5}^B6g|{9wpB1CIjNhw&~aRyI2o@$LyHsa&P=7Qu7Mm{~*4|WsSGEEv6$9
zgC4v9zBXGhsoO_xdLI;2yDn`hX%S<>e3}R7WD72*4eR!k7AjRvA;~1Dj9R7;>V#$s
zF0fCR`l(_?Lng&wj{WO<#sh>4`eDXJAb;iSlG=GhW5SW)3&yz1Ey|9`RC8v%&nuBq
z>+!CroAM9ECU2CzNibRYfC2lTcabm*SQ!0U-Ms4(mIi1>0-I|rel2Ucl$BpRgB)(8
z&W(Wyllo<4mj#1>U#;McShekm6#!azTYUYWR4#v*3%E<1b6GMtE~B#=q64FrGB0)~
zDOcpUzObnLh^{5$M;nDAF|YraG<a8FCT6pAb*1iA_lQ3FUD+e5On(A+fB1iqS_7re
z%~k?r2}6b#KHpSC7OEOo_D%B^k#x)&w|RD*m~mz9((Nd)O>vsj*>g>&l};<-WzsP0
zcCyrQ?9oZk9%a4a;h#k6IT^jjkT=D0FIEqh(-%omChT!rKqWF+>_`>zx$}PGH;~31
zK3aV13A{8n>8gM^HsKa@y%m!(Gp7(Gi<lL?8LlrsQ<%>StVYUW5Y>K{sTc(}xhO1L
zXM9EuXOANwgvD-VbSLX2?rEi^PnQ6RG?rOB$H-@$y9)pl<QW-eH{yu8aQA~z@7`L*
zJEQ15MMsy9c;s7s<n_pGD?S)Q8_f}Wy$j*7mn8RpLFKzv$VSSvq9hL?;d`mjX9%R7
zqb%+eJTwvK>7jb6t@&C-PGpLOd$~Cjx|a%hmcloW#jiOE;)vX2ioDGTI%NoFZkOhc
z#Hlqx*0(^w?7*L)(1Nk&Y|`_0!SOEEGH+TEp!uIQ*WrYq-KH6K+&Zv}X?Ed}CNmH1
zu#nOuggn?Rjr$`^0fd4OWF{)@p{!yTzhqgu)pDKyXpag+f>OV2ATt|u5?-yk*V>GU
zK6Kx+xp}~+lwbWpyz+yRko5`lkc+g3Ln!gXUQ#Q+ZF*Z8iyn>{=l09Tfu)d{vp$4g
zX3SQ(3fi&0$&}LbCY?WD)DZ`<Ufn0GevJ4c|77ztuzuK{S}hy5&=01l*}kn8@;Cui
z3M+oIxIYPFt45nj1TtJf8=FN#GMZ^Qw;~1Ez7$8k-tGc|P)de6iERU9wyb_HKQ2gn
z#WrawV57>5Rc5#*l@O<*C5AJ4=pQ973dgn$)N}f|B-I@oTiBC@m7(?8XOu26Is$|{
zrStOuoZ;F4=U99CV@v(Bt$KEiD0J35@zrgapP&Q>#xquJc=I@qSbd3(jC+YgV_B{+
zyU-YYf(ho2AlDYZmMyfJ_X;feKY>B*w>ij7n7mU#G(hk&q&1u2wSFt^@?&aH)aut~
zrQEwEeQR2y$QIYe5s{iydwm0ot~4T4XBfaGxQ8=AQlk@p-mDjp0N(wAzZdqu(9yBv
zeHIS&phAieu-@a4-7cA{q2VxL5!UC74F^UN-su`7eVL4IGll>iBS6y8kuYwsM^LI|
z3Nos?BQ8<_BS`SY(92(aj~sbqANIefD%A#(K5_{(xlQ4Z3?M~)534t*fBfvrd%x#`
zuU8IXx39g9?OM~5)X?qE?T`UtoUtaNBz5?|O{DGY*E~n=wwu9}(x+lAW$<ECJ3fSE
z!)8!SBr*QQb|%?tHnK0=*`l@R&#CDm*29lk3jfIbf6M);yuoGoO6+Q%_l2TGj)FVY
ztlsi|`72rXv-PuWPxA{0!t9SgF4v~==CW&rmhzr*Pt|4x>u;vpfA=#|PJkdCVX>V0
z+sEiz!AuqylG(|84LB6CdxOrE+?Q|J0NGm+u2qp5dC_Do3&1!NX5Psu>>19$OC=id
zz3G7Iooz~TGnks0u*f+endJHR2Jb>p-a>Rr{N9+Dzwwz%sY8^B$L|05a}CImT^WWB
zz)&7BBE6l^L_G8{N-puSuLepw>9I+?<#Rb{+@dgLpIU{EJ3;uj?>$cM^&h9H8`M`I
zu=HUX^553k$p-9pW=GiSQT??Uzx)lQSCj&!E_H_u@dl9wut0P8dOKIPS3xpAQBdyN
zB1GC@D?+jt3uj-Wu47psk4xnAaf?PPYqxmwgIwV39%$rgB>ftdRY-d~Y;?ZCD`u+a
zEGOZjl;IW+AGduJ7_#Re1W}F11oHfee_-@$>wljz4?xIX{EU)WTmGITb$V*Ye}v3L
zEgEwCnB^fk*32INZRC+pQWYaAtpMse&<7l8wzRKamNkL5#uaVsYfDOLI*v*A`z9O0
zVm<aU4-H4(<8kCLK`Fyv8mGo8(b3bxK}BM2``#;Nf`I9ty~G>-S#x9=(%x=ue0yJ4
z*Yj>PbhI|S-ah6}2qkq)xkk|?j`|%;J`9@=|I&SP`rKqkOp9lO&%?%$%{SUSe|{8;
z344X<yf<@xn87Ni<Acr|ewJP4+2XV50pr`CnoUtk_6GF<w_965D+Rn4yVng^G5D0>
z&e-(#6XUh9g*(^AYvTkiRw=1cXP8#NM^E(g+9e>|z`UL}JjZ0Oj-PGsq?=VE_a|`_
zZf?sswtu8r%XuRWoYT+Yo>fB{m|E&wE%-B5TWf|4T$AkR=;!G%tcC*~<KGK!h(B*g
zUkXo@E3gkJ;m-%^0LM-0t_FdjraGD~@9u?JklB-uXo+&e&I5(u9Te7*y3}sV4g*Tw
zi$Xx*D4N;F<)tMFDJ|--Z@(2e7ef2E#Sy!cR8c%pHS7w<9kYIeJ#SO;R{!8K_L$QG
zD|Q-e6<2V3yb^GGUCYUdxQcjc)L=h07yKfK1N;A|dh<Z2+W-H51~XH3A^TQ|5{9y8
z3vCoBRA`2fon$Etqam`CN^ysfERiTXnHdzarI0lvOV+U)%ou*xOz->teZGI(_diZ&
z=A60CbzaN!^?0U@TaueL`K#a2BA0Im3a<ZRz<_q62wNmVaMssddDp>>ys6pY;r^g^
z?kp)I2TTOaQdsw(mtaVMbTME#d*m5p@IcG5?|4-f0?#Y7?h0*~4<D}01|UeL9xRc?
zva<mDb>Xp|Wc!J-X*1TUcN=H<TsAJ(=>RVSz=xo<GJa1-_-=RY32#r&&<__Na(+K%
zLuFhZtKSO(oB$?>0<LNhdyNZ8EVu-5E9J-mwo4E~;(b0=&XQd)qqPwo78Z8r=uM<S
z2>SOjdb|et>1&sG0n47Gq#Zm!FDU~B9Rv=xzZ9hnpt49>dvj~o_~OxrLXMQrjMbn*
zV-XhGgH975?g`SJezYMbrXO|`lqVmpavYIRI<SdaqyI(L?#9iAfA_Y~m-LJ=iR+IX
z*mV%P{8FU~we}z1>X$hogfGpzw6IIg&nk6d>Gn}sz8+=jtPo)Fr(FSJt-LsqCrTlS
z6+&P|XP$6E5~i6VEC!Z0CBsYQq@<_a-ONiOY<%wFYns5wM437!1XMj~0)+fAIUSKl
zU~l1EzalYKHqM`sdpv&6h!AEm4#=N?QNSAjHE+Cg=Vo%&dq;>%Ax_9r+x8LDUABry
z9ecBGQi69i$7@P@+YNsoP(>fm6uS8m$a=ujzjD77b!f2^^BLqau3J~gasKu?p;QR&
zH_L>@L6Ab@DPLfNLg#4mj=g%*O)))Ld!_WWxvy}5VMRNUG-YaM@_tR!fhk-(zot}V
znrmLh&thn|?e~};`_BE>)o9t0zo|K8QlT~6Q+25LI0vyzOI#|K54R$V+WNsVY5FEq
zK*e*Z+Yx1HG(>Ky<5x-f1eL9&;Vq;-_=LC_X5Tt6lpXUsRA@bs?YUO%(1dY3JXWO7
zbTs&D5HLSk-&g&Lewuzy^Y|TH*8O?T(>K4Yb@7F!gstq$zp-MatY}eZTyW;d<<u$e
zY*@MT>HHOF%8d&qY*j8g1tf`|XUMc0*GEGhhJM4_f_w03$ne4;!`)naZ%~EVD{ffA
znM~Yxx)|aXu_z1LwAU~^l&6RC+sbWv9;!xAP~W5acZV7?UFcYV0R!PZvkl@FpqKyn
zP|bUZ;7aT>?=Nv5Ixc#TNc2t3$DyuEhwc3WLQQ_X-wJ1=E9dL?|8wy$e_1W0?}oCi
z*4-d<Mma!AML=8x3_7$ge>eZwIT{|U$mu|Nkk4^MhxkdSpiPs;k^+|OX=r5pOaY=p
z*xMH?@f`d0G@0YWo?l8L;z$~IijXGyG$Jx-CKqu*MEit;EDnr~gj%X2!r$sSlE64K
zqJ0|6`$1cJjo;aIovj1j9ww{&W+IRr6b;^+`%{FjqEB;x<^oHW(aG+GlXoB2FRV2p
zl3ry|a{yEx(as@`%w|2+G>a{n{ihxh_v*Egou~U?<iOT=Z6nyScH20%mCdOr>s?&O
zB@wEsn;+C=<Hrv*M`RrY3aqRCz*th`V8}v9!$SVM26%J}U+%4Pe&=tOLxQekd;lg%
z5mdlIYAXl}o+4gIxKoO@S-Qx!t09o@yvk~I_W$yJMGC^C4`uonCp>+ibaC3~^VFp-
zrq{{}O-B;!%l!VAR&f{|*n)RgcJkgh-s9-t#Np)GQ%Zj&R)>3w^Qne%j?il%hRSeX
zSneGxEajV^FJY_}wUtVv7Y5z?L65DGntyb(Y`|PU0(+^M!$BJ@@PC<7X^U?U-pR_o
zfiBj$jqHZB?_^-WMF5$pbHvW`b99A*@UF|Yqk#x^kz<#5Ob(eTD{NT;&?{4dc9>qA
zziTMwD6`vLBY?Kvr~C$824O<2U<)>fe-#^$&3P*EA5?DIA7g3fW)-qbR7pWCcN8B(
z5>(y7OgeZ(bvepheiqGY!?7mZ>NSZT6uWHj6B^QhfNg$7;ThFt+8e<YJR54>u+}8;
z+JB%FyCF!TwX!TK08CU5&C_c7ZoY$fSBSx04vK0qhYEEeVpWi|RRQb8d;Qo_ujw~D
zHR2jgsu=n@^3ds7oQd*8L*Yz9KdPiHc(vEZHZyDpcm{M)-iFmZDOBqZ<3hh_kn;U<
zz7s5iOw88Meu15eb6Z1KcII{8HX9{yDNs<fhr_u+XZa4>$kyoqbZj3G2JCn}W4MIA
zz3I~hq24#D!VZl(p^5XmLyWgIjao^+u<N&}Pa~YYXSu81t8dGpCFy?lF_>D&DE}O%
zV*h-|U{@UlDs0rs3$r9RHLuW5Y&~Gsjuq*4szw;MD8;CrjaG~%e)F<~Xb2jFd>vV~
z7@s;1W<EH$^umr;>Vz`TCy+`Qyy}AJXfE6}uMvD%LF>)62>HR8-%%;A9`5FVnQa=l
zp52Obw4u@X<jmxVk>Mq!A(tBd53aV?l|G{}_gGnnLs^G+T(G;d-5PG#RMAX{y^o?*
z`IU9WSgTk(M6mUHlf>jl|0s;&4WJw6V8dDSd5tUF&ib17IFMTZOgWl8cS39oVK#<@
z#8<1$Ye?@GZuJd4iWUvw3)qji3ONWh(@37r#MBmJXuys^uG|MfzAQD++ua)XUJ`<o
zt@;hs)GgoqbsKC&0A17WlW~Gz-@!wvS@f5`6><D5#O!00zf9%Oajg*s6TXeKqp?M^
zX>5A4O+FeP*t>E!|MrRABgfGtb!_tVZE|K<ZE+ZlWu1Y@u~{!2kl=Ba6VY})-9=Hb
zZ!w{=-QOYOcgP&G;j}k9<gyJOd<4IJy4+3VHwYa}0Ph5nb|^4PrTHL<o01o2qT?#z
zVn#(2t4?R^-<1Rd%zXq*#10w!^4)wHB}oKa32bv4n%ib#P+!QoQb}8>RF>Z*KU=B9
zZO=R%zE}azRz=s8v&p9*nPi?`*dH6Yj$%MA9x?&<I6LZRb_}ipsOxJ1+_|7QEWmJ}
zm_drJrTd$_|B=91{dSwL-_vB&Pt#thU^KjUgHS^R1~<D_nyV&4sz=?@y(%^TDK!Og
zw{N5oY@-lQ>jlpsKv6e*P%bzm_)_cl(gETc1^s%h`+u@V!{%G*W%$@;{IuoioHhxd
zOLn<<_es{DJTScae^G2brwiN%CDm<j>+yN=al=kugw_7dl>f5YmgCLSTdnr#=f8j?
zXPT!;<|VLzHX)VS7EJdi6fE4@NR#AI+yA5tpyJB*Lt!`JF-%h}mgT}{V>VXXqb;TE
z&3=D6nt~2o-6tM$ny0J{yU1YN|BIu3?!AetNM={lb=?oLpQuc1{T1%*V(L!c{!LWs
z8UenOH}02heZk6;NZgrr*ms+C%LBh%4qNFvJPG<!VSKUu32Q)H<RR@Zfs+KIxtnUJ
z?Ln4hk7r|j2HXDcT&4Yg@|XjajQutec%1xi{wlQ$54X|jHxd9*%VD;_597w~h#n`i
zF<fQETZ4UokCNJh2biiM4v;Y=eZD9PW<I;FXZl}0$2#YMUoR(IBk3Q_2N+QgcMSCX
zkefw%X+{&j%FLmvO*c_hVbp3uv7+mm=d-3h;^yc={OJRE7-8&pbp*h~F*{_onIT@5
z8!u-iC3;4#d}r^;gy8VLK+LyPx5E%C;QJ0^itCm1Uw(R<;pMxwAE1E;z5qk@_kE##
z9vpVXPv!<5Jp|$Q8q9!X&DuLO-#%}w^l9F&J4*aYky!tYJ6=BF^brb3S+v^jku@|Z
zs1}y*2?@F}`;I&KZtmB+5Nm;&O<e&Xx|PMK#nsfyM+%o@bt-iwJyX)%+V(qq^?pF$
z#ns(HfgR8aPhSt2WF#5w{y7=mE49@hqD)d7AGT4B-&-DEo1Rn#&uT1bhg!FZ0g<k&
zAi*iGsu@RDOW{}f6_vpA>|RsytWjVG_(u4SRq$Cdg<G<^Ld#7}S=V9<B4_L#$+Lq7
z&L(3v2*%7cfTX58mGY-art$s9^p>w8qCz)+EUx5G)9h(OC_?cD$e`{hy*%DaTe~uv
zDwYRFsw%vYaXu>P-dYe2QkGUiA2^MB>+8cB8gD!o-+`QR+lISTi-@+fKH8X=wFBq~
z54J;g8JE=3H7(M6!P`5OhW?z%A$h{tbq&~ZLO@EG6t0W~8OwPQHVa!YiEoFvzs$1W
z*%iOb9~=bYzD3Y%puzn06EqWP=PKJ0xN4wAs%YzU@QS?8XF$JS4F1kAT?O;elq9Qf
zsno|g&J9mvr7WnDh%Wr72kL4jU{LcM$bDw-pT8&5E%1l$0T;oQQ|E(~8EJt}s6)gu
z7}ReOR^J#{r+~~^?>hYtAN*#N<&q?B35MEiSTqGGBCu(SG@lZL7TgJD<#ZSfHUz__
zc%e`d2S=!K=AvQKmD%n`RjFcecahQxr)A8Os32zjs2t)DF%L_sE0Af-)eE6CFQXfU
z3+jX->kZptX5Rj0{OEt_4TF-OIV*(x+txc0O5yf0EXQ0;H5~%2W`8lvi2h|2xKw=u
z_$s5J((`KQ@7Au$pYL10#$N>xHE;<_Faf<7k;rc&0k==~YhJEMACdFxRf@Y2<2+{o
z_JBJS<|Kd2&pfR&<@ne1Rt<GCPJa!ggW)37#B7mg$I-t1`v$&>NIMV=3UadgbMDPJ
zE|oL2J9iEUW!DkcPbsymg1}V{$nxzn!}->Eo<2BjezhqE?TOT5g*Q)+cKeTs8$z;`
z0a6NbT7Z~)q&p`JuzY5op17N~r^&OgKsgLu9@o40XfB(gi&R=7o|SZ+qlHT@=w~;z
zNxUh3QN{UXAMsQL<^nhbM{!0fCDxx+J!^>LgkN=fH0o3FZOfQ*<QDR@*8XKv5SpqA
z3$>sRiM&b7T9G@7IXT>a3^EQ!i>jV@a=sP>cEINzsbo=q_UKs|96NsA@N08pLiZl~
zpVDRtV)C`$H^Gf<#qVu`9Txt|cEq`A<lB2=aUM$Fk<Sl>owiB6^&sF7p@|9$xuOqo
zy@_{tM&j_-X-L2X{tQw*?3H2s)!{I>t2Zf%NW~JO@%}w3a^*znW?l&%jYqB28P@iT
z(aLYu&W<Yg=A?!0HRCvhe8OhgTJqhTa$lTB<7(!s?DHvC_9}m75x52zrYlSj5@YtW
zT8%ji!D*cdB3j>5vRLwEx}g~_RsJ?Kc!|a=XGJc<EDk<sl@!Q>l>YIP0h1iW?WaCr
zZV_8K=T=Sq-_{0l9I{ZOJp_`GM)DV)?vLkK=1lSHIRL<PxJdc!`uA45`|Q$YNC;q{
zTMRzTU?QO0BGz)w&6t9)mM8sF^(C1J0j&mfBdf)UL%4NW67>f-#j~HuJ=BSPdE@n`
zqp^vC-Sj>%wKE#Zth=QtU(iO~pUsfm8*p>H$E-~j8}SGN%Z6#9R??Lfeesc<a;bE0
z@A>?kEiu=Z05uw4?+SgcZ(nbo8T!=*NU^q5k7neiS#7PU52cEZSkPi$0lV}Wa@199
z0=LM&qw}XH0bF3=j0&!`9*kP+dOyv7ErsXACu2x$;Q3>yw7QnxlIq^YRv5ABq5Y8c
zljub7a-bwAD<kpoO^74rA}H%~ZOXK#uUcSky#&D1m!*L+M<;%Ll8L91zBNrNtJ7=7
zB|rzwe?CmJdy82f_tf2H9<w<K8%w^lEj^{R+-5;84e`3z1oC!&d|LhXM<0-*Y&oCM
z-*c_wTTK%PCw~~<U(E39m5dJtCy>|xCuslAjnTzQUw6-LZj;ac`Cm|_L93lODZ~Rh
z8XQ5N1n6c)6}p_@6r>@^qt02~waOyw=?@42Et%mUM*3v1yYgmdvbyt|nM67=9S6S@
zveg)sLVg(b|700m8+!wKRc}YOJrwp=8E-r^!9uYKr73XC7n?E0OiC-=BzV+*X8B(M
zw3GDD(K9J_20O7#sMPawTM9?R2P$mDdDJ^U0li)kE{YS3HYF0q+ECY|!<{X6*oVhK
z<}A_r`i?V^xQ+dxWd~hU_=}4=TvwdGVMy|WnwK_frpGW9fsPjVF$L7M%uv{KWw*~|
zzj!WwmM?Hi9T7GW7AK!e(Vd-O?r;BM0bGu54CFi<|NS7@zZ(`xJQg66!(YYHY7;uC
z0CX^!D~2u4bYH;+Ra1-3WwZ#^o(z_8(bxoe@Ha56{*k!Ft_|!)HmVvEp*bgAb702|
zzVaYbZeST%Oe@Qj!gT00BluLQ23~?ky+X=;Milw7u^tn?w9Y!IfM4<ANb)h7>`v6s
z9EEib4`#kd_JqzDzsFu<J-q7yY6Fv>wtiMBmf*RHc>G@JjNCbRnY9xBzMp(pNT2&?
z|9{42>L>JDu5~=-F8qb|c|~_hkAZ2<z%p`=;I_Q*TV5a#2LtU%zkSVX>#283KA5p6
zAGiC)Ez=E(h`xl5AdmskyrzLPwP!n1B{X|glROu6AQ`R8jkM*u%P4~_h7Ymq4t4EH
zyU1_NTq6T#!#9+q_l&#)qV)M)EJ24EO_MilbV5OZ;H<f5;v-S@;WjbK?SW(PGsR0w
zhjDZ-;F%C!N(g_hGAQNrj&dds>LVSHq*5N)a2Fb22xh+NRPas~sv<pD$ZPKL_OFl=
z=P7^E>!t`GW45``_02pJKC6=e%NZ`#N_u~!a9gnUMEJ@6{*(C+xKc3V%3;Es!qVZX
z%HcGYt)WXhCnoGCiw|?%i{2;UzlRqd?aP;Y{v(b`##6~a=6z-zmt;ksw)-q$=T*7e
zVm=W#G;nu$9DS>Yd$tm|(J5OHBzhTleEbgLTB+iGkfEP1jGRgN@c*3Q?f7L=OP&6g
zx|tKk$A}~H#8E5w`VeM)NGPB5h&dT)HAD?O*?*PrlUs{8!QB+c0LyHW@tb6h&pv0C
zyN$8}dG!?>z|-&Xyygm9%8k^sNp(f*V0E_OH^>~He9kO_hO;H2&T0Km6WYImGld>>
zTL$K%8bex$BjGdWD{-5$w&Ao@-|_QLTG!tf{G7g!`^aL?wGW&ZVt5#C8zek&I}oWK
z|4%{Kb%lZY-cjD$#QESqY9^or$}=EDp!<w%6vH`r^*KQygEG1Z;*db6TJ7KiHot4M
zh)?Opc!rAvklqpLN2{bJ?SA_UO$WdAcg89G=FfH3&qRN;`<v}VP^~POCkd3-l=Ku=
zLEjdsVyQF14y?ar7CD(BLfC3!O4jt5Mb+WD8?letiRBU_F4L0byC*<8I0eS@>_@`{
zhk5Q;Z<N+<f}E-bs$$eEm$q~&g%WE07e6fxyls>R?B9So+4NSVRW*C%`q#I4a()ic
zz2;+RS;BpYH3~Av0(~cq6)s~Rg^PVZ+A}-v>w5sM6NI(gE&Q8!Ws*zp@5<UvZ-X1>
z&)vj{RIhzFYs|R@oFy$S>vszlLF;YTY7NA8+dMxfj{0L7286K#uU6acfe@VnxKjYv
zw{vt5sJ&_1nNvBZzRBI)i~b%cdLw3F<tL~=Ct>J?9J679>pYflI*xov@O%I>j!?Qw
z1l#IpSZ@%af=Cyw$#^iFIm7QF%;nDoED5~RfRN_YY1R!7JgpqI&<9-OoP72B!+#x~
z^_O$>l@PT!8pidxcx$W=fPIXXaq;K2%P#)t>527sPH*v|$UgwMR*z6-r9F%ce%HtQ
zCq-kyI3)d51&wyM#39#gQFYI2Iw4R6?sGf_wfdzP%v3x8lcn90VaQ`f2dB8fwlI{Z
z$0FcK@Rr7OB;zX#sG{dHynnfs{PO9m_G2|KJ+qr0|Mohob8<T94Moq}g5D4Y>`kX0
z6i6LwQF9#+ojJwluyoi6_T8NdN-#+nvIlUY1rVUt0*s#+X&HSpTIN%0?7*eTvFQ2}
z++}|`a}>26J+A_<0?hL!4)?AyTa$|uPtz|0Qkdvz)@2X;W;txE&thBpmLQ>~G0{->
zWz7H-2^yaf-{b3PFXu4p>miFE);Dg_&~Q1{Jt-!Zdt15g^*@@`a}#6DZd|lD%pJ)c
zmpeOkR7U=CYkISc#t*W>Gj{)gx?d%g&v~Pc`8Wg+sMI<d;~1v^g8h)Yk7wDQe{M=2
zMiE395pm1=&ECF6g};5I8eK1|aj=($v?&dxx0vWa08B1j4z%oU26hzV!+aP=#a`<$
zKYbrWFGrqe!5yy4%AB`;K>)G8LKyhQ%Z%&<*aTbgXw-gK&d}s+?Gh~D!)>^IE?}_c
zJ`?)zpe<waZqTOagcOf@=mwYqiGhWT(V|jxZ;mtK$oCZRb;|!HcN8n#L2A?K%QzvC
zGM*8q>Ag{jOoDh~crhc1U>7Mf4}y{UHy^de$~mMaolX1!CMKEfq2f?Rk|CUAUaVRJ
z3VoOK8rF^;d@T(|KYsfh9tY;A4R2Op7J4D`^Psu$^pmI*I#}xXCGB(EnIZLkbtMKH
z4R01;y>%T6v*5W;J2V%<nX;hM2>3$i|2ecaydlGCIt^d^_V%3r8X5nas&`H505D-6
z;K0vE!9EIEP@HbjI_S->=ETHkxHqzCC7!!BcJYR-qrvq-z~XhCrAG3NSqKf(Hz*g+
zi>Q+a#9k;jy>X=HfaNvB!QrW#Nj7Y?_``uT<t~#ke=dp?P0G3q#>4*)Zp~>)_v(EP
zw5zhtKYCBV6i@#7v|q=T7xIC*#%2S{IEQO!;&I^&ipQ^%e?Grm;oJCF6ffi#e4m&+
zdk1JijwRx;KM-1%<K#Fyx@z4_t>kV}P|b{V{a=n==DL@ts>IyeIbUe!Tn{VTp19y<
zZim3auguMW*&}(q;nw=3bG>IhZco8a|I(wkRn<Oi-u|i1c*%=nHsXNC22cxhc1^yW
zx-imTbx66WEE49`K+KzI@MB|4x_<%wvLI4(o?h*_43=gn-Ltgmp<QW17<g~>#GtX?
zHHcM2$U#x*2~Nzb;E9!lfA&T;aq4WK+bz!9yg0~gB<*zU?p#nNgQk~iu9A8Bi8JzJ
z5xdaC<Z&U#!C8=iCt-HuK;;~W23lvseG7nXZ?SxQ8^1|Che`_a3@>q-1HDb3Q35OG
z{Jq&L-^9eoB9?G-HbogTP=S35{LOa9Sm<&2;fWt-rRGo8ez<+*1qM_AOmvLv??Pw6
z#_96OfPSDLBdsdn&hBmDo`eJ#ue}n>vFoHyyrl`%;PJUkVYahk7Uc2_e+`#3aOw*4
zE!fK)iJ)zv_ai2abO$HnKuvZbd4Cn^)JAs_zc_j2hpnfN_x9$D0BZ@lZ%FC$eBS7<
zOZM&mPWOYva`u)&CwR*)X52_O6t_G7@NxIeN<6bA=@zjqn*@R<MoaSgx!3$U<wY^b
zbR?^@^1i=ibdcsyWv}R;z1CYiAXfeeaol4|RP}6nXY!1LHtOPN*w-Ke7=ue@Y}NsU
zrTcEDU!OL&cYt&5Pl*7uw_)Y2|9w?lQZF4Xs2|ZyKA~hZV{V?<*lgJC$FgOL-_C*c
z5+YX+DuvtiE>DfW=-Vr>w7<Bb^u`m>0oG4E2AC}NfWaO>yA89}0M%HMZY}?k@%!l`
zESs9Tujz51hxng-t#?O#ZV$NB%UZQ>sm2!<1o6D3&F0L8XCHta0GpK^hKWiG=NE0=
zJsBksuG3h<Ia3z8DSl@XMopGmS1#O9)BQQ$)btg{4b1Icidz^eSOOr#fA)u*E4Ma~
zAZbOBO|TITtT`Tj|Be5@5+J-Avzfm^0()K-F1~)+zfAi4aX7gRPniVMJLhQgUnRkt
zTl2?dpO1APK7^l2j)ia_ZQ$+RHyMo=;LCn5V#68ulHZ#>N)Qt(H>XWNa8U;`GtHj<
z2L=A2$1ZX{EEudEE|RY9_m{}J<T!cIHCS^-QCC=I+74j^RIhAj7Rwjrt4(jR9h;Uh
z0lm@>%%xQh6l!?0K_IKAIQN%7v+7Z=4H`2(W>Cw4rYw~*i~T>7!94ZhIUq8j9yoT-
z<>;S!W0CW?rJ2-$@nplTkN-;KXqNPQRSw*@;{3tA=FmaP?{2Km3t1iw1>;12*=RDq
zaq)5NC}@#VSK8ikkI#p0X1?nKSp!G)U#OYP?`!}y6H1X6Dxl27nWf-c3}&!)2Ai?U
zq0SLYg8TGZg(G=H?b-KaobX6%aW3I&0H_Z9m<}M7g~HN#93No9DkSE>8%UZf^?roH
z{#xPgngHmG!hf_gm*;rL)M`-OB)Qa<uRC$avmtHyLmA=x->Li_y_jp|#Rds)^52px
zF71K{Htc*uS-%aD7P|<>_BRCAfE#QDb>QgAGTP`D%6#om{Ateoz3xqD%$G`#_%K;#
z?|$0MtH^+Rps+G14iR3LW`RrTC*nbkbK);^%}KNWOGN{CfqlxNoG#^88DPIFlUw_m
z{VHm?2rvxr_kYUCT_X*5P3?25;B59kb&stizpsricl`;=h)w9?(Ehum2P1M*yCcKl
zUK}G=dJEF;rN?*$t}aET&^v<81RU|fZ+d}f8pK0MdGCD)A3n6dtDNH%iuKZ|Nx}W8
z;+pqa{Z~KDc44D(PPHkwrlL_r8*7sPc3-a1Dtx7KYo$^#k-!B!c3<gCIOFbTyec)j
z`q4CB$T66_p3K;ifH*o#tVZgMS?czveeTU`{^c=9TV(=ow`?_6yU%I|u;mUDdztZS
zZ@FPcUeQ&M$>Ku;TZ0Y=IjpLoOCJ6I^QB<UJ|$}+ukQw_pZ89AUvgTDS679J@Mlg+
z<rW1bdIT;qkE1os6df++`ionko!HAl(kG(3AiKc4<mOK5E<IbZ5XiJYa~8cS`GR4+
znVo!1r8a|n>iiccR{BsVeQ5tQ=>ZiX(k&a7s3JgT@jMJw8d#={HAnn|-Sxunk~y}0
z&g^!l1g#UeE^?82`vdECqe@)OZ`Sc%Rv2J9k5ND$D|=_=AB);qDM8b~!50Wq5#skq
zAO$@~mJYA|H^Y+tQ~iU)Emzr}yk;DK(S(h&rZO;*@GBW~Rkq3UKyub1)pI`3eLNC3
zfsG4(BITg{Y{+mY5CxhtE0x*XK%dzlm(Yd|uz144nJdh|3J&{h{PIDKhUwIRDS9jY
z6vf4^c{jmj<M@%Ayv6{Q;<NF^2jyGS_Gm0`>e2ksunu)mu&^HOM_x7PFqgZ%hD<?W
zDP%l_%u(iZhKvIdkki2C-4Ycc;bWOE^VIZ%Q#zBRK-!ax#~6P1Il~lhP9!ygoF_m%
zr7@z@ZCzA8_*p$QkVK`xepY4!Vi|zr{yOM)vOh6y<mjUmrF;8wFv2>Tqy;8SPcYrw
z=zU2wk9(M)dstUE&sA*UYe*@=13cxX)zlw0Kp|=}0}@TD=)7P46_A1N+Wt{`V{rPY
zJZk-Uv62No7EBK`0{s0(1Bk7T^5vMR=5-=ca+tEK|9t{j4O7odUx3Hh`r*8nt(>D@
zeG`ZPAA>g>s3flT!a8lfgCW}hJRDJbWiTmkP6!*Z3e734V(+xUOcipZ6~A6JY?=-2
zcyR)RyvhCk_o2deGZ2CKJNeR>-ei1D=AeySPI1Fqr7kI(EDe5_+t{ykS0Tr)Im>?m
z7QN@@3elK~=+(O=zpW~2^Dcg#IQfS|Wsk_aztQ_T;{bPz&TyMmJ=HY~s<YvLe6I!4
z4$I_Yklrjx74h|+n<+es>8Pm(d&x11aVx*d%LYT8d>2l}xAXwt5>)e8r%G*2!G$(o
zx1VF<?8LqXE*f0%#am5%`-M?P<K3&_siLS%rR38ZCtQ{J&=h1(oK)^XKh{YP{7N~j
zwa)_F2hG;Y-Z%9nz0I!K0Q92G?u~7v{XuthXom)1=530Kg87Cfp=r@*_*1y<E9{f2
zthw2Ktm7W|<#Je4U(4pabslKCR48~f`6gr(d1S=EhG?NOxzBsxO?{!`9vtz-PnIt=
zxrYvTYiLP&_5je$XNz0D#tfKdhY(1YHbwVJIlpVz(7%}XHK8^1y10y4Uv$im#QKew
ziy>YSi)u^(hw{+HO0ei0h~Da2pyih*bd&eEFr%fm$};ZZ6e@7MXKS?fj9hvCl1#41
zx3xfZUi=>pl&!_2$049o*&`L-G8&RvbPObYfv<yPT=ZEPFSo$w#dTqfV7@2GnRT)Q
zl$+OG(o>Hs=m$oTjgfW!c}H)5yuJF%fs_w=ANjj3VY@D{anP)}gxmUh@x%D<CZ5!3
zHHTm+SxeE6v7{vpu@%ziMN|~iQdxpqJsBMF2XZ$xD@INyV97!BV=(iW#X3g*A!BYu
z_4ed6f3dK)Q1y#6J0M(&?YJD@VQAriG^(oJP$}x9q_-zAkuhGh|GaY33Fq~{in@@$
zin>J(-xH*cgt;%*=ME|v<f-bJgDL<x2T0mLLU#Gi3yDJ-8&Zn48tS1%WpVpe?j}b(
zHHlXSDQFEUgg!!NNZ>x!NUc>5_se^Hj4>28Qy#tMD2oD~q=Ez>%42q}ZVD2l6Gj*n
zdD|3JmkH0uu*c>&x3pHqm8>pKGOk3$C@#+{8e}ppCg!V$%yb%-9V`zq^%Arwz{~2Q
zpO}CQQT+vhJW%9;7g~$2RA~6dS+ce~q69x`i`vBey&p!=dFtrl{>^jUm+fPQM(yFp
z`p4!#KAeVG<{%U^zsxQ7l^(u>`2}7`N62BZ2g;v4RVJCw^i~uYW@q4>kovacK$7Jt
z_u~j0JsA8rNl5_quUinb7vLw?ah+9SVpEltR=^$O32%<VCJO9s8h}x@%>qWz-~Fky
z)diO#puM?i=wNZH&EVXZMGnwk_$jpiD#~E)S=j4TF&_UXajM>)NgkVPm+E=+FeP-J
z2OR&We`RS+HVteZ0sB)W`vZ=G&2wt8NZR9h<~QApB1uiHY<0X%`aKeu|BQ`Sn_Mer
zW{y3;{-+g<sjtMB5UDHxh-%hcO-$i5(H0pq|5LD5!|Sq(0$U_d;Qej<WHgEQ(nj6W
z#l)hWfB9UnD;@t9b+yM<o^Un!&Kdxj$#0rm(QgrXzkn0m-ZN`sbq-Rhv2MrUs$jnN
z;j0X22i!Btq(_Fk#PbfGezSAI?X$F*m`cn?t6^q0<%ba1hmB`&@mAC_=yGn;MW@;i
zYsN}v^TxiUC0T;z5`r8Drd-1Kz5qS<5Y4|x{s)X}_7L{19V=VhE51+4)PI3%@x8Qs
zeQD4;Puw>eJK|`3wajDzh+VX33qnFwDB}%WT0MRKblQ0RgG)vi-|9V~k#u-)rG8xd
zQw~m}*4CAkx(G2;gdqs9f6e&bY>Z>auwWk&>|(ypaZ*8Ul=~@jLFm%1v~w@v$7sNV
z)Su*PO;GpA*3`S8ego*HoKcW*7HGUYHc@p?=9fnZS}~|9mT^f*!CB$V^MjeuNNS#p
zT(ADn-jI_$R|onQ0o{Ay6wl=^7yrV}GG~*41H;Yfbxw*?6sUNYBXoEH;X>C4iwyCs
z2gybXhB<_CVG#8?Zb-&?a59gI5T2IOHB%`3KT|M;q9DI38k5W4s+;E~^H=j`&Ywxc
zOo3Du0UCAJGsE`+eio>F1yma+pXleN@oQCMf!{^NI;a#s9?&3`5h47d(w{ludkWhh
zQmAgtz%?mh@znWbJ^p^w3R#)HWBd&iKb$!!2-A$c?g6U%(^|^ejNoYP=ca!%E+Ty&
zKqYYI=-0l#2O5tPvv{j9C*`g$k1s3UV>mAE`~aDieE5Z%4+f>)iO6bKne<IUN)Lp|
z$jTiCB~5cc@hUUe+1Co*2P=rS_Py#WCetktrIzPsgznV8q}PrE^$@h3gAJJtaqqeY
z<8?nQ(i&{x1Uu%0N#EOjSq`jCzyEwajuf)oce&--(;n!l^~97STn3!ugjm7dXr5O<
z-^j#@2=Y3@VLgJ`oIzXlHR5PP<qm03i=#4RSS){F>?xO^GERd_K)3N><`MwKULtNH
z?NwXR;RBVx6n;k)6wJY$fIZ`!`qclOW_)Z`wlH!4w?UHV&6{sS-H;9!0imn)R=3fT
zkGmcJPc1Nu@r?C+o)E}BL82^lWk<C-<JXm?sozca(rQq-ffxIu;lq?4u>!i>gK__f
z+00hXXccbLzoiH4UbMDv3w%8A@amhitOS83(24;8{U3k~IJYD3GPr!p^flN-kDsuA
z&U$RHrZq~~Gq~lyFFPRh<sAjl2Z~L+V8}1Mg}x|-0R0hdgD&PFV9uR=K#I+txU)t9
z1)pfv^?k&5CsEtTuT@x@APLxaY$!~G1#W_xwoy~yF(6n7{b!xyY)XX+e~zLEti5=X
zIaMRGnw{v-oMG>+1By<<u4nYn=&&`U;*KDbO?C|(7S;av6nwR`cpB_nu36TA%AFGN
zBYTO!upbJW+%=-_DF09KZ~J~+GZ7Ya0x7$^Zu{}muIz>1l$67(#@2gTlU9M*7yM$O
zJp3QC9fHx}_3Xr~#=Pg{chDZe*Bhcz9)!*jQGfAvkkvM)FoBORQKg8~&WNJtULgLF
z8T<tbCv~qTj5>~h^qF-+nGyDOO@E=l^$``1vL$kbi1m+vPpQSW$Ll{Sn2k2*LNWu%
z7@+U|E79;Lcipj+DsQ=7A;-PcL{866uxQ1ZKek_Ps)YaKaa>RRTm6Qfl87G{<~jc)
zV^-UsOvv8N{*6-hK<@S)*0*TZO1C_qy(_5ZQELYHroBt}`y+WOLQ8sN&h4h3L04}1
zMY^>ZytNft!jCck?AJ|WzbjRyc+}qw_iB^1UDCNK@ji8unT;txM{K-<QP4%)4Zo=C
zL9;KU(3Dpj97m?_STnOmSt70V!lJ?`23ap(W|}9ZM;uKQuqeR5%8EA!ZCJ{RhkNiW
zm>cNl`PjF*L>hKz{>99fl+NGmF{tG)#cVOC>LXz$Uy2*Pr?afT>MGrXoVGS)qVxd>
zPSyaNo2+25xL1$`=FeTD#0n?XiD~GBW@<U2w$5W$1h3%j4_Z%p1d1(+_iJA#dT<K2
zld$){Np6m8Yl!(_7X{aJ_lSgkd%>H*YHK4OU<x>M&;;QAfm;$pZJx(22?7AuwW!DY
zl>xUYl;WDlb66;R5lVfTuLTev?$|}EHQfu<4J!K62W(~>5t!#toUVN46_cZzH`X!5
z@XZ@0Brv7a#GkuguyZnCD01<k-JEtcWWHn<d4pel3SgPJm=V7g=`x<3tVzxVaw5&}
z(@9D<uKeX|KU<+^AJ-8C93|_?XGZE%#Gj8}cK(K#21-qy;ylgii=Wj&arxq78H1tL
zQt_=v-Fih=`9Byps)D97Go^sbqf9`@+G?vtmm1FPNtg4Ed-STst0HprR6F-d@xzxl
zDMiI_CNC}}>j%H}f`V1>>{C^=h47gqV4iM+As0diZG7BOR^)7ne0Cj7$s5iT!5WSu
zy7$yGwQiEA?$~v!GCeZPF6;9uG~}S*`%xVCEo}W$RSW+E1x!(yJ9fir4M;*hnJ4Qg
zSbGDa#4r2lp)*sE-(Jkos&dG(hkTgm9USFVptLTcV*6lpjV94af9VuwYlB!mYPGi*
z426I+IVr1pDl1AULCLWT=*7E8F!>f?rgRG|qb!PZ$JKJ5Vr|D0^1sSh+xS&#x+9SG
zk32>(9UJ)lCB1#XMaX%2(GhX~4!W(a4@_PA&OqhvN0iE`qWIOO04s;Xg79D#q1BiW
zRx82LS+7_c&$V!Y%{%%Y937amt9I#5Cy<~)wmjs+2L%e=ZeJ2hhp!+!HX~=^MdWpa
z?p^2+2m6Sk0bR5Jbb-Xe0_DJ>yMCB0Ltpz-o{WNX&JH+53+UrOHatLQ^<xbQ8kBS*
zQG43^LdwE32q1X2keI7-TMf)`f$AeRw=E%Xrsw<~+(Yqd26Tu4aR4P#@Va)gA~XgT
zgB_z)RQxrYH!f8I0{#<a-YY~t>dbm~N^JoN>MWezNtt0|MY`6&lHMx@F)7zPyo5(%
zfSI}ZJ)vIWGtY|`&{7WxAxo;{|NdO{r7nBZ4OPlLh9Hk?drcUA;PBNMPKWlx8~qUL
zb9m}HWPJ``WRK@dwU24r4?t8D;EJ)+4mHJt^|YEr40wvQgQX%vi;HeW*O+M+vZkHz
zBk-CAVrJDGz%ATZhb+!bV-k<w%jkTelmAjTi((w_?Q+<RT!Y&TKy3$OHv<H~)cR+h
z8fXx*hE1r5rE<t<SjaK(91Yw+pkVm>`MjkCsHb8^o%Kc6U-P>VN6iFu&5Ypdsk<&l
z+!h2zuN9CcTr&n8h8~~he5x(1GRm9DxQCeaIdBgz(aXlIqYH-}e9Ff^=n5mzL*Kkp
zQQMkTkXjrq;2WLNJU+LuLGszrovNo-kK94eeIj<M@|K2S5WyF^V(!vY6E^2&!2u(&
z!mYYFB2B~>ba|~wYzp1r#@TbviN+l=AqyKceGI01kwE$+xRQSTTSQSen$L6Mhr_PD
zUHe!21%7n|`73F0cP(Ixwy5C)yHI2=?OIa|_1p1~nTkrJQ!aFgf5;0X>~{C{GEbtC
zw!}}6>|aqbl{0Rd-)1>d*vEh3*1Q|@9Aw5hoH?6mPS2dsZHF$#vhhAEc*mh4tniuo
zlQ57-@W$-Y{}d%=6~*bQ1#{0oj^j4}Jbx_>B+MdlD@Ea@BH{L1JG2g4k-`<hq1#~X
z){H?)Ir^JRYcbo%j;rxLbTHa7*95Nld{f0HwQuxil(TKQT8Y}t+U(dAiF-<K-kk7$
z{U=d(oJP;Udx!4Qb04IEi4wiqhe6z)9WZ>bFK3rh&`RUH_At0Tw3=iVf8{3&hAj{M
z&2RZUT(B>RmX|O)b@)7Kf~_Gr^tUOrA^Gg4yb~`znp<dZ#Z-Zp!jAF#A-<il=7Dhi
z;=QSNDCx>T+;d<mJFR!CCg~WDr<#j|3S{Vw3x`T=^Cn}HMr~SRmt^<po&Se>vp&&~
ztU*5YhrgODlnq&Z;}+xnI%5j`kqnG!KxLFWgJ7&tJa>{CsTKSn$?hxjX<g5O%$YiY
z`tj9_v~2NyRmc9IwTD-qS_*xh7+yC9@9@E7mNMlhluNCdn7|vp+@AK?k>8|TGnDSK
zIL|#i?AqDihZo4iJS+pYH01068k?Tng-l-46JH=^Uwka?wBk2&Aj_umfQB54N;cwV
zwY~gcnI(z)K^#G2C5^Ga(k!tXIjJMb3u^%){nXfoV~^ZVs@=>y0f<c#9;E%5n4t>{
z-_sh!kJ^ZeixFN?a*h>4-+}Q|yhaJWqY|%3q^g(c4Yhmv&KXK{J>jbOQ!xA`YFNq3
zp7$At_+j@>;A8Rkm=@rQr;(R|=W5l+3E_4O)WgWYWN>R<_%$!+k4lCo%TdfZo&s)f
z#gQu#P_ye;R7`y$w6k)nvl6CBdeCVDgp_j!f?jcX7U`DtUXM99C;q0u`;^ycXzF69
zEtY}T;QgqLs&H<ZBJSAjYfkZA<I8zg#g*i<`rL=(f3(0?N*3cE>+AL0#G+IDO-;_n
zy2`n815u44aZBAFyo=L|&lMI$6kSHAA7MQV`+e3>=6mKJ26%&oA(|;g1i&j_bhUoP
z*B9xrjKlJ?yz|EzPdF#yLFZc0fU2IvurcyU=0L$gti=n&+s4KM@j^@=+YszJ*%c$Y
z!aYSDy)g2dc%wHFS{ijn$TIVwjw@-wgCv=W(QyYU^k7hnq8%$OyF-`nnWJy6zl1kp
zY6vqm#G2-FW~x+n180kHmQV`JUr2KF{jBa55pngSq5_Ivy?Nf2B#Fl8TnEsOpLvJ~
z1f{umOzvjlN`lxB<06ysx(3w1Byf>A=9HOl5sI(i3L99jz#xj>D<IohC*#-2P-Y3T
z)g3cqXarArY2O}t0N$+`oZ?R69;~DdRw7(Uj|Kr3n&O6g5K$y1<+oSJkIS8P`gVoK
zq({S_G{8h;ZTC5|ic9O=4kL6RUAy2Cp%B5+<Pp@_`Zmr#8bHS&jt<jdmJ0F|Md20J
zXxDO8bfC@LDbSx?9KtLPu`)F%@mbk%_TJzP#9fIzN*bJJWp}yFoB}w5rAXvsUM^=1
zRt_XQ1{-IxdEeL`oU?Pop$XQq#ijDaJzaR#a`UzYo<Z`n9ZsC><rfv9EpFlPu(b3n
z!eLMDK^wwB13EX*(Z1|4e`L$!y}l>^8eFN-TEL+q0PL(Fxef}YOGfX8ty*`MjU&pH
z5cU(9D~PL4|7gX`%&tIJf;Lxz*jh-2z>-{iTXc9(8*vI=SelLjFqaGMj4nYR<I(-!
zF~Cu3n@q`A)T&a`7f#K>@>}LcGdz}~mBY_qw<QjRC#kOae;^xz5dI>|nfDRTS|d4B
zs-OG~&vjUa7o|6{0d6NSWM)mPDggac(1rL0ap1D3YSrJ@IZa|BOh9#>O0M|8I3T3)
zh3Cm9Ls_S}kuxs3jG$sy0?P2Wz0^4yPS6rQkw3^k5jj}n+PVaM2H2LsXd_||`Y<#y
zv6Ow(=b}xV>U?j#3WE6VA}D0;)xtqsP>?%Vh|4|$b`h9Gp^B<qtz3}(K{yp55Xrfc
zjM-{~GLp3Uw9&p%>n+@~zJDra=l|?Ht9}iFL<v9mRvUhM5}QC^<a)SmufT{M@!{)7
z!R<`xSR9Ks1UCZY7~67Nv@@~kmq4$%s<qw`#G$cHd;Z~GtgqtS(4Ahn_4h20tu|2P
z|JX|MF7^hy(R|Ec^4i0cwZqlCrO)qyQ1dcnQhE2>&Q5P_{0dm4+p=0Q!Q9^I$U;X}
zcq|wAy0ggu`3;>-z62s13j**E18;X3qeacpM;E5r)--iPbn~@tk#_vBbmuZq{+Z{o
zR#o-<IdEV~&T(&r4YXT#{{KCNe*WopX%DLfJ)?!hxb4l`NEht3Giv8NmSJ0&P>tR8
z@}m!o{yd<m_!SIEeXB~eY*b>x)%Hn;!zOu7!MBDoE#DjT%87HrIfE~-fc<b=@bABW
zsy`$*2kvO&i$Z-wWkKn%Q>5L|q~qe^WphQ~-SiCL-Pop4GW6^>Zj0vLox*7%sSaI`
zQk?8T;(X5%Gnj<D!2TkfVmYhTZ69Xgc*TJHhC|PBO`A0baK;2lyXUdHf-CwViHm)s
zW-T=?SBUeOHz3I1=UI9J@LNlSF&b)b|F*&eSe~9cms(2RBCOi61Ef!hPv^k4&JAW+
z_l<@}Z9hI`y_+4MHT~@9zKEgBryNpwE~+J3E+}yN9l;;^vDem>hm7W@h}Mb^E?rZx
zbr0792o=NK*y3<mgI#t8vy7}Ob8~P5x6D!#;{KVvex8MyaI>}-Kix8H5Nuy`xOHo4
z)H<hoMiuQRy>qJlg$Dkxdu%nB7GWJ`u-V%E({T?t*V8J#HSm8Zn@iyoKBjErOPH+%
znF}Fy0k{Rw1VbnbAl^W{E^NcrTk`3eP5BCz6;lUoSj&oE1Gg{$?VG-OWky=6><84l
zaxNPLgPS1UP6KUAH72-Wf^%@Aq%txMXRCMBH;Wa0<vNG3=e89uVKxrM#Y+gjyj>8B
zLR7!^PcrXALJF6ZaK;7pHcZGI*AhOsn|AcBl(=zWf&0Mw$9fWGM!CAiTmVK6Ky|F2
zibvM)1tYi2_0w_G@!{VOg~g3o&vWo0PMiV$Ng(+O?%pcUma<R1<j}^$eTC)4{HwMo
z;j<{%Od)=)7cx_*0a_`qNR44pU@_MdPjb(9?SFhD27pP%Y%t3n;rj>&>E?9Ak;+uY
z=*m9LbFA5{)o@PhlQRzc{8-5zz@G?0_Q=N!h89Lp2394eh-S+#!nUxcV#5|JcBNJ~
zz-q%${!NiGZx5O00r8lkQHPxG51;X|=K6hMtaK0jPC10`!EiVoo<P7vxL*1l9`gSE
za9BpD`rr%Cfi>pKf$jmN_F3#o-_l$~l(SsG6ycm$56e~wIacuh0NY&>hUNjK^mTzv
zpj_Ym;0Ri$II!qF?0tjFUi8Oq`pXh6z|yld_<hR=8kv^0bSL`d=hH=c4*m~7BIXLo
zf%g+3sXkamB1B9SAcf$r=IZIJwDB`@4~5NABYv#EhIWY1*!x)oO0t-y9sW_LarBe<
zXgKE!RqV%gG}u6lC|o5lVYCroOwJH9==;)f$8$_xs>U2Jd-?k+i0)bXL!t9fop1@5
zh0(%MELWhZ_WGYIyR4k2IWql?7e>Q>Z4e|!!_&9FUHlft<^5H7|D?9p^o*z;I#9eS
z@dsZujv9cX2V<!Lminz%d%>iUUAoe(Xxo1xp6%Baa<u*oGR0;vFbh(si(^0nzF9Au
zDY4+<bFSHGw1O-4b3}FpMxwnK*dT$&<Js1wF5f3Q0#5$!<1EF;J$c+)GNVORTu~e4
z#RylF9637%7zNp#>~hFhfR<{Gs)yWNax@cK(YcD+C@MyH(gHr})!te5@NE-)Ai>@l
zp;+DD*$Rxc_Oi-f3ktr_pZ3uQ<XTkiYf?Gyepcev14{JHi-dCH!_L=}lW^c({rfSA
zzg2^((mxs@glwC)jN4zR-8fsHQ~%eo2s~iVD3@A%2{=Je!kQaYZAa!G1wyI0ZrC>W
zV4pqN^s&AhiEu5Jw$&jfL#PfQnHRf+-SMEmxblfNx7T(PIbct>$Vf^CLS2G#m_Fg2
zg0mpOKKbEDza!uE*t03ygeu<dFtU{UMF5Ul+r(4p+kc9H&^EC4={;`GU))hi4&Thh
z4(@v)xujZ1RSYjx2}jYxz?;3jAgosLst%&!y}(ya9Fm-i<9YUVCHkdNVEN+4gs!wx
z4`8FKZ?C<2uTe2!xpu%}tYG95?s4`Lz`5H3tUTJn#%gM%pY_JjI`y+gg_2PH6c183
z#Q|k;+<MuT(Tc)v(zkP6j(K&C4Ew3GAAnm8mHCTk9r=9b{2#UAhp9ldr>u+jVP2Dq
zn!eZaR_;#?k&1JB1PD!eIq!5m^heW56~bqhF<ao~*lKl0Exat99n9)`&U>2QCG&)%
z6=BjxeQdFi^bKT*S9`xv1ho+5X36EYiViiF#z`?G#LI(}FUpv3!s3*M+L--;i@-SC
zT>H}p!n}#fVG-6G2E3VFYilH#<rBkBq-7Q}@Cu>@!hEqZd#T%gXpjlb_&zb%eySXH
z1Z*9#Ag~-uCaX?rA#Wa9Qtf^Pz`=j=z$%qRZCheDWd-!#@`c|C*Q#7?`f2_$Rtk+i
zWFV`1X{#PQ*{i0YPRKM2(bu$EY1;oVGYA-V+%Wf*c`^UK9_$V&m}OJwSTc}Yx(E_T
zX`SOwfqhH2P9%7EEG?H;vcNgkO~I=h6eob2Gg)sX_h+R!cMX4T6j&qn4QH7&Ux87~
z-a3F$TQv23*pzBpxh>kRn*W3Uw9DNzMHjH7#moM^5;ja>bDNm$jc)is252^E>*9wg
z@Y@3u8&C>5wT?^7YL45#zwSf8qujYy*nvBPLY9F83(S;l+Y8Eo=ef0r{aQfdv=EhV
z-dV9k4ydMb9P!GgX5}Vnkaj8{v?0bm*1wJ`Cc$f5IQ%nW+>S$EzZqU-1-sB}B`lu=
zYC$4})cQQ1Y}`HVL;Sf$sutSOLk2W;6s-b69`bf4<qjr`#S5a{ODx$^>}NntG~SS^
zj-pmTW`?}ali)*`;72P7MW)=^IM#PFY~1o{c&>P#)dU|7B%YkR>{Z!%lGLv)Zq($v
z$D)(+8?fe<>N+;+6ajmEO}AQOvqMp2NOb~KtKM1rBphhpFKV}q6h3CKsSfDtkl#ZL
zk3>Pemj`@~x)u$I-k0;Ueei{2tc+zD*I`I&sD$kyJ!p_q93%~27l&l4`g=zd=@HQu
z5008!J>d%VS;hEpEY)#gz^_3n_1HI+`NHS<N%BLx52igrjsrWh%%6OGh&A5l%s7yS
z^e>bK1-@dnEo3c|5xDKAN^>+*Xawews|z|L$<a_9Fz^8UD*3A=(#(gZd0h}opsY|D
zFY(4_Bgcm)5igMg^uQD)o?4~b+}`%LyLhA>v{lDJX10X?wSfl}qd=f6`saE`U^;TK
z<VoI{`+H3*+7_dP6NH%qzadyE8E~?X2T*$6AN28-Fb(MB6c!Kwnud4@rb2|rmykaE
zZDeT0!`IZ1FX`SwrpLg34&5g@^SupVEW!~^AHvXwSl4{y=-DY&yV_Sq7ySc)OKF_c
zsMQ08Fg3i^Cp-j8Cp(2#$SoGv7g-4-pEb6cbzD_RX{vve+4%yYc56P4Bq<%H^H9p!
zY>I}i!it*LxjaJF{SzraW3&U_e$FU51+qSLjxO)4Ihu#KPwHO*#$Lm~Zi+ve<B07w
zM%ma2wfzXPtaEl-dcx=n&&5ml4*`L>VHZ+n)hs9wQ1Z`B<RMWXLFRN?sPazQq&!j`
zt8q~T1sdc^6K@Et+n&dP^k*!HErw(`c1EjluYO9CM1i~DC!Ufw3FEw_x57bPnW6FL
zLx&;$k@{jLw+;AJR=9O%qV}iu66O5DO~hT&?+_B-C<bv)Dk^j_l9ZJj=%hmf1f8eq
zZp~8zzlQrF!2((cVyhxWEFcUU`SdkIG5PP#=}z;jT&u3#bSscW<dc3El9uVOUNJZP
z>6s%o))_e3&4E$=58Ou-z&LOf>31#okT66|#;Z7OB7N;+x<*BOPT<ax@v#A^I&omD
zP6MU7%iJXdR<ilyXX5B^i^>3E*2$|12RL)vD`!vgBoZ2vK_a-r{kIz0MT;NluhHVl
zR=wiuPSb24nu0%}KrXQDoTRUK?`v1j<>)w0t5<_*=}38wyy%(hm*5+1c-kanqiq`S
z^J_BFt6t%*%QmRj+&z$2tfCu#3clQi-<*Ujx5<a`t`w<$<3w!FFYE#?&(`Xx))CHS
z@Oyy*w;y)hxeN?tUJq`F<4nJr$;O8anQVy?NW0P@jR9G^IH12V*^oHPLC*Emil8q5
zE4IwWetpVmscxQjgL|ni9uFL6)8(Ar-LIG_8jGCKeP~>70sWYa8EAvjLPeZ;4p<N1
za26u-W+6ZJ!Q;{m-bOlE)Xf*(;I^oXFF^1W&Kf2^;Z*y_dQV2ojP51lw-<O^AN6m1
z5+A)MqRVsOL7SNW^W%;9VV4bjMvJq&?wjWNIL_C}nD1@S*U6XGq$h3b>{RaoL@uyK
zNjlB>G8xmM0DWm=vHH>2Zdx<rM&k0HcF_-!!2ZT8$y#DRZ{1kjjlH~e_g~9tIDM*C
zb55xf)XYyNpWo)M=5F?%z8$RFg8)INb1_@X4a0%%RW6v4cO|VEq=gaJY_y==mqeu3
z6ItHdg!U;w-`jMpOFQ=e?xyjP`e%uO=z9l(3@+;t=O6VkQ|Mm`&>9<y4QZGD@zM+4
zoe}gRNp57w&Yx4~hfo4tbz^fk_IB0XuK|1Uf^(~|`ow6G8oKMz3*eL$TD*z3VF@i}
z%)E9r!Q8pyw6B*-wSZhuTY*2f`+xIV&{i9U3aI~AsW&LkrQbCq8I7{1NkZE@_cEh7
z57gc+{Qbc^*aoa(1I=Ham_MLfE$3(AvtPRXRoGon)h}JdfG!q0V;Z$L-GXH4J>0xw
z%=uG00swzL7jKT)fd9YVbZZj4xIVy61W^>WkmGjb%$0xSzgFF+SfOa{Sc=sTz1lM%
zmh*6kBbNnndrO>IA4drLXXixEaAx0MwIXe~V^^*GKm_+_O;%^{70y=Zq}ACy-D=L6
zqoEgJ<U%~97eX$4gGo{qpLzD+;?(HRU+(D+ytz143trW;sP&xUopaQkOR{#dGo>bO
z1bAiSvFPk?^+jTLkZ59ro|Q-DJba58#4{T@fSu#qizgkK+jlxDxPwh@5G02e<0SJm
zj4>rzt|YoUmS*Lr&o0WYBLzCxh{{JIJQkji%4qwAs?CU6MYX#ZhSSP@uxdnzf{3(p
z5qy)D^YcqQd#8(s+N+p>*gtVnaGw)<Mz=Lm{jd=0eZ==U(N-|u($Ye3d)|rUiiQi-
zavZULUWg9wtt5z|!=KNC0x9j;?={deQQU(&o;KK>zAqD9pMQVH3blJ3yQB6)e^2#y
zyp+GI>qPkVkUc5CJU=D=P^pgCRU?7F@2af<?p*~vQy}}hEcf-doL7I|KadFq?+JhA
zP#j$ZpnsHU<l<iX<<S*fI<yHoU_AYe@QcM>yB44V1F6v8JF4&Z>;cOjt!&6_WwD{T
zkY+x6%G&u)n{F>vnZPudCr#~y!C63k8d|1+ZsIYcmT=|KPn!-eRhWoy`q$l^-qiRV
z8?~ED1h(Vxa9S88tP?Co(U*L=FMkntUiyS95_d!g!7`#$)@!Bze_VZeJe2(#wIMUv
zRd$J1O3dV`l(LtyYe5?`%9^!8g&D(SDJn%#h&G8BWyv}-*6b0o8wy#oFJp|}Yo_1x
zdw=iyPoJk}rhD#t=Dxq*>s;qt=O9lzsr<Mbr*Z_4hxlt`S9`#uE8=ewZIjka!40o*
zt7sWMT+!r?>st+`)NZl6NjHc~2Y^aDUow@YUwSypr-EySCsVK6pO$>vjECc`rv08y
zm3amY6h}+yjw$-#d}^B~!qJH?c^dPG^NzpliOlt|JXOqPZw%GVmH$PxPY34Zm(l7T
z-L*n=pr+26Ms1QumT#2y=)AA6hx9+f_*ev_IVcrvU*k}pYkowQPY#eY2mcJdsXm;)
zQ>&<F=GfluKhl8A*VvtRkX!iCeq&ECNO8Jr!pfWBel18adxkLfRbJGCz%j-+Wp#mz
zG0ql+y8V&!3c{l7vM+K2BVjfX5<^(i=)f*bl2H?DK3UZA?|Celo(tu?JV^I77d}b5
z!iPd)-Ur6}3B5M~&JpB#MD#<`%w?X~B|Qigph19&Si+vs|9ut0-7M~Ryd2rIM~#cL
zMM$SJDS*w^c@i{fs~U0gp&y3B{5$0GR`=}h-lkff3ejy6{_JXWilB+>CX<+UO<wV&
z=UCJnDa5?YTbc(b6F`dAth_H^KmAMH(|&b$?ewm-s;9k2OD3bU?2S)?TOV!qd8&DB
z9e5Ma)u~DJ;wNfx@~x631q<Vf!KQH;9>r0?QI@Mu+0@Km;AF2cs;GS3)9uuHcQfNS
zP5kw(4zfli>|RbAWpV~T$wnDl(-+0v!)L0Vs-MNL+jq_NmA5-XzhP_9_s;-T@a)~#
zK1*x&GfmWIlaf7e1g|@P6xhf7`io7RWiGitobu;@5ujqfW>EHRO8W3+gQ6l8gl5h2
z?8Vq-u6xVhlNHZ?E`KRtvFiJKNt1nCn;?|H7H}QlnV(Y;>_gO^s}yNOQa}1IPfk3?
z9GRg+eF`(T-E<&q;vRi*nT@P~YO-9FG5wLs++~8nIa#FHga=EWPh?}WWo9EAo2gm-
zBKZn=y78IE&uvALczeb(rPJqB0{@YI$MwrtJrS+D-8@c7ajfQ5wg7ED>c}Y#s~s51
zpe%MJdWIE`A7_83`{d?Z^uDTp&XgFp7Qu8QR)4@W9WJ0oog#({7)_bksitL9e9~gX
z<%mAiVd*|>yQ1~j*$_1EdTinD0K*XTBOWF1eIB^cn-p*OwM*M!E&yTlmo^g98ZB5D
zekyr>(V(xj&<*Wy?aodW>s|G>;ftI~Zs|1f_s&+$_2+%it~Z7Nh3dVoyr1nascot#
z$>)Y<<i&Ekp<hlKUddK>sug*w+TW1jxx2XD;^+IV%J%Qr4N-kC$mJce)$1ii=`QKK
z-{jUmDs5CYSeO~HubZ+6bZI?h`YqRhu~L9&Hott&4OSKK|NQdo95~G~BBClb;HNSC
z$xbnGp1kZt`$c<dnDEqfgX7n;mrmC7&#{YAFizt7)!oF{KO~eOGJH+ey?-=ZH;z)P
zGx_NmprI&r04zjziV#%j6dx>8_M)=L+o<p?dw(C>NEaI#D*no1t|!R<gmNLxO}2Zo
ztMhRF@sasqtqSjIuG%d={?Lc}geF`hF1rJbrIz@+B|f6BM-9_0+x#MYXLmnCuim4k
zc-PejkhcWn_`$Q<;nEM5nrSBSH?Hm^o~lkJXkh!`|6^HsP&~7_Z42#^EB*H~#@;oE
z-mS|Up46Mj`m%?km#CvlC<Jz!LRYr>%-5xok2{_Gi|Cv7G0{Ku?r8;bMtv_rQ&)Y+
z^9&>1_kq8#+im823Zm>y8k~g@i?jVLb#wQ47L5{Q&)(jW)%`iBZFE87j>|i(04c%x
z|2+bUxq1G@S7;odU9|;&EW&(r!qjUKg%SGjI8Z@>OjGdZEQn}rOCnty&zpBg3VzoL
z`c{P0YK@uw%>+yY@A%XGzDVHgmq~A*BX0y9UKH*<5%YBYL~>ve8L-CMr22wq*rMtM
zNmw^-BU*2BJ5F5z6Ty2!auc3Qlb#}3R8|UW@@k-8=dbt+bj`#oTn5tRDM^_%e@&3s
zm`J_NGfd6AKzRXL_J7hq(Ij!1>+MaRK(;&uu*g!kC)=;7-TmUr8@PzWlHJc3cQ0M_
zqlpxtKJ1(NFXmC7^bFH8FS>b6*v&LWw^uDlI*m8H8~64$3e|&0_3&)=qK*=aG;l^)
zuRfA`b>*~hS?l=4N}BqKbFjD}g!Ad%G#k0BZsY50m6KQ@V6&dH!RFCLa$0a}OcDKw
zJipcDysT06T?VW7Gg^3hpKlX1aDqrPaPMYv-&(i6|JoTYkwd>w5e$^l#h^{jG>6oc
zH(xr1BcQi=T`Pe1D7V;j{(B-ysh`K_AK^m@pUVq3crnY()>H{E<SxOjp*ZQ<KcgtL
zdO|$!i>c62FG-8>0%2#m3v=-3hG_IqrFn}xjpx|(^zrHSqNP7m)^G88RMhy7uxM#R
z<B1p5;ul9@(tBQYNd&M{QU8Yi;4h|<N0Yh5LY*v%UynT5x$bvo<{EaD)?3JM{W1Io
zFMpIfU^;)46t<F_@COtts<vbI{;|`zf#grq5wR#Ow=UhT!}~CP&n+GCk(V~E^qw>i
z%cb0)=x$k6LISIe1F*K;S{Dx2y-q~5^ouah{_uXDl&>_ou5I_S(#Btsp5IusoL+AM
z=gPmOb^f?#vj2_o=e(OguFLGWUKJt#PQ4g%EuHDehg`BpJ-Yf4D6ZUrPT7lqf4N2T
z>3_7nXQcDp(&ON(K~2iq31i9vTGnUF*oBPV2+hzcF^j{vS05L<lc0;rCX){9pyo{F
z>N{r7ILSVfq3YD${LS2M6c#DCD-OS@9w8gdNa1rlpnD|b5GprPN;V;sOZ9;B<#j!X
z?r!O`80MZhp0gPG*-}CAmm*42wH9Lq<?5pOLX;q4=VTucZHJkvaXgnWbnjA=N$iC0
z+~GsnQ!n?GKS)w_;{rkj>4@dIK|~J6%fwmo1XAlo)g}bKRYS78-#d&Qu3P#ThPf?{
z=NN`AR{CLE+<;U-s9ECvI*UjH$1EM2qqPb_ow2md3PFsNb&gMTENFuKsqL>fAaiYW
zO8o`bfX_78+#kqD`QwoPtGDVp@bg=&lp*4AKIjuKA7=&bMWgbulu?4Ts{cv9XFuXE
z#)jGLLj6YV=6QSZEN6_(n!AGBBSz)UO%|ElxH|m(ZdOV2#ND3e`4*JayryzLq4Fkh
zErg*Irg#^BPN<i#$9X^ERVms=w*qd*i?29q-)HJZT;Na&OWc|J_5DhE$I3#ByABOX
z358ysy$Xa%N$N%gIKr~HxOTq$@coR7sVg%O1BT;j5g+FMZXGbLjQDQtaRK`>eanPl
z0@Q{PALO-Z$!<g?A(**X{%+0vf!vcr(fj`Hre<+LZr1r<wZzgi#Z%KmJe>J2u2E&+
zA&B#x!!>}?PTM;t=q9KbP(`z~*<A@oEYpa%_$0o|+IdQ(Yn`M|uCTEb(NbJHxqqZJ
zncW^#MhshfJjb4zQ<gY_ay)o$z#+wTbI#ihIKT9&Fwl_olGo*93q}dNJyUkpO~7<a
z$(yJp+Xx1%(OCUV)Nkv6rF6t^YtKS#h?+&wHBh2S8x2S);LcAK?5sCC2bIIyOZd5T
z_!Q6QSj)L|KlKq=W_R#rI}0$D+`{vrAK$h_k%3U5lqJj5KX)9Dh!=mg+6-Gds#En1
z7=&;vy0!1pAFaJxi-`2RhYcA{%GzK#5RjDUr@5iqou@!xpVIC3I6|8`zzxDe3d8aM
z)k8gnBg(NU<udV%-e!c>Sg`<w7Nd=8E?vEW9L$ijDu+vnsG3%#r!m*@SK0r+gi^@P
zNPbywujD6~>g7gDk-yoiJRit?ITZfypY;t1Ax36dfOPLn>)i_#$f7X7FPLjQT|I-W
zSK{<Z?gSkBfYgOCJt>ozfe{dRamI5Hjn<wTSj%7O7fxTa{PsMfKVaKayCM<Ha~tBU
zC6;l4IGY<^+n%}*VbcM)jIiuo%vJvzZF6!ozK6E_+%rIhw%ld<)AeeAT;}7eXQ}Tm
z;)$JW$&#lp$TjIKKSu|s=)mg(u6qJ{J&4fIQwyCuOB+cu0+TWfWmpyqy-DAeWtrAn
zyHZo!y$49Y^$<vPL&V#XA({2qxezkcO+~u{Ohd>QPC#$|X~D=hUflJO(I4+zsyPEM
z5()v6DbokUv}`Oq6ap5nnOEghhrmsGhs-EzU)vGzXGGK&4j|OX&=gMGrLGa@^w3=M
z8R<+1addNL(A)t!T;W`9d}DhnBQ3ETPEfhT(ts=bV!!0+={=;G2GA*?q_Eq6W^Y?{
z^$Hx1YVPmf;vl%R=;FX-5th*q$mT`JaFGm|-STe*8*KYu)f(JCI?#erUmESyN}hNy
z09618M#d4f?S>46L9+(iRs)T*_GKp0n6Vz=4rGJtk(1b^w`9~wtm5eFxPd~{t=J<c
zlWdOqZ*$asBY8$+?@dlDsz?^a?E8tW^rE&BQln*l#>PXpjnRaJ3==jrlZ_^5CRb%g
zFQ01k`gr70F(~6k975%Eh0br4dwS&mrGR{k7H>hJa{N6?(hHS<M4J45%)W~3zv$$d
zJjDH+Xb<-7NFbd_BbIKpOorK!nQ_YU0@uv=4uaJIf>2|}fylZYgu*tIl>LV&_up)g
zW{+k15f^=6H1>S1XPC;kaMuZG{h<`Ir$L{{OwLy@HIC?G=eF8UYn=l-i32>560LuZ
z>!<ui%cybA@Q)#Lt<5W_3$&#*TF!D!b~lC7V1lZRA$dCQ!!SUK+RUZNhuXL4R6_=U
zpf{_-CbgG$czWOs9WqVgzE^B``=nNWEP8ep9OssD**NK~$>-G?;TqYC_m9~+RPDEK
z(z^Xb8-Q3kp81p6#l{4BR+HV6W}}C*hFadmf4?)z2Z^E)%WT#s(K9fB&R{b`)j6F`
zvAe&Pvfj={Ve&V|V@htV>No5w>ieusnc`p|$7!wZLo8sF8&kf#43CZ|fo(T2t9X}N
zW9I^eHG`kx5H_#{#bhOrnB(JuMyP$|<v4q*IUt74tP$@20*GTI?Qy%wAl%c<CNbF%
zx&FsXx$e8&3pgfpzI-RyC$q*r8IZ91-Wb{3vBDRVv9WAkN9>f}*#$NtTZFUm4E&48
zw7VZq!`Wo-ISxdG&=Y~(Dk&^jX);-p52rkV5lac(+uiQz!FT@aduRx+Dcm!So7_*B
zDYtiG9}0Bh6zV8^J2&;rvPMy!*SVLnC)J?MV%P;xnYl3)JNqv!5~<7T?~e7jRI_%h
zzIG)frt!zdIP7c#nl}!sH<$i=U&46HFv8P~b$T>hFs|hH#E-Dio^3&lopd0G7(4fa
zyGi}m%(ozh?z1S_bbp_aw33txCns_@JBLyJjtTy#U5>@6@x`avikA(|$NF3B701|8
z_V2OWAJ8usbZhPLg`tm<)&A+cdLMkVLw@PiTNzT>)jvlE#|I!HR7g9c{MMDaTitf&
zc8y0rcc}2*7)xV3o(kAaV{Fub@ry=9raWlG@`xgFa@W9I?;LUndd2?;TTt%Q!We7A
z@6)5RRo{2sTwZLh(OO<cApZd+^xzRJKilIAwHtm{Tl93*(-}S4KN}s*<H6S)@|MBj
z3swaPaB8^qnx)mS{3mOL`X9M}oyP>o{r@;y!0vCH_UF%=(R~Wy&lJCXznoccfIF?K
z;OafyUC}L@&wa6{O*q6Vo_TzYYe;}H8^T*F3BAQDBR^cG40=7?)=vB29|akA)d|X@
z_K_BN=__U2;{qZXXyQVt+1ccB{ArmJaR;w}k5-iezLXQnTBbiLpn%WItt4ETGx}(z
z%0<dGOZI-gnZ^j70x!KeUT;c@ba}JZB=MTvjpjS<@BI`$mpm5}o0*&MmegSelks*z
zi@ZREUdTmvO%|}KQocTM|LLV5F}ZU_@v_xcIuAraUBsTl;Sm`kr&B^zG4>Wu-c9cF
zQjo++@?*Lc$22V<cy%!Z{InrS)3HhG(8n9sT9{7ix*`?x=iqMMJ;cs}szmP<r4qpy
zMqkmqyUmOG@iy<tuW1{tKV{l+?K<;xiFp4ob4*eq6|1vAN_d$eFma4m=|`)<cR*Gu
zujU(L**R%N*h~F{4ZY_255@?l-QR3Gj{X?47sj|78OKO?9QUG*{O1j1*QzlBpVhr>
zea)HDJSlXo06+@ElK8m@Fr9zQ=q&k6j*qvsFDV%*8|D{GwByQiaXEBZMlBV~9u2dg
zo*Z+!!YC|wfAhi9jmMSxbHq=eE-#8}K000W07q#48_W7E$#iIZIA!UaqU4OO<#4G~
zq<GGaRLE~Xj$Qe|JsPnCAM?=&`~Cd&I~iKt7zR#I4H?uLUb_6sGvHd#%yBiXdvS{l
zTS#tAU?s?fch=P3jk)Txjvhgos^q0eLRO9af@abBVtQ+WT=5r+PQLPehh7>8eo|j+
zFj$SAV7<<^cx3-@TMF`p-`rqj!zN?~g=??#46nt7bn(*pSDt<|Qx6v)$L)30%sF{M
ziKfQNmCB$vn<TAA!7@YZ(<Je2#sX*2kH&Os`SKXHi~3Z0&-?=qU(<P9W2R?9c;}ye
zeLM#S69RgT1=t$fQ;inA@7oh>I`%*AYOzOMZuZy=%g5N;C3fCCC01hDR*z1KDP77@
zQZ2;`b}^$c{!uH(U|i^L8$+VQR<D~B{_(CN<V;s=(zA-x1JVp8PHUFH>U?SA$_sDl
zf_%gG?%fTns$t#plF<mBcgQ`Z@q!#3ufQENBt=*631Gby03q+xUSEY2_0(-|l_mLN
z(2Uwx2_>xF5Gl$o`m3485+sB@cJV_<s?kaf{WiO$?8>4HUc_F&;rYPs%xZi*%RVVJ
zzs18qzItbz>d&9ve@3eyOCIbn78x7U<Oe^DwI_!kEOi&~+Q^Sd738YT^r504CCQqa
zgNtSxW>ja@IK>NtUzy~m(xO$@q2art^)aQ)$A5h$=C$r0N?-DsH1W2(F?p}{0Im!B
zSSe~;@LMc?v<?E2UxNzP%UZs5w^RP((k;t}M5E*Hn^jB%cKIh)#r*dzwO%(#nm=>s
z9rJ<ty~hrVc2BVGfzT7Y?H5bX=xIu1A1qR;N$v`t=p7$+6ncxq+3q+I^L?Ft6J^2`
zYYQgTFwM|4Op3JQ`KmRkQ@<rmg8^;kb6Bv>L}yVVzrQn;1{%QFt7C7u@Ro#Zq+sm;
z@tf6zJVeU2Q;Kz%YF8mr_6WW?bNaWsy2$ISB>qdG_q=F(7q+BA-X(LEd$KMS6!>B{
zji@hK!^2z4Ri`#XVqve&!!wgb?>TP?mZL^?!7#)FY)-B=v%z%Ep`<h@t3h}kve8*Q
zQ+59a%I5GIq^M|@^sM|CKBYe;swjM64#8`AjWcIvEs>AaU24hJ2zjvRGDVMwPrtI&
zu|KcDDlVzorN9`$Ql_ju;a#z|_>&Wvm%8RqvM^MZQiF)OtdJtzQZgl@)`6Xw1V;#J
z@FH~YpUNj}+db%7cuzzs#~WcJ8Nr{Ao#`d-^`Zv<26l+)P&AuG?<m%>Q`Z$9{M2_d
zG|p_8e*`<TK;GL#4PF5+l{JTs^C}{ZKjDF0HhYsSV1W3e{MYmxeC+I%=33*m&~7ip
zh;dxjZaX__;+|HEi_(4w;La-$d3i-ITOsQG_DzR0EQDanxlHd=9VU*ZVE^Vd@h)0}
zoWMR;`{NII0!|B#U<@~(<HIc)ufR7Bz3|##O=>X5&c)%7&iU5wGI$nFT|_t$VX*1&
zzov#DI6NKN&78m9FA%SNE(?RYMC?1feCWRPAbFXS8grb{5~rLnnSG`QmigFD39ilI
zy6Gy(^FOV1SHaWNCuq4XjBUOwv-xyJ6PZ^cf=ghrdgX4M>Yz0Tx7a8U#4F83EUdZ~
zTN)noxBt^|LlbrRTjAm{K@9~f3+h-p)+U)C-Ufq%3+V@A;X;D#Rp{J;c`O+2D7^IV
zhggb1nXt&hp^Adjbqf@6em&1$yrq}$_gUko(gljiua>}E0N<MYGA%VXGvp%CaG<-!
zyyfi>KWCT-tiM3fS8MT`&pmlhVh>6E{JvY!1Lq4rT>95r0H%qm&t;H(ZAw$qTo7qL
z*PoF^7)@c<I9X-?F*mSJox8KKf}e?R@Rieu>h_{>9nMkCm|_R|<dRjJDEGQhy80Q4
zVy#vkZ@MQA=kgTj%^hmel6h9jOq;^H2eDa{hJyD?r?wJEB}Y>q^O#^A{hm7Z(3sEv
zeYsj{<@T<k*kXFm(dT0!KPsB-jA#>YcTNS#+yJ$miUoDif+h1l$>YPpLo|>OuZ$Y-
zS@^oLU^@i_naexezU4Xg^@A6SV<D{J6idO><#le^8S-XTP`&@_=C-8}yM3u;3QIE8
z&bQ;j$Y5elQ$6|#;Jye}a9#RKu3q0nRO_4-e7pt}?KG|+jaY?2j01Eqx}I~jC-_o-
z!4Agry9r%fT5}YmP3!l=B_AwWx4b25AGH6vxR+c92{CG|{@-|c?gyA!Ya&P+uO;`}
zPn*J`Kie)*4f#H=V+MX`<&S6Uo`6S{3*&Mhzb!@mUSKL5;6I-dqjuJx(jVhbYE;Q9
z8`s%OGd)Ed&AZAo<qDHLynXEu%srIZcS8N%&5r8qaXHlGrglLk)}qfe<+nc;+mBBy
z{<<c==5vGkUFGI9rCnfG-TJZ3JXwN@q$6?Ir3Nw@Lp2*dVOVY{ESqp+%FB>vFM&Hn
zpq{I=TkuCaer8;tf*ifv`7;%(u6|#t>1KNRd!LTo2oo9Gq{z;9B`CK@a4e+gtZLkq
zuN3@&`l+_wCTvp&&HcLV<T2ImBl3OhoU}SDRv|EP@F9quNqbf^DNo&8pYnWcSgg?8
zKvJ0yUTMd(#v!%o^_p&N)(om#ZL)3jtT1LogHP<3;O}<)(zrkm`889wVvNw#^FiMy
zMKje`!7=goF@CF`9#`u-)T!X8sPP>8J+fxCUo++6cRRnC)Q^gqf|LLSLhs+xy9Xm-
z)_LWf{bqV7&6h-1-?3ZU@;bN0vkRx9u~^$cGCK)c;a5a_o4M_<K>P_o#_Wca*y9^^
z@>HQ#?2ob<99N@PSn;G%c$?Cdk#U!ILd^ROJnvP09E~DXy}0A@5NfQd2|uhKt7Hix
z9IN&!lF%M~B~KsHLmF}yPM<Q4%h<2Yuv0t3evmSk-?q~uAb?eiU;3)1d;C3EQEnED
z6)IkPUsI^4)oA5bjDl>q1JwBy|2gJb1B?MP#AWNDNG;aMTV0>6%u+m!QB7Yk1vvf(
zEFGXyiELZxe~~H>zb4;4{NhgM`GLDJZqWhB`>wPzzKu^MLP{&>W-4D?{x0cg^m+dk
zrA4uiyNt%4YPU*#a>b7>EPY>M#Y29=Rr8{LSjJbkjR(p7c$50`SiR98Y_4%OGsa}9
zBo#t(#j@{V+u~oTy1m#$TgT&zbWnMqBo*DpOo3#hKYdIHojp}$G4|d;O7h^;RodBS
z0m63%YwioPH^<Ku_n-xLXZ-V7WXKEO$!pY)ohRo_ktR;HT%&QtL7Z8aKq?*1MCRlE
zrh@ze^Q2ucQRU{)9u&v2)_l~JliP`s)n9x9DH8#*d*C;%Rg5?$c|a1C8o}il`_BAL
zp%@*Wo-6d_Jl?9$FK2YY7^D#8b87D8I{#Y(I+<6GxRyQkSion&rT}j#`wWFq{hokR
zUoT-hicxzi5s@ynS=ZM8<dvci%R+$b^1=Nu4|3o9^9j|fi>M>+hoT}bh?~Xr?OJ;Y
z^~SGm3HIO(6y?v}xr-LiJC2TjdT|Yd`i_eGUWI2zysqSdX$`=#`m1<9>7nBd+Yym<
zL>KFSDqt1*B@3f+w*3LJ8gL!)_(j48Ru$pm_H8CU>y&J^cfr67J9DG)^UFCy<;V!8
zd#LW0nf^Ld7<0eft*0t|c#)2{|5}ze9HME-OJS1_CTdtBO{T6Z)T)vxsH^J_FE>g`
zxXtr=Yps8F_2^`1KjB8p81F<1_b%(3iQ%LB+SvE(zwqR8DEC(}%S@i$O4VG%9iIam
zlXD^$^<lB<la#oH)tQ3%&x$kgDYhM#id?Maga<d?m+lV(N&gZroms{`B`|^)&GwT|
z^vcg?%t0<+*+jCx8rWLKVW%6=dofhvFq8m{N`8Ih#Dch#+7`=O+d!hmH7psxNwZ33
z=+@#0ew&xehF!8UG&G`&yAD0U-2O#puOR7Q-A(|5jq6qm-H%lQdp$k)n=)Otg!86$
zbDP|A(Qbk)I>LbBl5zK+*1$(<U<)NEsqtnV`5&M0Rv$sy!ICdeF;f4~)`C3)?Sfb#
zVT+Re;n?7zS33T;#{!8i+mEp!&WdCJD?(r%{dnzsG^_CNja}zlZMKCczTn&C*7D7(
zA{n_a7-2x?`Uz=<Cy^%)>%V`e;@|B#@x?EXw9f{MtZh6FMSti76JS>0BaZN&^txU0
zU|?HL%6bU72~|3WxtAQ++)mBc`Lhj_{U#YU&J|pLvQ0gOD{!};ZAm#3xqeX+&y0Y`
z(Z{S)wIY+~V6qF{tIX{s<F1&HltN&0Ed1NGZ8gwYn|*gv+NNW5&$tm1x47f`=usHH
zT#BGDE5Q<_hNWbGUHewF?)PNm224>I%>4D6B4;8f%autLVEuzRu~EC|=%UY!8&A0I
z2zGn#rxN+iZbiGeTIeIEICo{%FUcCFl6}Wqi}Eul$u`nf^**L~n2G>T%6vt}Ukh41
z&Nh96p*}0aJ5{QFDtvZgYV$rpqrA@8`CPP06Xi}9xL$NDw48~NJUFz`{cdH@rRKGO
zJG><|BP5~2idg11?nz^I5$v2KX9%c6V872zam>YMUbE%%-LX2%$7H-q(Be+E$T&yj
zLE5f8O|2VvvQkZneA!F{6ai<TlvkOi++mmUc}Xuks97#!7PeVu*WofC^-{G~t>3@D
zDizN#)~=yzKd%Qv!EhNPEq7@e0lbJV9};aTS`GiUtzg|)Y`}ssTeMLt)h42bTp(q)
z^9fIlhMc<7={L7&x6CtL)?@O23<uXsw|@QYHlcnn=`wKx&zr{YgrwE|Lei~h##pSx
z1mkVkSgZ~!`PSi}jGdzr0Sa--6DOK^7Q&gPkfyj2D=~uAW3`l@;>%+lEV;7qBgI8E
z<_AxngNorgL8Rj}b&!c&VQW}uk!#@ps`<N1@Ar?CN6#n(@7^M-YY60JZtl1ML_Kvq
z?#~~Q!>|9iRG(*=mvwu(+1i8}1@ymCDTVFShAOxci)YnQN9fd((vx6z%OuTgYq>A%
zJM&v7)Ab7Y4txsY#8YF}D*vn<uLWaBHB0<h$tlUD?k+`KmzOkKT)}dnug#h-E<H4|
zRqINUxMJV4(DMFLit!4_HCacO7ZHx>F>te2O~hkuvnFGkL6zLGXq<(KZTmjvIOPW=
zVPVP2z%jFwy-*WIFR}o2QBBsIy3GT66AUl#Vo2HIMH~DvOW)F;-ObiifI}fCkKk<k
ziO)7i1zVwd24^!^!-S))UJ7}g+3yuEN2#5}E$+miqi7}@Pwv(qcvn3`xN%0cdGX27
zC?+*NcfV7VPD#%c>AvCLpsHO0Ig@h~50B>><r>bRs;W)l>oD){9NCb~yPk9Js9?|?
zy!G}$F`q8rK5e?gs;XZyJ(IHWl+^xYm()<fjd6Isy#l@nf%C~WxvPZ*qsf?7De)|w
z63s^#|B2;eMni9i+!9zsU9cQYPxz#CIuG((gVG*%USBRmbh(z|WsPUbIAWzb?Gp}_
z1(A2vX~gs78`P}bPuJZL?9V$pU=yl$S`Nd14mYEcwYP(3uYHj3g%zJ0b7tvgL;OBN
zt$v3q_S<(^v__R8BBmfjmPg_`jF%Z}FLYav97}2h3q}N~_T&MOSN#~rp0{9}hp7?!
zjx|zaIPU{ir+6{XzC#N-VAD{#de4*K5X2DQuU#G2RpNY@p!=FM5PTu%s){6TdXi^O
znZkGisX0xn-i&M_qmyp|N(^<OT~b7s3a-)}!U>RS+HecvpS-o)7f+{l3Pe^b+-S}d
zJQQWzq`x@}cZ6L6*2BL3*L!f#BsU53kYuH5^<1Rlpnne2zMkL#3wRaST-fyE#Y@bu
zWRBr0t$co~A4I**cA!lRw?SmIcmY3q7AGBQ%~#9NAz(OJS1rmiKlV&}!3ds`O=P+P
zp-qyy61~iNZMk~y2aJ}FDsJ{qRk+$@#g)}S=rAM56vF^;TRY`%j_ezg*p*Q&U&}Mf
zO;#w(Sc%}dHkI%H3y^9p7Wh!|dlvnhN7cOeg!x*2;x@bvUa`co#<&;KQwdQp+}?bI
zrRugq?RhFEAFewjU@^bI!-)V&>Y2g{)w8|X^W`Tpt)AraHv}OBvOe?2X~wMr+=SYH
zjC&~^G_PtggkYxSLN4yhH~2xOg~du>n(rs%J3?HpRt%MY*2!39Q8wO|qVrSD@D<DC
zMSbTLF%F2DB&%joSDM!LK)|P(wNhJ-3XgEbAU7>~-|{MC%wpHNxEZb@L*(XWZPSAH
zWS?{8sJ%3y)5Olqvv7Z(_V}9tx}^*9KuLRokj&eM%MM#{>1WwIFdO7gFm_EQHdxd0
za8qQ>vos|C`V)KOjV^{hL*gvinZK0lLV{TgWQT+l&fl3RB-nKD6y4K}km%zKhS)HB
zWj!RrQQWCaQx}{5$Sfyi<afa;RM(`ko0gou$D)wdLt{OkB7lW`ZrJa3T(?NAYy8-S
zfX?7xo&v`|DrOZL#o(mV@EKs%T9-c4)%&;kB>6r0K*utVNf$Cf7^ZDm2k2{EumF)y
z6PyEuCcfG}%ZA><XL8X_V&~oRyD_zNq5IN+q6m+{zJ5lZ;kqLbgKM&q3s@c*y9ud9
zXIEwZwbKSG7n$&+4Es*FhDUb%C=|~?9g6L(0fN7AfWz9Y6yYw^iH}Em=Ww2d+ED^t
zHj;K4w%&gclvj&>;0QkP!RmXPo3mQEz$OL{-;H^ZHh~N1Ri{vJEoANel*}sYeqX9^
z(d{PUMohlmBX*wev=4T9g?nIJDZo!OL%V43rT(>D2_ncycKKdZ0Kf8;#Y8gNi}Iim
zwU0e2BDgfuoGkc`JGYNl>D<;a1$=KTg`%^fVFV-3-(urcZN0l*lLU;30#^IYswVPE
z{b|s58y^=K(}aoUK|w{9ZPQ?3i;9S!GYXSGxL%1F%~|O($mou_ac6wgrwdrr`1qcy
zxh>r$zUx_y#BndLg(@)YS{N5tWND<yuge%~x7+Z#JXdg@?@kf3-#s*}6eZe9W{$N>
zdi#%p{$I`8|F*9Csj%0#EoS*T9O>VplaM522lnP9n!47v29>{Vy`*~8rM4`z+m`DN
zwI*?WR(D0BFIR{x@ZDa4tf8r;RW>}R_Nt@T6;?nk+T@01@O;F*Q&H45O_7$r8rj)K
zU0q=cad5^z^ZvI--!Oipv^f;q_^G2R=6>w%*Oo=Ryqiha6WZ#EKi?`KBg6D{z9oiG
zH6Gah?CXXUyb=SP@b>i2v)%HP``HNVym-@Mey8VEKZcuZIM2uAbm`^&r)cbs_#PaA
zRl-eR_jz>@xksu(8pg$<)HW}*MB25OZ?|H`uQ_gC^JlUF*oN{KU~L4utqku$=DjV|
zJKZl;NEL%6a|_+AF>or74GWzXv@>iesiTtuzOsWls_RN5@8>(JS8yuWF)V!48XKr3
zyzKsEJf#BY=EWJ=QyXL5#c4GUTZ(kGJEU^biHwD%BF@2_Eoqm#WniI9|0sSBo|_{X
ziK~aYVcZvYrIEtpA+XuYe}ovX(I1G;5tfs6pR6g{aQSphP>k8HgHg1GSekp#IuDVZ
zUT64nPWUgyKd*C~98G}3jQ=(xB*+B=F0Yy}?$6WV{v5V3U$;#$0I9CA{4V5D^=L`M
zotmvH97cgZU&Vqp`I6hid){2JQTALs>(?RC>|YjU1gS{rWMVv-*v-w`vt>`efgE<e
zhgsR+`Cj!aB1O*a?x(jAoZC;%>ta8#TOZZaig4(3r+z&D(t-R0lW5O%Oq#ULgR;&;
zV278#Qjn}W;_BDfh<Hcr{I2pD9VzsP?RrybF|RpsuZzj>?|FO9BK{al8#qKA!EB=C
zkcCfU_K>(91ZM9>i^2(VdF&uAwtgerm@7<C{l$~#5~N~xfqU*{RUAy65WZ0ZTh6Zn
z{;mA5(w>W%DNET<F7bJDq|3vAvK)FRn_d}0?~S5PTdZ-{BxyEM=sj+o8unZ%zdqjm
z_PR{|>dC{)vy#xSxuq1SJ4AN=MG=VKla;fdgpsD0SIyf9_Y+EQQnP5RGW{iiF@hx;
zU657q+(L4W4>Y@&#2Q{vYJUXwoC0Cs<ub3R_K`mLQ9bV&nQGb9^r5}BrTD;&Z}Qh8
zuuOkWz@Cs-;ZH5tt?d`9E81p6{3dO{H6uV-4uRU8-YUgmB`jCh1f-FIxw&rLx3+}4
zc;a4xe1Hm>zvpo9DGc5NR5#-=*jjEH&tG>NoDbl;oJK&jqL(=o(XCYYZ_jKqXsxYU
zl5QtlE-W<p`Ylp-wF(ftWH?+VLATQU;q;}}qXi-8B(@X9Z2A7nQIvjT>^VRN7Au7Y
zCb6q7fsqmMKEeh9&g;|0kLh%(kvVk6f4u!#Vz!^8r>MWS=>d%LSP_@?kw0d#ac)cM
z)}aw&@b<%Rcnj^;PhW+Gy*6Y{Wq<iDToJ6&rnzC0`)vTWFj&mS7_C~>(s`>mm&3td
zN1MS38O5h1XzSQS8F7W^Dg2|Hud3RF-kzh@c`6^4;^TvxpI*PyY1F%Ex8}}OHa?$>
z5XeD425*oz_{BrjaCeNq6F5#Bb-1^RF_r#nBIve!9K5aJFTv5rI^MR7f8lGnyIE5}
z4>=V<S*qmi<G`S<nU<C(lIl~-x_7y}uAdsd+u>;30#7w^G9G&gM|f2KFxYA?`hfs6
zgj&#2YGN&o+>nZdBfwT)#i7i=pOg?ZT-RDvDIv0@TKAoKz~=fv+S)76z-vLQ<DayZ
zFGG9np|syjPi2F$ds+uk*G|RakR6g0L0NkX7T_oUC=9Pt!Q#pibjIE84+O>a9SsAA
zkxkXu*&#IeBp;h~O2<(>JT54IlWkUY>$7Tm?MysishynjY%EMhf3X3rf}tK8KC!ht
zG--0vXV^&x-n~}C<?*i!hUr%02sP@|9NOwej_ZW=qz8*|<wkYkwi8mtHB>s+GSoCM
zHua60?UN#^ws{f8sh~Gqs9SRKUVfUS;f9pN3g{w%UINmmfWr=#Hqy-XZw@it_c_gs
z`%;e6esjX+&ASa10&D(t_#6B%Yduhp4OTPjILGVOGF%7afqk62XE;`ZO_h^k+E(`@
z+%(T0LXnVC+uSm^9Ur<tLnHFPCV>@#-GoIIAbk%y*)Z0*k)n?f-$(DTpbn;k*&%_i
z&HT3yHJ@?x?sM!bE!C?8VyFI$;_3Z37{kP_&T_Lyj%2P|%@|KJ>b!5lczj&R)}O~}
ze-9M1n<mWRSjjl7!5jp=grZ=oVeYIESN8EH#nTtg#^|ns*!FhNvV)j*K|AXQAs%b*
zb>Q3uXu4Qbgt@2~{GDm~8xmzNs_ma$4Hb3Nhv-9P`>#0jzTN;+JO2_uqWhfX_u_zb
zO1;^*LDEe<8kDqI@Ga~EQyWQVtidEHZuE}4prlusNTV%JO5HK4{uDxH`+t+HHbl?3
zFziBA(Y_%oI&LjnlAw8o3+Pm*6w{W~z*bkV%IRSYFm2?X@*eIA(P0Ur(XL8%*;E)S
zIbv(jON!K8nkaY%zvbIQ)p3Qyt5sh4=KmnO>nM{$ym_(BiwakAH7}fLZ0$K?Zo!SL
zJjOQF_3w-=`J}VRU;D!GQgW{1gpPRH%-K$!`ZePO6T>RrOXTHDpq*@W+kricH783`
zvko8aHRKgcdlK}`(-zULOc{T|%brR4<S6K_`F7feS}=OVp>C&e1$V+#lu6MAXx}-~
z7i+n@m7V=X{}H=|92q&Ce0|e}t=x{v6J~EF?l7UnUrU*O!dqqyBbW|K(}KQjZq$O?
zR~<h;6&`$L<E^!!C8UwN%sOB|S>O&id0PBFSjg?U#D7x8Z4Qyw`LMJmt`Wn32s@KV
zUL6EM)T+JiFLrP1A8)B=hAs0%9$eEa2_>n0I*fZ{Fn$LYJLmyE`D(_$82^0fcdG$c
zH?HBu3n=ks??d|)Z9xgHRg^qo(-Zfx4^22lZHz&X!ULDe;FpwU)>;F*syhTurwq53
z-GnnO@rvUoQP+73Tex@0+H$JE45;-f_rAZ|XRXnNa#(s2VCGau92H7m#TXX+Hxv{M
zyVNFTN`tS5j5S)fqvgGX64uGT`)ysyN}B@aiD~H#feF3nZvI?$6EPoE|FksWWNFl?
z($zFic%5O%)|O}#cKqH0ixhfyab16y1i)dlKODfaI>tSh?o8-9nw-WsFyd%4P`zco
z0pXT?zt-#*%-@7#7b?lBqEtX$yUWewKZsje=I+q!5gC-}G37pYN3V;2%o@LtE|ACE
z0~9bwN1NjEg1>bdhYMF6>=s!Vd<SI0Z)^NgI`r`&P@{H?&_I}mp3g7dLaTLBml6<S
z2?dn*u*j^9aWm4D0!7tw=1iKLKYimByzq-VE@R}-qhPXp2X=u2i|(<>$WZzDbD90F
zLc6Y8@EZN(b(g;i(5fw#ny0fSQ=631gR3(K`+x`XVw(`iNdw|Hhe+gbd%&ElKt1^-
zL$~58p<&DGKF<mD5~K<C3UNNYU1#Mv8i=X+1CO=3M~26T3HRg1_Sxwmh0PExEgzbx
zY^I|f?4+48F2HmQC0h7*B=6XiXNibb?lLDlZ&a0W#?IxEq4Q+`VFqVH-kGV&^nP_(
znATA}Ri7N@du5zcxN&lGPOd6B?U`xiGazYd<g+3%Ha1A3^xv{4v2$<9Dp3@JZzrVB
z+*h<WQGwkY0gG^d!1H}d*tsXbdQl8&on)`zdwblr=b@HiOAAfXkjGiIn7>Juhd$G8
zW@Ed=A?)^FuVZQ${Ti9bB5&CbdwHz;M|R+{Hn;0ApOfJt7Z1QRT-F@)8&Z<K-#!Q#
z1qKd>+ED)-&eEEcYoe_@_r&9a7Qp^seL?!dfpZb#U(FWa!O{Pyc)5_+%rTk62QB%`
zLI<!|B-3lE|7x=@1{$`$!M?LUz3(-bvI?gN_#mc_H*5wyBDFs?TK&of3~8@4OMSPc
zV5!2x?fAKI?PqlDwC*uy!i75>F6HLqHX2HD^-mDlf3g&{!S03QmG{SRb<MIGwjHqN
z%1Io8rhvPpH0E5<yD%3y1AsG>g$3U4?aeC+KuG4?pNEPkOyG$tE!ZaU(1vV>b(|8k
zgp5v|n}7%ClOHzcOfd9%f)i2%?;mZ;2>P~byIe7u+1D<43k$hkU?%*kw+XOrpF+?8
z_k^h5GlW5lz%*qBbfZAEfmRRZrJKC@UbomLU6se>Da;Ro4CDVIwIr*(H=j_};dwMp
zCe=3z4?CX?&Cu`2|J{%8U7*aaKqAsw1L`og2kmnanxadeELXzH4Koz&nkn;B2$0IN
z8irSw#@IZ}^<Cf~I3N+`OmE>S$Z+OS8cci8DDNTI^@Iw?VXy&-E@}1d(@QbuZ9|u&
z@9AMrhlj`6cmgRPm7N|qw6G-00TGT(+C^P?K<5aFec5GV6)}DOa-cj=X1Q<}raK#D
z#q8@yvI*${Tw^lnJ*Z<6|7p`(+u4^@Q8r9vGW9bDh<)m!FMhMSD5)OUX-~d`$>=Ey
zyL*LAQns(vj!)fWu`yk(_ajotZ98hgVJUyakD!Fa`w6T2VLM~<Ysho9fu2MTLOP(M
z(pQ*zdj<FB0Ibz7dP=`^)-(W=jkDq1OQu@W*!<EzyK%8?P+LX^y_6Ocy&U?=qBD90
z*8EJKr|tA3Y)EHxUaqO?6TS7){x=H)6^8P0(em#yTmV32{}+*@@H=ZWn5GTm&#zw(
z!(8<DpDp*Mb^JFJT(gxb<X1dm;z7#3UAX;tT**=9F(Z)^K-yfPujcU%f7aYj6{>$|
zYrltaC+hv=yU^9aZDDN4=nt$AGcT;~bI?*};S{UN(Ygf)hMc3D<&m#>!|B5j^gNx_
zys#gigO*2YKuJ)Am^`W{g<s~%Ca?=B;C25!dV~2@TUC$iLM3z2S*Atv8yo}YI9jk3
zcSytYPbI{sCH1;>d0x%@6xFb?%<W?3rrj#XS1qnoQ5M}HO+kM$x}{xGy`=Wk!z7y?
zv82gyF9jqhNnU}0KggUMi#d*M)lzkuK73brp1r=ShMOMs&zf8cs$%=KNhr}nYZcou
z*d9+3ulGPJl6I%_aP{4@q*89SIRSd_bP192P8zjmAtsWC@#5eHh0KewM>a&{?V8fW
z>DQN9Qy_<mdk<J%)S}WQ5qnLIr}<hkUx3%dZ^7h%|GsQ*@;NX4{<_>8?m92x=+2mB
zj9fI25_b9tdanhA2w4m1v!xHNCU-B+Z&Cdbd~jjM-tqZu#5rC%qm28Pz(_#UY<2@h
z=kuYF32uxg*(ip<;FiKp-v>U4qEppAIMG?zP~~*d1>%;!Hq6gUUrP*iu+S>HKMNeZ
z^WS3(28iuHu+W;Wg!ZtVzH=CP)_?4hw33n!-+%4U&nLN?EW=_b$U`AyX*!|34~w>3
zHGhSJ&I5c^lL7!DqQIji4d1yq2?ghch-|Q&y6mOMXBPvKqUjR&t|&TvCw7-xCAlYj
z1QzgdncK6)Y46HSnC_kPoN9$p2?p{ts|rKwkKldZd4qiKgyk=(JEQ4>F^&7SaX1rD
zO`Pm<`g{<|c-vjv)Ca9S$0er_*_DQhr$ymo=1b73)0C5aC$>g|zC*#=B1iCCRvSj~
z^3@&x^+Vq=m94Srb7R=_yUf><X(=Vi;jXaBNBA`_pg@@MA8p<V-EzFJVYdplXP$ek
zK(3;dMGV$_yna>^&xjBhM88@cUBRzo7-vOocz^KBJE%nXZocyVr4hV*9J~61dnSU7
z0m74tUxOy8peYK`jmKcL^BV?u?r#O25Z2LSkdJ8h8C|MoaMn6~ak>ob_vZRH?Ys4a
zgD+zMU+$R6)`HW#Qrnx^1!T(9@%PIJN7k@CzZSk9|DWh#@J0|+hfJ8q>r)*6d^sda
z3jKbk^T`7aM(B$LI&vG(k<otG_JiD#2d%kWYKbASs$Vvw)LrANM>9AmV%ywnKoJ@f
z%R3K6OXf&#yC$tgAi6|T*pz1x_Ci15ZqLKZ$fXw7ZnT?iVir>sb$tT}UP#e9_$JT{
zPI}We=Igk&wL%pOcJDCWhgTlswK3WI-e1cXm!RdH8?|etR{Xkb8et)@Bt;@f*-pe!
zx5Gh8JLy1hO&Jg3#bDP7dpoqQ%PH1Eq-tX1#x^8m!T<N=#pIUu2GgysMMDDd5o4B2
zE}pFjBhTy0Y!%DWTi(9dYM|j3C?4HqP{>aaXkNNNREpLA&|v~tj{=mS2casu%!$Kv
zDC1pXpNb*!T+Gb_WC9o**{}<o2{?O5XI^i50L1^;ldX<JX>tTJ!sdh{#vI&NOj}iZ
zo-_>kwQff;K!q?Wz4@AgiPJTmAX_I<DtIl~DiEYA!9Ao;)vvTCq(S+(sM`8O!YVPi
zoF<)v{x4L4WS2sldiFlz<!)LZ6z7ZBWkkhGC!m>)v66?d2ERy=1278}7-%=A@hDT7
zCq+~9Zg4qX`VE@-Ef&%M3^>s*h3*1?PLIxf8xkn<Uf@>hEo|%$0Q*T;%+xfnt&w(Q
zbF=g*z{(O9(!!TQ3ESrnT`ZaAJnW#Vo2ml}djI5-kCa*}Iil+T&NuI-hDgi*Vz!gg
z>Z{)IJ4hc&AIZ_?*L(?aDd4)e21ftv?*Y<;Ol^{bbdc}-J11j!3fB7ra4hM8yAC`L
zV*{^4BZ+Sr8c9PRelKAgr+M%69%X83N|7AQ%W^V|kqdQ{l_$Jo))uV&!>`7cu=Qhv
z<31U*^C%kk=5xG)D__L_M{9OD^a>%X_!4bw;-a5|#QY~j*@Si{N5;sB=uKwn)?N+#
zQ&O+-RSA{?CSp_UZl{jTt<MY)JbNjKr@Y8>O<Y@@4(Mo1TF|&&UgW{W%L$oPoXr-H
z!p#U}?Zwc7k*RX~_@xxQ6ZU$ilb&ATLZa1rhu%q(5E68*I&Pl5&cvvXGPt0SuiT2u
z6PK2C1kI2w<+!s*rZR=~<X=S{^{U8g=vU!ear*q2=Qvuqg8lzogq{^6J*)7N&e;44
zXc|n{dPPC-%vKto?<er~f@}6t^yQaqwH&!4H;i=HInN}{-Dw_vFDI~-55}{VgNOA4
zB~we$-fEC^VNv})S4yY(vk1rH4lwxfxt1v9{kMWtY2p=M557GrN_y}@r*olXNk?d_
zHJv%eJ(UhWxtjO<9k~hqwikX+<S!SFqGGyE@{Xrd7TS2fTSIMlC08q785+dXFfbM;
zEWtH8dz^P5oig192=dgj!sSAmP5V*hxCEOaXl|B7o4@HlfTX8WrrLNZ*77U1A!_C&
zbs%+4wCIJAuu%SdF};8O_jOBpy6>J`xNCoY!z<Bnml0ycUy}XX+Di&`md5mZ)6@Jb
zUzEWDa*x+H6Vcs&2!qqOo&LXXNcLa60yWxvsGhu1S^se>ep~yj5~w+U^5$8~ciCEY
zN5=;)$ubXIasK|w`q+lI(xg#K`urGoOS*_D`Lv?Bjcl5?J#g1sTZfOaGn<Z)S6)FL
zsja_~pXqV3UeYwu|9aNaI;r9>#~{7uD4Fr1UE-Fl{@0fB??Pai!Q;!kZ;EyfBX9Al
zd>WesG4aEIOK&XNkX5`&LNif^qsQNys~39dO7?TLeBGjHT;z5js${s%_M(EnkOO>f
zC(j0#rY2tD)Qw26*{+=7Nbn|edGp$v7J-%QC1nN(Js3D%l9QNkuN|eR-PqW`X^G21
zQfYwDeGqm0eEl6EbXD!;z4e&XyFC19zh(c0JE812CSf`><c3HKezf_GjsbBVS_jxT
zXzAbaf$qnHdp^PVz=wRkTkdaX|7efqv}v8z+xyVNw(wTQwKESgG7Ju_EBzBztjmxA
z(NN@2VxjW4<ZYYoIU`!!&jvh&$uC#}LW@foGHfl*ua$|hE(UIndqV(IN61H3T&cI$
zwLhTYCMA#kj-<sb4~tHQgSOSL@`i8k6ko0<?UVKkE{hZV-X1VMF8hJ}dcma@Ke`qw
zT;$)h%7^K0|Dm_1>nqKl78+GV#^XtgJ|Js2pNlS6yM#(43HWej|MEw_;TEiwdqZY^
zYga#sg&-`*s7k(K_AY(7-_rJ)R=`sO!Nzv{uW{J~^6NQ}!UafszbS8&v)RjaDTK#~
zXn1OkLkLZd%jS?@FX}d?;c?sL4o>0Z#W6>$3!;Lpr6bAAs&;iL?1`VG@V4b--&E4;
z&R3I?m$SO~VvKxH^l{46f)J&>bm?BA@Ty<Fi%#ghM&WI!%249@1xghE;-4<~gc$t5
zxa=J=Y1*!KPe7%ugqK!FjGF0y&QL#6mFDK~hqHkF9G8tGlV<E{y>9SK%=&c1y`JH|
zkdr!taCmsBgrf$hP;?m@O7fv5VT_S-lq$-{>rQF7?po?@(yWg)W32tFGHBye-vr#4
zOW)h30_}3Wnk<tzO(P$e$thm8NQ!y~yI-I!gA#aSw|#y=sp{nyA_wnFE><uF_T`U;
zVBDWV^FPLBC>^U!4xm#DV$_t9Y$}e*yV+ig>fKP$Z<)e<N(h{Y*`(C3x1f!S)eF56
zkawm9e)e}FRS{1NRF94JRYUL8_dc1xDxQI^`|0Yd0mmOgeJA$G*U~^RG~&sP0C|wM
z`+y_*TqB@1<E`m);_-D1Tua?M{Ezi5+Z~S?o~NN?{_%awKE^!z7*#v)rzO0uw8&ny
z-Ung25rW?o$Myfeqm=K$wi+PR)dQRDk4u9(SCapTc9Ybn^niu&Ur*p%57>_`_}^&Z
zf8=|z<l}8EE`2rJCmYk4Om6}-YX9%I7h>`x5o2y;c*Jd>2O=-tKUHe}0&r|MvsUt;
z5>{uZC5FfQcPk+b8id`hwZu`Q&8K`*W}!hp*sqN3NDe?i>OtraGbuE8euDb}mY&H)
z($DhN<-hf}8-_xxLTyD``u24k6@{NxB1e0Vme6S=XD&yGGneC#Pu68x(L46<0mqgQ
zsh&3^^JtY+w)o@-wxd4)kq89953|V|fmZ@At=`_6l32HFC!=-<JDrGj^P&(TQz3m$
zw`EK=UJLK{jO&WbU#Fevw`jL0cKGX7eTR2=Mk6Xd>>?<bRgs;hm0|B6uH(=Y9SV2^
z7%Etel0s|Y?rA7}CvtGb?M%18KKDKVw=wu}0of1ey%(?w<0NZoZ!_gf>q&;2C+1u#
z`U6UDQnE@JWv}LV;r!E`VBwB)l)TsMFBq%gT!jlLRj1^aF8_EnbG$HJ7yC2yvBU&w
zG9)fj1hK=0TdPU*+B_cZF<lZ)Q7nOxvOS^9$7K<+@t?;1t{u9zwKKjzbvUPn#jeK_
z(Q7q~>&sY{q%J(sO=FN?Mo$zu7+Vf=5leMTssu2Ls*=S2jF62)zv3tv4KI>mn;E_8
zx9%S8T&|7cwXOir=jk%PNy3tGY&1G0Rb74ZAuZVH(pdXlDR8<#@PmOkd!hz88leRH
z<mO-5)}InY4pJLL)!YU~pB}I%Oxaw@cr_JpjWl=M8%(wiuFRW#m5p~j?fs8<)_O;w
zIIA8u(Es-kQJ;+DH=C4v92L)PDUrN<UKS~ulDI>=HSQA{e+@n=25QZ;BU|kcy*oix
zn;2+5>M?MX4o?6KPIzQd!oSBJxT5r1(Bg#Hs0Xjjj%}dOJ=^m>{n&;I^vaLegW*`c
znU=UsJ*}c{MICbk!$#Y{taR^4Gcw@$iqGFzR-xHgi!}wuCsg~NN8o9WX^)l06fCb?
zHc9`_q@8=mq_H#M_!+CYmX`PG4hDj~r+HPoqc=iu<Pj#D>gz?jdr|Mee0e%^^i*p6
z^KU%c5hlX@mm=Te6sIYJ{@5<INuqg|Yi|$zAampTMB7kZsk3g)<=$_V{?_%#DPt%)
zKKaR8qIS%Jy@{eA(jgg_4?gnXCNISCXtWpC?%HZ-QP}CuS0_*~{kHwWrdYSYLU{bZ
z*)8@UJ13Wv+{Q}f-~K+M<^fIMWAfw?K2q+h|2aX$l1rdps_B$To-1`sZ)tO&jo74I
z{Ieg*ufaNOmqH-l5ZR?VYsiV-JXbn=Q!J$}kV=@+t8IMGDZ$dQeaQsrHgo;PrqVO$
z#o~`H#l#F(ntd1(CIUxbCg&uZ=1}L*95Dl#$aA!>0w)%2BS$y$DA_32_TwQ6thkh^
z<_AGXeW)V@>EG5_VKuhlyoWm2ywLx={zkCRNjvHnsliohWr(N#HwElXW6`7~2Rd^W
z$tlUzdfK^+9=|6!wV&VYbzSajh*ax0M+_CjV|_S+bOYom&K+@kRLQ_OZWPo<Zbq~U
z3xSXL^}qIULhSsVH?EBhrm{Qz-u}AZAbWCp=1jfnl+8(~(V;X4+!?EW3u^$l6Ee#r
z`eoxyO<6J+cgZle0BVIzYO1sIW3#bwSP^w6LAsXcfkQfc9WTF}3<uV81#aEjq<M$O
zTD9liil79#YDin9$BqtYh9X})-**TLDh*hT^cqpplFq}g+UI&Zif^Sz^Eh5aVNZ_o
zpF;dprp!DMs<N(LR=Se^q?eNXizNN?%txeZnUe@cPUSDpz&V1`k{>~{XWxy&%uC6}
z0vUZgu?sI8%D8i6b|>R2+bOe(lM$1Fqu6z(T_<$Y7kLXF4+P|QhHZ6H)2O~Z@PZ<;
zKLun|o&ETb;;&C*V23WKd+I3o<XPv~K*Zs=N`&Kk4m$3#KIn|yIth~n-bsx=_+uRP
z1|;kX`}tx#E=gKYekfx*lLJCxzHZs_XTd8l`_ZeXz8#Bo=!)P;g@CP&)O=3M^govj
zV-<6{2i#xQnn<ZSlg*3nH?`y(Ze}Zjzgr(Xht(Y?#ni0ecD;M`eW4Fowh_<JVS=uC
zN}00sM5xcYiRn!*BrY`vJZoGkJ+-laFbPsJS)Pl~1#`r*9te%yOkQ!RN2Ml#>7!Q1
zQHhREpCzwvkeEiaROa&xPE8L@btnX)YLlL#Htz}ihFA^wKU}?eAXMSoK5iY`*s=`C
z+Csz(S&Fiz%~}y9W+>Ss(ZY;vY$c^ql&lp(*_V`AkYvlgGxiw!GL{+3_nGPQdEfW<
z`_~-joH_HH`?;_CzV7QP*qZN{3?!h^If3s?=i*Y=VsBayM~?KZJTfdDLonDm>A#;N
zaR+`^6{N@%NgPE|LX*bFm}arKzudw>8*n;+vJ~M1rhSql=%_{XFUVh=)-9Qv{y5I|
z2m04ChZim+4iD%H--6aX*sOa1_Bhs9pwBrTQ>H(UE;xGXdp*$3@?=v;CP=2Cqw>N3
zPwLR;PpxsiC2`ZB(i!+-g-6xyeX#7O>zI%wN!*g8MEIiqXb11C5$HgT0cQ)l>OCju
z)SZjOA1r<hZXI?(GCMF%^+q#aqY;PoO|qdpYMnJe_EY0JNB!_<<8YzDI$!+hdND<v
z^ywu_9g}sr7MRnzBkZ!z*HNY}9duW&gjIe9*{$B%`nh7MVs^@Kv$>e?eU?wsRoodi
zn6_MrGx-_Q26c)7Rt8q1b&=2y>^`!DYaU~BZciBDsLV#I*THz8W91FE1V(V7F56G%
zdk~eW_*GovBLI$ZHW*T_1Uf%s5xB!zOTTabY+33C>j8mcUC1&(KPzm}nzTU%cxWQ<
z{*}$1n&$5ol`pOnH$2(FW*ay|jSzk+Iuh8mQB_IYP~4Jo&ckgabv*X9KKIIc4CW*#
z`il9A#Ag(`OAA*?+*A}#P2LAq_R&dr;KtmR&uR;26T&rtKT|Bk;6WsJw+&`C7v$G3
zDSh)%;9WLT8?ldcGOakkiXc1iimly#NbgkB$Pl_vpYTe*3i8t|1r=22^OzQqs4R@(
zr|(li{@6|HeR>zgso#X{c7k*Ve?0xHb1<B^4;VTsm4<CugUK5RW4>pYIy;)#@%jE(
zfNt*(&2(AT+sJmFqrC-p(t?_8@aysv+BuQCv7OHiGaIQRPT6P8vousf`nnMbt8{un
z{?>4h=0oJc#SdV-F-*BeTl!AG&YaUP9@R=~Cd5GhETh=FS;{-s1NuR?PjqFOw@;J(
zcQ%<t-$^C2HGNfJq{>?OGUE1r(3yv3QKzjV12;$d<p^Oz9hG7raT(0tTId10iO~jV
znC~dAO?t?9$id+gFS}x6RITSAD?R8f4~dEV^ldQZ5WG%~Sxuj+49q^rqS6O(hdKG=
z<cCr<kURYliU;647Uf7EgKH@+h1-ZjFWIPuTwV@LQ*}au$3gdp5-5C<s{HJ<w7b+<
ze_mEZt8SW~d`>7ugGB9z%zC(D1PZSs%l0b&a2!AGoLFnnmTCXKLJYeF2;rbD=G}_J
zWn=71`P~<EY)J{PqhY?6j|Rxz{<Q&+{Lu#_8Z}ZGkDJEWSN-XBOy<{s7l+<pg{3F(
zI96JA{%bhZP<SzIH0>LG9R3ZG+-m8DObB-qwnX#SIt;yT?*bgo6(f0PuH)p5sIaC^
znOl{O_J4gsh^F5F-a^u-konn|{vK-@>eWZ1)z`PaY(>1kVfH}wDka_=I3(iMDZKqX
zuu`DLP3+;%QB(5VVzwE@T_?<)z6?Sl(BS&dcaWq$td3*Wc7de<`;}3_fW-gBWpHhz
z&0iiLV=G|0q`)a}8XFEoGC%%%%hxEzGqVK)S%&RyF#ad6LmThQj~GH1WM@EcXak2M
z(x@35{tBz%$+PCK-wvsm{Scd5(=;;3UU&&40vFza`+r2A1ByuVzO%b|;qG9p*|*-S
zm*KS|G6+XCyIuYNA|k-Aqa&gm`|j7??%Z(sDk(u?cI>_A;?r4xWIZ*P1J1Oi47xfu
z8m@I&%r1JnJEX*=zeRj`e(+-a1Z%9|_pu&akOSj1PL(;p$6~p$l63Ayd$lt9ePrIS
z)=qQe_UbTwLZ|3JDel{6ZX<k<*7`5y8JJV${&T`lf4gG<Bd$)*8$*X(U`=#jF<P2c
z0oTpXBudR0T|9nu60quy?>?FYU+2?P$1Hw_o0Tt^>$u}iZcY))($D5KfNPxHUTt7Z
z0liQD@$JI7wYiDd=9q?n#N>+XKu`$gpJ$9D&3Ygi*ZHj4=$4$6boLevIgT!PL=?IV
zF)h3DxF|Om{B%YDePRBCzJP;{nfKiH!fTPvk2wLdO6L=XKt*sf-bW@13^rM~QzH*p
zZB~AzW14bM+wOq9O*yR8Anjg%ViO0`+;q?fc5=iGKOS;j=Fx;?jUNK6g3O9W^)i9P
zgsK9Ab(RLHaA=VW|6`EGdtdh$kRQ8s@t&+`31Jlr3W#+uO);eYIB+E0L`5isG|U(t
za9r03P(6Hjlnwy30P5Ie*$-aybF>m^Qf%|V&z-e`x1Sf-pa0#kL(idO;r~#Vc<!?Q
zJQ2`J_~Q2iw?D8K#HlixB8-pae}#B2z`auMG#&GIuX{4{8<H_n!_fdkPx45_!_!s_
z>T=MnFQ@A=mr5SUJ6?z(aupjj{DbX00BNKxgSsPHHP@EI^5pkPs^Kx$d3Hy-@(Vj@
zvl=qa;|ffK_9IJ_68~b&WM?A)bH{6*=jg!tzroAppS*RjwoUbk>^c|)O^$80>#l@y
z*w#~zux9d{5sZgZ8(>-r$TMKvJl#7h#l52NQOWCJX!!3_i-xAwhr(8jky~Ss$(U@k
zfSUS3_|F#3Pss&oP}^2HxoW?P=#jv-jj9UbhTK+)vhxnb=N|rmhwtASv(=dVuQAC4
z>ngq%2>ZFGD0CYGq{)e=dU4WbM|aybM(S<@HGu=DGM^DcMZ!y8w!bmB)t|gAu-{t>
zz^VII{v}-iC%g-aM_|6AjbBq7n)(zA8T;cHOpD&K_>gA3{n2j{qyet;W@l^*ls8oB
zMp!w?FbpL|q7(j-dZ{5N=z;{tV6Qs7AW#}4RLR8vQ@lO}_MH5nyI896Ww7UH(mX?3
zL5%^G_CQ4_fwFc;*SzP6Ts?Aa5`HHRe}2V<qXWsm(F2$9+UT3Cg86a?b26Px)o;a5
z&m#NNf*-H(JDK}=W1oq0h4bP<LX2DW2%djm(qpJRX|El!XF|6lxzW!N)5ul(>~f@0
zptkdoi^m~5CV)rAOXrb+95vH^(F;8H3+5F50+h)+c+fjA`jmj)F_Bn<r|%ln=L8oW
z#pw3lh-H^GGJ<{Q#K?k<#r9#~-wL7ox3)LUO-;QbAdXz&5LI4cgFab!+%B@swvd3{
z0G1f=bQ&P=ld?9<hkLg_x6iPn0@%4O1^fgoOCvC`<HeZRk)@CL(*kc^3HbR2ii@Ku
z_g21S9&~(e1%@7>z<sF1U}xVyK60s0U99-gw)Yoy)B(i00a>L_CjrpF)eOM>>g@WH
zs#W5VC?LXW8t?@f-FHxgk-q+fdkNsf0a+z?(?77B3Z8c*D|#o*SiT7{4Jr(-$dyt!
z*pZ%s5ha(38fHEt=l+)BgEKte*fbh9PuOoZ$pnF^)@}J^n%4YTdO&r_rgR?R)zbXa
zR$|VC_~yAimSxb876eocei-bi<p8SH&y;|Jzhj%pS**uVm6qXvPD$Jb`lefd;qH6%
zIG5hqp)wDU_n(APwF3n?$Dsj<U+bLzi-8`sZL0|f^m|+f)r_ffj`xR{Rkl;mZY_Qg
z%K%3-y_LDU0--g=tS5BsDjpMc?*ELHLyznehP92);nTq~Jqc90v^Y@?!h}2)+tR=F
zvCS0hk}fNlzO&6RpHizw0*0%19R7zw@U_YO{=S|qRI!ix2?=&o(|SdH#Ep*ImUL3J
z7U2hxX*GlSHbUR-9vbB22MB(APyw>qv>T#}iM0vGJf$Z-f`6wD-;auHJb){SZE0@4
zlhp+eG2Z`Pq(kSpE}#K|aTP4<8)J@RKHYy7!ogSOuhjN{m?o`_)~vDG>NCZ_L!4_`
zkk^C>EG(`zzgswt-_FZ01FC#6s!C@Vg=dihPfJ2kc1VP<B|g-+)a?2sUf{zEam0N4
z2EBB{bxfjcuOWj?^fkd<=TIuYW<GRw<2k~<ndu@AlKTW|S+ZdJH}l>L*934ABOzsX
zK<@rcMp_M0+A*Y;wni?dxAAEJNCi8$?Qw5P&m{;iRdSv#4{7uf<t=da_MlHz7B2=n
zWA|Pg?<o~9b9RkIm~Ru?5BPM3u+i0r8JQdN8(xSl_y@vzs)JMD%~ey|@@s;?x<}se
z3G)iQoXqfSx_()7GM~V{U~Hq$le~p}``)Q_0IE=xFlz*G>w=Bu-0o}R4W-sec0~wx
zHWIrWb|)z0?%S_4(6rilk{|R7LeUZJS`5LZ1lWzmn&tb3C5Gyt9Qg{E)*poINaA)R
zCFT}wOYlbX`PY>|1RLIERc2l&IM^Ct8{+?sb#8HKez6x7{3~Ne(kGYonDc=WH<xn>
zFkfH8F+<ZFH^y`}jZ{e7duF_+<0@qNSDYi-zFcSs=F6@wfykcH)@SBNGC$`X2>F%4
zBIT2wnj8xDwyKu0Uu`_9+;6|`fG_;-2=0f+6i1lZ(^{)XnMykXB{{Jvjrx7|zZd|0
z_krgU{$|@AU+*64o(^F)t%(!S`-X*E^f(`o7cR%&#O_GOtUqYoO?~p4`Fd9QmLNnD
z84@=3haNTN7dKz+?0j(kcC&4luM|&uWiv$6alOKy>04r)eN^d_-DQqm(&zyA7Q4@k
zX*y}^9W4^{s^Fz;7>7!Y;8nteQ#|7p*|pKyMB1<6FM8?v*Jk?&vBn=}xn1rE|ERyK
zSdXMk=7SJisSqquw(D6swS~I(BB^_V74j=Qw4M1w*rqjdn+#;`V#a{lLz=M_`xWeN
zcL=ds-qQV`$j5wYyA7zp*~jC!+g)I?e>jqq&9Y!2>{T7nh!cv|#I2k~v_E#W%lL0D
z8EsG(x;mPP@{H*N&OV$Az+-z!=>(FJoPWm$S2>NgPR^gH>H$?*mDx2GgkqfxC@;m~
z$R@}k8I1oWs^WQRUa<lbj+iqc?AapcOs_x~tuEef8`u|Mbd>r<_oTEZRi1B0mFd;E
z73}8HGV45unpcJ`m#=~RHfLSq#HvktOw7*nWhW@)smN?D3e!~%&=-}QL9s5-{r>fy
zZtwPF$LkY>G<GgaceKdUd}>_}$X)EzaS)E(wSZ-bq@HN2vrJegi;P3#km?@vs0Zi?
zD03sRL%M+yom;42B>|?UI~Re4bh8*kcutcOX(x<3>z`7|-Q()Pr*;+UaPuK(Y2bR$
zBo7I5YN;{F!|xOJ&h_#Lk3JB{xx;vlK8z)<zw-|C!p>`yRON{q#lRlM^r-kTHKnKm
zwPT+1Ak-fR68K(mRgpy;;@CL@`EAhXx?c@!Yc)4R!iu$dZ{%-%1@Oqhs0XAQ#qxee
zo_@X-%4`KF<pn2G<&UAW8YD_Tq{m}AAg-v=fu+Zz<R}N=60*71Uz|}PvjX~NW{+l~
zgHZ?IvSQ(_YrLA9IVyb25K6K>@d3Y8{#H(pX10S-7dZP5q5aHSrN{f)f@E*oJw=`m
zjSL}cASqNx*KBq`0M|X6E*;d1Vk3<sB}Z9I^#a$9o&MNiK&i|Rz+lP#Rsi2ySs=&F
zv#2G50tm6^Gmg}@*|dNmn<|_EMLS387Bn!>C$9>dqERuuzk+k8Z2Infk8K8_5cF(l
zfsz=|L?d~WJ*9y3_eZNLpvdiK;jRM)BMUSK(g^)?H3$jo9AmD0+Mk6Zafk)zrjz9)
z!}Dp?JzAW|bEDX}QA=s7fd~C%*h}I+1PrfU>>=xHI&5I_y_c$<;j$9S9`p`i`K3Ac
zA3Mkj83N{52pR0WKWUu`8JKkqj4SMSh`y@Y5=EPZ^4(|BxD|oYhYWyacYGKXDCq@?
zC<E95_Db@#&y{stiT2Ik<H9^Vbm|>8ob$cos-A)0@70`JT>)^cjR)_9U{8c_tcXnD
z(CeyQ%4!h+0zBfR!Ol4Q;qfHu_`)u*7Y%qMd)Px%dRk~14Eikp`92KVMaIyt@*U$z
z@9LPU7M~V;Jh!>z_O7sUcugzmKL<GHeTCf$-9%Sxk;+x>?o05iApCM`$_W5~rAaS8
zfQ0|7Y7;A7wmyen0wq;yz*||NBbn#op4HPSbJp~G$)UG-#EteuhwfJvK05#AiEQ;8
zcY8$qvAaQZrG+(W&z~gvtvEwnHrBSOvCWzCCX{eDaUcZR2e`is;M2hXKI#53A|tEB
z%%eqK8taC~dM6usRNH3w)g$L}9QLS>y66YRrAK$*0zqZfTLDecA3H-?a(q{q^Y07g
zg3GwqnH`V(-d}pMCDv>YSDJLl(ZFU_yd&OvJrmeL1v{+Ma~J1|Jp23#T;aE??2$a=
zMV41Qt*0-M>0Ovvhu*Y6W`Bz-d^v%FM_{4aU$Pg$U@y1I$2Bv)kwD@`RRM8>g$h<*
zLaE2i5Q(H;JR-Wl7kb9f6gk0E4MUIeNQA@FfV7m)weQ0^k8ZA(7;rcfa?Dkxfm%|p
z!;%-=v!E)Z42T2G8wc``KpxicuCrmEXs-DyW-LtH558Fm)0}qDADZ2-w&q@_@eX{|
zi@YD$!G9kZz{U|b!WIJ^v5V|$K;s*e-<p*7<f>QmHjnDOk3l@z9rTbh=OmE5C^T~{
zm~$TQSXc)^^Tsq;0EMuCGz@R<f=c79|AShj2Y>kA>_7yx3Y&k+NMIHceYsw-=>v>h
z*CTit>T9kizPZS=gPXYG{4i;BBBhfk==|q87(0N13D*K5mE}5U9@}UT5}9>f;F<xl
zM=<+U>ekK!cGW$Q+um8iMGt44Jm=cWl4SYfhlPuH_>3u^f({d?<8Yp&GH}G1We_WX
z1x3;$5My6n>|=K#AJTW5?W3n8F~~ugAVE6S#-qP93;?wDJ6~kvpjQzgPx`X~f;>ti
z!?d!IXMhj)Xa?lV%#XsYK=#JFwQdKMt0&4z7+c&rOsf}pqXf^HgemZnbS(bk0NZkc
zMn1*si~)!j2ebtw=HM#*NGqDj`mtuP$5kl-*O4C$`WJLw(C?uU+(Yo)OS>5jseU)X
zKEn6Spkc(nJ(x4~wjPARR;R%4wBjqWg9X<tXal6)68@Z>GXfo@&S`o1{}KACFxVN(
zpc+?vHW;u1lO|6g_n?*8_T|=sS8AU9lQ1yY9n07@evQxRQ6cpr|2C#YFR2)nW*=~8
z(4MwF@dEx<Gn{D6+iyBsHzoege1b`ds>tg6+>SAx0q9+tiOB2f_>WUPCFP5;X5PLX
z%&Z875A58T|Dk{V`<!jc<+(D*SN3>%KFJaMf(-tI!N8~wF!b7;0L|EE8T2xU822eJ
zcpP}&A0?Q>nOJ98xg#go+7r+-CK4av$`_Gg%6eYfAirzmfUEg=xBUceuYTTJbbi*_
zC*Jl1(NFNUH>u_-F9WWZnMpWA8=r1ImnfMIiY;{AzkU?Pt&O_xTB^#UBP;4+aN&-m
zvrBY1y?U6m)eiY<64R2<xmBH@dE&>nqheKQp}=2q)Uh&TnLgt1-}8sA_34}ed2&Sk
z^#zvq>!PDs22C=U-wC)918RH5+TqF!X5ApaPf}JQ%ny25Jrg!gH2?dSpey3AhRYj<
zg_YqezCG$QxCb#EP+O`wGzlF`z$`aP)WYFUkXM(n4ky8zQ#=!Ku-4xLl$U)2L75#)
zmu@ryKnJfxX7W(|QV(^U=B>11OLR!7p*vLW7Qurb)np<a;_=WGmvR!wxU_(FJbCf6
z>=kP;Lcc<HK9!h&!yAy1l6t-Jzft}HALJd0-FW+Lb+H8EZjpEJBkazkF|E-(xVdZq
z^yUL-bI)dYRH>Up2FVC4#$lP@N0)Zh)_l{&BdPt~rWUEpJ@ZBN5xtH*X$%Sp4LLj#
z{HSfOh>GkPa0A0Ynx|)(#LQId57TGk0f%M+pk5dSp1bRB`@6m~JYuSm(6^r!qgtg&
zq1R+~6F^Gnum-dVI9@>o%KQie(C<O_p_KwL>m}QaXRxOvv7LX6iVVf*b<MF11l`}I
z7@98bli?Pf;%3OBc^2S{T!SOHb^TE)IUXYSKQi%HuCgR5CkD~W&5J?KSQ<UW@BDQo
zNkh1+wC4W4U{Df@m3O>`4`ydbi)q#)uf^k8L{jh1Pl5e=S*+!?fQ$44S<w-N>;Dwe
zcz10?ck)|@=BPVLGWUsJAO47oxhfAlF7zpkZVFQ)g!xzui>(!t5d_FtdyVvk6VnQ<
z)~*qlV!Qz!V}4`Iddxj!v{9uZnO`e`mzc&(3tnPoy9m?c*+eey<b(9QXgb(<hkwBZ
zU$`Y15hv1-`S}cS>@OXr?AmB<BCoCC4F`g+!!4&PQp?s3neX1b5pA&J`%goTmue$Q
z$&cG5hA>k(Jj9~`DLyzLAS;9>LIRDRg$KtfNz4l_e_jBR2Hb<(W=-(i+K7mE7+p$_
zjN?b{KI2_^aIArpz5>IgNi8#d=?H8AhQ%k-{KD>r&?Ip*Nr}NlTR%K@!KJ6VpOspE
z>kFLa7@<#+fcpO)z&dE*tx{QdQdcsbtK-@MOX{c&fyPIoJ>wmIa4dktJe-xlGuV6T
z`m~u#?N2z6Y-v)-U<{RQ;BI0!Bx8mjWN%p8I_OU4Nu#O4SS|4<x*A~Yu_gh0ye1g~
zdPGUE6PJ8LGJmo{oXM*huTBucDF3uK`yXrrwcbn0yM@^pj@KB&d+S*8N&itH#CKL-
zS$2P4`hFV-APVi7@uCij^yl3I$dYq~nV|hYnAn|tIc!OzcHm>`GvisEk&mfEx3xhM
ze|@G|JNyzHMOec<rJuk9Ig|z<08P;~HCgCA|Lula|0m2hLXQFk7$~UKM<(Vnx*J`_
z%eg+OtnoLkmT;(zIEN;KPbX08dEf{z4@=3F=*(BiK}IC?&xa0!u(t_@+pr%F>wk9m
zr&2d06Xbsh*tJRz;?Or&oeF}snXs3kX@36|pu=v`&+q4-8bni^YbDyVhWtKU19}NQ
zrT>PNAd9&%!!}*C%AX)4=w59dXGc`*uq!BR<}t*-D~a3Wj4f-0&634wkPy_G<fotE
zYgu4|{A?7d&8LppXw7ZVFQ6F2`_2%|89|c$m|ofKs??@YCg`0<a6mNDUKpP<mO!|m
z=rsWxkhOM*+bm@?VBd!$2O@_?F#c`e*4Fzb!$E$v<T+Xk8d15E5%I(KcEDT%X5Ir(
zq?Fx}*x{6Q=}oW)@@6d<F+*tG`ZGnotbaXltEGA;k)C@ddvfE(e?2T`+(<d#IXy1A
zF9ejnuiBe}DL8a93|D5b*`Kkbp*@}zh>7Js;a|W6y~s-MDAQHGy|7EA#-koSwfs4!
zBsirz+xKOzYNd^whKzdPmP&c6dqgAhFGXa%8P-CaR5-)})xItSnwAS1$c=u;kVi~q
z4=U+--A#nL-3Ar-cUaLciVAEluPP(1_h-y&^!~+0#6UpWk+#UAdg7iLkTb~XL3eq8
zUZ8T018W!7w<6Q`%}4{3Fn4)6BL2xR9n56(Xhu8O30Gxiz@8*~gFpcPOF%K(p%F54
z%i|dh(po>H!y_iMhp?9B?Ec~2LximYB(O{W^R$LQ)l`fFNhSbuX|3{!)Uoad*2SLw
zOA(1B4ZvMgB!(}e2h%nyp}9fLnD%#_X4%&c(=PZS5aaVf5#`<?X_^m!lvbhxQoV{V
z`IO^_${O)g*;;I-ckX=?=$NtN=$gfmDZDv7FzftWas-q0h~%M`g<_llfL$Dx#{q=;
zpO0&XrAmUy1?4V(GO7eTv@xvQPolId95(Fpy?v^1(*cq<_!si#{Wi_ZjW|JuS$pX?
zq-Pd4OX2<61GCTXXp#C+-x+Y_G#lc?FAmV={n~@+nU%Pa53h8v>6vZ)S=<qn?9Pe0
zG~m$&+#r1zB+P&Rik&6e&)d%*>vKp2ZasaC5p<I0e*xO(l%c9kiceh@m>27bX?-qQ
z(d~FX5_7s<+%G?{G69bZy0NhfW>NaK2SCyKX3M1<Whu`TeBYv!)B5Z~S?3-SWcv5R
zU0}@f%YP9MauQpA`0vv${Of-;%xm-JmW$P$UQ_|``Z4K*s=c6lN1a|*$;Fm}QzRU&
z7gKN1>;MMeG4EN`Gw1q-7x!j<d4ZF3#usPimD$Wm)q%IHrC39-c2039B0jMm5GDdE
zH)z4syF;`^z<awoq;$V=0bQWCI466XCx%WtI#vdJ8*Xopmu-*$#xOp9bwH^-YLuAC
z|9UXGK2bw36ICKGlmsfVyZ<>y<d@Uez62NO!4DtIjBOMs?s!Y5A_P`5E;CBM%;l@2
zChDQs=F@I91Tpl6KF|EIM<5|RJx<%v+o@RI*#PXhSIfWE0HqQK?clN06^kEbN*x-O
z0OX@TTS0pkdJE{iovF(W)9AA7$<Zl`RIl?phUVAh9HOrsM}wWV7|1nafn2k0^GU)N
zUiPz7OiAeW!%V6tugAvU=+w0|Y9RhMhyMuuVz+kZX;hL6f1H|Fvc~%u)$h$(bQ$KY
z2;M0eaA5^@vqL7phz%zBmbn=Do98GP;$Omz1R{G!FwDR}HPRj@C%GwgCk56kVo{62
zL4}{fMli$;01{{{0jc)ZK^2dFggpK1k~MU}xan&VV8onJ3E5;vZdXH=c^KntscXMM
zh;J~yI44+a@&~48+M~l7ja>Q(_hjfi%No^~2i~3ooQIg(HVcBqSI9g^H|K!VG?G>g
zndbq*S%vP%w4(<$->;o<Zh9jjXZ(TPm9z;&FBqQ+sJW(=I0P3wDrt3=BTQiMV%SlZ
z68L6643I<g=dtkyw2w`@#3}yN(=V}N#~!k<zv8jP0p8zW8d~tR#qnop=z@#F2JLw~
zcmbi}ZwE{-gTJ)d;3^EZ<P<@<yTPUB;U7S#NP>!0a9YNxZaVyz^#;J+;srPr1k4BE
zIeqW(KTmH!Foc<Taj>=xnVU<ed!-&*b-J0j2<GO<=>u)>z_y;M3WJTYj0NM?(-MF{
zxhjVMs?A-Wg+Q`>8(Id#48%xy!e7q!`No5`|Lyk@w@h{Jsmmz!OjN-2TBMd4k^yi)
zVp}rar`vEX0v`7CjCL)k<#=+s3j#aySr$1l<XSBJ4gz<+?woAyvh(+Tz+C-tGJ_{M
zybpWQlo-ui_m2X+DJL!+kyi)fw>Nus3yrX-^BB~a#P{6iYZWW{?-c?Y#sSg6?5@l$
z0p0y7`kQ_jPKECm=&2Zho9&QslUry3UzYJ#STrd3zw)1FL411`eRQbMTn7Cc2D0|e
zeOzF?rP{{x#R}H!I18;1KuH+KQjOpJ7lh51-e@;0-8YN-TI};~m3{V^Ss>52b(cDp
zMa+e^B%uGANW6!?pikVrwCGXU*LlBRYd0eC*xeh^eMUBn{>K-%R{`!!H=yrO`Z6N`
zp5;zo<sr-^8};mC+$0cROD$PUU2CJ#13;u14rMX?o?mP67%@6M@j$D=MXDbkohpHG
z!>%0$l)h`9o^$gHJ$!egH6*dhVZ`v_gROlhkSoc6Nk<oa7q3x~_S8Szsy;A8ix7*K
zY_9=^APjZG;Sn@fG61ypy4hUkTd%%4a(4s`#O7*3D_LLbQ(rPJ@X2__q@WQtUrRw(
zJfd~nA3@8)=3g@b6q4RZpSxg?y8w)V4$Irbp6cDszmf2mshHg!c3In|B@IItTsEMs
zWUM<Y&Uf0JtbwEq?hmmIZ!jlJEY$pyiSu5<{g}px|M;VMUJo?+-nD*HLtTh+PLsJ=
zfCCt97=?M%Mpe6(x{!Ihw;DTSMcBv5h4S?#(8amC699M2p#%r*cHu7s>FZ(^8On+{
z!D$S3T!tvM#5#2)W6e2E*KX!MXqwGr&cecH);TQ;PQN5>6)mD4VOJ-O|2B@GeKa+U
zeow(XvspF<cpV8LjpBZ975;}M7c-pDlcQ6dbG@+ny+gFdkSsIzv!v5Nn-l0_V>c#^
z7aPf#YhQZ<3bv%T5~@blB0%Q`_a_F-R?_8W-AFqtK$c2cxqi}kqtR-V%flFOLoS&3
zOl0iv`^w&qqJnq~Mp$eBSLB)>-f)3q{9b5`$Q-$bNA=sUX~U*x6tHldRDc}xzf?Z&
z^&?S{vhmi>5LA0&^wDOq{{vKtu1;MWQ91pcwr2=!I2GFdDT8Ij2EC;OcqYdhkk^z}
zkNM^NDLW2+#<89~W+tY+z1n2EXR{SW>@I$em-k8I?VfM(&uBuUkK8l9I)jeivg7QX
z?&?>=zBP4k2>E=|8x@@79X!BB8<6TJLDo6CvSU@8qk7omA)}Xq+GoCn?s(yLyoBbw
z16_k9dZkVIdi8rJE?=+fyhu;Jb~TZ^WvLU3&#&GcFxnazu}yt%MUv2p%v(7pcHq)s
zP%ftopeX}KvPnQcSkqGPyH1&w=dmqdbV2Yu*Zo@>jP-9(z*xTp0zaR=<<&aL#k!@5
zz*n{zUL&$O?;}{9(`>~x_u#w?e}fUsnEl6Z)T`XPETOrcmA%G%J6Ou%qi1nl*Ck9n
zZuJvaO9JqHoA}rw?>tlGcpqkT8PbxHcw(z#Zb;lF%3oC;)BxE2noOewj-O23u^y0c
z@$F7@>&~i!#_zwtGHZgPeB$a(Xr;<HyHiSZbOOhNj_pc6ol()fL~ZzI=&eqq+d_QI
z8%~%o42|T)yB9p>7nAg5YEo&<e@4EtUJ5s3NHHFC6DkepPs-Y;i?tJ@u5u)<t)@m3
z6Th%cC7@SLgqq-BD8305l;kBjD4|sg<+)ApeAWItJ`&21M-&2f09|mm`kWwNp|;_I
z!Vq5Z4t9P}q+{(2uwq#?!EJrwVz`&z(!jHu&mFSV9{BoD29l)^TJ)jf>oYRlHr&h-
zA5I2NCWkDhhc2q4g@zkGM!!>wW$%h7ZodT5Az^gskn_O)!hB#rLi5yzf=MnhtMeg6
zzixsrLRT;WKgiQ5(6G&3ubOkstGYXGcdfA}gea(&vG(QtKUIz}x+=$c@da{6k8$Kx
zi@-aZ`gzl276m)4AKE#8dV6rE4CvDAx1i-(y`_D_1#Rk9z~U9Do6$*CV~D$3(8b*W
zvAlHA*~Thxylx|80mTH-5j!(OmBUh;Nz@g#*+!tHr8YQhSt9T{{fSE<tE%?d3#pm2
zfXPqSs25^r)Hf(%V&=~cOK6^uUi-x?I+p;{{!`m>KTrYjyiq6*u2+IH?dCXor3y%W
zL)9Yxv|qM@%rxTGCb`-Zq%R^PeMu%N#-4-Tn8uJ$3Nt(Qltfn+h*T*kpiED3F4ff$
za`Eo$eVcKcS4=o#x@P18<ZmNxbrP(%wymPuc`fCJrEsI?S*Pdy5D-1IrFN%72G}_;
zf0cyZ=clc@)f*>!M-0WVyeVV*t`vZ%AV$jj%sMHl*!=Rp1Ve5&uq`Wr97V%w+rjdh
z@<XpwcP^hcQ5W;w6VrTfRPfJoyc%(ryB`RKt(RAy#IsbF34aq4Bih20omg#VUO?E7
z;aJ{qaobul%er0Gr{$JtEtEF{;Ymre_%d!`OTw5E>TOyGyNJN$$Z8VLGZc(GVa36A
ztao)u-l;zvsm~mfA2KP=zWw1&Z5TJ_QKO+nXO2&cu@c{3j(%bm0kz<x_F6CmVN3$`
z78SzID_|J;=1)TMg)*%>H>9Rh1W~@lw8vtn8b(5XJ|L(OnR&EPZSh^q#X}$tXoh>r
z#~g_MeJxi=^}8-u6&8K}IY#Cql+P8(7Fbhv1Es+cz>!tJjGa~BVJI}377)TjIgeiX
zBcF%RUmQu3Mj=X=6<!lq_SvGj@`Mf*WU#r{iCov6PmHK?)Wdo4*RA;>EU5=<3h?9s
zWHKsPWZvReu}vu+syrs*sa!JzC;Uu!W5Q(T$=clIh-txXcX6%QT-ud!d5vfJyRA6X
zn6=15VEJj91<`P3NXIA30O@$(AEFAkM0_4`Z?yxm8GDApry3c;h}s6*icdfk7(0h4
z75Tx>ofl#dDx%Qakk4@K(oSEqq1y~ma4h{c#Lj)Eem^0KtEY{G2eL2b;x@XthX3>N
zc32O)^{gLU8u2|t_eFbM#y`TPP+oop#h?y_K?r>aYaxz$5M-Pb<lJl1&^sj0TA}#-
zj1`009CTOryY<Lee1Jfq)6$2HiKj?*#ta=7&gS>V+~9C<tV9-*2j1k<Z<T@|thvQQ
z$(pE{Zu%hJ*QJP_jflk^kSO53$=<38+N!IIh)|c^Ct5NQm00o}4P0Dn=q|1{xQz#3
z^#8SYVHNnD&c5#Wrc!HtTG-UKbs$66HnlhxJxak$1_uBA@ZNfB<b6#n?~Wl^E?oJ3
z-2CIjVdJfIDwqi3$zN0=(R4JNPmTxO8{cQH`P$pl^9A++#GWFrX_z>KucR*uYup}N
zkYU3|bbOH_vTNasgv9sqTML|y>!d%A<I6^Zvvt9s&2HeNDd*ex=Z04&bG3Pw>muXk
z(_gWwRz$u<oEF)pU+ph#G4RMo)0T5bb62guZ&YY`qF-FZgd<J|m<j(->D-D0+;sdR
zdT|lRFq}wz_WnoVs78*4NA*NQ$}82AVifv0=D{6%fI9}7zx^%)HsBfa+<5p>q&R;;
z=xDudmG>sy&vkfXw*~l1C0lrOYiXYPec!S^)V3gh;gzaw?dMJ2;NwT5xW-_X+qW*)
zG{;5_$WG~dz4u*u2gEhgm|`lJ#$f1W9-&%z+U9T0&?Jfd0$pEOUsFB%ruFZXCM>^?
z{_QZx0b=kMxM=|{q`Ta`9);0n-K(ox8@Z7AA*B7n8L@C^I}AO;1EOErn%DlKi^w)1
zqLyYRi1%N>KJoN%+f#$Buza***b2K9a2I%;-}_{5xB$66&((1^g>K=@;IEm|hl=F?
z`ro-TXdU@C@c?hi%@Y;!KLs<^B1ibUqULyzi85&B2#`=V9w;eat&5bmvM?6R#EwT7
zeK^3_XJX-ubAZXAW##K%afPE7%4p{~ocjAO2rG~1Z&Jb3m^>#^AGABIH$}a)e-sve
zzv#?{kkm4aKiz!K-%7g38{FhFyE@RzR>TyTM!r>9mr4N&h0kw+5bpJt5yHn~gy<7F
zZViGLG5rINZr=2MUCD{+4mSVjCr67S8$QD={p6~KUD}+m1&{mq8%iFzIab-$63cQY
zR0I<AehS(G!~BgAdJoT7z3^eBd1u|>nasU1o>_fUDtxKfQ*Q<Y1&}}d<Z6MnZOPp7
z*S%h6T#;n)cW+;&eU#~p)5$Q3F^M|HHX8%>qN3~4U&iGmyRjQ9uZGPt<_2hFusV^n
zF}C@bY%ufVn%aWH7cP@d{D3ocJY^08BM}+in7iN<fEh2AXYt%%sJGy0v6&%<Q^8dT
z_tm?Cd2nhsOx_lGW)}3|sHg#5L+1tOBz3+CQJrtI6VI{K^EK4>nB^F-Vt`z0i%d|-
z^~ilvb3)8VK3p*0Re$IlvSm!#9%EaLaRnNviPCcq&sP32NV>sPEafL>Y|b(U!z|k!
zi6(`OWy!*2g3@|;;+NLU?^cKLg&CSkPqH_8FE@L?MFsJ^OZ5vU4O)^r0yFM-9#fxH
z<3m*0M=9(q+YzXuB<dTk?(#T_^ZeqCk$q99UkmfG625K6G2y?H-^e@N-`fJu;Wml(
zhHJPyZsSrD8RH9a^6u>&`J9vzqP$-F=W*iT@&kWcY2X#t$hK@pCt)jW^xgFitcg7Q
zwPirgG-pKKsdemI$d)p0OIfJNTXwav-@F8<<bM4C!u&dyWHixNT!DrSq_3NNa1x5$
z`JK71HTb&NVsSsoa{bvOJDbE)78DOE;-NB@s*Iy53w3(SQa;3`|GXl<Hq<-4e+kC~
zO}X`{B)dON_a+kDY=1e>ny5oG7(dS%1_JNgT&UI@sPK;$22@cb_{Qz!ach_AI!Cya
zoO8wv>MTXrBtzX(Z$n$kH(ScheQ>Ye^Q$?y#l_rF%tyJkUSvz$Ij!^d<x?934lwNf
z!<N6?0-*-#+jbMg2~AY*n-8of-<}GRg9M&YI!_{-khBe`SL1=f`6u{n$O{PxyDMw{
z%!#Mt@5_DSu=?MVxT5>BepFXsy6<j8#wH)F1a|KQLO(5P{Rs6@AnT0qPL@F{af3R+
zl^dS;f#CvKm?Xk5@j!yMV23Z68&^)nm76bBiD38*A*2uI#D$y5HKAfR4x1;cys}xU
z0>c9SVT)g;0|knx4n?nSZh*HCCZap$Hw<_5@$qFJx5JFv$%~Pm)B!>H<-=7glXa0d
zMihim27i|YGqu~(!1CYf=4vR<SeaRVA+j((P!vG9`12&iolu?gNw*p$&e2^??JhSj
zz=?bT!$-5U=h!H5cT8G$Na%|YLwB&%<$7ZV*k%V>sp{jr{FIsJq|D5-9?k^01D5Qj
zSB42RO%kmPtgG}5x95K|hqJW0hvOd&khxhaTw~bfZ&Go+`ZP@>IHbQkoo===J21EV
zXShQ4uN9@r^nmF-W>fEPyOv<%r+R?}VFWC@W>Be_(66^UbOegc+T|}VRWmIPpce;%
zR&e-lmLogK`wPn;o~@&9&u=aAO2o6RKW6G^bcim(ax=nSl{f7-ZCCNu8VFn3r$+q^
zBvXJ&gXE9+*X?Q~NPqcOe>uPbyrrNb!)Gylw@?3Xn(P6@_p2vgg#8tJ@4cGroy71V
zxCP}+Syup=vFx~6e%|3bg+r|JPG!Gl7;h4_47_i2F9W{<eko@$oD*!A!-=`_H5V4C
z8;5I7z<GtOc^$%(ZTv-!2T3#+e9pR1O4dI%y%P=kK`2a;H^wcDa=1wM`|GXzyEQ6;
z!sqwJ|6L<1SBDKhHAuXpBp-*HFhRbP!94z$?<%55B<g<q=IK4?ZS6tmG-e8WR>8(7
zet@tEiXZizBrd(6$A@^OoE5loVq2qT6jef(4}<ax8@>DzuO<nCm%&!i(C<@mCS}Sq
ze!6_Vka-i_`X{bQ+?jrt<SpcQQ<qrIAujGmWmRMPruh+LKq-P@MCE2!1%I(|sez2~
zdA%9S3%~Kb`M%5%?=2zK>C>hR(F}Fs_P)2$pG<jED&tJltFL4g3c-l^%pE))dR8Ew
z1iOW8AAYI#<k}?s$6WBraE0SIQEKG0fStiE6IL}PmV6V?G0o_*jptNzw?%rdn<Jus
z?pjJk6VY;@D!~vje8&(m^tkl6(}G>c;G1{on8v+#Y8BFh%5j9<m!NkVw&Pr)*L<>L
zMwjvudRQ;;>XQD`OlcO#?Ux37Mfu?KUFS|c$>xOgo+~i%w@>^kogh%Y7fhdQj4;`{
zHvyrPjn?QI9H*)t;6AU7{c22eIvHm-$Jg~ZQKW^j&Cwc#=HMT8X2h~hVe5UryuAk%
z_QfARu!yB<pxV0GzVgjt*C}v|R{T>chrz2|;v|dsQ{LM^gGHxF-@w8PveSs$o#dh>
zT-uXy?!xa~?)E>Mxr$k$WhKrZ27+!z@#1T6Ad4?QjXb;4aU?X43j27|)qAkwT>9ib
z0?Q2)o7kyFRB&H8{uFT+h|qU`RO?M`Dj`X1*zrmr#AdkS7aBCO`THJ#&v(=+0dIaj
zMewYF^NH^+4^Hvb0?f4yxV{YLt3@2%bj2kqd(UIAcbP@}ih+d(usi)kpdXNkTyM@d
zMc@smIAmcOdhetyJG-vhVNVNu7(Wzpt>&9{j>)&pDVrmSNLipKlRnVFM;@f(Qv@eB
z0`qbPl;#ESV=>6LGC>iw`R)ce`hAP+N|P)b>%^;qsQaT2<qlgX<knCVfrYP7Q-0jm
zB>=PGcC7;v8y-zhh!-wW5f~*{D{jmK`8Ev`QS$sUWImAi3C?b6Ry*l)V#onvdRyFH
zvYP`)je;#PqUp~wr>&j}((Px$dDEY_m=jQBPL$vgb5S4s*mvaHk)Vh{V6(Gf=V`Ms
zT(KOH^GUCIWZqPsMZ@|39B?_Z3=H#ux`%C3pLi69lke!#Z}6~Xf<Z#xAT*I5w|%Jr
zG0dJ>3?p}RdO-=EJ!6mK?~KF#dkUcJp>}n{<o>gXVMIq0mn^FbkBz+3ngVu5gtSX$
zqvg5=@4xqn3r;@#y8k5Q3pBA(TAzGaq%)sNwvo?98dEyj-6K2((gVL4rt@|3Bg7!a
z(wVc9+$%Pitz2;ZjBU5B{L6pjJ3r)5ub1_}4@4X55O;tVQ154k$e*^su3|%K_XS1M
zhlMwvgDoh@c&ReYW7m&W8j*e0Iu1{6L?+7wi%eR~9uiUUin_$|`fPdcXJ-!Iwl@%q
zx-`iTK$ab-w6if(+K(St2RsDs1r8$zPOR4PM6i+=YV<<?)aYAR-SP!`B{Zipk~YH)
z>M!;kEU-C80Yj%Y@(+>5VCXb`s=U8?ZMdRvDl6BSP*NPNYcg3$F95A~arN6=0?4bP
zY{>i_sA|l)_FEG}Z9`h*w$;tV8Qo6#Xr%EnHs0}TmgK4LT21PrZVf(1ERXN{b2oJv
zU~0dv{p{KJ1hCQm!W)xd+`(&<G?;y;J^FlNnd3;*Z@#)H>c>;t&6(SnMLO<@AI+2Y
z1c%57QV$7%dHVAgf(OBdeE%mLhl2+#E_TL$5*(k3tj>{KD*;#}{uA0P(K`0k(Q6K9
zI-;SC%>ox#fFxvV{9rUPs9&hW`>%8QuKVo#PQ1E9$5={1%M{Eq17jI%&n?sr7dSq;
zy%?%3fW3eTcRNZpq8$C+4?~iA{$aJ!{B|WQ+PwR2c;D6y`QSwLAOF7#Vb}Za=T<r1
ztk(_+ugLbd-aertxJoY2b?MpOU2Ww$`C-eT#XX2}__FWKoB4%vjsltY+<^v!(Si|0
z_WKmLkQN?*LT*qulG5pwxV?Vd@hFFgUezrQJ@b6-T@<F}D-ArsA@BsB`(EA14Uk@q
z<;B~UMNR29nRB0hQRI&Wu@3N}ctEU6+i|N8y%<ET;~en_crEC7|L21hpzp^#0SEHW
zN9vLKTR;%@Dn}m$zy_LG>Mg>pqrP&tm7>9N0ES-lBY;43=mgjt<Mh0Y4?!oM>p~47
zTRgb!2(A^FR0A^PUFv<O!QRA_uL!1&E4gQ8jET}Y{6P5`LENS*Kf4F@-C3ODJwBhZ
ze`WFF1G!HUzRW-1o5Qdp50MY2G0Z>y=vspU#TU7Ub_8*~SX<f6KGs<t93_IQ8%ChM
zw2#^K82l5J@7<u@;a)w0E-2Zol6&ZHl}fh>0-y$=+a%_Wfd~44Q2u<tg~LfZIa%SN
zczpg|lG!7G%q(?H#RE?H|2p1UYi^4VT_QG)Js^Xv|0Z&y+M;qptL6=f1iY^*nhc(&
z4D~LB8-}tKaDHzHX=`Ue!@+=*{H6mN=|lWME1JG>hT`?M7zpR9(zV}-Dk^fE$h8PK
zaGwrdJ9bV$*YsKh|3~edbfPkAIQxK`j~XbtE*K*>#@L2p(gJ^%*@5q|WFE;O{?)6e
zhBuu3^q_uXiq(!Kc&8SAa#g|%HW0V6DKq@YLjzb2@w&?CARrB)TJNyt3^$Lf;w*|1
z%$>V-dO$+sHisZ~)~%X*hO8V$Hbzp$*t%lU0um9)<c{!kzpUiz;p~BD$Id|2K-(5K
z`;+S{tc?Q3flpUiFJ#tPi=X;w#nBo4`f~EKw1767suKnjxtx^uEVysT03ZwT@LA~t
zQPoW%t8{0^75XCTh!HY{XUrJXBkF`SUmVO%ky1ZsDiOa-ug`VG;K)C@UROoufbyb^
z`~^<l;qW-Fj=0b;d2v%XHM86lQN?a%VdT)cmNU=OFQHl1(s1d1b=m<#=}hgakZEPy
zw6c(5AkPypVfOkoZI)h2h$Z*4AZUNa&}Zx=0Xj|^RwJ&7s-NZ*H~kZ^GF-5XtkA3$
z%#`@8KST9mZnHzT0njxZmH|3+)7A<nl@S5P98U!@H+~B`>&-GSBjpWOPI(&Hpx&|v
zi%E~D^Cd4zIr_e5J~{-uPFNQut-s+aD^HsTiqV0s9u*-AGn~h(*QT5^($eoS580uI
z?2b$ihgEXOUNOr0IwC4?GFcJKQ}>^Xe~+Q+W9o2=%0g)GN7I2kn^J3iaLc~HnOdW<
zjO2bF@Dhc9mq?XX2Oa}%GJRRu9o^YhM5q@DT<r)=Y^nodo)Vdi*Q}x3)Dj%AqMU>N
zxo~lgS0Y6>&}Ib)Vsn|sw^VJ?m&nQ&p?GghHd@Jak!{j$#t<?T!3rI2(08j-5+ji%
zNZQ2B?x?!*m&>1@=2^yKUvfHD^3cfu)#cRca&rM3C4K3Op9eMteVsTlxAlxw_2EI*
zPnWC0mcHPYz6gbTV-(OzoT)A6stTop|M1nWJvpA?_rR5%WQQTy$!`un!O5?d+_@um
zG^4Wo<*ylUDaU}vijMAbO4GyS*<o#ijjNrf#k2kI)vTDE19Bdly4{k1X|Khj@K72%
z{{=VyMaa|JcmQaTu8T^p`Q7}WG<#JIwbHLE-oZ-~L3>j$-pM0@N>r(jc{q;am%Ke&
zQ75iKYzx+bn^y8QUQnj-@=ittD)obf@}Okks3-^+)ye%*sIt-3GZ!C>T=l8ydI0d%
z?3d{PwV=hR_Ifuh!o>)k%~7oC`*+J9&bEl$@TS-UKoB5NnG*S9v{w{!)O*CGj5ev?
zw17%6ozZ#3Ixv797&y{999agOibUqA=EG^PI;76)3A}1dvZ(7c)?BJ;-l*~lTlAU^
zRGXZcs-q#)Zzbk`F8?b4(OK6w{vL+c&g1Wc0m!iAr2uCAI8&3a;k7&m_qr4nQANeU
zY7pKt5+_JgIwVcvmZqO>wD|i!>sP?fJ&?b4L)@{FgCpLa%vkj%BuxXVW<1bS`ebou
z52R))h`G;&*ppA*P6$Zd7Qi>d@Lpk?UJAg{<q5LX_<5D%hc@CDJGQSe4w2D7oLuVb
zv)K>p^WI6QV2OU|Ghf!_%a1JZO7yr@K4%u28)9YeP}vV&t^sf(yP73HL|KK*6L7e$
zId=K;Tc*sO&V9}sXBn-Q9q`D4C8z-O?!wX}(5x<Yqt|w;?ya8TZZWwd6OsfEaSLNQ
zBCKzAGL$Luqn-GLWUtcPS=K@(-qDc0-%B><==~t34mMU(*ARi@H+oSC0^p}JOsTpu
zp>OWDeG8g-@rVy$LI?G3BxEL?^@u-#TjJj1%yPnStC3r&i?^D}`az!fcg_R#E-iE>
z9de|i&^sbD>hS`qr&=0C44QqMxby2SC{+~ahq{G9GNbk<PG{c#Zda&v=b_F(djlvK
z8V?DnJ`q2I*pf>;5{(K_2;+KpI{lmq(e0GjL(W8Kt)6(X*+rWu@S;j39(jlgm=5JK
z-yk~NyX<AMb_Ze~E<PG^tpjAt7JW7Zbpz%OBX-lA5CgtbpfICp_~pTY=oyW%^F%||
z0|ks7hcz>bFENcJd*jDo@1|4P;TNpmmWp;h$onQG%iaTpnUepx(etdMBmS4~<@%sR
z3S3E*@=isQpmLL13=ex0#yJ%wmuSs4*<J&F+L6y3`!WybaCCNEvaj#!A)GQ`T{Yru
z$_f3wPMqhJxEJcH<P&2bo*Hf3tJ9Dc`oBk5a+gF^uSdSUuab!1LP3*MG^bg$=zXKF
z&-=BAr-*E;MnX-fu=Zf^xNN)HIw2zygyqM!kue9<Dp2e82n!$Lb}M^vWtv|MSUq8d
zLa_jXd?h`OuZmrx$5s;CDw|LfzZoKz3v#ln06g<m(W>u25H0C}MeS8uz&G$d^gjR>
zVqZ0aHFZLB8j`z)MO_bYK+RWLqln+dtq?TDMEPt~P<EJjPN;Q4%e6`6-?-M$8xQ-w
z`O62VC=cGCql5ue3JSZG&U-tXvwhy>t-8fwb_BTJB{5!cQv~fuqI@DM$TjS(Y22{*
zt*|9`h)~Igd5hZVx~I@1i5Q_{LZ$_$)QK5K6wG45;>(n?cV)T_zo4^K<ClJkz!u{j
z=3MRhXQh=b<{hfg8~_Mm?xByY&^u}w{2e{M%)G~NkT+cWZKd2%mw3ZZR~ok8&fVqk
z<r%ycE}iA^jfLA5&3;TsxZso(!H_$<ymxre_E|SlkC65)M%VO@k?<0Jj0P}F@MQX)
zh&xvo5^q?Q(mDdY5!!7>$k@T(rT^slA<kheZ=$$ut(Yf|4oTd;jvw{o5Ai5;xn(gC
zHiy0;*>i5*1oc)XbTXYyG;uFOXFq%YiC6txC@cPt7T68QdDQaZg6%`0!KLjF6+(><
zTT0=p9LL9)-rRfAH}vV19`wyUnGk@3>V?<}P6-nXSzKr3Kqs(H>!C}lq=3M2zh~7v
ztilDG+_piN2^!nT-IzpaMHJCVrWV?Mb;L2!q`y@3yfg$KA`|ixM$k53nl)n1>lE5w
zivJeY-*@vQhm%t)C@Y?IFksHj5AiotEzq?h<Zvr2hJo8ChHgA%Ew5gKQcrlqgBR^2
zP1IH%c*nbjS}P*}9=064B{P|qIR8xNMMjqRp#thYTlw=Sj6$f$p*Zt>HcOgfar|PY
z+(#}-a4MchQ4SZF#}TNOEJ{tgo!33s-C}&&6n%V+MjqRSWPaf0v&C@a2^}cV^&@aQ
z6WHdPMH)g7u6zY7`B20~dl#!#Jb4zGoEA(;-?b)lbY)zKD6$VvIXH5Qu=?1xMAwi0
zYj}fiAYP!WPRN1S&L15GZy<C3@yi^(N`9`bzlg6FcxUge|Ib|vF1pCWz+3oWx|5mt
z!{mV>+E-aD%T*-vY`7u{lN}<ma4*VihkM*%<i~zgS<LtuZgcjl2m*Qk$O;w5jKi-Q
z)N5%)9(#wmStDWd?1ywc`?c$-^}juz<<{sL@CO$g1e2KQ8LF$V{^$3Dy#ggI$p=mO
zoPp0}@`5x7N*aVo3WgO;$4OmGTHl!fB1=q`!W}y1e($(rWfMpq8on~C<S$B$FuE<}
z+hDMz)8f|`ke=#&>)0`(h=1QL|AAW!X7p>MIO8=|n|X=Tg+jF>7lM2`NT5e@f8P7i
z&aL3!E2@vcW#YPabG)(ucD&PG^Bnl7Tza??MSPXFqO}dCLor))6a|R%bNQ{q1$S3%
zA56w|h+0<9o&HMCg}yJ)F9k3g@LR1!KJ1gYxL)_x%dv3Z*c<5cVy6J|iV@}H{~i>7
z{5?l!Ot`ma=e|px)fw{!CnQa;T-}n`y?tdDw_Sw?bRorH-`Hu;z2Al&#U8w9|3qPv
za%BS?pvEUO2tVbAXX?@GWdZH|yW_G34NNMzr%fKo!9J!=kt<ZlBLm1pRPbo}4!bK$
zDc%djhN}ndruE|N{C==H`qoa;5gTc*nr)AVe+N#m5*rvO0=xNC8@nWGJ-F_%a0J6#
zlSgO`eyS6nMlJ8VzzoXluS4%l36;5a9B`EBV`f7DX}O?%1U=tZOO{MnZdBW~Ct8|c
zkB`JM?`CC<3U-hPOb{_ND^v)IIHgWVgV@gbZC5#B&3Z4uIh;a=#Vq%*F5<$7O>Qyp
zX5ueyrL#b+3413%J7Qo)R=>I=DMmqrz{DbkW`+u}A;7yG!ovAS&5Gh_4>B8E6(DZx
z^#bBX18z5hiwct>BSUyd^XVXA7=LrAs3Vx4Z9L;#K(x|*^EJ?(X~(fda&e1EDWV9X
zmJd^i%%$uQ)#SS-VjrRV#L!$%^)8G^SG^lI;(B^0^m@XR5l_nm7E^wr&?lZL&UL!S
zC%~J!U{0sp@I3zKaK)%SN=um^h%l|35bv<L$F>!N+x`hyEcsHCQ7f?Yo#TCtxq!Qo
z3yl_k5>CZ2ai=)P;inss?`49Q)3=Q)M5}c_fFI=xNAGc#JEfCxuT+Qjo}z-=%JC=C
zw_(!#$nX`C3CH=N!3v=gVvVV@VQ<pG7KfkoceunmWSJ(JMqktF;%PY-4!Lv~h14Fd
zvWP@{zYR9?=U_8Gk<Kj!qFlIQTG^4|-X;E_7LF4FuSWgkZ?+%b08L5^$5WvL2oOlJ
z`CL8j2Y#rNG<oQv0ExJoHo_sm26p?{hha>0Q7mExOzAI_46pn(`E^gQ+`x+)A$Dbp
z2%1SdF<@!vcH%j;2>*|%bB|{-e*gbwHaROHDW?*VW1*B&Iujz~ILaY8mP3Ux79CJ3
zqU4lAA|`~?=1|EwIm=;$%K5xu4!>*b^ZEWh|9JFxY~8!J-Fx5f>w3Me=WAl!R9($;
z)U?^x^w<d3>T7GCt!s*_8>I#^EDF5qUJ{#aOMNVtUDRiJz6`cHRA)3$QGODNWP}1g
ztM_dgJZJ1?>i4UmLkb%HFAEUQ&L?;}9T*IWoC#^T^NTXyvMH#s;Zk~wTEk6b2@Ian
zF=(zy=E+hfAQi|+1%58?+gI_Nz9GjOmS5GIJAU8PQ8;l)86};h0*kROou|yeyK*!Q
zrSKP@vyXEZOW$IK)OEQ7FOY=h4`?p$Ic{$-BsA!uY_d5oTI`IJ?X~hSY7Mn{8^95B
zxJ>XD;eQV?f-g_2sQjQQV~or)U5^1?078g@h)>~~^}@J(g5PV+HN2VEO8L8YTe5q7
z@bUpyjyM#wBG@LucAGp1ufk?ii}dsHM7mmg=uZ!MU;Bw4dpE?}@oiFWP(>FRf0v^y
zo5lHR^CcbRLHEC?_%RY!)|Lq_<I1lVm43(By<xqTlM#0xBet{U5V<N-kDz4w6RfKc
z78FDmJEjblbTe-6HaP_^_XAU7FNBpovS>dxQMRnwG^cEKvTu}XEmp*>eYZOXTbZ}l
zb!uDo=4j&<p`Y4K8SjM>YoqfnwKQivPvhWnO-;bljd`T=`Lz)MvgxjwW7j&_f0b%&
zuZa8dJ=qn^S#Le2Jp9?Nl$VR2)5A<y<0h=7FHu%oR?V~NW5)R+BIcDP88^f+2lulR
zEL8qm!<nmSeVkeXC4s|GeZ)M0&LVOH-;*@X|0XpZ+yEfR1x?&}MLAc0TEcYrwcQRM
zpDS<9l6ES6`2EL`OV)&OW6Fa<2`6VMHoEqAU!{mh;NV~$SGczD+SyoJUOPrbeH7lv
ziuny_FO_RysY@hv&n-30FOKnXYS6-!+#;AIYjf#&8M?<v5Z^*pvkMz(Dtc#d{sXcy
zqUiE1NhdY|o828wpH|>W-sI?)k5r)X+S>q2qkCvuKWAmw!~2p3Vk6ucUJIFCiQ+hs
zvtSEtWxIPxJ$t3+@<3=pe=7Je%=$3RrErM#k)V)b-Qvd!miqLrvbnoP)^=*yEj{U5
zp^<axrA#1OHPd#s=)s@iwP!3nW~h^mWDBkY8+$$>`vR{=Vp#x#^dSG=<7TUlvY!VE
z#Ewq#vOy!FmDK$IPlOpdSXw#qin~6@_&uhPx|m{6H6wb4^80`4Ew4~&S+ter&{>S?
zoi21xLb8l2Q$X)!9qw&ehCnhcD;u44!+_(wBZ4wINaxeq*xhh_{->rRn_a>DiEP<L
z{t-8=REjKfbjbvX{o`8@w0x+UAdismw3eQ2KAY)9NZ`LD)_xj6Sh%q0@Z>tnm_Cfg
zfm6zO^@%f=kJi-HXC#M;r7{F25mLx>BjIb20H*l9GuY!yrg&je+ehe@DC%vZy>pxS
zzda%}m9hSc51P~Ge}H5E3X{`w4Fv>Xx-W(qe<{Akz1^K(imzfM5~QeLc=&ikqNqJh
z>qp%&+d3r1#}04u!Eg{)M<f69-Z^r8)e4X^72q8Z^1cO`foH<^hAv4_R$Eyo^snNq
zjLs_!k7mZt^z|*zSa;Rqbt5^ATaG9G%Qp^V<Qt!{d{1l<5#FgX<vbU9>CWww_@1--
zn7xjHc<B2bXT)w-wDDN?h^URc>blBT@^;n`V{lYy8xv!~wD*CN?2QrecEyKx)4W<N
z{#y>_BMIlDSUcl`m~ON5C4u`#a+lU==~;dgTv?bsc8DUqEQnIt?8!|pk1Ya=X&B9E
z5zd74X!V!M#kp5`pG0frjZLKtniL5uPL#EI)`f<v!F)w8#Li=zy$K&-FD`y6nuZ_4
z1Y@Qe$kb8xC7`K*+e39G0JYK-T@muL6rHfU;JPH*2yiQ4Lo{OGRxDH<JIGg!=BByn
zd1zDthcH2}`YG2yJZ`3e|C3@mO}BO&x3xLP`D#P)$t;wz^|51*!_cQN3k~FzQ7{-n
z%CMuV_WlvrLUP_Nx56}*cqN~y>Sg()2qs}@#sdKo5?maOg1x%E5>MO#%hKH!%9pU4
zF#r9}wg)sS*3#xf576e`zS%|xBM##J0Ui~Nyvb4EW6oWu`wrsgP>Ooqfm9Du_51iR
znC1c7w^P`xz&5SkFH~4=`i1?K3*dTs_<n{@>6REOlkSc7B`%j+?E7mc(Vre=MpH3Z
zJm71T;wgi|%v^c3sH-3z_%)uSqD$qdOWxf+PrUB@hs6XFO<=FY_gu-BHYxYQ>QEmj
z209&&CdN!&0G!lb$?%_QOL1J6@K&<+U=iq*BTvP#msr$NWt<MT#!pWF1i1mLuReqz
z^h>OQjmMq1Tw<}W+fJevHl5VtcgT1am(@uJ5;#||1JYMssQk5?^CKFxkdBwT<fd%y
zq*)7HK=v1LKY$zymK`!3B$jfEpnf^+u>rBEN`Y3*-WTvz^@O$>kYxt17kD9eybOgB
zZ<X2Rq{#6H5o2a9)Q$&s2%e=yaDTT8_fxTHK~w}XZU9@bbKyh-KJxKukP*0q66);!
zZe#P1U}-FIPi}^Gx_!`Bbu#qeWOt@S*mNw*+Pt$G8bFslVJ$$Agce<`e&r4Zb=-t!
ztjKCWGo_hrcv-gpBVs=s>;2Z$_EWMl*rhn4p)vVEJ)5wei*)P-xptbl^@pP|xyE^z
z13xE(i9C$Ooe1*&gHE<1pH+Dl547b4mRz6KQP73dJCkQ5jkn(cZ>mv6mkofts-`6B
zk$w@iwfvqrW46m_I*s7IkTd=_jrJdX#%xX224|brC>_tYs}`-I{cCdMC#ZU<kZHxw
z%(QA55AN_hHpxx*po=Q~)nes%&?zuNT%EU&ZeJbOTgjCT>9JG$pzglKvLu#g<bnL|
z<a_Ae%v+2aY9_=lY_sF;hDFuppf5I4Waq^~q+HHEohsaYfi>dlhK2Mp7WX$qVD0;5
z*y5p+sJB=!M}>8C(=x&~&AK)_yJ+kGG0$O}$NIVz{kByXV<Tm5TL+~Y)qruXhEmGV
zNa}a+P{+<q*ED9m`xJLS((2<WgS~V;C^T5gKpes|3XOw(gP!VlKu=TdeNtKVQq$$O
zWL8n57PO2eLMA5Y8w_bk*);OC8hc-#;(6;k3@7ru)rJnPHh(RTIMcvzsf9zd-&9F8
z{EAAAP8)0!T+BI9{iQ(LSgdd&7>+Sb+c4y|<arOao`<auXGKJW>}JWv1~lb+VHB+n
z@(@t(VKl+3{sObcie2+{Z;oEi=3~3;f2rnv>?NqN4*KUoJQZbifbvGTVQWXCh@o0H
zC6(mx8I|Lb$6j<A7PeQ@-*5$5PF*YT*(5Qf9~1LGZ6aqpuN7}y?jQ`k1n2U$JMrN=
zDYL+iphYvDA!$BLP=2GXwni_pUSPXi;^-%t*+m7VoB<GEWnj;C-oPIfS#;W}vkaLk
zurVBGH~TV)ugLveo<LB<IfN~uW3`UF3h?>-Mhj=lTK-=5PZVGLlx`!x@)qG(#pQY-
za)=iljE9a#JpFwtqT)Zj`|-mU&6Z$y<5aA`Go}hP#L54Ur=axNRQ)LIyq4><c7f&P
ziIR0b)0U`CR$?;ZGNL?^b2^aYI1N^U(sRArDwvNakQs{0twM0u(-|YYG+VX*G7=sA
z@kDtIqOk^KtTE9G2&PmtBSas78rd;n_|2YuUhZd%z8&N{)eAqo*?PnbCz%$`J|NV>
z2)fcr0z%jD0O`;tzAQ7DHKqRhZVa0fyi+O~@b%C0J@GMbG}tB%%Pdt{3-ch(U0J>h
z-RG~027DDdzg!*-t-1AGD(#GN-QbX6_YJuA<)Ui)JzaVj5jPjoLf&NiHyB|1<gG@l
zyi5DDze0ALwJ;ZuZ0#Ila^R7yDA{(->h~#s;%C7d`?s%FJUINAs{4h#*ho8&y?7>*
z6M*F>o+oFjJ<(ZtLJZokv$Ac!*h#LN?{h7suQjr7B?$l2It+H=`&7mRbA3EZtm5PO
z3$?yxDgHY?l-*`|>%&<M6!<G)FI1S5Ea<~nN$3lt)tU<Z+U7UY{z%lm{5WgO!*A?C
ziYw%J5V#)CT&NxoENFlJ*EnT55@GH;joHp6kQz{DLE4@gaR1^XNlXV}oy6+0dca@2
zMCUputcBTj^Ja?ZY&*%0qDW_m_#|5Yl^Bdn9BxxRT)D`lbU~>I(WXxx%Y?s<0sc*M
z5IfiV#?ZLyjTG%pPY?Azs1mPWEXjG7c)<M=-<y{p8)*7z`nD(SO&QjdDhPBi7S9nT
z{E?z8nBf0NEgq}gvFiUb^WJ(*W1o;#ptm*3;IV_4u^xu;BBS6Kx*7nXmu*i2;vg)B
z{YGa@C<vOaCP`~)5wS&zfk$+xD)q^NC5}%tZGSah41cqPxYJYh$I(EJMWx%0>Y>Qi
z?(1Bv+5fiLJKLxt@Ogm$I2TXB$w!M|`H&R0QKaX`qiht@Cv<DZ1AY=_US(N)SBMwA
zXK4zX*cm%aPXl>!6w%Wl6Ug_jK3Oxpl+u38rA3Of@`ZULOXkORVMj%JVLZxFF@4gN
zbke-1=wQTpR#umf8K<tn9?ZFL4Z?&IW$A{Fvdbw5m#kVE@dXF(f)1ym%B5XF3$cK9
z_@7g#9S=BUUa8fW+e6AAR9)lzVEB7+TPQC?wsK;5_{dS!Y`UK%w3erT*u9iLc?6>C
zFhTRf_Kk?q2J-wU{LK!EDU?mIjer42Ltz`%)$7%hETUOk3A0Yv<#YI1f$dt+WtGBO
z*(EXsuCMz~ZYh#$mNr@4DbzyxHDSlzLIN2~ICr{g?}wK26D=RPsyH~4DtiV_!IX^;
zHJr%01*<y*ztZK&5&w!eV`e4a(m_aSz4&U-3`3D4&%_}pa$tW`o}3!fa6vxS517%s
zeuHo11lPb7CGsy3EV~jptOkNHkXp8X4|xAl=zaAbb!2S9TM{E6gw7x?w_31d5Rb)@
zU$wgMLdc=2k;jm|>UIB%M}*tJ(fPm&CuM(^n7ZVOwh6s#=<(Rcp~9?@1;ZwchY#_;
z|2=gP?1lC0qllAI@;x_FP|6=<<{S+go_H~`ipksTgU~=-iP#fVu59vm6`fFBHIQU;
zIhwcao-XYHF;Gf}#xb7U*Xn(}?U?YumD$7HC(v95tnS|pg#p~)JW03Xo+UkifH8|D
zQl_h79;Chf*ea|<qQ%QtbI&tUg2zR$+)8Bd`0dY~`w?R^l#C%cMJj1fSrg>dLYQcU
zK-Ef`EK>-xNL~E+WOnQU+}tIC=i7?+riRU%VOOr<=gls{wifKhO&{TsU-rGps&uK8
z?cC{6jv5Qxa4xdO;>WW16^%*@-+&8mgd_895za>!lg?CmBdaZNL%Hx50%9Bm$Wmhh
zEJEt*oZnj}S<1|MUrAz67$&j{{+|2;_C18yrv~p4&my`o+l|eT(sMqTDbtx;rvHBD
zAWne9djm5w5p(dOduxL3akl;1^W;Qe(UXW6riUc9gZ|9D;Se=3@%N33XIO0p+Sd_9
zfmY0`Wt51i#Y(Ldv2l?-r{k$bLexZi6lTxCguS1@u>+Bpg5n|3BfKh}1wCv{dwYur
zLHMz~gyhVb>!>9+^6GoUl3PY_tn#7Bb~#f;ck|2r#TYIQ6uuBW42Oro8X`IYyJsOi
zMy$Wf+o4T_gZl=e4f$N$?+Iq0D`>_IInV_WR9Cvki{5KPbZ8t>BND|$4$!IEcM&z`
zMqYl8m~-13Ooe&>4`U}gIW-~qUEcl#hT)63xP8Epui|$kmXojI)GrvjT&~L7Bjl`>
z=G(RNu(jh&NvDswfL}0x5kA3GTr_x}%%>)(Vl%;4v^zP#3^x+i4%6SGZshs*h*3B2
z;=hv>JO3o{oK;c7ci0d({W`&M?Wh+MohoP_6deUd{NaffgWShyy0!SR92MgL&y3J1
zRSMM#4+t^M+Djgfe*RQ1yM-+GV<~C5JM(x(b(Zv-ZpX_cT<yO(tC_ubd?ZjK9A(gT
z7tv~!$5Y;g>z_cDcU_=CN>GY!ML?3mg|7asmG(oTGPvlY-F7q&B3rlJX^?BHsEaD`
zoQa=JGcjDv84Ub3Pe~W9cLG_`^)E<QWt^vk?QSlT&>5lQYNo^1GeMqQLi9|?1O}9q
z1HCK{_xiln`d=jG^W4)C`P~<Z^qel#MPmB+SlxJj&S?+sqrmp2>nGSfJGb3HP9wpN
zcAf~khtq9@7*~Rkki15>@b+CSrzG^oUORJTb>Z43kXc<n78l#S?lx&&-P+=CbUJhW
z2$Jwna#6{)ungi>DT}K{S+qyZ8U75@0F~;fd>LYN-Gm1mHEP(d%+KJCL6ShtWP=?q
z6Vavoxr3`@_YiPr*SIlGSL<HopXP1LiR57n(OaWzyiRtt#aPHp2KCr}T>t$$WaNd4
z168}`e!}#0UTR=2G0+V^otGULaMdxh+A#0KB?rCyi5h-;&ay3Vqg);srw{C8=-SE8
zeiFTf#deKYkFEOdjzbbec*h)O_Ys)tJF>d;72u`{NL`DL%^d6M9;VMw@6hFESe!Q_
zfwE-KV?kEcSuuy-yzs;Mo{%B9U`0A|I`BO==J@y1-va;~hInyq_{BU%8pfFvThDGU
z_ZNqC#`x?xVdm4{aum>x_2i{IWM?VNywqRAS%=5!wqFfKCRy4CAUW8FVaR&ijj}Tp
zCwC2eVn5l~PMa&KUVVZ}7_dGMck52(-MXNH@xN<YKB7H`t;b|ia#S61_CR=YYEUjQ
z$PGWAmmOrK`ti7`v<)};$-L`Vw7vg@8ApznUg$s8xIewYH^_x+#7#o1y06yx+v%T!
z3bvJoHumhV3f<vbi{#+Z@fZwBoC&hVFL*#eVxfkZfUSG`vy*<TO4jFtRWj+>|CDn<
zrlt3efk2XMr-*yQ4+G&cPiZ;n%ZavHOu{7*XN{+Nz$E#>{z{&wquka-IxW7*Msl&p
z2K!)<1j_G3iXi;sg&6Dk^ESm3ZKvY@x;h~2jR%kO64Hbly%w6hIF%~6fy5fI2RGkD
z@tQ8RlCKtb>Yi!)iRb>G$4w&EwaQdo($}?;8j+`pfF)A%DRjkyyyAiUT?&JTwbz2>
zY$OUoSDXU720~xjJi0YMJSnruObOd4LC||!U^1#eJNp=<`hK_L_fg7fNIp?@0JZ3~
zu;j(r0&|)h9;qQEF&+@B_>6N##hy>aSm^*^-6MZ}T|I7PA*Lb(q$44hNu%G5Lh5-J
ze;R`Ksl*(@TkEzD>)}k286rs_9f)hE_v<Yf=B1GeKJe+8k8CMQ@;3bAuoL1>7h$lT
z(hHeH&<oVK>8TR^v0!D`h0~Jf_u@UC%hZY<1}n&xp8KD~)Yzh*lxuP%h&XmZ7viE5
zCf`a*{RVhxjO_wEMV%R{ssa+fPmfn)?6>=?5-xXVo+|fd{b3;e^4B`LC=HC)s<#|9
z^71IlzWpWcKGXqs?kF84-ez3G6TwSMv}s_`Jvts?ij(aYQfu;FI(+o<tn6pOSMGVi
zFo@o@K0Yzi4{1SAkxh3^sf+|)DRQsGBgb9Xz{q?wmq{mbV;tu<<2WV}Jjnsby72P?
ziscWDE(KKWLj5G&!!oj8EEq@XU>qrvYy9+rQ=#e^VYMxp26!2Hn+*mBYgHaOUV7|e
z1sV#>2Yun^3$r?g?(}3n<lk=#PtdE4^a|F8Aqw6muTbk%`-^tj_g}vdvkyQiUD&RY
zK>3wO*=8TyptoS1+G!dH#)o53<KD=Gl60warz6pCz2@?~*bBh&vn20*Hl?Jzq5y6)
z&noW7AF|Q;EW|C$e8NiI>PD006GnKf$|TLhq&Uc7fgE8Ni!6#<lQuEgI~!UP1v3LI
zQC_#N21V`^TkI?^5NjCc{Q{K2p|*QfG(igO8G>Rhx;pTRTspr031^~^;-IQ|qhMX~
z83v#rk{GCupO()E^f#gV`Iw$|x)g4$L%W)7{5IDVh0gU>2X<QTz&86p&Yoo3muux8
zJ{-+)<_ak3cA)Dt4+Q#3W~wqF-|-|V9jf3HlC1PkMbCM@smfpn=QsRWg7tpZS=S{o
zk=~qt2Veuq(Ly>=?vf}N(%-kkr}f%T&cp_bLr#^xN8@CY_DUC!Mtbcy3P>kPP6Js_
zN|V>mVd3NJ61IeaZbo)RVSG@JKC&?W3{~bz94W&IDWoQJX)J*&A*to%nX_YG87Ofl
zMRcv5WDj(!s881akSGblPgJjbEzhq&W)5Fx>Cz`pWa4*|PvpZ3Oh_GVfdIfq-^!!U
z?TGpYHmbpZx|^i!g8}z#9;ujj>07<_bMS#JKfXs)URvAWAf`v3Jei5;(cc?b@^)t8
zcUHJW_wn-=BiXNnUsl?seVxRbA0O1EkIav6SrWhON4j>p1@>lBd<o{2ouaWee9)$z
zfM9hAwlcfpT~G75glKNi5)1H$;9(Z&bF`&x|E;QycRV$HDn!$7d(D~XmSg`G5#AOa
zkb3bo|1G<DO+~g_cBj6#MHK~z`YL`b_;5`B&$l~0d(5P-Y`cN^(Lnw?iulnW6Hs3L
z+-&g~tF@u<c7@*E8>kOvGZy;{H240iHSiNoH#7qyJ0YU;iptv#7um5pagKuzre63#
zj5V37Bp%n>fGmlxqq?W35fc;beqYo7OG`}rl`cUrT(62jo_9FpG)scbF3&8<fb3El
z2L+r$DgLIVfJbjT4WaM<W6`mZN1F-Oi&JEi!R{MPPe@7n{jto|%HCRI_dQ)B$?8Rp
zK}KY$HI}CUriM=|>z$QuuX2(dyC{V;*tbXeGF631TcQ7oM}1Lzx(q^ZupB&ruj2Bz
zXQ&Sxy+Qc8=xQcdxnGg347-n({xa?EpN46+X?1n(<^nYOQeoapqc0gY|A3;KqlnE0
zz=#*EQaDcgs>EHcK7sOd>5A4$EiRg8@OaS$tXu3QkauDtIR-gSo<PSoiS9Yd*VfBA
z>!8sj!?ZnY6UT?M#vBiB|2|s%+cJV&2NNKBpYBxoi=A5{vi`;DuEX{)-<1BrrhARl
z`ev7X=T@VP$-9Ga_pOEONd#T)Dulq>{7khd!gg<0X-6ZnqD|%;tb8x&Y&=j5k<!_y
z*ISV@?tT+3tl*x^*1LZ?)Mfy(K)&@{?)%3<v|yPe9xJY3`L>dJI5j)p?~*;n{T=N&
zWKt*9{7d0vkExh9-r%T9Ih63Jz;)dI<6E(NJ(6K<w;^D4+9HT1hn%($EyrG<^`=%9
zWxsv@>ZZiDQr%2WO~a%1faHb%%X4^o+}&x5)OgOfj@!$_cwxYT98y8~Lt}tIuxsb=
z%W-#qSq$cAy-*<J_Iw`+O|ZSFA$Ebe?fy!{+{5Bzf(3XMtLj~(ECO}Y5cngXFSrHR
zchu0tJnxmSu3DfLiJ*y|6DpqA=N7(R&huv#PoHt|>qF%Cpg+O;)TMJ=0xt>}NX~I&
z%cTlDr1s2#maU+jbmm7d7sn+W`Yn><5(u~9ZoBNYEZ+3-+c{Ss8j&t7hIQQ$i*&=Y
zbb^!SEYiVupGy&kk9hohHYKfxcFx9?<8t=g#^4=6$|cRTEk$v#(R7f=r)I4%HZ4Mj
z_viF~|9eQ1t#>Pf8n=aD_!rT85gFPV+{p+uu&CUbieE}&G4I|;w-9b`4({anB6z8u
zt#N!ANMx}%<Xa@mB{2?rGh{}va~yRewRelRez;Z8;ER580OXh#D~77-uuSN&zZDNv
zOMnp3)Tw^3&lI$B#ZK8X&cPAOVvT1lxx20VB8$59?N5-*H-Fjem(FxWN(ae(@I~HJ
z;KK0vE(jE$W$Xj9@!bB1wC0iv2L)}_S=>8ZF`5SIuXp~%E-Vqzf3bntA>5w61^TtH
zXS|X>E@uBzb(dI{&j-wESJ1i}a<vN#0jBHeHE*H=yvGlrl(OsD&P|N&?8Yuk5z*aP
zU{P>S@~+-iYf-gkham20hNJX%SI~kR@^_c$3oL4Zz#kWVPNU;2f*=57JI(x1nkt3<
z(`bP9NMrl^yNoK!_f590uJo=zMB_&M;m57FZ=j~!$kg|UDL3Bt#5dF`l8ca9NK+*p
zFV_;gTd8bil0h*1)y49KsJXoYb2Q`-A^qr@{U<~Uq3-Kb{t)h$#FgeQmX}0LU-GHu
z*AuiUOKGFZt1N6HA?1ecl`Ai1f;1~vR`vc&c;6>1P7Qc@a@6p^NSFU>h(gz!9t`ZK
zkwgar*VAVFy620yFT-x8w7}1JpMi@v6WY_?MG{R7-0f#X_wYMB<MIeStxoMdAgt6&
zni#puz?Jovl0+HwU!z`l!jv@UBYM-ic_gy?RlL%kto?);KME}XKjXKk>Cw~DLHnB#
zcz5A;$@%rr9nrN$p3`*3S}?nW7@7csXdwsook%NuHBUKrJQ2_@;hQ`G*81TI^4t<W
ziTtqUHBMRM(83)%<K0o;t!hFOb`Kh5h(oVrS_I3h#CTj&M8kctDv&F}nKTPf2oseH
z*Cf?dohN(kcne4m0a5!|Ek&WyZ@ibqgxe-e-mS7Q?=4(CJBk#8G<B9WI3VY|+C?8j
zOMD?DVqct^oU#+@BYU8HLM!7xg^Tm2YIbea#{#U}<*h8vV*V<by@CHszdKU{<;F!F
z-<C^vor4c)IAchME9c%{hw(tU|0#S*epsg1_LPRbk}}&`-To%D)%Ni}zb|x31OVV1
zv4Ha?JA^lMq=oa?7qFa;4PG*DAwkZpst&_byhXT#mil8PC!*6KWv9}3s$PQOe}*Zc
zO=3Q;X}u3J&MR=V%Hhg4NWyo~NrB@HbOB$lB|k6j7E+w=Bb9yqke5cyXj=-k346Hb
zPLJesSYsHbY|IYIxf&Q%oBI)6DK|N%+XMy6x8W1@)9--C3O{sa(PaW#<9shXUBtZX
zI&wOkrSX|$(wb7j=g|LFZck==e43yM+B8&r+)e5!VeZ$DI;~W9kqThb2-B-e(OW2|
zs$FvPDxl55OF7jWxGIWrmUfXg@fR4=G}fz0RD_ae)?+UWuof={37mP(q2c$6D*>Rb
zh4f3zMK#=ulaCyI2R6mrTDxP^v)k_2?ZJ<=vxpydDG8nNAkTOp$)(W8{o<|p(Qr_$
z>?zWph9Jm|;9qs^@by~ogJOad4IhMgKi%tXOL$~-xo>qOm&NRu#UmNe*t`}zyf_O;
z+#W`eNVWHx*@ybtTmFU}tkj75milm~a_zwHh5<qGK#}_7P8N6Bz|HG?D$CE4xOYWW
zHL~<Q&Vq*$6$7pDlOE6kEvmOG*?a^)Deb_51TLEri+9QQJiIF>YXG}S>17G>(xVVw
zrbWAy<oeN@n)sdig^^sH8uweb&2r!IT426W?r>g{VE_A{F|w!C<^$jTz8^b1>meSL
zC>J!fM5~5PJ+BJ6Z2y(_<B%*)bQHXsupXOyukOG!3U?eT9=(mgVMfIx@mVlsz{b~M
z!RocauPsHxm36VsZ>u4K$9au;5co8Po=)7LiX^IZDvCLjILz09i=$&12-8uU1Iy$P
z(}T}c$|C8R!au^#Z=^bT-+?vE;phFo0Bii%++`Os1Np0vu~J^4YdC7t{b>N<rSfu+
z|6R@9D(|#rW}MK|g}Bj>b?hCGU?m6(q)DE!V4osao%#Zti^UPc8pl0LdeO=s2N=hK
zP@xqW=c|Knl71<;4>ZKwR&gk4{(GWc^a8Uka>Kz}?_}0R<`aYnBZ!92tK7w-1jvxu
zOVN<_+O#|q&8TFY44RI9J*hC+HTHEz_NJti<_@ivgm)8xQ%g^0))V(sFka@0Mzyrt
z2_dzLZzip06V@Mq)_l_l2M4LU#Xd_y<BSg4iTZhbC|J?#+`r3VRg_;!Sn>ZVh3vo^
zF+;z8e+VyWD?e<?k}n~bMY=HOu)0rCJSb8zNFP5dFB24_!k#jzZQC6iIiPhsA?eV|
zGh>S$$RX>XA#0X9UeF<qGFvWGD=#Z>&F=RdVo@Rq5oD4q5B$%Im~7&%SG>Jp*IlgS
z3Md+D3Jhw~5^;=sBkfrQ<rniC&YgDp82o|K?H+i;GfBx!PTJ&<Bw<pXJSmSXEKQx%
zt(6V*mY5A+FO$D1?mWW=vzgFc7o;pbLv&fg7X3>1P?69MC;^Dr<2ClzmEPlFbsr2E
zW~4lQ7|@=NLEFOObj{E@3tnTFXwcGZYDxr`5io+Of><h?MIU|RJZOF@Hhng!Xj9H>
zUtS&OPDrLooeK{@_E`V7Seg7Y3AF-;y!@e01(wvslNbXRF9fhRc~u=>{`WbIf<}Ov
zv`w|W-30OLiRj?xZ#`r*b8qXXi2iFQ*`NMWmsb3|HvIfbRW)SK_$JB7kF7E8Br}-^
zivCF8c9mG)pDWN}^obMX+L0PwzQnrS;3@wW?0mQ)dJ9%^2z)bJQfw>wye3OC9V?5w
zG%lF5t}x0+iawGYUrUn#e%;4vGNpTRhe_Mn1plmk92i(OM*ds01)hMS&1RDutEF^^
zr1nsWPFXs^p@QkxCr@W0`t>scW8aO7E`Iq?FqTqE`t(=F{f7u2JK+s_c>v&jH!270
zBq`}JZyY#-mfBl#lHcs(^5vD;5u;0cLJZumL)$i%todQi&&TJp=8l-NG~YOWCDJm>
zerv^9=$3#qaRWc=v|a1`k=$9cz(EJ-hnzn9S`hF0N8;7wxi%og#uRx49jRPa*(rAC
zZOv&pA>r-Z5uBCoO@A0a>MClXSKyIKs>;vgU3DK|>A1IJ)$^xH6H3|bFSry+<Exem
zX9A8?E~%7@p5U6YvX?rNo7@2|j;}q!wf7Us?J!*p<cU#4SHs@`K9%+x$8X~>nnk8#
zDCMc^y4#}!1_OF-l6DOS2-_OTRTPzrHa$M*{;fyj0ZN$^9V(MVcJd}oezfE9CPn32
zsKOLh?~f}Wj;yyoJ$y&r()LkuR>RW&Xhe+5cJT-5KEY3-+LyjvW@$`h=N_t=B3riI
zsSd)ul*QklvTq;md>>F*oF;L>zkd^oiyHFyD59ewJ0Rv=j;P^*>?nTn?E)9Jr|OyZ
z$CyQ7T*`?VF^>yE+co8f5BP2+`0pw&+b`5>^+$(mz%jKrukG$m69w{ET#CUAHZv-V
zZNHwx>%KRols+4^42WTloca+s-{!lXho2O{QqRHPSj~G7D4>%a$zfF_dQ<$_qM&58
z``A2l15A-ak}X<j;!b4`9nuo2M(jz+N{8o8K<Hw%MbMBOh!4ig#g|KTK0nKmFIMne
zeXBdAZqK>v1loYU0xceA%E~$Xf`G4<{14gjp#EoXC)L$5-!|RdLI^iZO)bvEFA88+
z&%s|9juGaWsnTs{(Ks!!8PHLEKW6m|a#W5yABPx~gQzX&t0z4=Ans$S$SJPS;~xjQ
zDRC6mT>4K7mSSQmRktw**WdgJ?g4SEzptm>ot4$@8Iog$mTpVMq2C*EYH<3xg)SUM
z7aJ)~?&Yc<WRTeC4~RHb`w-$2Y7g!^RL9OjXJ_O;9yaxHKN={u<u}(!t4gWf)*(%M
zz4nfq6*~(WEb7)}u9f-ij)=-B+-G!@&w8;Q@g;*Yc^8zD4&p{e@Mdj++#9jXx8tQF
z8R@5_tlMTF{;Vb%`b;%27}23#vHEmnJvXLqO~z5Fg7u^ElCIt}xVSEC+t2-P+7|VN
z_+%LjHo;9LjQ#G;>uLUiN^k14S6pAH+`=v~<rpalY=rcMz&JnYoSfV|Z+BLu4}T{e
z0US4%OJ43k%;oM4j#crUh}8!rCeb~wGFjF;(m>2GIQcgh)dEM)MN%#5HYOibcQvj1
zFP7%y=atmZf$S2Va<9j0g!#p<<Ra%S&TfF0r<v`WiCljwn;ypF&zt9bm>DRMmzIc_
zzgVgDBE7M$rly7l>gN(l-=bF^wdOFN^<b2$eao)=Fr+yJVU0(s9ny*Z@S{fTrMjDM
zZdm>=6ehg*#MxTzK1MJkOCK?f?t1b90at;c2S@WPRTb{?MmJlcoXytY$Iwh(e~*u@
zh@if<Hkq>Ij6YR6U-glzBek4*78V2DjTed`^7g%u9XS?pkszpW$PQ1}eJ*Wp`R6(a
z2sKy5Lz<Y{6Za@YajiVf)q>5;A07=`Orz+zqmNtrvoYgcK}&AP@h;<aU+#*~Rg$||
zCkVEZT2X@DRz_~h_(G2X5E!y1bFrMp6%peg^sRc>2XjX?=gR<EW$5B7Ux9RHm1Kpd
zsV>5V7m4>_p}N3(&-24NQGGj=toMRY2zNTV6`raJmIN@;jrkP|sTnEwYI7(ZH9fMz
z5Dpj#l~(vA)nfP+yq!V&-HV>SYCM55nDLW1mqZL*P^GK{;1~RSwYWcg-p%cuKqAan
zHOtx;oMwSA!`&~5^yV(qOClt6Gh)rsPlots^C}&_j){F(yW5vYFYiM664R%3zZCS)
z!X6@%@-4a`IA`+yucvU$1rh1wE>sXPea2Pz)ZHt%0Ln~wlcEY21fq_&!-r_{e?=Aq
zv_JqouB7}jtl7G3r#KIHvhA6l5jw)$U<;8&#e;S;xJNsUK1LN#x@~6iOgSsBp2-3~
z)qm?W<{@?(T^gGl3_N6mud9mT%CkFkrG+#-VaMA-dI*9vVcOCij{neo^S)SZUFLh~
z%jg=|F#{(5H<Vf8K{vuD;fmY+Yp{WBpNrAE-S^H?X8Dy5ziq2pF86|Baam)BSQb}l
zL9c2ObnN1VO)x`*3oB=zyRZ#Sz-%O_GhwqAYG63hwzbF0UEx8SuCP+fwbWvp+yAB`
zQ9)j4%IBydL#?B({a)^^Y%*OejiPxPk6U>u9L(`c%og~E^a2HziyDr+Etg<g@?*ER
zc-Pcw&He6c6(#>VWnSFIWPw;>MRBE5xV%=`rYl;%$aWLDxlN)nfh{A<F4BCS_I`@C
z>?>Q{6&Mzt$>8sjvu$`Sg~V5V&`O=W1~)@!LHw~sF+`Wou^lUgn$JE`x?@Fm9YHmg
z>^u6n@Y(|7;-ai{BK}xc!7;A(v42KS^;>>F9OLF)j4Zfzvk2m|Y9{}wL083U-u^88
z<o<pt*vF?uNdbjXmUH4f^e+a2vJ-s9R$>`z+35`&FG}*Mk$&Q3^{%D-A0+z%2Wv8L
z3)ZMcuagUej3K-j4q?{W>HHeUcBA2$@Ac<p?nakMY@P-`X%+I7n`(>N=L1ligmdxS
zUw9rUA>?)*G^T1#Gw$r_SVSoT*=LN9aJ)LqE+QpzSmb~rszfIg;ZR^#9E$QJqdbv3
zWofA6jmE>Sn{hMh&U^W8nCJh*YHrm(`7MfjulItKH)l-cR2r*i`vCf<xTo)tkIia`
zr=ItvFFy+a-2o;Ctt*=WoQYB||D;RPSJNP~{Rs=zZ+V;~%9a=+a&Pc=<e;E<Sg+pJ
zJ{{H}o7t@CXISGY_CAit)WyTrw;7uh7Ye!*A=D>YK8T6d9NLpT{|vh*a3@LgYP9a7
zqAM++qa@&j`dDnd1OJBgra$=3J<_BmuFaQj*MRT2O@VJM1}D(R0!$y#oWU&FdsC}w
z<r%wwH$76gQF+%DM*0%r9Pt=WUR7@bHCZWTk6V%4R<;|$4^IsZi#vN)Hu+U<tOl~J
zZ8WhdWBWdBlbx9lKffnmVVwV&@6RZsr?J}Y(xYQuYNHkLl^`d?s$9gK)BSa_De~I9
z0)L5d?d+iom5iVi*};%a3d`}}EWA*cv*A7;A@!rhyB<jza3;(-s9XVAq&^?9LDSX{
zA9Z25b=^nEY>Tkk^kOqtb)l`b#@3>|Wai4ZiVayOZ9)_Y+;TRHKmIw{^x30B(}Tq=
z?WL>5kAX`oqGigiT?qQb4EHQlEmG$(GS_Z6EQG}*usgKiBb7eRuEIs?)U~-fF|*E8
zXx?tHk>VBIZ?IdRza{=`k~($&l3)Y#bT*c{C=(1->73<~(RWRo_O<n=s(Y&4c?nPV
zM_(F+x+Z#ghK2;K?7|o0byo^B<+Fxf{fvHy`Y`JB=YaH$o@Pt9;4xGG|D;og_Gt$`
z@r5Nt2B91p*(>4Hs?BXV1&3n4&0bJ3nzk<A{u^y#cV=^Og6&eL&#^l_qI^)PU$zTc
zw`N)Nx}6=uIf<<H^+djFBXi&Bsr!6CmZy=koARp{G@+0NJ-YQ@e>O{{@&eZg2kEOI
z+DX7O{3)x94gH!ta=!FfYz5kXGgV^aYm@m~Qy`W6SYS{~r%RWoOIgcc-eX-*28sKT
zYT#kF*aiX#c>9A_1Y5`uw=Shae|Gn0X*N~9<<`ots3UH*gP;lT;%Ntm3<EBPn6PeH
z&6w-_y54$gzS_AoLP(g0?WadPzp^}Hov9MbgG!tVDzQB-VC&ED^PAOEf~}zmQ)|KV
zpTWm71L;?KJhNmpi5D8-{R`E<m&9zV*`l(9c=P?2bzm<#FAqypMbD*mD8q&IMqjJh
zk_&oT?axHWYu7GUJ+I(B<P7;n97^OnHPZ4U3Z9K+l`e`^r;_E5YVi@woKh#XlOXw1
zLYhJ|!Ouu7LI;Rvz3Q4v7*#%?;EB?k3viv8PBTF4^qP2<D8)2Lb}gW=sW;iaw7k-m
zFw~dwP-qdn!%>PWHSrr8CU=?gS!dw*#+fhxEnh?%@D^;#49sC?K7o0Fv)^7t(pS9e
zPM#;^bq?|G^N2S5VxO+a1TUH3=cEp4xjwpnJ<FXlg46hemB-`tDj)?J*XEhGQ&8&8
zQ;}E>W-g~CVcAvUS9nt-O{oEoJC@*t7adQ&#xkQ%re&sln!$26{l)PW28eY?*!9_9
zauaj#p-&M`kBs1EXaK>S+nK(6li(Y(Gp~MIY}X1Ykk5{@*7=bLsW#y1M+P!n{VJHb
z^!vMPI}!RjD*ddnw^Xu%lPcGr%mlAU)99yBr%ut@5)MvLt85f<iGJ30A>t+7*2;!p
z!UD17%S#-+0ZEPju_5kU);W|JU8VrN(azVq?)~#?KYYxLzd53_p;9k)$Kbryl4x;c
zVrj-`tdc{(EzsyxTw*F9zJ{lJx?yjKzxaCjhucrTl$3OXME*dsGWFFK8O`!lMwTV>
zW$Iuj_`V`1KF_Xu($9*Zn_xJ6ul4IIE^7S$J?;q6(ECqC?ADN}LKx(;9RnYiE*;F6
zM|9{at|{_9o8Z1VZ!T6ReyxN)7MhUERdaXD<_Hs6d!y15yKf>Luz!PU>5+-1onM`*
z?aL4x5u62#JO3zRqQMbYQUgMr^F&)-HW&RCb!`)%3yX$d3KjUBX33L*Sh$Q01^{A7
z%cE}2fdS+w2Ucqw&GGc`)m<QUF~GRzDj#AcCW=l<LxYcdhrd&B#XHI=r)pmwwpcYZ
zLj?YMle}#(DE#H4<B)pf|Eqw~cPu7nVQZFDvQCfS16UMHshLF9Ggyf+aADT)o6mAy
zeUTTV$=9YxnP~~c*WAO6$|375j90`jn~}`|kK1-Hj{5<_maE))4@OZ%20Ir=WR=0{
zjuK+cR<4F*REj1IJiC`rzs1-%{DRKP17eVr&I*St)V=jCrTWmv9dJyrK{#6&8fDlQ
zBZlP2vvKejTFuJE%XeIFq!DfbI&^G}Tc&o$9pZAe1<M^GB%RgB2IbmTF`5HsRqTKI
zKasI5tVmM^K*~A%v_QLN?edQ#9w9aPvsZJis^50JJOdr)LW`gtIb@-QF;)D^;g-`-
zE&pg_;aLp5d+g2hfx&>UH%U7O1D4Vz%)CkQq^*JAz^Tq8pzUWRQJGImIr1%VUAf47
z3$b!LbXS|)Zjig^*Lu+Q)QT_AsN>4Az_sNfvn+lrg4~?tA`}BP+MnWbC?XAEqDMbL
zn?Vo{P_0~&Ee9S%o{hT#^w2YtRy*_z^ddBMwg_J&uI5;P&FB?SKT-oqn*CuhFK&sJ
zt{glWQ53Y=lWQN)p-$RqA0TiZnmkRK-C6k;3)qECkr458Jo_s`z=pV*Z-KHQzM24R
zNSiC?Z8(E?1&3mMt5N?}iE~{CWNYn~oWR3ocd~~NV@56XNPJJ}zL=JoC&g}k)xex<
zRk@E5ksJtJY}s+q46bsv$d>}Xys`=i>qXf;)y3~e81-K`5wit*a;R-M2!KvA0S(Px
z*Gm>ycQif~>+9KIv}cCgkkwtr%ZG+BQ%9%f7GZyycVT^gYZg{3wf*GIWxE9&5xr~&
zUDc=#8pouG`p+U$Atcws%xw_6GNVeNS>b0?7d17J9kn#y6Q0Id?6NG~$KiIPeMXp>
zU<u!U+N^H9cu>I5pYZh^6hMwt8$c1j9YkCqcd-N!(`IyQir>E$BVpp-eNMYr`9w48
zrX)rrn>&iQQq#o}MNFG>UAc)GE(*7xN1xxXck^&%cFJD+lEgaZR&>-2S>JVLWzu1e
zm?&au7{I;|-lR`elKo6guHT|*;FJ+MuZmr<!q2Nhqunx2(XtM9(9LK&Cs}%XOk5Zw
zGeY`9;&uG2DkLCW3RkSEdQBZvp+fmf;AB9}8PPIU_-WNvO-8y%k7+ZU#88hDJR$I8
z-F-%yNnjIG&`I+Bo=*?z@AGo=-hHfD)Czur4WW-)!+LngT{y}FlH65ClX3hzz>=$%
zl>e(JT99XCWTftX0&a-u7L&vB8j}s{Pb;@Y<I3B6bXRmvK@KU8^c4-+o5tkn|2*vS
zhhc{{ij{CO(Xt)i%XQqGBmd^uU{L=}vglw?608#Y{tz654{+DtMHKm=q)o;<c1IEE
zHC?DE;?ubcHTFR*`h|r0p0DL7<-<0Z*k@IK%&beMl@G)mL9w^{ZvKpGd(T;!`gE@`
zWK~Z4VL@%0_G{PFTxd6=J&T`WharU6WV^kF33iibw;#$OzhQLH0`Rkb+qKR-&v$KE
zO*6E<$*1y?(uUj0$f2n2!VOKpRd!*ym?z&<S30WJ_|4fi$FkZgD(>*sboN~`SX!JH
z_tl?;0G_m4%Bi<-;Pyn1wngIE2|g1#J#p)d+cgmYHH`Z{hj1JebeuaYb1kx~i!~*A
zzqqrF^Y1@A_3<BRMw=aLxzV+GvX&`-rSzGVP`bU)C-Ay6nyHgU%uqrai6QMUZv0jy
zdk<Tcgw>HIgI4XE4fPDaOjb2Ang8{r7#RwT${f*a6U_FoeDnQ*U??h!X33wKStKVz
z8J7byTacWrnB&`e8s#IGL|e}>Kdnl&Wop%D-`$?*F>BnIb;uKP$kLSF7)+wMa>kav
z_0BuqaWDukK&SjV(b%lVEOJ~ao2Y-5{)QV98inZ1Y`t4CtXaQ@H?_y6C;0E+tt{1~
z1+xZ(O}<?d<+v}qePg}N=qJr$e>wm%b8wOUHGLw^YH_MgU+ry#aS79(Re_9EN>-^_
z<*<T9yR)?NdOOR~QMxPJWomN~|Ng5N6qpSt6%fJyS@DFj1o_?{KgF`7bNKN&vD3T<
z?_uY@5)HGLIzWZjT^sE4%9Ip+8y~8lJKc}kcT^Gx{6{Q+0(a*IjMoGU^nDkNhZ(zR
z=dd;8UG)H#_(8;3^ky!3vm<3~=20*R(VMwSh5Y5ba`$#m3L*E2hyrAGzLGgHj_70;
zQft4<a>)!KB$I0{yR2L9O%pxVU=(mnj+rcM7*nxo3@O86zFRKl&_dUd(pU0~z6ka=
zWDkaP&?+>lHpk)c#`A>cvYZ<8N%jU9+_FAp^kwiGm1DyKx0%cTAb2Tl(`+7=qcvV0
zJ>)6+NxWq!jAtA5z<*Dhv=CdxqBqlBgm)fv;`qy;f+!11`}lV-0Jp_6c)u`I=Utvl
zb;$R!W<!StFwrcPc_mhXl7jARwJ^=zOvZEqw?pijJ(|0ClN}JFrDIiwI=~_emA)+A
zE3mhqeA^|v6ex*if@0>IqKVv=2Pxe^nHAZZrGA%Rs<+YWZ_?Z>4BGvP3}HgTWH;)b
z23^tKDBOL|wTsgPa#&&51|Ck-tYFMG8`Il@qeMiyuFjW;8<c9_f3i9*0+T&W#7|n-
zRXT%ZO<3vK4K(#(pHDiq-k*#V<s=)mW|&}vc?&p`3g*00ZHj;UKsO(@eJJTmUV!#d
z2Woy2OwuISuE-G?)AIxM-$!PC8_XG*H>#^^WfeZ$)3~9NeC9r#l%@p^x%!C(FwrH!
zmW0+8@m)lule<IkGVjRo5}&h%zkQ#sL@()nT%~<qk!D>t*!1+=@{?=;!%@6N?rmaQ
zJXO5b9Gk}*7%YJN&A6^VP=6g2lgitWPFDa%x6?+)!-S)JHk?v<Ht&WbU?lCSKX<_=
zEiXLd<8f8e(Y$#3it~9k-8OmNn1eFnfA7l<&Z_hKB&6bp09;_K)4K}@eSL4bMltp`
zFrz07EJTpIl$LpRXkl5`7=%6o>SxmuOg%NEj<0in`3jmk|7#B)uN)X`t5m8&eb(dU
z8VNNy^5NZ_OG9(9b_}QYR-x-ufndPF70rY>gmFgPRoGF9UTTdO5eY^Y@w|~zIN_1J
z$52rq#1yUvt_XIO9isL2#=>hfL^bNXkIf`zF4U$o@zw0`;BAZu7nwWadprx{%WSqM
zBtAHY2x((a0aV+@>4f}4EZz3A9!drURkJM^RClV!9B`SY$vsyp*=}6W4_&_A%CVXS
zNK7FvejBA@zEwI3GTf!=RQ-v=4jSWJ3=0`2jJY37whtXjLt_ebKBNK{^eR6<ajo0?
z_oPDXPURq{eS$cARDgt--M<+Q=>WFYa?<#!Q!>VU&_kVFQZ#I-xVI|ZChe8admCsH
zcL+Fti6C)|pLw-!*yqG?lZWKZuk0H_KY&iURB_D*e)`AiQbX{Tbw^e{7jN02yYWgf
z<a*fJ$yn_zmZQX<*kZUC59S<Q#lMLebb$!C;2%O2hjrH^ABZ_}(P%wljK@Ekzj)5x
zmN<H^@F)Y~AwmB?j&{dt&Vai26}<pzVI<s>tsctICjiaI7*oF<Hh=OW`Mln~(W0l{
zpq;JqS|kNuH6A7t_jt?y2Zig_j|U;Ugp3PwV^r)5J{h0;su4DKlCu2EsD^g>{p6V%
zmqhN0o$8$#IkMOc&+}U>m9w2tnc)=}IE#9r5EF6*2Ln}~RV~(@F8Ok!t*!cwZU?W-
zttYxGul}8biI%n2>a{*4PO&J(unbopc?XT6M>4l!s+M0tBvBY6lIUa4Mn~CDHz7$3
zX4tbI|3$D>hkZ5tQf#RZIxB?*_U@4W-XMRr_1x>j1L4U6<PSq04uRafUnWO$0sa`l
zRUIERqz^N0k7qB`djC?a{v}x@p-Er3B`!EwNN2RzNA=0`ne6rPun}S(B-U`#>rT=X
zwsp)7p50hipz`kztes_&>L52|R6hgUo>9x~rZa%D{`mKn+plehx>~>W6izT#G-h^6
z?W&B+d#&sR2q)4col95@ONtuXIQf4Q<Y!i45N_ekLBNX}Sb~3A#uDX3f5=2C!vwm_
z0)!s{SL~5W#6zRq9fk?GTu^AweE=>eoMlSvjMu(;T*&KFZ_(Kq_3=}UwIqkEz>^2F
zCN>TYOP?gO*2D)5>jNqt3UAo3l#IMncekmo@_Cz(X_zs1nwMEtOYgv*8g7d^xFcl>
z1vfx*@1G}FUw$%$tc|lr2=h+Zm3daiFjBc&%A1<kUXgE~lw6wBF<?{VM~Am_)yLyT
z8~9@t)8}<-FAle*kPL)M-9GG8qW{ub`Mh{jkuc{(S)OMdZnz2#nw?@(JucY;J+}8z
z%9pGWneh)Q-Y}*c|MR%Y_La#`uL0n5<?6v*_Wsl#&}d<GEFghHCfPnv7$Uqey=}rS
z>S~?SgSr?4^&!S=G__DM@OIdwQ!ETuI1&HiQ0i*r6GPDk3!17|lukG8U=CzSm)V`_
zYLmSd!6N42>nt<dledmiPP%wv``UQu6h!Sv82ue<yc)=-vgBL+43|~E`@o>ih;JdM
zL%GM}Dq7(TyuysrqUMJR>hA~-&fa1MS*EhR#<FtKf8c(sAu8AupntRSK<3jOYKsxN
zI$r!I1E!KCCX{5V7mr|S4Li#;avE;U`FTB04di6{a4hWQZil|;d*#MixyZ5OmG7;-
zL>OKC?-TBTQHMCq_&Ik9M)8a+b{f5!ya_;v*I@Ng0k80)=9%X~F#FV+G@y7of&2v7
zsy@$BQo3AHYEVEzdl)HfulPXOX)Rd(9hrQka?k^L&~`A6tGsl%yc8y|(SD$p^f$Eh
z6zXUyRNs*t9GM&iG#kaAfoAgxYG56<u3dINSZ^`BnlN-~PDDiR#%#lBeoa-!OgKtS
z=`s_N7#;=2jNwQs9%2-(r<mTniy)+3hY<sDMkq%Od=?Tz=}}{y{!65A&p&Og{PxuL
zQD(T&v^;rQp5NC?qQA&x4i=2q<VC9v5s`s3?|p1aEt;u=F1+qubN?8EJ;|D43mrhO
zmi#Q($06$SU1rxkG|Bj-(sGZr?y@;{xs$!R^vUdn#+Fw0rzz$M!>&SY;2(2YJ#kKK
z^#8L8S45q-7OdT^*C27{#9|!Rj$Mw3bJ#k$?t$^%0gWoEd7<XfEfcV2_;B&3n9Ixv
z*j6CT7jHh&GH3{t+d>)V1S<Wq`8KU{!uv{D<%9!=BTfoMZAThRw*eQ@XbpB?jsKvJ
zQlmv853tb(6RG1tx#z4RrX4Gfw`j=Pw<LcGo6r0AoRg!3grOZ`0;%RPAMCM%Y&TXi
zPq8G}ngW^v*m>|ubn|wtT44@cVqOz)>$<MaqOuc`#sekM+W0{n6Abpri-G+W6I?a-
ze*Y?-ldrT}ef|E9MvhBW>*kd8PWI{2S9DjGN{$6<$JXkBvg>JSPBNAD%Cs-*=H3+`
zb$W!+J^lt;6%W*|`&NC@ZOH0~MkyzJLu}^~?5SK+qpX#%|C@_YBJtN;^0E*1*B=2_
zXRgr(u%f+EgA<9ty{t>U#t^q`R^do_1SBPC;h!!@0tfqr)pG-t>uQws5;%)AIsg@d
z>&Vw=5$nIZ7(FyJFBtA&u0ySAP3@3&UY4hKD8W`0h_kA0P0Kgak3Kf}IPkyZ`kEXZ
zXVl4lz{QL46m0pfER(@V8u*7Z;Z8EjeIpVz(Vp1s>E3ur-xy!D>+GtM05ozL2Bk#t
zAQ2AOxL324qM&ernnK3$>SlXX6%9f-qJWbbL1q)y{#fXc?$+zzgxvXB2*r<abBrN1
z#RE8!>5)?D?_%?Elv%9$#92AGtYKWvSsFU&L7t3bFSIyAb&p%jy{;D$smaM$5O%d{
z9<KBa=i)2&6Z9ti`e^rjFd&@iPj6u28u}htq@6O*%X*ixQ>Dyq&X#E4O*)?Ma(5J`
z>UovrZv4r#iPejGTiT>ljLT0bqy~Jo0ARxs#~V?nw>hQNareR%u61EGt9_-P%QWq{
zNL<db*q3c5(E$efCG#Ec?FPM*HIr_N3l8#$*^jrOZHUYH7W>NVB)W<!=CRQt$4l<^
z!OpQi-zpztpk`nMAsJGHDFF(#p0!ubF%VRSW%KS3IqyZDd}H*1?yL__mG6OixJ<U#
zw`?atNl)mY*<aHSeee?3FM6-%`5S4If-qG7#HRC}<kY}$-|t$c@FK}0LR<&rj0cMT
z+y*J^`kbSo3-W)!5m#iUNRt_Hr0W$PH&`&G&yjF3FsTrREu;tKul>ez$}QZ}JiNMh
zB<DXtMk-ynqlDXI!ABnF1eSJ?K)BJ};fpfURpvL)PYDh}_^NFWwIHm6gE=S3e}~AJ
z%WCOzB}xNT?eNaUW|mV;-gwKW6-*i=SwnY4RyIY=<|5>-78Q>d`2^v0Yi2EH%Mqiw
z<oOQvdW#Dy;#YR`vTzH<<=a|}q6`EB7|8>3aJP4&tc<h%$^9E-^*Vn%sDsJ|fW;f{
zHdA&-xqd?%!)o(yM=;Jhnwt&xIax8=a~IRt`JG*nr{YCfoO9WkFqIk$xYeE<Cd76u
zU)3^1j}{$V<*5PS&-S;9V1i}j!Z0T}V>(tiY}PM2_;ThcrhZ}j(}*alU}YYl(*hz<
zPENGtN9J@|SS(MW5($Fxl~*IT6tH{;#);qi8H!ikH`9%cX14v5KE<}DUhXyywM7P(
zijUu%e|?s;dY)t|%9u3zM8z=>bPiUpaqoa=`pbIq91uPS=A}bkHnW6W0c7<`N7tVw
zMmaIcg*v(<PLJlMPn9hE(J?sJD}7mGcI-Srwtrh-Q(%w?s9h?He&ekFkE=6}hid;H
z|JX(tTe4?qLy3_rMYgmeq)?GT2-%XQ7>qTAQp8l&l6}jbGPX!avhPDl_T5;<@_Ws6
z@8|RR{{FZ<?!8Vk=ZrJ&^L}m5C+y-sqNn?p)tx$-?gpJzHXf!zw6`axmPnKk$JL13
z{!&j-e)5$qlZD_X+3_dHZ`TH?@}R#lkSubw(AyRO6Cw%|GY6Z6qm`Z&_y|xou^(qw
zzrPa;3ZI4UJaX@j8$4TQZ~H+r_nSea5`WZ!wKD{v?v)!GpUBh;>)gtml>)GBcq5yt
z#r3(CeL7G7e9BO@Hm01+BIRTZkn8Qz;ezCMJi+)fk;`pqn;{$FH&?RqzGo3BqzZh?
zqTSpGU}TK)s}QKuA$QRN1+O4}<Z@m6y16|@cm|if+f{!l%j4<>JpMSd(bhG~av~NR
zCA&m@t9dJBGytc)z#{5v<PP7ueNAFW3lC)gvC1MRSP09(Ol`cvS{R&b;*3tOAW3`Q
zW10KmB06^;Xu`g3A(*M2S6Bdpy8+da5AT1hxyA01`JlcwO6g}?4aoDh2$&6iSk9Z&
zlV&|7DCj9Waxyh*uiUL9N~L{x$_$_6J(4`j&{<*m9ySo<YsSt&6Ey*_W;meNN_c_L
zqTU}>ds0zRH}S<{Lj>#laZzMVkqL{M4rzu6(Eu7=f0`j09B0;OyV|V?);WD;?5Mhq
zlb{-ZyHMFV0F4&_XxvP+w@`UECW7pkc04_?`bA}s<GfZX%eJ{YO*t=ikcG<)9XWfs
zQGX(E@&ZmPQ6=72l*e58rHnHD4%`+tn6;ll2AG2*f%spA1{nINLgxXxWBpaG`>l7#
zkWyedxlzLlnxuo!40mzO&7V_a4U%|;jG7=gdV4%z{w(}``jIe7Bkn+ZlCF^5z+)#!
zrR(A2E@XtA;UJ8&0GAH?EXesqp^c*A8I+(4r%sFTJr$0^J1?RR-#5nn_Z9X4`Ip2w
z*n@}cG=u6^FWr&x)-c7cv}s99ToU$KG|Z(jC$gRV^j^fo7$)S^MJ|)>cTq7{R6EjF
z09l-9E$x*K1s|YxukTQGT!MmTbIGU~g@x*ki5vEL_UUPW(Oh6I8L|yG^8q!IXD_OS
z4)CIE8cB6beY^nZA3e{Sps3)Hl5R?udUJKnf&*-T%Q<M>d_pML0JBycyY9h#gf<<#
zf;`%TjEGXZL^j!f0kaG-LL^YC(hiHiP%XQ;ULPWoZFqZgH}C%GJwN{R<_-WGBq<8*
zYZtI~Xph>i8+GhXI~DKmrhU_OQ;G~DRX&MQYsqb=(rSLgD^&(9LY6KpO(+Heg@*6j
zwnCwX_h0!XuDep>M39PXzk9e5JN`s<u<nAngNNpt`q7@ZYT}mpb1$oQp3lJnJMSKD
z$9C)t=L0mQCj={+`sL~)0E|zg*GaKrJs2-rzl$@@g=tZcpvben*~ppt`mFkd&1Kqk
zZNla|ro~ub)CZ7sKRyJqD>lqNip9KDlV#5*$tv>mIgq!k9$Hp?>3{d$twUNBXpP|9
zDp}oQGY4oJVpt$zI{vR~6531v)X^Gl_x-#`=!Aszn`s6L&WayYs$$nLr>6qL?P9`o
ze|`M0(2X+VdED#X2>VhgKBjE+dRHtgvFE1RqmP?*%(t18IysrT+KmXncJqMNm6jwd
zbef;iSeK;;h-*!Y9O5UO7^F<NQpvpPcCWRO{Y`|K-%KU3Fm7#GT(Q~q?rg|noDhe*
zs7-f(xPcdcJ!OyYh}O%m2rm(To9HxK3RXm48{%OQU@VSU>8vUrr&2Ed9&qK6lhcLX
z*|-^2^4$YV>fyrH6wZ<xnp_UX60>uIP|H{~l6Yz*L7FgksmaWRc<2|FAB!dvVu6Ey
zju;sEbrtkz2|D*Nh*Sb&^sI>$brLLL*qh%+PfTraAU`0?u;~DQklq~2d7agh{sEI0
zD1yjeO%O7^g<7pWwxrVDxg-Ao&3Ul2QFhfjB^qE|xk8Hn2UvBuws?Ba@eg~CMkfa`
zR$?oO6E1&K3QYh$*9Y?`!<c90yws$vAc~LX=%?k&=X9=^sju^3)?>hql(YzmS8V>-
zBHX(QHz)bK`^NK6{2VQh0<KY<&zy<aePX~6;FGqnC4zUH@e?+IN!9Ghbk9`Td=b3*
zm379I)&Uz*>AsQ2(?u?PrJZDy3Jsbd$X+gwF{#?*A#TRNCN>F%d)>~1p6Z-<=`oQ8
zZi(d|UwR7{s0iuVQXQ8{Fo{@(6#A6E|Afn_$nF$sIQ#LP+v1n%uZ0ZL&I>bO0rO+&
zgV_sG?DWMQ&_uM0etOAW*fD{HWWq-2+6Dwv&}OhL^}W$2jM?OUkN>qIPX=hT+xPdG
z{hyy_`h^V*y4)Ijk$kvzkhM=Ii~_^kk|JzLfk*a%tzTH5h~o&jEn9!n;@z-`;r@8s
zwiIDIhie%~@_v%b4<@5N8IV&6(KK|DG+KUZe>d{(0puL^LFad2z4DeW@)cR^$9%&5
z1HRm6m@|P7Q2ahH49P}iS$f|mv%fzf(IDH-ivU98zmZ7PM5m(S_P9oU3RY=0p^U*p
zh30L}8}4l9mA`1h8zQ6GU8{5ZI;B3maI)5)p=&1P$LT=J7dC4SJ4OG;<j1;OLX*}^
z{1G3?YXWgs7@8A|)Sd+pRX7NpykPs9&w(EE_sm2allP>Mtr9IH$^(rHh=pEbn6_7{
zrj!mEuK7G=)65z6&Ob|kt;i7Cy=;5zuO>p&Jw;D6`LXI|+mcCOG`>OX(I-6|)U6s;
z5~>N1`T(ryFVlj=ji`mX#mZ&gV^Iser-zJx)nBq6{Dk@X!~7lU#i>sFq-C)Wioj81
z0Y>|p!fw@F4+8C^TZ7(fJiJ}9#SL9KFwyLD%vsduH5znV6a5!9rsYy0>r)|Jas$>t
z?2AcDewo2(`V0NDiY|n2o`8#A0@R`h#{j(5V(8<QbB-@J`Wf*RmFs7i$96kXB~uh{
z7o>fx@>P38`^E!2e8lOH53l&Q1ur7&OV{g5FUb%h!oMe6gj5%3@C4<oYxW+84(Odx
zc5q3AJ1<253LYy65^z*KWB*t9ms1TcSM_*#mo3W6deqkyFzY4o<)OfYlCbE(1ASF(
zNwr)u%ExxjFf(WTms#(sN)9A-mi<^?K1e<nlN!ufHLdg;-lLmA0*G{ikk;vkB-f{`
zy!tHz-d@`?VNMcUNHy<+*uLQc|9MBkyd#&^KM_=ERk4ZSU@bzj?0mO8;++tU;Mx#i
zD_#zJQ-%<v^@rPI&-ynCp>mNZn>reX&NNzT&6&$851RYy-7Y2C=$t*NlB|hWtv_S;
z`9CnaM&UC$o`q9G`u=T$v~>Kq{^6d3=B=*R)G7QH>i|kUJM^WSp7B?P$DRznYd97(
z->UZBQ?L%#853kRpqQT6mBq4mGBCj1zhJM93O(u^20UD+Kj0R*G3$-=)Yf8Ip~=9=
ziy$%7R~;-)V-FMu-N;&_u^6>dA8EMGW1A?Igw+?^r(@ix{)3k8|Nhj-JJ-g!XMT$D
zUNNHZY#!HPzO{ae-0+`Q@4J6_xDEMw2wWE<?T!%t@v@1YNW4<D_ShNwTl^RKZPPDi
z0Z7l*-+nqb$4Yk3&{0&jZP5P-6j5rw02Lyaw$Ip*P&eBJTX7>+^q?qhxYBK=z++hM
z?7WSC_WY1B&`B&Qy~-hv&t~A;>%U)%Ty(@1vr?R=+e&!c2c#bo!%58w#g@>JRFrXU
z*2<5El&+x8Qb5dY9D&Ba>@MEn9Mfbk#?ni)Hc#~vFZf4X)hA3!0$v--O(_GmV@Xez
zVZ#_x;N(GTGpDEeEMPW<xzX6?cNWwNMT$9qW3vm)r~Z8xf<wN&nSy{=mS#gH=bx9^
zy0{MZH#mepn*9}<<lY~F21m?g@2<nH)zFmTPZnXRGcj&1&*0o2h=103PBfYswm)|?
zJ;}j!=j3|3sC6V^8#+M}Q{WI^2_M6E=$<=Vu;bCDwRNG9zT7;2SG4;d9Nw}=7qyyZ
zp5SU|oK-@%u70#816eh#H$f?cC9F&3b?c3-ihFGlJ+~8Ff7M4jY7|>&O4rSD?TeW%
zm_O4zWCPn7?FXB$FRlOjxk{u6UF+tEA3L0mDmpprF5upx`*2k6xTR}wJ!ElP6SlU<
zX;1r!eo!>AEzAFIR+z6ieS2NA*`DdNhh}czMySdPc~wuuxN?U;>06sG9DEPykn`6)
zj&T&`1#lg{F5?N?>NMY-?TKHLl(%E%@6dZy4Vno2yWPR2Jt@h%KGZ$gPsQ)ISNiQN
zFFgMHW^HQsEvhblGGCo#8$F$WXP)ciht?_BJlpEg>_Fv`dCiz5;yiOt*)iLXw>t6{
zcw3#09pJHAjXI`$I|Ux&Dh!)&T4?gtDug>?3`MSO`6D@Zc#({j3}yo6xRT%Rz!;-K
zM>$BbigNA^=C~hE_<95tKgne}KG4vqSKD`}lmyk9f<Jzglg~-m@u7grcT%*IF8}g9
zboBVJ8M6Pee{_+h8^!SBH}cD!@*!NTr<vAk(Nl1^f75~V>8rnKsH+(BhobS?z3PZS
zG|nOb5ds`$^EYAKC2+sJx$dF<EGnUn>%9bHfHH-O2ri<X8qFP+)@8dusEIhWe0^j-
zHZ8b$ruoSP<WZl3FIlFVrdE>?CDY8cd=OV6CCf_p!J+i3-se%i)xWjG5GDaWZ~!1!
zi;f>9g|JqSI()2QqklV~;=8}J@xphgg^^Tbbmpt(Tj}WTCz)pU<y(kcJ$GzxL$E_E
zTHN*Plio6l4q>%we!*av`m3K;|9A#C>dXZ<!-X1x&4uQyo(u^k1ymbX%V;pvYI378
z19py{EmffHSbsiq_*7&&GqYt$?JQ&lZWEEUUtX*4kXz25thLpfs)P`iu}=(UogJH+
zAK{mkAyoJ?O*Y352aY7OBhwih5ep$NCrf5KXv9k^5<?l3`{t;0bEaSP;^FM^GS9g(
z@1GY~-LIIuue6WpF%*H5ecZ3|-dm24*|rMuTUO>15wJLTpd-F~*9%qt)d2i}^pogi
z4mV1zC-80nD7%#SG#F<r3Sc_}jcMO-3_XJg)MG<V2bm28KJgxNtZg9YkpPeJRan+8
ziQaRMWa;H;(i_X1oju=LJw9a~mlU{=%yzC-<AdsZi(7ObwrOd_eqDXm_HAp|em)=0
zaJ5InBAppOH95mY16=Fw*VaE|A8LBsJM#&A!F+pVHrV*od}-%FI}Fa@B-82E{2wQV
zi*@ie*?T@kYwWzqgR0kd-NOyu<lVNOJP;|U8O`sNw0Wok-An>(9UzPPwkEzp&ho6&
zTnW?PHISVRY0}a`xAtB6q6d&1fu#(gnB_XOE=T2>{^tJB#CS`HCN4PNv_c#TxSpG;
z{4(l_icpvMOcn+dhZD&ghxFAxazU-r6m!&-S0dnj;~MX%YzG}z4`y)&4J`ep#mY5C
z4YlY>`mLlky^o5sUv4(h9aG*jaYid~jD9f|yROYOidKoPJR?rCQt@oOUiG8E$;ha{
z(~v)!q2!Njh}&)SWNr2t^s}uAg6W%T>1s9!HIDG>VpaF!#8@|Cv0K_eA6Mz9q+dPN
zaCjypVta39xV!oy@hAI1j;cMsWBQ*=)xsTnNn%&(Lt%Uaox5FZ`bgpF4mV#8UnY?_
z)HJ*ahM}FFTZi3H#-F*5%^$v6$64oW>qaf*QifSskKnP~I%*liB98KD50Bv08D{)O
z;XdpXIQ3N@9ewv+XvRCabWj;q%OxL{Q*o=Nm$ucLg$GjU@II?_+M35~Eo@*V4fv{9
zEmuw7uF0iiA5iTDj7^dLA<&Gx2#0)N1A<Y9KsUz3h8IyXM=};wF2g#=nyjvzgb0!7
zE=xd(ec&$oRi0hw?Em1jv8`{qKfgWB=q;@BYQD1c6Y4T~F5A0L-1uhgQa%0AeETcI
zj%}K>np?Gwv~3#AbcEpBt~OB7zNOg{L^XvpbLq&a$yKAoBvy?S9OSHSHqr1*T=$jP
zRYZwlSem(x%BU4pW%Ec>I(gUn4qQ>@i29+d1N8~N-q^}h8rzGS>rF@e_VrafhREGW
z)}fWgc$A>FePR&#&HNwd<Dw?H$;$6WO5+iSUbezh98rU95P56<$15o^iK#!QKiJqH
z>fs`h0ES(<cl!dj{}z;Jzp<~N1GlS({ZTKftX{jak6H=2E`HHyHplfUR-LLwENRj;
z>$4QSJp|dT*X%#oTva2ZNMxWJ_)((mLbQJqJ(H=h*6^F%eAZqrwe@0r-Y;7G;|8xO
zt+y}d_tE}u@FB-tZ&p<XN|#qNoDTz!4Sq*xt%mc+RMsh0TA$_yq`WT+9urO05l~FI
z-E@)Bvf!JiEX=?E>jQp}?#q&qxV<UWN^3993_YgpF!LOFER^^&j3}$I$+KJSH57wF
zG-DZLQ<)Nu_~O2v&`%l7EP4Xr>|amv%S5SWKlv7iJriQ}wC-yB<&);GWaDW&qN~X~
zL~sgI1;~whxj5UNNEQcgTAt}<JjhIWuc>eHU?5PFN@95gV^u%XjO*o~5IQ3uGv0_`
zu8)?3793s(^VXye`tFfk!Syw619w>EvdP#k?}?DT7Wv_H3no~q%lY(Am=9l@_;!j_
zQ0H5{rzrAap+D_MGj%c#hTH`jTo?ko@dvJA;*skw$J%;<5&|gj&hAxrRns`{&YwqE
z&H-xqp^3NQBV%g)S`-zOb$d61dH%19aKp8gZnTx^MiO460OD;T3q81CIx?%K%=!zw
z4GwxKNvY)lOF4w49IiO$Llo=A`tsyhNJO2@-~zo4nPZ|*^p*<&kizb86acf{D<z_a
zz_8}@d18#gTvjnrO~<6v=zosjC{Rj_Gl0j<CZjI9tb|D1ZkTD>Ay6{e|9O!DC8GV)
zDF9i&4~2`3Pk_>!IX24~qOxBm6r`X$;gWR99S}I@K4%JKT)+4(PXi2SRDT$BG3K;z
z&pt>?R8eY9o4JeYeY+&?$9JlMN=cidA2b2noK<H9v-qI#k>=_^l;;`SW84z`F>ci0
z-n*ZEuwQ>wZuF9SUd^uO5l_eyf`I3*fXQF>MPzyDdO5g$D_Gt0Z0j?<UstF*Iro&w
zQmAxVSoI0P|8;l4kY%w-&)C3lT;i76G$fOvUc#UUfM%ib3TiMjj+CP8z}jko;bz6%
zx5zsdK{AG%Nl7vVe`o1I<_7JQ(VeSF(gi<oyz-ni%eS9OMDS7P<X@Y63-%`Xs6&Nu
zbFw#L4LVh_x_B;76c@dxI16tdf|St}P?f!Q8LT~50<Fa}hT|s(8c1$5jC`hN)J2e#
zS$t?nbPSkvOo6FgHxGij*w56*=f0drgt<B&_j?tyCIB#bL8xV|Dafime))t{ec^M2
zjq9X`tT~B(_))Yl{ZQ4K0&%T`slN2tLa*{=IF~(HBMwC56|?bTorw5X$5>aP+n;hw
zBmFN)D=dfW<zLz!2P~X>@BoQ2_mKV$sVR`THX37pOL9f$MMBV*iDi0H#4FM0{}h1~
z_xFDjS-t*v4gldx+^&SoZ!QddN*I^ZX}A`RoL4e8%@Kz@2R&d9hxV}!Smu5XCCu3e
zIL9*DS2j&KfHKjfkIs!|p~fOQ`h?Ssw;2!m$vaI4x6g!~HeS=1JL<wzUqr_<6FvPm
zDI=-&fG8pqcx2q?`aPq${-lLBxYlZdin)s&uYUPk(<%zulR^=Psf2oapZ-+VGr?yr
z@q(d|Ok3|~UoYxY7YmWw2D26fMe?dA<P7q&D3o(@X;POEYV*`L{%p$Q{Xva-Yygn6
zHRIXqzi{KLX~n-G0uQjNR~Mq%jIk4vTq$`;%TfSQ{!{2_2~R0UHlDjl_ey*K5BhP0
z`5I>7ANF?IVPn1tTJ7J=Id~TrfYZsHdS+0VE9%o33-zFlBU*_bW>?dfdLx?QX*o$N
zyS?=$1UfvJ`l<Qd<xZwH<I5W$PaPC;D$NnSx6{@5O1Am-`(K{W9O2DJqHM}A<VpIO
zEI`;5+GF0|geP8o?w&z0+Hf;IHyHm%4H^5)WpRDVdqXA5bEhsE9{C9u(JeQgDyu(<
z<&MkSXrTbQ0W@v}pz+cTLswP9JD=rl*-k^Day@en3rmKfo9fK|%wcSa#Xa~YmFwpr
zp=<aj4Bq|sLVyI=cD@oTdhd0Dz&_MagO=UPzhC!GCTqgu8pw#w|Jco@q%iY7AAE0}
zoRppbDu0wKJnzkdotmkS4VF8cJ=a|v#pB}g<f$32Ikr=tFu(C>0V*ni(auf-rM$mB
zzJLGA&_E2OD<>+J6{fhN`(O=%sHGNaMJ42P;?U-UTWTeS@Brcd_9)tHWHogo^5!3w
zyzk1Cq6+i%c=W{QG(o}BA^xb(hRUpCXLK?V6vx!Z7GASNPXeWsbUb>aD2!AeQnE*A
zx9+t!c#Vyerr(rmQyUx-3x|L}wsL7KBzi^^nq6w!9hwRmE%(S?rLW7TR4?xMjI2BW
zPB^7KZDnF_pCI|}$2CxE$JVk(<&Y_vAbZSxA2TwjoZyS(qajTi6jW4gY!g(+d)(iB
zc8+C*0s#O0-J5d4TGuO_-#h+-T@0_k$`cn+u^miY=%MS<(6wUSy;(E01l+oKh2NI9
z55ZT)LF~=#mm!5!T5Os34MO%mHZWSDs*gTxP)kxHB&40>fS}^hA8sKm76r*}`+3~<
z{}2RB{BN{QWF=zp{7J?am7*r>&|4sNYw)@lYLs2#qZSk|wNL(azarKpO9r49;;umA
zG|ynqTG%@^KU}Zo6`+&weWu>9RLQIQwv1JzTE%Bl{kg*>DsGIf%jAdn>BfrpaIbFH
z(66(I`WbvB+Yji^w<~>(*eZ}bj~C+i+W*dx&ly%-PYAxYXv;)GP`Am;d%i|MtD&?k
zqVQpXUW!|(1a5-?vsFXC!jj|*$_Y%w)bSRNJz!vd>pOn~8W_)^Y8+~J;8dFb`exx&
zY+h8Rw9h&_tW~tdSl6T+hF|%Yg$nrm{ymqv*;80~C!v#T>vTDVrMA%BLADdOEH`!1
zhb7C;B4CptTJ6I1-_Gw9W#M~1^<cgpffBZcT9<z1a25ui<V(}3w;|)?v^mipn&HP4
z6!cl|fY=-i4^uGTcLPXgJ5;}&$RtgS<6a9G^KNK~>BPFI+kNJYLvOV3Lc#USpC~r}
z*W}-8z$$;5;5NjS>T~zZ#MBAsh{LS^r2ie3j*UFlNglml8xf%`ee)0<kI|qpQb&+}
zh_a?)7sN-%uWMN;9hKJbF0*HY4omgr>hP8A(%*Q?TfO>b&iih_+}UN7ob+=mDt!0v
z-@2v7dFpGW-tSY-3SQ*>Wv+)oKN_WYeFQ603;30xJs{OZ2~(SGN_c(x!?+yKZ)WTu
zBAb~wJS-@9Jf{9cjYA?htxkOz_WI#jaiV%<f4Q&~D);=M^b5PwOk8liM)j2G->a~e
zvOWOstbvO1&M@>UG^`!er1>t)t;$h&rA&7l$_b|Eja**nk2=_0xHShQ{3bmQyAn!-
z18w;$b{j`29aI~+vCv7dzq_z+qq7X7yFA$QG>ZtRk9{i7+GsJfRM;NVU)o<;+)d>d
z&JNh{6=U{%gf>f+o87Z2(sO5TyMUQP1uD$f9i87ZQbIc4RAE|t!k=0S^kL=soR{6{
zyXa?Ay}SF2e<9i5*ZqbCx$(4jD55=>LH$ObHWhL%r?Ij-L-;JpF+TrcToM<Tn}AHZ
zK|2NX<n>jtLausw_sawyd0%-aQ{x`~HBjcwO5T6M-TvC|Q2|3XeALlC-P&BH@HUql
zU0&(s;mY3=<>+N@iniabjzUq1fPa4qBtfNXqp9^3y9Uo9QGHPpwMCpsmtpfX`Hm?w
zR)586tnOO`xA@?&j+-`J5Gpl|zxJ~({MUa@<5hxD-0tw{j)_9(Mw2uTM&X5R5RKcd
zRHaXrSwfN*zoDLHi%T@SZn%}p31#LnbDcYB>b>=?U_*&4ob!4RFlFrqP4&#)E^CL|
ztGEX<8Fh#a^b>5ik)2IIkbu*;3|JJtp*NLY{JEorw{YyAQ?kgAY`YW&SK`y%1XltW
z^adAp<?Lt2<39#QSFa3T44H&NNI|SmZxa`laXuqgTcz8>*VyqTgYv5~*`=lp+`$=Z
zB59Gnzsc77Mt76Fx2%DObI&;2yy(u2_sX0F=vDY6!{Hr(ydok`W96pO!1rXH;aZh-
zd5VS!aaTLDyuOEQH6<7KpJJGGvC4_+Si{!mL#x{O_^k)~t<h1i$@|_@T5+lxU>^Xc
zDv8bB16>tUUirR(ECOyj5fbvxQ01{cgH2FLhUxZ(r>{;Nj~@z*Ww<)+maAf+ffjsl
z3*Lfi^wl7?NAs?z#Ls$Pxiyz$L_$OvOh3X)alz*u{ArC)szZV0u%AW}3xz*HVY6<d
z)*nCJ0aiXCeM;wmBEdRfLCO|jI7O~Ci<bVGLhr(_sK6Y+v=2q)bC^t3{xZB^H$eUl
zgx%WD9nY*y5yanFgG*1cl?u<^UcQRl?7k%WM=fPF<KP8l(&H#Mr?aI+XSB#J;juz&
z{m~YGTBH@@H_KQ<Q2B&uDoQcDi}4t+k4j1^^AD@_oMq6-J*Kp7H!mAVvc`~Iairf5
z`(h2r!vKQ4G9?r<<8PvXw?-H{ihQ5~1}9_bO4dQa*L1ZlqyNCm4F`M8i$6!zzC6MY
zkX9*U&X{di+$PA|Vhy)bYKMR~b1A!IKkd=p96;z*G;9DJiM$a@w~SWns6=g?kFrs!
zNeerRtIibHm$AfcSrg%}Z~cBqinS<YKT^E-wmv@S>(6n3Dc|@zTKJb<__$HTL6iH)
zR7W^X;T<5IDjDt3ul$*XVbZS*m`n>Mo$W-+yHwK7-c}rE`<$XehF{BW3Iw@u&i7E&
z7IV4CXVmJFytk<zOr4D-vGC&#RkTLQm~5=TRIv?aTMM_z{aj7i&}(o&4pTA{OcErQ
z1hC^{KGRsKJ%y3I<3JCm$7A*_y$$c&%)B`SL;u1rEUJ<|_RCw@A~NrsW%!)8_R|;u
zb&){baCyQ`A~R2~Rxh|$CDDnf=yb=hP&bS8*I;xIpf_b)^;VN#-rV5}n%IrJEORiB
zQb*8&Y61l<mZ`jw8Nxy~;y%w8gxXGrEfp|A`5AX%D2<MWYvZ==G*N+G-c{yOY!bE-
z2GknBp{g}zN+E~r)2f}N|CXEYc?R=UP2c@k2I@#3T~OY080q8oASXRDdY3CzewG&R
zyF$>MqY>DjOPKFOjATJKv)D%Yhr^cSu^B~$IseJ~DEv^a&YnH3fL@!NG6Qm&RymN(
zXD<@VU|xFJ!LH7qPcD+4xjfk@vSPByj5V_2aRG>tim^&QS#DB^F#&YQbC=lL^UN6f
zvj{Vti2f`}l+`1wLp<W{_~WE3G#~UN9C82OpBD59e<L2bYSqWz;E%6(K6-{Zx;$XU
zkVvw}%@`J`sMr`~eB$amZ`Ai9FzX(!-H{VF-o#jL>@%1}Q*L~DbvfyJu#l?lVS~<A
zp8nY#7kKWZa3HPcD`5I_6hX`y_x8$8KK+ZQTq!AFzSpmi?pT>Ui-fo63~&@0|9%V-
zSg-u#%z5q;_D0pCNoFiEWr{fHX$i{PsOhE-#!awc0$Ze%4l2&8lznHA@rjtYUSizr
zT@@1k+8HZVwI)C*!<b;L+aI~UO*mTql$me2jaKV6@Ba+PX*6`Caml8B+_UUt{j=?<
z&n3Ol>77LC3{zV-=nRsVHCkFT+Jz;F&JG4PUa=Ex3>Vga45C=G^T6{$o1K?T1$IB0
zU33_}Cuu6cIAE{12@^CiUy(n%u?u%-es=3`79CAe;i^RDB3~Z}s%GSnxG8QAFc@B7
z==-u#R9}v&*J^CPdzEpdYV)nZ2lXj$eW;uEQ{J=H>sP$tTVQ##)gs0JhrcOZ%=Gr^
zSH1RVjm`SX-e>^JJX`AxUItL?uV9tNGGY&(b|5(sMi>b$*jEsV{0F5!EeZFNv!c1&
zJiHa6nN3yv%KUFCNq+^gFm=$E!_}{=pfD@vYi7IuwSb{QT(wY?P)8nlvYW0WFKXj*
z<M&q{9xsX=Jn=x&Oh+Z9*)=5j4jNYqC;7&Ae1GyZ?={)r-9U!bl`u3S&_K!y-!h_P
zi&-tsW3<JH&%jrOy!+<Y?qsX>+y#-)YI#0&jdcgcnJEHk1u-*~;^VObbScb}BF}ue
zvPd2o<<r3Mi@)ji-^o270xxP1)7Xmf9;)|ckZ&3E=Y<0o+=(zax8N=dqlXbsb5*7f
z+O=}*JyA~LkSQbO2QIn)%UB8JCv7C%$jVCjQTz}``KP-0p&}q)lriisgeTBBr#Yp2
zvtqnRnX#Q^yzLFA+J`sEf%ESF8O!5S*f6I}dt6ez!C~&<1AWHsc`(^$yc&~O*<C>-
zc7$4g+4#AwQdpM$l~iPcu(;T-x=$>NBr?gh_!r?lGzSQ8*asDQYr`b$9aaPP3;3Zg
z4}p1C@Rxa4uu6Un4gZ1IEaB0QWe=S8{W@m3_)Sww)2RP7m73R2-U4b~*33k1!`Vx8
z1vw@sISShgqM)*$HF?RekaMSEa%+3+ZK&ajLIq~3M&~XIif1%Pwon}iQpFX3mKdun
zg;NFFQrxdV&g%@0Qb+cG=2ofI#dp;LxXrqoaxtrvi-~?`F!ggx;iOE({Z{AS<~l|v
zA3f(E0DQBDwe$MAcQ55c__L<vy|X4@CcE)f^K+)Cl?Zsego5<u@W+DE&CQBw%DF^q
zklY@O*QC;DK26zuE|HL@yC$4;>=xx?^P3oo+0NVM<$pVS@orPy%VH}$=2UsQzl^d7
z?2*;hDR>Fu8fCU0raz8u1K3(LsX?PK?DcKF8=UF`Hd0$>ntfwn@^dr}JE2X}7JFgC
zp>u3%j4;sYVzG4oQpwt`D0%N7tJMijfIPOv(x#xFE%y?f0q{b!?)UVB2aiN66VlwP
zo9A*q_F2`&b7!B!RU5mnC#rBQ!ovIe+wAu_Ma4_Urqh<yk5<#dk!RN)3fv-nLxZ<s
z|I%B0a>>2IdwF0SsNoL1eoQ$x?t=gGgH(SXzy{8Mh-m1OlT+VV`xbBzUEebdFj{(5
zuw3pdS)z!6hGM}U_iXiY!_y<mXa_U*{HMy1CfPsZHcvQelB<EmxT;Mv8{4oooi^@%
zuRU_%*7s<jCZn5cBa`t)$l+RZF`y`Ke@opv?E7fodjbcn5!g&UlZBfDr(!0{#VzL7
zz4!YujiT2VW4C?t=2jKut+=O`N4rA8UY$4Ki>c-q=|8`xIkuVtCeX%_rN(^)7HNHy
z9kFn8(q*tU1x>inM3+D%1t{uhIATpo!k44qF{W_F8*odpt!~_bGVvA&>zhkd=*_wm
z5cMfdH}<|a^SH`nt_)<P;h0Q~9U~u`GNP}m@9<!DVh~#<`a7cbwtp;*CE-PyWQKi^
zIaj_Q8=d5+Q>C$$z*pvhu_yjq$5!MtuLAoAFB6fwEJuBJ+r-j>y=82Ainu$;k7W|t
zQ#N3ZHV%fZU*^xoAZ%96^-{0y@U&Leb;FD7@N}r{dZ|?2V-BFK?tV9R!TgkB5F2@Y
zf>r$(nN&*OLku7>9t+&MSkVc{N0+JwlyXp{?1}w4f2y{r%j&eV1{qR}+e$}|q4i&9
z<ghap#(E}PnDD8h5Qa-D4^?f)fM~QThc*9tL2C}HS9s6~JL3oYOL~pBDJ*>gBA14?
zOm$BcccY4;5Z>5D;bWb<D3TXi-*~%x!7|gSSS4SD=zfSS%cSuj-|TmG$i2|@VXwJs
z!irV12lhS%0Xv7ggQLr37jg-<N$|iAI6DZ)6(of1m+n8112%<<^1s~d|GX1v=Q+uP
z;+R6t9XD-8uq5FQ%_yu>ZYD-ky1gzw<2XqNgjj{}+E1GgQ}*Ijj(we6BDceM;gdzq
zXb%gB`UCUW)R5Mq;Jra{s={tjCmNOHFTHwmR5lK)DV-e1Tm7@_&41W5@hV(mU*2T1
zSmwUkDDZ<y$6+$1JLm#RaLH&t8;D^PECzSUsQ5*&2P*RKb=iE)da{b9`ypFdO`VUI
z=6vwCLz0s?oW}bTDmt;t#x7Nzp74244>;}3`%&jTv1ju`L0Al<Yp)l1;uPCC6!j3P
zDw<Mw4GkLG0?(H-;I;CfjHJ2Nef_wKj`nc{pzL^7{c}jQJDbu`=Oc~=*8zTK-iX3W
z6@qzyufQ4CUx}Jm%j6>p3k)My5+7NnmK?Q*GkM9WqQf}Gy6L>M<;*e<ZigL5mq~W!
zdPR;Bk!!cb*m(XR3dM_H<hUO0LY^eQe$B0ZbCy<VM%bTqvyQv*%iyKy-fcZrg*VCb
zHNkB-vUfUPS&4eu2W#YZp-P^M=&IV`kYk!BKQIG(?p7;d(-A;2P(NfPA^aRVrvOp5
zOcMZb1jnn|_zIh4_+m8^wjFocD&K7pH!z<!^>-9HE6v>6K2?LYrq3U*GU~BdYi@<y
zq5@x9sX7XmHNB4`n4VL7Js;+)<KiPAb7j&`rs9u)(nL1^7oCdinOUrbz(9qedCa`9
zwd-bFsD{r^<aX)$b}Zc{T5Y*9d%N3_0&F<kzdENbouhvOF<>LOP|4`9ONq>kr`sc=
zcC`w{oZf%sB^#oqh`%hGHGKYVYvaB^dK(Pwy($HBUkQKygY)O}6v|H&BJ!-iRpqqS
z?UI>~LJ8n~Set1C@G$W!#@Z2e1=zvE*-YkMp8GGCJpK9iK5C}fjTg}}H)5L3SA3yC
z>nH>Ko$z00wEFdZsqF20IQp@NyYYs!S2Dpn5hIk{LSy53OE0C!UNjJ4gF)QGA;uok
z;tdhTjeI35Maf4j3MRpEaOWQXCYlVFShBOIxznUixA9i7<>r9tBr;F-s^{s({2fL*
z<gQ_W8Myv^fn;PyOg{W}a~9Q0C8~J5%SX<jlx(b8E2pP0Y^{~>`zV-99ONBzo}5ZT
z-AL;<PzQa}Y^=}fKLq!EtL?wPpB5*ZKjSZ}>#B(l?ez<TLHuL9L_oB!zj!!iJZw`b
za>DkydF?FY5hPBVsbz`dcGFw<K8npWVgBL7ci?I)&n0^#%&SIi*fnZRl$ok;K1TZ<
zQr~RUT#(e?S*P>)z>LR~I8XS;Id~<8R=@0`{U3}xoCLdhvNCy^vxDw~b-VYU&^tHe
z_0@MC=lQ`x*{HcCnd!%>yS#_Hgq5U&&@NFVJ;LY8^0rp~oWd}*0;zt7xd`_j4G;Q4
zt)AFzb!p9Z39r4MQQOAY9Z8yPW8n=9&5m}7HW6-L6K3>reEh7=k6JnSl&HJ>ElKv3
zy!35Hj~m5A{L6QC^)6-XV*K+m-}pxJ))tLvU-`v6Tr{?wV;|#l6M?Nde#YEY7Fr~?
zxiLHTxNXA@wVC`I89QOQx30FTeGK;yMg9>M)`t-AbS`1D6S1Bp;m1+Xi1F`reYcI?
z5TiqKuP@8&g6;FhkTKog1iV{mVhr=u@)?@b+xBkar<JZ<Z6!?J!LU+0s5rAo+}Ez>
zn)|d?@yK{R9kF<IOoF2ML`q=J{*IE&M?3W$^v{{nTFsl1<uq@td<xNrTi!;wG0^v(
z&-T`zfo-qR;`QoZ!^=m^Gxs5?e{?dJ82j{R(Ucf}1rJ8CO6K9r);Dz|+mjq7(+Kzd
zHmf(O1TJcXrd4qMaJ!92oMx8QT?hjCjt+4_DS4VIp=dBW)LY143;PxJS@rs>@flM*
zxL(yU;Gx=I)*xk~z2(i*@}5uk+VxJ2i6wWj96>wWSoY_##a$NM?FBpk0%M=vJ2VB|
z7f7O`$UmFowk~uUfp6Jx)wVRz(k60|6=O|iERhxG3T}6!0f})*I_ae4+x>bCeD<e0
z)BOv4v|y<V0S6QH7}$4C=al?jhNUblJ5i-7X+u~-<w9E(>6Np$R24}82KGM9mw&KB
zuD;FUVI|EvJOdW`(clEI9+=8eT~{pg73T<0ZkzitLl;3AVqDbC>7r#m2mc>h3gJ)6
zSQh;BH(f-@s+-*|88WNNvw$~bWKB2rAH)ibU#s@)w(BV8IxPki8H3A|U&VTPH?3P<
z^6W$f-6i*@JkkQw^}Q^Q*gl)vFQgYNr2?R({|>0IS^<JntTGu&Oy8F_8;Y>eKCJ7D
z&vjL3tr(j!gNk2Bd78I3E3@)M)_GyZK!&Rx_Vx2eO~{L|astu#FTaEJ!xa-=KIw9S
z8zE+VxI^Brhad69U7iue4*ttYv<zu$v5b8NyN;%4_ZeCliC{V{>y-bABX;p;D$R(4
zFX%(0ux#oRs02E2p9VASpdvxo94iz76PmxWNHrl4(nlyu5*aPsvP8^X(v$xa=*WRp
zE+VgYu?n_6wANDb3@9U|2@4sCz(scq;3OB_sl9mLjY?tN`fbUp3nS17zy0sDdH+K(
zfe!C_{Z>0er^@%v3a9bsP^+4@pZ|LedXmygJooHBo4b;58~%7X6=lxC<B?RDS7Z0i
zJM7NocNXV?bu^+>Y5$QP9>GuF%!~QWwLjR;kf`!+wDzQtai8XKz4Y&sNp>WqgxYGD
zOYV$=Q}|e4y1iMku(h3PbF@yAchx$1sU~%#rbQiQEZ&^N;*Yxdrt3Ad6CE1-=DaH_
zValScN#l<*uR`9YdV_gzxz$rWz${T1;L$r~YrcL<mjR4Jx&ZfOp;g0I@tWoQgQ~!E
z8TlJAjZh<|cAi9sw`M)3dipGL={{T{-x>L}T%XPkyU8QOjiuE_O5Ek@TlCe_VrldA
zXMtlE{tvTz6`0+q+iMOMtG>5v_^){wJTh^p8-sk7C1pENDCslxov2NO;O_DDcX?Y4
zm%p;S9#S>g>n57of8fl-?jIm7@hEoQT8|}dDV|=0w>q6#psOPJ;O-J5i-A#ih;`3I
zdt~PZTv6nX?_1cYL)yqXp5&DczhHm$m}sVUmikA}S*IvWHZ98ew!!&6e?KF<O!3~C
zO)~{S1oF<~y=u+0y32lsx4}2S8O7zwoKHB@b=zc};N+AUU+fC#&dm&ieKb1Ea=M@0
z6jwA^4~t{S1~}58HdQh!fTLqw%UE9jaZxhm5c588rg!HQEU}uT95ll<%zj9bb#9El
zYJoFif8`7In7)cvGI+Ctt%T7#80J>OnZEOfYgH3fGAQqIq-kuIrP4=)mOYyqkj?)!
zq+08I#43HfU~bnZ`cP)V$ZfxkJSB2y1fe=&Li?bPM++r8@r@1bG}NX)0gzPkK`qj{
zYAfue{&B1ZXE&y?+M?};v|dDEgC>lQT%I4K8__1rzXS6LdFxWdwU*<i1F?%SEaWk7
zT*lRQ=)Rz)ntoCF+b}ZJn{)`2M3rC4-{|1?2<<;)l0n(a^Ah%mVwot6(;D5I`nvh(
z+i8`ImO`n{m@G9So!q(UsiEDJ@$H0jpVYtT&WO2MT&eH7u=`lCN|M|!1}kS6Lt~1p
zV6fI>gSQ_zV{ib_(;|?|@)n&xqjkuNrqcx5X+nF|Sp(S6hAUOeF}G70`HBV(=&YXM
z;i#zN1u@ey&mQQ9KdYxLEp1Q2#P6j$m$wk;D<xtZ-n07YP}LI8@~M;3u6LJS+B+s;
z?=Bgz1?hNu%Lr?Brlq11O4kxf>F*B(B#6ToN-^R~e)uO`Wv^v4-LW2a8ZCKenr|l9
zZzi;I&Klp^w;~yGZ|9G|+7OZKHUB6-Sd6D<=E^PP|C}S<!r8gFvl!U_xoJ%+K^fCD
z3?iy7e^Yi;D!Wzsxamp&A?)>`YkA-HIlXs$49uS&!_<6Pc`5z)5Ew{LX3aupKg)D~
z@BUKwB-EN8MGuWHf`-gz#Dp%$`OrwAbwALiG-Hw}496<{3?ypu2Cj{%{y#8Qts2NM
z%tKLax@Iig-IHC$du9V>?q3+o5IPkJ@>Od_)Rd3&57isM-DPqMpus0ti)u+K{qF(Z
zy}zc$#_CU$7nj!D^iJx8HCyfHBfKzXhkEDb(6p64Uj}WF&slaOOwXrtr~|U;$+JqF
zK<1*(O3*ZxK3}|CpNW;czmgf#HIwt2(ei2w6JCkP+)}#HQi?o5)M~l?@JshMpQTAd
zshpmOA9U|Kb-%#}BG&a6u4O_O?R@Ar3|)HanLGx?*oW3b`>Uo^rylJ=L9LyFvZtvp
zeZF8gm|~Xk>WVSisQj6bDpu50<^w`YfF4Wb>31OpO)diZs#E1exv#|%iml$N{DX!j
zg~3bh+%dt;I;MLIET)#9FGdKC3r9E8+MutftXpi1^jEDa5LZhO#D2hiTa`Vhc@pdB
zrlj`}=v31D5?j-b!``pwKn*eHIPP73x#9;~qOP<;&(FdyvuyQ6RRFc+S*OPL^NzsS
z1q@k(OOT$kH()U>``zNX^6R9PVCLo0YwF{HD$)q4VLS|WSVyP(7E59x;a_p^S4<Lp
z*A!$3-xLXukX4X_e)5Q?Y@-g7wr)iz8Ly}p0qs+Qe8e$9u>N5M1rlTE9qh3ajP@o9
z_EmN}@@%74#j|HnF`)`Blt~P!s&xf7)f|?dj&=ASta0B<nv^-R<`=Foi}4Nr{Xknv
zlb1B=^P9Q>I`{2T6s_|1-cYH&UfyGu_*0yh-Z_(Fm!)QQx_0(kN2}&k^bDgg?XxF%
z6~8bpl`)nUCx%Xl5s_V`Fce0Yjefgg*Z6YQCV%TRJk&kktN>-&;|K7a!R0m8L|FL?
zF(mC8h5O9ohKuRJ+Lk!d(1GlUBb@sAnD}aP!JN;@DzfYYP}s#DALq7#o3+*L#V#2>
z>2cU<+G1dM4f3O6Gll3*$X&Vb`I_&4yHthka}pybCBM0BjoEO;En7bai+T!sxt(>-
zZ|!^w)&a|>&9KwA>p=Cz`ph)Z^u=BzPbb#_L%I0I{E@)#y^nM0j!C+uEkP!^2u<#b
zr7J>5kuEpr57@cihi{xtNN-(KKYu7#ccalDsiuoYM^SI|sno{U&NiNF2Wgvi1@(M^
zJ=RDSOD17oMt^U)1N%hhclMuMyoD?3AG`BOj;AC_f3}t(04<cQXROHzYs6xvxSG>>
z*0-xDScdOtmGH<V<Ve$B#Nk0`b9&H~Rfv1jd-f6Cd&Ao<%Q8aGS$1I-{`C?^CfkJ#
zn)Eq4_?~tDgwVlQdBtR2pc#}T%)USjN~U|4GaFxBRk&7yPVp{xV8;)xoLIL|y0K@z
z;wRY*%oqU#@ro|=tcmio(^4kpMK~_MawYm`VS&TL-gT=LyD3vEfD+8qO=pr2wQY6f
zk@<MuYd=FUFM~tgT8S~OLtfGhB(S{YO5w+QWaCDmoq!4Et0+VLOfD4xxs05(6)2aY
z@~W7<a$Gdc!htF;+n|j7c+Trk)e3WYf^;{pdqv&Q#{y!{r<SBYXAy-z@5{nkLXpbx
zGnScYbO(l8ct0)4WV!h%m*s2Fgzyny22r5^^pu~rb72_-O4QYew7VINksL^o3UMJ5
z=5(_K!#rfV+1bwaaLJ5>+#6R<++$4ZrU|sRN}BH924nH)WR@ALe#PTV7#W>3JaN;g
zdc<KhF7TMj8hy0x(2;brm499!Fg#gBe0tij+)?8;Pte3G27RT%^#8+Ij92-1p%6}A
zDwE5qDk+6QLMT!aZ?<wN4~aKB+YYCH`}^z;;QsS2PWtby8ZJVs05j=F7Gb;-@gwV?
zSBce(`@JQt3f-ee9tnqYyU4KD-#YOd_S65K!=cVXZ!QR#ZnPRqSb?!)Pa(^OxB*H0
z{|kxgg|Q@abc>OcaOk0Ym73w3$U(?)Tw$XYy$(ms`aizfHxOtiJ1%_G6oI^QV!mRM
z>UGwF2t!l;5BtFSRl9q7#?pwuCtoR~*?;Rr&*ppIg}`b}Cdu2^y>XT`FB$22w5RA5
z*lWJ=5_m+h5kYx(KAa7-Y_a)xWm-{jj(cK}!#t@|ed1`Y|AIVm?FMc^URITy13RW}
zrgMRUofec`zBaPa!<_21oP(Ovy1>aqM+;Cf<|Pu43b*HkPjCd5TfLF9iX@C_V^|^y
z=i1Ki(@fLdSd{O1URe9xpAWk}4l3Gfn5CRN*l%f0wO6F2c9qr`+@`x+m^Tjgwl?Kw
z0Us|5{`ZK$$c#H-Haf*|<z5<KV|Qt0KgZ%i7*oc;pCK*K_q9}=!+S}}F*w8}sCxAD
z;r@FI)ODOHG^WA|Fd?i2<PpY*yNJN*0Je1sz~%2p0CpeQ5KCQK#r_MUZo#``Y-x2t
zRHCu=>K`FhV#t8SLp|azT_Gj+d<3d1YQmzty1RO{e9l{?YE@|iI#LLw)eO=?*zY7c
zWsX3}>In;_gPt6OSr!aC2jL0j0WqRt>)2Dh>YxmkglmBZn9ZOlIQx$e8E)b^ZmQDd
zl-N{&ta)p8xNz#!SE2th?Ex<0-D}hYyO=z#sdGonyFS56m22wu?`v$gt}5*v>No%W
zrdEMy=}j-vkmGT8XY@-i2K2LhMRWh!$BNn+osaj#4Vo%(6gqy>O)>wB_%lUVT7f^=
z<MXnX4%y!(THIlqG(i-$VD~c|fX6*Wl|p6q=S)uLe|vZUY5GF<II7%2ub5qC{92a=
zxjfHDMV+i<pBPi-R`#-bNC<>2n=9?^-Zc)L+mHCb{Ngj%NtpRFR}5Qy$A-a}k0969
zHi6Ce7nbXn#dMsTs~>(<B|h8;I<@sJWOH?h5}lk5Iga%rjs$;;vi<@4d=I#1gR}dn
z3ZvD&zXzDbdnJt2jM>GZc!PQ$#zVuqy$^&@^?uGilrZX6`gF%}EQC>*&`6GRXxURb
z$BiZ+NIJglJpp^?Z`T@4!1FOZVgD!CC*zYSN{lzO`gL{}yhZ9Jc#Ys33_@<I#+$+p
zh9*Ydy2eV$XTMlf7`t4^v;dK`v|0~`2o&t$ylMLK<n=@4W$QP23dMBLDhC^%3_v7t
z#UtLCyzUL#bTHj!EnQrlfB@IC!zg!esN);#nO+-KO1R+>Kj+8H%^`aN`p{asC)ycb
z-zyP^Jc8NQnP}2|U~f0(E;_3D<zXpTWGyk%Tq0Ei+578FiwqVe%`gUe&f1VL;Vd?~
zCke~+LXY{U^lX1}M;N)F`yt*66=@S!wf5W@d$?+Cw?N`m`<nv;2h@qb&OA@OaS7id
zjVpL}jvDhspc(iur+-m8K9;3pS;&7Hzr!h*M6gF0mQeugk{D)vLJ$PF?G~yxKVBGi
z-Ln|zlpt=od?axB5N5*ww+!&E3)kQ2<-;}h29s`x>#%EZz6++I1RI`&J;PY0cs+&l
z(oTK4#oFVLWc|eugtC{I`g$hASX`el`p@f&dmrFk{hibsd}(AtOvK`%cJzXsfGi(o
z@t^aHihmaNn*3s7_hs6P?d{m0UK2&2B=FCMP>{6RG&Qjo)}|ZRfUP`2m!q5iHO+lE
z=%OEi>loj2jkV`!h^f|gGr^{$rdwlex8q{<eHy-?&Eca&Mu_@?otZcY!9nb&&D7V*
zhrW2;y{D2Y-A|WVcVkV4=>g3z6D-weyYClu(~`=bDE#|l{)3C>zi;nnyax^nw+(9Q
zdP$0=r8IJ>w=Nfo)5rQfVXN<Kl7Z{JW1*We9nwtA_5LxTjdR}jr%;j!@?51!SF?Ew
z<e+lnHJPr1m-dhz#)i#-vT8|c6zefE?S7B=M8|C4RBdD-Na7|xa~&3tQQzRf05W~T
z1c++ZJ>zuyu2+o}`GEj@cNt~sD8+f<9fW6u;FRyuo)u0lIx=q0Y-!?691m>JeK@PP
z%vsVK=1Q%9gb{a(`m#JqbQAz+wzIr6OK76cCH8tZ=;|O#-KSO#s4`(I-;(7&@Q@2l
zzH^slur^nV7B8%*sdXGVXM&wGq5b5%Z?5nV4z8v@wmMx$$`o+MwO-|Fpsu#td!P8z
zn<y~sBl$oi=+kL-UT>Nv-&^fNaoq5*X62WtSX|YlU|LsmXogCkul8oNQOcP@P|m!T
zg;A{<eeB;}Eoa?I=<EjX9oeW&Re25?WGcxFfYevpdm4GN<M|0M{Ot8SbDu0{kd3e8
zSouUBGi^n@W!PI&*i^@O>&7|y=-DUPN&o7=Q?MRye?on+qlR#m9I@4ohjh_{hA0u_
z+%Z1lq#)=cu#$fVlCyY$Yt_|nx=XvSI#}joBBfCW_&5|t1+XySlW&qS#Vz)#bOU41
zp8hao=Kk^fal7kvj~I2TWL8|WxYIIw71Xj5u<y7?0D3i%)P?9b`9X5?v1RBle3(YH
z(#hOVzX|QgMf~ae0%vmwvpF>7rEj1U4BF<Rz1|5fUtLAKt^Qff%_?Hs44q_<eN-q?
zxf#@N9?QP57w(P^txS8(`+mks+{E?6&xoWFM1OxPsc6xXuD>w84=B;+t!7Nm4S;VE
zKQk~-Z8(AmX|VsoYBmxyxe4M^N`H`tUV9ZDv{>{3;Q7z6|CsM0g1#rPLaDWMq7K;)
zyg{gqtNEzgvBy#u2B->Q1rJ01hF5-kaG00mD9<nBn0<E7QFaL1U*~~DaM2Oafdxk}
zX?h}MagKWTMQuu7z;j0jIns|E=?C@Nfsw)&b8z!y-ri?fmb%Z`qjO!o)#H=Ovm52j
zOhmd9$Qcuel6(ZOi!kJL-PSfHy?(_Qp1U=}d9=$#chsPC=ir>bU=(T4nZ>0tV&Lg>
zqtz^#mv5Wa-3<9<Btym3P(wEQmEVjjrPQ|+4AdI=JT^Ku6;5Q_R&!vqWNNuYTT-pV
zHsHMUkFPf{^0?dGAMZ~FuIJ>(GY>FxC*XSRM!@+IU5NIhK<K~1@Xlh|;F`3(w3)xA
zPt`?tc*Y$)dfTOP`XgpLmi$kc<p%Irr}4n{jF%f_<LM~AxJf!K#^0#1Sf8aPnz7g)
zn=rPbMn2o`+;|m}9*roiF?}L)fxiPyo{Zgj=eyJSI-Kh0=@lfx^<u2HmTAtR7Xu|X
zAU*UR?R!#vQ}(gQ8Pw0T<7KE!8|8<4L#vBzfPUkOTxcS!{YES_vDcw%Z?eh=XJvF|
z@-B16`a1lH=Q>GF{6k%+NWT#?P3*<!S{o6EbQ_7jqxsIPrX^FlX-g*}_~V>6Uq_s*
zf|k2KO~Y8yC+Mhak4!Gr;I!e5h7>Yj$zpx}G|{xgiYQ@_e*z8Op!$K}wggjMwSMBa
z`d<A*smHCnc-Up!v6204Mp3?w*4T-&v@d!1jE<%>bv9zRsL$`@W$qWMf<wMnmQb2%
zzL2Xp`}Hd&0He%+(DcL47rAXm->BHK$n~2ReOI}+@tY21^pp7lW`WADe<0z*kfIlh
zethEw=WAtrp=Wb^sK$x~&4eUj`2}u^5YU#kGR#0CCkcPTt@L)!nd>MTK5F~mN;4x#
zAiY4$NT!2@0*2yG4>>y|&`q&1nKLohOxQs<xyFs5IEA_QKudOAUVkSE5`m^}nJ7NF
z82ZK=P1J>aMv|t_Sf4Cv)v9V+WoGW#q7bdj*ZvZqW-fl3pqyBGf%qf&cLqxC98|J}
zqbz(i;OcxV<X}eXr!t1gg%AK6*Y-!MH?K&$T@*om%@^5qK(>gcGhAcsF&ZnczIKE;
zF`+f%2-Yp8LN#li9`)pDYwf{b%miZ}VipL^eylE=YBCT5nZIip7ffB#z$a`oXkAJP
zm@_1<+T-R70kYn$pYiERY_z1%pY}%}>EqgSxpnPLz^ow#4wyCUP}#M9ohw#r@Vfa9
zQyKS$5Uq{p4Qj!c8eBXkFdl1nXD#o#o^dZtnu8|BAuyb>AahViWvm=9Z;{4$A(L68
zcsAROncW~YLX}T;7xZbZW&U&aK#w_;;KGv`@U_?IHlyX5G#wPW<_$4x_PBY&J*p~c
zR}9yTBo1We`=u!^bB5%}?(w&W+5jYp8enSU$J%n7ZtzW2Wfe-VfQ$c2S#HP7#eFc(
zw`53Mx5q8P3<(*t3QbhyvR8Xz1I@6w-ih_E(dXa}^7(yd$AGYt9+LiSv6poWp2u&4
zRb&8%f2yK21E!Xk@mz<=-0+m+a9xVeV>p310Ml&Ap5jHF_L+8VoG?nE`!X)H*RY+M
z=%F^fJzMGZxCJX!i|!2uI3Y8$D<b=JrT|9sdlcE#jh(tf)74F(VH6WsJIa5kpf*P6
zQ1+mny}{L5MKJ(V<0M!sgX51JU_HqCWSIu($d3yMr3M;O>T3c_B4@K}N_%7NAzzWN
zKXL#iYozsuhxOlz&$C%b%y|n=&&hMhjb}3OReZ^>OydunktdRF;AZ3tR6g>6o5Fc3
zQ*gSW`lbo)(8nIP{i(vPnqY95DMs|)vGOLFf_q}@qHGY#8c*6a<<Hkq&B*}eH+c-a
z#I$@gbYgpzsh8rAC5%lJk@(g140t2~&fcqv4Re05JyLmGIJ?Sy@r0p$70<Y{o?iP!
zS4QF#VQvLMoErCzlwA{!vz|NX>IEh@5E-iJd|z;H{jU{kU#*zPw3>V0D8*JqMnf%s
z_!4q(iZHu^7@SIn-b{x@|Hp3Q<+M_!h(N9kb&bS0w(@SD!6};ZZpxq@r0MRo08D>h
zzu`}S(Qng7%g4a)XCJwy8yZaCQYQ<tihsi{RQ`m70{u~q1FBWBsKzAhpfN!>2`dDR
z%^|t*t)Y3f76i*!68q?@!A@1qs1RDJ*0MNnN1MF;7O1p+j3)uC#1)(Sro{glA||O?
z#X`x1!mKBfy>P25V35x66h}2@+6xvvq6_c)%!xbz1oYLqJjPJW`Gxk!Ww}4k7xTuy
z@~mk<3EuyITzz>wRNwzUqZwsaF;YS$TMP;zB3a5>wjyR^OV+ZLnX#q~r4VJUY!M@}
zB*qYB$vU>Njmo~SGZ@SF%=CVLKA+$3pZBB3`(F3nIrrRiUdwZ-2xC5IC{LhO%wRVr
z7OLnC4@b-$r*TIVzWn~Yn16I)mSN&4so->zCXl~00q0dlw7-V`7<mUyX=?-+?v!)M
z`cGb9=s+^savRwVbYE_NzpCwfhnQ4(YoRqV$%^C{@IX$@H%;I5+c$22@(V=nY@ioF
zqGNRZ>0?>X+^eMraP&pYF-S{*gP(i;Hn7F1D_9##t1iRS!F-tyCV!7NLMwkr-6p;2
z0B}XI#}69MZLma(e(gyJ-WlEu3O2h?ns*+||C!H@sTlhe7tpx_?^hHW9&s5oU=A<;
zZ3?kn&*a|R0?jAa7*~axAl0eqx)AZ#4wkwBE^_+S{&$f{_14d#Z}i<TWkx6*3~rj=
zd!^BH1<&ekNaDk9tpGDzM*3wyvQnGs_wpQ`3O{rNwJ5~`{S(0kZk4o5W~Yxp(^a_l
z9ptkNyS~Z=W?2aOo;4=aB%D_}9^CGd3J`xe2D)}Yf3?G6j6LZgME$3pK(hUh?5R_-
zq03^(jjJKcVplcXVBja|MhSZ${qK;S1wyVgnIt1ZSH#HR_=*@<VDJFb#-=h*k_Ng?
zekdV%&<v7d0)^FN#71iZBpLByh4j3CW_)L;dhFf!^<*hwRE57*Tjv9<jhFv4a?)%y
zLG@(ysPg)<SjlH28c?4ZO5IyrOz$zu{{`v+#O+Th?Czft3(G6g*1=lWiqIqC4n>~3
zZ-GbGoB=3zf}O^>8^3#}$UFGXO6LRPSIou4_ydxPFZT>5U=|FRhZEXqzVQ+tsEUbo
zp&zDHPS^QH@0A#+q*t@Q<JU5oW(;m&V?J36NAnjVvORivL1_$^4VKCT%$NalQ^H@j
zm(P7#sOm3M)ygfh__E*UUW6?ir6*us`{eM@XcKL_k4xL<|KS4|JeyJ74-M!lT%YKA
zRk<s+rp^4a@!Sh1BhNe5d;5karkXgM6)yb{Gr1jP)$jsH?}>#-d}&!>;pAmSQfs{`
zs9u}0LHHHRx^(n%7S?vK@=WYaMf?8#OL1p-vFY?4bS;_OzPOT7b^$gNtM&p3SDr~#
zRYa8*+!Jw1It_NItl1g6Yw2iaKkloRLjy+x4ZbxR;T+GVg&$en1Nz-;Ai4FSWFk(*
z;6pkY6w5ad$PohZdN&Yl)R@*Z{91D!*r6<7>_b<ez94~3F`>no+zwp#orKy`LeIx^
zj_ELw+3^bzP&^zo6K*c5yJiN1BzhQ9jeR;L>AwZ)Y#78k9?rjRCqkCCHsG8_C!G<g
zmh~*q{1D9qi`Cg{CiEqpj_R!S`cB1J3OE7@$*zrxXSV0RNII$ah9p)g{LwTln`6;O
zE;1fevr|tpeDw;^K4fOq*HY1*w{&ibc*dy^KVpNtfx^D{*yd@XfoMI~ylMSx6r0-<
zLK@FxksNv$IfCt=;>**2!W(JsNh2%2vtE{HG`tX0E7`f2=#S)aLP~)(PMcDNkd;``
zSq30~&v7CWuYcT1#Ib($rPDj#jGjk;WRQ=LEyU~hSosn)YC|<>X}|sK%^FI*JoTa~
zAWX%(GK^7IL*5v{yhsMxk`v*9etQgxdy0-{v9LVuM1Q24-~fs9&}AJuk-&I$>htu0
zq_iu1ZUo=Ty`W?z`&Y|PHU_T`N`l`)HNNJpR1|Lf3Xl0E#d^<naB41U1k(|KFDGmq
zV=zUjg(;r6$Rs4Z0?nK_Y;Sb%l&t0kz$?bU4{jWjN=rTbBo~w3{i1c!HD6HfR%JRj
z(WrcHEgbtRlAX>qoBHr#Z>`nZ<^I?tWTSN$gd>PDQalpPfrkT=VRj7S?SgB=J`Ap3
zG6@$+D?y|6ekutZ*|M()GZ4Wv!ttL$&44Y<)BmK@>J&#pY|`)^rD`F0)l}`YEU&0N
zj8BLCGIn1)_sy)UX(eBJ>suC_?j^qM%8opn?u&gv*m${snNpshS&7E3kS^4({Kof~
z9T>`FZByt=cE(KD;s2IbtkW@1fMC4k7z@t$glh$!$-Oum3-AHif9<|HA%6@UG5#|X
z_wSIo-iS@kJis#%ayXMUjM#hj#UVDD68PzBU9t0GWjVs*;=X>xxq`Z90`A|Kopud?
zk=M^YEAUG;_Dcfp`Br85hq0I*Zxp7ert~;m*!ok}^Wy5~j14d!A;ajQyLGfhCh4|M
z1Cl@z`gw^Gq|ceQ%w0EP4=|H>N+z^FL7yh!*p7E*wXT%)41}M#R;QKH)>F(?H}ZqK
z60tFy0KbPkxlo+YqJfwnXvIEky3sYyP7rZOU-f%YvsvVYy&t;fRHR`;K-&%a?qM@N
z<0v@zfkp|bd8J_LKlP6p<Z_q-@+1h#?7hX^C0)P?9*;t%1i3^Or~itvvo~RYt&4)?
z*!wk|tbx@Lt%s>b_pY}O8ta3lnbw*BKa135XfS2mnFq7@y@-1N<m6$0)|;I!babFI
zlC}()YX&L6=~e&S7)RCM><f@YA>kmo%mMhJ3<Ox0;rdA3sqm-|Ux=Pdcv(+tzZ!cD
zg0H9e6^aWTs@R05jDfKLqLxnGcs7@hr_C2fR`=RVVKp1EdSF0-%N7C=gOBP2Q2T)F
z8=rSTk<f)RXj^k)<T~u~00NZ1!S}Z7jNQFurScvyD!f(FQl6|=6e87P0_so`sTv%1
z%_3M*0=`HS@W|61-Z0-RstQ=}vyaX8@W1fu*^Q#Ir$?el?+d`q?#klV<DtK;Jf9*%
z8&kYnD@-S{3gnr>htQjH*hKcnbbpppJk@v2ww{7BTFN21tP^@nv7aEU4su_MLuh>D
z?Is9ST6qXZI0EmJkV<zm6%#dtAG$bYp97h;!mLTNci{%jt07jaH60Hj*_+3z5~nIt
zv6I~6M^|sdXwvxYcqqlnvmbedM)Oi+z4DEOzxj2}fAo#|rjLlF`=?n302J~H%683D
z3Z(^o0B3DkdLa6%uH!goq8;m2&G&RH`ziKQg@d07@Aw7Q-t`|y;`ftl;gBOy&jLBq
zmyAH1{~G@_)EC!KsEn!8*N}2R@e=yPGz1ADML%b3rh?b_5AHS@ah~$^08(J%ukuoq
z3XhlZT|GF-St3IO;}lM@DBQ^k+ifVDG2;6uH>88$J^$&x*jpV-!mQxZ2shEn2g>~s
z&)Ne$dd({k6_G?sH!Ha6#LWd`v2thL9(j(Qw0R%KW{HH(K=?i?TNGX;XAf6n?)o^y
z6ihJ@)!H71)n0-g_=w-v13h`o>kTUNyUC0bSiyv@4<Ppvk($6#L#}2z31y24Tg%#K
zsaSK{>Kl$dX(#&IV-3P=y*X=e;=HSQ3}M;;Wh)Z8mbJ%Hg1O&e3Y^mHA2=X>=g_oS
zhzI9g80$woOAnOmnwKgnV%X%~D=pG2PqvV}Z9|8PRvjw1yR5o`urqB$%ex&s;JmvA
z=5L_x+{UhuJk44qrpU;iUZbYW;baS|1BpAi{m5`1F+SZQf~Evvc9FvJfho_)yL$R7
z(sm?hEsJI$!930PQ`}kAQgeqXig%Q|Tt;(36H3bizQ)i9f<JLburJMH-#y#DEv0q~
z80zrPi+ecwmk&=OSJrSc0t+P1X{6b<oA)HHLtfou65?KbxRdo}yIYqg-TK(0=54jV
z+0L6LB(d4e#JzO?P$SdNozFu0u5LG3*4*%$CD7?!&s?P0nw!7I;7skfdf;RzvvEZe
z@Np8Sfn+=pyWz$@iW`cn))h*xKz0#&XS-U3<R{NS*qr$lW2(oSkv1a1b6H!8G3U$U
z@<Q|DmqV0c*M773D})>{z;O2^e#QlRgzl6iZT4#Jx|<NdJ&>pFC108wp>hZ6C;}6d
zadwoANXT3klM){R_Q>#!l+9y`Zj_LUDvcEw3Q*`ZH8Rsc*rBw!EM_G+%|OL(9n~4P
zAp$psTY<?qTOS7M&VI0P$ef_dmUGyL^I&1^r2`{u=GU2v9h?~n_Y4x59=x5k<JW#3
z&9)7`@xq!r_5`JCEutqS1KO+S!Ew{=8Raz`klKmK;j&O4sQz^PWXn5N2Pu-!Dvq|<
z3-8+5G}@jqr-e^F7P=jL@U-hYJV?had{|j#@yrw`tj|jj#me%4w^!&S*8f&JtL(RW
z-H^tGQ2=&N#zJSo^O4O7Tq)`PhAT6*S!o|1rEq*YUUmsNA9`es!?&F<?}kFAhi+%V
z{M$7XeTHi0Q3@I;|CvqA%e{w$_7u_}eek`gYRM3xJv@Ow)Jj5X`%eEJxyFs6aIP|H
zj?6SKw)N+O8T7lb-3oY!ge&bHel&I@C*>7WXjuJ`b-JzEQWzVmdMem<`}w$&uVCi~
zv~Ebvi=*kNXl6<;mNvsaiz9!o=AyW`;PA5Ufvf4#EQKxnrrdQRj^5St70CNrRkUr)
zM0AXa=TYvDtRp6#n>xf4j@r+*$rAUEgB<HG)D9PPp8P?y`QAuul2=FJ0aXxOE{ryF
z3)}ZoFU5J726KbJFfV9qi8@UM0qE7N$ie)FRrF6Nyyw%Cyb8;c9OJ3jLit-(J57HU
z^n!LU6Zz?HS5D8IeH5D%)Z<>g^6XmS5G!l&o2-x1e_Kj_FZ7T$_*Ffc3Y_jWs*J+r
zgo?v~I%*yTkeNhxt0>!;?1!gT3QRn$9ZbL9zI_F)u(x>Eo;$-G&FCH2E=WJGrsC5U
zD)|)dk+n-ljooEG)rNBvYyI+I7KWJ=(SdLv4}<T}<LZXnSUEhUZd~^4wI88Jno7m5
z1j^9>5$9{a)zM%amht;9E`gY)QOiI~TzT#XY0JOPQS`1zmhDgB+fgLN>g9Fx3T>m+
zMm}$&`%&N8la}4@PN%u#Nl~EqZ@C0|X$r&qkIA~fUE2800n~6!`ym!_CG|%Cp~BNy
z2Ea2_T>~sK7ltuQ1Ak9L7o@_Kx0k2X?z5N`?@IcA_w{3r+g4rzlfwZ?D~0x#y`WtA
z-o7Zwi4a#r$Y${9T#J)&dS|Yq#DfQ&+PQ^1`cv~Zw^L%1p4;bL^D><aFM--G9x=-|
z310hqk_Qm<1Zvp|gEOoH@WWk;v!#>I5^cGT>XYQ%7|pH-FB@Q&uunMRW3BijO*^;}
ze9<@Zv7GHmmP{gz&SXGf1|Yu%^w%XE`S7=>{a}(N9XZ!1$9HhJanXJe_;Aw;*Zh0Q
zy0tC=qiJyEAq^A_Bqx-a`Tl2#>bd?RP&a_>1yJxmP<+{o1=7jtiTW0_x9arf=(v*f
z-q-zFilc{>&w*s#5mf4-rDZSX0Acr=_N}XvYG1y**3T4_t2+2lLP!Ik$KtSLb`Yhe
zFSx!%3|9R5RX6^$Wb-I$1ifm%iQhYduAx>H5~z?(An6^UQSQDr>Kt$Ohs6+KBX&7$
zl&Kbu`Na;x;PgdT`x7~f(77jSpYHoyMZ!a_e3xU<Jq`QA4n)|Y-{I}+zRD`?-f%VP
zQNKGY!*67NF@?`LzVlU630Z=I<OTAF{T8O8?NEB1c&`iy`8qlJjA4c*FL>f-573RK
zoyi-ukO}rt3}ti|#JEbZJ!@xPH+?x?O7eKdB7aXNd=-k^tc6Um1JtA8I!I24xuq`a
ze)cPeSyG*1G@`GG-iy)N2*ZI)Y#Dl0<LR|{T=+87TSeVJTHxIG_T3KvokmBLAWZR^
zO#mgg>__9r+V-6~UeUWxz=`AFDTL;K{~G<|*UImchd$xADhj6p+FCh=d1Lb;xOdLb
z?RVF|!{GwR6MtqZv<`N!vzcExe(4RRlqV~aJw1K%U=7`V=}zd9j)Df;>v{inz8ib=
z!e40<P`+IDg{IHaF&$R;a?Oonl4(_k*Y4jTvK90>>;-#!nV2sXA}8dgYhIK$4>;@c
zv>rJ88uG+U@$PdlL(cz<DGGeE^>Y5PN1*Q>d9|A(AQt)wB+;S$aDZZxD4VD^nv+pw
z+pQZ%eXfd-yXT~-Vj8^tpH%5_CqM|STBL*r-&|=Ee87=79{_=ZA)yO*Kp4UupQMlx
z_z?Z*l*K>Ps;~f&%#yCZepc+sh<5-P*53O;`<n@UxxCLWhkiPN0^Pd_fG;_1H-h0!
zF$st}Zs-%LctmKNXoRji^ZW24Iu7-d7iMVzu}a%8j=rWGcl_XnQdQc_sB>t06~NMg
z+FN`FBP3&F9~Z`maR&}=pjM6znSn57U|W;z*?BQWZx<vtpfw#Zci@a)|H<**h}WHa
zGdPl4@tPchH}>lzmopJEG58GN6X0LJTUqWZ&XtV#kOftH=cM<u^&UvVZH_SbMHp95
zw6W0OIyAphtoXb)q9s3N@su{y1ZXOSIUL{j0I^Y<z`qxH^%o7{IAmrlg&`To1=;qM
zku?Y-<tMIG+)2}<cY$4jdlsJt*Yya*%$|e;Nx~XKl}u3=vaY5-<Y0J6u}2|3EN#P!
zJO{<)G^!l7>auQ(7)sgq^E1U6;{k}W0oYMNn-a`7&N^CXlqYP|1=*gReGEoeELVCg
z5@gWv2pLm+M$?Z&-<aT4*XQfTTNLNKm<=B-@n%vT8R*8%PLSDLo%$1VX>--T8ziRi
zihX*C{{BGds7VCdn1HX;+$_3`jG4KY2B)r>-hMc9_~ViJ$Iukri-|+y^pdp?z|bMu
z@gMuC$e-5XO}^-~Y5lC4<jqqou<*N&JEOEVKoWjGblJ&VLq^jnXQe}u!r`ZZ{_dw|
zD66e1P>jv~C*MO9;-h-9lbSZ1(JnAEq77~z5j_^u3HO1`HUFF4_}Zud#z<AoWZk&3
zWMx7Pm#E{q+z_E59ZTv3k4jUxo#uJp`PO{g09aX+&tt70KnxeW#GhV;Ei~h)W6<G*
z4w`S<X)_=3b4~3fu4~?UKMSn5cI4LZ9K#9Ng=Y3j#Csqb)iwMfZ|q}1&m3=$&?l6O
z$<fDCGI7Gdgj%_}lCY)l2DB3DHEz9Y@$Cf!MNJ-$=qb&gskwpljT#qpKXlW{9JJgX
z2GnZhd@Oo38~R&F{wob5k{OT!h`x^GttQBdG-zadt>3@nQ~k>G=0Q`%$hpU)-Gd<B
zR=vc$AdRQSLx-&zKw>LJor=9dppA^2K$)6BFO&J9mALg`EB<>((FLHsK$GH#J2mQ4
zarLC3+V7C7hb2caz;L;Uu)(I1Hq?9HZm{e!@-4dWm&(JibkF_2=#W*qigS_X1{=Lo
zYDLj%smRG}EU{L*DQCAwqVFr>|2dwYB4_j^r0Kf59*126n`?bV$O0dk+5{m>kD~q2
zTVU03&Q6ivt|;`9xf4>O4@)1BhcWPi&<ZPks)R##)t(6-wlfa>c4b2Hu8tZ!M6qQk
zD3O<1@%Pz@4ixVOgIVPlW)RwcL`LS;&FnXOQF7?2ka<2NxXF-o2D-EX)Cjy%Mxf6|
zYI>lkq@g?jX@bKT{x!1gbpM*}7i<-*et5P3xjxZ{YB%p*UPl>TC`d<l_f}QVorP0h
z=}HZCGs#}PG%Dg$-fBW_(sY$6VRWUYA#@Q09#90EjPr|#?6&U_MJWufpbU`$d~vwV
zCM!6dg%qCn_GhpCqE2S15mtr;_U%e&7#z@(07*&K6#uj-+XBz#ptknr-GL;FYihTc
z-zO}mxCu%LAlIUCvU2#R-?Me_m%p>(*iBWwvQ!?2Rlzk$mq-4hFY?%vabQJkXdiH;
zPTPTwb@*PnhV`EIR<>3v?8HAuzfWU0r*rrmxlT&5WZA&?)cE`bg;r_;YaP0MtJSQ0
zYHx(mm%gT<R)NYGE#Z=<){L%~Unsq=mA_z-v*3Cq<LZx-AIT%hsk#^!i~&Ptq6Avn
z+dy%*>Id7TpM>(8=68>Dnatj1wRH}?g%$N;NN((oxEHfmzDuFIJo_der{bS6hkI&+
z9NywDf5}D!9qkBQG)ZUzF9qhZ;O<iMtk2nLOq1gcvtWbWiW5$T&Ts+>k+U@zGR)r@
zUafYs@FMJTfXd+<yA=zZjA@l_t{$(pw)h}_FQHX)jVX3umb-2>02ex=NM7rQ^tz1(
z9#kk#jSuUMz+%P2XI$$RuM5g2+N~JjWaO%Jvt057+9GNGac?_vj1|=hBkc%m;%$AF
zZa4gN2{gA?f9>NHbx`+_%ZKHP3zr>tQF8;E@4($1Mxa3HhtL~Q{^8qTCQl!$f%b5o
z<1*hPCqQ65SQ%SGXIFWI(wkZ6+>!ftknXt9IjuBNl=o>~tiVSyf%;|vjSXG!TUF1W
z_gho%51R3vHx8yU5pCH+e7AeFs1-PHoNhgw|H!v8RZDGFZSC%b@1`Zh0H~?=kk{X4
z6%^mwK^1XYR-fFSKXKPu3(E2AeJA)(QRtzvDm;Or+MjBfve|L~lj3P-N@n2*tPTx3
zT`lwg2O3TAy-2-Zz@4|0)umb0Xu7M|DWs-~c@;pL*X^iS9AdHR89sYp%@&KOoi}CG
z3;!Y$q7^MDf&Mkkn1Fv~*rRZOkkoJ+Q>Z(C#uW<m5AH7(nKq@~25K>hpAZ;qDBTrV
z=7}$#Mv$1c*0W*$_7D52(U)ruAMypAdCvRb=XI*n{4sWe)R>w-v$CD70;hhZryTH%
zoMDif@S5wY`_k0QmnzF~*|}=h-lUN6$6+qLQ-Gr=ho2WjV(EM&da9vzQCzt?u3p#J
z-7_q9&arm&*y(pC{&250-rEGq!wc~X6KaYMq@$`|HVjM5*NxqWJ!10N0sECnk~F;q
z_QHat?jPjC<hFoewnGJ|UKSM){x?v%tB#jiTo*s!tQQN4kA@@*{N_4(41^Iz*Oh)5
z&(F++&71N3Ic~^$WWQK7nvQAVqo45$oY8U(oZ+b&`+kMf#Jz~4>dPBBwCc1b+c3Wr
zhJo!vU_b_NsClQovBlu*oV&`GjT8<XySK`98y=_XWqMKWKhJc#smSln-IXbYd*a%x
zS?UfI$FmeQGG>29fdEbNYpa!T@B+BleQBr3i8zbpOD)aFYc-NtX!u1B%HDpE5(7cM
zyyw*cAl>SUaa#F3iZ`UFf0EQtf1#aN)jOkk`4KmLXX#y^{<9Db2Ffeq<9F86xhAt#
ze8arWJPJ{M9Y8B5tNL|R8I(>WXyoc>Z0S9%|74*qD?WcHb&xl<wJrR-QR!oiu9)R<
zX>zINhSF6HG`a;W4OOyAg=eb7;^k5-9ts0T@g)!Zk_UT~*YQ8aHUv<d{cIg*V|=^+
zWuaQV+D(eyswUep*w6rGXn=omShvE(4D3RyMTL~bio!3r%gBZhlBh20RsYvikZCyr
zas(qWxzgZ!kNc=2k4lQ0{<SUx-Mz#QXBqn~-XnC$1Js)nz+Q>`u9nibwR*{ZkNnW&
zp3Cq?h9AOkDIi%at2YTqVN|nb>&8?0Ts=e$E8GBhjN6liJb)n&@UIW+;$7fdV5KNc
zsSJHj(l%GSS>dCV1_IZ4Ml9c6743_dIy&f&s|&bGeE;#d&E8_ZToy?hj*d|Qf>$2w
z7_Z~xVhX*g{iDZZ*5K0{IU!cPxK~%`T?Pb578aqv=t3oCamql2P{%*_;JD$BTfCV@
z*21^<s{C!sXp)KQ<(gK7GlH@q4O21fwT{mwLKBa!Z`1GaPwpe)G(G(}`;8r3*=j+=
z89bxe!{ecX3TKgvDTq_v_>k7@ByX)0gqG8Zke@ZnkU}FbnwTN7i8&du-U{bGi`1MT
z+LkkwEp^bsDir;K0gp57H>znTiqX#uz!wrWAOIfyEZA-kBg=Z!Nn)8aT#+JwPf}ab
zl=>L*Kb;>C<a=m|holW|l}5xZoblfeos(hCK&*Gd`Sp<^Q}5#}Hs4u12K$ca%v#EW
z8rpB^RiG_$^WWs_p!|&{R59AN??ydvb#rGC5(V0N-uMwU<h2n@C}`K5oCrs1l*eh|
z@FIo_a8b5W1cdP;WxetGt*oMYei{R1+Z8!qEG{4c@mBT$izL?Oq8xtmFlaqtUPL`V
z_E7qed+;16js>yhzu%vg=a^0>oK4c~Zj7K`V1SfMs<F^F@0%;BRd{Kpfmx<%7I}*o
zd+EKFNRY+8TmW>8KjB8@`c-eN|FHZlJ$qCiNbXj^u|tvUzKE9q-r&2T>d5gB1~l5-
zy=p>%k<Z1Ls>x=%8zShXtXZAgQ(a>=dm@QT<Of;_>Q~;#m)ot{B4oX*?h)6Hl@Gsn
z)7IS68;<8EtX@;R!lRI5w`zfqHLZG_n~jy>HRrZ$0RIuR*$cc!`ZY>ceXoFEezqQ3
z1iwNNag49>WEHQJb+@D4p4ul@^&(UP{csx0!v_3JJ+uJcvG%!GY<OlOY9ugFM#|p%
zI7^V=)?(<a4wBLdbO9yMZ|=U6KI9vpOrYe>R|9hX6o_ye&xX#4k--TA2Di{L@@qcR
zGsm=kaaA}ohwGl*1cY#R#71cX2+J-E5a-`!lv>Tc`vsEXW7m86L$n_8n}RwVW6u~c
zV0TBn1xyXOw+A+@_xt(QhHrKM;d%fh2Q?`#5op)YS+O|v#{wsPr$4P7NKzK_+Xm!?
z;R^>VpKJa1_*|#~2r3ejbBeN)_<>AqqP4c7V`0_kfSol8z0U)%0eMqIjy;hzZEqDN
zD4E`_9RUt!378=R@NVADyXM(LhKi>_+^GV$Jpt%?>{17A12PsJs#85>cWXCt_n0Gq
z6J7U1^e51#h|JAv$H`xwhe|a3@6Xizc9FW^>SGCs4mUEcT^&>f@2SCV*$FgCs-lXr
zWxTID;j~GT+ALXi!(oYnil*N0RR8MqLFhVt{g8xTmtj?WYjs(x=_f7#d9pYzR`3+0
z-l|GXs=_p=gZ!Ybz5zYQGMTQ6z)$cQ>(#)8dca7f_<@Y6DykwI`|yyiZ!JfDY!bON
zW;uWQsA)x5vj_%|A}cl56~MlEj|SEo76FC9Tvi%?h(};JyS;zP-<5NH8S)2EeoC*8
zflgd&zDxY)z4_#jOOMt=6Nipq7^w(mLwSs*H#2J31b7*tCZ5fKwu7sdr53M-=(s6;
z{lDy^U^9Ghyn-aa5;m22c>Ak|XVp-kC{+^Ad5$0&f!^PYgU78ar~tTfD=R1S>tvJq
zH*$U&>7T!8gs%V)>M~@ac@&rm`1)858Mk_ewe949WG0x8^=kjm*Np7XDU`0|)=;i_
zIvX#|W<HuO#8lW)z{*|sd0#=u5+9IZhR|i0<30%rE7tJEoEhk<I-aGRz?)ee_*bzF
z<kF(Qij&;HZj;csC=&i&i<3|8>{TQBcJx0PNzHEMS>m4Th!+q%YqKL^#8#_!1Gpy9
z=|@EbD%)mikIvK0ql0^bZdSh;oJR>NMEiBb)KH%;pq)Y&_*TJ$!9MqoWq*=9-^T)T
z;GFt4a_OIRh7S*Dl|b&TMzLF5Y2uv?{J~T!)U-m)T$Az?fp*fu0?QrOsSi1`S^<`C
zmya4g+f&fr*u;91Q_x1%JqpNb7ZE6I{YUEzv#DpCZ`E`iUf(-_x~+h+3<CA`hX6Wo
zJsnLq2!5!xKH~Q_%<@;4D$4i5ez~u=!J8BSu1tQRbOasemkZ~!bM>nx&>=O?)J-Y;
zfcMFH$cjvz_QEHW?sf;ikOu@1!?Hz^mJ%ohojW_zO{r_Fe*(1UXM^bE3k23Lbk!nG
zW3OO_33WtDML4;MS(cD!OhCc3p>uh7N;moQ0#dydNGmJcBC}9_Nges^R`HgjFN><d
zn`IEi#*kKKXDB-~c|XOuE$Bes7Mtn$*NwC?rGw%6_Zq_Sx>C1+phWii(RO}Qi*B}`
z?#v&-0vq>`qu&ZUm&g7Y_l^Qg!lK%gEI<)&{vKyLoC(F{4SA~3&ff(f;kt7JNLy6!
zTGqCO#G1O)sfqN5y>ss?j+Z@&6mB4K(mQNgv>hw>I#OqsIRA|eeuj{*vi4muP|ZPg
zB}_s_$6~R1ng&`%!F=0bT<;3|vYMMJ^#KB5Dpe(>Q|%mm-(CQXmR-fw^PFEocWd~A
zj=K;!j}uT6u^NWtX3jl@8<0N!gIj`ZA`dtq`VlX6TascFZhR}C>0AUV(7`PU)uoy{
zf=y{k(#kRCuQ{J-SL{PTezs<wi+P#)njYBEmV5cTw&-VcD&=m})V0D+E6u%V5RzBf
z1mf}ecQ|Kp8<bxDKBP7+Jn;hn*@kaxO{k+v^*|S+J|lEnk-XC%_Ktou>g^=!Or);(
zk}t1bqNQbMSb{<Wa%BwUSJe-fvt@p9%DT2kx4}xzeeL~p9HxALH<LGfRS~(_51Dd1
zfu)Q;ov6pEb@sN8q3$qy>Lb{5Hl{9YyaT<eF*o)&95A)|*)_7Snf>e|R?gHAk3y@9
z0+qlX72pItLRS>;YM^-*K!&7tNO0ls=X;$CsW%r-5TobmS{*C#I8X>RZel$YaBJy-
zMidu75)&34lkDDt4O=n*g!qS%NE9X|s%>5g)a5l)_8rQ5uPD&W)aNWM$?9PGbb16c
z6oAJQHdIxF>p!;YxrnR9Pp)Qj7q%Q-&{!veK0kvL1a0l51KmNQuPhx<@yIssM2MEj
zS<@K#y+~>V4#9&ru61$S1?z(vj~|f13pR6lAa@Trc&MMGwO;WzkJ+!$w4S=?r=T(<
zddx7=RC7w<3qu-W6Y^{31g3Nn6#P^i?pd|}G`?pg0plgBcJ$V)S9pOOXvy!4MgtJI
ztBC(9W&J6dPwnRC(vbaW1uqeRQ$htv8l89b;3M8@?qTapEq;!`40D(Zy*e=SKRH}a
zo|^eOYUW+|94R^t)PrUMM4(Px08wZ=<n|nh*wG{V%yr+p4h==?pq#uV(%cj#r@mtl
zcT{A<G%Y5ZE>JK`W%N>}(U$@q8M_BwEUAf=Bi+^DnJEgP(X);Dk{{%mVUPh`KICii
z>_SRcf}(=`>It*rod1!z11%&4OA_&Df9xCf?d8iSe=3O|)pzAx13GPAi+Ya+Bhd6j
z#38;a;~NBIS<hpjM{X{E)dO~r<`f{45VdPZp+5yE3N+4pfFR|S`c#^jp@|X?wCz*V
zFaX3Yk(<FY-2UEq_s(4+?b^VIvHR0{rH`|ZJxWjiK^gLU(*yhND#|)~h>?d)cZn-!
zau~4loI%U~ewH{Kb2+Z(q6SDm-OzJO)Kbv%dh@C4gNbME6GBtirixQ<m|T_X1Bn+^
z+&~?m$qr2yyTfE(9Lxv_yjxucN$%>cKa5(;T@SiMZ^r`B+yVabVci1OLtX({WyxJQ
zzh^1HukXprD=&p_H{4sX@Ulq{Jp3Uwzwta`-oSOCZhX~zZ7-23Z(4X^n6RouUM+=Y
zmA#k(PECP@MSbZ9v!k^ikc6sPBnQ@)={XE?trVJD_F`J`!%WKH=j~S@R7t?iOo`Vz
zieW{v@{{R57kFC(3+oeT3VaUK{2r-ia113-N{Wu3{MG^lT1hjE8vMUW1{8d)E#F-H
zPH&8k!wZ`Bq9{8N;XqiL;jhhT7^PwLLE+3vcKV6YK(eY|irj|D9TDfY0-)n&2!e;d
zeJ6@Q!^-dR_##hRcM;b>KH!C$u&#O8V>FCTQTnH8qz=+5qSQR|A+!73`~qcB+!8bv
zy7nKiS}TP%mAzfo0>%eJJ1oJreHpIS<l{ewVS$T}w15*~(!WqOPL-S$EoH)!md<Pw
z1yp})qwq;l))@SV0rHv%mN^q_GmsmdsJ8Q<Lpr~&Q~b3YR*Xd~AIiX_<ReZM;zN3}
zzj|xsa~CY0`*i=bUGO?nxLP`o*&KU1wx$<fs7ZskreQZzLHRj?Stzl;_0qM%mba`o
zS5Jjgph#LRWR5)pYa1X386+~P2{6No_n<qyT#SEM94Ku(mq;amZQ?ha|1nZz>3zD^
z)@W8807h|3oofRoxd|}yO>-PeB66_>aZ0XQa~ue1XyG5dL594RF0|Ss;7(?7a<gD`
z>go{yu%h`}Pt?pI`|>4ID|XZ4%!V!+ywH4WIM~3Gkk?Q_p+5mtkd%T7Vvc*((`;HF
z>rk!ls;(Ha0VQwMdW}=Poa;b0I6tOl%Xg&yNsEm@#Ua+jOc0yzJ@gZ?J`RT`B2TP@
z#~e=-p8c+q`{zR(PZo~--RdJm*oF>y>o;U2(h=CP*tTWoGxNrA1p-*|U14mZ)TKR3
zk@)p`=x_L?Eg;yE%B}SDn9=CxKeq!$pK>`6o)>2$z<xSDn}@uS9>m+teb;hrrtoQ`
z=@N@Lv*G3ez&SEpW;9Qx;qV+}<%ggv-Onknj{7>o2JAl_PY|xK-E*zbuZSUk%y`I3
z*C5{3l^R{$JytV;FSzbNyPj*b4!>OjH8mIV_HPI^Qh5k5Tv7h3E^ERZVIpR@&?(yV
zYzEDUWP<L5((04u;cq8<{T5DN=xF289^fr@$_qblNc$s8=jc_J6SjXFQ6tUQ01)r<
z(bfCMvP8AJfsiyc5>Km#T2$X7ZXdJQ9`VykNmY6+^o1!&2PiX<8IT)FLQrvaa7N!$
z*0xwl_1ufGoVCUlTB_h_l>f`I(1TkPvG(fG8KiZ3@Kn~0So`^zn>cn_Nzdowupz4E
z6ju<0W`N($gi;a!b|}o*B;}CzO=4|LL3lvjNav+m->1!w08nKJA>&=`OWfXXJAfL%
zgFXX-ZS@DY-1-s=+XdK~0e&+RI-LL@B9OIWgIv%Y!a~}YFC@>op5uA{4*bvmo^W-|
zO;vcUZhYvntqe<+@}mP#x}*4V2|}hF?`uYTc^g@#Rtvy3y)KIq!SD(eN!vQHLj0%=
z(i(-G%32f4S)bAeb>}pPd*Wt#InJ2u?iKpSJ!Qb2ff$Oz@9A`b=Yv20`c%ZByvxLS
zKd;UVU_p->Agx8f->-@Z4DOqgof=*OT`5~;3$17YM&k+|M_V@f)hvY(%7Qsgj(q;w
zrgl^HUWx=(*rmM+gsOJw=#8v-y70cBO85_w(NCdIEkXS?i9P10_aZ3~2(TGr%+?j+
zXzAW5u1B*kE817+!a(QZuZb>v(hmOteQ3O#VCj-IKwUj0hcY#VvZXo{R?QCB*`dI-
z=bQxkU6T~(h>S^BU_LWc#&j9Zf5;F)%Ss47T@~!3N3ZfVT{FTB6vOE6?|Kku<Gkn2
z5OI*JnoR;13Eaq<a=JDD0D`ns$?N&$U*|s48yaT^S)*&9bT_k`Bgp1eA9H){n~#|p
z8JC@6B2E>rgQ{uHFdg&(>26lGKzwUAPBF*cB<5No#E+f2@Ig>+ZHgl|;qRZnpPuRq
z;mBpRZF-&MpKHRB)f+tmB=JWANdX|#r>hZgaY~pDhP#y-dv3CFnWZs>uYAy~>1c$M
zT44sH*%@L7P1HcO$j$2y=zd35fL*80+$)WriH8<gwXgZgYG3Jnzf=ruT_rK=eGPa0
zetBx_BAvsUP*tQ!VQT{MMv>kh7xspup9ffUMaktc+blq7waALU!A^@rB*Ar@o{vW!
z6l{Mt#~*UtRwX734wBm?C)_EC8NN966wDQK%F{V}5NgbFNgWFzy$xc$T7i*fxP<<_
zfg{IIa-iP&6C-X3^Bm@4GfVCal$|CsNg6*JPj*}oR&)W^0fyx`LVN24KlLF!7zfvD
z=1jLycF=hQ_lc<rD`GwL?Wgfs2g~_rZ|0v$M4>G($PC4WQw&9iLwPfNYVRnZ&QR^u
z9<xw<9V~{x`vA9IU<EI?)9D403mkKwo4Y}oX}2=Z!;JL8z<<3bRKPq(y1{PE2`3u^
zRJOBy?&dbxeclgR?DwNNB)_#_HzimyWwiMmahpX}@CG{_5>Z~o!pTIo0ARx6<bOV5
z;pi_4=?p){cLTTi&z-`fy4N7S&6Y7|tL!7?1f(Gcf8M}}pt}>QDl{oljM0Xpo)_n)
z@u342p8+%Q>kn!`jfE~n2WGU+5Rk>9hRH;MP0sGkR4EkI<-tr3p{cq5rfwj&L>wFn
z$&)LNy>K!%JmxJ75G?83sOhlZb~?Z|x|<4#n*Er2tKN8Fi1%B}FX9<T9z0#d4_a$=
zWnBaSK$u#J)`n#`Lqg5z_6s5y;PqQUr)7aAP%Yg36!_9#Irm)muUqxJv;~Hdp}GJv
zXYF6as3bOIm>mf=cDC;l?B_fYpxM52y5lxVLGodzJpg_@1!8FHm3~K#^GG3Q1)iDM
zZ^ts^hMzBiR`hyKgMSxKJOl8QfM%eU7SW@?_5BQRwFbg*HX~?GtjVKyN;z{iI?kN)
z7KLf00BMoG4vZ>3(|ZV@Gzy{-#e*99uM0-QsZeujx>}^%-VI|vTqvE((+?SPOGhUO
zNv{GdFiR_i8!tO+<M&)H|0)aA$K~*(-HIPhro9SQ@ksRB2X*w;2AC^oO(S3+Q4O$#
z-%;q6vZ_)7MX+yJ{Le1SUvq$(q8W+(z{l=4TMUm)<MM8BCn%ysy*2JBR+{S{ZjEs<
z&f~p)P!8B1=y^O;JJp~?=0Q=``y+*6qTzF(94yM(H_TNEZdj^b?&9|7q|reBGK#~w
z5rwuc>(iq8BdHX?SJk5O5A^%{ddl{FyY8fxTmaE4U^yv1Z5ss|=a{bu44p)^mwfYi
z##vS6swTMzH{ZN4Hevfsz#KVU4*TAV`Qyg?y_c}guhxGwCCS>kCin1>f}3d+O%ASh
z$mIwe7&RmiyjWD^(fE)eoRTDas}P;h_N>J##~27}ykcjRJO66;!SLd}wn8bi&&ET9
z_L2Q21V?07y$R9!E(_TWzfi(Nb{jz_7Htl{{B<T7hJDli7Mh6BMX(YRwKm@1z=LiG
zN~I~;p0UtSCBOTS*~rVuT{n44oZuVSq50nvUj2F_MSeMZW!Gh5yo`I;>1?}BBwVwG
zQ-CuAxACu1I}mdUzWR`tg@0j$jiXk?DRZ`LM1@}7UMpdmaRZzW01HctD-ll*{Xp8+
z%<_ptGFJO`Q#!V#7Y{^LIZFU}V$LS#E;*g=K<-80vtuipg?h%^-+N=u?L4^`kb^2;
zEJr3e-}UdFob7vL^;)iKoyxU#BqxA@r2BgYpTcLq{_dS(2V(H=3Y1Y|rfkNnary+H
zW_=y*4cZyQ?zV_>R9D}Zb_A@Z>~wtL##pQg0NeRI=8iQXCjlXZdfYY!xdr6yEE`0E
z{H0e(pIk35nq~6q-5~Ni1toW#Bljg1=LOA8(53-7sO;{;XbdIiPqBl~TYby?eFlMr
zqW1oXexLO3akeYqxs|KIbH^9G5q3|&*qb#)9+kRq!+Le^vEP;h)TJW;xYxVW-$tDS
zTr4kWJ|)4gcB^*$B**I}UgziG6){Z;@xWlCp<t^dZJ`-3jfUB-k0EAYGjOH6Vv8rN
zce{6*%Yn8fw!Dq`u#f*5{n2;nkKURaOtRzm^>+{4br0?Yym0ws3AMs=tY8Z%siv$T
zXf&L&4|R5-zD4v~JBM3P1v#qFJ^MJ^LC!H}+bH<7B!ZbzHu$+3I@^|d>yE#>rF%Yh
zf5PfDnc7*^IiK{0iE#4ntKbcC@TvkrdE1M5x7eW7<;VD1u)5@<^4v!-o|6-O8m#U=
zNmhh0nn5sqz+KM%&<Xee2An;I$Wfbd^I}}<Yq%VtUYQ_9V1l2~biIJNBW!I4_*#15
zQC>3JqFKGCsy_jAJW~P_^9_9_k1xxUgO7G-a3!nBHGp+BPMo@Ky@hcAh4Eb(=AE*b
zU6QoyvsNRq@yjg5Y&IQOmj@P)uS?o^W4Y)nQLsVCmduIZxS}TE8=>p9<NJ&G$M?qC
za$T(9U>WpU8uHrbT^%vl)>`?jwZ#Y_DDQixKNk!f`q@~-!4_Ep4OBv-SQrWe*@EDM
z9CqlQf%0#sTka7sjQe$6&OBsI2EQglMy>#+TlBTfKX!v>L>Bx#CT9n408d@$`Vm9f
z5nq$U+EDs=bPkjw*1u+Fa_~kp@r%y8_eyI<u#eMcULVa8YunSBfSE90b_;rv-1ds}
ztQBi5d8s{RpBd;yIQ<6L97$OK9YO+q_C>M%8ebnxO%5I`!fv!a!`=!I{b|>Bf9cy9
z2Oj(=JCcnDe-U5<_a8|~>b0={%%npMvaa*>WR6Q|WlV+Ms)On1eSRkSsx{YT*)i+;
z&-NEYoF%v$?OeDl-nh>fu~Cr#@kP9tC;6?v_gN`DeJ}QHII%TY__5Y~!01|AKSJ-~
zQLcv2jfTF$?)c9C@n$x_RxCux4F%}NrMx~*pKy%3Jn;prk|8(Bsc*#&#gVuC0M4-l
zcG(|N4WtN=)T<%$Vx8(==O!lye{_Tu825IY6IKVA-qD*nqcl6V#j1;V7rh_g8D1(n
za>%4oIv=s#q<B=vT+KE{p&QGpj-b%5-P;PVM^k9#LCv4PXD`Uxt6DN;9&(AP0y?T(
zF;#{|0IoMXS3%mOt9o1kq8%#35pk`<Km&?mivS8yCwl>;2FUj_O-C60kvErNBF2_H
z?rgMy^)};Y#+Z7WM+5ymCME~XgJXYxCw;lD4b&y@K)prOZK#c|*Z9vxip|LHeS|4V
zRdPhm^h4piw>uybG8|5(RkL|^T&7h~xgaV^)hLYN$Su3Q7A@E9nvT+h5u5Q-V@$;6
zTY=UBO@#&7${FB0dC$5af5xvi1mj|h2%mI9uHFrqbULV>&+f#ho?IDPL(=9Dj+zSG
zd*!xh3b?-!f;G|ZB(a!XQ*UA%+f%wQJv(^LB?NbLD31%LfZ{pbU`KI6ur}D8BsE(H
zHG>X}3a|)BkKqvDX!MQ$`q!mMnz_gdh}QmrWS47pyo;IrV9Ej$GY(9Ac!NNB>V*~q
zg>2GM03BMMs+mE!7vNo$#qBGgPbF-5CDYOMy;VT1F@o`?-y@Kr-Df3w4rG0UUYSNi
zF}QWS6$FEe0j;-bG+zY=yPxayK`uG9*Z7!DYwUl7#xl@x@>8ij57~x3a=nKtVs3vI
zrm3f~00GV!yM66d7b?J8oSzHyT4SfV=xv3|-+R6=Y4<;WO*!)Ey^on*kve2#wr@*?
zs3=bOc++l6&Vwe)XaxWzvItC@XN8(7)zu!C^Ug_K|FxWYf2ss6mhl#`xIOE3S|B2`
zXAwU5h)sz6PWo8Llniwp#8i&B^&%^XBdGRIHQ9x-_qjUXF`@7fqr8rgHt5nXBpVh-
zFA#6?y|8fdBKllG_GL#g6Q3W|6kKA<E!)g3gXIiA&CO;%COtPud_H_R05Q4eklgwt
zv(xz>jGJ3{0Vy#)3zNvTnJN#o^vBsb)uSvh8*FGNX@D)OY%{A2mN@)0E4zM^&yq57
zsu8YC&71lOk-KhE$rB!%Y8g`nLRLjhie;R7elG}MO-rs#6{+8ge;aLf8t-E_kwlNp
zy?{GSykpz^@;O!IIloRfAG^LYT-U@gA}4Jk5p}582DXZ_&5APE<nZMRmo~R^s?;g>
zWWIA;QjH;@Pne+bqkR9$i^Tila?EhK==HI1K9xR0&cu}0NPXAse7feqTt0JY*~>Z7
zAKT}xEoNsGU&I%n9*G`u=l(vb7I3EW1D#d*S6k7Yh1T)KHSiPZ6Ai4D_K%(@pejy6
z;<kG<{?@ZVD5bPtL;wE!Z>np}WgR7KAc)F>-`k(*B2oQ8bhO0^4`LXAR~Qh+_|6mW
zed?H!>Q~((kZb{qD^T-5VSpEnO$Y-<p!Nscs61xoWm_v&3N(3IlGo(`d)8|u1xR+_
zqd{Lf%hUMme!utX_f^ec92!{q;W)3AcrSKSd~{q}0U0d(J*krxSu>zdTR;0~<ih1_
z_+be$z)aBPM*tv;V+I{~ex04x1!GNQ6IM4k4r5>tAavJMBBVnXex~n2C+W-m+pyS3
zHTank0EAhrYM}xp6{^yzx(v6+G`jh@dLb2zL|nVn5&OlV@HKTA9zRgo`>Wsx1ki%V
zz#{a(jE^+Q=0A4?VraBS#BCVNpW_rP5YMlQ#yme}NiNP@FE%5N!c|9@VxJQt1d`uW
zhR%E7=evRTN3gHEqu5Y*Oy2ZxQJ>i)7>ze#Kn{Ued}frb!iw%7<l<x5sSc1dqp>=<
z#XcaE@@F0i6*#rToM|-<-ksB5*@XQXm#;^7^*X({Z2QLA5N4>pN93&hm;aa)6{$ZJ
zXmt%O_RifTaT%C|IN1>JJjDSrjQ3hrC5S@DyFb5bIS{_{k<IOH>BCh`!-<B~Qv%YO
z425lwc{Lu@`B+qTYV{<sDaBt9;{1rpF1bD%`mbgLc*N^|&z<>Ecf2pNqvS-sJwd#Y
zE4N#-#lgz$#CqR9u=n8Jbdo-MB>G2)*7wUb%G`zkw$yT#usUr-%q#T4^>-}I4sIQt
zDLQ~sc!B2uW(ka}k;M@=99P9wm26#{^SPJH&hc#Qfn#`L({-)2TpVzlY63bTYyK8h
zwr*Z(AM2;aavs!dh-yy3y;wU2upI*|J!_PtcV&5#HT_e@&RM6G2_rWYfOqO}&9Xmv
znZndO(6Rj4<(5@5?VGFKvaz!C<WEkyYw57dwCnzhl|$4@b;64O>bW@=(t<6aka#<V
z!odtXeB8^Fu|_C*akp0rDVnIs_;;WCGD`!iTnq6&6y+bW2ttFDpnsm>qL*Grc#OrW
zpy9B;MR9)a1D>n{?CI_wHb6k$fS;UWepmK>Qma8Eu(Wz@w(p#FPd5)?(&(X+dWz`6
zNZ{9nKy=8=++-k6QH5Q2%2~C^*F*hFD8n{=7+e2!RZ#P69zH69R%=RCa-NeyOAmf6
z3r`^(_;mDfBP=~q{_BTr6*{hbZVoI0@8?{5+Y3s|`l}2<gt$e}8MzBhl=!9?^hSPi
zc>Z4j@I%Vo>VffxWoBKUi=xuIG^e~f7!W(~VF+%fQaBW?`@%i&oPsL9PH7X;<=G|r
z7Q6nNp8!ZMJGvBe-+$IDQq<l$j}<6?|3@<rv~L8AT{k-J-+gap?d#7hfT4zjbpQve
zjemTsTxmAp?7jA1&AtZgLQwwtUt&71|2KP@ME7s^5U8Iay{M{Z57`JKig;o@>3`JM
zWhOv;r4d-KWS5$f#K$u1z@u`_AM#UaP@NT!SEyC|BWUnV-n1mg7T<4sW+Z79f15Be
zte-ynh{AXoj2vwgP1*VV-pA*;sNu^g2y9KAFk6xYziJxp#>jH{QRrxQAYZL(d@t5s
zy;Wll^!Zx@MRn+!7$(%xv^3nzFc43OnNuRS8s#(HZPEELPQqbh4;43~^)KxXXs*Rf
zfF@G)JUTeoOuKaESW42u{!d<ae~kBM*k<V(CJRd192Nws4sDd3t@pSA`o*F=Qi^?c
zHHP0g5Wl*(1ajB;t9==HMC!Pi{yj#0h_><^UjVKK(j-8eADZbq_q4x6yw06>^g@#o
z3kQ&&&PE6CbbvZ9T_K|M)!-LNhc79`4!g;_8Uo?G8{apFK~jdsQzwM6L)4v}tcUJ-
z$tg(zYK^X4DM?oIv!f9Cc;33%Y7$7^<k78+^EP&N#`6<vHiBlyi;I0$I>n=!+JEko
zly;)wS#NQWPUFw-PR@L%f?Nt<;Hct`0`gs*P0uIy-j$9%l-9inhPyR&b$de(nSf`c
zB$JaF9~5SrV&AFXygFVkK#bAZ9H$SHES51$(6QDQsMEa!*C(I=t^5F-3hj!j-xvo_
zx&$D;)xL4&k4_4%-@gx}n`hh4I1t`AbI@r-M}RIUKw^s#Hu!xt_8#)QS*Q@;?>_&v
zT^@*yR3P=IA}fKe8lEB2mJUb}BbcJ|MGig#5ytWRinp2cr)F<5kJ(_xY#?!7T4Uh=
zML&CCm-J~08gG2IZj|Dcf%?ew{~hlcFLqd|*dN9Blw{B%OD~4v>y^P1tn;7I`1-W}
zi^<wssG)HyRMU{_$b}}^Ncs!Hp$$UjWpdE|d?h}+gFo6osN58IrbU^}-Fx0p#*ulz
z1~Xs-are>!C89>k<a<`PyG3nqd7GEz>-M=I<TRt$f~2V`;zpb7Uf~qlS!=>CsiIhB
zdA8U68j6nIRrLW?K%15SuKL$<jIU>ZEQ?}!#0~CY$MTy(7j`i9n@pf$S&#ssyMt<d
zzhsMOTyhjjvU6+@kRzGjmCri%k^w1_)THchOik$lWs?3!5>AC@ztTp4m89dyqbUwq
z2CC_A`hoTw==icBa8|89HHDVZ6%zWCDU%qvhk+Xc=plXTY$KoE1lZH}pBidZx>T2e
z-786|Ri>|o3z-a+@`DQQzlwzhz#?TKmSW3vQZG(4Gd6M$J^@2EV8$mjP-hMNd_Dbn
z<6rE-i%;A==B$?*$-tn9kwF5pAhxWIE~xGJ@<F@VjtnyIpywqxsGLkSvtvCCOuX;^
z-X`wTW~zT*fcvH~N%14F12;B`Q)gQR>m>jh(jR0JZ5?Vr#UMH&0_Bd8m(>G7d_ID1
zq*fgqLGQzw7<ga8ayM!3>zN&0G^?A9qFs1uxCevSz$dU^5bqaU?@N4B=V-s3*x3I0
z2DiZEQB$d7hujgg(gYTFMC=?XllI<c{3+Ad><S;<i=Vl<%AFAsUwFcg-C#%sk1_pf
z2Ho&Ow8=reU(LR>)F2vDalStMyrK609QQxp*YSlr{4Pu<_I)>RxYldn|L%*RRV1+Z
zB4X#S)a8O0CPfK+%+1<BC+nx`ctjk(>gjbm3Kqe-Zg-LlB<-oAiABa(An^3lQdu^`
zcjuKBwFrk+0m!K-;5J*4t<%a;l}t$v1=tnn&ILmQ?Z5p4#tlfTAVvRrVvMb^)#&M!
zTb^$Rxzvk8oX~mSd<cNL{im7vdqU&7#I4EkQ~o{P{+_9dIm^5-dEyJ1HwqF+K#O6O
zK%N{c_A7qxQ~YdlKQc>9<KAm6PAxrDHt=d~O27iiuO=(~4Uh#jC6rt+2ir`mEWoDU
ziRqNQ!8|67Uyf%Qlg`0d8_5<DSmRqSxOnASvcQ^;X_8>i=#?fKBhyJ=plhWXd5TQ;
zt&){zb)cte_OQrFD}i0yjPkGQa@<1xBA;pz^y*3Zt{AVuO2&Nr=lVPfgO#iU0&D_l
zgO!g2q8l}9(*F@8YqA0wDUPNZD*c5HD+dLJ9Zj{rUiB7r9*9b%YmwL>_Z8xSm%C)%
zngzOuO8RtPl<z9OxPdjMXXHPUWm;22MLfg}bLK=|2H&lzJ?@QiK+YGTAV8<S-UYy{
zGa9ykq`e0!lHYfK+OWx7V<*f`<$;-?YzgPV|7J(-<H3j3X1igaTppidi^1xn#&*D|
zq8w<W^JxQu8*cr38BBl-C=jAJZ?W(j=#EeKUzixcLuzKjj%MXyq$SAH(qzGOjI>l*
zK}JC?CQrx$lrT6BIT|Od)AhOkD}tDo|3)Y!smvS@1=t>WS#Jk{Znp#2q+OT)N3z~U
zT2*f%YvHIn)z+RhEyd_OPq-2~eU=0iL>aQ0oILpW2e_&JhTK}#<{W8X-~OvZK&IbT
z_aI#}cN1R*TOYoR@BQppox9MeF<k6$($V%KOjbLIU%mAeC5_%g{a2H5?BjQFiznb0
z-z_O^g_K_V0zRPWdbZB8&CW8IKKU|GPRUz!LVNxKrNa{?IvuPx@3ziG0LIh`sFye)
zH+z6&<|QDRsrtc8`{9AJQv<9@E@}Rv&g^ZBXUzl|8a_S)w3D@MK60c9C1r8>7g06c
zKjme>9Yjtr1SV}l);t`sG0U(YrG#e>IWNxrz-MxgI<Dgdh&Kme!(|)8Wzc(M-C;fX
zZ&%a!<&-ApKJO}k=<Ldf{?xrsp%f211(;jmi?)CZAn$vMR-Lye`>LO3hEG2qlR$C+
zbDY1OI|`fRg{9vJRBq*0{c7C|^DwF>4gjo}K!z?yYuQF?8T2d}C?4~EJ0^V55MJ<2
zNn_+?z3g}2)XLB`5B!=3b5GgOXFR9U^3>&N*sGI9tK6fOIRh-tZ3BVyn%n|N%vL;<
zQ@p~5jV)$4TOF^@x_WVs`rB}Q0Wu3v#)ra4&E~RJJf<<FuYCP)%g(mvaLj~ySBk0|
z!#7pIY*!=mk6;FjCI(Qag_F}OwVItjc}=l=VG}b6Ji_twKR-e_-zz*5eCWTf`n{>E
z@z($$=(jUBP4OUq1e0(rYuUmAKc?3Vw-EA3Xucsp+y}ez@(z@ohhOLhcB#r(T&-$a
zkF3;s>fq@e&4Rw(?F$@F;eVMzES8(oMq_yy80)!@h3yGu#FKDHz(AF+sEbWb8jB)q
z4vpko#0L^-QlA4ZEa7wikFU3ks$*NahLHfl-JK*rAV_fAXn^1l++BmayCpaThYbXR
zySoMtx^Z`RcfKa)p8MWE-@_QlpnG@sl3uH-X4RZUht5Gqegvd9uaX9w;LeL$ZzrM7
zi#UhMI-wagz7^?t2U$B(GS5z52&3_I(%0)=E&>jXZp*GWuF6B^b$MZl@_s1#Z@l?4
zXUg2TaHKs|ugfCnJyn}RUFFLv*rVBkT>(3fuMpUeyziT%$5ZU#j*D8aC!vmuI9tjJ
zuV*26!?MXXL`KrW2-w`Cz`I)gQp~|Ec)ureSXAg$-rv}{rseM?-)`KXoJ^ia8E~Pj
zduQSMk~z3&sj`aXOpBwe(FL)#ZP%NAD?hrdE_7d5=H=mgb(rr(bcV)zx8Z&gIrQ}j
z5F+_=g{b|&Ov>nd(z<xv3TnT1zTjV+E)Tfw7riD;?S(#UgF-<93j$D%SCb8JiOWMX
zuf_`fHkbFyXvkjW01XQJ3G(}<H-~=><<mnzuOa(%w>4Nh;&|j9t*g7G20*V1F*7d!
z|Ks$q^*<+=4?fBg-%%K9q(cZv3{pNig}vklH<fvK_#Pd;kh^`j6guukBSWAGhsr(Y
z^sP2)3phAzJvfA}tjj*wEe%e0=XFYG7J*Qc^g$75CBx!`<LY@d*#MtEJOsjx)*=9^
zGZIt7SFLDDV}zn&me+<afcoXXJn5v4OtaW>QNvzonxirF%ym#GVqqf_03s0WwKxy!
zXoIjQRl9z<vtUW3QM+u;OCH`=?uig*<O)zS*4EwEP6KTCfML_*?&5e9cL-4I&Ewq*
zN-rDwuB`3-Q<()QO9@^v16f)_t?q!i;{M90IBD@05chTbWc{zZfNF^@0zY3x1Q?z~
za0f!j=)WDmqeL$@-2rQm;XfpM(V#y`b3B(t(>v|B>6%cv-FG9S4!%91UXx#;3#SDy
zW3^>?csOnT_?;#lNvlr6qBsjc|B}H+l`gx@oraMv^V`+$v2b^kc7laeO+DHI5i%7-
zc0>7=ts)&{`4;%X5W=E8D`#6iUXH|&RZ#Gvw>uA-Jdc2Nru&d;3tpx>DiG=FlTo%Y
zujTV}wq}$R?(^;N12zaV=)%A9nt#t2>_b%=QRy6x9NNzVMsBtsXtYc3J4)fS=ijH4
zzpM^lFf&Hy_qYZ`$OF2j{3?}m|H3_`bq}7)mjKV3NCMJ!*!{Kh1U|d5C4Mt`=<Kf<
z<o6zt%MO`KgmOSJx6j|x06MtsuvB#13YwgZ^wbdK7|`#7GM&)=54Wf<x~kWvJcQ9K
z{b15t0AuJ1vdZS-H6h|*H)_x60eBjOfCY`9@~g+-$h8#!<**wS*tOQ*cI6Sq9RRv?
z(~Nx!Fyz#b4Ni8GgT1A*bFW2!ja!qjYjgi>)<fZ351P=2KW<Z4ven%N(4DDi+1$Rb
zePQ*kP>RuA2<aR}PHk1v@Op#N>Yf=GT`~7J(eCe!Y>ZKA^MbPQud<jw5uo65PF*em
z<<j&XJ_r012C*PsUmze}zIM^ckJkIW<15Mt7P6b7VNdBEgTS)ti`s1XFSFCNtxgOS
z+!fm?CbH032P~$X3zc9_z{M|I%6M-e*q7se^*k`v;6tu*^)pwkx(LjiL>jQup_cU%
zpp*F2{3>)w_@^m4B@j@}y1DAy5~CochthOZCDgwg(rmxLTfRtuf@t<#&>FF~SfaP^
z@N&4w@904%9p<*YBwe^Jt$8eAt+*k(gMS3+EaXKk3E!Ur-V0X&6*k=QN3*51uYd%Q
z8?pshB?ylz3$i5X>};9xaVB{M*u1v@MzP7Zmv|I#lQB*Ci)zN|_C|0C2beTfSHV2)
zowNs3sQ>LeOkv$kVco0zCE-F-4>15xNz(YBXX=hcqE9Gh^vm(87Kre+?lM5<)<y3s
z{I+l(jAGaYeEDV2q<Oog!XXe>>05CRJ9d}y-Ddz$fQ6T~zTXcTQbcx*!G(C+cqajp
zZ@`odCZX^^?k5WZk~0F}NQ!?>|HOjVoJ542S1kdvg9&iA4j6zmz_tYd$SCMPp;koB
zyXeP)hm+0BL0v%w+@ab;7)z#@!`bIHz?PvTv@Z0vgX9eyEqGB-^Ev?=t1*+`@qfJy
z-f+Mt()v_a*j6sb%GK_ejjb?u_LvK-GXLQqf8mYL9?^0Ih|{jnt`Q6xyAo*^cQ0Pf
zSeF8f<h~orMF7y?3xOD->MlH7b@)Ov=4G>hUX1-0Z6~Nzskfe2Z@e9?msXJpA>)9$
zz;x;U1q^L^=evJ#nZVY(&8(bOahLhFdbj#$S=rw?oME&CfY{8xbnoPWC_OX`S^#j&
zsb0H^k=rRg0@Q{7%Y%-TF|`tlL|&3X&CI=H3jOCuz9sq#?k?b+9(%lRzs9-)tE^z9
zjlu+ly`s(|2E2{i`E&*k8vs`N>kxhO9FbK6BFv^H9cn@zr`0^4k{FMnfy%CzZnF11
zHU^wBA;?%mgI-yLda}wj;G+wE@{I*00C?$_;nt%~sKvn?4`&Pz5apH`&h&5>LDRpZ
zg3VzKL#a&knjM6$Oq95?Jbc($SfEFC8b<NBI<W7B{dkYs5?$FF4}fUWKzjdQ@Co3c
zo1Z@zV+Y!amFo-(1z#(U4snV>X-xE590VLtKt#y6-XGn>mJnqqauK~pPyVU7>G+=j
z&?eOK;D!ed0MeIg+Ud+J3?Le^?0{wC{3_X_|8Xc@oVz#xI<X}T0GVz80lS)@Xrb#B
zncPWXAT^ZfzB3UvkSXp&p^whf_9q0$`g%_Rlt9R+AOU(t{|NJRCQ97U8qU<4M%i-%
z@1Rb>2{bk93i8Jt_CI=_KyaBv&yz3$K;YNklnhrppf7DiF}hH`!VEY8g1wTyC%8EL
z+BokW#ll+qg3!j407BWE6x#m!zt!53z|RSgHuig4v9Lo`;OZk^onlc4KC{d7c+vlh
zy1;qKC4NFWn1hJO0l0{@Y$uz6dxA;`(%)+CS35dFix7J+g~b4w)}YAsz-s~^4QFLk
zHogU>Qq^<z1(uQrR0QKeS}t^s2myGEuOUt}nVBy6zK6KWSCYWbYS8Cf6;4w>YgrGy
z;ed~Q1hnaI@S|JS26X_1u$NpUpbXhOhUq}D4NmW3HaiIDxBtO&_H-KR8dde2<f1m-
zqNHfNFc)0?MSTCFJ$pI|vzk^BHwQDln78M-&B*Uvql7NMm$|<ayhJJhGuXeRU&J+z
zI`a|$>p>)*uhQjT>6jNdCthg;&l{Mb^Phml$v=J8I}^b`<u$O#vg-(4s_0%$K}~8(
zTpna40;nBfr9~eS@7YG}5`z70FWB4jqbd3IOOC)YfR!w3_FvPQnQaAv<mkCHvfqS2
zEw~J7_bE56Tmq+<|JSWBkL4%eP@0%S$`DwQoFo<vjmt&`zo-nS0+jOJ^vUFKGFztm
zNx(d9APFaZ8%j6h+tCgvNZ)M%=+d$zkOr%$OJhl_E-_t<BM=>@vw-}u#Rb5$xdH8F
z_?czND{*d!2|oz&vU>=X0E2aLKGOmwY3ifOXxrp;8@u4M%D8}}`em6)I!9S~sOlw&
z$C|Ard}^Q&ED9h*46u1asj>)qjP(M+8a{XeRy}0057*GtA<sJD<{f5m2wMN>C5s{i
z{#ccTZ;`wO=r!KY6`&*)Bk6>8ghJ!h-{IB6sjUR#<s*9&t7oDO5;NTFTB0#G@t)X|
zQB&Gv`lXinY5Kxj=leCT)pgu5jEXh+)e5m<>RnlPBfmGJo)d)T)P=5tf?JS>cIvkY
zz?0K>KdUD~e$fpL9}+g&H6h6{+BP%|(6m2uObC>$+0-2wyXrgi0dltzOeb{9^+~HQ
zOZ8SAT+(vzR-WhsDw=J@axV}9w1tKsx8w1uHxLB;=y>2*eyD{ypC5gw4sR>C9rKeT
z4kb@(M@Rx??E@PMVDbLPyE5{+ss%7hhxwMrslSHDVv1za)JEv|x3j-WSaon}%VJYN
za`Mj%ox6+9Ey8lyABX{~FtkZJzUO}vmbjM1hQ%q1&L1VvbMYPb{TU@Nb2(se(mX5t
z&aGO{tpF*A7(lFX&r>RReTuW3n@cT>S(_0WsRuy4097xd70>vzky0@riai3JJQIB<
z^FoT8|9iFT?Z!V`1kl5({kI213u6s(kT4`|u<Z`E0a4|bJ1SNA);)S%RQXoP0aFj%
zs9_l<7A;=|q0JRv-S*5GM8LJ~RP|adg6>p(S$uF?VHOACiCC3ypsI$n@xL&u0NmUE
zLP<>+K91I{hHuS#9DR|Eif0Prkuz7+CjQGX-hX|7_6#8F2u5nj0m*QB%3kOIVb%Xo
zcr$b=*QZ0nBdfJkDeeMswJhK`P~ofmFTZ%7np0HdL9vk;Mx{aF1eDNkikFhX-@wYE
za8*5^p4AO09RZwe)l>aq-vCg}0OF4l3Lt_H<RrHct+?ZA%MGUC)}9L`SNV7CF6IaN
z1+@brhw?3ZMN4Fv?!1LyJZ=}Ra>WGD$na3dPB8!Px5k-{-<t#W4qNvQp$qHc_GT~t
z01+p-eWE=yGz1yI&Q(RHO;<a}bZ-JcCEvZn9CzpV=beSLipW0Rd~p0Zf`Kg_m;9AV
z<KHcyv<{(uNw!p+a(QmF4x*l32np=)D8@;PsS4OXY~4SEF0G5(pY=ch+zyNSnF4KW
z9V1)N;{jl>Gw|jw9sTo^1>hDjAjcwa@lDfQvZa;>1vU0A@<)Ogp-X4o%PXkKd5KF}
zBjpw(<&E@V&9PvQ_7!;#cfc(vth+C)L&#r}Ei~mN2kfUp^@B`P+a5~2QE0Ruk5OxX
zx3RzeQ{2I<#qY5Ow@AzB+~MJ&N4yhidU(_o!P)Ca;G}_nAR!<QSy}^(rLHjxTauP%
ztLd@ufb1{8RemXkLmq7b3diff0M>fkE<gXZ+z5fwAC}r78u{b=9+2%tx%sbVZC+5A
zSZkhcs~CRaevx$2mF5eaiqX1-tc#4%8r+!|9|qrPs#^pEYC7|W0V1jJ4kUJi(f^3f
zzTCqPnDW6!p9xg1GU)-0hC%!<qfGOH*C}Nl41(80yWmFwAaKn;PG<ebe8s~ynMKdm
z21<d5<wob+s|@Z&=go4_-h_<T2zbrWc@I*Et>?@M3HtF!e)ZSIy4LVLVjpiQY@8On
z)_a=Ld)5g$Rr^>UfJaLNfLZ{1#0#`_3qDlh=D98ynAI~!r?d5)^)bZ%5)A-jKoHLE
z-_NhG@XvIN?%d#M&%>g?Bg+d%09mrPrPDB4Wik7+@4En0+xQrP3J4{c7ia3oxkl|0
zxyS&!TSH}{cPkSh<?8lk6Huq@b5A`(z8{U2PO{dckYw=|ISvO3i^AK=++VN|L*<s-
zMH?ndXRhQo*e3YROgTn^-T;zcy8A2RICbeS&3Cn{9R#OgS8N%dv+j>n(Fc9|1^`-a
z?x*v3p$mVGZK-}{dd7dBeE=|sa*9;#D*~I$ZrOp0uyo?}>p0OEPPW{GJ)OJT)}u!N
z$N3?2osz%+sD@zmp+qus_wBCbnGfv!z0~sci*xeh7u5Ay?$rl^A2zpS`g1mZ=y7-R
zKn{bm7t^EX^7UT|@4NZ1)ZG4BWdH}|)9T}4H>jlb|6x+x2>2!@4=-+(O#h5djT?{|
zkZ_65iC)XxBLAm!UgvW^;(!f+7+tnpoO>+;XQ8Uo*)mzvp^b&2w3_ZaqW?Cl_WdQS
zzW6u$?iA<(;uoIpzAt_rcIU02CP61>Ygt00S9nKy_41M_+{>eYeeWsdd%^&O&rkP&
zM75q{e2&4;;W)%Ne~^MZ&P^(ju+D$Ad$!Mk*}b1unRfu_N+CZULFYQjdM2UaBhxOg
z(Jy0VdLqBi&{pT?;SBx|5|KulN-w~p0hN16`P0$90=P%(36N;^(zYQrDSYJD<Y|hJ
zYbL$X@id(qFx|)>LC8lk0P|N*-7A7+;T}_)Gk(BdF?#OgR}O^=Kqr@X-#Gvh9siXY
z8fnc2aFMjo^G^PuRe)LfQR{)3fEfUemTwZE);0TX4(@h<a6j@JCO{gH(nt+pNVXvv
z{hRQzuK8pPh!W#k19C*vE{@hjKf)F>frz_z++{i5hW7!@neecRG!T=1kxs$V^Fjus
zQ)Fb)-J|=$QfbWe-nMVTz{#!PEgD?)^yGM5YQjv|P+n%|2tDG_8hluBbVhveOPU!3
zX4uGzci6G_`}Rkyh77Nl$ckATpm7=7hDPkmPMYR7{$_d^kWV;UWP+>LrMj-FAW6Ts
zeb<A`8c^yD^Q|hX38RV=6)@I;THH1qJ)ds}Q3k<NvQ5G+&Ib@*=oy1;An}oB^7D#M
z|8*PAiqE%)kyd8F9MiFNO*ZGu*dy25dk5?nE8hJsz+vxi3qXR!HT?zEGEZF)^WqQ5
zAKo`u`MPJ5OmO+SRF_rT1i;|(Fgunobx@IgM$~KcA$=b~@SEv&EfMB7Q_Rim2@pY`
zf2%<wS;ujPX_Cm#m@`p=?W%j$!UR`*@$Q13q3501!32W|lO@@Ey*v1Qzj3%obU+j9
zFWWS18dKIekOJ7jaL_oKxHF1JKqrWzEaLm~J<E*FnH3Y<-y(iVtuOQ0R0=R*kg5Vi
zh$dgmi&$dpu{(GBB}*e1Z;hq+e3oe)h)>Uo@cuxodNUIA!}}cIDY#N*Lde&FpNxBM
zjv9Wv&kw`DEC6)qKz32IAiHB3!0rJj!tyZ%Y;Tg6s2g22n?&^j9=)pPMK%I~qYlQe
z^L3PzM6aPi=#)gEb7rH-W)p#PAVS5dPK*W(A@(`dpF>F$x~ODw=N7zR2_*{#d}Pb2
z-?J4T6AKZ(W8~7j!Z5~{2PO<qRHcK)+=7xDLK(0-`#5geoBP~ZRa*xoX2X(ChJydM
z)`Dckolpyia!pr})|&R3gavS_f23`J{xyH|;%?h`aJOHv%mDYOo%RM~ej>5~Z6XbP
z7)f+BA0VZ+^>7nveo)VYpmI(ppeIZkpTTSvhI!`c6%H!?-!guZOb<dwbdg+-8GW#{
z%SlHn3KgI`Cgb(8{$Kq~6N3hjtgt(>m&9HOzD%7I7X17>OvtV%^g4a(X*|?Ay_sh;
z3!Ag>h(5Gbz+tQ}AoK-TL_MmW>-2!8h&7Qe<vPT|E9)I^JZ8II(_49-23iWwZv0j(
z3QxEoIaN7il5xa)LL{yfD;IAH_)YiBOyp+36Z@|}HcL<8$)?sGo6fKU!pM$3Ug$gd
z>;2OM_LlsOqj_072fxSbwb=@8{PYfJcu_#0YIp_d|7m_gx?6sB*3Cse06V15Dzg?X
z{E)g}2V2Ac-eZY=bn4bn&WM|rvu!{_4&Ykkd@IQr;Rvjq|2}BqHBz-BN0X<Iv$gdk
zAT}^ug7T@~Zw>IU4X@(MUeW3bZ9;Hcg$EEa`1c@zs>y%k72!Vy-U6x!r}2P?)QTG~
zmw2OMwq1R`TV<G`u>uA8igv1hM_s1pS!Cn+)%UanpnxF&@o?5T?B&_~a+c*rjc4Xk
z2_yqD_RmUM&r1H03ho>IW3GA!<j8jgp$+&7i9qoKag1$EuWe1(G@EzZRo$h4#i3H9
zD$hS(btWi%%>5S0(g<!-(`)lTI>F()Q%($XWz{h@o^#L8FVzIy>GRg}To}Q+?{;7<
z*G;;+s8GvejSpa&`d}DFzp^J_XB8OJS|DHSsyY*irQN>1jdbCE$l6>+>5gJ0d16VH
z)t;vQ8V~No74#HMx%rOrTNUH9->wX$kyc-2_@a;^3>1ucTZ}=@o(qCsp&xHoHG*pO
z_m#7^C3FlE6-A=pZ^&|qU}@lNk!8!(hF_x}|E+37(dr*62R}ZLsYxsMNEK#C$WsSr
z#Owp10*RyjZ0I&$qGvhL5o)GE=w;b4Sc?1Vq&(V9CL#{M6i@({e=#l!U9XyBSJvn2
z0k;YcKlveqU*b5BsfBAKRgb_z5R+KN&&fKuu+Davj8bhHdSx_CAHYcTVIwUIsglb+
z&m7&z{$uM_&yQYsy^$RK5hGtvKzUvw!yonSlD57zw`8&pg78^1^1CIi@M<GD>LW&a
zpn&2$RR$ER1qdrLtZOcMD@8J6b!5bDauD<stN9cwq1p(=zF)s-1sHlN04A0qV1d#C
zg%AFJj`hmto_{IDR29Ofk=Pl<?srsrrNkp|1$8A&bR`Wx!}{7ok0tP$ZJ)56m77?t
zN}3m?19Zro36{tP_xrjB%gdov8;>%G7NBnGc7o79qi^9x6Bg3gz<(aekr*+e0Ey(#
zB-R7{IoD|Fd$Dn73H10|?QF?x9gHE6?7!Do@&(RFYsTE&t>KIwdv#l^B@3HlI-X<7
z5)Gyte-p>P%iSl*;RutVQ$Rx)-sk8Xz(FWKlA|zUA_$Vor&$*;9_^-2bFVJ{;Z<<#
z{uZLR!K##+Y++I<Qw1JscTZ4@k`8VMFQ99|sV~GiEyBg_22slIHUz;<Rhds!0iA@k
z-%qSe=x8TC)uAYr#RaN^BK***U^r(e2uc+Lr9xkR$O22V(g#>)o%p}w39v@dyuSDY
zLkuB<-J50Gn?=btMZC;m0G?v^12YAr!`<Bin#Jvv#88BgIQ&GF`9u})xLA8J{Y01f
zW|hAdoo%OK2~qGgei`QB>5b&-kC^y^!pafIzRpx(@YV?0**7>wuzaqDir>OOE;fY}
zo3fUJMW<k+*!R^D;gqAhu^C%F1hO2Sau?%&a)|nW$G=@VZcM;{`+wGa{m~%|%4geC
z|8E0+lDSHUl<bQdNjbtl5)ALcMvWAV8~9yVrd(*jk2`#JpEE>wpC<odT&Vg8iDS)I
zb`o5yK<yJYB+Xtm`%8VqSPv9ZjKHC&g>D&~?%cM2OWbEvF`1$~XQ&5CGyx_0U6NFi
zxfZLB48Y~k^-)C`EB|I6P&v~A6B)ZpJ41OeqIxjG9&iVO(qFBtR6D7yJ3^V+PGR?5
zVA0h4(jS37Xka^NKq=qGxN^kug_Mg+rJ=1k$+zJf$=ii0{qIe{X#3m-pq<|B3bH<<
zkBKS70ZnA>V5u(fAe2X>o}9lbp`%pO6-hhUL??8z?CL8_qgHNTP+~AB5&DXxgUqd1
zUv8^IRS5UdWAJ?!kue4uG_EBza$!TS`HTah-U#MFKUfuBJB_-Cb(ti7Y{I;fA|Mrv
z*Z<`$Fr$v_h_1BYXB>b+=y;YLJkvfXkIKv$poMK@wZA~X0rQ!2;2PKm+Pk4~At<s9
zIhw$f1IEn{#o9eHb~f|xtdz?JkNCQS<>ltS{Jjw<cztY=vg7MSzcvPYp>H0j94uD_
z9%*+6tI6di{1B>hyzxf}jeA}LM)fv06DA7!(v#@Y6Mo`6(A_@U9%%1-5%7Rnry2A+
z4LxAiToK5R<SC4p3WDVFX+r#f2NgFG1oe5r5|UVdj@b3eBU2m6Qy($a1IZQBKtcvH
zQ&Wq-Zz~Jonc8>hWf|MEdPLBXqM!P@^GCSz!|u6#0u4cQvdPf!eBH~Bag6MF6tgAe
zmiaQl|7}R=2Jn<hHA{-^XeM~Rfhi)x@>V8=4gKa*=fK;Ay)O|8taOrvJ~VN2g_&XB
zh{TXrxatp~x%V86(5ts0)!VG2V4AtO`;o!Su)2_)ce3bCsw>ra(ftuq?1d`jPg{Q1
z&1)@na_CmPrKuGS4g4sJ-p!zJ?KYoASF=>Bx;7uAt3~w1tBigD*G&;#?S3v#-Y4qE
z(Z_>p!*jKo`wCK>p_ZE^G((rX<)qTh(S^EajxH}wuM@+jRE?$wt2^(m^J5oxzN-*O
z_AbrsLKLLz{_Mat>(JIyrC7zfrqR>IiSO)4O~rir`c2#AK5HKGvvWNcTZr?`=%Z!c
z5!)@R_S)&#=7fmz;!VZ#gjH_{L^Cgssl~$G+j7mB%j>T8x#Ia|^vEX9hTEwoE49_g
z!SU=dRYV|M1QG!W65w#reOj;)067{Gd(NT_9n~Z*)kH-pKVR-&T*pD~y~&ds`5lj!
zwMdx`yN9M#kM2ZV9-LHqZLSXnwv5`lYv&KCd#~4XiNQJobj_Yki&M+G&tBH0_lH+y
zim-|Z$sjNpf8EW4y(`~ydFp<}?ZeE|G|D>U;I#Whobz$5Yk3~B*^(Z%^t2Pgl;`bw
zE+8+3@Y)+m*<DEx7OG5$3QArI_7x7)>({TLFud>70BxZEeh~qGxmq&m+8bLsFuB;+
ze>JeN`O4^OWy$#RpOP4vuU*V2!N-rdV%Oag2!`QYE#X3Ck2lag3TvakIbx@3p1m1~
zHIa-DM&m}O&s#rV?y*Jeh5i;nfiL{|DyXB|`E`rm<I&+Np~}$Dr4_SxQRU=VMa|eV
zzW5SM8dc|9>Wl`R(Y)F@{gSc;)BTMBhYC!CXA+P!=pkIi5>41@YkK)6htB76!)a7B
z-E5Bx<~~%!A$zhI*0C>91}pSTEC?4?x0|3%0V>j&Hv?q>8DBVD5GQp_$d28SZ4l>6
z<h>6b-kzV;C5x7nEiHP&y!4FR$*uc1(C&9IQ2$5I;QZ4wj`{|c#tuw>e|>!E7^`S)
z8-He;;Nxrh6bFGYYlu0N2*yHCGV)5SwzEA>tao(n@a?gxX=uHj+tT$e1afz7)6tJ_
zp-4~IZo2|4)Szt4a1Cww{o;u*v_d)|oc<eh+Gsmp^Et!)#^(inbC~>ME0Z57Rzd#B
zeirhLCVAC*QxWcRGTAZlxx&@{keKa=0==47UlNa0C}I(5n1;V_#@Cp0@wO}l61hNs
z>YBCZOOf?c8V=!6>{TPpd5l*xCghy%+yCVDEAosah@V$2ern<8(>jWm`(fuGwqZBA
zFi~X-Esbs5a_KW3F4O*``z`c^0J}wjXs!AcG&%!@xLfQsW)wrryVE;Rf2=6^<-`|r
zrB6lt1`AkTn>m`}N95IpH?S`~yM{*_O#s-3?Eh!aVgfyDWMe3AZ)5AgWN2e={L-xv
zUk0r^nK7EL>8X~nxBYxIFmi;saS;oYO57a|-_^g3G)|pfo<@87iy>sm*|evsX^B)O
zQkn2Th*)9pqvTHlI12TlpbtGe#_Z@Jw9E;TvV$6(1nKRW65gB!-^(?+zDy%k<Lbef
zzD3oy2<Moh^RLh+&d>jrCd^~6z5iV!aSw)mptc$+t;ddBRquUXf`JV|;V`E52k!k3
zld_2s(53{E`GOh&akL%F8pw?-oaAhO;w!PPa#nJy-|=3Kh03~ek^B^y`mFto=&i{I
z;>->fzAH2EJsbOl*~uo4%x4R~p;c<EQ?+Z!F78H@*TPH|Xx{uC;cbM3^D}>E+mc6@
zgVw%hVF9iGyI(0?wO7lVm!yZkNKhcc>UERNls-_5Oa&jDt>L&sY_DcM^Yk&*<@7Kv
z5EjFogv6cK`_+I{@DBt;u2lPdFM{7nl?Gd)rVJ2Wb?O>|*+iQrT&$eQGujW_av1F@
zaBBlu7lM5l*`EKt4YI;RqE5h=9sZwVhVj2+rf+NeGGyt|GB%wrtHV96^6wfMT4IVH
z@K!0#!gFY(b0q^<_$-@J65j{fbfHkWMriJ9E@!-V-Pszs1VaaA;brLkkpOuOV;9sr
z%jJQ0bOviG_J<$Xc3xwa%)&mt9v1nGWDtYM!C{sWtE*4aO@<PsY(2lQtIf=}$#PJ>
z@9}PB@>_?mOg*(xq`tJ?yS{N<za3#M(s7@x@ox|>yLmFNt&em5rztdgILqTx?@Bd|
zePcf8BHtafsQBj{yq?cLhC1HHbyXND6jhev7(g?;u1Rw_?_IOb9AtX%{p>16%@i<R
zS^T~=B)xAwY|`>hDTZX*Pat9~wder<WvUZyv+vykost4{-T(jciv7RcX6WSLXk+!a
z=Y}hgI+<~TRu}VL&(13$#Ee&maq%i$M=#YvJJ|Hegn4<q@jr?TA?KHcfF4DPF=jC>
z8kp$cLouMD(J<IN{^FA8=wHzz3(VYv|Ip+-t@Q>jv>!U`1I1VFJRFN(Gs7#WiQI;a
zZ$xdrfbG7pMGki+AFM&g@hD9y%m!iKQh9RUp6;<fN}(AoAKxt5P<mKpdz;SxZP)4)
zly4&N)ThAr|J^Q45gThqV{1oUB{y4R2kn=3wZ#8@iAAqHMK`SC2^#YY>HI{=2k{CV
zwUdov>wlxq26ryIq{)9bBl;eyrhfIO#ni-r`_zb`P!F!h{v9^U_u#is$%WyARFpPV
zc_#_dJprz@V|uWE;yEaPIow5lNll<giueKlEk=v5gTz`!h+PW57|I<)vNWnBfiNC4
z>=AAE0L87T!sx2CZr3Hsjd+yG7bW=`(zy2CfgqP(Qqu{ZZk|%B{~)u`R#QE2fTuS>
zYrd!rQ3DSFiqX^bsag9pD@*$eg8aGvItO2X-axpA2@Lj5({Z2}=o%uXp?aa1+^tn0
zIsv-EOBrwg3+Imi5|l8iflipkYX3$D5Gyk?MxB(*E9u?mPUk-FG~>-2{@x$zOSJEp
zwV}V!zvc=~e~#fvxw^LL41(8_GNJHrg4a!2I&N>hj^QCmUH39iXcZ8)n(G!{oS?Nj
zwPLg7dGI*WA+=zGS$DnOT*e%`JFxC(b0##(tAzY=l1z)RvGndj_*n9+xX$!4F9&ZI
z*nNOGIR*cJjo*JZHwQC)dt)O-M|*Q?Q-{9;*fMWFKUd3e1uhdDD$Lm`jI|tufD_|t
zrVE5@qlpwL1Ys%a@<Wt_-hMJ5ep@f}1)?EW5SP&>0zOMC>${EflyE19a*Z)An-aQh
zo=FHFY_Grgx?l4A*ygRiHEgJ1U1@M>BcR>lb{!X2n%n(BbLjanPhp|y;gQC)N=BvX
zEtAS_+vCL#Ywx?V=bMbD)>%u^MyHzFx(vMe!@IU-ucl<iapOui#bOBV<A{g?V;sYy
z+VHaVlyS-*jxe@G#`C)4<(B))LzaFO0d9yv-Q4)s<>$MjJsQ)xfhUK=#>wNQ=d;zs
zjHlCUnX9O_dCtegA)e%Ms2zpWYENmOyI%S3X+Qi68Xupg$KK`Tv-stPM&ii3(V)`r
zj<2){EjS7G<z2FhJm^%&95<_7|Cl7I`f$zKOE^?Y)K+uN%mnx$dg02EaGq!%_GW#r
zfglU#ef^n*_6GarN__pfU@^%Di=Xqg3_$JZA=PFl(%6>0q?LtEn9ArgrPfe-T63Ov
zmi_sDc%<<DX`1t5`FQ!0PZt;$btr<YNOSk(+K^y$<lgV$AWBOPA!gUY6vI(wWansE
z#|`N@N7bdqwN+Q&jbF?AHyJj9i{r6i2oec3Lwh<|h!`S%iDAz`b^*wSlYRMNkhgbf
z5q*-veIAvH0bFx;SeHJWTEw|xSu?LBut)IR{;`?4?fFf}skB*ssL8tQ{hadf$WhH6
ze4T2fT;iDMxG5MV7C!fOJ7aNv(B)Xbv;Gc>U)F;T=~bSI4~mXg<?lPHlp9bK8YQiG
z#Ihp4u2+do2dkW_tUM++%B9*ponxst<`R_l;#ge_8tlPZD^e333m7}XtmvM}(rKM{
zAPZCLDtvpl6kA4k{aR?&fhVqOW!e0gd*GPgXOVOH308E%&3zc%Ks+M;RH+x1W}PwA
z0FM5=V{?TirzoWQM=v(MtD(yK<#cw9s#^Lj3-|Y)Uxo>DEPbB*w8`NszL!Q^H40N+
z3dl}CP9FIAyXMHho-mV_!PC|J_zIsHzVG%%)q_vHf_n2UIYh9i4>A_SN`M+1v-o~B
zKO1yxrUPP~^11)$(a*`2eDXUn%uyVy9W#`cv%olDnQA3y{;9{C4_Y^yXM?H1ogg65
zCEnERP6<J4Re}>`fg)T6=cfL3DD23>Y#oY|z)AZraDB&##=T#!$pXa=z@Jk$PS~ut
zlR#z8fyU3RN}eu6{zw(&Iim?Ho3a~j)^sJ$6#OI2)Ec#!+HN#k5uccxH0o?J;`DU)
zo4EhjXmwQl`4g!e_51LSU&NzlPU%Uwnj{ir_D)M8!ZKHNd;U#7YJY7|j8Y;WlJ4li
zZ1%YO%HCauN@Hw#ma_^{eZ_gEFX8)Chwo+JSu*CQMDIs<QE}!JItccQEDPXzn~oXq
z6$hcz{1sxoiw*Z2-0&a$h*EDabh+j}5}xKxaC9B)F}?2PtdvLg>#5IY+HZ&+O0J%i
zp3>i7{OGy#H~U<QwYQPn!F&>Neu`lE5Vu;FKsWTd;?1gyFzViiFLYo*yXCPSjt*wF
ze4<iL1jmxRey;O=RN-HyB_dg01LW@+i5~9uq`xN+5l4x$W_#MM^|!W&AovvbWD<*s
zu=IUuY$hANcUk6Tj%~TSGZ29o9=F4G)uOjxF6M<DjP<La@8X~>hVP=Fh&h_<5n`u%
zHL4eto<DWDQGG&31${#qK0in$-c)aUkK|slUZ~GTW%_!7J%?aO?KX$*fS|OW0gvB6
zAZBH2FJdQ>0FQPfr5nDM58m#zuH{TRl2ag~iri^sc4wfh3`saHku;6VXHjfhS};-4
zX+E;l!)Grd!i*5~0gcV>M)EbzldJ5oQ|N90aa`}+FpF_|6~cau(gJg_#D2U&$(OWM
z4aX*hK>6)%gK-2B^hUdbm^E0W=L#eGNS@UFVLs_$OQ)TF_MK|_!ieTsIs!I&MD4Zz
zXH+vWxcR)nII1~;p){4so5SR@@}kZdz51cSj*^)YIjnDeWC!IZcwJVFElLSyn9RWw
zStUZIuq24zbnMeR*!Fa=Lsg30ME5uOKOolfI&Q!lp2W3+xK4ie8f75EZ^H+mwWeT_
zUPPWY*1(<CJ{9qcZfnq7oQw(jSUf{95vU+LtOin}y@CjqwRYwCX`#)z<>y)fw39XR
zSLv^HnY|1fg?=G#xC`-=F})ACa=8+N#qDG{+4&G^M049U^#vA$An>|G;qfT_G60SG
zBhSDn3TX4;?udP4yuY^IR!5&Bo6C09Y@llTSY}q0P{PJBPk;GL^E{JpGTR{-f#_#H
z1=*sX#{K+Hln9FDd?5t(5#B9o70N;bH0#fY0qL0ArQ)~ZmlPT@Occk>9ukptCeUss
z;36J%EOd2)g(;e&L{?KuG;zbp#rfE6u-4>sYflZbHVBP+rFP-#y@p-J{cg>>nI}!+
zNwq=K27W4Ci=7T`xJA+++vXDPu1TeqaTCPLz)7t9eD(rOTVrLK=mx<LcDrlsR&`2c
zdBKACHpK=QD7L0IDE)YZsR5M9+h$88n8-h^#;8bY@t^W)Z;~5=dq(k-nMb?l^PKjY
zT};&NGpr#IRnq5t^GD2|{l)VV@q8^Adc(OwE)O#+e!8KU>uGao@YzcQeY)furyu6s
z^`Y}&+k(1vqsN4g+4XSrKO(qdmd{Zg>*8dt`*@tEyW}^>rLr+w$oiYRcO(RUf!*l6
zEA~XD1tY&=owHKT9k_C;k@ZZ5<grL*f_iyc`fYA|Ji_3Q;ZMC4cRj95uEpb7Q*y5s
zb+Ductl!_fLg`y8L7O-xKee1t^Kg7Kv_hXQ$|Fd6*aZH)pjub0h$7)xt&_=roN3I9
z*4Idyd1|~Qx3hK5^Ojl6wKH2i7w@b4RcE+FZ(nY*j%<^+V4`Yh`PX0(m;TylfdMi_
zIG;OjMM*YX>UA2@L($@C{&w-e%?~KQ?AD<ot;PvWJMd8@Jbs3K9ubFg%Qo&<#ET`_
z<O`>WFF_DlLI6b-8Mb$i8-kd1DfNslg-3ea6IM?yF}tcaNWGe&8Qc?u;v0|L?(n7v
zhP1{|i!DcUWL>}BVSz-X#J~JujiE4CU7VV%AkDO$9Ik<+us$F+YlIvt>61VG5gSQM
zt{Sh)MmykiiNE=57ufH(Vyo_S`c0Wyt8I$auE<<U3WsxcvRr1d`1H~&({p>fe4ide
zdpV7DY?V(sWQVkp^oh8+D{7&J+{ChJAn`~>2Zd>ew>tW`W32<?gu|pq629;?nd7lW
z%)FHmr-F4iQkct~%);ZyYbL>R;~|-@{OTM3fZrDcbaZUXjnUBX&FqqMOdRN%FefLi
z_}di5wARVi&Nd1(^EXZK49a9FD;VBpc1m2sE+zF8VifmOAfT$Q{%z%>4Q2Xr{;=C4
zpO~TfxA0sOs{Ysh$XRGb_p7Lp3H(X2js%TFY!q_aSj0Naci0Rt^ZUfBBvK1B8cwCg
zuYQS+L~Fi{j1R@R;SZ#qdtU>N_d<ouv-#{M$vG9TXGnU~Ike^;)yGdwg*i#5<=|xU
z%1|3`zgrRP2_3eF^Ima|uq9?$JcOt)pA{(rdHYq3fC{Cj{hbk$ea)*#!ZqT?d~~@k
zGWggLP^(Y_4<630<L5eAEv_dBDgAg4$W|?!aWD2xY>>`OY7CM+<Ey}5i*JZLABO9S
zysmVgbvnv)WD8fB(-~z{Xa}27Er4W72p<!>n8i2Lhtym<fNrgfE<<Af4s3KCgPI9v
z%itnRCF$Ej<bH9Wxm|bekJ=^ggo`v1LA^ndyp#H?&-8b*r_4_jc>bo1&3$Mh?96~-
z_><-(I-W#3`9z=Z*3gG=XF;EPGgthE`?mTObim*%g|2sOb<D2y-0xNW38;v_U_u--
z2h3^ndngF;qw|Kl@A5fDTQJvO!5al4XtTn+d-F{maxS)#eElacMo4k}(hkO$7?qUd
zm0R;P^P&iYc=>xaZ>|Ors}Og_VQl%HHjaExi{Y$H6!16D!guSAK%?zw(tGDjk?S7)
zO3FEn1h3Uj1-s%$Omy;J@I>th3alX*hz43?PHKuiL>;f6Ixs|sjx!#5-Fgn9H#8~k
zat(|6s5c1Q-uS<s)ZE-#?B)&Iv-K{`nOt7d;a*1b@oP+bJ0$<nLYa!U@h+jte;Ua&
zWfYXHFln0|(v<+yJYuBL@lJg3O;MQ9iEHJ9o=+5;Z>ULoi@hU`YP+b;c;q+p4)0na
zij$M%zH!!{?pcf)PcuK$><LmT{5~2)7>zj&BuNetcYGaUgm=dXW?Ssg6NcfUzMVhm
zn<*><J?nUG{-&5#dDFMt#toU8@G79ejvE@nq7?i}(BpbZGD}TH@6ue$9BM~IYaeyT
z+-gh!pCLxORX_egRXO35U<<+eEh_~AX)pXjA)1Bf6hJ_J)FHG5e&ZWA<Xj<L?zBmD
z!W;55>M~tD+cDXK%IB1C#y^-y*f21!*pz<1d08)rx)Y0;O&V)v5(*9&6Kn$S5@k$k
z&{T&b;>$*fAE<l}J2VL^AR~@MujCTv{LPFJlg>u&8zlN!gc)v>Ng$Ly$BmyL0=ZL=
z<MiY9t2^vjnGV5kCe^Hav0mS{7fXlIjqRaDsp2w%?wKf@WO$c{J!<Z)i1x;@`fp?4
z;k3NGnUTMK!a`E{nP>Wd5crX&S>Nb_KacgbPjyJ!+6`@7F5&p}420x;aMo&`+iA7z
zpjG2s<|kYpDnOR5dkpLVijdrwk8;cKD>B&KmS>pa)4+hDGG3l+ttr#SUcWT8)7xEL
z!IiJ}G(3wc%*^P!LF)TN(9TXFbWW}Qh^2VC3O$*v4*RHvR+(*J)2^jcKJ&Hpx)AkC
z=6=ekXiJtR7JZH%zsB2hH`y!w<U)g=b*eSr7)6HZn7&ZTOa*1bleyK2XzDvab;F<5
zD7dT@d}7e;d5fU4lHO@61RIbX{K_=d@P@MJO;odjI?2E~UH0p%DFR+3{zgJ28Fy-;
zsi&o7O?l`TD=`?N#Z4Mb8CPNW2eJ+xc5z7n@d*f;Z5ENb_lM7w_+nl@9(iEs03zID
zHu=#@P}1Vg(R3*FxrUQ@(k@{jI`~^w1PXVIg=!m^ek#~VB&$Dt3#yuzBT43=hIRw#
z)2cM*{LUO)&}Y_y6V#9zOQxF+n~#29@7}N#T6RX3=Fv^j_D_B*erkDK;&X3s)S%jo
z<S`oUz#CYd!oU7A#s*0Wr=e}<O+jWhkjb5i7H2HH2n(i0Nh+O*SdG4{m=r|dY}EIM
zAEi6owUg4^mIjLCt@5tk`ISg-`DEPK{$@d|sSyfi>i9sCj4<QUm%u#5c}g1?2c5tS
zGZf$E8k)1+pzU>Hj(U7-I`!Ez8wE4`Te>gjo5}=_%*``{MWcJv)-rqEyi(54y$8!M
zVjuIkOhg0a)!@^poS-{f9U18|Q>`S;bi5?!VH7U$Z_WW7(GQvv%qwVS!=bRYC`0Up
z*@hF$haPWKFUM}C6|(AIJKq(5Ib2(?7%eNjuV@Nq3h*YIJP9pt5Kqz>V@t;y?lUoB
zA$s^mH;-SGuT$q4_)sP=OZiEa`iHXWr#+Q>TGO7GaEz|K+ZCkIwIPN-8S9zvM8xx-
z$MkkOH><1T8=jyhSY<8)v@edCZe}w5En-UJ7_JfRa+8F1WT>#&^y~57Qj08d8X1mq
zl`UmV^gsBT2{>F|vbBWiAVm$^Z|XdvO`P~vYA;4Ftg)0i4081b4{|MMn7`}eKMlVi
zv5NdyHKUm`KJP%-SFgr6K^DG<+&8`d)3@2(!ub4pu$P?IM`0BC=kV+85R%3XuTH1d
z%hFe@&?vr;6Zw>1iJ>_1d`%`KTy1IJ3R@u}xWsIUlgf<5u$T|G>Fu~Os#W&nOYBR%
zZa-x2BOF$v4Owv_KodruKW`c5ASPzy-m9PM_S>;U{Zr0Jvfxtrv@4I{$mNek{iYyU
zlVXu)?t5pT1>Ial%*^a;i)*4-U(Osxg$pGHossxGgs+*GY@JHjj@YtzdE8tf87q5l
zR<hDO{fTc9^-LGl2cCn^?_nXvzDyd18#475D3LkN0h%m7me<vej{1<To&JnX;uU<-
zh-}@Xt%v#EntDM@#?qFG(jfN(GQeeS0*kEg7;fsWr|iu7f!UBC7OHrg09i>Io-NM~
zcDxe)QFX>JIf#6&_D615Z=MJ%8`TG%f_2P2zN0pIfMCxRsvLWc5sOUgm)%|Dbkh0f
zkdLsbH)aiH;d_oirldRdX;%z$bn7kOyiGbys_~jMgwG{G&Roa0T$%klY>J@(k^M;_
z%orRfPceo)SpVcWzv`4`fq7JU)i-sbJx|>n{cvrTQa$U~ADRd*f<c%9Duch8tFJV(
z1>fz#$TjvCYAa<cUTZsw=TR8FPh%0t#6s+FyTTNH=W8Ed@4Pr#UxMiab-sx;HHkJ=
z$nCTt+h+3NbBe^nD9b|?IZosAZW=O2fsLnJ779^LWq|E(ZK($ic!|Vs2jc$TV8^cX
zGq(CR&@e_A$Ia8Nz|Z4sG8Be3*qsTN>iAebPS{E0Mre{M&KNBAfM1JQ`g+!^A{#(h
zKrFhnici}H+^%r<XEuUW`_|~4GwNRGbi9dal_MEg@i-H&B)=#4@Pgn<ZQsS4&ta!$
z`+%SSv!=uC)1SmE>a<;vlJmXv?O>O^-ZVn^tG?s#S05Tk8FK=#Q{2rO<De3p9&F#O
zb!DC#z3nRFoNeehXOt0w>Z<NX{Zg&Mk94DPbY@jMtZ2$Q1gV_y{luDeM36N1$tn4m
zw8rEvcmiY20bngjaBtAOhp&t-KIL6~g}VVtnMTyQW2IgV(}<7z>@?~vI7D08I)*Lk
zOwkYkvmll!BK`}B5|OEnMvq*`81oqx%cjEF!;x(jj>t(Vqw4#%A5TiJo+-qTKb?^v
z2vKVogg6jv&BkdLNgR0bwNBLrE#*K_*9C`<hB@QWo4@@Ln@Hcqj6W=^W4{0GJd2e5
zHf0l26`$P7R%_k`>tTTzF&zru)i};2awmIUAn~D9(A|)Kl3L=Q>DD#ZZ`p=k^uFU7
ziWC@1>>0yS9+R@;3UL8YAq)s_m{jxxlJDjmAn)>!$H*jY|2+7Ues;kAgv}O(cj0Ks
zceArsYSa)m#KABHXH6DU9%e8^bM^U{-R;vzbg|pvCn^WJj_RTh`@tlV7)HYWNqp&j
zZczzKO2x>gM=2&`W0o?$>*U;5hrL?MWR*4H*ye1kly|<WTk2>J9~TIkiykRDOG4M<
zw|4v@s!sFi>mCG^={2$U{hs7Elv&?zUuB^G{G7c&6+Ygcb;pAOi}S%yBq1LgC!7ZM
zVr}>52bI~0n4c$8O`ht-v1k1f16CHOgm$ObUdhy{C9E<kkm}#EyR^adx4VKaHJo5J
z%!KTnb9(r9y+R~wj?#tM4P=v-qh>5_{(E?0xh@w;V8#>7iKJxb(Hy&xn*=k7$f4~t
z=s#z5x?E$~%PqGjtM?zSDx-cEYhp#@w@FLZvieuRF8wCA&nG~0K7_nBJFDTO5*oyD
zKJoifmxC<K_G?Kx2O|Re39)zFM*2d+ZR-GIZ`2cMjN@dQ$B3HQk+2C`9LHwtgxD%Z
zkcv!;eWKEP;iJP>iPyHN67bq9p=hs&c8OwJ+5Bf4#^SgF74XA1^`Zvq(GW$M<tv_j
z>7?(k)*GsQ{Y)jG72Fm`Qt(y>v&bBU2@}WV-6|iq_M=~6*Ea_{;xCYHi8(DIO73P8
za8TThcX2C~5@+UoWlvgt+}~!g`SF~0I;NC+797rtUmUxJB=3m7BmWkY%48znW(UEr
zi)1Qafvix6B(oTasqgyv$>*W%`P%2%=6TuY-e)K3`SIB@KBvfKGaicL<^ar*86f63
zOVfO2GKYSwJs+E7uKq#gS*nte<9WX)*_gO;Q1Q<+g;Rd89WzOgE3uUTI9z5FL*4g?
z`*tI%klR$ZZCt;&iN$Xm<#p3daF2aRf`6LqNR*vsN}?cs)Q+J|c$A#%x)R=Xs#Qa(
zbye>KH&=M<Bm0@b+@fDnVGJK7DQZME+wIJsj3AAYglu$8r4nu#8dCMdw;K6lQ;ey`
zr`(!D>E?~IGbnyl+BwFRJrv|eHAE=-(q>+#yh4NVrq|U7IQjDTmLWH3l_+ozW<#%a
zHYa~_>ZD(G*RtL!4-Rka%P5#2rlr-DYzQehfrygimH8BHfEltVM4xTA*-ZhB<rd?T
zUx1(T`Igh_?YWC`(2fK-{}aJ4SP=PqTtaKK^yIMv1pIM|Ya)OQscR>S>Tq#IN+q}G
zZQ02vBqz;;9tZO<)s7;w;o`EyfNtm-W-y@nBX$;<MKMAQrb06DasVZb(?yljs>Av1
z%pgpuR&aV~s05U4h9NlzD8S+qvI;+e^QvS+WH(1<PfXrp1z~1pmhan-MD6*BP5PuT
zpeeKf1%+3wghWe4uFW?pm3@3kye3Tn$N6%wPc1`%wOP>eE*<h6BJ<MtvjSn4{zl5d
zh<Tcz3q8ao9CgG|f*$g()kExc9UaJHNm_Dhg39<mP;sXFGL1ur#91vkf-mm_J$O41
z6D_n@C{~Q}8>g9_KTH(b$a`#^9H1YcShY&m^_xhcwNIFr&?n9|OIPA<xx{q6J-ME`
z(6TfP3jXuy#7vWA6fxiJ_y;EkCf%xd^>H7BSf@+eK!6C-gS92}gN<rO**CHDl>|A`
z#{jL^r_XLGqDaT^Wu^Q`#^3LM-@P9CEECpi>FjnH^5#(8Ef&WajaYYu;Pj)!z@h(A
znk9Zx(L&${OOOtS!<pkXw?txQKIb2>-re@k1z>UZpw}C(Tbk8-qI76kr)wNpEN#zi
zsrXqY6feYvLQ{G*Op%^XZcEJ=8_wO~$i@W1HXi2_V=Fn<?Da^UesreRQxJ`9u;^Jd
zXdmI=y^1L%b6klv!wT?Q(M*As7?$35+e)mNiQAS8Hffntw2}#1F!=7wjd&io-acbx
zp1hRUZCIInbe7{7yUUjPtEfaR*>e0KqX~=6jVh`@o_9}HQ%ZdT?S@|ypKn}UjK~cB
zXY$ThwYpzeuO>3wNyty?dI|k}puurQ2q}qr*0O&blQK(B#s2&Z;xHz65)K;oTYv{a
z5Xe0_zoG7NPi9<aMHXG=G{4q98>_d6#TChpe9HOM@R8J=sB}(YV?M$_XjWq+5H@YG
zif}MlaCx5p5A+coPX!hZ;(U4KdkUIZxuovRupF2cF-_^y5!JTGt%#?saMW8^zixHN
zb0C{pQuYjFqxw~I+zOeYGmW3Ox}ZI51YFto$xV~wjT+*VV=kefuyW1K#aCv2n#IES
zOUNRiO!djS>cvK}@u2e^u~D%DLUNfM`$qKcTe>Kb%ktc7v4DP=P-o0tmJ}rnh%%UP
z<*{}s{kJz#(kK(o0`m$^wa_}h0tUi@40NsZeb%?p6CvH}xB8>4t9qPfbQ~esjMxbg
zPk&5=ns2M4td+4YV*$1cyL^SAHrauZSqsJL&YaOk2SK#R2H^eZq&|fj%B=68$c>BI
zg2BC}@68Cu<_;u<pa$=CuHv7x{pPe!3M~fv&U5yWb@p#$wFXgcxdg-M#cL+w{x}Q?
zg&*O~y2Yj@KkPuAF*=8Q@VIBy93gP5U^t^yGuNz>#1q*1l=yqzC&AK+oJjvfI5cHH
z>j)V;acEs2jZ@m*DJ=ds${CCRQBbDFs3YFGf+!z+++<t<-OmaIvg8~J=5M=#u+V1?
zf1G6yF8$#R#}~~?2RNzFa!lwd-lqjx`1Uj_kFcf}@<TOeF}B@eW{w(NzLTm`JK;?}
zsx62UV3-awxcj~8pnjt%s>MIY*(ywY9{cBf1+TIc|6=FXH3l|Mb^+1Cax`ro-PZg5
zMqA^)t`aU3HJNgbW>>nDm}I^s8AUj|RN);So8Z9;<4&B^{?C+J5#6<jRY_E80kX=Z
zPxwiRz772_BtOSK1ek$KmzrIY5YK$>C%HR<pLK`JCXang&-j?^EkjnBEnJfNW{0+l
zjB1S2bYP19w2at`RkcEw6w|B`Yz*89LAh6AlSabU%chZq)jEYXBy@`;R+06fM+dmf
z?U#%CYD^`pVh`B_E$n~xbsrCi>Eoh|G5utdZzroN;Ojkt(kwxqPRO~_2j9vReRBh=
zaD3l#@+56|oFCMOm>gppm!4d(pbB}Is{LThl)2Q#Z9~gW2Uq8P4b@(?7=ZL{x{)QX
z^*M2QsoJX(+QDVZos7)U<i=B=VY{+r!nOH4^C)D5=luVx>n?!e*xEk<<B}kO;O=h0
zoj`DR7~Fku4eoA(ySoK<cLulM?k>RtS?;%6d+&GuyYE!Z)J)ay?dh)W>Z+M@o-<Ea
z0KJ;PTr;~~_w|d{`<>av1cu?a@qQqSyT*f&t)^taO`nqSoD!3)AWlY?D|JA5aBbJM
zIBDt8Xk3TV58AW|){hOO&D)B5{gvvlT6rw&r1WA0wnuDZKi(%SxXkB43oGyZ+|(kv
zIY8|0=DTEBaxL~u?BdSgrgw8PPp+O@V4wtily0f{V#+Gugp|^5@3oJpXtp*9!-;n|
zYNm}P)<(M+X_5_+rkxA*dJx0-v!K+|89>MS$N%KT*>6U4nw{1h!0JK-Vvz8M?q{)2
zLxx8V7B!)18GDk0INf*<^|s?-+V~R@Xi%PFC_;HPWQ8D+{MwVJROa53PBmZ6Y0U21
z^d}qDcZu%hc5*(l-sx@b?Xk)#_!k%u%Qwg-Shy!`v}%<sz<<VBmO#DF?{dLhp;Hk(
z<9AVV9E83!Eh@3bt@tHr%*njXvF@&dd(PX13%4KR_`75%Se1XHZmLIhy^8dOLOoe;
zlS7XLaWNHg;tJ<Na}M!NwAXUia0@pPCbU{jjv`DZ&Cmzkaqf3~>2pq3sux_#=xQ^<
z1v9}EQec=TyB{eI+(ATTgwO&qK&@_0Ycp^;q(GbMvL99R_3FXVHuiZEOE;d8+c*iU
z=`gH5)>!yKPeF&H=Qxk9p=X#F(B$)sB3mE?<j!SW;j!I<B~%Cgv~Z!wB7fei&PDkh
z;`Q)}k+ofEqp(7kJ(qCf{XZA65_@kERI`p}_MQINwr>*>D-eUL-sZQrbR}*NmOShG
zS5_ddU3fGgq1#UQh+hbjCQe)mq~0cJO3(qk+ZfsBA@UZDu=_*<7H1FsV?U$s-$E&L
z9XHIIH-MQ9UMox^%F9^zKgc=@M!C#S`iY$`9%BDokr#pA7;9vwmie(dv{d6gu383v
zMM{X7GT!1-C~M5Yl6Umt*j3t5#27TK6jOBaG>iz%(qx_60?vMX+U<%n{)$2}c~m|E
z|AEp<0D#C^G|m(W@^w~Qn(6oJKWdUAPuHR}e?<w_JdMF#%M){TW|FlaL*wPyQ)ON=
z82bt70TSl^I(60)RGq6_Pb6c#{|!&Lm2}0szh@n74=fwv=@%Q6D2#)|+pCzjU^=nu
z>*3bR=skXP-p<wS9g7kxv6-$H5P6sUP&qruK{R@D`xzhF<j{6;(CR+1A1WM<8%1!z
z>@IDBEqT-{NgcKgAAMx+oDcUkCIpu1!U&{6N<$=d3?P$02kIssKM1DzxNb?WTh^{5
z|7z!0OZMACVaiK1#>WMro5S0e8es?VTTH3gpVjs?HqamMl~R8AjYzE<Y~*9J88yoI
zK|b$`J(#VdV!++8B2e-~*DaVm-+T9qbq7p0uniJdn7oBnL!%XPjge<G(uEf`rKwB~
zE*7s0M}P41>iYKAO$Gge?wG*Q$Ka3y@z{l`Ia2EJT^g%Tc;ZSPcF-?Wo5!VG#7sg)
zvGha<tTLiF15#UV9Pjh#Q9?NOYQ$>#`X{FMJ>Pbno>nWy*+=UZ%(4pNW5Z<a3Dh&H
zh-PUSs4YK?K&!=*e|;2cKXk#fjPYE#loof8vkkv|^iNtgW5Ib6-uwttxVQ!bbva}e
z`oNp>eE#G)u{EztaMBa1(vlz;?y4xLkwCg#<#<|3@47P1Z8k~XV2n`FZouN7vx#(o
z-D`WAPBeFug-UWcGqwo_WkUf>%Ej*C@l9zT9YS(zJJ6*l<C`<A3|aZPwNKr?<sv`i
zlMD-Op<lVh2FD*39SH@95qgYD&Ug5Fs58CptzpJl+(&h_7(eQU@1S6ITpqWeQJP)Y
z7BG}}IlCZKYwpx&J%!&1fziK_oXijDaWbCGiQ1m@br}~n13Q}tALp|mXE`xl_`Ma5
z-b()(eEF^;*96WlwV3KnXx3hunJko<G=%SUMAI+7P8Y=1D;_vJCXh$vmP)S$quIwl
z<?KK0GkA}vAIpl@=kiY>?pTA8e#4JyKXa$7zg~<C%8+N6Kl=MFzwu<~4yj_v*R2<W
zIn1JxEwd|mx*Pzr>g%>Vvom!H)~v5ny6UqqX5f8WwJT@&dS?!AM^1$b0D$3(1ytJ1
za)aanA7`mp)WG80m+jKXlbvHST`UmS<9AgK!|yz@F4t<AA7XZge-^f}Yb_5eZ6hOl
zL4QawE@x>8mC@KlaZagM4L}fPKdI>b+6(06U7JV8gs5<qb9BwFD@=kJIuDV};zg01
zP5bSEQFx4cef0L=m6|j0Xop@>M<}t(`V^aQf<*iZH@RT%LVCKjXa_7uW_;W_zqG4<
z^TRx(TThY_gvSn)$KujId?Jv=`TP?vt#gB44jZ<@lD0zrvydyu160MSZ5}W1p{iv_
zYb)-C6Hqj0yL%>$hcvAD!-2x|dOzHQm4FqtxgFFz9w0CJ<$VQho5pu2f#LKfVx`Ta
z?r7)dnaEa*s2sK=a^+m~t%7Y&I1nyFqR<p$V8CdlyHm-1`&U|CfbOr4p)Y#dlh1BB
zEJ#L}+kW#YuD7JA`-#WC2%L8eaz7`H)2lMSb-}V}TeRD5HALW5^unM_5h8N1lr`1x
zhurPu)1(a2Q9_^i3$z93v~%uh&lz#)8?1CQU@NQ!OTJ)ctZNlw*bMph<Ng8Or}{T`
zNr%EwQVaQg9LUWm@BvL4tAl>+sS3UUwCTMsZ%snRUSne5St_to<jVLCp(|kmSEbA`
z6ujnbtMvUme&TBl04uQ4^_Q>bjHF}^mQ;HL!q~gAz3>VEqGqOm{E#$j5slvBH^0>j
zxGSVhc@cKo<TdOfU^b}Atlg3qI+g`dYVAU*TgNu?#e|nJa~*E24qTE?$33#lD<!Q1
zN_esCkP4by*uJT7n?%r!(VP*mm~xh@j)zYP)#g69LCo0zv^AIyNZt4{&Dx|TBXfLm
zQ-&0>Fc>{@$@rCYk*e(?uH@hOdNN*oyk?8RQFZol^$9E2Pr(e)<1m+vzh0hnnck#X
z_FOAs2kwi8i6{p=@lhkeb?7AE?y&IOe3G@yhfBtiKRFR&kV}?78j9eosAe-L_=PV<
z6xoN57bo!WHMjP%R)U_@q7&`AA4*EjI)gMS|6K4(BMLbVu`7=8X)niR!oFBr+ZdM%
zqtG7XiNz0MRZRid)q{-2U==2}iJ2uWc<9LbIP1ex77=K(ndwJTr2KgAVdPlR0&aeV
zURzs<%|0mvEiPY-{7eKn=nyP~W*)}$diiB1{|uie|B{QXT#{X7rC^5~?7{Js+eI|$
z;fTWH#M8B}b0>L{fYm~M$-qnLwv1b#Q+i6G@QBKEJZZ22FHQDdwnQsMbLC^C&E5io
zaqARwksF8uQfu{BmHc&TvPZmuzE!PxJ@x$}5I2Hm+~)+duH6poOZi=8DcVYRPeJ8I
z8@RTZhdLNl4`=>!F}=}NA-k#`mxu+0gL?7Gz)Mhps{sNus!iF1((09e8#-1La~c;%
z;E+0gs)th3D0Ce{%7vG|%k39SZmu~3EG|p@5a|H|@))$OCp{o)k@?vFn%nn|H_xEN
z87toH<`o=WwHXbyYF=R>xFm&!?W;G4VsFs}IJS~cw5q<iY9%f-M>-iiq#-NFq=Y>s
zU=P~7@vPovM4Wu5b|6Tf*}92!%k|gCZj9_ZQtPhR>xG*jR#~3dC({O~u#Vm~WCnsQ
zI-O2Suu*p!brN2C@=J<;!)Hv)H@v2u-OA4p@@s+L!a7-XO>fmc`xLGl2NR#dvlAM0
z<l^^K{|S@o*FAhlmcmH~nVw@&tQsL#Q%H4i<K&0T(6^Zr<7Ey$L|_cT1&h^45yb1(
zH{!w|rcz%`xCgX}n}|BtMGk!tzXYiNIu)^?2Ul@Sxnz&&T&1w0nM@1XEXyyQaZU!f
zHiVT1j*EGDw?8*UVwK6?CLRMlT(z2ID%K2@4lG_(i}ia{WIyMC(8jDnCtk?1ine<C
z;_)Btp*zfjsBB&)TZ>W72WF4NLDgkH+#Z@55R%k*o3r#YKT{#G*z(aQFX|UP$Vcvf
zQ!>i<of@TKBO4d_LzmlSY=mcE@yjs*lB(=I(MC~TmzFmu{sj(t^QtO0sy6$ZV>k5A
z7~N#G_<%c%sRzv@zG1WWB}18&xvUvRjkw&kwrD#aD%!We32fe2K(f?Bz)1{`l#klN
zlz-kgX8RfCZEKVumn(x{LS!y1KluJ!OW}rVDjc>@cARu;60F&t-5XlNetSxn5>Ki#
z(0SlPXIV9tvx#Y96&}(zNSxEWk=sgE4^hGQQH}I17XfJeVr}V|bD&*?06Z((#Lv4`
zirrT3pVvTDW2R{C>+t8kGk3prDR#iJ$=&WtRR?N?A`rRmwcUH~m*Om8J*5eo1lC}~
zM`PlhxX*D_%LL#rFWd9JiASaxk2_Yd?g{196~_GUt-DFHvE$L=*=!$521G2NtkEk;
zUyU<L@Ne4Yp2Uyt>=w_a4tSQ^>#FLt=dyGNIwnUdXtl7gRU!NbRir$Tqi25)U&IGd
z0*oX?qw9duE1eA3r91}1k36HWjZG`YiWoE|Cl;vZk7>q+WGQnUeJ6-*uUYM%Jckk~
z&xIm2f{!hzj9u7-`CM7_SehF@w6oSSW1Roo5nRt5$(2M^&FM5#z1gtZY$>HDq;1RO
z>wlGj??mRzxYzljkPHs0O={==EE(8ll9x~U-OvR6>n^{7tBPu{n+O}i?=kf-H5v>0
ziL6s4wnvo9tet3_udqH=*H>G6qu%L!r3$?^O!R^Vg|0l|tn@wjVj(krFC-%dMLMZx
zX<g#&q1G(}Yz<bQWR+Qa6U?`=O(SBmL0|amu*ZMNThGE-gJ?-wRm5&p2tY8Nj0hhE
zgj&>`i&3w6sAOI8l|-otg!DYo*2#j~CZt)>Bk9V>B0LF=-Z9A|I@2+sRdy-IZn`l_
zi<AAq1~FUmthdk6H0OlnLD1i0w-UP)509qdG7_?`!&VX7Su=L(+Dh`>F@`MuT-!O-
zaU<#XCFc~R&ym$%(R`tm2LF}<Zc8y3YQ%5+QpC5a{LS=0G{{qZzsxkcT$?AiqLP~T
zJ+lB?ys;u?hLLs3@@XTFa#Bm2#;L6;5hZy5p}=<Qxj5D9RdDVVNAWUlvin;Z<*9Yr
zS`ck^*YK6I4N8{3kxDiGFU7DqD%}F!gT-Hl#CO_+Lt_5))xBmJbG&HviM2!~?kmr-
zaLS3JQRIAsy`%6><{@WFtX@+;zNMH1-+bcyr5jl|ZdO^EHH<X3um@Y(KKhkU!_Ma`
zaa#ZG^`}vyYVq&R&uNJ$QqGgS{&)>#2EU7=ne)#*ioq!qY)5w7P7fOC6WFWLDHuzS
zfM>nMp($g!gq}ZjI}iC{E}1{PN|8Ny($H<TG3ShUF^7-SKR@$iR4D@%PXyB(aio8b
zsboK}W?hV-ucI#}qT?bgM~J3y(7R%_bo#ba3@-oBF`?gxGMVYKCncq!BUQ+wL-e5q
zMj!f}3joeVnnsRMc;a~AURMjKFzTB5DIWG!GJ0%cUz~P9wF+<g%vWCpx9}e6UC3jE
zy)%xXxE7`Y;V4wF<Zda3>#L0k`+)Wdj`TxvHaUyS4Yb<=<P^gZ`C}Hl!|R~bf)Y7T
z=uCHKU66z*>y{vx?JeW?Z+<j_^Pcw~#tKv^2?_BZc;ja5&FSlOBsF+ZEnABWZSDQh
zf}ADAWjPSV1H{*aaL%)OoH<s$@i<>Bn~+p}1>0IDXSSV|hXsV>1?nj4MG94LTP2a-
zbY?ixjT>|m_9C?pH8q^?O8&&ls+HoJY_ea1g(0s3I83z?tI~y*TPJed(A{IPNKFWX
zXNkHBvu(q1Rs+LWCv$QSX5Fv=VWw!TSU)gj1V8$8m8<UrI8!GChB;hqrlF=~-H{!g
zh!DtnA*xXE`3$~>oOTe;fh}uwE^nf_MO2&JlGjy*<q}wVOg?4FjqQJ8r_^*_M`~GM
z(-hXy{|)v)$fP@#4-Hj6Df-RFsb4sI<t=wV>D?ClxMNqQ)9)dF@jzwTuBC|K)JIFc
zB1hY*rhw1BBJ(C^=1ngCvyWBELsxGs_D}t8i2YlE{21HU=V`;QWI|$=WB~m(OMh?`
zGz!|m)P~92l!q1~V%ql0g!-9?VM-NeCPF8JN(_X(;+PiUWtNpwLYMCBRvlw144FcF
zF@vt%^h(+~+`vbM&+MO80@NJp=?`gX)~uQkrGBR{1oGSMp2lOmjq7}%#~AD_T`zR?
z&cK98vR(L%2qx1x6((Vg!<&}RHiPAf+^RdWV1aCuBxFud!@1$1d^#=EZ%SrIU29-C
z7gOJ-j>#_2b!}_<sRbJqV2kq<QX}!@({cgh*xDf*%%nZ^`YZh^ljNjkGE&JlmLr3u
zytXvDES^RvZ-x}8JVQ*$miaQWdsfFxG30yYs0?nw{C*oBI;62=J`jJK`NQ|7vz!-(
zkJ<@(hEAINHiWZ*8M-Gnnga#o0_AX|cY5KTb>-%h<Yi-wEBE;aSr(*A&4bu01}2aR
zKSyl1WT(YB=d2>-ma~PLKSap{eBc4L+{Syc`#TT077dh=46=jG!ms4yz7S<vmFCqd
zHy;7?M9p5+8^8AL4Qc4+i*8I?4(J_pf4S~!`$3&Jc<w6o;wEPfAuG8~o#Bdhwt_V5
zY%_xFF;i)?@HFxL=*sL`ygws6_CTlNNFb$+BYuzec8h9m>d3zq>l1Gaziw3ob4rH<
zXkERS1ZT>!e@bjnmx|B6B$_+O%u~hhoPRbM3V7==6qB?r-z5Jrn>^BV=SuK9^yQrq
z@RXGpw-h-a=q;e$1*ODi4F{WNE2SZ!_o-ZSn-cr3u1C2UF&@k}{YHP3%AV<V)J$Do
zTQ@tF|9RTf3}a#py=%@Fn7qZr|6x=eW&u?!oJ!2y_BiNp`CEOfs1F$T%WU~T?F5f`
zP%x6DFW%XKZ~-kjYw3NNeOd2~0c22p$wWhH4P9YEsq|Zqf_ttxmI>7H-ov-^-o<(b
z^8D1;krtGPw9ep7LmfMew65E2emc6Tfe$vzLw9T|sJ2-ZKSSr)k*hK}!f_o*wgfeY
z2RoDbd)4#JE9A7sjEhXQa18^r%p6q?EHMEIwX$~a^FtVx_k6K}sWo5()tV@h*RW_i
zor{nsji;OAA3feEdb)^oOlC49CHF@Uk<2oPQWagCiRDS`iaAMQ)%CK34ZFs>3fW4e
zyna+H$Cb(?P;&-PZN*RxSb6^v6W0qWO*{;W)nZEdDO<K07kP<VFu^UTp7c%{ohKY6
zOncbpqLetv-&of6NcoeY-*rX0HVQHwSf$MI!qw=8MTX;V9U_J+^>#6nSA6}mqV6m0
zaZ)rP{a~T8gxtG-_4TPM9Qsp&wGJlREgnL1tNCJkCy(0*Ok-^-jxDlnBw$pD(*1iC
zzB2?&No;b07!H(&<Ry6AQE%kahS~rMp%rq84Ki8$z|%b;S&fg*ZbvFdjLZ-=-tmDW
zru-Tg%hXPGv7Ls$F)FF567Ru}X>57G84mI&2icRWF#e)?b+3sPdw$=B!bv#4AdZ?x
zIzLttLT$Y|{WnXAY^@``Fg_52O*tg0u5E%#wofnIpvNZNW#9n|(WsDuM#uYNnHeR=
zNXWw7Q4EmCN0hz^`*95EzkW32W=0`Xb<xdf9WIer@ak4Zbfg;3?MDycF?(}kI<xMk
zblas>f_P%wniJ??w7Uk{7y4>)csSIK^9)1wEHIKtdsAtqMQiqF(w2VWZl<Z5<gkAX
zu%c?R27{Eq(|7%f>#k9#J1nP12{@>o8-?wFUJ(F+fu;Kx=&7TDT{*emH-6nbAe&mf
z@=GHD5caGwl7V`aw4^)Xo5PY@9IhsYX_neC5iN|Tf-;Q>EkCV7d0in{k~{hd5Jz=}
z|G><;2u#!-oF?2JmAPQ!;*pbR5(*Z%FEp^ht0rQLGGHLCXYM1^1;PSUG8YFzHp0#s
zRNIIxOi+}vjCd#9qEnD+{xEot7wcH4p|O2XxFFLN*w2{*`aiU`;YKTE-goh(SRjHT
zD2_-sfirJP^=I4u-$WZ6Z|6PKhbh3g>W_j-su`Z5SRIKT4mpdaFC=d#l+yVh&8M`K
zO<!hj!uLMuH$l!ZiU?d-O*!4MG*ud}waX3&tZav{jBUj32PD$(c$a!CxS4SFbvoYL
zFV{f%r7|dB&pEF`42eQjt67W6D<OQT6i{%3S|y!5PA8J@uA6M)8&WTD$S3DGVmCmr
zp_<%{782opzbJ!{mw~Lh{Az=WnyDt^cRKERb(5oEfhh1aGTGi#4vB~KtnM(iFXS{d
z;U0BfZ%*c|EwGs7F9U%pa*P&vP9Fiii#mdGk!^xb&CVc+xBBbe!ZN;#52M?wR6LP~
zL|r?Ki6%7o<_Dj8d3K~zXcIl^$f-MQ#2`z)MPuV_l-0)Qd~&(rd7@vY$f@V-Pd9C6
zO>&e~)g;g)1KqE(cKPWd4#D+<JT-hKn^x6>&R<vwlvds#(n{viMj~bLxa*NH)J6~<
z%PsnDr0gTQv3UE!L`;{kUKW2&vLzeYY`u(wo5Wn6*_pYG_>2(;ILVeFWPebDgm>yr
z3y6Xkc~iYZk<9fsA?T;m#ia^`00(*?NC35r#an8iQu3L{`w|97SF#yJi0Fr`)jQtg
z_f6+Nv89G6n_Qbmjo>T9xm5LnL`$n5Ya+OzIh3U8S$U5$vk_ciPzR*;)gcqUF4@;S
z@Yin(DrJ|-5fy&XQpD^M;JUnFwSbI-N|mpqGEi>BTk}vF;UKRwv7i3M%!}{2DIRBn
z-puhnX3H_3E8zYHSznw!KWgGIDk_-Z0$Q<7VWRlAw<D^L;%L0K)YrNE7D-d!$MJRE
zlba<dpl?_wAETC)44(JOktC2<TXhTcaWlPXf|b#~)zXImuFKKK0dDA)p&3&$R&f6H
z<RC(Gq{VRhebSlLY~k3Yqn2~!>thi{S(x)t(#8Tv@9ye8R_OT~kLsue9>8~IUqw%q
z;eEaD-SADd9QKtd-Mjf7XSqEj=Nu_zrPw!&Cx{gsl_BDZ6p`odw#-J5GN*~}wk+6a
zCW5qMXRREvU%pp0Z_m^IPw(tXJ5>GF3#96Hui!kgs+#p3S2#J9^X5<=3eOKlJK!XM
zvk5;X;Mvl_&LZOm{Z~NAuF)5V3g>4)okNUAj1~=?Qlo}xN@Ydo0$sSenD5mownhcL
zIWb9pG+K3FX40s>O(M}2F&RE(QD-e3cZ#NIkVbpQ@)xzVqTtw?1KjNH)Yst)rSt)!
zRPHcLy4uBY%D4%s$A+7M-j;>>az;a54`Qn|l}1Bx0*y%CWGLJyHf>uJpKpWg-2-W|
z3G0iF)(z-s1PN<(FXZ4yhPh>?Dbs!MaN-)r?*V`re&UR0Ix8^~b>o=Cy><C75CiB2
z`)Tv`6`X(@ZVES$Xt2J8)=*$`lBAT7_oFiw0Ovp~6Ve@d?_klgj)?H*F!B;Ak-l75
zKzb#NAR^M_unZAu)R84rB~{hs$5jW{vgGl#Y2Q@&sLjH89uGm(Q}dm){hP$R?fJ+p
z8m=ROb}}3N#YdSZ??p}#Y?EZi7-BI2iZw{nw1zsAf^e>o-tL<GM-(}lFGc!|w(T}o
zDcXksU%+%7V8;G7)1yeEp7Znj027)`2j~T256nAFh1M^vqQ=JK!78s0sXnilXE81!
zt_3IbU-k25b7E;da5+YxIj~PJT+wCv?w3f^Ai1*3*wKggwXf1vy_TEDyhJ@dtzJ7S
z*(~Y|{77D$qNtZ3`ZaF3d0ix6cIL;KOUQ56C&*YZ<p~EaU@uQSxYvJj0x2KzVo{@4
zxPFc}Dds&<F@b|Cd|CBOwJGp{i`3{&D+RL*0nOHA!LR_<q|~ye_70-5gRS@=JycxG
zj9JL3J5t$LV0sC16jX*O=0>HMkwaEx{o+lCPG=fy95z^dkvT0`eM52N#C{ZyLf_`x
zR1H;igf8OgmzKI}+)gR+<5)Y4p@5AtYcnFYh`sL01yS?u2_9c@(jZcB+l8TaoNPsX
z!YReKSHGHbk*g!3%oi-V;VMR2z)9=Y^mMVih{9W*LC)bi%15t>MxrGs5f&`o)hagy
zZS?C2(lXEd9@lbw_v{mEeX$jXPLhbU3}1HpYB>z}4GPW+1QYBI4y)4Mw&CuGb?FF0
z0b7P;D%Rwrn>Ua`aHC5W4<o6ZW9@QY@uEZ88rX-2Qz?@Dl^Sn~53_z2Dw-}ymn}BD
zQk|7;mcwm-J@6JtoZ`eQ=i7`l-)e4j#sD8^^pHV|)Z>X|lPJ7F@24lfQkR!W8tGs8
zO-I^EUqQHL!CVfvaAwK;vC}GhpaCCv#f#`cwt6U;)68o8yP~D2VeO!hzI7y+$4p!1
zps?P;&6k6KUl_OyZvhFb-eB!z%PsLzgnWN=Wb1G7NldPLE(WQg@A4e%7?V5mi$y%5
zif);vTue#>9lbb-5_&gx1TP3YFL_#0fH3Ub3?L|Arf{TS_1^q7T^hKJWdjFf=TwbH
zYjhH{Ql>XyE<wb&#^e8n42sjI&Rr554m8uN`6ed6@KqLF?c^kT+b4+xD{SC%!HbFB
z_V@Ubhk)7Qp+Ea41&o#!mU%J>om9i^44iXD$myS4+CDJo@i1_&4mUY9_?g?Idc=oc
zL<~)!xyte~c3B&D9+biQR=ICAUCEkQP&Uz7=$ahg7g|r%wWPRgJ)$U0NsZx65lTvK
z0&ujMgzQ%}R<Ws#42)GJSD9BmA}Of5mt2#eslC!Ba9xy@p0L`h63(O(QBJIHVN|o)
zhcU7nZo;^e<}pIWctX|#e1XLARXe$hPJIWZWF_^r(*dsthT*FHGYBi=lqbkRRu*K~
zi~%NkKSicfI>~q~ki;$1?Kj1`Obdf6GxIO-lP_p<ziw9A8d4+EX4zO6mVENT41KFh
ziu2$HEUTNJNxg~Pe9(Su<4K7o7~An3jp~OfTyElQV1~g|$j`;kC+T@zAO_-#;i~A(
z8RBH1Xt5oZ-r|hz!}B*|o^+j9356++Y`-mebBCyB2OBjQ-tDlOJBxwa?A+LqkgXCm
zhHAu?c|8T`*n21TK&)BRx!&8DnY_w=2jDvnP&Q$vBejRha?+@+_R@FV#PE{xOy1^A
zgTC}^ur^QT0D4r8KR8E@^D}132voNWTxTW9#5B)FQZ*JQ#+zc{YVl@La9zPM?8h^(
zSs(l1NAGZ!tQ+LDkJ>4})KGTsYtNf#9y^m(XBBrP$JYSq)fN1|d#Ag(ck<BzNTKU=
zm0$Lox+!0ZufBXkXka1$1m-c8k@GvDg+{sCBcnuH4J<&meth=L)YJjS2KDA)qA+G6
zqvbDS$;@clR%Gw8E2y|fbMn|F4OzxPv2<B&s?Ejkkg`_7JP~Feugz_J6kZw*ChBWr
zbUd*+Zo&BIxt2(aX5!qP<rZg-M|T`xmohY5<|!mO<mut}Q%K^gE;r)~6H)7Y--k{>
zx;eoEJkUox!na5+NZqTymE7;eTd&A+P6x$pP6PLJV_`p?GnFRwfgz9V$aVATQ#TZg
z#e{6yK4suKD{1T1$KZ_AJ#Jt;$v6RsE-RsZ3L2AQp372?OL6MJ$-KTj#}PS?+{7Mm
z8ToRvM|7_G%cug4p`p)@8kc4}Q}yfatUf!^bsvQNoN~uW7<mL_PU${Y&{}eFjeKxt
zn0$XRpEfwwS6n@Dz2D_DM!hpDYgfHKwX(czwK=4RSU5xbZj(&+d-teCL=j=Q4L|-W
z#>?dO;$>klQ)GAcLrltb*2VSVU8?X3M8@1|vq2nXrQ7~V&m0+VEI|Wx!I>awr*bnZ
zMxTbpB4U-K+CXlL@uUdk>n3eN6@$-xWlk=F&Rtc28|P)Wbc!|_C5yNuo%}V?<P;x5
zZD<-MR&6xb>Nb~IxSW8LbZ0EWre3~(f8xGv=Rt0MA$STpXOW}A<$hcg$lltcSH~Rt
zjKx#JiGfr6<BLt=uZu8X52-I22Upiwc@sTqJ0=rDc|G~OAM0Dahq`RVK<*DdLv7W8
zpRQ#p4rRHlHZu1vN#QoNjFu|#IUAts$L!r0ENH6bZ2hLn*fA4JW9hoql~rY^IahhD
z8P1Ef*}OPTxRt_NQ&{heLyCH7reLfm)Zsk!C4#qc&PCg<9^+AU_puXv)Pz<$Aw~Xq
z0^U=0Us0hS2ctpfnygyfhp!XtZE@mGLXSg{!+iqFT48e48opD{BAn--ikxYP)wHPk
zO{BvJ|Ds`CvqIf^>wKJ#FVvPZ5iAESrEdg_Ipmz1t~)a6xHUTyeaaG!o>#6)zoqh%
z1BYkqCnNTnVx%#;Dul{)e+c)L0BG$_QN~ts)VVG+DXHgds5)L+Ye%P@AUQziykEbW
zF-)exqA};On8N=EM~Xi+B$sBbgpe2>jSdDZ+(Z0P@9XoaIx6iTK<FbA-g}sNt`m(X
zc{;Md3QdfWBb|Q!Ko?vAQyrzItJ*rQ$)(kNZc8h!n!}yGWGmDo({0=2?SLLwHk*SE
z>ssz^!qRJ_t;IQJGE`EfX$W<wKp2V_v~ywD55k$Mzt>`hoKaxvC0xx9&|4-P6<{Ko
zA-F|D8j&iGaJ>JN37>I7vK_k9sW7<%oo40n-64Gj?KENmI!mtOsmDK|D(N@rstuK4
z;TsChXZa-Uo_J(`pet(rNGql`6w(M9yB#GPg~Iz?b+BCAq_@@|&&^qLGO~?>O6r+b
zUX@RVF&wLaE6w2B<e(2mXNAa0$^POh_=8Y8_!gRj5^uA$#Ct+ZuvOw%FJFl|BI(k~
z97k^L^lNJ^ZlL80g|93SJHgf6*^_DH;;#WmHQjc_V(2}oMH!|uvKFwR42%tJ>HIo$
zR2)^oh1@Tu`iZW6=)pBV4Wc73Yc(6mr+G2$5SQ+^XwE%_t7r6OEjapZDeKwoAk?5_
zs+G@AjlhI;BkXa2fvFX^8!Cqu0JIj(j}B^7=f&#be#3g(?pi=_u(`J2vzlCoE{9ax
zE+y}Tjo5dywCz2|hD89W$Em+~o*3?*pU+u_XD+KH`J%M(D5Rg!;)!0x+RsTDd7#K#
zc8{zhftc3KY3Yn9SA7#E0Luk6JPsxK*BrKz(Nnd|uRpTH6dF*zt)I7lKk-*J+4RC}
zKBJeGfy~{(J#9u}n_O|+RMs=Y?_3)=6%C1Sh~RWnSr!~bhh<9;>XvSHX-%D0#9FAo
zhBRGldC?6QSpV59OwDfa(p(d*79W@}Ni5yIow;vIpZn4HhUk<@@<oI_NK*pxG4gXE
zKE6z9hA$`r<AIc-H$@ApmkyxoIj_mGS4grI<*aAA%8ivwD?^f_l-X6j&B;D8As=?)
zp6k>GTzL9G8UrODivLj4S3<!2>8{S$ItQsZm_pWrD74pMx;5*iZR8+Q#(KH2Z?fZ)
z!snbMx)oLH-pCKx&l^wWrU*11-OIH~WBk7b{2m9dFA38BfQ!xbPP2WRa?~q~%4$@q
zuqV6h1}QVVSI=<?8BpZMe;#UMAWYzzH>P(|(l5KVWKa?OiT9$NPe&Cva)DDZC|Z<;
zYzlDHQf~K0(JotI3vlzv%KOH}%of%A^H1YQljS;ZGbm?|!Y-IQo9(+t2Z@A9kgpt`
za#%jMuq0UTDXmu*P_con-tcABT*=S-sJu#k7pTC{QuxhSN%7C#QhH??rYu`sA?#Gn
zaHUBHwI^61z?W{UDXG}S#wpuLQ!dffD)q1&zCrR%od(mD$!Zf9D4ufQ_-U_6b0U`F
ze%osi>|{dKPwm=ikU5V&b;^23+LVooiqs_UWH!}ZO4GsBs5G*ll#5XbjBLBa*o6>7
z998FOKQJT3A9BnxS81=r$EV;Y@v{Czb5!j!aWR26S8lB|a;?poI6!)Mw0$_PKC{Qk
z#Oz3|7n5z4!N0yj%d2S7<ekZ`_>2Fz>*4G)`#iR#)x2Gah|!T_onfm!Gz40-5RAg|
zc1TJx-egJ6UvYmW(R#2vS6uE3OFn*@=&YPw09D`gSkCe`3Wr$)Lqd-p1rn?Rt!LAw
zYa7hL0eT188VMD9*X#?f@<>ujZ`f8yIv7<Qy3KCPXiOGC*%FNl%<xg9Z^4=5Xq@Hc
z(0`DL(X?EemYKMFub-><&JgWz?zI(%ml>W$e~8Z3n;xCiV+vkzEe3PXYWecAXC#{G
z&Px|lV%X$_tYM&P(-W9l;AO~JCV6_n*;Yb3y5#W=SN1e8j*gTq9CAk3jUrC-STF7L
z=)qK#!lE)92eAHvcKoIlt#M6@h?5TvDpPY(pCikV6+eCeVUsiv3^LrVIjGFz`+Vb^
zE|7zkTF-(7>YbL)?|-M&eqTDUX2-)MGf@giohPQsZ112M*dZt~oNF5yv86t{^^myi
zTnhx`HNvNu$qt(A0wr{<YUMf(oYK7G<H@`$zG`9oT;o%ckNkuKNL^*u*4>~sU5@BE
zrBApvfT=5|?2qw<qMlLC;dh9H?_g}60EcM-v}~+1>|SlPL`qX)71!BKGmO%g?Qa<}
zv^QvVv~Ii5B%_9c1&c8;(DBt>?E9t>jxjd&8ONTiE7MIup@!NJ-}SMEcuA%+?Y>8A
zLOh->S^{So9!zhh$*{o<ItK2?GD#;nYPiR0yo|7kEFAcFp~6<7I*T8U`GOg!1vxl1
zTIKqamWPs&G|1fa;=ea-$5x+&o!&30l?}>-<iT8Mo(3d`{lIp5&W)cP2tAShC15xW
zuxz)iliONZt2wcO#V`ydGV_ogGagJj%T2K42@@^;<ETN60Hk)s;FplOu|N)V&5FHW
zxMfbtUKj=M_B|V?1jvSai0enl?F$EUji&4>2O85ccp&zDtO9C7lSVjB-i_8hw|hJO
zR8KVy6<AmOY(qa0N&YDp!t8r$1Lc_PdZy$B)jPM;RA?|&;7wXMU)?~BKiAl?B55vP
zZPFD!U9R`4xTJ1xp$L2s>36!vNx$@mMW2Hzs4Va_?S{9L5y4<@=d_n(MP}<)Kpdou
z*yTAL-cI}wc(e%zt)m*B{M?*hEvW{TYVE|`td3Z5*tjOQ8ME7$7)hR?Iw`&ASirTq
z2)ePYTbSIrFSp1`-RdS1x+DOHF-1ADoALhfN%Lwd?U##4vB+);-P)b4WXDP3q1y1C
zWH&>+6rO66HCOAM%`-RWD43(C-lwX?Y?eSqN*;=7Ikmi}k#Y1&F@mYi<EeYovbxW-
z5#%k2`LT6`LAF@^^_J!Xa=mBMQN9__t+&{>wyw^_q^!tT&)D<c8{&)qpYw7C6dN@v
zk|z4e3H;eXe674BWNMQ&Q7dLk>mf0nu=&jJ@ueAe2eRrROJ4es2-=Dr)bJD?EIt|g
zN#LoZCP5N=xAd$whJiL4I*UTHJZnx0*6Qf3pAjmNYvGsu&sUgHbyei9$`d4~EHXw^
zjP7(PAQYq$((I3inOM!3Pea#{o3@;*zQ6zcMR@_$8ZX0T-YKsSQ128QBoqe3--c&!
zI(z!XJJB}zuJ(O=fBo<J-<;=v2+w~9+0$cnUfz8$duRv<)c;CRzkm8pf&LQ#{df4I
zbxSrK3<Lx$IRpgqe}(nm+r5XKoIT#P%)cbDe@C@ipVdp=BN*>nc~AeN2H^kicAYFt
zO`V<ok4E~RH~%3w|DQYZPu~>hAMGF@IuQQd@b6at{#yUEK>xB(|1NbY=)d;p|0ARR
zyU#!6%fE27zsp|wKYjj(Bl_<S|8yAt5;Fg;F&XIp>1F;q{!fqaFRbzJ@{#*T{QuC6
z|4#o?{rk%-{JR?E|B?P%F#LCef3kD`-5^>48sh&!1^&CiKTr1mK7evc|2csF!>Uu1
XfqggbARv(5AD`b(Kb)-hCy4(A>9wj|

literal 0
HcmV?d00001


From 829fc80e3ea89c6e59cca583aaaa70b8a9af99e8 Mon Sep 17 00:00:00 2001
From: Frank Knoll <Knoll_Frank@web.de>
Date: Sat, 27 Jul 2024 17:26:44 +0200
Subject: [PATCH 02/16] adding empty index.html

---
 docs/DrugsForPathologies/index.html | 149 ++++++++++++++++++++++++++++
 src/help.txt                        |   2 +
 2 files changed, 151 insertions(+)
 create mode 100644 docs/DrugsForPathologies/index.html

diff --git a/docs/DrugsForPathologies/index.html b/docs/DrugsForPathologies/index.html
new file mode 100644
index 00000000000..91cb49f18c8
--- /dev/null
+++ b/docs/DrugsForPathologies/index.html
@@ -0,0 +1,149 @@
+<!DOCTYPE html>
+<html>
+
+<head>
+  <meta content="text/html; charset=utf-8" http-equiv="Content-Type" />
+  <!-- Meta, title, CSS, favicons, etc. -->
+  <meta charset="utf-8" />
+  <meta content="IE=edge" http-equiv="X-UA-Compatible" />
+  <meta content="width=device-width, initial-scale=1.0" name="viewport" />
+  <title>Drugs for Pathologies</title>
+  <!-- FK-TODO: reactivate GA: -->
+  <!-- Google tag (gtag.js) -->
+  <!-- <script async="" src="https://www.googletagmanager.com/gtag/js?id=G-ERHYDH4P64"></script>
+  <script>
+    window.dataLayer = window.dataLayer || [];
+    function gtag() { dataLayer.push(arguments); }
+    gtag('js', new Date());
+
+    gtag('config', 'G-ERHYDH4P64');
+  </script> -->
+  <!-- Bootstrap -->
+  <link href="../gentelella/vendors/bootstrap/dist/css/bootstrap.min.css" rel="stylesheet" />
+  <link href="https://cdn.datatables.net/1.13.1/css/jquery.dataTables.css" rel="stylesheet" type="text/css" />
+  <!-- Font Awesome -->
+  <link href="../gentelella/vendors/font-awesome/css/font-awesome.min.css" rel="stylesheet" />
+  <!-- Custom Theme Style -->
+  <link href="../gentelella/build/css/custom.css" rel="stylesheet" />
+  <link href="../forkMeOnGitHub.css" rel="stylesheet" type="text/css" />
+  <script crossorigin="anonymous"
+    integrity="sha512-w61kvDEdEhJPJLSAJpuL+RWp1+zTBUUpgPaP+6pcqCk78wQkOaExjnGWrVbovojeisWGQS7XZKz+gr3L+GPYLg=="
+    referrerpolicy="no-referrer" src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.10/pdfmake.min.js"></script>
+  <script crossorigin="anonymous"
+    integrity="sha512-EFlschXPq/G5zunGPRSYqazR1CMKj0cQc8v6eMrQwybxgIbhsfoO5NAMQX3xFDQIbFlViv53o7Hy+yCWw6iZxA=="
+    referrerpolicy="no-referrer" src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.10/vfs_fonts.min.js"></script>
+  <script>
+    document.addEventListener(
+      "DOMContentLoaded",
+      event => {
+      });
+  </script>
+</head>
+
+<body class="nav-md">
+  <div class="container body">
+    <div class="main_container">
+      <!-- top navigation -->
+      <div class="top_nav">
+      </div>
+      <!-- top navigation -->
+      <!-- page content -->
+      <div class="right_col" role="main">
+        <div>
+          <div class="page-title">
+            <div class="title_left">
+              <h1 id="heading">Drugs for Pathologies</h1>
+              <p>
+                By Craig Paardekooper
+              </p>
+            </div>
+          </div>
+          <div class="clearfix"></div>
+          <div class="row">
+            <div class="col-xs-12 col-sm-6">
+              <div class="x_panel">
+                <div class="x_title">
+                  <h3 id="subheading">Associated Drugs</h3>
+                  <div class="clearfix"></div>
+                </div>
+                <div class="x_content">
+                  <div style="margin-bottom: 20px;">
+                    <label>Select Pathology:</label>
+                    <select id=pPathologySelect" name="pathology">
+                      <option disabled="" hidden="" selected="" value="">Select Pathology</option>
+                    </select>
+                  </div>
+                  <table class="display" id="prrByVaccineTable">
+                    <thead>
+                      <tr>
+                        <th>Drug</th>
+                        <th>Lower Confidence Limit of Proportional Reporting Ratio</th>
+                      </tr>
+                    </thead>
+                  </table>
+                </div>
+              </div>
+            </div>
+          </div>
+          <div class="clearfix"></div>
+        </div>
+      </div>
+    </div>
+    <!-- page content -->
+    <!-- footer content -->
+    <footer>
+      <!-- AddToAny BEGIN -->
+      <div class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-title="EU Safety Signal (All drugs)">
+        <a class="a2a_dd" href="https://www.addtoany.com/share"></a>
+        <a class="a2a_button_facebook"></a>
+        <a class="a2a_button_twitter"></a>
+        <a class="a2a_button_whatsapp"></a>
+        <a class="a2a_button_telegram"></a>
+        <a class="a2a_button_email"></a>
+        <button class="btn" id="PDF">PDF</button>
+      </div>
+      <script>
+        var a2a_config = a2a_config || {};
+        a2a_config.callbacks = a2a_config.callbacks || [];
+        a2a_config.callbacks.push({
+          share: _ => ({ url: window.location.href }),
+        });
+      </script>
+      <script async="" src="https://static.addtoany.com/menu/page.js"></script>
+      <!-- AddToAny END -->
+      <br />
+      <p>
+        <a href="https://howbad.info/essd.zip" target="_blank">Data Source <i aria-hidden="true"
+            class="fa fa-external-link"></i>
+        </a>
+      </p>
+      <span id="forkongithub"><a href="https://github.com/KnollFrank/HowBadIsMyBatch" target="_blank">Fork me on
+          GitHub <i aria-hidden="true" class="fa fa-external-link"></i>
+        </a></span>
+      <div class="clearfix"></div>
+    </footer>
+  </div>
+  <template id="template-number-with-bar">
+    <div>
+      <div class="number"></div>
+      <div class="bar"></div>
+    </div>
+  </template>
+  <!-- jQuery -->
+  <script src="../gentelella/vendors/jquery/dist/jquery.min.js"></script>
+  <!-- Bootstrap -->
+  <script src="../gentelella/vendors/bootstrap/dist/js/bootstrap.min.js"></script>
+  <link href="https://cdn.jsdelivr.net/npm/select2@4.1.0-rc.0/dist/css/select2.min.css" rel="stylesheet" />
+  <script src="https://cdn.jsdelivr.net/npm/select2@4.1.0-rc.0/dist/js/select2.min.js"></script>
+  <script src="https://cdn.jsdelivr.net/npm/chart.js@4.2.0/dist/chart.umd.min.js"></script>
+  <script charset="utf8" src="https://cdn.datatables.net/1.13.1/js/jquery.dataTables.min.js"
+    type="text/javascript"></script>
+  <script
+    src=" https://cdn.jsdelivr.net/npm/chartjs-plugin-datalabels@2.2.0/dist/chartjs-plugin-datalabels.min.js "></script>
+  <!-- FastClick -->
+  <script src="../gentelella/vendors/fastclick/lib/fastclick.js"></script>
+  <!-- Custom Theme Scripts -->
+  <script src="../gentelella/build/js/custom.js"></script>
+</body>
+
+</html>
\ No newline at end of file
diff --git a/src/help.txt b/src/help.txt
index 6d820e3f7e0..fd491570f8c 100644
--- a/src/help.txt
+++ b/src/help.txt
@@ -4,6 +4,7 @@ Local:
 - http://www.howbadismybatch.info/VaccineDistributionByZipcode.html
 - http://www.howbadismybatch.info/SymptomsCausedByVaccines/index.html
 - http://www.howbadismybatch.info/SymptomsCausedByDrugs/index.html
+- http://www.howbadismybatch.info/DrugsForPathologies/index.html
 
 Live:
 - https://knollfrank.github.io/HowBadIsMyBatch/batchCodeTable.html
@@ -11,6 +12,7 @@ Live:
 - https://knollfrank.github.io/HowBadIsMyBatch/VaccineDistributionByZipcode.html
 - https://knollfrank.github.io/HowBadIsMyBatch/SymptomsCausedByVaccines/index.html
 - https://knollfrank.github.io/HowBadIsMyBatch/SymptomsCausedByDrugs/index.html
+- https://knollfrank.github.io/HowBadIsMyBatch/DrugsForPathologies/index.html
 
 jupyter notebook
 

From 951ea589821815ac291c64668b383b0df8a5c12a Mon Sep 17 00:00:00 2001
From: Frank Knoll <Knoll_Frank@web.de>
Date: Sat, 27 Jul 2024 17:27:50 +0200
Subject: [PATCH 03/16] correcting a typo

---
 docs/DrugsForPathologies/index.html | 2 +-
 1 file changed, 1 insertion(+), 1 deletion(-)

diff --git a/docs/DrugsForPathologies/index.html b/docs/DrugsForPathologies/index.html
index 91cb49f18c8..0058175ddbe 100644
--- a/docs/DrugsForPathologies/index.html
+++ b/docs/DrugsForPathologies/index.html
@@ -69,7 +69,7 @@
                 <div class="x_content">
                   <div style="margin-bottom: 20px;">
                     <label>Select Pathology:</label>
-                    <select id=pPathologySelect" name="pathology">
+                    <select id="pathologySelect" name="pathology">
                       <option disabled="" hidden="" selected="" value="">Select Pathology</option>
                     </select>
                   </div>

From e47aefd9bf41e62f478d01a984adef6d3176d205 Mon Sep 17 00:00:00 2001
From: Frank Knoll <Knoll_Frank@web.de>
Date: Sat, 27 Jul 2024 18:24:12 +0200
Subject: [PATCH 04/16] adding pathology options to html file

---
 .gitignore                                |  2 ++
 src/DrugsForPathologies/HtmlUpdater.py    | 28 +++++++++++++++++++++++
 src/DrugsForPathologies/__init__.py       |  0
 src/HowBadIsMyBatch.ipynb                 | 26 ++++++++++++---------
 src/SymptomsCausedByVaccines/HtmlUtils.py |  6 ++---
 5 files changed, 48 insertions(+), 14 deletions(-)
 create mode 100644 src/DrugsForPathologies/HtmlUpdater.py
 create mode 100644 src/DrugsForPathologies/__init__.py

diff --git a/.gitignore b/.gitignore
index 4205fabf39f..794095fc5ee 100644
--- a/.gitignore
+++ b/.gitignore
@@ -15,3 +15,5 @@ src/GoogleAnalytics/__pycache__
 src/SymptomsCausedByVaccines/__pycache__
 src/HowBadIsMyBatch.py
 src/data/prrByDrugAndSymptom-EudraVigilance.csv
+src/DrugsForPathologies/__pycache__
+
diff --git a/src/DrugsForPathologies/HtmlUpdater.py b/src/DrugsForPathologies/HtmlUpdater.py
new file mode 100644
index 00000000000..a446a54e642
--- /dev/null
+++ b/src/DrugsForPathologies/HtmlUpdater.py
@@ -0,0 +1,28 @@
+from bs4 import BeautifulSoup
+from HtmlTransformerUtil import HtmlTransformerUtil
+from DateProvider import DateProvider
+from SymptomsCausedByVaccines.HtmlUtils import getOptionsWithDefaultOption
+from SymptomsCausedByVaccines.OptionsSetter import OptionsSetter
+
+
+def updateHtmlFile(filenameByPathology, htmlFile):
+    options = getOptionsWithDefaultOption(
+        defaultOptionText = 'Select Pathology',
+        values = list(filenameByPathology.keys()),
+        filenameByValue = filenameByPathology)
+    _saveOptions(
+        options = options,
+        htmlFile = htmlFile,
+        selectElementId = 'pathologySelect')
+
+
+def _saveOptions(options, htmlFile, selectElementId):
+    HtmlTransformerUtil().applySoupTransformerToFile(
+        file=htmlFile,
+        soupTransformer = lambda soup:
+            BeautifulSoup(
+                OptionsSetter().setOptions(
+                    html = str(soup),
+                    selectElementId = selectElementId,
+                    options = options),
+                'lxml'))
diff --git a/src/DrugsForPathologies/__init__.py b/src/DrugsForPathologies/__init__.py
new file mode 100644
index 00000000000..e69de29bb2d
diff --git a/src/HowBadIsMyBatch.ipynb b/src/HowBadIsMyBatch.ipynb
index 383ea805f87..636ef91a04b 100644
--- a/src/HowBadIsMyBatch.ipynb
+++ b/src/HowBadIsMyBatch.ipynb
@@ -622,7 +622,8 @@
    "outputs": [],
    "source": [
     "import pandas as pd\n",
-    "import os"
+    "import os\n",
+    "from DrugsForPathologies.HtmlUpdater import updateHtmlFile as updateDrugsForPathologiesHtmlFile\n"
    ]
   },
   {
@@ -709,12 +710,17 @@
   {
    "cell_type": "code",
    "execution_count": null,
-   "id": "5bd7d025",
+   "id": "5535345f",
    "metadata": {},
    "outputs": [],
    "source": [
-    "webAppBaseDir = os.path.normpath(os.getcwd() + '/../docs/DrugsForPathologies')\n",
-    "webAppBaseDir"
+    "def saveDrugDescriptionsForPathologiesAndUpdateHtmlFile(drugDescrByPathology, webAppBaseDir):\n",
+    "    filenameByPathology = saveDrugDescriptionsForPathologies(\n",
+    "        drugDescrByPathology = drugDescrByPathology,\n",
+    "        directory = os.path.normpath(webAppBaseDir + '/data/DrugDescriptionsForPathologies'))\n",
+    "    updateDrugsForPathologiesHtmlFile(\n",
+    "        filenameByPathology,\n",
+    "        htmlFile = os.path.normpath(webAppBaseDir + '/index.html'))\n"
    ]
   },
   {
@@ -724,20 +730,18 @@
    "metadata": {},
    "outputs": [],
    "source": [
-    "filenameByPathology = saveDrugDescriptionsForPathologies(\n",
-    "    drugDescrByPathology = drugDescrByPathology,\n",
-    "    directory = os.path.normpath(webAppBaseDir + '/data/DrugDescriptionsForPathologies'))\n"
+    "saveDrugDescriptionsForPathologiesAndUpdateHtmlFile(\n",
+    "    drugDescrByPathology = drugDescrByPathology[:2],\n",
+    "    webAppBaseDir = os.path.normpath(os.getcwd() + '/../docs/DrugsForPathologies'))"
    ]
   },
   {
    "cell_type": "code",
    "execution_count": null,
-   "id": "013ffd05",
+   "id": "a2398b3a",
    "metadata": {},
    "outputs": [],
-   "source": [
-    "filenameByPathology"
-   ]
+   "source": []
   }
  ],
  "metadata": {
diff --git a/src/SymptomsCausedByVaccines/HtmlUtils.py b/src/SymptomsCausedByVaccines/HtmlUtils.py
index e2d3f34ec2f..d6ad2747233 100644
--- a/src/SymptomsCausedByVaccines/HtmlUtils.py
+++ b/src/SymptomsCausedByVaccines/HtmlUtils.py
@@ -1,20 +1,20 @@
 import html
 
 def getVaccineOptions(vaccines, filenameByDrug, defaultOptionText):
-    return _getOptionsWithDefaultOption(
+    return getOptionsWithDefaultOption(
         defaultOptionText = defaultOptionText,
         values = vaccines,
         filenameByValue = filenameByDrug)
 
 
 def getSymptomOptions(symptoms, filenameBySymptom):
-    return _getOptionsWithDefaultOption(
+    return getOptionsWithDefaultOption(
         defaultOptionText = 'Select Symptom',
         values = symptoms,
         filenameByValue = filenameBySymptom)
 
 
-def _getOptionsWithDefaultOption(defaultOptionText, values, filenameByValue):
+def getOptionsWithDefaultOption(defaultOptionText, values, filenameByValue):
     return ['<option hidden disabled selected value>{defaultOptionText}</option>'.format(defaultOptionText = defaultOptionText)] + _getOptions(values, filenameByValue)
 
 

From 854878a59276ccea1e77e4b0afc3415ca6fd2735 Mon Sep 17 00:00:00 2001
From: Frank Knoll <Knoll_Frank@web.de>
Date: Sat, 27 Jul 2024 18:33:22 +0200
Subject: [PATCH 05/16] refactoring

---
 ...DrugDescriptionsForPathologiesPersister.py | 13 +++++++++++
 src/HowBadIsMyBatch.ipynb                     | 23 +------------------
 2 files changed, 14 insertions(+), 22 deletions(-)
 create mode 100644 src/DrugsForPathologies/DrugDescriptionsForPathologiesPersister.py

diff --git a/src/DrugsForPathologies/DrugDescriptionsForPathologiesPersister.py b/src/DrugsForPathologies/DrugDescriptionsForPathologiesPersister.py
new file mode 100644
index 00000000000..ada1a3cf44b
--- /dev/null
+++ b/src/DrugsForPathologies/DrugDescriptionsForPathologiesPersister.py
@@ -0,0 +1,13 @@
+import shutil
+from IOUtils import IOUtils
+
+def saveDrugDescriptionsForPathologies(drugDescrByPathology, directory):
+    shutil.rmtree(directory, ignore_errors = True)
+    filenameByPathology = {}
+    i = 0
+    for pathology, drugDescr in drugDescrByPathology.items():
+        i += 1
+        filenameByPathology[pathology] = f'{i}'
+        drugDescr['PATHOLOGY'] = pathology
+        IOUtils.saveDictAsJson(drugDescr, f'{directory}/{i}.json')
+    return filenameByPathology    
diff --git a/src/HowBadIsMyBatch.ipynb b/src/HowBadIsMyBatch.ipynb
index 636ef91a04b..399d9b1dc84 100644
--- a/src/HowBadIsMyBatch.ipynb
+++ b/src/HowBadIsMyBatch.ipynb
@@ -623,6 +623,7 @@
    "source": [
     "import pandas as pd\n",
     "import os\n",
+    "from DrugsForPathologies.DrugDescriptionsForPathologiesPersister import saveDrugDescriptionsForPathologies\n",
     "from DrugsForPathologies.HtmlUpdater import updateHtmlFile as updateDrugsForPathologiesHtmlFile\n"
    ]
   },
@@ -685,28 +686,6 @@
     "drugs4Pathologies[drugs4Pathologies['PATHOLOGY'] == 'bone cancer']"
    ]
   },
-  {
-   "cell_type": "code",
-   "execution_count": null,
-   "id": "4444d234",
-   "metadata": {},
-   "outputs": [],
-   "source": [
-    "import shutil\n",
-    "from IOUtils import IOUtils\n",
-    "\n",
-    "def saveDrugDescriptionsForPathologies(drugDescrByPathology, directory):\n",
-    "    shutil.rmtree(directory, ignore_errors = True)\n",
-    "    filenameByPathology = {}\n",
-    "    i = 0\n",
-    "    for pathology, drugDescr in drugDescrByPathology.items():\n",
-    "        i += 1\n",
-    "        filenameByPathology[pathology] = f'{i}'\n",
-    "        drugDescr['PATHOLOGY'] = pathology\n",
-    "        IOUtils.saveDictAsJson(drugDescr, f'{directory}/{i}.json')\n",
-    "    return filenameByPathology    \n"
-   ]
-  },
   {
    "cell_type": "code",
    "execution_count": null,

From 4a837ed1750a3a6089342788ac65f201f39f8052 Mon Sep 17 00:00:00 2001
From: Frank Knoll <Knoll_Frank@web.de>
Date: Sat, 27 Jul 2024 18:38:27 +0200
Subject: [PATCH 06/16] refactoring

---
 src/HowBadIsMyBatch.ipynb | 71 ++++++++++++++++++---------------------
 1 file changed, 33 insertions(+), 38 deletions(-)

diff --git a/src/HowBadIsMyBatch.ipynb b/src/HowBadIsMyBatch.ipynb
index 399d9b1dc84..ac8d62b672d 100644
--- a/src/HowBadIsMyBatch.ipynb
+++ b/src/HowBadIsMyBatch.ipynb
@@ -627,6 +627,38 @@
     "from DrugsForPathologies.HtmlUpdater import updateHtmlFile as updateDrugsForPathologiesHtmlFile\n"
    ]
   },
+  {
+   "cell_type": "code",
+   "execution_count": null,
+   "id": "3f60c4f1",
+   "metadata": {},
+   "outputs": [],
+   "source": [
+    "def getDrugDescrByPathology(drugs4Pathologies):\n",
+    "    def drugsTable2drugDescr(drugsTable):\n",
+    "        drugDescr = drugsTable.to_dict('list')\n",
+    "        del drugDescr['PATHOLOGY']\n",
+    "        return drugDescr\n",
+    "    \n",
+    "    return drugs4Pathologies.groupby('PATHOLOGY').apply(drugsTable2drugDescr)\n"
+   ]
+  },
+  {
+   "cell_type": "code",
+   "execution_count": null,
+   "id": "a092ecf7",
+   "metadata": {},
+   "outputs": [],
+   "source": [
+    "def saveDrugDescriptionsForPathologiesAndUpdateHtmlFile(drugDescrByPathology, webAppBaseDir):\n",
+    "    filenameByPathology = saveDrugDescriptionsForPathologies(\n",
+    "        drugDescrByPathology = drugDescrByPathology,\n",
+    "        directory = os.path.normpath(webAppBaseDir + '/data/DrugDescriptionsForPathologies'))\n",
+    "    updateDrugsForPathologiesHtmlFile(\n",
+    "        filenameByPathology,\n",
+    "        htmlFile = os.path.normpath(webAppBaseDir + '/index.html'))\n"
+   ]
+  },
   {
    "cell_type": "code",
    "execution_count": null,
@@ -642,19 +674,6 @@
     "drugs4Pathologies"
    ]
   },
-  {
-   "cell_type": "code",
-   "execution_count": null,
-   "id": "492230af",
-   "metadata": {},
-   "outputs": [],
-   "source": [
-    "def drugsTable2drugDescr(drugsTable):\n",
-    "    drugDescr = drugsTable.to_dict('list')\n",
-    "    del drugDescr['PATHOLOGY']\n",
-    "    return drugDescr"
-   ]
-  },
   {
    "cell_type": "code",
    "execution_count": null,
@@ -662,7 +681,7 @@
    "metadata": {},
    "outputs": [],
    "source": [
-    "drugDescrByPathology = drugs4Pathologies.groupby('PATHOLOGY').apply(drugsTable2drugDescr)\n",
+    "drugDescrByPathology = getDrugDescrByPathology(drugs4Pathologies)\n",
     "drugDescrByPathology"
    ]
   },
@@ -686,22 +705,6 @@
     "drugs4Pathologies[drugs4Pathologies['PATHOLOGY'] == 'bone cancer']"
    ]
   },
-  {
-   "cell_type": "code",
-   "execution_count": null,
-   "id": "5535345f",
-   "metadata": {},
-   "outputs": [],
-   "source": [
-    "def saveDrugDescriptionsForPathologiesAndUpdateHtmlFile(drugDescrByPathology, webAppBaseDir):\n",
-    "    filenameByPathology = saveDrugDescriptionsForPathologies(\n",
-    "        drugDescrByPathology = drugDescrByPathology,\n",
-    "        directory = os.path.normpath(webAppBaseDir + '/data/DrugDescriptionsForPathologies'))\n",
-    "    updateDrugsForPathologiesHtmlFile(\n",
-    "        filenameByPathology,\n",
-    "        htmlFile = os.path.normpath(webAppBaseDir + '/index.html'))\n"
-   ]
-  },
   {
    "cell_type": "code",
    "execution_count": null,
@@ -713,14 +716,6 @@
     "    drugDescrByPathology = drugDescrByPathology[:2],\n",
     "    webAppBaseDir = os.path.normpath(os.getcwd() + '/../docs/DrugsForPathologies'))"
    ]
-  },
-  {
-   "cell_type": "code",
-   "execution_count": null,
-   "id": "a2398b3a",
-   "metadata": {},
-   "outputs": [],
-   "source": []
   }
  ],
  "metadata": {

From 1374d4a73f9ef46a103dfcca31ec454524d9c55e Mon Sep 17 00:00:00 2001
From: Frank Knoll <Knoll_Frank@web.de>
Date: Sat, 27 Jul 2024 22:57:02 +0200
Subject: [PATCH 07/16] adding DrugsChartView

---
 .../DrugDescriptionsForPathologies/1.json     |    1 +
 .../DrugDescriptionsForPathologies/10.json    |    1 +
 .../DrugDescriptionsForPathologies/100.json   |    1 +
 .../DrugDescriptionsForPathologies/1000.json  |    1 +
 .../DrugDescriptionsForPathologies/1001.json  |    1 +
 .../DrugDescriptionsForPathologies/1002.json  |    1 +
 .../DrugDescriptionsForPathologies/1003.json  |    1 +
 .../DrugDescriptionsForPathologies/1004.json  |    1 +
 .../DrugDescriptionsForPathologies/1005.json  |    1 +
 .../DrugDescriptionsForPathologies/1006.json  |    1 +
 .../DrugDescriptionsForPathologies/1007.json  |    1 +
 .../DrugDescriptionsForPathologies/1008.json  |    1 +
 .../DrugDescriptionsForPathologies/1009.json  |    1 +
 .../DrugDescriptionsForPathologies/101.json   |    1 +
 .../DrugDescriptionsForPathologies/1010.json  |    1 +
 .../DrugDescriptionsForPathologies/1011.json  |    1 +
 .../DrugDescriptionsForPathologies/1012.json  |    1 +
 .../DrugDescriptionsForPathologies/1013.json  |    1 +
 .../DrugDescriptionsForPathologies/1014.json  |    1 +
 .../DrugDescriptionsForPathologies/1015.json  |    1 +
 .../DrugDescriptionsForPathologies/1016.json  |    1 +
 .../DrugDescriptionsForPathologies/1017.json  |    1 +
 .../DrugDescriptionsForPathologies/1018.json  |    1 +
 .../DrugDescriptionsForPathologies/1019.json  |    1 +
 .../DrugDescriptionsForPathologies/102.json   |    1 +
 .../DrugDescriptionsForPathologies/1020.json  |    1 +
 .../DrugDescriptionsForPathologies/1021.json  |    1 +
 .../DrugDescriptionsForPathologies/1022.json  |    1 +
 .../DrugDescriptionsForPathologies/1023.json  |    1 +
 .../DrugDescriptionsForPathologies/1024.json  |    1 +
 .../DrugDescriptionsForPathologies/1025.json  |    1 +
 .../DrugDescriptionsForPathologies/1026.json  |    1 +
 .../DrugDescriptionsForPathologies/1027.json  |    1 +
 .../DrugDescriptionsForPathologies/1028.json  |    1 +
 .../DrugDescriptionsForPathologies/1029.json  |    1 +
 .../DrugDescriptionsForPathologies/103.json   |    1 +
 .../DrugDescriptionsForPathologies/1030.json  |    1 +
 .../DrugDescriptionsForPathologies/1031.json  |    1 +
 .../DrugDescriptionsForPathologies/1032.json  |    1 +
 .../DrugDescriptionsForPathologies/1033.json  |    1 +
 .../DrugDescriptionsForPathologies/1034.json  |    1 +
 .../DrugDescriptionsForPathologies/1035.json  |    1 +
 .../DrugDescriptionsForPathologies/1036.json  |    1 +
 .../DrugDescriptionsForPathologies/1037.json  |    1 +
 .../DrugDescriptionsForPathologies/1038.json  |    1 +
 .../DrugDescriptionsForPathologies/104.json   |    1 +
 .../DrugDescriptionsForPathologies/105.json   |    1 +
 .../DrugDescriptionsForPathologies/106.json   |    1 +
 .../DrugDescriptionsForPathologies/107.json   |    1 +
 .../DrugDescriptionsForPathologies/108.json   |    1 +
 .../DrugDescriptionsForPathologies/109.json   |    1 +
 .../DrugDescriptionsForPathologies/11.json    |    1 +
 .../DrugDescriptionsForPathologies/110.json   |    1 +
 .../DrugDescriptionsForPathologies/111.json   |    1 +
 .../DrugDescriptionsForPathologies/112.json   |    1 +
 .../DrugDescriptionsForPathologies/113.json   |    1 +
 .../DrugDescriptionsForPathologies/114.json   |    1 +
 .../DrugDescriptionsForPathologies/115.json   |    1 +
 .../DrugDescriptionsForPathologies/116.json   |    1 +
 .../DrugDescriptionsForPathologies/117.json   |    1 +
 .../DrugDescriptionsForPathologies/118.json   |    1 +
 .../DrugDescriptionsForPathologies/119.json   |    1 +
 .../DrugDescriptionsForPathologies/12.json    |    1 +
 .../DrugDescriptionsForPathologies/120.json   |    1 +
 .../DrugDescriptionsForPathologies/121.json   |    1 +
 .../DrugDescriptionsForPathologies/122.json   |    1 +
 .../DrugDescriptionsForPathologies/123.json   |    1 +
 .../DrugDescriptionsForPathologies/124.json   |    1 +
 .../DrugDescriptionsForPathologies/125.json   |    1 +
 .../DrugDescriptionsForPathologies/126.json   |    1 +
 .../DrugDescriptionsForPathologies/127.json   |    1 +
 .../DrugDescriptionsForPathologies/128.json   |    1 +
 .../DrugDescriptionsForPathologies/129.json   |    1 +
 .../DrugDescriptionsForPathologies/13.json    |    1 +
 .../DrugDescriptionsForPathologies/130.json   |    1 +
 .../DrugDescriptionsForPathologies/131.json   |    1 +
 .../DrugDescriptionsForPathologies/132.json   |    1 +
 .../DrugDescriptionsForPathologies/133.json   |    1 +
 .../DrugDescriptionsForPathologies/134.json   |    1 +
 .../DrugDescriptionsForPathologies/135.json   |    1 +
 .../DrugDescriptionsForPathologies/136.json   |    1 +
 .../DrugDescriptionsForPathologies/137.json   |    1 +
 .../DrugDescriptionsForPathologies/138.json   |    1 +
 .../DrugDescriptionsForPathologies/139.json   |    1 +
 .../DrugDescriptionsForPathologies/14.json    |    1 +
 .../DrugDescriptionsForPathologies/140.json   |    1 +
 .../DrugDescriptionsForPathologies/141.json   |    1 +
 .../DrugDescriptionsForPathologies/142.json   |    1 +
 .../DrugDescriptionsForPathologies/143.json   |    1 +
 .../DrugDescriptionsForPathologies/144.json   |    1 +
 .../DrugDescriptionsForPathologies/145.json   |    1 +
 .../DrugDescriptionsForPathologies/146.json   |    1 +
 .../DrugDescriptionsForPathologies/147.json   |    1 +
 .../DrugDescriptionsForPathologies/148.json   |    1 +
 .../DrugDescriptionsForPathologies/149.json   |    1 +
 .../DrugDescriptionsForPathologies/15.json    |    1 +
 .../DrugDescriptionsForPathologies/150.json   |    1 +
 .../DrugDescriptionsForPathologies/151.json   |    1 +
 .../DrugDescriptionsForPathologies/152.json   |    1 +
 .../DrugDescriptionsForPathologies/153.json   |    1 +
 .../DrugDescriptionsForPathologies/154.json   |    1 +
 .../DrugDescriptionsForPathologies/155.json   |    1 +
 .../DrugDescriptionsForPathologies/156.json   |    1 +
 .../DrugDescriptionsForPathologies/157.json   |    1 +
 .../DrugDescriptionsForPathologies/158.json   |    1 +
 .../DrugDescriptionsForPathologies/159.json   |    1 +
 .../DrugDescriptionsForPathologies/16.json    |    1 +
 .../DrugDescriptionsForPathologies/160.json   |    1 +
 .../DrugDescriptionsForPathologies/161.json   |    1 +
 .../DrugDescriptionsForPathologies/162.json   |    1 +
 .../DrugDescriptionsForPathologies/163.json   |    1 +
 .../DrugDescriptionsForPathologies/164.json   |    1 +
 .../DrugDescriptionsForPathologies/165.json   |    1 +
 .../DrugDescriptionsForPathologies/166.json   |    1 +
 .../DrugDescriptionsForPathologies/167.json   |    1 +
 .../DrugDescriptionsForPathologies/168.json   |    1 +
 .../DrugDescriptionsForPathologies/169.json   |    1 +
 .../DrugDescriptionsForPathologies/17.json    |    1 +
 .../DrugDescriptionsForPathologies/170.json   |    1 +
 .../DrugDescriptionsForPathologies/171.json   |    1 +
 .../DrugDescriptionsForPathologies/172.json   |    1 +
 .../DrugDescriptionsForPathologies/173.json   |    1 +
 .../DrugDescriptionsForPathologies/174.json   |    1 +
 .../DrugDescriptionsForPathologies/175.json   |    1 +
 .../DrugDescriptionsForPathologies/176.json   |    1 +
 .../DrugDescriptionsForPathologies/177.json   |    1 +
 .../DrugDescriptionsForPathologies/178.json   |    1 +
 .../DrugDescriptionsForPathologies/179.json   |    1 +
 .../DrugDescriptionsForPathologies/18.json    |    1 +
 .../DrugDescriptionsForPathologies/180.json   |    1 +
 .../DrugDescriptionsForPathologies/181.json   |    1 +
 .../DrugDescriptionsForPathologies/182.json   |    1 +
 .../DrugDescriptionsForPathologies/183.json   |    1 +
 .../DrugDescriptionsForPathologies/184.json   |    1 +
 .../DrugDescriptionsForPathologies/185.json   |    1 +
 .../DrugDescriptionsForPathologies/186.json   |    1 +
 .../DrugDescriptionsForPathologies/187.json   |    1 +
 .../DrugDescriptionsForPathologies/188.json   |    1 +
 .../DrugDescriptionsForPathologies/189.json   |    1 +
 .../DrugDescriptionsForPathologies/19.json    |    1 +
 .../DrugDescriptionsForPathologies/190.json   |    1 +
 .../DrugDescriptionsForPathologies/191.json   |    1 +
 .../DrugDescriptionsForPathologies/192.json   |    1 +
 .../DrugDescriptionsForPathologies/193.json   |    1 +
 .../DrugDescriptionsForPathologies/194.json   |    1 +
 .../DrugDescriptionsForPathologies/195.json   |    1 +
 .../DrugDescriptionsForPathologies/196.json   |    1 +
 .../DrugDescriptionsForPathologies/197.json   |    1 +
 .../DrugDescriptionsForPathologies/198.json   |    1 +
 .../DrugDescriptionsForPathologies/199.json   |    1 +
 .../DrugDescriptionsForPathologies/2.json     |    1 +
 .../DrugDescriptionsForPathologies/20.json    |    1 +
 .../DrugDescriptionsForPathologies/200.json   |    1 +
 .../DrugDescriptionsForPathologies/201.json   |    1 +
 .../DrugDescriptionsForPathologies/202.json   |    1 +
 .../DrugDescriptionsForPathologies/203.json   |    1 +
 .../DrugDescriptionsForPathologies/204.json   |    1 +
 .../DrugDescriptionsForPathologies/205.json   |    1 +
 .../DrugDescriptionsForPathologies/206.json   |    1 +
 .../DrugDescriptionsForPathologies/207.json   |    1 +
 .../DrugDescriptionsForPathologies/208.json   |    1 +
 .../DrugDescriptionsForPathologies/209.json   |    1 +
 .../DrugDescriptionsForPathologies/21.json    |    1 +
 .../DrugDescriptionsForPathologies/210.json   |    1 +
 .../DrugDescriptionsForPathologies/211.json   |    1 +
 .../DrugDescriptionsForPathologies/212.json   |    1 +
 .../DrugDescriptionsForPathologies/213.json   |    1 +
 .../DrugDescriptionsForPathologies/214.json   |    1 +
 .../DrugDescriptionsForPathologies/215.json   |    1 +
 .../DrugDescriptionsForPathologies/216.json   |    1 +
 .../DrugDescriptionsForPathologies/217.json   |    1 +
 .../DrugDescriptionsForPathologies/218.json   |    1 +
 .../DrugDescriptionsForPathologies/219.json   |    1 +
 .../DrugDescriptionsForPathologies/22.json    |    1 +
 .../DrugDescriptionsForPathologies/220.json   |    1 +
 .../DrugDescriptionsForPathologies/221.json   |    1 +
 .../DrugDescriptionsForPathologies/222.json   |    1 +
 .../DrugDescriptionsForPathologies/223.json   |    1 +
 .../DrugDescriptionsForPathologies/224.json   |    1 +
 .../DrugDescriptionsForPathologies/225.json   |    1 +
 .../DrugDescriptionsForPathologies/226.json   |    1 +
 .../DrugDescriptionsForPathologies/227.json   |    1 +
 .../DrugDescriptionsForPathologies/228.json   |    1 +
 .../DrugDescriptionsForPathologies/229.json   |    1 +
 .../DrugDescriptionsForPathologies/23.json    |    1 +
 .../DrugDescriptionsForPathologies/230.json   |    1 +
 .../DrugDescriptionsForPathologies/231.json   |    1 +
 .../DrugDescriptionsForPathologies/232.json   |    1 +
 .../DrugDescriptionsForPathologies/233.json   |    1 +
 .../DrugDescriptionsForPathologies/234.json   |    1 +
 .../DrugDescriptionsForPathologies/235.json   |    1 +
 .../DrugDescriptionsForPathologies/236.json   |    1 +
 .../DrugDescriptionsForPathologies/237.json   |    1 +
 .../DrugDescriptionsForPathologies/238.json   |    1 +
 .../DrugDescriptionsForPathologies/239.json   |    1 +
 .../DrugDescriptionsForPathologies/24.json    |    1 +
 .../DrugDescriptionsForPathologies/240.json   |    1 +
 .../DrugDescriptionsForPathologies/241.json   |    1 +
 .../DrugDescriptionsForPathologies/242.json   |    1 +
 .../DrugDescriptionsForPathologies/243.json   |    1 +
 .../DrugDescriptionsForPathologies/244.json   |    1 +
 .../DrugDescriptionsForPathologies/245.json   |    1 +
 .../DrugDescriptionsForPathologies/246.json   |    1 +
 .../DrugDescriptionsForPathologies/247.json   |    1 +
 .../DrugDescriptionsForPathologies/248.json   |    1 +
 .../DrugDescriptionsForPathologies/249.json   |    1 +
 .../DrugDescriptionsForPathologies/25.json    |    1 +
 .../DrugDescriptionsForPathologies/250.json   |    1 +
 .../DrugDescriptionsForPathologies/251.json   |    1 +
 .../DrugDescriptionsForPathologies/252.json   |    1 +
 .../DrugDescriptionsForPathologies/253.json   |    1 +
 .../DrugDescriptionsForPathologies/254.json   |    1 +
 .../DrugDescriptionsForPathologies/255.json   |    1 +
 .../DrugDescriptionsForPathologies/256.json   |    1 +
 .../DrugDescriptionsForPathologies/257.json   |    1 +
 .../DrugDescriptionsForPathologies/258.json   |    1 +
 .../DrugDescriptionsForPathologies/259.json   |    1 +
 .../DrugDescriptionsForPathologies/26.json    |    1 +
 .../DrugDescriptionsForPathologies/260.json   |    1 +
 .../DrugDescriptionsForPathologies/261.json   |    1 +
 .../DrugDescriptionsForPathologies/262.json   |    1 +
 .../DrugDescriptionsForPathologies/263.json   |    1 +
 .../DrugDescriptionsForPathologies/264.json   |    1 +
 .../DrugDescriptionsForPathologies/265.json   |    1 +
 .../DrugDescriptionsForPathologies/266.json   |    1 +
 .../DrugDescriptionsForPathologies/267.json   |    1 +
 .../DrugDescriptionsForPathologies/268.json   |    1 +
 .../DrugDescriptionsForPathologies/269.json   |    1 +
 .../DrugDescriptionsForPathologies/27.json    |    1 +
 .../DrugDescriptionsForPathologies/270.json   |    1 +
 .../DrugDescriptionsForPathologies/271.json   |    1 +
 .../DrugDescriptionsForPathologies/272.json   |    1 +
 .../DrugDescriptionsForPathologies/273.json   |    1 +
 .../DrugDescriptionsForPathologies/274.json   |    1 +
 .../DrugDescriptionsForPathologies/275.json   |    1 +
 .../DrugDescriptionsForPathologies/276.json   |    1 +
 .../DrugDescriptionsForPathologies/277.json   |    1 +
 .../DrugDescriptionsForPathologies/278.json   |    1 +
 .../DrugDescriptionsForPathologies/279.json   |    1 +
 .../DrugDescriptionsForPathologies/28.json    |    1 +
 .../DrugDescriptionsForPathologies/280.json   |    1 +
 .../DrugDescriptionsForPathologies/281.json   |    1 +
 .../DrugDescriptionsForPathologies/282.json   |    1 +
 .../DrugDescriptionsForPathologies/283.json   |    1 +
 .../DrugDescriptionsForPathologies/284.json   |    1 +
 .../DrugDescriptionsForPathologies/285.json   |    1 +
 .../DrugDescriptionsForPathologies/286.json   |    1 +
 .../DrugDescriptionsForPathologies/287.json   |    1 +
 .../DrugDescriptionsForPathologies/288.json   |    1 +
 .../DrugDescriptionsForPathologies/289.json   |    1 +
 .../DrugDescriptionsForPathologies/29.json    |    1 +
 .../DrugDescriptionsForPathologies/290.json   |    1 +
 .../DrugDescriptionsForPathologies/291.json   |    1 +
 .../DrugDescriptionsForPathologies/292.json   |    1 +
 .../DrugDescriptionsForPathologies/293.json   |    1 +
 .../DrugDescriptionsForPathologies/294.json   |    1 +
 .../DrugDescriptionsForPathologies/295.json   |    1 +
 .../DrugDescriptionsForPathologies/296.json   |    1 +
 .../DrugDescriptionsForPathologies/297.json   |    1 +
 .../DrugDescriptionsForPathologies/298.json   |    1 +
 .../DrugDescriptionsForPathologies/299.json   |    1 +
 .../DrugDescriptionsForPathologies/3.json     |    1 +
 .../DrugDescriptionsForPathologies/30.json    |    1 +
 .../DrugDescriptionsForPathologies/300.json   |    1 +
 .../DrugDescriptionsForPathologies/301.json   |    1 +
 .../DrugDescriptionsForPathologies/302.json   |    1 +
 .../DrugDescriptionsForPathologies/303.json   |    1 +
 .../DrugDescriptionsForPathologies/304.json   |    1 +
 .../DrugDescriptionsForPathologies/305.json   |    1 +
 .../DrugDescriptionsForPathologies/306.json   |    1 +
 .../DrugDescriptionsForPathologies/307.json   |    1 +
 .../DrugDescriptionsForPathologies/308.json   |    1 +
 .../DrugDescriptionsForPathologies/309.json   |    1 +
 .../DrugDescriptionsForPathologies/31.json    |    1 +
 .../DrugDescriptionsForPathologies/310.json   |    1 +
 .../DrugDescriptionsForPathologies/311.json   |    1 +
 .../DrugDescriptionsForPathologies/312.json   |    1 +
 .../DrugDescriptionsForPathologies/313.json   |    1 +
 .../DrugDescriptionsForPathologies/314.json   |    1 +
 .../DrugDescriptionsForPathologies/315.json   |    1 +
 .../DrugDescriptionsForPathologies/316.json   |    1 +
 .../DrugDescriptionsForPathologies/317.json   |    1 +
 .../DrugDescriptionsForPathologies/318.json   |    1 +
 .../DrugDescriptionsForPathologies/319.json   |    1 +
 .../DrugDescriptionsForPathologies/32.json    |    1 +
 .../DrugDescriptionsForPathologies/320.json   |    1 +
 .../DrugDescriptionsForPathologies/321.json   |    1 +
 .../DrugDescriptionsForPathologies/322.json   |    1 +
 .../DrugDescriptionsForPathologies/323.json   |    1 +
 .../DrugDescriptionsForPathologies/324.json   |    1 +
 .../DrugDescriptionsForPathologies/325.json   |    1 +
 .../DrugDescriptionsForPathologies/326.json   |    1 +
 .../DrugDescriptionsForPathologies/327.json   |    1 +
 .../DrugDescriptionsForPathologies/328.json   |    1 +
 .../DrugDescriptionsForPathologies/329.json   |    1 +
 .../DrugDescriptionsForPathologies/33.json    |    1 +
 .../DrugDescriptionsForPathologies/330.json   |    1 +
 .../DrugDescriptionsForPathologies/331.json   |    1 +
 .../DrugDescriptionsForPathologies/332.json   |    1 +
 .../DrugDescriptionsForPathologies/333.json   |    1 +
 .../DrugDescriptionsForPathologies/334.json   |    1 +
 .../DrugDescriptionsForPathologies/335.json   |    1 +
 .../DrugDescriptionsForPathologies/336.json   |    1 +
 .../DrugDescriptionsForPathologies/337.json   |    1 +
 .../DrugDescriptionsForPathologies/338.json   |    1 +
 .../DrugDescriptionsForPathologies/339.json   |    1 +
 .../DrugDescriptionsForPathologies/34.json    |    1 +
 .../DrugDescriptionsForPathologies/340.json   |    1 +
 .../DrugDescriptionsForPathologies/341.json   |    1 +
 .../DrugDescriptionsForPathologies/342.json   |    1 +
 .../DrugDescriptionsForPathologies/343.json   |    1 +
 .../DrugDescriptionsForPathologies/344.json   |    1 +
 .../DrugDescriptionsForPathologies/345.json   |    1 +
 .../DrugDescriptionsForPathologies/346.json   |    1 +
 .../DrugDescriptionsForPathologies/347.json   |    1 +
 .../DrugDescriptionsForPathologies/348.json   |    1 +
 .../DrugDescriptionsForPathologies/349.json   |    1 +
 .../DrugDescriptionsForPathologies/35.json    |    1 +
 .../DrugDescriptionsForPathologies/350.json   |    1 +
 .../DrugDescriptionsForPathologies/351.json   |    1 +
 .../DrugDescriptionsForPathologies/352.json   |    1 +
 .../DrugDescriptionsForPathologies/353.json   |    1 +
 .../DrugDescriptionsForPathologies/354.json   |    1 +
 .../DrugDescriptionsForPathologies/355.json   |    1 +
 .../DrugDescriptionsForPathologies/356.json   |    1 +
 .../DrugDescriptionsForPathologies/357.json   |    1 +
 .../DrugDescriptionsForPathologies/358.json   |    1 +
 .../DrugDescriptionsForPathologies/359.json   |    1 +
 .../DrugDescriptionsForPathologies/36.json    |    1 +
 .../DrugDescriptionsForPathologies/360.json   |    1 +
 .../DrugDescriptionsForPathologies/361.json   |    1 +
 .../DrugDescriptionsForPathologies/362.json   |    1 +
 .../DrugDescriptionsForPathologies/363.json   |    1 +
 .../DrugDescriptionsForPathologies/364.json   |    1 +
 .../DrugDescriptionsForPathologies/365.json   |    1 +
 .../DrugDescriptionsForPathologies/366.json   |    1 +
 .../DrugDescriptionsForPathologies/367.json   |    1 +
 .../DrugDescriptionsForPathologies/368.json   |    1 +
 .../DrugDescriptionsForPathologies/369.json   |    1 +
 .../DrugDescriptionsForPathologies/37.json    |    1 +
 .../DrugDescriptionsForPathologies/370.json   |    1 +
 .../DrugDescriptionsForPathologies/371.json   |    1 +
 .../DrugDescriptionsForPathologies/372.json   |    1 +
 .../DrugDescriptionsForPathologies/373.json   |    1 +
 .../DrugDescriptionsForPathologies/374.json   |    1 +
 .../DrugDescriptionsForPathologies/375.json   |    1 +
 .../DrugDescriptionsForPathologies/376.json   |    1 +
 .../DrugDescriptionsForPathologies/377.json   |    1 +
 .../DrugDescriptionsForPathologies/378.json   |    1 +
 .../DrugDescriptionsForPathologies/379.json   |    1 +
 .../DrugDescriptionsForPathologies/38.json    |    1 +
 .../DrugDescriptionsForPathologies/380.json   |    1 +
 .../DrugDescriptionsForPathologies/381.json   |    1 +
 .../DrugDescriptionsForPathologies/382.json   |    1 +
 .../DrugDescriptionsForPathologies/383.json   |    1 +
 .../DrugDescriptionsForPathologies/384.json   |    1 +
 .../DrugDescriptionsForPathologies/385.json   |    1 +
 .../DrugDescriptionsForPathologies/386.json   |    1 +
 .../DrugDescriptionsForPathologies/387.json   |    1 +
 .../DrugDescriptionsForPathologies/388.json   |    1 +
 .../DrugDescriptionsForPathologies/389.json   |    1 +
 .../DrugDescriptionsForPathologies/39.json    |    1 +
 .../DrugDescriptionsForPathologies/390.json   |    1 +
 .../DrugDescriptionsForPathologies/391.json   |    1 +
 .../DrugDescriptionsForPathologies/392.json   |    1 +
 .../DrugDescriptionsForPathologies/393.json   |    1 +
 .../DrugDescriptionsForPathologies/394.json   |    1 +
 .../DrugDescriptionsForPathologies/395.json   |    1 +
 .../DrugDescriptionsForPathologies/396.json   |    1 +
 .../DrugDescriptionsForPathologies/397.json   |    1 +
 .../DrugDescriptionsForPathologies/398.json   |    1 +
 .../DrugDescriptionsForPathologies/399.json   |    1 +
 .../DrugDescriptionsForPathologies/4.json     |    1 +
 .../DrugDescriptionsForPathologies/40.json    |    1 +
 .../DrugDescriptionsForPathologies/400.json   |    1 +
 .../DrugDescriptionsForPathologies/401.json   |    1 +
 .../DrugDescriptionsForPathologies/402.json   |    1 +
 .../DrugDescriptionsForPathologies/403.json   |    1 +
 .../DrugDescriptionsForPathologies/404.json   |    1 +
 .../DrugDescriptionsForPathologies/405.json   |    1 +
 .../DrugDescriptionsForPathologies/406.json   |    1 +
 .../DrugDescriptionsForPathologies/407.json   |    1 +
 .../DrugDescriptionsForPathologies/408.json   |    1 +
 .../DrugDescriptionsForPathologies/409.json   |    1 +
 .../DrugDescriptionsForPathologies/41.json    |    1 +
 .../DrugDescriptionsForPathologies/410.json   |    1 +
 .../DrugDescriptionsForPathologies/411.json   |    1 +
 .../DrugDescriptionsForPathologies/412.json   |    1 +
 .../DrugDescriptionsForPathologies/413.json   |    1 +
 .../DrugDescriptionsForPathologies/414.json   |    1 +
 .../DrugDescriptionsForPathologies/415.json   |    1 +
 .../DrugDescriptionsForPathologies/416.json   |    1 +
 .../DrugDescriptionsForPathologies/417.json   |    1 +
 .../DrugDescriptionsForPathologies/418.json   |    1 +
 .../DrugDescriptionsForPathologies/419.json   |    1 +
 .../DrugDescriptionsForPathologies/42.json    |    1 +
 .../DrugDescriptionsForPathologies/420.json   |    1 +
 .../DrugDescriptionsForPathologies/421.json   |    1 +
 .../DrugDescriptionsForPathologies/422.json   |    1 +
 .../DrugDescriptionsForPathologies/423.json   |    1 +
 .../DrugDescriptionsForPathologies/424.json   |    1 +
 .../DrugDescriptionsForPathologies/425.json   |    1 +
 .../DrugDescriptionsForPathologies/426.json   |    1 +
 .../DrugDescriptionsForPathologies/427.json   |    1 +
 .../DrugDescriptionsForPathologies/428.json   |    1 +
 .../DrugDescriptionsForPathologies/429.json   |    1 +
 .../DrugDescriptionsForPathologies/43.json    |    1 +
 .../DrugDescriptionsForPathologies/430.json   |    1 +
 .../DrugDescriptionsForPathologies/431.json   |    1 +
 .../DrugDescriptionsForPathologies/432.json   |    1 +
 .../DrugDescriptionsForPathologies/433.json   |    1 +
 .../DrugDescriptionsForPathologies/434.json   |    1 +
 .../DrugDescriptionsForPathologies/435.json   |    1 +
 .../DrugDescriptionsForPathologies/436.json   |    1 +
 .../DrugDescriptionsForPathologies/437.json   |    1 +
 .../DrugDescriptionsForPathologies/438.json   |    1 +
 .../DrugDescriptionsForPathologies/439.json   |    1 +
 .../DrugDescriptionsForPathologies/44.json    |    1 +
 .../DrugDescriptionsForPathologies/440.json   |    1 +
 .../DrugDescriptionsForPathologies/441.json   |    1 +
 .../DrugDescriptionsForPathologies/442.json   |    1 +
 .../DrugDescriptionsForPathologies/443.json   |    1 +
 .../DrugDescriptionsForPathologies/444.json   |    1 +
 .../DrugDescriptionsForPathologies/445.json   |    1 +
 .../DrugDescriptionsForPathologies/446.json   |    1 +
 .../DrugDescriptionsForPathologies/447.json   |    1 +
 .../DrugDescriptionsForPathologies/448.json   |    1 +
 .../DrugDescriptionsForPathologies/449.json   |    1 +
 .../DrugDescriptionsForPathologies/45.json    |    1 +
 .../DrugDescriptionsForPathologies/450.json   |    1 +
 .../DrugDescriptionsForPathologies/451.json   |    1 +
 .../DrugDescriptionsForPathologies/452.json   |    1 +
 .../DrugDescriptionsForPathologies/453.json   |    1 +
 .../DrugDescriptionsForPathologies/454.json   |    1 +
 .../DrugDescriptionsForPathologies/455.json   |    1 +
 .../DrugDescriptionsForPathologies/456.json   |    1 +
 .../DrugDescriptionsForPathologies/457.json   |    1 +
 .../DrugDescriptionsForPathologies/458.json   |    1 +
 .../DrugDescriptionsForPathologies/459.json   |    1 +
 .../DrugDescriptionsForPathologies/46.json    |    1 +
 .../DrugDescriptionsForPathologies/460.json   |    1 +
 .../DrugDescriptionsForPathologies/461.json   |    1 +
 .../DrugDescriptionsForPathologies/462.json   |    1 +
 .../DrugDescriptionsForPathologies/463.json   |    1 +
 .../DrugDescriptionsForPathologies/464.json   |    1 +
 .../DrugDescriptionsForPathologies/465.json   |    1 +
 .../DrugDescriptionsForPathologies/466.json   |    1 +
 .../DrugDescriptionsForPathologies/467.json   |    1 +
 .../DrugDescriptionsForPathologies/468.json   |    1 +
 .../DrugDescriptionsForPathologies/469.json   |    1 +
 .../DrugDescriptionsForPathologies/47.json    |    1 +
 .../DrugDescriptionsForPathologies/470.json   |    1 +
 .../DrugDescriptionsForPathologies/471.json   |    1 +
 .../DrugDescriptionsForPathologies/472.json   |    1 +
 .../DrugDescriptionsForPathologies/473.json   |    1 +
 .../DrugDescriptionsForPathologies/474.json   |    1 +
 .../DrugDescriptionsForPathologies/475.json   |    1 +
 .../DrugDescriptionsForPathologies/476.json   |    1 +
 .../DrugDescriptionsForPathologies/477.json   |    1 +
 .../DrugDescriptionsForPathologies/478.json   |    1 +
 .../DrugDescriptionsForPathologies/479.json   |    1 +
 .../DrugDescriptionsForPathologies/48.json    |    1 +
 .../DrugDescriptionsForPathologies/480.json   |    1 +
 .../DrugDescriptionsForPathologies/481.json   |    1 +
 .../DrugDescriptionsForPathologies/482.json   |    1 +
 .../DrugDescriptionsForPathologies/483.json   |    1 +
 .../DrugDescriptionsForPathologies/484.json   |    1 +
 .../DrugDescriptionsForPathologies/485.json   |    1 +
 .../DrugDescriptionsForPathologies/486.json   |    1 +
 .../DrugDescriptionsForPathologies/487.json   |    1 +
 .../DrugDescriptionsForPathologies/488.json   |    1 +
 .../DrugDescriptionsForPathologies/489.json   |    1 +
 .../DrugDescriptionsForPathologies/49.json    |    1 +
 .../DrugDescriptionsForPathologies/490.json   |    1 +
 .../DrugDescriptionsForPathologies/491.json   |    1 +
 .../DrugDescriptionsForPathologies/492.json   |    1 +
 .../DrugDescriptionsForPathologies/493.json   |    1 +
 .../DrugDescriptionsForPathologies/494.json   |    1 +
 .../DrugDescriptionsForPathologies/495.json   |    1 +
 .../DrugDescriptionsForPathologies/496.json   |    1 +
 .../DrugDescriptionsForPathologies/497.json   |    1 +
 .../DrugDescriptionsForPathologies/498.json   |    1 +
 .../DrugDescriptionsForPathologies/499.json   |    1 +
 .../DrugDescriptionsForPathologies/5.json     |    1 +
 .../DrugDescriptionsForPathologies/50.json    |    1 +
 .../DrugDescriptionsForPathologies/500.json   |    1 +
 .../DrugDescriptionsForPathologies/501.json   |    1 +
 .../DrugDescriptionsForPathologies/502.json   |    1 +
 .../DrugDescriptionsForPathologies/503.json   |    1 +
 .../DrugDescriptionsForPathologies/504.json   |    1 +
 .../DrugDescriptionsForPathologies/505.json   |    1 +
 .../DrugDescriptionsForPathologies/506.json   |    1 +
 .../DrugDescriptionsForPathologies/507.json   |    1 +
 .../DrugDescriptionsForPathologies/508.json   |    1 +
 .../DrugDescriptionsForPathologies/509.json   |    1 +
 .../DrugDescriptionsForPathologies/51.json    |    1 +
 .../DrugDescriptionsForPathologies/510.json   |    1 +
 .../DrugDescriptionsForPathologies/511.json   |    1 +
 .../DrugDescriptionsForPathologies/512.json   |    1 +
 .../DrugDescriptionsForPathologies/513.json   |    1 +
 .../DrugDescriptionsForPathologies/514.json   |    1 +
 .../DrugDescriptionsForPathologies/515.json   |    1 +
 .../DrugDescriptionsForPathologies/516.json   |    1 +
 .../DrugDescriptionsForPathologies/517.json   |    1 +
 .../DrugDescriptionsForPathologies/518.json   |    1 +
 .../DrugDescriptionsForPathologies/519.json   |    1 +
 .../DrugDescriptionsForPathologies/52.json    |    1 +
 .../DrugDescriptionsForPathologies/520.json   |    1 +
 .../DrugDescriptionsForPathologies/521.json   |    1 +
 .../DrugDescriptionsForPathologies/522.json   |    1 +
 .../DrugDescriptionsForPathologies/523.json   |    1 +
 .../DrugDescriptionsForPathologies/524.json   |    1 +
 .../DrugDescriptionsForPathologies/525.json   |    1 +
 .../DrugDescriptionsForPathologies/526.json   |    1 +
 .../DrugDescriptionsForPathologies/527.json   |    1 +
 .../DrugDescriptionsForPathologies/528.json   |    1 +
 .../DrugDescriptionsForPathologies/529.json   |    1 +
 .../DrugDescriptionsForPathologies/53.json    |    1 +
 .../DrugDescriptionsForPathologies/530.json   |    1 +
 .../DrugDescriptionsForPathologies/531.json   |    1 +
 .../DrugDescriptionsForPathologies/532.json   |    1 +
 .../DrugDescriptionsForPathologies/533.json   |    1 +
 .../DrugDescriptionsForPathologies/534.json   |    1 +
 .../DrugDescriptionsForPathologies/535.json   |    1 +
 .../DrugDescriptionsForPathologies/536.json   |    1 +
 .../DrugDescriptionsForPathologies/537.json   |    1 +
 .../DrugDescriptionsForPathologies/538.json   |    1 +
 .../DrugDescriptionsForPathologies/539.json   |    1 +
 .../DrugDescriptionsForPathologies/54.json    |    1 +
 .../DrugDescriptionsForPathologies/540.json   |    1 +
 .../DrugDescriptionsForPathologies/541.json   |    1 +
 .../DrugDescriptionsForPathologies/542.json   |    1 +
 .../DrugDescriptionsForPathologies/543.json   |    1 +
 .../DrugDescriptionsForPathologies/544.json   |    1 +
 .../DrugDescriptionsForPathologies/545.json   |    1 +
 .../DrugDescriptionsForPathologies/546.json   |    1 +
 .../DrugDescriptionsForPathologies/547.json   |    1 +
 .../DrugDescriptionsForPathologies/548.json   |    1 +
 .../DrugDescriptionsForPathologies/549.json   |    1 +
 .../DrugDescriptionsForPathologies/55.json    |    1 +
 .../DrugDescriptionsForPathologies/550.json   |    1 +
 .../DrugDescriptionsForPathologies/551.json   |    1 +
 .../DrugDescriptionsForPathologies/552.json   |    1 +
 .../DrugDescriptionsForPathologies/553.json   |    1 +
 .../DrugDescriptionsForPathologies/554.json   |    1 +
 .../DrugDescriptionsForPathologies/555.json   |    1 +
 .../DrugDescriptionsForPathologies/556.json   |    1 +
 .../DrugDescriptionsForPathologies/557.json   |    1 +
 .../DrugDescriptionsForPathologies/558.json   |    1 +
 .../DrugDescriptionsForPathologies/559.json   |    1 +
 .../DrugDescriptionsForPathologies/56.json    |    1 +
 .../DrugDescriptionsForPathologies/560.json   |    1 +
 .../DrugDescriptionsForPathologies/561.json   |    1 +
 .../DrugDescriptionsForPathologies/562.json   |    1 +
 .../DrugDescriptionsForPathologies/563.json   |    1 +
 .../DrugDescriptionsForPathologies/564.json   |    1 +
 .../DrugDescriptionsForPathologies/565.json   |    1 +
 .../DrugDescriptionsForPathologies/566.json   |    1 +
 .../DrugDescriptionsForPathologies/567.json   |    1 +
 .../DrugDescriptionsForPathologies/568.json   |    1 +
 .../DrugDescriptionsForPathologies/569.json   |    1 +
 .../DrugDescriptionsForPathologies/57.json    |    1 +
 .../DrugDescriptionsForPathologies/570.json   |    1 +
 .../DrugDescriptionsForPathologies/571.json   |    1 +
 .../DrugDescriptionsForPathologies/572.json   |    1 +
 .../DrugDescriptionsForPathologies/573.json   |    1 +
 .../DrugDescriptionsForPathologies/574.json   |    1 +
 .../DrugDescriptionsForPathologies/575.json   |    1 +
 .../DrugDescriptionsForPathologies/576.json   |    1 +
 .../DrugDescriptionsForPathologies/577.json   |    1 +
 .../DrugDescriptionsForPathologies/578.json   |    1 +
 .../DrugDescriptionsForPathologies/579.json   |    1 +
 .../DrugDescriptionsForPathologies/58.json    |    1 +
 .../DrugDescriptionsForPathologies/580.json   |    1 +
 .../DrugDescriptionsForPathologies/581.json   |    1 +
 .../DrugDescriptionsForPathologies/582.json   |    1 +
 .../DrugDescriptionsForPathologies/583.json   |    1 +
 .../DrugDescriptionsForPathologies/584.json   |    1 +
 .../DrugDescriptionsForPathologies/585.json   |    1 +
 .../DrugDescriptionsForPathologies/586.json   |    1 +
 .../DrugDescriptionsForPathologies/587.json   |    1 +
 .../DrugDescriptionsForPathologies/588.json   |    1 +
 .../DrugDescriptionsForPathologies/589.json   |    1 +
 .../DrugDescriptionsForPathologies/59.json    |    1 +
 .../DrugDescriptionsForPathologies/590.json   |    1 +
 .../DrugDescriptionsForPathologies/591.json   |    1 +
 .../DrugDescriptionsForPathologies/592.json   |    1 +
 .../DrugDescriptionsForPathologies/593.json   |    1 +
 .../DrugDescriptionsForPathologies/594.json   |    1 +
 .../DrugDescriptionsForPathologies/595.json   |    1 +
 .../DrugDescriptionsForPathologies/596.json   |    1 +
 .../DrugDescriptionsForPathologies/597.json   |    1 +
 .../DrugDescriptionsForPathologies/598.json   |    1 +
 .../DrugDescriptionsForPathologies/599.json   |    1 +
 .../DrugDescriptionsForPathologies/6.json     |    1 +
 .../DrugDescriptionsForPathologies/60.json    |    1 +
 .../DrugDescriptionsForPathologies/600.json   |    1 +
 .../DrugDescriptionsForPathologies/601.json   |    1 +
 .../DrugDescriptionsForPathologies/602.json   |    1 +
 .../DrugDescriptionsForPathologies/603.json   |    1 +
 .../DrugDescriptionsForPathologies/604.json   |    1 +
 .../DrugDescriptionsForPathologies/605.json   |    1 +
 .../DrugDescriptionsForPathologies/606.json   |    1 +
 .../DrugDescriptionsForPathologies/607.json   |    1 +
 .../DrugDescriptionsForPathologies/608.json   |    1 +
 .../DrugDescriptionsForPathologies/609.json   |    1 +
 .../DrugDescriptionsForPathologies/61.json    |    1 +
 .../DrugDescriptionsForPathologies/610.json   |    1 +
 .../DrugDescriptionsForPathologies/611.json   |    1 +
 .../DrugDescriptionsForPathologies/612.json   |    1 +
 .../DrugDescriptionsForPathologies/613.json   |    1 +
 .../DrugDescriptionsForPathologies/614.json   |    1 +
 .../DrugDescriptionsForPathologies/615.json   |    1 +
 .../DrugDescriptionsForPathologies/616.json   |    1 +
 .../DrugDescriptionsForPathologies/617.json   |    1 +
 .../DrugDescriptionsForPathologies/618.json   |    1 +
 .../DrugDescriptionsForPathologies/619.json   |    1 +
 .../DrugDescriptionsForPathologies/62.json    |    1 +
 .../DrugDescriptionsForPathologies/620.json   |    1 +
 .../DrugDescriptionsForPathologies/621.json   |    1 +
 .../DrugDescriptionsForPathologies/622.json   |    1 +
 .../DrugDescriptionsForPathologies/623.json   |    1 +
 .../DrugDescriptionsForPathologies/624.json   |    1 +
 .../DrugDescriptionsForPathologies/625.json   |    1 +
 .../DrugDescriptionsForPathologies/626.json   |    1 +
 .../DrugDescriptionsForPathologies/627.json   |    1 +
 .../DrugDescriptionsForPathologies/628.json   |    1 +
 .../DrugDescriptionsForPathologies/629.json   |    1 +
 .../DrugDescriptionsForPathologies/63.json    |    1 +
 .../DrugDescriptionsForPathologies/630.json   |    1 +
 .../DrugDescriptionsForPathologies/631.json   |    1 +
 .../DrugDescriptionsForPathologies/632.json   |    1 +
 .../DrugDescriptionsForPathologies/633.json   |    1 +
 .../DrugDescriptionsForPathologies/634.json   |    1 +
 .../DrugDescriptionsForPathologies/635.json   |    1 +
 .../DrugDescriptionsForPathologies/636.json   |    1 +
 .../DrugDescriptionsForPathologies/637.json   |    1 +
 .../DrugDescriptionsForPathologies/638.json   |    1 +
 .../DrugDescriptionsForPathologies/639.json   |    1 +
 .../DrugDescriptionsForPathologies/64.json    |    1 +
 .../DrugDescriptionsForPathologies/640.json   |    1 +
 .../DrugDescriptionsForPathologies/641.json   |    1 +
 .../DrugDescriptionsForPathologies/642.json   |    1 +
 .../DrugDescriptionsForPathologies/643.json   |    1 +
 .../DrugDescriptionsForPathologies/644.json   |    1 +
 .../DrugDescriptionsForPathologies/645.json   |    1 +
 .../DrugDescriptionsForPathologies/646.json   |    1 +
 .../DrugDescriptionsForPathologies/647.json   |    1 +
 .../DrugDescriptionsForPathologies/648.json   |    1 +
 .../DrugDescriptionsForPathologies/649.json   |    1 +
 .../DrugDescriptionsForPathologies/65.json    |    1 +
 .../DrugDescriptionsForPathologies/650.json   |    1 +
 .../DrugDescriptionsForPathologies/651.json   |    1 +
 .../DrugDescriptionsForPathologies/652.json   |    1 +
 .../DrugDescriptionsForPathologies/653.json   |    1 +
 .../DrugDescriptionsForPathologies/654.json   |    1 +
 .../DrugDescriptionsForPathologies/655.json   |    1 +
 .../DrugDescriptionsForPathologies/656.json   |    1 +
 .../DrugDescriptionsForPathologies/657.json   |    1 +
 .../DrugDescriptionsForPathologies/658.json   |    1 +
 .../DrugDescriptionsForPathologies/659.json   |    1 +
 .../DrugDescriptionsForPathologies/66.json    |    1 +
 .../DrugDescriptionsForPathologies/660.json   |    1 +
 .../DrugDescriptionsForPathologies/661.json   |    1 +
 .../DrugDescriptionsForPathologies/662.json   |    1 +
 .../DrugDescriptionsForPathologies/663.json   |    1 +
 .../DrugDescriptionsForPathologies/664.json   |    1 +
 .../DrugDescriptionsForPathologies/665.json   |    1 +
 .../DrugDescriptionsForPathologies/666.json   |    1 +
 .../DrugDescriptionsForPathologies/667.json   |    1 +
 .../DrugDescriptionsForPathologies/668.json   |    1 +
 .../DrugDescriptionsForPathologies/669.json   |    1 +
 .../DrugDescriptionsForPathologies/67.json    |    1 +
 .../DrugDescriptionsForPathologies/670.json   |    1 +
 .../DrugDescriptionsForPathologies/671.json   |    1 +
 .../DrugDescriptionsForPathologies/672.json   |    1 +
 .../DrugDescriptionsForPathologies/673.json   |    1 +
 .../DrugDescriptionsForPathologies/674.json   |    1 +
 .../DrugDescriptionsForPathologies/675.json   |    1 +
 .../DrugDescriptionsForPathologies/676.json   |    1 +
 .../DrugDescriptionsForPathologies/677.json   |    1 +
 .../DrugDescriptionsForPathologies/678.json   |    1 +
 .../DrugDescriptionsForPathologies/679.json   |    1 +
 .../DrugDescriptionsForPathologies/68.json    |    1 +
 .../DrugDescriptionsForPathologies/680.json   |    1 +
 .../DrugDescriptionsForPathologies/681.json   |    1 +
 .../DrugDescriptionsForPathologies/682.json   |    1 +
 .../DrugDescriptionsForPathologies/683.json   |    1 +
 .../DrugDescriptionsForPathologies/684.json   |    1 +
 .../DrugDescriptionsForPathologies/685.json   |    1 +
 .../DrugDescriptionsForPathologies/686.json   |    1 +
 .../DrugDescriptionsForPathologies/687.json   |    1 +
 .../DrugDescriptionsForPathologies/688.json   |    1 +
 .../DrugDescriptionsForPathologies/689.json   |    1 +
 .../DrugDescriptionsForPathologies/69.json    |    1 +
 .../DrugDescriptionsForPathologies/690.json   |    1 +
 .../DrugDescriptionsForPathologies/691.json   |    1 +
 .../DrugDescriptionsForPathologies/692.json   |    1 +
 .../DrugDescriptionsForPathologies/693.json   |    1 +
 .../DrugDescriptionsForPathologies/694.json   |    1 +
 .../DrugDescriptionsForPathologies/695.json   |    1 +
 .../DrugDescriptionsForPathologies/696.json   |    1 +
 .../DrugDescriptionsForPathologies/697.json   |    1 +
 .../DrugDescriptionsForPathologies/698.json   |    1 +
 .../DrugDescriptionsForPathologies/699.json   |    1 +
 .../DrugDescriptionsForPathologies/7.json     |    1 +
 .../DrugDescriptionsForPathologies/70.json    |    1 +
 .../DrugDescriptionsForPathologies/700.json   |    1 +
 .../DrugDescriptionsForPathologies/701.json   |    1 +
 .../DrugDescriptionsForPathologies/702.json   |    1 +
 .../DrugDescriptionsForPathologies/703.json   |    1 +
 .../DrugDescriptionsForPathologies/704.json   |    1 +
 .../DrugDescriptionsForPathologies/705.json   |    1 +
 .../DrugDescriptionsForPathologies/706.json   |    1 +
 .../DrugDescriptionsForPathologies/707.json   |    1 +
 .../DrugDescriptionsForPathologies/708.json   |    1 +
 .../DrugDescriptionsForPathologies/709.json   |    1 +
 .../DrugDescriptionsForPathologies/71.json    |    1 +
 .../DrugDescriptionsForPathologies/710.json   |    1 +
 .../DrugDescriptionsForPathologies/711.json   |    1 +
 .../DrugDescriptionsForPathologies/712.json   |    1 +
 .../DrugDescriptionsForPathologies/713.json   |    1 +
 .../DrugDescriptionsForPathologies/714.json   |    1 +
 .../DrugDescriptionsForPathologies/715.json   |    1 +
 .../DrugDescriptionsForPathologies/716.json   |    1 +
 .../DrugDescriptionsForPathologies/717.json   |    1 +
 .../DrugDescriptionsForPathologies/718.json   |    1 +
 .../DrugDescriptionsForPathologies/719.json   |    1 +
 .../DrugDescriptionsForPathologies/72.json    |    1 +
 .../DrugDescriptionsForPathologies/720.json   |    1 +
 .../DrugDescriptionsForPathologies/721.json   |    1 +
 .../DrugDescriptionsForPathologies/722.json   |    1 +
 .../DrugDescriptionsForPathologies/723.json   |    1 +
 .../DrugDescriptionsForPathologies/724.json   |    1 +
 .../DrugDescriptionsForPathologies/725.json   |    1 +
 .../DrugDescriptionsForPathologies/726.json   |    1 +
 .../DrugDescriptionsForPathologies/727.json   |    1 +
 .../DrugDescriptionsForPathologies/728.json   |    1 +
 .../DrugDescriptionsForPathologies/729.json   |    1 +
 .../DrugDescriptionsForPathologies/73.json    |    1 +
 .../DrugDescriptionsForPathologies/730.json   |    1 +
 .../DrugDescriptionsForPathologies/731.json   |    1 +
 .../DrugDescriptionsForPathologies/732.json   |    1 +
 .../DrugDescriptionsForPathologies/733.json   |    1 +
 .../DrugDescriptionsForPathologies/734.json   |    1 +
 .../DrugDescriptionsForPathologies/735.json   |    1 +
 .../DrugDescriptionsForPathologies/736.json   |    1 +
 .../DrugDescriptionsForPathologies/737.json   |    1 +
 .../DrugDescriptionsForPathologies/738.json   |    1 +
 .../DrugDescriptionsForPathologies/739.json   |    1 +
 .../DrugDescriptionsForPathologies/74.json    |    1 +
 .../DrugDescriptionsForPathologies/740.json   |    1 +
 .../DrugDescriptionsForPathologies/741.json   |    1 +
 .../DrugDescriptionsForPathologies/742.json   |    1 +
 .../DrugDescriptionsForPathologies/743.json   |    1 +
 .../DrugDescriptionsForPathologies/744.json   |    1 +
 .../DrugDescriptionsForPathologies/745.json   |    1 +
 .../DrugDescriptionsForPathologies/746.json   |    1 +
 .../DrugDescriptionsForPathologies/747.json   |    1 +
 .../DrugDescriptionsForPathologies/748.json   |    1 +
 .../DrugDescriptionsForPathologies/749.json   |    1 +
 .../DrugDescriptionsForPathologies/75.json    |    1 +
 .../DrugDescriptionsForPathologies/750.json   |    1 +
 .../DrugDescriptionsForPathologies/751.json   |    1 +
 .../DrugDescriptionsForPathologies/752.json   |    1 +
 .../DrugDescriptionsForPathologies/753.json   |    1 +
 .../DrugDescriptionsForPathologies/754.json   |    1 +
 .../DrugDescriptionsForPathologies/755.json   |    1 +
 .../DrugDescriptionsForPathologies/756.json   |    1 +
 .../DrugDescriptionsForPathologies/757.json   |    1 +
 .../DrugDescriptionsForPathologies/758.json   |    1 +
 .../DrugDescriptionsForPathologies/759.json   |    1 +
 .../DrugDescriptionsForPathologies/76.json    |    1 +
 .../DrugDescriptionsForPathologies/760.json   |    1 +
 .../DrugDescriptionsForPathologies/761.json   |    1 +
 .../DrugDescriptionsForPathologies/762.json   |    1 +
 .../DrugDescriptionsForPathologies/763.json   |    1 +
 .../DrugDescriptionsForPathologies/764.json   |    1 +
 .../DrugDescriptionsForPathologies/765.json   |    1 +
 .../DrugDescriptionsForPathologies/766.json   |    1 +
 .../DrugDescriptionsForPathologies/767.json   |    1 +
 .../DrugDescriptionsForPathologies/768.json   |    1 +
 .../DrugDescriptionsForPathologies/769.json   |    1 +
 .../DrugDescriptionsForPathologies/77.json    |    1 +
 .../DrugDescriptionsForPathologies/770.json   |    1 +
 .../DrugDescriptionsForPathologies/771.json   |    1 +
 .../DrugDescriptionsForPathologies/772.json   |    1 +
 .../DrugDescriptionsForPathologies/773.json   |    1 +
 .../DrugDescriptionsForPathologies/774.json   |    1 +
 .../DrugDescriptionsForPathologies/775.json   |    1 +
 .../DrugDescriptionsForPathologies/776.json   |    1 +
 .../DrugDescriptionsForPathologies/777.json   |    1 +
 .../DrugDescriptionsForPathologies/778.json   |    1 +
 .../DrugDescriptionsForPathologies/779.json   |    1 +
 .../DrugDescriptionsForPathologies/78.json    |    1 +
 .../DrugDescriptionsForPathologies/780.json   |    1 +
 .../DrugDescriptionsForPathologies/781.json   |    1 +
 .../DrugDescriptionsForPathologies/782.json   |    1 +
 .../DrugDescriptionsForPathologies/783.json   |    1 +
 .../DrugDescriptionsForPathologies/784.json   |    1 +
 .../DrugDescriptionsForPathologies/785.json   |    1 +
 .../DrugDescriptionsForPathologies/786.json   |    1 +
 .../DrugDescriptionsForPathologies/787.json   |    1 +
 .../DrugDescriptionsForPathologies/788.json   |    1 +
 .../DrugDescriptionsForPathologies/789.json   |    1 +
 .../DrugDescriptionsForPathologies/79.json    |    1 +
 .../DrugDescriptionsForPathologies/790.json   |    1 +
 .../DrugDescriptionsForPathologies/791.json   |    1 +
 .../DrugDescriptionsForPathologies/792.json   |    1 +
 .../DrugDescriptionsForPathologies/793.json   |    1 +
 .../DrugDescriptionsForPathologies/794.json   |    1 +
 .../DrugDescriptionsForPathologies/795.json   |    1 +
 .../DrugDescriptionsForPathologies/796.json   |    1 +
 .../DrugDescriptionsForPathologies/797.json   |    1 +
 .../DrugDescriptionsForPathologies/798.json   |    1 +
 .../DrugDescriptionsForPathologies/799.json   |    1 +
 .../DrugDescriptionsForPathologies/8.json     |    1 +
 .../DrugDescriptionsForPathologies/80.json    |    1 +
 .../DrugDescriptionsForPathologies/800.json   |    1 +
 .../DrugDescriptionsForPathologies/801.json   |    1 +
 .../DrugDescriptionsForPathologies/802.json   |    1 +
 .../DrugDescriptionsForPathologies/803.json   |    1 +
 .../DrugDescriptionsForPathologies/804.json   |    1 +
 .../DrugDescriptionsForPathologies/805.json   |    1 +
 .../DrugDescriptionsForPathologies/806.json   |    1 +
 .../DrugDescriptionsForPathologies/807.json   |    1 +
 .../DrugDescriptionsForPathologies/808.json   |    1 +
 .../DrugDescriptionsForPathologies/809.json   |    1 +
 .../DrugDescriptionsForPathologies/81.json    |    1 +
 .../DrugDescriptionsForPathologies/810.json   |    1 +
 .../DrugDescriptionsForPathologies/811.json   |    1 +
 .../DrugDescriptionsForPathologies/812.json   |    1 +
 .../DrugDescriptionsForPathologies/813.json   |    1 +
 .../DrugDescriptionsForPathologies/814.json   |    1 +
 .../DrugDescriptionsForPathologies/815.json   |    1 +
 .../DrugDescriptionsForPathologies/816.json   |    1 +
 .../DrugDescriptionsForPathologies/817.json   |    1 +
 .../DrugDescriptionsForPathologies/818.json   |    1 +
 .../DrugDescriptionsForPathologies/819.json   |    1 +
 .../DrugDescriptionsForPathologies/82.json    |    1 +
 .../DrugDescriptionsForPathologies/820.json   |    1 +
 .../DrugDescriptionsForPathologies/821.json   |    1 +
 .../DrugDescriptionsForPathologies/822.json   |    1 +
 .../DrugDescriptionsForPathologies/823.json   |    1 +
 .../DrugDescriptionsForPathologies/824.json   |    1 +
 .../DrugDescriptionsForPathologies/825.json   |    1 +
 .../DrugDescriptionsForPathologies/826.json   |    1 +
 .../DrugDescriptionsForPathologies/827.json   |    1 +
 .../DrugDescriptionsForPathologies/828.json   |    1 +
 .../DrugDescriptionsForPathologies/829.json   |    1 +
 .../DrugDescriptionsForPathologies/83.json    |    1 +
 .../DrugDescriptionsForPathologies/830.json   |    1 +
 .../DrugDescriptionsForPathologies/831.json   |    1 +
 .../DrugDescriptionsForPathologies/832.json   |    1 +
 .../DrugDescriptionsForPathologies/833.json   |    1 +
 .../DrugDescriptionsForPathologies/834.json   |    1 +
 .../DrugDescriptionsForPathologies/835.json   |    1 +
 .../DrugDescriptionsForPathologies/836.json   |    1 +
 .../DrugDescriptionsForPathologies/837.json   |    1 +
 .../DrugDescriptionsForPathologies/838.json   |    1 +
 .../DrugDescriptionsForPathologies/839.json   |    1 +
 .../DrugDescriptionsForPathologies/84.json    |    1 +
 .../DrugDescriptionsForPathologies/840.json   |    1 +
 .../DrugDescriptionsForPathologies/841.json   |    1 +
 .../DrugDescriptionsForPathologies/842.json   |    1 +
 .../DrugDescriptionsForPathologies/843.json   |    1 +
 .../DrugDescriptionsForPathologies/844.json   |    1 +
 .../DrugDescriptionsForPathologies/845.json   |    1 +
 .../DrugDescriptionsForPathologies/846.json   |    1 +
 .../DrugDescriptionsForPathologies/847.json   |    1 +
 .../DrugDescriptionsForPathologies/848.json   |    1 +
 .../DrugDescriptionsForPathologies/849.json   |    1 +
 .../DrugDescriptionsForPathologies/85.json    |    1 +
 .../DrugDescriptionsForPathologies/850.json   |    1 +
 .../DrugDescriptionsForPathologies/851.json   |    1 +
 .../DrugDescriptionsForPathologies/852.json   |    1 +
 .../DrugDescriptionsForPathologies/853.json   |    1 +
 .../DrugDescriptionsForPathologies/854.json   |    1 +
 .../DrugDescriptionsForPathologies/855.json   |    1 +
 .../DrugDescriptionsForPathologies/856.json   |    1 +
 .../DrugDescriptionsForPathologies/857.json   |    1 +
 .../DrugDescriptionsForPathologies/858.json   |    1 +
 .../DrugDescriptionsForPathologies/859.json   |    1 +
 .../DrugDescriptionsForPathologies/86.json    |    1 +
 .../DrugDescriptionsForPathologies/860.json   |    1 +
 .../DrugDescriptionsForPathologies/861.json   |    1 +
 .../DrugDescriptionsForPathologies/862.json   |    1 +
 .../DrugDescriptionsForPathologies/863.json   |    1 +
 .../DrugDescriptionsForPathologies/864.json   |    1 +
 .../DrugDescriptionsForPathologies/865.json   |    1 +
 .../DrugDescriptionsForPathologies/866.json   |    1 +
 .../DrugDescriptionsForPathologies/867.json   |    1 +
 .../DrugDescriptionsForPathologies/868.json   |    1 +
 .../DrugDescriptionsForPathologies/869.json   |    1 +
 .../DrugDescriptionsForPathologies/87.json    |    1 +
 .../DrugDescriptionsForPathologies/870.json   |    1 +
 .../DrugDescriptionsForPathologies/871.json   |    1 +
 .../DrugDescriptionsForPathologies/872.json   |    1 +
 .../DrugDescriptionsForPathologies/873.json   |    1 +
 .../DrugDescriptionsForPathologies/874.json   |    1 +
 .../DrugDescriptionsForPathologies/875.json   |    1 +
 .../DrugDescriptionsForPathologies/876.json   |    1 +
 .../DrugDescriptionsForPathologies/877.json   |    1 +
 .../DrugDescriptionsForPathologies/878.json   |    1 +
 .../DrugDescriptionsForPathologies/879.json   |    1 +
 .../DrugDescriptionsForPathologies/88.json    |    1 +
 .../DrugDescriptionsForPathologies/880.json   |    1 +
 .../DrugDescriptionsForPathologies/881.json   |    1 +
 .../DrugDescriptionsForPathologies/882.json   |    1 +
 .../DrugDescriptionsForPathologies/883.json   |    1 +
 .../DrugDescriptionsForPathologies/884.json   |    1 +
 .../DrugDescriptionsForPathologies/885.json   |    1 +
 .../DrugDescriptionsForPathologies/886.json   |    1 +
 .../DrugDescriptionsForPathologies/887.json   |    1 +
 .../DrugDescriptionsForPathologies/888.json   |    1 +
 .../DrugDescriptionsForPathologies/889.json   |    1 +
 .../DrugDescriptionsForPathologies/89.json    |    1 +
 .../DrugDescriptionsForPathologies/890.json   |    1 +
 .../DrugDescriptionsForPathologies/891.json   |    1 +
 .../DrugDescriptionsForPathologies/892.json   |    1 +
 .../DrugDescriptionsForPathologies/893.json   |    1 +
 .../DrugDescriptionsForPathologies/894.json   |    1 +
 .../DrugDescriptionsForPathologies/895.json   |    1 +
 .../DrugDescriptionsForPathologies/896.json   |    1 +
 .../DrugDescriptionsForPathologies/897.json   |    1 +
 .../DrugDescriptionsForPathologies/898.json   |    1 +
 .../DrugDescriptionsForPathologies/899.json   |    1 +
 .../DrugDescriptionsForPathologies/9.json     |    1 +
 .../DrugDescriptionsForPathologies/90.json    |    1 +
 .../DrugDescriptionsForPathologies/900.json   |    1 +
 .../DrugDescriptionsForPathologies/901.json   |    1 +
 .../DrugDescriptionsForPathologies/902.json   |    1 +
 .../DrugDescriptionsForPathologies/903.json   |    1 +
 .../DrugDescriptionsForPathologies/904.json   |    1 +
 .../DrugDescriptionsForPathologies/905.json   |    1 +
 .../DrugDescriptionsForPathologies/906.json   |    1 +
 .../DrugDescriptionsForPathologies/907.json   |    1 +
 .../DrugDescriptionsForPathologies/908.json   |    1 +
 .../DrugDescriptionsForPathologies/909.json   |    1 +
 .../DrugDescriptionsForPathologies/91.json    |    1 +
 .../DrugDescriptionsForPathologies/910.json   |    1 +
 .../DrugDescriptionsForPathologies/911.json   |    1 +
 .../DrugDescriptionsForPathologies/912.json   |    1 +
 .../DrugDescriptionsForPathologies/913.json   |    1 +
 .../DrugDescriptionsForPathologies/914.json   |    1 +
 .../DrugDescriptionsForPathologies/915.json   |    1 +
 .../DrugDescriptionsForPathologies/916.json   |    1 +
 .../DrugDescriptionsForPathologies/917.json   |    1 +
 .../DrugDescriptionsForPathologies/918.json   |    1 +
 .../DrugDescriptionsForPathologies/919.json   |    1 +
 .../DrugDescriptionsForPathologies/92.json    |    1 +
 .../DrugDescriptionsForPathologies/920.json   |    1 +
 .../DrugDescriptionsForPathologies/921.json   |    1 +
 .../DrugDescriptionsForPathologies/922.json   |    1 +
 .../DrugDescriptionsForPathologies/923.json   |    1 +
 .../DrugDescriptionsForPathologies/924.json   |    1 +
 .../DrugDescriptionsForPathologies/925.json   |    1 +
 .../DrugDescriptionsForPathologies/926.json   |    1 +
 .../DrugDescriptionsForPathologies/927.json   |    1 +
 .../DrugDescriptionsForPathologies/928.json   |    1 +
 .../DrugDescriptionsForPathologies/929.json   |    1 +
 .../DrugDescriptionsForPathologies/93.json    |    1 +
 .../DrugDescriptionsForPathologies/930.json   |    1 +
 .../DrugDescriptionsForPathologies/931.json   |    1 +
 .../DrugDescriptionsForPathologies/932.json   |    1 +
 .../DrugDescriptionsForPathologies/933.json   |    1 +
 .../DrugDescriptionsForPathologies/934.json   |    1 +
 .../DrugDescriptionsForPathologies/935.json   |    1 +
 .../DrugDescriptionsForPathologies/936.json   |    1 +
 .../DrugDescriptionsForPathologies/937.json   |    1 +
 .../DrugDescriptionsForPathologies/938.json   |    1 +
 .../DrugDescriptionsForPathologies/939.json   |    1 +
 .../DrugDescriptionsForPathologies/94.json    |    1 +
 .../DrugDescriptionsForPathologies/940.json   |    1 +
 .../DrugDescriptionsForPathologies/941.json   |    1 +
 .../DrugDescriptionsForPathologies/942.json   |    1 +
 .../DrugDescriptionsForPathologies/943.json   |    1 +
 .../DrugDescriptionsForPathologies/944.json   |    1 +
 .../DrugDescriptionsForPathologies/945.json   |    1 +
 .../DrugDescriptionsForPathologies/946.json   |    1 +
 .../DrugDescriptionsForPathologies/947.json   |    1 +
 .../DrugDescriptionsForPathologies/948.json   |    1 +
 .../DrugDescriptionsForPathologies/949.json   |    1 +
 .../DrugDescriptionsForPathologies/95.json    |    1 +
 .../DrugDescriptionsForPathologies/950.json   |    1 +
 .../DrugDescriptionsForPathologies/951.json   |    1 +
 .../DrugDescriptionsForPathologies/952.json   |    1 +
 .../DrugDescriptionsForPathologies/953.json   |    1 +
 .../DrugDescriptionsForPathologies/954.json   |    1 +
 .../DrugDescriptionsForPathologies/955.json   |    1 +
 .../DrugDescriptionsForPathologies/956.json   |    1 +
 .../DrugDescriptionsForPathologies/957.json   |    1 +
 .../DrugDescriptionsForPathologies/958.json   |    1 +
 .../DrugDescriptionsForPathologies/959.json   |    1 +
 .../DrugDescriptionsForPathologies/96.json    |    1 +
 .../DrugDescriptionsForPathologies/960.json   |    1 +
 .../DrugDescriptionsForPathologies/961.json   |    1 +
 .../DrugDescriptionsForPathologies/962.json   |    1 +
 .../DrugDescriptionsForPathologies/963.json   |    1 +
 .../DrugDescriptionsForPathologies/964.json   |    1 +
 .../DrugDescriptionsForPathologies/965.json   |    1 +
 .../DrugDescriptionsForPathologies/966.json   |    1 +
 .../DrugDescriptionsForPathologies/967.json   |    1 +
 .../DrugDescriptionsForPathologies/968.json   |    1 +
 .../DrugDescriptionsForPathologies/969.json   |    1 +
 .../DrugDescriptionsForPathologies/97.json    |    1 +
 .../DrugDescriptionsForPathologies/970.json   |    1 +
 .../DrugDescriptionsForPathologies/971.json   |    1 +
 .../DrugDescriptionsForPathologies/972.json   |    1 +
 .../DrugDescriptionsForPathologies/973.json   |    1 +
 .../DrugDescriptionsForPathologies/974.json   |    1 +
 .../DrugDescriptionsForPathologies/975.json   |    1 +
 .../DrugDescriptionsForPathologies/976.json   |    1 +
 .../DrugDescriptionsForPathologies/977.json   |    1 +
 .../DrugDescriptionsForPathologies/978.json   |    1 +
 .../DrugDescriptionsForPathologies/979.json   |    1 +
 .../DrugDescriptionsForPathologies/98.json    |    1 +
 .../DrugDescriptionsForPathologies/980.json   |    1 +
 .../DrugDescriptionsForPathologies/981.json   |    1 +
 .../DrugDescriptionsForPathologies/982.json   |    1 +
 .../DrugDescriptionsForPathologies/983.json   |    1 +
 .../DrugDescriptionsForPathologies/984.json   |    1 +
 .../DrugDescriptionsForPathologies/985.json   |    1 +
 .../DrugDescriptionsForPathologies/986.json   |    1 +
 .../DrugDescriptionsForPathologies/987.json   |    1 +
 .../DrugDescriptionsForPathologies/988.json   |    1 +
 .../DrugDescriptionsForPathologies/989.json   |    1 +
 .../DrugDescriptionsForPathologies/99.json    |    1 +
 .../DrugDescriptionsForPathologies/990.json   |    1 +
 .../DrugDescriptionsForPathologies/991.json   |    1 +
 .../DrugDescriptionsForPathologies/992.json   |    1 +
 .../DrugDescriptionsForPathologies/993.json   |    1 +
 .../DrugDescriptionsForPathologies/994.json   |    1 +
 .../DrugDescriptionsForPathologies/995.json   |    1 +
 .../DrugDescriptionsForPathologies/996.json   |    1 +
 .../DrugDescriptionsForPathologies/997.json   |    1 +
 .../DrugDescriptionsForPathologies/998.json   |    1 +
 .../DrugDescriptionsForPathologies/999.json   |    1 +
 docs/DrugsForPathologies/index.html           | 1062 ++++++++++++++++-
 docs/DrugsForPathologies/js/DrugsChartView.js |   71 ++
 .../DrugsForPathologies/js/PageInitializer.js |   21 +
 src/HowBadIsMyBatch.ipynb                     |    6 +-
 1042 files changed, 2186 insertions(+), 12 deletions(-)
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/10.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/100.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1000.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1001.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1002.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1003.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1004.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1005.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1006.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1007.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1008.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1009.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/101.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1010.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1011.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1012.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1013.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1014.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1015.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1016.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1017.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1018.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1019.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/102.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1020.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1021.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1022.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1023.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1024.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1025.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1026.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1027.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1028.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1029.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/103.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1030.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1031.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1032.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1033.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1034.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1035.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1036.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1037.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1038.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/104.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/105.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/106.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/107.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/108.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/109.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/11.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/110.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/111.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/112.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/113.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/114.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/115.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/116.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/117.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/118.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/119.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/12.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/120.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/121.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/122.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/123.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/124.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/125.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/126.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/127.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/128.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/129.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/13.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/130.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/131.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/132.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/133.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/134.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/135.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/136.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/137.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/138.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/139.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/14.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/140.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/141.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/142.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/143.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/144.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/145.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/146.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/147.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/148.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/149.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/15.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/150.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/151.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/152.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/153.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/154.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/155.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/156.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/157.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/158.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/159.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/16.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/160.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/161.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/162.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/163.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/164.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/165.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/166.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/167.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/168.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/169.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/17.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/170.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/171.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/172.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/173.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/174.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/175.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/176.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/177.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/178.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/179.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/18.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/180.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/181.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/182.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/183.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/184.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/185.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/186.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/187.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/188.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/189.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/19.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/190.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/191.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/192.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/193.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/194.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/195.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/196.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/197.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/198.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/199.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/2.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/20.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/200.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/201.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/202.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/203.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/204.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/205.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/206.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/207.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/208.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/209.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/21.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/210.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/211.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/212.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/213.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/214.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/215.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/216.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/217.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/218.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/219.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/22.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/220.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/221.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/222.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/223.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/224.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/225.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/226.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/227.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/228.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/229.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/23.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/230.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/231.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/232.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/233.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/234.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/235.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/236.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/237.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/238.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/239.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/24.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/240.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/241.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/242.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/243.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/244.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/245.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/246.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/247.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/248.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/249.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/25.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/250.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/251.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/252.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/253.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/254.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/255.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/256.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/257.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/258.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/259.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/26.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/260.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/261.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/262.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/263.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/264.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/265.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/266.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/267.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/268.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/269.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/27.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/270.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/271.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/272.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/273.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/274.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/275.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/276.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/277.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/278.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/279.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/28.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/280.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/281.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/282.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/283.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/284.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/285.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/286.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/287.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/288.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/289.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/29.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/290.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/291.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/292.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/293.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/294.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/295.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/296.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/297.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/298.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/299.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/3.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/30.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/300.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/301.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/302.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/303.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/304.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/305.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/306.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/307.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/308.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/309.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/31.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/310.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/311.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/312.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/313.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/314.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/315.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/316.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/317.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/318.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/319.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/32.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/320.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/321.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/322.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/323.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/324.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/325.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/326.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/327.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/328.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/329.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/33.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/330.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/331.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/332.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/333.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/334.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/335.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/336.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/337.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/338.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/339.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/34.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/340.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/341.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/342.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/343.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/344.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/345.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/346.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/347.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/348.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/349.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/35.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/350.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/351.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/352.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/353.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/354.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/355.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/356.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/357.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/358.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/359.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/36.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/360.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/361.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/362.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/363.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/364.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/365.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/366.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/367.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/368.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/369.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/37.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/370.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/371.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/372.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/373.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/374.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/375.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/376.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/377.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/378.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/379.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/38.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/380.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/381.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/382.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/383.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/384.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/385.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/386.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/387.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/388.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/389.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/39.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/390.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/391.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/392.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/393.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/394.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/395.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/396.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/397.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/398.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/399.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/4.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/40.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/400.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/401.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/402.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/403.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/404.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/405.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/406.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/407.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/408.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/409.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/41.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/410.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/411.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/412.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/413.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/414.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/415.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/416.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/417.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/418.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/419.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/42.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/420.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/421.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/422.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/423.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/424.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/425.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/426.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/427.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/428.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/429.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/43.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/430.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/431.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/432.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/433.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/434.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/435.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/436.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/437.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/438.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/439.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/44.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/440.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/441.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/442.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/443.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/444.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/445.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/446.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/447.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/448.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/449.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/45.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/450.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/451.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/452.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/453.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/454.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/455.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/456.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/457.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/458.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/459.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/46.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/460.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/461.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/462.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/463.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/464.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/465.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/466.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/467.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/468.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/469.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/47.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/470.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/471.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/472.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/473.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/474.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/475.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/476.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/477.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/478.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/479.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/48.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/480.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/481.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/482.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/483.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/484.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/485.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/486.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/487.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/488.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/489.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/49.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/490.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/491.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/492.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/493.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/494.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/495.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/496.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/497.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/498.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/499.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/5.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/50.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/500.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/501.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/502.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/503.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/504.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/505.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/506.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/507.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/508.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/509.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/51.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/510.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/511.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/512.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/513.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/514.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/515.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/516.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/517.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/518.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/519.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/52.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/520.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/521.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/522.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/523.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/524.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/525.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/526.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/527.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/528.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/529.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/53.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/530.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/531.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/532.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/533.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/534.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/535.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/536.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/537.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/538.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/539.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/54.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/540.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/541.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/542.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/543.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/544.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/545.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/546.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/547.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/548.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/549.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/55.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/550.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/551.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/552.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/553.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/554.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/555.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/556.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/557.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/558.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/559.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/56.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/560.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/561.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/562.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/563.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/564.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/565.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/566.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/567.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/568.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/569.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/57.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/570.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/571.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/572.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/573.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/574.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/575.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/576.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/577.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/578.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/579.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/58.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/580.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/581.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/582.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/583.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/584.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/585.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/586.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/587.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/588.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/589.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/59.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/590.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/591.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/592.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/593.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/594.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/595.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/596.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/597.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/598.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/599.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/6.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/60.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/600.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/601.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/602.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/603.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/604.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/605.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/606.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/607.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/608.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/609.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/61.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/610.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/611.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/612.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/613.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/614.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/615.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/616.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/617.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/618.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/619.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/62.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/620.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/621.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/622.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/623.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/624.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/625.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/626.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/627.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/628.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/629.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/63.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/630.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/631.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/632.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/633.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/634.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/635.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/636.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/637.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/638.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/639.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/64.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/640.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/641.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/642.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/643.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/644.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/645.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/646.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/647.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/648.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/649.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/65.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/650.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/651.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/652.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/653.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/654.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/655.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/656.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/657.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/658.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/659.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/66.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/660.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/661.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/662.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/663.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/664.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/665.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/666.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/667.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/668.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/669.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/67.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/670.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/671.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/672.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/673.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/674.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/675.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/676.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/677.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/678.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/679.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/68.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/680.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/681.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/682.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/683.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/684.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/685.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/686.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/687.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/688.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/689.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/69.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/690.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/691.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/692.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/693.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/694.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/695.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/696.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/697.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/698.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/699.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/7.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/70.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/700.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/701.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/702.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/703.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/704.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/705.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/706.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/707.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/708.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/709.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/71.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/710.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/711.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/712.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/713.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/714.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/715.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/716.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/717.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/718.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/719.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/72.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/720.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/721.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/722.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/723.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/724.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/725.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/726.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/727.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/728.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/729.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/73.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/730.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/731.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/732.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/733.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/734.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/735.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/736.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/737.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/738.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/739.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/74.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/740.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/741.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/742.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/743.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/744.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/745.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/746.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/747.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/748.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/749.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/75.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/750.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/751.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/752.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/753.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/754.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/755.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/756.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/757.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/758.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/759.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/76.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/760.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/761.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/762.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/763.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/764.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/765.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/766.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/767.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/768.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/769.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/77.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/770.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/771.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/772.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/773.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/774.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/775.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/776.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/777.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/778.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/779.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/78.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/780.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/781.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/782.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/783.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/784.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/785.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/786.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/787.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/788.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/789.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/79.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/790.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/791.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/792.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/793.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/794.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/795.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/796.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/797.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/798.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/799.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/8.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/80.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/800.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/801.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/802.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/803.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/804.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/805.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/806.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/807.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/808.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/809.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/81.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/810.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/811.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/812.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/813.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/814.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/815.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/816.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/817.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/818.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/819.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/82.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/820.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/821.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/822.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/823.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/824.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/825.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/826.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/827.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/828.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/829.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/83.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/830.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/831.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/832.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/833.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/834.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/835.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/836.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/837.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/838.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/839.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/84.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/840.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/841.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/842.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/843.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/844.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/845.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/846.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/847.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/848.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/849.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/85.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/850.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/851.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/852.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/853.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/854.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/855.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/856.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/857.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/858.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/859.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/86.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/860.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/861.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/862.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/863.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/864.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/865.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/866.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/867.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/868.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/869.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/87.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/870.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/871.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/872.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/873.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/874.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/875.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/876.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/877.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/878.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/879.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/88.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/880.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/881.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/882.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/883.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/884.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/885.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/886.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/887.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/888.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/889.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/89.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/890.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/891.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/892.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/893.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/894.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/895.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/896.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/897.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/898.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/899.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/9.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/90.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/900.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/901.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/902.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/903.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/904.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/905.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/906.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/907.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/908.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/909.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/91.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/910.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/911.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/912.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/913.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/914.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/915.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/916.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/917.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/918.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/919.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/92.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/920.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/921.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/922.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/923.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/924.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/925.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/926.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/927.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/928.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/929.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/93.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/930.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/931.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/932.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/933.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/934.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/935.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/936.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/937.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/938.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/939.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/94.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/940.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/941.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/942.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/943.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/944.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/945.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/946.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/947.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/948.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/949.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/95.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/950.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/951.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/952.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/953.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/954.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/955.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/956.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/957.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/958.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/959.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/96.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/960.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/961.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/962.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/963.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/964.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/965.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/966.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/967.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/968.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/969.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/97.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/970.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/971.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/972.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/973.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/974.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/975.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/976.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/977.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/978.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/979.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/98.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/980.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/981.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/982.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/983.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/984.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/985.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/986.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/987.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/988.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/989.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/99.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/990.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/991.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/992.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/993.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/994.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/995.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/996.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/997.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/998.json
 create mode 100644 docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/999.json
 create mode 100644 docs/DrugsForPathologies/js/DrugsChartView.js
 create mode 100644 docs/DrugsForPathologies/js/PageInitializer.js

diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1.json
new file mode 100644
index 00000000000..4e2fdac672f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1.json
@@ -0,0 +1 @@
+{"CASES": [160], "DRUG": ["DEXAMETHASONE"], "FATAL": [32], "PATHOLOGY": "abdominal discomfort", "RECOVERED": [28]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/10.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/10.json
new file mode 100644
index 00000000000..0017d55e258
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/10.json
@@ -0,0 +1 @@
+{"CASES": [120, 310, 467, 294, 176, 436, 696, 120, 214, 493, 701, 340, 577, 644, 723, 2210, 131, 168, 171, 19536], "DRUG": ["STOCRIN", "INVIRASE", "CRIXIVAN", "ABACAVIR", "NORVIR", "LAMIVUDINE", "KALETRA", "INDINAVIR", "BIKTARVY", "EFAVIRENZ", "VIRAMUNE", "VIREAD", "COMBIVIR", "EPIVIR", "STRIBILD", "TRUVADA", "TRIUMEQ", "ATAZANAVIR", "NEVIRAPINE", "ATRIPLA"], "FATAL": [24, 35, 44, 21, 10, 24, 36, 5, 8, 18, 25, 11, 14, 9, 6, 18, 1, 1, 1, 2], "PATHOLOGY": "acquired immunodeficiency syndrome", "RECOVERED": [22, 12, 180, 21, 45, 117, 176, 59, 30, 209, 305, 37, 79, 84, 26, 114, 36, 11, 23, 625]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/100.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/100.json
new file mode 100644
index 00000000000..2fb4964d091
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/100.json
@@ -0,0 +1 @@
+{"CASES": [221, 49023, 3630, 197139, 179, 714, 226, 407, 126, 1535, 779, 319, 13174, 10674, 634, 2044, 289, 1166, 566, 151, 157, 18685, 102, 682, 246775, 13987, 2631, 2054, 654, 302, 580, 771, 555, 1088, 668, 224, 50116, 28543, 190, 10881, 109, 1109, 113, 341, 1107, 11494, 3333, 129, 133, 71683, 1055, 182, 44632, 580, 101, 111, 391, 292, 738, 298, 366, 513, 626], "DRUG": ["PANTOPRAZOLE", "ABATACEPT", "COSENTYX", "ADALIMUMAB", "HYDROCORTISONE", "CERTOLIZUMAB PEGOL", "MYCOPHENOLATE MOFETIL", "KEVZARA", "RINVOQ 15 MG", "CELECOXIB", "INFLIXIMAB", "TOFACITINIB", "ANAKINRA", "RITUXIMAB", "ARAVA 20 MG FILM-COATED TABLETS", "REMICADE", "ARAVA 10 MG FILM-COATED TABLETS", "ETANERCEPT", "GOLIMUMAB", "TACROLIMUS", "LEVOFLOXACIN", "ROACTEMRA", "HUMIRA 40 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN", "MABTHERA", "ARAVA", "METHOTREXATE", "CICLOSPORIN", "TOCILIZUMAB", "ROACTEMRA 162 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "RIXATHON", "HUMIRA 40 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "XELJANZ 5 MG", "CUBICIN", "ROACTEMRA 20 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION", "IBUPROFEN", "XELJANZ 5 MG FILM-COATED TABLETS", "ENBREL", "SIMPONI", "SIMPONI 50 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN", "HUMIRA", "DEXAMETHASONE", "AZATHIOPRINE", "BENLYSTA", "CELLCEPT", "ORENCIA", "RINVOQ", "LEFLUNOMIDE", "ROACTEMRA 162 MG", "KINERET", "XELJANZ", "ILARIS", "OLUMIANT", "CIMZIA", "BEXTRA", "ARAVA 10 MG", "ADENURIC", "UPADACITINIB", "INFLECTRA", "ERELZI", "CIMZIA 200 MG SOLUTION FOR INJECTION", "ENBREL SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "LYRICA", "HUMIRA 40 MG/0.8 ML"], "FATAL": [148, 26023, 1695, 90068, 73, 279, 77, 105, 30, 252, 103, 40, 1318, 1018, 44, 130, 18, 67, 31, 8, 8, 920, 5, 31, 10911, 589, 108, 83, 24, 11, 21, 27, 18, 34, 19, 6, 1259, 701, 4, 219, 2, 20, 2, 6, 19, 198, 56, 2, 2, 924, 13, 2, 484, 6, 1, 1, 3, 2, 5, 2, 2, 2, 1], "PATHOLOGY": "arthritis", "RECOVERED": [1, 473, 154, 1324, 22, 132, 2, 30, 24, 296, 109, 64, 2523, 739, 239, 524, 106, 164, 172, 35, 67, 5811, 33, 184, 9568, 2132, 604, 648, 266, 139, 192, 174, 205, 511, 117, 104, 3312, 3775, 54, 1065, 17, 175, 19, 30, 135, 1979, 344, 58, 34, 9208, 364, 32, 5338, 121, 35, 40, 56, 50, 88, 116, 132, 66, 105]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1000.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1000.json
new file mode 100644
index 00000000000..3641cd38359
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1000.json
@@ -0,0 +1 @@
+{"CASES": [116], "DRUG": ["CARBIDOPA, LEVODOPA"], "FATAL": [5], "PATHOLOGY": "tremor", "RECOVERED": [4]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1001.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1001.json
new file mode 100644
index 00000000000..7f3c95df124
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1001.json
@@ -0,0 +1 @@
+{"CASES": [209], "DRUG": ["LYRICA"], "FATAL": [2], "PATHOLOGY": "trigeminal neuralgia", "RECOVERED": [61]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1002.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1002.json
new file mode 100644
index 00000000000..c412c3ea72a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1002.json
@@ -0,0 +1 @@
+{"CASES": [2769, 143, 646, 5859, 119, 514, 461, 145, 166], "DRUG": ["TRODELVY", "CAPECITABINE", "PEMBROLIZUMAB", "KEYTRUDA", "ATEZOLIZUMAB", "SACITUZUMAB GOVITECAN", "PACLITAXEL", "DOCETAXEL", "DOXORUBICIN HYDROCHLORIDE"], "FATAL": [230, 5, 15, 135, 2, 7, 5, 1, 1], "PATHOLOGY": "triple negative breast cancer", "RECOVERED": [333, 5, 79, 1424, 8, 50, 115, 44, 27]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1003.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1003.json
new file mode 100644
index 00000000000..ae89f7f2b90
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1003.json
@@ -0,0 +1 @@
+{"CASES": [175, 10018, 299, 1316, 14184, 1310, 5337, 113, 4004, 770], "DRUG": ["DEXAMETHASONE", "AMINOSALICYLIC ACID", "PRETOMANID", "AMIKACIN", "BEDAQUILINE", "SIRTURO", "DELAMANID", "CICLOSPORIN", "LEVOFLOXACIN", "DELTYBA"], "FATAL": [89, 1420, 39, 161, 1728, 152, 545, 10, 346, 45], "PATHOLOGY": "tuberculosis", "RECOVERED": [48, 1903, 49, 171, 2256, 277, 961, 81, 843, 150]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1004.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1004.json
new file mode 100644
index 00000000000..256e696da38
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1004.json
@@ -0,0 +1 @@
+{"CASES": [212, 271], "DRUG": ["FASTURTEC", "RASBURICASE"], "FATAL": [70, 13], "PATHOLOGY": "tumour lysis syndrome", "RECOVERED": [116, 75]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1005.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1005.json
new file mode 100644
index 00000000000..b93f990d8d8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1005.json
@@ -0,0 +1 @@
+{"CASES": [194], "DRUG": ["SOMATROPIN"], "FATAL": [1], "PATHOLOGY": "turner's syndrome", "RECOVERED": [24]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1006.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1006.json
new file mode 100644
index 00000000000..9dac8d31a17
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1006.json
@@ -0,0 +1 @@
+{"CASES": [318, 251, 344, 246, 484, 913, 793, 737, 184, 1609, 326, 920, 141, 1171, 165, 2468, 598, 107, 3921, 19687, 1032, 964, 1849, 6435, 1571, 15581, 3134, 690, 1102, 538, 5696, 1755, 2490], "DRUG": ["AVANDIA", "INSULATARD", "JANUVIA", "VICTOZA", "ACTRAPID PENFILL", "ACTRAPID", "FORXIGA", "INSULIN HUMAN", "LEVEMIR SOLUTION FOR INJECTION", "LEVEMIR FLEXPEN", "INSULIN DEGLUDEC", "TOUJEO", "MIXTARD 30", "JARDIANCE", "BYETTA", "LEVEMIR", "LEVEMIR FLEXTOUCH", "HUMALOG 100 U/ML SOLUTION FOR INJECTION IN VIAL", "NOVORAPID", "LANTUS", "TRESIBA", "INSULIN ASPART", "NOVORAPID PENFILL", "APIDRA", "INSULIN GLARGINE", "HUMALOG", "LANTUS SOLOSTAR", "LEVEMIR PENFILL", "INSULIN LISPRO", "HUMALOG MIX25", "NOVORAPID PUMPCART", "NOVORAPID FLEXPEN", "FIASP"], "FATAL": [28, 17, 15, 9, 16, 30, 19, 14, 3, 26, 5, 14, 2, 16, 2, 25, 6, 1, 36, 169, 8, 6, 11, 34, 7, 64, 11, 2, 3, 1, 11, 2, 1], "PATHOLOGY": "type 1 diabetes mellitus", "RECOVERED": [59, 118, 42, 87, 189, 461, 250, 262, 115, 695, 96, 239, 52, 333, 48, 1116, 191, 38, 1338, 7543, 333, 387, 644, 2309, 638, 4079, 582, 267, 370, 153, 1286, 656, 780]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1007.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1007.json
new file mode 100644
index 00000000000..a1c4acba17f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1007.json
@@ -0,0 +1 @@
+{"CASES": [216, 297, 146, 262, 291, 633, 561, 2032, 285, 179, 20367, 2262, 399, 24815, 363, 126, 173, 1108, 199, 20991, 1721, 126, 103, 18935, 166, 865, 3681, 3041, 562, 39189, 324, 6336, 1629, 1200, 12482, 1939, 829, 2715, 361, 1259, 277, 936, 1590, 330, 10713, 241, 291, 304, 767, 3890, 1065, 109, 718, 971, 173, 1527, 119, 184, 128, 2795, 30328, 2803, 404, 149, 375, 3710, 1384, 2726, 477, 15191, 483, 784, 357, 1504, 1888, 744, 108, 218, 4678, 221, 114, 129, 18866, 142, 880, 1917, 154, 466, 164, 2702, 1027, 1545, 1782, 385, 208, 218, 22069, 3127, 5161, 310, 1313, 328, 597], "DRUG": ["LANTUS 100 IU/ML SOLUTION FOR INJECTION IN A CARTRIDGE", "EUCREAS 50 MG/1000 MG FILM-COATED TABLETS", "JANUVIA 25 MG FILM-COATED TABLETS", "ROSIGLITAZONE MALEATE", "MIXTARD 30", "AVANDIA FILM-COATED TABLETS", "ACTRAPID", "ONGLYZA", "ONGLYZA 5 MG FILM-COATED TABLETS", "ABASAGLAR 100 UNITS/ML SOLUTION FOR INJECTION IN A PRE-FILLED PEN", "AVANDIA", "GALVUS", "BYETTA SOLUTION FOR INJECTION, PREFILLED PEN", "BYETTA", "INSULATARD", "JANUMET 50 MG/850 MG", "VELMETIA 50 MG/1000 MG FILM-COATED TABLETS", "GLIBENCLAMIDE", "SAXAGLIPTIN", "JANUVIA", "NOVONORM", "PRANDIN", "ALBIGLUTIDE", "JANUMET", "JANUMET 50 MG/1000 MG FILM-COATED TABLETS", "VILDAGLIPTIN", "METFORMIN HYDROCHLORIDE, VILDAGLIPTIN", "AVANDAMET", "VELMETIA", "LANTUS", "RYBELSUS 14 MG", "APIDRA", "ACTOS", "INSULIN ASPART", "VICTOZA", "EUCREAS", "JARDIANCE 10 MG", "EMPAGLIFLOZIN", "LEVEMIR SOLUTION FOR INJECTION", "JARDIANCE 10 MG FILM-COATED TABLETS", "JANUMET 50 MG/1000 MG", "OZEMPIC", "NOVORAPID FLEXPEN", "LEVEMIR PENFILL", "FORXIGA", "INSULIN GLULISINE", "INSULIN DETEMIR", "JARDIANCE 25 MG FILM-COATED TABLETS", "RYBELSUS 3 MG", "INSULIN GLARGINE", "JANUVIA 50 MG FILM-COATED TABLETS", "EXUBERA", "DAPAGLIFLOZIN", "TRESIBA", "TRESIBA 100 UNITS/ML", "JARDIANCE FILM-COATED TABLETS", "XELEVIA", "NOVOMIX 30", "INSULIN HUMAN (RDNA)", "LEVEMIR FLEXPEN", "JARDIANCE", "LEVEMIR", "RYBELSUS 7 MG", "LANTUS 100 UNITS/ML SOLUTION FOR INJECTION IN A PRE-FILLED PEN", "CANAGLIFLOZIN", "HUMALOG MIX25", "INSULIN HUMAN", "LEVEMIR FLEXTOUCH", "VICTOZA 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN", "BYDUREON", "REPAGLINIDE", "FORXIGA 10 MG FILM-COATED TABLETS", "GALVUS 50 MG TABLETS", "ABASAGLAR", "DULAGLUTIDE", "HUMALOG MIX50", "BYETTA 10 MICROGRAMS SOLUTION FOR INJECTION, PREFILLED PEN", "EXENATIDE", "TRULICITY", "PIOGLITAZONE", "INSULIN HUMAN ISOPHANE (RDNA)", "SEMGLEE", "HUMALOG", "BYDUREON 2 MG POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION", "NOVORAPID PENFILL", "INSULIN LISPRO", "TRULICITY 4.5 MG", "INSULIN DEGLUDEC", "BYDUREON 2 MG", "TOUJEO", "RYBELSUS", "NOVORAPID", "APIDRA SOLOSTAR", "FIASP", "INSULATARD FLEXPEN", "ACTRAPID PENFILL", "LANTUS SOLOSTAR", "INVOKANA", "TRULICITY 1.5 MG", "TRULICITY 3 MG", "TOUJEO SOLOSTAR", "SITAGLIPTIN", "JANUVIA 100 MG FILM-COATED TABLETS"], "FATAL": [67, 57, 18, 24, 24, 44, 38, 130, 18, 11, 1234, 131, 22, 1352, 18, 6, 8, 51, 9, 898, 70, 5, 4, 704, 6, 31, 115, 94, 17, 1124, 9, 173, 42, 31, 308, 47, 20, 62, 8, 28, 6, 20, 34, 7, 225, 5, 6, 6, 15, 76, 20, 2, 13, 17, 3, 26, 2, 3, 2, 43, 460, 42, 6, 2, 5, 49, 18, 35, 6, 190, 6, 9, 4, 15, 18, 7, 1, 2, 42, 2, 1, 1, 136, 1, 6, 13, 1, 3, 1, 16, 6, 9, 10, 2, 1, 1, 100, 14, 22, 1, 4, 1, 1], "PATHOLOGY": "type 2 diabetes mellitus", "RECOVERED": [80, 147, 28, 32, 138, 19, 258, 291, 97, 79, 1713, 654, 81, 4755, 153, 10, 90, 386, 115, 2709, 839, 47, 24, 2593, 82, 224, 861, 90, 250, 11414, 115, 1962, 619, 405, 5432, 712, 298, 948, 201, 604, 44, 238, 681, 146, 3701, 109, 161, 129, 301, 1353, 309, 41, 273, 354, 58, 536, 52, 80, 42, 1274, 11634, 1193, 158, 86, 136, 696, 362, 786, 249, 2824, 250, 370, 182, 327, 431, 162, 59, 69, 1462, 60, 38, 6, 3987, 30, 247, 377, 28, 144, 56, 463, 328, 615, 463, 92, 73, 75, 1728, 808, 1075, 56, 201, 178, 390]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1008.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1008.json
new file mode 100644
index 00000000000..bfb2c66cc57
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1008.json
@@ -0,0 +1 @@
+{"CASES": [186], "DRUG": ["THALIDOMIDE"], "FATAL": [21], "PATHOLOGY": "type 2 lepra reaction", "RECOVERED": [58]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1009.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1009.json
new file mode 100644
index 00000000000..be15a22cf50
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1009.json
@@ -0,0 +1 @@
+{"CASES": [1313, 314, 506, 602, 444, 1083, 255, 208, 134, 1610, 1940, 6194, 2334, 4465, 308, 871, 2151, 13297, 853, 14143, 768, 522, 1882, 2291], "DRUG": ["TRACLEER", "ESOMEPRAZOLE", "PANTOPRAZOLE", "CICLOSPORIN", "MERCAPTOPURINE", "ENTYVIO 300 MG", "UPADACITINIB", "ENTYVIO 300 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "GOLIMUMAB", "AZATHIOPRINE", "REMICADE", "SIMPONI", "RINVOQ", "STELARA", "XELJANZ 5 MG", "INFLECTRA", "ADALIMUMAB", "ENTYVIO", "VEDOLIZUMAB", "XELJANZ", "BUDESONIDE", "CIMZIA", "INFLIXIMAB", "HUMIRA"], "FATAL": [146, 26, 37, 27, 14, 32, 7, 5, 3, 26, 30, 79, 28, 46, 3, 8, 14, 84, 5, 67, 3, 2, 4, 2], "PATHOLOGY": "ulcer", "RECOVERED": [358, 129, 159, 183, 115, 314, 36, 78, 14, 210, 554, 865, 424, 748, 66, 80, 408, 1885, 128, 1284, 118, 82, 280, 344]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/101.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/101.json
new file mode 100644
index 00000000000..beb0796b0d2
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/101.json
@@ -0,0 +1 @@
+{"CASES": [225], "DRUG": ["CUBICIN"], "FATAL": [11], "PATHOLOGY": "arthritis bacterial", "RECOVERED": [96]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1010.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1010.json
new file mode 100644
index 00000000000..2ffdc66c509
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1010.json
@@ -0,0 +1 @@
+{"CASES": [656], "DRUG": ["LEVOFLOXACIN"], "FATAL": [18], "PATHOLOGY": "upper respiratory tract infection", "RECOVERED": [182]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1011.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1011.json
new file mode 100644
index 00000000000..18f2b665243
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1011.json
@@ -0,0 +1 @@
+{"CASES": [255], "DRUG": ["KEYTRUDA"], "FATAL": [37], "PATHOLOGY": "ureteric cancer", "RECOVERED": [49]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1012.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1012.json
new file mode 100644
index 00000000000..3aa7a085f58
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1012.json
@@ -0,0 +1 @@
+{"CASES": [275], "DRUG": ["TOVIAZ"], "FATAL": [2], "PATHOLOGY": "urge incontinence", "RECOVERED": [109]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1013.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1013.json
new file mode 100644
index 00000000000..15bcb94f1f5
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1013.json
@@ -0,0 +1 @@
+{"CASES": [713, 301, 1976], "DRUG": ["BETMIGA", "OXYBUTYNIN", "TOVIAZ"], "FATAL": [55, 12, 4], "PATHOLOGY": "urinary incontinence", "RECOVERED": [215, 87, 341]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1014.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1014.json
new file mode 100644
index 00000000000..e7f904d5ca5
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1014.json
@@ -0,0 +1 @@
+{"CASES": [119, 9526], "DRUG": ["AMIKACIN", "LEVOFLOXACIN"], "FATAL": [3, 51], "PATHOLOGY": "urinary tract infection", "RECOVERED": [75, 6761]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1015.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1015.json
new file mode 100644
index 00000000000..400b127a86e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1015.json
@@ -0,0 +1 @@
+{"CASES": [9999, 166, 14892], "DRUG": ["OMALIZUMAB", "XOLAIR 150 MG POWDER AND SOLVENT FOR SOLUTION FOR INJECTION", "XOLAIR"], "FATAL": [113, 1, 52], "PATHOLOGY": "urticaria", "RECOVERED": [1358, 77, 2753]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1016.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1016.json
new file mode 100644
index 00000000000..e4da4bd9630
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1016.json
@@ -0,0 +1 @@
+{"CASES": [129, 393, 1204], "DRUG": ["XOLAIR 150 MG POWDER AND SOLVENT FOR SOLUTION FOR INJECTION", "OMALIZUMAB", "XOLAIR"], "FATAL": [1, 2, 1], "PATHOLOGY": "urticaria chronic", "RECOVERED": [56, 93, 283]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1017.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1017.json
new file mode 100644
index 00000000000..1e390380290
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1017.json
@@ -0,0 +1 @@
+{"CASES": [250, 8938], "DRUG": ["VOTRIENT", "KEYTRUDA"], "FATAL": [24, 262], "PATHOLOGY": "uterine cancer", "RECOVERED": [12, 2576]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1018.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1018.json
new file mode 100644
index 00000000000..6a7b52fbeda
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1018.json
@@ -0,0 +1 @@
+{"CASES": [2266], "DRUG": ["ESMYA"], "FATAL": [12], "PATHOLOGY": "uterine leiomyoma", "RECOVERED": [896]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1019.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1019.json
new file mode 100644
index 00000000000..76746dd1482
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1019.json
@@ -0,0 +1 @@
+{"CASES": [164], "DRUG": ["YONDELIS"], "FATAL": [27], "PATHOLOGY": "uterine leiomyosarcoma", "RECOVERED": [44]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/102.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/102.json
new file mode 100644
index 00000000000..29cd66fb60a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/102.json
@@ -0,0 +1 @@
+{"CASES": [205], "DRUG": ["CUBICIN"], "FATAL": [5], "PATHOLOGY": "arthritis infective", "RECOVERED": [61]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1020.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1020.json
new file mode 100644
index 00000000000..a51e679d168
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1020.json
@@ -0,0 +1 @@
+{"CASES": [152], "DRUG": ["CICLOSPORIN"], "FATAL": [3], "PATHOLOGY": "uveitis", "RECOVERED": [35]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1021.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1021.json
new file mode 100644
index 00000000000..c774264f50f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1021.json
@@ -0,0 +1 @@
+{"CASES": [182], "DRUG": ["PLAVIX"], "FATAL": [12], "PATHOLOGY": "vascular graft", "RECOVERED": [25]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1022.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1022.json
new file mode 100644
index 00000000000..d48b3cf2091
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1022.json
@@ -0,0 +1 @@
+{"CASES": [156], "DRUG": ["CELLCEPT"], "FATAL": [2], "PATHOLOGY": "vasculitis", "RECOVERED": [15]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1023.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1023.json
new file mode 100644
index 00000000000..b549b47fb2f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1023.json
@@ -0,0 +1 @@
+{"CASES": [349], "DRUG": ["DEFITELIO"], "FATAL": [152], "PATHOLOGY": "venoocclusive disease", "RECOVERED": [44]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1024.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1024.json
new file mode 100644
index 00000000000..67e32a0476c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1024.json
@@ -0,0 +1 @@
+{"CASES": [1340], "DRUG": ["DEFITELIO"], "FATAL": [473], "PATHOLOGY": "venoocclusive liver disease", "RECOVERED": [215]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1025.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1025.json
new file mode 100644
index 00000000000..9ff93cc5707
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1025.json
@@ -0,0 +1 @@
+{"CASES": [276, 222], "DRUG": ["ENOXAPARIN SODIUM", "ELIQUIS"], "FATAL": [12, 4], "PATHOLOGY": "venous thrombosis", "RECOVERED": [77, 68]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1026.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1026.json
new file mode 100644
index 00000000000..6208e3824bc
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1026.json
@@ -0,0 +1 @@
+{"CASES": [155, 104, 225], "DRUG": ["KALETRA", "GANCICLOVIR", "TAMIFLU"], "FATAL": [15, 6, 2], "PATHOLOGY": "viral infection", "RECOVERED": [41, 12, 78]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1027.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1027.json
new file mode 100644
index 00000000000..8f1b2a62002
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1027.json
@@ -0,0 +1 @@
+{"CASES": [753], "DRUG": ["JETREA"], "FATAL": [2], "PATHOLOGY": "vitreous adhesions", "RECOVERED": [262]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1028.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1028.json
new file mode 100644
index 00000000000..f23e8bbb9e8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1028.json
@@ -0,0 +1 @@
+{"CASES": [303, 323, 256, 2175, 790], "DRUG": ["OLANZAPINE", "ALOXI", "APREPITANT", "EMEND", "DEXAMETHASONE"], "FATAL": [220, 19, 15, 116, 17], "PATHOLOGY": "vomiting", "RECOVERED": [33, 135, 96, 971, 371]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1029.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1029.json
new file mode 100644
index 00000000000..4e2bc46fd84
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1029.json
@@ -0,0 +1 @@
+{"CASES": [101], "DRUG": ["HUMAN COAGULATION FACTOR VIII, HUMAN VON WILLEBRAND FACTOR"], "FATAL": [39], "PATHOLOGY": "von willebrand's disease", "RECOVERED": [21]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/103.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/103.json
new file mode 100644
index 00000000000..36ef26dddeb
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/103.json
@@ -0,0 +1 @@
+{"CASES": [742], "DRUG": ["XELJANZ"], "FATAL": [2], "PATHOLOGY": "arthritis, rheumatoid arthritis", "RECOVERED": [83]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1030.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1030.json
new file mode 100644
index 00000000000..1bcb1b76395
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1030.json
@@ -0,0 +1 @@
+{"CASES": [308, 159], "DRUG": ["BRUKINSA", "RITUXIMAB"], "FATAL": [8, 2], "PATHOLOGY": "waldenstrom's macroglobulinaemia", "RECOVERED": [25, 51]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1031.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1031.json
new file mode 100644
index 00000000000..dfccf9bdeaa
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1031.json
@@ -0,0 +1 @@
+{"CASES": [190, 673, 4418], "DRUG": ["LIRAGLUTIDE", "VICTOZA", "SAXENDA"], "FATAL": [7, 4, 22], "PATHOLOGY": "weight control", "RECOVERED": [57, 188, 1477]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1032.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1032.json
new file mode 100644
index 00000000000..dd3b00fe949
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1032.json
@@ -0,0 +1 @@
+{"CASES": [150, 143, 1633], "DRUG": ["VICTOZA", "TRULICITY 1.5 MG", "SAXENDA"], "FATAL": [3, 1, 8], "PATHOLOGY": "weight decreased", "RECOVERED": [70, 7, 606]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1033.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1033.json
new file mode 100644
index 00000000000..1d7d5ce2d65
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1033.json
@@ -0,0 +1 @@
+{"CASES": [106], "DRUG": ["BUDESONIDE"], "FATAL": [12], "PATHOLOGY": "wheezing", "RECOVERED": [20]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1034.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1034.json
new file mode 100644
index 00000000000..fb5c6ddcb2f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1034.json
@@ -0,0 +1 @@
+{"CASES": [138, 191], "DRUG": ["FILGRASTIM", "NEULASTA"], "FATAL": [8, 6], "PATHOLOGY": "white blood cell count decreased", "RECOVERED": [28, 25]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1035.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1035.json
new file mode 100644
index 00000000000..052aaf1055f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1035.json
@@ -0,0 +1 @@
+{"CASES": [219, 261], "DRUG": ["BUPRENORPHINE", "SUBOXONE"], "FATAL": [10, 10], "PATHOLOGY": "withdrawal syndrome", "RECOVERED": [69, 81]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1036.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1036.json
new file mode 100644
index 00000000000..d54c9732dd1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1036.json
@@ -0,0 +1 @@
+{"CASES": [286, 105], "DRUG": ["CUBICIN", "LEVOFLOXACIN"], "FATAL": [15, 1], "PATHOLOGY": "wound", "RECOVERED": [82, 30]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1037.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1037.json
new file mode 100644
index 00000000000..c9e755be0d9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1037.json
@@ -0,0 +1 @@
+{"CASES": [281, 102], "DRUG": ["CUBICIN", "LEVOFLOXACIN"], "FATAL": [15, 1], "PATHOLOGY": "wound infection", "RECOVERED": [82, 30]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1038.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1038.json
new file mode 100644
index 00000000000..86242006169
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/1038.json
@@ -0,0 +1 @@
+{"CASES": [157], "DRUG": ["OLANZAPINE"], "FATAL": [152], "PATHOLOGY": "wrong product administered", "RECOVERED": [4]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/104.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/104.json
new file mode 100644
index 00000000000..bd9f55dc6bc
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/104.json
@@ -0,0 +1 @@
+{"CASES": [35478, 23997, 190, 938, 1392, 2103, 120, 1925, 128, 263, 7719, 3606, 241, 2415, 1562, 269, 4264, 6396], "DRUG": ["ADALIMUMAB", "COSENTYX", "ROACTEMRA", "METHOTREXATE", "ARAVA", "ENBREL", "STELARA 45 MG SOLUTION FOR INJECTION", "HUMIRA", "SIMPONI 50 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN", "LEFLUNOMIDE", "SIMPONI", "STELARA", "OTEZLA", "TREMFYA", "RINVOQ", "INFLIXIMAB", "XELJANZ", "CIMZIA"], "FATAL": [29222, 1996, 12, 49, 43, 45, 2, 32, 2, 4, 84, 36, 2, 18, 8, 1, 12, 16], "PATHOLOGY": "arthropathy", "RECOVERED": [96, 2664, 76, 172, 352, 376, 32, 396, 32, 145, 1061, 534, 69, 165, 336, 159, 424, 693]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/105.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/105.json
new file mode 100644
index 00000000000..5d8632e20fd
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/105.json
@@ -0,0 +1 @@
+{"CASES": [274], "DRUG": ["VFEND"], "FATAL": [10], "PATHOLOGY": "aspergilloma", "RECOVERED": [88]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/106.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/106.json
new file mode 100644
index 00000000000..0a21a6714b9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/106.json
@@ -0,0 +1 @@
+{"CASES": [115, 436, 295, 129, 1802, 788, 438, 4553, 375, 178], "DRUG": ["MICAFUNGIN", "CASPOFUNGIN", "CASPOFUNGIN ACETATE", "POSACONAZOLE", "VORICONAZOLE", "CRESEMBA", "CANCIDAS", "VFEND", "NOXAFIL", "VFEND 200 MG FILM-COATED TABLETS"], "FATAL": [53, 198, 97, 26, 348, 147, 64, 487, 32, 4], "PATHOLOGY": "aspergillus infection", "RECOVERED": [6, 64, 42, 17, 456, 118, 96, 1199, 102, 92]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/107.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/107.json
new file mode 100644
index 00000000000..860717a68d5
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/107.json
@@ -0,0 +1 @@
+{"CASES": [200], "DRUG": ["LUVERIS"], "FATAL": [1], "PATHOLOGY": "assisted reproductive technology", "RECOVERED": [184]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/108.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/108.json
new file mode 100644
index 00000000000..7640690b204
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/108.json
@@ -0,0 +1 @@
+{"CASES": [195, 103, 234, 199, 151, 356, 2170, 815, 516, 171], "DRUG": ["AZATHIOPRINE", "MYCOPHENOLATE MOFETIL", "SOLIRIS", "CICLOSPORIN", "HUMAN NORMAL IMMUNOGLOBULIN (IV)", "HUMAN NORMAL IMMUNOGLOBULIN", "SOLIRIS 300 MG", "PRIVIGEN", "CELLCEPT", "KIOVIG"], "FATAL": [90, 6, 9, 7, 5, 11, 50, 15, 9, 1], "PATHOLOGY": "asthenia", "RECOVERED": [14, 14, 18, 56, 30, 47, 238, 381, 70, 69]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/109.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/109.json
new file mode 100644
index 00000000000..7764d1e14bc
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/109.json
@@ -0,0 +1 @@
+{"CASES": [143, 141, 194, 3099, 39697, 1523, 148, 343, 33134, 116, 426, 15991, 500, 2743, 21104, 3026, 179, 1774, 35735, 1381, 252, 2687, 3272, 358, 486], "DRUG": ["ONBREZ BREEZHALER", "DEXAMETHASONE", "XOLAIR 150 MG SOLUTION FOR INJECTION", "NUCALA POWDER FOR SOLUTION FOR INJECTION", "XOLAIR", "INCRUSE ELLIPTA", "UMECLIDINIUM BROMIDE, FLUTICASONE FUROATE, VILANTEROL", "HYDROCORTISONE", "MEPOLIZUMAB", "INCRUSE", "FASENRA 30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "FASENRA", "ANORO ELLIPTA", "TRELEGY ELLIPTA", "OMALIZUMAB", "BUDESONIDE", "HIZENTRA", "RELVAR ELLIPTA INHALATION POWDER, PRE-DISPENSED", "NUCALA", "DUPIXENT", "XOLAIR 150 MG POWDER AND SOLVENT FOR SOLUTION FOR INJECTION", "BENRALIZUMAB", "RELVAR ELLIPTA", "DUPILUMAB", "FLUTICASONE PROPIONATE, SALMETEROL"], "FATAL": [16, 11, 11, 120, 1028, 33, 3, 6, 577, 2, 6, 218, 6, 28, 211, 29, 1, 9, 181, 7, 1, 10, 12, 1, 1], "PATHOLOGY": "asthma", "RECOVERED": [16, 32, 86, 737, 8919, 213, 50, 75, 7337, 9, 187, 3657, 34, 645, 2581, 814, 34, 508, 8048, 192, 124, 212, 932, 20, 72]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/11.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/11.json
new file mode 100644
index 00000000000..a3e13554190
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/11.json
@@ -0,0 +1 @@
+{"CASES": [143], "DRUG": ["ABACAVIR"], "FATAL": [17], "PATHOLOGY": "acquired immunodeficiency syndrome, hiv infection", "RECOVERED": [1]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/110.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/110.json
new file mode 100644
index 00000000000..cbc64d4cb35
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/110.json
@@ -0,0 +1 @@
+{"CASES": [516], "DRUG": ["TRELEGY ELLIPTA"], "FATAL": [12], "PATHOLOGY": "asthma, chronic obstructive pulmonary disease", "RECOVERED": [77]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/111.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/111.json
new file mode 100644
index 00000000000..b66de10a15f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/111.json
@@ -0,0 +1 @@
+{"CASES": [355], "DRUG": ["NUCALA"], "FATAL": [4], "PATHOLOGY": "asthma, eosinophilic granulomatosis with polyangiitis", "RECOVERED": [39]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/112.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/112.json
new file mode 100644
index 00000000000..ddf1d63b212
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/112.json
@@ -0,0 +1 @@
+{"CASES": [112, 537, 561, 102, 114, 257], "DRUG": ["BEVACIZUMAB", "TEMODAL", "TEMOZOLOMIDE", "AVASTIN", "DABRAFENIB", "AFINITOR"], "FATAL": [14, 56, 34, 3, 3, 3], "PATHOLOGY": "astrocytoma", "RECOVERED": [17, 127, 48, 15, 11, 97]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/113.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/113.json
new file mode 100644
index 00000000000..14c42812fe7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/113.json
@@ -0,0 +1 @@
+{"CASES": [218, 339], "DRUG": ["TEMODAL", "TEMOZOLOMIDE"], "FATAL": [38, 19], "PATHOLOGY": "astrocytoma malignant", "RECOVERED": [49, 21]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/114.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/114.json
new file mode 100644
index 00000000000..d7ebaf7617f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/114.json
@@ -0,0 +1 @@
+{"CASES": [178], "DRUG": ["AFINITOR"], "FATAL": [3], "PATHOLOGY": "astrocytoma, low grade", "RECOVERED": [62]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/115.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/115.json
new file mode 100644
index 00000000000..3e3a1e0b48c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/115.json
@@ -0,0 +1 @@
+{"CASES": [280, 172, 405, 2304, 168, 425, 522, 2861, 430, 14208, 209, 1010, 3185, 166, 529, 227, 158, 1024, 406, 4877, 332, 8236, 335, 359, 231, 2379, 565, 124, 273], "DRUG": ["XARELTO 20 MG FILM-COATED TABLETS", "XARELTO 10 MG", "LIXIANA 30 MG", "PRADAXA", "XARELTO 15 MG FILM-COATED TABLETS", "ENOXAPARIN SODIUM", "ELIQUIS 2.5 MG FILM-COATED TABLETS", "ELIQUIS 5 MG FILM-COATED TABLETS", "CLOPIDOGREL", "ELIQUIS", "LIXIANA 60 MG", "XARELTO 20 MG", "XARELTO", "DABIGATRAN ETEXILATE", "RIVAROXABAN", "LIXIANA 30 MG FILM-COATED TABLETS", "DRONEDARONE", "PLAVIX", "XARELTO 15 MG", "LIXIANA", "CLOPIDOGREL HYDROGEN SULFATE", "MULTAQ", "MULTAQ 400 MG FILM-COATED TABLETS", "LIXIANA 60 MG FILM-COATED TABLETS", "ELIQUIS 5 MG", "APIXABAN", "TIKOSYN", "DOFETILIDE", "EDOXABAN"], "FATAL": [52, 24, 56, 308, 22, 51, 61, 326, 47, 1285, 18, 85, 267, 13, 40, 16, 11, 60, 22, 199, 12, 274, 11, 11, 7, 44, 7, 1, 1], "PATHOLOGY": "atrial fibrillation", "RECOVERED": [151, 45, 123, 673, 88, 136, 213, 1138, 119, 3576, 52, 184, 747, 50, 138, 94, 44, 233, 100, 1411, 102, 2591, 155, 161, 90, 853, 86, 30, 25]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/116.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/116.json
new file mode 100644
index 00000000000..b296ee3c25b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/116.json
@@ -0,0 +1 @@
+{"CASES": [105, 179], "DRUG": ["XARELTO", "XARELTO 20 MG"], "FATAL": [12, 17], "PATHOLOGY": "atrial fibrillation, cerebrovascular accident prophylaxis, thrombosis prophylaxis", "RECOVERED": [23, 30]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/117.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/117.json
new file mode 100644
index 00000000000..f60701320b9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/117.json
@@ -0,0 +1 @@
+{"CASES": [151, 187], "DRUG": ["ELIQUIS", "MULTAQ"], "FATAL": [10, 6], "PATHOLOGY": "atrial flutter", "RECOVERED": [39, 56]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/118.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/118.json
new file mode 100644
index 00000000000..57e94a8e463
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/118.json
@@ -0,0 +1 @@
+{"CASES": [5952, 328], "DRUG": ["SOLIRIS 300 MG", "SOLIRIS"], "FATAL": [467, 18], "PATHOLOGY": "atypical haemolytic uraemic syndrome", "RECOVERED": [961, 49]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/119.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/119.json
new file mode 100644
index 00000000000..7b796edc2fe
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/119.json
@@ -0,0 +1 @@
+{"CASES": [166], "DRUG": ["LEVOFLOXACIN"], "FATAL": [3], "PATHOLOGY": "atypical mycobacterial infection", "RECOVERED": [32]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/12.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/12.json
new file mode 100644
index 00000000000..27ffedb64c4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/12.json
@@ -0,0 +1 @@
+{"CASES": [286, 550], "DRUG": ["OCTREOTIDE", "SOMAVERT"], "FATAL": [4, 1], "PATHOLOGY": "acromegaly", "RECOVERED": [6, 59]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/120.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/120.json
new file mode 100644
index 00000000000..947892540e5
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/120.json
@@ -0,0 +1 @@
+{"CASES": [162, 291, 208], "DRUG": ["ZYPREXA", "OLANZAPINE", "LATUDA"], "FATAL": [6, 8, 2], "PATHOLOGY": "autism spectrum disorder", "RECOVERED": [28, 114, 53]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/121.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/121.json
new file mode 100644
index 00000000000..2e1f744a439
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/121.json
@@ -0,0 +1 @@
+{"CASES": [137], "DRUG": ["CELLCEPT"], "FATAL": [5], "PATHOLOGY": "autoimmune disorder", "RECOVERED": [9]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/122.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/122.json
new file mode 100644
index 00000000000..58f55ba975f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/122.json
@@ -0,0 +1 @@
+{"CASES": [124, 155], "DRUG": ["CICLOSPORIN", "RITUXIMAB"], "FATAL": [31, 17], "PATHOLOGY": "autoimmune haemolytic anaemia", "RECOVERED": [18, 11]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/123.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/123.json
new file mode 100644
index 00000000000..13150d5225d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/123.json
@@ -0,0 +1 @@
+{"CASES": [146, 161], "DRUG": ["AZATHIOPRINE", "CELLCEPT"], "FATAL": [23, 4], "PATHOLOGY": "autoimmune hepatitis", "RECOVERED": [17, 33]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/124.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/124.json
new file mode 100644
index 00000000000..c16ea5ad3b1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/124.json
@@ -0,0 +1 @@
+{"CASES": [114, 372, 113, 153], "DRUG": ["MELPHALAN", "BUSULFAN", "CARMUSTINE", "THIOTEPA"], "FATAL": [16, 51, 10, 5], "PATHOLOGY": "autologous haematopoietic stem cell transplant", "RECOVERED": [17, 48, 33, 56]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/125.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/125.json
new file mode 100644
index 00000000000..4eaea34d345
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/125.json
@@ -0,0 +1 @@
+{"CASES": [351, 636, 368], "DRUG": ["SIMPONI", "CIMZIA", "COSENTYX"], "FATAL": [6, 7, 2], "PATHOLOGY": "axial spondyloarthritis", "RECOVERED": [50, 100, 50]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/126.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/126.json
new file mode 100644
index 00000000000..a1288dd0f40
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/126.json
@@ -0,0 +1 @@
+{"CASES": [363, 287, 447, 1213, 1879, 128, 158, 181], "DRUG": ["BLINATUMOMAB", "DEXAMETHASONE", "BLINCYTO", "ASPARAGINASE", "CYTARABINE", "CLOFARABINE", "MERCAPTOPURINE", "ONCASPAR"], "FATAL": [67, 35, 28, 75, 77, 3, 2, 2], "PATHOLOGY": "b precursor type acute leukaemia", "RECOVERED": [68, 116, 209, 528, 379, 46, 122, 127]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/127.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/127.json
new file mode 100644
index 00000000000..70b9258ec74
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/127.json
@@ -0,0 +1 @@
+{"CASES": [531, 300, 1572, 255, 7972, 331, 223, 187, 734, 8333, 115, 851, 101, 5136, 9245, 1305, 3819, 262, 2912, 2109, 165, 227, 230, 327, 205, 524, 379, 385, 672, 121, 818, 421, 549, 1339, 105, 158], "DRUG": ["FILGRASTIM", "BUSULFAN", "CARMUSTINE", "IBRUTINIB", "KYMRIAH", "TISAGENLECLEUCEL", "YESCARTA 0.4 \u00c3\u00a2\u00c2\u20ac\u00c2\u201c 2 X 10E8 CELLS DISPERSION FOR INFUSION", "KEYTRUDA", "EPCORITAMAB", "YESCARTA", "ASPARAGINASE", "METHOTREXATE", "VENETOCLAX", "CYTARABINE", "RITUXIMAB", "AXICABTAGENE CILOLEUCEL", "DOXORUBICIN HYDROCHLORIDE", "GAZYVARO", "MABTHERA", "DEXAMETHASONE", "NEULASTA", "IMBRUVICA", "PEMBROLIZUMAB", "OBINUTUZUMAB", "POLIVY", "BREYANZI", "KYMRIAH 1.2 X 10^6 \u00c3\u00a2\u00c2\u20ac\u00c2\u201c 6 X 10^8 CELLS DISPERSION FOR INFUSION", "POLATUZUMAB VEDOTIN", "LENALIDOMIDE", "AVASTIN", "PEGFILGRASTIM", "BRUKINSA", "DOXORUBICIN HYDROCHLORIDE, LIPOSOMAL", "CAELYX", "ARZERRA", "RIXATHON"], "FATAL": [128, 60, 264, 33, 955, 38, 23, 19, 74, 811, 11, 80, 9, 450, 809, 113, 307, 21, 205, 143, 11, 14, 14, 19, 11, 28, 16, 15, 26, 4, 23, 8, 8, 19, 1, 1], "PATHOLOGY": "b-cell lymphoma", "RECOVERED": [105, 79, 226, 18, 1601, 98, 155, 25, 286, 2654, 52, 236, 4, 459, 2281, 596, 848, 27, 866, 221, 71, 47, 8, 71, 15, 160, 303, 43, 205, 103, 494, 28, 77, 163, 6, 85]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/128.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/128.json
new file mode 100644
index 00000000000..9c81c7ea8ed
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/128.json
@@ -0,0 +1 @@
+{"CASES": [144, 105], "DRUG": ["RITUXIMAB", "IMBRUVICA"], "FATAL": [5, 1], "PATHOLOGY": "b-cell small lymphocytic lymphoma", "RECOVERED": [33, 22]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/129.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/129.json
new file mode 100644
index 00000000000..de4c0650939
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/129.json
@@ -0,0 +1 @@
+{"CASES": [252, 619, 246, 948, 384, 149, 147], "DRUG": ["ONCASPAR", "KYMRIAH", "BLINATUMOMAB", "CYTARABINE", "ASPARAGINASE", "DEXAMETHASONE", "INOTUZUMAB OZOGAMICIN"], "FATAL": [26, 52, 17, 43, 12, 2, 1], "PATHOLOGY": "b-cell type acute leukaemia", "RECOVERED": [83, 142, 85, 166, 84, 58, 11]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/13.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/13.json
new file mode 100644
index 00000000000..2f8e1773cfa
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/13.json
@@ -0,0 +1 @@
+{"CASES": [158, 559], "DRUG": ["IMIQUIMOD", "ALDARA 5% CREAM"], "FATAL": [2, 1], "PATHOLOGY": "actinic keratosis", "RECOVERED": [87, 259]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/130.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/130.json
new file mode 100644
index 00000000000..847d49a44ff
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/130.json
@@ -0,0 +1 @@
+{"CASES": [318, 512, 104, 218, 1993, 1149, 743], "DRUG": ["PREGABALIN", "FENTANYL", "DULOXETINE HYDROCHLORIDE", "SUBOXONE", "CYMBALTA", "LYRICA", "IBUPROFEN"], "FATAL": [111, 37, 2, 2, 15, 8, 4], "PATHOLOGY": "back pain", "RECOVERED": [57, 74, 22, 54, 500, 212, 182]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/131.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/131.json
new file mode 100644
index 00000000000..e4782f99795
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/131.json
@@ -0,0 +1 @@
+{"CASES": [106, 902, 698], "DRUG": ["AMIKACIN", "CUBICIN", "DAPTOMYCIN"], "FATAL": [30, 128, 56], "PATHOLOGY": "bacteraemia", "RECOVERED": [24, 206, 35]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/132.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/132.json
new file mode 100644
index 00000000000..aab82dd2741
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/132.json
@@ -0,0 +1 @@
+{"CASES": [778, 466], "DRUG": ["AMIKACIN", "LEVOFLOXACIN"], "FATAL": [103, 4], "PATHOLOGY": "bacterial infection", "RECOVERED": [96, 88]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/133.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/133.json
new file mode 100644
index 00000000000..3fc46236c81
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/133.json
@@ -0,0 +1 @@
+{"CASES": [435, 208, 588], "DRUG": ["ALDARA", "ERIVEDGE", "ALDARA 5% CREAM"], "FATAL": [13, 1, 1], "PATHOLOGY": "basal cell carcinoma", "RECOVERED": [149, 8, 248]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/134.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/134.json
new file mode 100644
index 00000000000..f91b8a90c72
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/134.json
@@ -0,0 +1 @@
+{"CASES": [198, 327], "DRUG": ["ZYPREXA", "OLANZAPINE"], "FATAL": [14, 23], "PATHOLOGY": "behaviour disorder", "RECOVERED": [59, 133]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/135.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/135.json
new file mode 100644
index 00000000000..71368678d43
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/135.json
@@ -0,0 +1 @@
+{"CASES": [661], "DRUG": ["CICLOSPORIN"], "FATAL": [41], "PATHOLOGY": "behcet's syndrome", "RECOVERED": [163]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/136.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/136.json
new file mode 100644
index 00000000000..a12e5f911b5
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/136.json
@@ -0,0 +1 @@
+{"CASES": [174, 176, 387], "DRUG": ["SILODOSIN", "CIALIS", "UROREC 8 MG HARD CAPSULES"], "FATAL": [16, 10, 2], "PATHOLOGY": "benign prostatic hyperplasia", "RECOVERED": [60, 28, 153]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/137.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/137.json
new file mode 100644
index 00000000000..61f61a1ab24
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/137.json
@@ -0,0 +1 @@
+{"CASES": [171], "DRUG": ["KEYTRUDA"], "FATAL": [13], "PATHOLOGY": "bile duct cancer", "RECOVERED": [16]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/138.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/138.json
new file mode 100644
index 00000000000..85aea1a5810
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/138.json
@@ -0,0 +1 @@
+{"CASES": [137, 4396, 1319, 890, 5798, 1048, 7179, 207, 2749, 141, 363, 309, 583], "DRUG": ["LOXAPINE", "OLANZAPINE", "ARIPIPRAZOLE", "ZYPREXA COATED TABLETS", "LATUDA", "CYMBALTA", "ZYPREXA", "RISPERIDONE", "ABILIFY", "ZYPREXA VELOTAB", "ZYPADHERA", "BRINTELLIX", "SYCREST"], "FATAL": [36, 211, 55, 28, 167, 28, 186, 5, 44, 2, 5, 4, 7], "PATHOLOGY": "bipolar disorder", "RECOVERED": [22, 1387, 203, 154, 1069, 309, 1391, 93, 584, 17, 210, 57, 229]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/139.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/139.json
new file mode 100644
index 00000000000..eb4a2cac177
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/139.json
@@ -0,0 +1 @@
+{"CASES": [1313, 991, 1002, 266, 325], "DRUG": ["ZYPREXA", "OLANZAPINE", "LATUDA", "SYCREST", "ABILIFY"], "FATAL": [45, 15, 8, 2, 2], "PATHOLOGY": "bipolar i disorder", "RECOVERED": [363, 233, 246, 86, 46]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/14.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/14.json
new file mode 100644
index 00000000000..23600466b95
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/14.json
@@ -0,0 +1 @@
+{"CASES": [585, 2945, 368, 2875, 106, 359, 398, 568, 101], "DRUG": ["CLOPIDOGREL", "PLAVIX", "EFIENT", "BRILIQUE", "INTEGRILIN", "CLOPIDOGREL HYDROGEN SULFATE", "TICAGRELOR", "BRILIQUE 90 MG FILM-COATED TABLETS", "ENOXAPARIN SODIUM"], "FATAL": [62, 281, 35, 262, 8, 24, 26, 23, 4], "PATHOLOGY": "acute coronary syndrome", "RECOVERED": [223, 559, 172, 911, 39, 126, 122, 264, 38]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/140.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/140.json
new file mode 100644
index 00000000000..93618498217
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/140.json
@@ -0,0 +1 @@
+{"CASES": [290, 573, 154], "DRUG": ["ABILIFY", "LATUDA", "CYMBALTA"], "FATAL": [198, 11, 1], "PATHOLOGY": "bipolar ii disorder", "RECOVERED": [12, 92, 24]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/141.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/141.json
new file mode 100644
index 00000000000..2b7c0afb8d6
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/141.json
@@ -0,0 +1 @@
+{"CASES": [118, 142, 1816, 111, 153, 132], "DRUG": ["SUTENT", "METHOTREXATE", "KEYTRUDA", "AVELUMAB", "BAVENCIO", "PEMBROLIZUMAB"], "FATAL": [18, 15, 151, 8, 10, 6], "PATHOLOGY": "bladder cancer", "RECOVERED": [8, 26, 202, 34, 55, 25]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/142.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/142.json
new file mode 100644
index 00000000000..872b52f8658
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/142.json
@@ -0,0 +1 @@
+{"CASES": [181, 879], "DRUG": ["BETMIGA", "TOVIAZ"], "FATAL": [8, 4], "PATHOLOGY": "bladder disorder", "RECOVERED": [45, 108]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/143.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/143.json
new file mode 100644
index 00000000000..8badd4ec505
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/143.json
@@ -0,0 +1 @@
+{"CASES": [656], "DRUG": ["KEYTRUDA"], "FATAL": [60], "PATHOLOGY": "bladder transitional cell carcinoma", "RECOVERED": [148]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/144.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/144.json
new file mode 100644
index 00000000000..d7e886741c6
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/144.json
@@ -0,0 +1 @@
+{"CASES": [160], "DRUG": ["ICLUSIG"], "FATAL": [38], "PATHOLOGY": "blast crisis in myelogenous leukaemia", "RECOVERED": [20]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/145.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/145.json
new file mode 100644
index 00000000000..57c978b8547
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/145.json
@@ -0,0 +1 @@
+{"CASES": [308], "DRUG": ["EXJADE"], "FATAL": [105], "PATHOLOGY": "blood disorder", "RECOVERED": [19]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/146.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/146.json
new file mode 100644
index 00000000000..373a2e845cb
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/146.json
@@ -0,0 +1 @@
+{"CASES": [171, 349, 670, 546, 646, 620, 119, 281, 321, 806, 496], "DRUG": ["GALVUS", "APIDRA", "JANUVIA", "JANUMET", "JARDIANCE", "LANTUS", "VICTOZA", "INSULIN GLARGINE", "GLUCAGON", "HUMALOG", "FORXIGA"], "FATAL": [8, 16, 12, 8, 8, 6, 1, 2, 2, 4, 1], "PATHOLOGY": "blood glucose", "RECOVERED": [25, 95, 114, 105, 155, 155, 52, 84, 60, 169, 116]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/147.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/147.json
new file mode 100644
index 00000000000..c7fa777ec4e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/147.json
@@ -0,0 +1 @@
+{"CASES": [114, 229, 258, 172, 113, 117], "DRUG": ["APIDRA", "JARDIANCE", "JANUVIA", "LANTUS", "GALVUS", "FORXIGA"], "FATAL": [8, 8, 7, 2, 1, 1], "PATHOLOGY": "blood glucose abnormal", "RECOVERED": [32, 47, 49, 74, 12, 23]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/148.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/148.json
new file mode 100644
index 00000000000..02510115480
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/148.json
@@ -0,0 +1 @@
+{"CASES": [317], "DRUG": ["GLUCAGON"], "FATAL": [2], "PATHOLOGY": "blood glucose decreased", "RECOVERED": [56]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/149.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/149.json
new file mode 100644
index 00000000000..e8968708818
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/149.json
@@ -0,0 +1 @@
+{"CASES": [231, 244, 174, 189, 383, 525], "DRUG": ["APIDRA", "JANUVIA", "JANUMET", "INSULIN GLARGINE", "LANTUS", "HUMALOG"], "FATAL": [8, 3, 2, 2, 4, 1], "PATHOLOGY": "blood glucose increased", "RECOVERED": [61, 31, 40, 39, 72, 81]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/15.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/15.json
new file mode 100644
index 00000000000..0eae9bb967d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/15.json
@@ -0,0 +1 @@
+{"CASES": [183, 531, 339, 225, 126, 393], "DRUG": ["ALEMTUZUMAB", "CICLOSPORIN", "JAKAVI", "RUXOLITINIB", "MYCOPHENOLATE MOFETIL", "BUDESONIDE"], "FATAL": [65, 87, 31, 11, 4, 12], "PATHOLOGY": "acute graft versus host disease", "RECOVERED": [9, 46, 28, 14, 11, 24]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/150.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/150.json
new file mode 100644
index 00000000000..25a1b0618b1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/150.json
@@ -0,0 +1 @@
+{"CASES": [839], "DRUG": ["EXJADE"], "FATAL": [133], "PATHOLOGY": "blood iron increased", "RECOVERED": [220]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/151.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/151.json
new file mode 100644
index 00000000000..29558d58eed
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/151.json
@@ -0,0 +1 @@
+{"CASES": [520], "DRUG": ["VELTASSA"], "FATAL": [17], "PATHOLOGY": "blood potassium increased", "RECOVERED": [122]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/152.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/152.json
new file mode 100644
index 00000000000..efcd0ca93ca
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/152.json
@@ -0,0 +1 @@
+{"CASES": [306], "DRUG": ["EXFORGE"], "FATAL": [30], "PATHOLOGY": "blood pressure abnormal", "RECOVERED": [34]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/153.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/153.json
new file mode 100644
index 00000000000..2e74465d2bf
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/153.json
@@ -0,0 +1 @@
+{"CASES": [122], "DRUG": ["EXFORGE"], "FATAL": [4], "PATHOLOGY": "blood pressure increased", "RECOVERED": [24]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/154.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/154.json
new file mode 100644
index 00000000000..5ce971c6984
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/154.json
@@ -0,0 +1 @@
+{"CASES": [521, 195], "DRUG": ["EXFORGE", "MICARDIS"], "FATAL": [22, 2], "PATHOLOGY": "blood pressure measurement", "RECOVERED": [123, 102]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/155.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/155.json
new file mode 100644
index 00000000000..082805ab408
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/155.json
@@ -0,0 +1 @@
+{"CASES": [288], "DRUG": ["TESTOSTERONE"], "FATAL": [10], "PATHOLOGY": "blood testosterone decreased", "RECOVERED": [45]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/156.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/156.json
new file mode 100644
index 00000000000..6d36ad48d1b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/156.json
@@ -0,0 +1 @@
+{"CASES": [106], "DRUG": ["FEBUXOSTAT"], "FATAL": [2], "PATHOLOGY": "blood uric acid increased", "RECOVERED": [21]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/157.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/157.json
new file mode 100644
index 00000000000..7c6813ce656
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/157.json
@@ -0,0 +1 @@
+{"CASES": [357, 312, 458, 1021, 114], "DRUG": ["SUTENT", "VOTRIENT", "XTANDI", "IBRANCE", "FASLODEX"], "FATAL": [62, 44, 38, 37, 2], "PATHOLOGY": "bone cancer", "RECOVERED": [76, 8, 25, 82, 6]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/158.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/158.json
new file mode 100644
index 00000000000..d4b9eb89ab4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/158.json
@@ -0,0 +1 @@
+{"CASES": [124], "DRUG": ["FORSTEO"], "FATAL": [2], "PATHOLOGY": "bone disorder", "RECOVERED": [10]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/159.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/159.json
new file mode 100644
index 00000000000..fec17edb201
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/159.json
@@ -0,0 +1 @@
+{"CASES": [491, 379, 746, 2964, 909, 9215, 446], "DRUG": ["CYTARABINE", "THIOTEPA", "CARMUSTINE", "ALEMTUZUMAB", "MELPHALAN", "BUSULFAN", "BUSILVEX"], "FATAL": [144, 62, 120, 465, 125, 1215, 49], "PATHOLOGY": "bone marrow conditioning regimen", "RECOVERED": [106, 134, 260, 829, 173, 2253, 104]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/16.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/16.json
new file mode 100644
index 00000000000..52e657937f9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/16.json
@@ -0,0 +1 @@
+{"CASES": [609, 627, 2500, 715, 3484, 316, 221, 508, 733, 102, 194, 178, 179, 114, 347, 154, 172], "DRUG": ["BLINATUMOMAB", "DEXAMETHASONE", "ASPARAGINASE", "KYMRIAH", "CYTARABINE", "METHOTREXATE", "CLOFARABINE", "BLINCYTO", "ONCASPAR", "SPRYCEL", "AZACITIDINE", "KYMRIAH 1.2 X 10^6 \u00c3\u00a2\u00c2\u20ac\u00c2\u201c 6 X 10^8 CELLS DISPERSION FOR INFUSION", "PEGASPARGASE", "VENETOCLAX", "MERCAPTOPURINE", "INOTUZUMAB OZOGAMICIN", "DASATINIB"], "FATAL": [84, 66, 217, 62, 260, 19, 13, 28, 36, 5, 7, 6, 6, 2, 3, 1, 1], "PATHOLOGY": "acute leukaemia", "RECOVERED": [153, 220, 808, 177, 645, 78, 73, 210, 412, 16, 16, 142, 49, 2, 195, 11, 16]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/160.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/160.json
new file mode 100644
index 00000000000..a6499c2acbd
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/160.json
@@ -0,0 +1 @@
+{"CASES": [991, 3966, 462, 167, 351], "DRUG": ["BUSULFAN", "CICLOSPORIN", "BUSILVEX", "METHOTREXATE", "CELLCEPT"], "FATAL": [191, 585, 38, 8, 16], "PATHOLOGY": "bone marrow transplant", "RECOVERED": [138, 1154, 121, 40, 49]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/161.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/161.json
new file mode 100644
index 00000000000..af3a0a2e751
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/161.json
@@ -0,0 +1 @@
+{"CASES": [117], "DRUG": ["IBUPROFEN"], "FATAL": [15], "PATHOLOGY": "bone pain", "RECOVERED": [59]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/162.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/162.json
new file mode 100644
index 00000000000..752daee0934
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/162.json
@@ -0,0 +1 @@
+{"CASES": [100], "DRUG": ["ZYPREXA"], "FATAL": [4], "PATHOLOGY": "borderline personality disorder", "RECOVERED": [29]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/163.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/163.json
new file mode 100644
index 00000000000..e1184c5dbe6
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/163.json
@@ -0,0 +1 @@
+{"CASES": [155], "DRUG": ["GLUCAGON"], "FATAL": [126], "PATHOLOGY": "bradycardia", "RECOVERED": [5]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/164.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/164.json
new file mode 100644
index 00000000000..496e43e104b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/164.json
@@ -0,0 +1 @@
+{"CASES": [477, 257, 176], "DRUG": ["MEKINIST", "BRAFTOVI", "DABRAFENIB"], "FATAL": [16, 6, 3], "PATHOLOGY": "braf gene mutation", "RECOVERED": [149, 59, 43]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/165.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/165.json
new file mode 100644
index 00000000000..2c7487318f1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/165.json
@@ -0,0 +1 @@
+{"CASES": [151, 183, 420, 257, 194, 557, 124, 122], "DRUG": ["BEVACIZUMAB", "TEMOZOLOMIDE", "MEKINIST", "AVASTIN", "BRAFTOVI", "TEMODAL", "SUTENT", "AFINITOR"], "FATAL": [23, 23, 52, 22, 16, 39, 6, 1], "PATHOLOGY": "brain neoplasm", "RECOVERED": [4, 24, 13, 1, 38, 135, 60, 15]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/166.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/166.json
new file mode 100644
index 00000000000..4e6a7a12ed3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/166.json
@@ -0,0 +1 @@
+{"CASES": [148, 108, 316, 243, 302], "DRUG": ["BEVACIZUMAB", "BRAFTOVI", "MEKINIST", "AVASTIN", "TEMODAL"], "FATAL": [23, 16, 45, 18, 15], "PATHOLOGY": "brain neoplasm malignant", "RECOVERED": [4, 2, 10, 1, 91]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/167.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/167.json
new file mode 100644
index 00000000000..a59d745680d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/167.json
@@ -0,0 +1 @@
+{"CASES": [148, 233], "DRUG": ["MANNITOL", "DEXAMETHASONE"], "FATAL": [29, 43], "PATHOLOGY": "brain oedema", "RECOVERED": [17, 55]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/168.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/168.json
new file mode 100644
index 00000000000..6f0560351e3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/168.json
@@ -0,0 +1 @@
+{"CASES": [146], "DRUG": ["FENTANYL CITRATE"], "FATAL": [1], "PATHOLOGY": "breakthrough pain", "RECOVERED": [94]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/169.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/169.json
new file mode 100644
index 00000000000..70512d77a68
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/169.json
@@ -0,0 +1 @@
+{"CASES": [200, 1120, 145, 230, 178, 773, 1979, 1092, 819, 139, 584, 6515, 4190, 306, 14428, 733, 668, 1281, 107, 8103, 1472, 4687, 2520, 260, 1590, 1286, 216, 11208, 14280, 4312, 3965, 531, 8653, 20188, 3027, 7128, 109, 778, 544, 1364, 345, 1014, 407, 683, 68385, 583, 339, 292, 148, 104, 1603, 168, 1256, 117, 609, 711, 132, 428, 522, 1089, 1334, 320, 257], "DRUG": ["SUTENT", "DOXORUBICIN HYDROCHLORIDE", "DEXAMETHASONE", "TRODELVY 200 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "VOTRIENT", "ABEMACICLIB", "ABRAXANE", "BEVACIZUMAB", "AVASTIN", "AFINITOR 5 MG TABLETS", "METHOTREXATE", "HALAVEN", "TRODELVY", "HALAVEN 0.44 MG/ML SOLUTION FOR INJECTION", "AFINITOR", "XELODA", "ERIBULIN", "LYNPARZA", "EPIRUBICIN HCL", "FULVESTRANT", "TAXOTERE", "AFINITOR TABLETS", "PERJETA", "KISQALI 200 MG FILM-COATED TABLETS", "CAELYX", "PIQRAY", "ZOMETA", "HERCEPTIN", "DOCETAXEL", "RIBOCICLIB", "CAPECITABINE", "TRASTUZUMAB", "KISQALI", "FASLODEX", "PACLITAXEL", "KEYTRUDA", "ZOLEDRONIC ACID", "FASLODEX 250 MG/5 ML SOLUTION FOR INJECTION", "OLAPARIB", "DENOSUMAB", "AFINITOR 10 MG TABLETS", "PEMBROLIZUMAB", "PALBOCICLIB", "NERLYNX", "IBRANCE", "KADCYLA", "ATEZOLIZUMAB", "DOCETAXEL ACCORD", "CAELYX 2 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION", "KANJINTI", "ALPELISIB", "NERATINIB", "PERTUZUMAB", "FILGRASTIM", "SACITUZUMAB GOVITECAN", "EVEROLIMUS", "BRAFTOVI", "KISQALI 200 MG FILM\u00c3\u00a2\u00c2\u20ac\u00c2\u2018COATED TABLETS", "NEULASTA", "IBRANCE 125 MG", "IBRANCE 125 MG HARD CAPSULES", "KEYTRUDA 25 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION", "IBRANCE 100 MG HARD CAPSULES"], "FATAL": [48, 173, 21, 32, 24, 80, 193, 104, 74, 12, 48, 498, 320, 22, 1005, 45, 36, 66, 5, 372, 67, 213, 107, 10, 60, 48, 8, 397, 477, 141, 128, 17, 277, 642, 93, 200, 3, 21, 14, 32, 8, 23, 9, 15, 1489, 12, 7, 6, 3, 2, 30, 3, 22, 2, 10, 11, 2, 6, 7, 14, 9, 2, 1], "PATHOLOGY": "breast cancer", "RECOVERED": [24, 263, 33, 100, 32, 34, 142, 177, 129, 46, 200, 2167, 748, 110, 2354, 150, 100, 262, 27, 1112, 497, 925, 792, 91, 538, 246, 13, 2738, 3940, 697, 622, 153, 1438, 3163, 735, 1667, 8, 241, 45, 265, 109, 184, 99, 173, 7144, 40, 131, 69, 112, 40, 219, 56, 344, 43, 73, 48, 4, 145, 170, 392, 390, 160, 83]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/17.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/17.json
new file mode 100644
index 00000000000..9e019f9bfa4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/17.json
@@ -0,0 +1 @@
+{"CASES": [280, 148, 200, 13633, 328, 172, 250, 440, 702, 2727, 3410, 245, 115, 528, 1088, 9520, 2177, 147, 631, 6362, 1644, 277, 214, 840, 1089, 165, 3788, 446, 2000, 262], "DRUG": ["CICLOSPORIN", "ALEMTUZUMAB", "PONATINIB", "ASPARAGINASE", "TASIGNA", "DOXORUBICIN HYDROCHLORIDE", "EVOLTRA", "GLIVEC", "CLOFARABINE", "DEXAMETHASONE", "ICLUSIG", "IMATINIB", "EXJADE", "BUSULFAN", "BLINCYTO", "CYTARABINE", "SPRYCEL", "ONCASPAR 750 U/ML SOLUTION FOR INJECTION/INFUSION", "TISAGENLECLEUCEL", "KYMRIAH", "METHOTREXATE", "INOTUZUMAB OZOGAMICIN", "BUSILVEX", "PEGASPARGASE", "BLINATUMOMAB", "BOSULIF", "ONCASPAR", "DASATINIB", "MERCAPTOPURINE", "KYMRIAH 1.2 X 10^6 \u00c3\u00a2\u00c2\u20ac\u00c2\u201c 6 X 10^8 CELLS DISPERSION FOR INFUSION"], "FATAL": [161, 63, 65, 3947, 88, 40, 46, 66, 101, 385, 478, 29, 12, 49, 92, 804, 184, 12, 47, 451, 110, 14, 10, 36, 45, 5, 88, 7, 27, 2], "PATHOLOGY": "acute lymphocytic leukaemia", "RECOVERED": [7, 13, 27, 3252, 45, 15, 62, 146, 127, 718, 494, 61, 30, 77, 197, 2294, 247, 76, 363, 1340, 567, 77, 41, 291, 286, 37, 2302, 99, 496, 234]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/170.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/170.json
new file mode 100644
index 00000000000..5ec360967a1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/170.json
@@ -0,0 +1 @@
+{"CASES": [276, 418, 429, 314, 5289, 566, 315, 19829, 132, 171, 125, 370, 2787], "DRUG": ["HERCEPTIN", "LYNPARZA", "FULVESTRANT", "KISQALI", "FASLODEX", "AFINITOR", "PACLITAXEL", "IBRANCE", "BRAFTOVI", "CAPECITABINE", "IBRANCE 125 MG", "TAXOTERE", "DOCETAXEL"], "FATAL": [37, 26, 18, 13, 169, 18, 7, 312, 2, 2, 1, 1, 7], "PATHOLOGY": "breast cancer female", "RECOVERED": [53, 80, 40, 52, 735, 38, 63, 1409, 4, 6, 55, 221, 793]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/171.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/171.json
new file mode 100644
index 00000000000..54aa6d06eba
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/171.json
@@ -0,0 +1 @@
+{"CASES": [912], "DRUG": ["IBRANCE"], "FATAL": [2], "PATHOLOGY": "breast cancer female, breast cancer metastatic", "RECOVERED": [143]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/172.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/172.json
new file mode 100644
index 00000000000..c24cb6495c2
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/172.json
@@ -0,0 +1 @@
+{"CASES": [308, 156], "DRUG": ["IBRANCE", "FASLODEX"], "FATAL": [8, 3], "PATHOLOGY": "breast cancer male", "RECOVERED": [19, 18]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/173.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/173.json
new file mode 100644
index 00000000000..c8ad00387d9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/173.json
@@ -0,0 +1 @@
+{"CASES": [112, 1113, 1885, 124, 191, 1658, 199, 5269, 118, 188, 337, 3893, 2550, 1821, 3723, 311, 127, 476, 440, 138, 657, 1538, 262, 233, 323, 6739, 183, 515, 195, 569, 737, 131, 36608, 213, 130, 339, 293, 737, 126, 270], "DRUG": ["SUTENT", "ABRAXANE", "HALAVEN", "HALAVEN 0.44 MG/ML SOLUTION FOR INJECTION", "AVASTIN", "DOCETAXEL", "KEYTRUDA", "AFINITOR", "LYNPARZA", "PACLITAXEL", "XELODA", "FULVESTRANT", "HERCEPTIN", "RIBOCICLIB", "KISQALI", "FASLODEX 250 MG/5 ML SOLUTION FOR INJECTION", "TRASTUZUMAB", "PERJETA", "TRODELVY", "KADCYLA", "CAELYX", "CAPECITABINE", "BEVACIZUMAB", "ERIBULIN", "OLAPARIB", "FASLODEX", "IBRANCE 125 MG", "AFINITOR TABLETS", "PALBOCICLIB", "PIQRAY", "DENOSUMAB", "AFINITOR 10 MG TABLETS", "IBRANCE", "PERTUZUMAB", "KISQALI 200 MG FILM\u00c3\u00a2\u00c2\u20ac\u00c2\u2018COATED TABLETS", "EVEROLIMUS", "IBRANCE 125 MG HARD CAPSULES", "ALPELISIB", "IBRANCE 100 MG HARD CAPSULES", "ABEMACICLIB"], "FATAL": [24, 174, 231, 14, 20, 124, 14, 338, 7, 11, 19, 218, 128, 91, 182, 15, 6, 22, 18, 5, 23, 53, 9, 8, 10, 191, 5, 14, 5, 14, 18, 3, 781, 4, 2, 5, 4, 10, 1, 2], "PATHOLOGY": "breast cancer metastatic", "RECOVERED": [18, 46, 443, 52, 30, 496, 34, 923, 27, 19, 70, 465, 604, 257, 634, 86, 42, 163, 116, 11, 145, 218, 20, 32, 9, 1060, 72, 94, 36, 139, 101, 40, 3951, 50, 47, 38, 82, 109, 42, 14]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/174.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/174.json
new file mode 100644
index 00000000000..846b6f513c9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/174.json
@@ -0,0 +1 @@
+{"CASES": [383, 127, 129, 1493, 1875, 749, 1053, 441], "DRUG": ["AFINITOR", "DOCETAXEL", "FULVESTRANT", "HALAVEN", "AFINITOR TABLETS", "FASLODEX", "IBRANCE", "IBRANCE 125 MG"], "FATAL": [40, 10, 10, 97, 107, 34, 36, 3], "PATHOLOGY": "breast cancer recurrent", "RECOVERED": [89, 35, 19, 773, 376, 178, 263, 166]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/175.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/175.json
new file mode 100644
index 00000000000..68f1d71e0e7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/175.json
@@ -0,0 +1 @@
+{"CASES": [251, 150, 118, 143, 189, 143, 2384, 641, 693], "DRUG": ["AFINITOR", "CAPECITABINE", "HALAVEN", "FULVESTRANT", "KISQALI", "RIBOCICLIB", "IBRANCE", "FASLODEX", "DOCETAXEL"], "FATAL": [21, 8, 6, 6, 5, 3, 43, 9, 5], "PATHOLOGY": "breast cancer stage i", "RECOVERED": [61, 10, 30, 14, 43, 43, 337, 91, 181]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/176.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/176.json
new file mode 100644
index 00000000000..e1824d8a25f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/176.json
@@ -0,0 +1 @@
+{"CASES": [532], "DRUG": ["DOCETAXEL"], "FATAL": [2], "PATHOLOGY": "breast cancer stage ii", "RECOVERED": [125]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/177.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/177.json
new file mode 100644
index 00000000000..8d21f04e643
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/177.json
@@ -0,0 +1 @@
+{"CASES": [269], "DRUG": ["DOCETAXEL"], "FATAL": [2], "PATHOLOGY": "breast cancer stage iii", "RECOVERED": [58]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/178.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/178.json
new file mode 100644
index 00000000000..d0d070e4976
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/178.json
@@ -0,0 +1 @@
+{"CASES": [222, 105, 108, 178, 116, 2333, 588], "DRUG": ["AFINITOR", "FULVESTRANT", "HALAVEN", "KISQALI", "RIBOCICLIB", "IBRANCE", "FASLODEX"], "FATAL": [21, 6, 4, 5, 3, 43, 9], "PATHOLOGY": "breast cancer stage iv", "RECOVERED": [61, 14, 28, 40, 38, 327, 83]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/179.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/179.json
new file mode 100644
index 00000000000..b9d64dc861a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/179.json
@@ -0,0 +1 @@
+{"CASES": [198], "DRUG": ["IBRANCE"], "FATAL": [7], "PATHOLOGY": "breast neoplasm", "RECOVERED": [42]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/18.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/18.json
new file mode 100644
index 00000000000..e4266b825da
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/18.json
@@ -0,0 +1 @@
+{"CASES": [234, 160, 110, 572, 2092, 339, 193, 311], "DRUG": ["CYTARABINE", "ICLUSIG", "EVOLTRA", "BLINCYTO", "KYMRIAH", "ASPARAGINASE", "CLOFARABINE", "BLINATUMOMAB"], "FATAL": [86, 32, 19, 49, 155, 24, 8, 8], "PATHOLOGY": "acute lymphocytic leukaemia recurrent", "RECOVERED": [29, 14, 9, 87, 526, 27, 21, 67]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/180.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/180.json
new file mode 100644
index 00000000000..93de5473719
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/180.json
@@ -0,0 +1 @@
+{"CASES": [459, 153, 253, 448, 160, 103, 167, 109], "DRUG": ["ALIMTA", "PEMBROLIZUMAB", "ALIMTA 500 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "KEYTRUDA", "MEKINIST", "PEMETREXED", "TAGRISSO 80 MG FILM-COATED TABLETS", "TAGRISSO"], "FATAL": [77, 12, 19, 28, 8, 3, 2, 1], "PATHOLOGY": "bronchial carcinoma", "RECOVERED": [184, 32, 100, 98, 18, 27, 34, 17]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/181.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/181.json
new file mode 100644
index 00000000000..1fb085c3e09
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/181.json
@@ -0,0 +1 @@
+{"CASES": [206, 2130, 156, 128], "DRUG": ["KETEK", "LEVOFLOXACIN", "TRELEGY ELLIPTA", "INCRUSE ELLIPTA"], "FATAL": [20, 39, 2, 1], "PATHOLOGY": "bronchitis", "RECOVERED": [53, 634, 15, 36]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/182.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/182.json
new file mode 100644
index 00000000000..2e9e0d47910
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/182.json
@@ -0,0 +1 @@
+{"CASES": [151], "DRUG": ["LEVOFLOXACIN"], "FATAL": [13], "PATHOLOGY": "bronchitis chronic", "RECOVERED": [28]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/183.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/183.json
new file mode 100644
index 00000000000..7a871429c46
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/183.json
@@ -0,0 +1 @@
+{"CASES": [104, 204, 195, 197, 152, 177, 243, 280, 1809, 280, 4252, 241, 226], "DRUG": ["NOXAFIL 40 MG/ML ORAL SUSPENSION", "CANCIDAS", "CASPOFUNGIN", "CANCIDAS 50 MG POWDER FOR SOLUTION FOR INFUSION", "VFEND POWDER FOR SOLUTION FOR INFUSION", "CASPOFUNGIN ACETATE", "CRESEMBA", "VFEND FILM-COATED TABLETS", "VORICONAZOLE", "VFEND 200 MG", "VFEND", "POSACONAZOLE", "NOXAFIL"], "FATAL": [60, 94, 69, 66, 43, 46, 30, 34, 195, 26, 328, 11, 10], "PATHOLOGY": "bronchopulmonary aspergillosis", "RECOVERED": [4, 37, 15, 51, 50, 17, 82, 131, 480, 70, 1432, 44, 72]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/184.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/184.json
new file mode 100644
index 00000000000..1b96aa278cc
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/184.json
@@ -0,0 +1 @@
+{"CASES": [142], "DRUG": ["VFEND"], "FATAL": [6], "PATHOLOGY": "bronchopulmonary aspergillosis allergic", "RECOVERED": [56]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/185.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/185.json
new file mode 100644
index 00000000000..efc96d04e84
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/185.json
@@ -0,0 +1 @@
+{"CASES": [612], "DRUG": ["SYNAGIS"], "FATAL": [21], "PATHOLOGY": "bronchopulmonary dysplasia", "RECOVERED": [118]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/186.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/186.json
new file mode 100644
index 00000000000..10f48841ebd
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/186.json
@@ -0,0 +1 @@
+{"CASES": [120, 1469, 233, 231, 283], "DRUG": ["CARMUSTINE", "CYTARABINE", "METHOTREXATE", "DEXAMETHASONE", "RITUXIMAB"], "FATAL": [21, 192, 17, 14, 8], "PATHOLOGY": "burkitt's lymphoma", "RECOVERED": [12, 352, 117, 33, 69]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/187.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/187.json
new file mode 100644
index 00000000000..a840f88b091
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/187.json
@@ -0,0 +1 @@
+{"CASES": [287, 186], "DRUG": ["SOLIRIS 300 MG", "SOLIRIS"], "FATAL": [3, 1], "PATHOLOGY": "c3 glomerulopathy", "RECOVERED": [25, 2]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/188.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/188.json
new file mode 100644
index 00000000000..c4b7251bbba
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/188.json
@@ -0,0 +1 @@
+{"CASES": [137, 443, 251], "DRUG": ["DEXAMETHASONE", "FENTANYL", "BUPRENORPHINE"], "FATAL": [13, 39, 2], "PATHOLOGY": "cancer pain", "RECOVERED": [29, 127, 9]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/189.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/189.json
new file mode 100644
index 00000000000..1d647dd8733
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/189.json
@@ -0,0 +1 @@
+{"CASES": [251, 384, 239, 350, 476, 212], "DRUG": ["MYCAMINE", "CASPOFUNGIN", "CASPOFUNGIN ACETATE", "CANCIDAS", "VFEND", "VORICONAZOLE"], "FATAL": [67, 96, 58, 52, 54, 18], "PATHOLOGY": "candida infection", "RECOVERED": [57, 81, 37, 96, 173, 63]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/19.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/19.json
new file mode 100644
index 00000000000..270c7b19f30
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/19.json
@@ -0,0 +1 @@
+{"CASES": [314], "DRUG": ["KYMRIAH"], "FATAL": [34], "PATHOLOGY": "acute lymphocytic leukaemia refractory", "RECOVERED": [46]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/190.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/190.json
new file mode 100644
index 00000000000..089abea44e7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/190.json
@@ -0,0 +1 @@
+{"CASES": [126, 403], "DRUG": ["SUTENT", "AFINITOR"], "FATAL": [6, 12], "PATHOLOGY": "carcinoid syndrome", "RECOVERED": [28, 18]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/191.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/191.json
new file mode 100644
index 00000000000..5e87193d1de
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/191.json
@@ -0,0 +1 @@
+{"CASES": [215, 1106, 110, 261, 617], "DRUG": ["AFINITOR TABLETS", "AFINITOR", "LUTATHERA", "OCTREOTIDE", "SUTENT"], "FATAL": [45, 190, 16, 25, 46], "PATHOLOGY": "carcinoid tumour", "RECOVERED": [32, 81, 14, 28, 115]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/192.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/192.json
new file mode 100644
index 00000000000..40c862dd2c7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/192.json
@@ -0,0 +1 @@
+{"CASES": [170], "DRUG": ["AFINITOR TABLETS"], "FATAL": [36], "PATHOLOGY": "carcinoid tumour pulmonary", "RECOVERED": [29]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/193.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/193.json
new file mode 100644
index 00000000000..1447f3fef5f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/193.json
@@ -0,0 +1 @@
+{"CASES": [129, 142], "DRUG": ["VYNDAQEL", "TAFAMIDIS MEGLUMINE"], "FATAL": [14, 13], "PATHOLOGY": "cardiac amyloidosis", "RECOVERED": [6, 89]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/194.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/194.json
new file mode 100644
index 00000000000..4f35071abf2
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/194.json
@@ -0,0 +1 @@
+{"CASES": [629, 190, 309, 980, 604, 206], "DRUG": ["REVATIO", "CLOPIDOGREL", "ELIQUIS", "PLAVIX", "ENTRESTO", "JARDIANCE"], "FATAL": [93, 23, 15, 46, 25, 6], "PATHOLOGY": "cardiac disorder", "RECOVERED": [109, 41, 57, 194, 111, 49]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/195.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/195.json
new file mode 100644
index 00000000000..253275a3f95
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/195.json
@@ -0,0 +1 @@
+{"CASES": [120, 175, 569, 279, 595, 173, 550, 467, 350, 301, 454, 248, 18059, 164, 2473, 170, 331, 345, 229, 108, 3602, 504, 967, 1947, 365, 116], "DRUG": ["PROCORALAN", "SAMSCA 7.5 MG", "NEVIRAPINE", "ENTRESTO 24 MG/26 MG", "SAMSCA", "REVATIO", "ALISKIREN", "ELIQUIS", "PLAVIX", "JARDIANCE 10 MG FILM-COATED TABLETS", "BUMETANIDE", "JARDIANCE 10 MG", "ENTRESTO", "TOLVAPTAN", "FORXIGA", "NO TREATMENT RECEIVED", "FORXIGA 10 MG FILM-COATED TABLETS", "ENTRESTO 49 MG/51 MG FILM-COATED TABLETS", "JARDIANCE FILM-COATED TABLETS", "CLOPIDOGREL", "JARDIANCE", "ENTRESTO 24 MG/26 MG FILM-COATED TABLETS", "SPIRONOLACTONE", "VALSARTAN, SACUBITRIL", "EMPAGLIFLOZIN", "ENTRESTO 97 MG/103 MG FILM-COATED TABLETS"], "FATAL": [30, 41, 106, 36, 73, 21, 65, 55, 41, 26, 38, 16, 1082, 9, 135, 9, 17, 16, 10, 4, 119, 15, 24, 40, 7, 2], "PATHOLOGY": "cardiac failure", "RECOVERED": [49, 49, 291, 81, 121, 18, 365, 43, 56, 163, 131, 66, 3763, 61, 737, 92, 130, 148, 77, 7, 1187, 290, 218, 316, 216, 58]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/196.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/196.json
new file mode 100644
index 00000000000..9bf5701eda2
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/196.json
@@ -0,0 +1 @@
+{"CASES": [569, 103, 722, 198, 3867, 119, 265, 278, 190], "DRUG": ["NEVIRAPINE", "SPIRONOLACTONE", "FORXIGA", "SAMSCA", "ENTRESTO", "NO TREATMENT RECEIVED", "JARDIANCE", "VALSARTAN, SACUBITRIL", "EMPAGLIFLOZIN"], "FATAL": [106, 12, 72, 18, 309, 8, 8, 6, 1], "PATHOLOGY": "cardiac failure chronic", "RECOVERED": [291, 11, 239, 27, 850, 57, 99, 28, 141]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/197.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/197.json
new file mode 100644
index 00000000000..d7ce7103b1e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/197.json
@@ -0,0 +1 @@
+{"CASES": [130, 266, 180, 139, 1247, 208, 159], "DRUG": ["PLAVIX", "ELIQUIS", "BUMETANIDE", "REVATIO", "ENTRESTO", "SPIRONOLACTONE", "JARDIANCE"], "FATAL": [25, 39, 25, 11, 72, 8, 2], "PATHOLOGY": "cardiac failure congestive", "RECOVERED": [14, 15, 17, 16, 285, 38, 89]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/198.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/198.json
new file mode 100644
index 00000000000..5963ee5349d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/198.json
@@ -0,0 +1 @@
+{"CASES": [245], "DRUG": ["JARDIANCE"], "FATAL": [6], "PATHOLOGY": "cardiac failure, diabetes mellitus", "RECOVERED": [74]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/199.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/199.json
new file mode 100644
index 00000000000..d892b8147f8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/199.json
@@ -0,0 +1 @@
+{"CASES": [137, 337], "DRUG": ["FORXIGA", "JARDIANCE"], "FATAL": [9, 16], "PATHOLOGY": "cardiac failure, type 2 diabetes mellitus", "RECOVERED": [48, 128]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/2.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/2.json
new file mode 100644
index 00000000000..60a2dd56a8c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/2.json
@@ -0,0 +1 @@
+{"CASES": [116, 291, 105], "DRUG": ["PANTOPRAZOLE", "FENTANYL", "IBUPROFEN"], "FATAL": [5, 7, 2], "PATHOLOGY": "abdominal pain", "RECOVERED": [60, 72, 38]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/20.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/20.json
new file mode 100644
index 00000000000..7eb5ea3d4d8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/20.json
@@ -0,0 +1 @@
+{"CASES": [171], "DRUG": ["CYTARABINE"], "FATAL": [26], "PATHOLOGY": "acute monocytic leukaemia", "RECOVERED": [11]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/200.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/200.json
new file mode 100644
index 00000000000..4e508b76daa
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/200.json
@@ -0,0 +1 @@
+{"CASES": [221], "DRUG": ["PLAVIX"], "FATAL": [7], "PATHOLOGY": "cardiac operation", "RECOVERED": [30]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/201.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/201.json
new file mode 100644
index 00000000000..e23af570685
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/201.json
@@ -0,0 +1 @@
+{"CASES": [112], "DRUG": ["ELIQUIS"], "FATAL": [6], "PATHOLOGY": "cardiac pacemaker insertion", "RECOVERED": [2]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/202.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/202.json
new file mode 100644
index 00000000000..c40a27e15fc
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/202.json
@@ -0,0 +1 @@
+{"CASES": [172], "DRUG": ["RAPISCAN"], "FATAL": [8], "PATHOLOGY": "cardiac stress test", "RECOVERED": [112]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/203.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/203.json
new file mode 100644
index 00000000000..33439e8c6d4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/203.json
@@ -0,0 +1 @@
+{"CASES": [117], "DRUG": ["ELIQUIS"], "FATAL": [2], "PATHOLOGY": "cardiac ventricular thrombosis", "RECOVERED": [7]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/204.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/204.json
new file mode 100644
index 00000000000..95497beb34c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/204.json
@@ -0,0 +1 @@
+{"CASES": [101, 1254], "DRUG": ["SPIRONOLACTONE", "ENTRESTO"], "FATAL": [74, 39], "PATHOLOGY": "cardiomyopathy", "RECOVERED": [15, 268]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/205.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/205.json
new file mode 100644
index 00000000000..6f656dbe554
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/205.json
@@ -0,0 +1 @@
+{"CASES": [233, 359], "DRUG": ["PLAVIX", "ALISKIREN"], "FATAL": [19, 9], "PATHOLOGY": "cardiovascular disorder", "RECOVERED": [55, 203]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/206.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/206.json
new file mode 100644
index 00000000000..922fe5ee1de
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/206.json
@@ -0,0 +1 @@
+{"CASES": [194, 172], "DRUG": ["CLOPIDOGREL", "PLAVIX"], "FATAL": [23, 3], "PATHOLOGY": "cardiovascular event prophylaxis", "RECOVERED": [66, 66]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/207.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/207.json
new file mode 100644
index 00000000000..7b5c4cf211b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/207.json
@@ -0,0 +1 @@
+{"CASES": [171], "DRUG": ["PLAVIX"], "FATAL": [5], "PATHOLOGY": "carotid artery occlusion", "RECOVERED": [33]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/208.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/208.json
new file mode 100644
index 00000000000..48caec90114
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/208.json
@@ -0,0 +1 @@
+{"CASES": [212], "DRUG": ["PLAVIX"], "FATAL": [12], "PATHOLOGY": "carotid artery stenosis", "RECOVERED": [84]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/209.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/209.json
new file mode 100644
index 00000000000..4ba552c0581
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/209.json
@@ -0,0 +1 @@
+{"CASES": [138, 505], "DRUG": ["RITUXIMAB", "SYLVANT"], "FATAL": [17, 40], "PATHOLOGY": "castleman's disease", "RECOVERED": [24, 62]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/21.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/21.json
new file mode 100644
index 00000000000..09ee13e76e2
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/21.json
@@ -0,0 +1 @@
+{"CASES": [168, 162, 485, 104, 901, 220, 402, 745, 544, 3102, 309, 852, 156, 1377, 5629, 879, 5577, 1844, 446, 252, 114, 232, 150, 100, 505, 233, 423, 130, 102], "DRUG": ["EVOLTRA", "VFEND", "EXJADE", "CICLOSPORIN", "CLOFARABINE", "ICLUSIG", "VIDAZA", "NEXAVAR", "RYDAPT", "VENETOCLAX", "ALEMTUZUMAB", "CLADRIBINE", "BUSILVEX", "VENCLYXTO", "AZACITIDINE", "VYXEOS LIPOSOMAL", "CYTARABINE", "BUSULFAN", "DECITABINE", "SORAFENIB", "GILTERITINIB", "SPRYCEL", "CELLCEPT", "TASIGNA", "MIDOSTAURIN", "ASPARAGINASE", "DACOGEN", "BOSULIF", "DEXAMETHASONE"], "FATAL": [71, 51, 141, 26, 212, 40, 68, 118, 82, 403, 40, 106, 19, 164, 669, 99, 574, 171, 36, 20, 8, 16, 10, 6, 30, 10, 12, 3, 2], "PATHOLOGY": "acute myeloid leukaemia", "RECOVERED": [23, 8, 41, 21, 141, 8, 99, 70, 88, 432, 122, 95, 10, 169, 860, 243, 1591, 633, 53, 41, 18, 16, 2, 10, 95, 78, 118, 12, 29]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/210.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/210.json
new file mode 100644
index 00000000000..ea202d6908a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/210.json
@@ -0,0 +1 @@
+{"CASES": [4306], "DRUG": ["XYREM"], "FATAL": [7], "PATHOLOGY": "cataplexy", "RECOVERED": [804]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/211.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/211.json
new file mode 100644
index 00000000000..973a5002d51
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/211.json
@@ -0,0 +1 @@
+{"CASES": [353], "DRUG": ["NEVANAC"], "FATAL": [24], "PATHOLOGY": "cataract", "RECOVERED": [127]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/212.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/212.json
new file mode 100644
index 00000000000..5a59b2dc7c9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/212.json
@@ -0,0 +1 @@
+{"CASES": [319], "DRUG": ["NEVANAC"], "FATAL": [24], "PATHOLOGY": "cataract operation", "RECOVERED": [121]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/213.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/213.json
new file mode 100644
index 00000000000..b4132a7f7f9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/213.json
@@ -0,0 +1 @@
+{"CASES": [213], "DRUG": ["OLANZAPINE"], "FATAL": [25], "PATHOLOGY": "catatonia", "RECOVERED": [58]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/214.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/214.json
new file mode 100644
index 00000000000..bf0ea5a86a3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/214.json
@@ -0,0 +1 @@
+{"CASES": [182], "DRUG": ["PLAVIX"], "FATAL": [4], "PATHOLOGY": "catheterisation cardiac", "RECOVERED": [80]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/215.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/215.json
new file mode 100644
index 00000000000..a0135594072
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/215.json
@@ -0,0 +1 @@
+{"CASES": [168, 443, 228], "DRUG": ["DAPTOMYCIN", "CUBICIN", "LEVOFLOXACIN"], "FATAL": [114, 47, 10], "PATHOLOGY": "cellulitis", "RECOVERED": [17, 140, 128]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/216.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/216.json
new file mode 100644
index 00000000000..952ca2c5019
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/216.json
@@ -0,0 +1 @@
+{"CASES": [101, 295, 266, 458, 178], "DRUG": ["BUSULFAN", "CYTARABINE", "DEXAMETHASONE", "METHOTREXATE", "CARMUSTINE"], "FATAL": [67, 98, 34, 46, 8], "PATHOLOGY": "central nervous system lymphoma", "RECOVERED": [11, 20, 3, 128, 23]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/217.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/217.json
new file mode 100644
index 00000000000..cdf66c6528f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/217.json
@@ -0,0 +1 @@
+{"CASES": [103, 2370, 352, 1681], "DRUG": ["ELIQUIS", "PLAVIX", "CLOPIDOGREL", "CLOPIDOGREL HYDROGEN SULFATE"], "FATAL": [11, 100, 6, 23], "PATHOLOGY": "cerebral infarction", "RECOVERED": [29, 833, 85, 353]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/218.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/218.json
new file mode 100644
index 00000000000..597a4397ef0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/218.json
@@ -0,0 +1 @@
+{"CASES": [138], "DRUG": ["PLAVIX"], "FATAL": [2], "PATHOLOGY": "cerebral ischaemia", "RECOVERED": [43]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/219.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/219.json
new file mode 100644
index 00000000000..f59e9e8b2aa
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/219.json
@@ -0,0 +1 @@
+{"CASES": [101, 439, 426, 3361, 173, 946, 56097, 105, 454, 367, 14807], "DRUG": ["PLAVIX 75 MG FILM-COATED TABLETS", "XARELTO 20 MG", "XARELTO", "PLAVIX", "XARELTO 15 MG", "CLOPIDOGREL", "ELIQUIS", "ELIQUIS 5 MG FILM-COATED TABLETS", "CLOPIDOGREL HYDROGEN SULFATE", "LIXIANA", "APIXABAN"], "FATAL": [12, 42, 38, 267, 11, 60, 3442, 6, 11, 3, 15], "PATHOLOGY": "cerebrovascular accident", "RECOVERED": [54, 75, 75, 607, 37, 301, 7754, 52, 70, 191, 5769]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/22.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/22.json
new file mode 100644
index 00000000000..5ddb53cbfdb
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/22.json
@@ -0,0 +1 @@
+{"CASES": [122, 114, 177, 123], "DRUG": ["NEXAVAR", "VENETOCLAX", "CYTARABINE", "AZACITIDINE"], "FATAL": [24, 22, 31, 12], "PATHOLOGY": "acute myeloid leukaemia recurrent", "RECOVERED": [18, 8, 26, 13]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/220.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/220.json
new file mode 100644
index 00000000000..79e0b98f002
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/220.json
@@ -0,0 +1 @@
+{"CASES": [433, 523, 375, 163, 55485, 186, 242, 262, 14754], "DRUG": ["XARELTO 20 MG", "PLAVIX", "XARELTO", "XARELTO 15 MG", "ELIQUIS", "CLOPIDOGREL", "LIXIANA", "CLOPIDOGREL HYDROGEN SULFATE", "APIXABAN"], "FATAL": [42, 49, 35, 10, 3386, 8, 3, 2, 10], "PATHOLOGY": "cerebrovascular accident prophylaxis", "RECOVERED": [71, 105, 70, 31, 7649, 86, 161, 33, 5743]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/221.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/221.json
new file mode 100644
index 00000000000..bf80f6fc207
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/221.json
@@ -0,0 +1 @@
+{"CASES": [185, 109], "DRUG": ["PLAVIX", "CLOPIDOGREL HYDROGEN SULFATE"], "FATAL": [13, 3], "PATHOLOGY": "cerebrovascular disorder", "RECOVERED": [63, 28]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/222.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/222.json
new file mode 100644
index 00000000000..6eed9bbd828
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/222.json
@@ -0,0 +1 @@
+{"CASES": [300, 100, 1399, 163], "DRUG": ["BEVACIZUMAB", "PEMBROLIZUMAB", "KEYTRUDA", "AVASTIN"], "FATAL": [46, 5, 65, 4], "PATHOLOGY": "cervix carcinoma", "RECOVERED": [92, 9, 270, 49]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/223.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/223.json
new file mode 100644
index 00000000000..cbca449ef6d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/223.json
@@ -0,0 +1 @@
+{"CASES": [292], "DRUG": ["KEYTRUDA"], "FATAL": [13], "PATHOLOGY": "cervix carcinoma stage iv", "RECOVERED": [96]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/224.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/224.json
new file mode 100644
index 00000000000..ecaa3ddcaf4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/224.json
@@ -0,0 +1 @@
+{"CASES": [508], "DRUG": ["EXJADE"], "FATAL": [52], "PATHOLOGY": "chelation therapy", "RECOVERED": [121]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/225.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/225.json
new file mode 100644
index 00000000000..0d1a152f53b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/225.json
@@ -0,0 +1 @@
+{"CASES": [181, 239, 160, 232, 171, 829, 228, 160, 162, 315, 215, 415, 1035, 2048, 508, 1762, 342, 454, 131, 1313, 253, 130, 329, 149, 306, 135, 101, 214], "DRUG": ["CAELYX", "BORTEZOMIB", "TEMOZOLOMIDE", "BUSULFAN", "AZACITIDINE", "CAPECITABINE", "ASPARAGINASE", "ALIMTA", "CLOFARABINE", "BEVACIZUMAB", "MELPHALAN", "METHOTREXATE", "CYTARABINE", "NEULASTA SOLUTION FOR INJECTION, IN A PRE-FILLED PEN", "IRINOTECAN", "NEULASTA", "RITUXIMAB", "DEXAMETHASONE", "NEXAVAR", "DOCETAXEL", "KEYTRUDA", "AVASTIN", "PACLITAXEL", "MERCAPTOPURINE", "DOXORUBICIN HYDROCHLORIDE", "TAXOTERE", "THIOTEPA", "ALEMTUZUMAB"], "FATAL": [141, 81, 31, 36, 26, 118, 32, 20, 15, 21, 14, 25, 60, 113, 28, 92, 17, 22, 5, 50, 8, 4, 10, 3, 5, 2, 1, 1], "PATHOLOGY": "chemotherapy", "RECOVERED": [26, 20, 13, 42, 6, 109, 64, 19, 15, 50, 72, 71, 152, 749, 172, 542, 67, 258, 4, 424, 22, 24, 51, 32, 101, 47, 57, 4]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/226.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/226.json
new file mode 100644
index 00000000000..10bcfd37b85
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/226.json
@@ -0,0 +1 @@
+{"CASES": [102, 158], "DRUG": ["PLAVIX", "CLOPIDOGREL"], "FATAL": [3, 1], "PATHOLOGY": "chest pain", "RECOVERED": [26, 101]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/227.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/227.json
new file mode 100644
index 00000000000..b54736b1c1e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/227.json
@@ -0,0 +1 @@
+{"CASES": [5498, 490], "DRUG": ["OCALIVA", "OBETICHOLIC ACID"], "FATAL": [309, 15], "PATHOLOGY": "cholangitis", "RECOVERED": [866, 46]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/228.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/228.json
new file mode 100644
index 00000000000..37eaef76636
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/228.json
@@ -0,0 +1 @@
+{"CASES": [366], "DRUG": ["METHOTREXATE"], "FATAL": [23], "PATHOLOGY": "choriocarcinoma", "RECOVERED": [71]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/229.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/229.json
new file mode 100644
index 00000000000..70932bdb3e8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/229.json
@@ -0,0 +1 @@
+{"CASES": [140], "DRUG": ["OPDIVO"], "FATAL": [2], "PATHOLOGY": "choroid melanoma", "RECOVERED": [20]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/23.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/23.json
new file mode 100644
index 00000000000..7dacb87932c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/23.json
@@ -0,0 +1 @@
+{"CASES": [195], "DRUG": ["AZACITIDINE"], "FATAL": [7], "PATHOLOGY": "acute myeloid leukaemia refractory", "RECOVERED": [19]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/230.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/230.json
new file mode 100644
index 00000000000..5e270bc84f5
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/230.json
@@ -0,0 +1 @@
+{"CASES": [828, 123], "DRUG": ["EYLEA", "AVASTIN"], "FATAL": [10, 1], "PATHOLOGY": "choroidal neovascularisation", "RECOVERED": [255, 10]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/231.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/231.json
new file mode 100644
index 00000000000..aa83be7f7d8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/231.json
@@ -0,0 +1 @@
+{"CASES": [239], "DRUG": ["EYLEA"], "FATAL": [5], "PATHOLOGY": "choroidal neovascularisation, neovascular age-related macular degeneration", "RECOVERED": [68]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/232.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/232.json
new file mode 100644
index 00000000000..b22456150bd
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/232.json
@@ -0,0 +1 @@
+{"CASES": [112, 196, 214, 700, 274], "DRUG": ["CELLCEPT", "JAKAVI", "MYCOPHENOLATE MOFETIL", "CICLOSPORIN", "RUXOLITINIB"], "FATAL": [41, 38, 15, 38, 4], "PATHOLOGY": "chronic graft versus host disease", "RECOVERED": [25, 8, 7, 82, 49]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/233.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/233.json
new file mode 100644
index 00000000000..30f92acc84c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/233.json
@@ -0,0 +1 @@
+{"CASES": [190, 279, 184, 1050, 102, 375, 856, 146, 425, 1890, 2184, 6079, 663, 133, 1102, 807, 868, 3712, 3735, 674, 246, 170, 144, 1754, 2251, 255, 3967, 25366, 32613, 1443, 431, 6903, 7042, 3432, 2464, 847, 4016, 102, 297, 320], "DRUG": ["EXVIERA 250 MG FILM-COATED TABLETS", "HARVONI 90 MG/400 MG FILM-COATED TABLETS", "PEGASYS 180 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "BARACLUDE", "OLYSIO 150 MG HARD CAPSULES", "VEMLIDY", "INCIVO 375 MG FILM-COATED TABLETS", "EPCLUSA 400 MG/100 MG FILM-COATED TABLETS", "SIMEPREVIR", "EXVIERA", "OLYSIO", "HARVONI", "TENOFOVIR DISOPROXIL FUMARATE", "DAKLINZA 60 MG FILM-COATED TABLETS", "BOCEPREVIR", "ENTECAVIR", "ZEPATIER", "SOVALDI", "EPCLUSA", "SOFOSBUVIR, VELPATASVIR", "SOFOSBUVIR", "PEGASYS 180 MICROGRAMS SOLUTION FOR INJECTION", "MAVIRET", "DAKLINZA", "REBETOL", "BARACLUDE 0.5 MG FILM-COATED TABLETS", "INCIVO", "PEGINTRON", "PEGASYS", "DACLATASVIR", "INTERFERON ALFA-2B", "PEGINTERFERON ALFA-2A", "RIBAVIRIN", "PEGINTERFERON ALFA-2B", "HEPSERA", "VIREAD", "INTRONA", "TELAPREVIR", "ADEFOVIR DIPIVOXIL", "HEPSERA TABLETS"], "FATAL": [27, 35, 23, 94, 9, 32, 62, 10, 26, 110, 120, 331, 36, 7, 53, 38, 40, 166, 164, 26, 9, 6, 5, 60, 77, 8, 120, 708, 861, 29, 7, 94, 87, 41, 27, 9, 42, 1, 1, 1], "PATHOLOGY": "chronic hepatitis", "RECOVERED": [62, 81, 67, 170, 49, 92, 475, 40, 78, 489, 366, 1003, 190, 43, 410, 145, 170, 1071, 608, 106, 38, 60, 40, 252, 624, 46, 1401, 7287, 6887, 197, 114, 2863, 1262, 1292, 433, 157, 270, 39, 36, 24]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/234.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/234.json
new file mode 100644
index 00000000000..2b2fe8ca277
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/234.json
@@ -0,0 +1 @@
+{"CASES": [1016, 373, 663, 792, 248, 2446, 834, 1736, 297, 320], "DRUG": ["BARACLUDE", "VEMLIDY", "TENOFOVIR DISOPROXIL FUMARATE", "ENTECAVIR", "BARACLUDE 0.5 MG FILM-COATED TABLETS", "HEPSERA", "VIREAD", "PEGASYS", "ADEFOVIR DIPIVOXIL", "HEPSERA TABLETS"], "FATAL": [92, 32, 36, 38, 8, 27, 9, 18, 1, 1], "PATHOLOGY": "chronic hepatitis b", "RECOVERED": [168, 92, 190, 145, 44, 423, 157, 425, 36, 24]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/235.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/235.json
new file mode 100644
index 00000000000..edbcc8127d1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/235.json
@@ -0,0 +1 @@
+{"CASES": [190, 163, 279, 100, 851, 142, 425, 1866, 2184, 6049, 133, 1096, 862, 3694, 3718, 674, 162, 2157, 144, 1754, 3869, 24269, 244, 30397, 1431, 404, 6825, 6971, 3327, 3973, 102], "DRUG": ["EXVIERA 250 MG FILM-COATED TABLETS", "PEGASYS 180 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "HARVONI 90 MG/400 MG FILM-COATED TABLETS", "OLYSIO 150 MG HARD CAPSULES", "INCIVO 375 MG FILM-COATED TABLETS", "EPCLUSA 400 MG/100 MG FILM-COATED TABLETS", "SIMEPREVIR", "EXVIERA", "OLYSIO", "HARVONI", "DAKLINZA 60 MG FILM-COATED TABLETS", "BOCEPREVIR", "ZEPATIER", "SOVALDI", "EPCLUSA", "SOFOSBUVIR, VELPATASVIR", "PEGASYS 180 MICROGRAMS SOLUTION FOR INJECTION", "REBETOL", "MAVIRET", "DAKLINZA", "INCIVO", "PEGINTRON", "SOFOSBUVIR", "PEGASYS", "DACLATASVIR", "INTERFERON ALFA-2B", "PEGINTERFERON ALFA-2A", "RIBAVIRIN", "PEGINTERFERON ALFA-2B", "INTRONA", "TELAPREVIR"], "FATAL": [27, 23, 35, 9, 62, 10, 26, 110, 120, 330, 7, 53, 39, 166, 163, 26, 6, 77, 5, 60, 120, 704, 7, 830, 29, 7, 94, 87, 41, 41, 1], "PATHOLOGY": "chronic hepatitis c", "RECOVERED": [62, 55, 81, 49, 474, 39, 78, 480, 366, 998, 43, 409, 170, 1067, 604, 106, 58, 600, 40, 252, 1389, 6979, 38, 6306, 197, 108, 2852, 1244, 1260, 270, 39]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/236.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/236.json
new file mode 100644
index 00000000000..3748dae79f1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/236.json
@@ -0,0 +1 @@
+{"CASES": [294, 405, 1631, 1928, 101], "DRUG": ["KIOVIG", "HUMAN NORMAL IMMUNOGLOBULIN", "HIZENTRA", "PRIVIGEN", "PRIVIGEN SOLUTION FOR INFUSION"], "FATAL": [6, 7, 23, 27, 1], "PATHOLOGY": "chronic inflammatory demyelinating polyradiculoneuropathy", "RECOVERED": [156, 133, 384, 903, 47]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/237.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/237.json
new file mode 100644
index 00000000000..86b87d09268
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/237.json
@@ -0,0 +1 @@
+{"CASES": [171, 102, 167, 3265, 202, 1007], "DRUG": ["MIRCERA", "BINOCRIT", "VELTASSA", "ARANESP", "JARDIANCE", "FORXIGA"], "FATAL": [25, 10, 10, 157, 4, 13], "PATHOLOGY": "chronic kidney disease", "RECOVERED": [37, 56, 5, 448, 44, 350]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/238.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/238.json
new file mode 100644
index 00000000000..ff00e00877e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/238.json
@@ -0,0 +1 @@
+{"CASES": [147], "DRUG": ["FORXIGA"], "FATAL": [2], "PATHOLOGY": "chronic kidney disease, type 2 diabetes mellitus", "RECOVERED": [49]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/239.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/239.json
new file mode 100644
index 00000000000..8fa265ed9bb
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/239.json
@@ -0,0 +1 @@
+{"CASES": [114, 206, 175, 362, 181, 765, 891, 1158, 2219, 318, 2634, 172, 417, 929, 168, 1486, 420, 103, 289, 450, 117, 146, 3040, 2505, 107, 112], "DRUG": ["CLADRIBINE", "DEXAMETHASONE", "EXJADE", "MABCAMPATH", "MABCAMPATH 10 MG/ML", "ALEMTUZUMAB", "ARZERRA", "RITUXIMAB", "VENCLYXTO", "OFATUMUMAB", "VENETOCLAX", "GAZYVARO 1,000 MG CONCENTRATE FOR SOLUTION FOR INFUSION", "MABTHERA", "IBRUTINIB", "CYTARABINE", "OBINUTUZUMAB", "DOXORUBICIN HYDROCHLORIDE", "KIOVIG", "PRIVIGEN", "BRUKINSA", "RIXATHON", "SPRYCEL", "GAZYVARO", "IMBRUVICA", "CALQUENCE", "HIZENTRA"], "FATAL": [47, 72, 48, 77, 37, 138, 122, 145, 269, 31, 251, 15, 36, 68, 12, 90, 25, 6, 14, 20, 5, 5, 104, 63, 1, 1], "PATHOLOGY": "chronic lymphocytic leukaemia", "RECOVERED": [10, 29, 26, 89, 59, 149, 215, 216, 436, 94, 536, 84, 116, 191, 12, 364, 15, 75, 175, 31, 32, 11, 1119, 430, 22, 47]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/24.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/24.json
new file mode 100644
index 00000000000..1897b286ce3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/24.json
@@ -0,0 +1 @@
+{"CASES": [197, 2352, 1209, 473, 229, 1247, 761, 182, 582], "DRUG": ["INTEGRILIN", "BRILIQUE", "PLAVIX", "EFIENT", "ENOXAPARIN SODIUM", "CLOPIDOGREL", "TICAGRELOR", "BRILIQUE 90 MG FILM-COATED TABLETS", "CLOPIDOGREL HYDROGEN SULFATE"], "FATAL": [31, 319, 149, 47, 22, 88, 43, 8, 23], "PATHOLOGY": "acute myocardial infarction", "RECOVERED": [51, 541, 503, 183, 73, 360, 202, 79, 150]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/240.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/240.json
new file mode 100644
index 00000000000..c8b1e6745b0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/240.json
@@ -0,0 +1 @@
+{"CASES": [132], "DRUG": ["VENETOCLAX"], "FATAL": [22], "PATHOLOGY": "chronic lymphocytic leukaemia recurrent", "RECOVERED": [11]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/241.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/241.json
new file mode 100644
index 00000000000..3a9a5c50c15
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/241.json
@@ -0,0 +1 @@
+{"CASES": [115], "DRUG": ["ALEMTUZUMAB"], "FATAL": [3], "PATHOLOGY": "chronic lymphocytic leukaemia refractory", "RECOVERED": [53]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/242.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/242.json
new file mode 100644
index 00000000000..2785e1b731d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/242.json
@@ -0,0 +1 @@
+{"CASES": [130, 149, 117, 8036, 315, 149, 342, 2652, 23709, 943, 108, 1705, 554, 16085, 260, 330, 2305, 2738, 427, 617, 3873, 7882, 253, 1388, 200, 371], "DRUG": ["EXJADE", "CYTARABINE", "ICLUSIG 15 MG FILM-COATED TABLETS", "ICLUSIG", "BUSULFAN", "BOSULIF 100 MG FILM-COATED TABLETS", "PONATINIB", "GLIVEC", "TASIGNA", "SPRYCEL FILM-COATED TABLETS", "SPRYCEL 20 MG FILM-COATED TABLETS", "IMATINIB", "SPRYCEL 50 MG FILM-COATED TABLETS", "SPRYCEL", "TASIGNA 200 MG HARD CAPSULES", "SPRYCEL 70 MG FILM-COATED TABLETS", "DASATINIB", "TASIGNA HARD CAPSULES", "BOSULIF 100 MG", "SCEMBLIX", "NILOTINIB", "BOSULIF", "GLIVEC FILM-COATED TABLETS", "BOSUTINIB", "SPRYCEL 100 MG FILM-COATED TABLETS", "TASIGNA 150 MG HARD CAPSULES"], "FATAL": [41, 25, 16, 965, 34, 14, 24, 176, 1260, 46, 5, 72, 23, 575, 9, 11, 76, 84, 13, 18, 101, 206, 4, 21, 2, 1], "PATHOLOGY": "chronic myeloid leukaemia", "RECOVERED": [11, 24, 41, 1553, 32, 65, 91, 592, 3312, 144, 30, 224, 165, 1987, 105, 103, 289, 648, 131, 126, 506, 1130, 50, 143, 71, 123]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/243.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/243.json
new file mode 100644
index 00000000000..24b46cdd942
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/243.json
@@ -0,0 +1 @@
+{"CASES": [184], "DRUG": ["ICLUSIG"], "FATAL": [26], "PATHOLOGY": "chronic myeloid leukaemia transformation", "RECOVERED": [38]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/244.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/244.json
new file mode 100644
index 00000000000..4383fbb84aa
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/244.json
@@ -0,0 +1 @@
+{"CASES": [180], "DRUG": ["AZACITIDINE"], "FATAL": [79], "PATHOLOGY": "chronic myelomonocytic leukaemia", "RECOVERED": [4]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/245.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/245.json
new file mode 100644
index 00000000000..fd3e04c36a6
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/245.json
@@ -0,0 +1 @@
+{"CASES": [178, 15146, 189, 190, 542, 2818, 1836, 534, 457, 172, 1020, 462, 480, 991, 175, 397, 251, 312, 750], "DRUG": ["REVATIO", "TRELEGY ELLIPTA", "XOLAIR", "ULTIBRO BREEZHALER", "RELVAR ELLIPTA", "INCRUSE ELLIPTA", "ANORO ELLIPTA", "LEVOFLOXACIN", "RELVAR ELLIPTA INHALATION POWDER, PRE-DISPENSED", "VFEND", "BUDESONIDE", "UMECLIDINIUM BROMIDE, FLUTICASONE FUROATE, VILANTEROL", "BEVESPI AEROSPHERE", "ANORO", "NUCALA", "FASENRA", "SEEBRI BREEZHALER", "INCRUSE", "DALIRESP"], "FATAL": [30, 1860, 11, 11, 24, 110, 70, 10, 7, 2, 11, 5, 4, 8, 1, 2, 1, 1, 2], "PATHOLOGY": "chronic obstructive pulmonary disease", "RECOVERED": [9, 1872, 24, 25, 179, 444, 278, 131, 163, 8, 187, 172, 33, 345, 30, 85, 34, 164, 117]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/246.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/246.json
new file mode 100644
index 00000000000..20912a6fb99
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/246.json
@@ -0,0 +1 @@
+{"CASES": [251], "DRUG": ["TRELEGY ELLIPTA"], "FATAL": [3], "PATHOLOGY": "chronic obstructive pulmonary disease, emphysema", "RECOVERED": [16]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/247.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/247.json
new file mode 100644
index 00000000000..0a388d90d04
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/247.json
@@ -0,0 +1 @@
+{"CASES": [175], "DRUG": ["NUCALA"], "FATAL": [1], "PATHOLOGY": "chronic rhinosinusitis with nasal polyps", "RECOVERED": [46]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/248.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/248.json
new file mode 100644
index 00000000000..3d43424cdc8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/248.json
@@ -0,0 +1 @@
+{"CASES": [125], "DRUG": ["LEVOFLOXACIN"], "FATAL": [1], "PATHOLOGY": "chronic sinusitis", "RECOVERED": [30]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/249.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/249.json
new file mode 100644
index 00000000000..5692e02456b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/249.json
@@ -0,0 +1 @@
+{"CASES": [9341, 9937], "DRUG": ["OMALIZUMAB", "XOLAIR"], "FATAL": [111, 17], "PATHOLOGY": "chronic spontaneous urticaria", "RECOVERED": [1209, 1858]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/25.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/25.json
new file mode 100644
index 00000000000..ad6a4e8136a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/25.json
@@ -0,0 +1 @@
+{"CASES": [292, 104, 299, 780], "DRUG": ["CYTARABINE", "MERCAPTOPURINE", "ARSENIC TRIOXIDE", "TRISENOX"], "FATAL": [34, 12, 17, 30], "PATHOLOGY": "acute promyelocytic leukaemia", "RECOVERED": [71, 23, 82, 299]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/250.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/250.json
new file mode 100644
index 00000000000..f16c19480fe
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/250.json
@@ -0,0 +1 @@
+{"CASES": [444], "DRUG": ["XOLAIR"], "FATAL": [1], "PATHOLOGY": "chronic spontaneous urticaria, urticaria", "RECOVERED": [50]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/251.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/251.json
new file mode 100644
index 00000000000..2f0dd76f254
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/251.json
@@ -0,0 +1 @@
+{"CASES": [234, 151, 208, 222, 841, 1093, 3413, 231, 1567, 218, 609, 525, 121, 1022, 274, 146], "DRUG": ["AVELUMAB", "SUTENT 50 MG HARD CAPSULES", "PEMBROLIZUMAB", "OPDIVO", "AXITINIB", "INLYTA", "SUTENT", "AFINITOR", "CABOMETYX", "IPILIMUMAB", "PAZOPANIB", "KEYTRUDA", "SUNITINIB", "VOTRIENT", "NEXAVAR", "EVEROLIMUS"], "FATAL": [24, 10, 13, 11, 34, 44, 122, 8, 54, 7, 18, 14, 3, 22, 2, 1], "PATHOLOGY": "clear cell renal cell carcinoma", "RECOVERED": [25, 63, 22, 22, 168, 160, 926, 21, 276, 26, 78, 91, 27, 212, 84, 8]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/252.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/252.json
new file mode 100644
index 00000000000..92375bfb9e5
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/252.json
@@ -0,0 +1 @@
+{"CASES": [589, 112], "DRUG": ["DIFICLIR", "DIFICLIR 200 MG FILM-COATED TABLETS"], "FATAL": [55, 8], "PATHOLOGY": "clostridium difficile colitis", "RECOVERED": [104, 43]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/253.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/253.json
new file mode 100644
index 00000000000..db41cb112c8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/253.json
@@ -0,0 +1 @@
+{"CASES": [488, 647], "DRUG": ["FIDAXOMICIN", "DIFICLIR"], "FATAL": [43, 46], "PATHOLOGY": "clostridium difficile infection", "RECOVERED": [85, 133]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/254.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/254.json
new file mode 100644
index 00000000000..2098e9ecb78
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/254.json
@@ -0,0 +1 @@
+{"CASES": [208], "DRUG": ["AIMOVIG"], "FATAL": [14], "PATHOLOGY": "cluster headache", "RECOVERED": [36]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/255.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/255.json
new file mode 100644
index 00000000000..8a033507227
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/255.json
@@ -0,0 +1 @@
+{"CASES": [138, 114, 235, 260], "DRUG": ["NOVOSEVEN", "ENOXAPARIN SODIUM", "PLAVIX", "ELIQUIS"], "FATAL": [80, 7, 4, 1], "PATHOLOGY": "coagulopathy", "RECOVERED": [16, 32, 57, 60]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/256.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/256.json
new file mode 100644
index 00000000000..8e0732a90e3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/256.json
@@ -0,0 +1 @@
+{"CASES": [261, 117, 607, 715, 475, 1086, 2133, 266, 152, 1177, 2011, 1761, 342, 2382, 6384, 4759, 310, 889, 2225, 13939, 909, 14336, 565, 2415], "DRUG": ["GANCICLOVIR", "DIFICLIR 200 MG FILM-COATED TABLETS", "DIFICLIR", "CICLOSPORIN", "MERCAPTOPURINE", "ENTYVIO 300 MG", "INFLIXIMAB", "UPADACITINIB", "GOLIMUMAB", "BUDESONIDE", "REMICADE", "AZATHIOPRINE", "ENTYVIO 300 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "RINVOQ", "SIMPONI", "STELARA", "XELJANZ 5 MG", "INFLECTRA", "ADALIMUMAB", "ENTYVIO", "VEDOLIZUMAB", "XELJANZ", "CIMZIA", "HUMIRA"], "FATAL": [64, 11, 55, 30, 15, 32, 58, 7, 3, 20, 33, 26, 5, 32, 79, 50, 3, 8, 16, 91, 5, 67, 2, 2], "PATHOLOGY": "colitis", "RECOVERED": [46, 43, 116, 184, 132, 314, 304, 39, 23, 247, 560, 218, 130, 434, 911, 792, 66, 83, 448, 1983, 135, 1298, 87, 370]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/257.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/257.json
new file mode 100644
index 00000000000..a333ed197b0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/257.json
@@ -0,0 +1 @@
+{"CASES": [330], "DRUG": ["BUDESONIDE"], "FATAL": [10], "PATHOLOGY": "colitis microscopic", "RECOVERED": [106]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/258.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/258.json
new file mode 100644
index 00000000000..315404fcc55
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/258.json
@@ -0,0 +1 @@
+{"CASES": [569, 443, 1083, 255, 202, 134, 1575, 1940, 6190, 2332, 4447, 308, 868, 2141, 13250, 849, 14127, 738, 513, 1880, 2291], "DRUG": ["CICLOSPORIN", "MERCAPTOPURINE", "ENTYVIO 300 MG", "UPADACITINIB", "ENTYVIO 300 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "GOLIMUMAB", "AZATHIOPRINE", "REMICADE", "SIMPONI", "RINVOQ", "STELARA", "XELJANZ 5 MG", "INFLECTRA", "ADALIMUMAB", "ENTYVIO", "VEDOLIZUMAB", "XELJANZ", "BUDESONIDE", "CIMZIA", "INFLIXIMAB", "HUMIRA"], "FATAL": [27, 14, 32, 7, 5, 3, 26, 30, 79, 28, 46, 3, 8, 14, 84, 5, 67, 3, 2, 4, 2], "PATHOLOGY": "colitis ulcerative", "RECOVERED": [175, 114, 314, 36, 78, 14, 206, 554, 865, 424, 740, 66, 80, 406, 1883, 126, 1284, 107, 79, 279, 344]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/259.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/259.json
new file mode 100644
index 00000000000..776f3e6dfbc
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/259.json
@@ -0,0 +1 @@
+{"CASES": [381], "DRUG": ["ENTYVIO"], "FATAL": [1], "PATHOLOGY": "colitis ulcerative, crohn's disease", "RECOVERED": [66]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/26.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/26.json
new file mode 100644
index 00000000000..f44dc8e986b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/26.json
@@ -0,0 +1 @@
+{"CASES": [323, 114], "DRUG": ["OLANZAPINE", "ZYPREXA"], "FATAL": [44, 3], "PATHOLOGY": "acute psychosis", "RECOVERED": [93, 53]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/260.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/260.json
new file mode 100644
index 00000000000..cb727011c69
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/260.json
@@ -0,0 +1 @@
+{"CASES": [280], "DRUG": ["XELJANZ"], "FATAL": [1], "PATHOLOGY": "colitis ulcerative, rheumatoid arthritis", "RECOVERED": [19]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/261.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/261.json
new file mode 100644
index 00000000000..c9d3ca72bd1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/261.json
@@ -0,0 +1 @@
+{"CASES": [5189, 307, 486, 211, 8225, 1225, 129, 1959, 212, 8591, 893, 4571, 168, 205, 2220, 501, 3741, 204, 216, 1929, 1001, 213, 205, 308], "DRUG": ["LONSURF", "ERBITUX 5 MG/ML", "CETUXIMAB", "ZALTRAP", "AVASTIN", "IRINOTECAN", "PEMBROLIZUMAB", "VECTIBIX", "OPDIVO", "STIVARGA", "KEYTRUDA", "BRAFTOVI", "REGORAFENIB", "MVASI", "XELODA", "PANITUMUMAB", "BEVACIZUMAB", "SUTENT", "STIVARGA 40 MG FILM-COATED TABLETS", "CAPECITABINE", "ERBITUX", "CYRAMZA", "AFLIBERCEPT", "AVASTIN 25 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION"], "FATAL": [903, 46, 45, 17, 657, 96, 10, 150, 15, 593, 61, 293, 10, 12, 126, 25, 154, 8, 8, 57, 24, 5, 1, 1], "PATHOLOGY": "colon cancer", "RECOVERED": [684, 74, 79, 74, 2476, 323, 18, 502, 33, 1719, 146, 819, 30, 29, 644, 128, 727, 76, 128, 561, 229, 56, 56, 165]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/262.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/262.json
new file mode 100644
index 00000000000..b45a152622d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/262.json
@@ -0,0 +1 @@
+{"CASES": [324, 112, 2753, 794, 1310, 266, 750, 153, 222, 220, 104, 218], "DRUG": ["BRAFTOVI", "KEYTRUDA", "AVASTIN", "LONSURF", "STIVARGA", "IRINOTECAN", "BEVACIZUMAB", "XELODA", "CAPECITABINE", "ERBITUX", "SUTENT", "VECTIBIX"], "FATAL": [36, 12, 247, 62, 97, 19, 42, 8, 11, 8, 2, 2], "PATHOLOGY": "colon cancer metastatic", "RECOVERED": [52, 11, 903, 214, 250, 51, 138, 49, 103, 38, 28, 98]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/263.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/263.json
new file mode 100644
index 00000000000..4d7e87446e6
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/263.json
@@ -0,0 +1 @@
+{"CASES": [308, 505], "DRUG": ["AVASTIN", "STIVARGA"], "FATAL": [38, 54], "PATHOLOGY": "colon cancer recurrent", "RECOVERED": [113, 127]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/264.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/264.json
new file mode 100644
index 00000000000..b6fc11d32f5
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/264.json
@@ -0,0 +1 @@
+{"CASES": [195], "DRUG": ["CAPECITABINE"], "FATAL": [12], "PATHOLOGY": "colon cancer stage iii", "RECOVERED": [121]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/265.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/265.json
new file mode 100644
index 00000000000..f547fabefd5
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/265.json
@@ -0,0 +1 @@
+{"CASES": [113, 252, 121, 134], "DRUG": ["AVASTIN", "STIVARGA", "IRINOTECAN", "BEVACIZUMAB"], "FATAL": [10, 10, 4, 1], "PATHOLOGY": "colon cancer stage iv", "RECOVERED": [22, 44, 47, 44]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/266.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/266.json
new file mode 100644
index 00000000000..b3bc465ed59
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/266.json
@@ -0,0 +1 @@
+{"CASES": [170], "DRUG": ["STIVARGA"], "FATAL": [30], "PATHOLOGY": "colon cancer, metastases to liver", "RECOVERED": [6]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/267.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/267.json
new file mode 100644
index 00000000000..abc032e39d4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/267.json
@@ -0,0 +1 @@
+{"CASES": [146, 154, 249], "DRUG": ["IRINOTECAN", "BEVACIZUMAB", "AVASTIN"], "FATAL": [17, 10, 14], "PATHOLOGY": "colorectal adenocarcinoma", "RECOVERED": [48, 30, 55]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/268.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/268.json
new file mode 100644
index 00000000000..6952484aaa6
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/268.json
@@ -0,0 +1 @@
+{"CASES": [138, 466, 3384, 9663, 518, 245, 5034, 108, 411, 756, 1201, 3319, 405, 250, 1235, 597, 667, 132, 102, 1258, 114, 419], "DRUG": ["AVASTIN 25 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION", "XELODA", "AVASTIN", "STIVARGA", "CETUXIMAB", "ERBITUX 5 MG/ML", "BEVACIZUMAB", "ATEZOLIZUMAB", "KEYTRUDA", "ERBITUX", "BRAFTOVI", "LONSURF", "REGORAFENIB", "PEMBROLIZUMAB", "VECTIBIX", "PANITUMUMAB", "CAPECITABINE", "STIVARGA 40 MG FILM-COATED TABLETS", "OPDIVO", "IRINOTECAN", "LONSURF 20 MG/8.19 MG", "AFLIBERCEPT"], "FATAL": [16, 47, 331, 930, 46, 21, 381, 8, 29, 53, 78, 187, 16, 9, 44, 21, 21, 4, 3, 27, 2, 4], "PATHOLOGY": "colorectal cancer", "RECOVERED": [64, 141, 842, 1612, 133, 76, 1304, 72, 68, 194, 240, 1127, 107, 68, 208, 88, 172, 58, 16, 355, 48, 142]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/269.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/269.json
new file mode 100644
index 00000000000..bf44a3e16ab
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/269.json
@@ -0,0 +1 @@
+{"CASES": [325, 124, 494, 2483, 100, 4226, 778, 2663, 298, 293, 3210, 186, 461, 916, 956, 110, 351], "DRUG": ["CETUXIMAB", "XELODA", "ERBITUX", "AVASTIN", "ATEZOLIZUMAB", "STIVARGA", "BRAFTOVI", "LONSURF", "REGORAFENIB", "CAPECITABINE", "BEVACIZUMAB", "PEMBROLIZUMAB", "PANITUMUMAB", "VECTIBIX", "IRINOTECAN", "LONSURF 20 MG/8.19 MG", "AFLIBERCEPT"], "FATAL": [37, 13, 43, 202, 8, 287, 50, 135, 13, 12, 128, 6, 14, 23, 23, 2, 4], "PATHOLOGY": "colorectal cancer metastatic", "RECOVERED": [70, 51, 140, 575, 66, 558, 184, 1027, 68, 45, 717, 59, 69, 145, 269, 48, 107]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/27.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/27.json
new file mode 100644
index 00000000000..1cea42c0a6d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/27.json
@@ -0,0 +1 @@
+{"CASES": [106], "DRUG": ["LEVOFLOXACIN"], "FATAL": [3], "PATHOLOGY": "acute sinusitis", "RECOVERED": [31]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/270.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/270.json
new file mode 100644
index 00000000000..8ec80d7d299
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/270.json
@@ -0,0 +1 @@
+{"CASES": [650], "DRUG": ["STIVARGA"], "FATAL": [140], "PATHOLOGY": "colorectal cancer recurrent", "RECOVERED": [130]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/271.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/271.json
new file mode 100644
index 00000000000..70bd272d06b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/271.json
@@ -0,0 +1 @@
+{"CASES": [260], "DRUG": ["STIVARGA"], "FATAL": [18], "PATHOLOGY": "colorectal cancer stage iv", "RECOVERED": [18]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/272.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/272.json
new file mode 100644
index 00000000000..fbd93102ebe
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/272.json
@@ -0,0 +1 @@
+{"CASES": [175], "DRUG": ["HIZENTRA"], "FATAL": [10], "PATHOLOGY": "combined immunodeficiency", "RECOVERED": [28]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/273.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/273.json
new file mode 100644
index 00000000000..a17b2d16ffc
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/273.json
@@ -0,0 +1 @@
+{"CASES": [138], "DRUG": ["LYRICA"], "FATAL": [1], "PATHOLOGY": "complex regional pain syndrome", "RECOVERED": [37]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/274.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/274.json
new file mode 100644
index 00000000000..bede762ba7a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/274.json
@@ -0,0 +1 @@
+{"CASES": [193], "DRUG": ["CICLOSPORIN"], "FATAL": [39], "PATHOLOGY": "complications of transplant surgery", "RECOVERED": [86]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/275.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/275.json
new file mode 100644
index 00000000000..c79f103fad4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/275.json
@@ -0,0 +1 @@
+{"CASES": [293], "DRUG": ["CONTRAST MEDIA"], "FATAL": [2], "PATHOLOGY": "computerised tomogram", "RECOVERED": [8]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/276.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/276.json
new file mode 100644
index 00000000000..5b22399139a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/276.json
@@ -0,0 +1 @@
+{"CASES": [264], "DRUG": ["EXJADE"], "FATAL": [15], "PATHOLOGY": "congenital aplastic anaemia", "RECOVERED": [71]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/277.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/277.json
new file mode 100644
index 00000000000..8483a7a87bd
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/277.json
@@ -0,0 +1 @@
+{"CASES": [148], "DRUG": ["GANCICLOVIR"], "FATAL": [3], "PATHOLOGY": "congenital cytomegalovirus infection", "RECOVERED": [29]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/278.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/278.json
new file mode 100644
index 00000000000..9156c0acb3f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/278.json
@@ -0,0 +1 @@
+{"CASES": [179], "DRUG": ["REVATIO"], "FATAL": [22], "PATHOLOGY": "connective tissue disorder", "RECOVERED": [12]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/279.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/279.json
new file mode 100644
index 00000000000..686c4477f2a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/279.json
@@ -0,0 +1 @@
+{"CASES": [3195, 200, 4656], "DRUG": ["EVRA", "EVRA TRANSDERMAL PATCH", "ELLAONE"], "FATAL": [31, 1, 6], "PATHOLOGY": "contraception", "RECOVERED": [851, 81, 1270]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/28.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/28.json
new file mode 100644
index 00000000000..ec0751cd99f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/28.json
@@ -0,0 +1 @@
+{"CASES": [156, 178, 4597, 101, 818, 196, 1495, 353, 208, 170, 6634, 1572, 214, 10860, 383, 599, 278, 1445, 754, 123, 223, 3236, 1408, 287, 205, 588, 2388, 3554, 2002, 1900, 263, 459, 295, 266, 134, 2297, 553, 161, 144, 956, 255, 587, 800, 728, 450, 259, 261, 205, 105, 434], "DRUG": ["TARCEVA", "GIOTRIF", "IRESSA", "LUMYKRAS", "OSIMERTINIB", "AFLIBERCEPT", "XALKORI", "KEYTRUDA 50 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "CRIZOTINIB", "STIVARGA 40 MG FILM-COATED TABLETS", "ALIMTA", "DOCETAXEL", "ABRAXANE", "KEYTRUDA", "LONSURF", "ALIMTA 500 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "DABRAFENIB", "GEFITINIB", "MEKINIST", "BRAFTOVI", "TAGRISSO 80 MG FILM-COATED TABLETS", "BEVACIZUMAB", "STIVARGA", "ERLOTINIB", "KEYTRUDA 25 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION", "OPDIVO", "CAPECITABINE", "PEMBROLIZUMAB", "AVASTIN", "IRINOTECAN", "PACLITAXEL", "CETUXIMAB", "ATEZOLIZUMAB", "HERCEPTIN", "TEGAFUR, GIMERACIL, OTERACIL POTASSIUM", "PEMETREXED", "ERBITUX", "REGORAFENIB", "TAXOTERE", "TAGRISSO", "AFATINIB", "PEMETREXED DISODIUM", "XELODA", "PANITUMUMAB", "IPILIMUMAB", "MVASI", "CABAZITAXEL", "NIVOLUMAB", "ALECTINIB", "AVASTIN 25 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION"], "FATAL": [31, 29, 695, 12, 90, 19, 144, 34, 20, 16, 603, 141, 19, 879, 30, 46, 21, 107, 50, 8, 14, 200, 84, 17, 11, 31, 121, 179, 101, 95, 13, 22, 14, 12, 6, 103, 21, 6, 5, 29, 7, 16, 17, 15, 6, 3, 3, 2, 1, 2], "PATHOLOGY": "adenocarcinoma", "RECOVERED": [35, 40, 1056, 16, 102, 59, 329, 140, 8, 76, 1837, 389, 27, 2449, 136, 289, 34, 133, 136, 10, 65, 443, 214, 28, 70, 113, 627, 651, 514, 536, 36, 98, 49, 32, 38, 462, 99, 39, 28, 148, 19, 133, 176, 196, 43, 41, 34, 31, 4, 88]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/280.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/280.json
new file mode 100644
index 00000000000..1ba186a125f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/280.json
@@ -0,0 +1 @@
+{"CASES": [122], "DRUG": ["CETROTIDE"], "FATAL": [2], "PATHOLOGY": "controlled ovarian stimulation", "RECOVERED": [60]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/281.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/281.json
new file mode 100644
index 00000000000..423dfee741c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/281.json
@@ -0,0 +1 @@
+{"CASES": [177, 134], "DRUG": ["TRACLEER", "OPSUMIT"], "FATAL": [44, 30], "PATHOLOGY": "cor pulmonale chronic", "RECOVERED": [5, 13]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/282.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/282.json
new file mode 100644
index 00000000000..d19626b3def
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/282.json
@@ -0,0 +1 @@
+{"CASES": [233, 1263, 229, 462], "DRUG": ["CELLCEPT", "CICLOSPORIN", "MELPHALAN", "BUSULFAN"], "FATAL": [112, 295, 52, 44], "PATHOLOGY": "cord blood transplant therapy", "RECOVERED": [8, 277, 14, 91]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/283.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/283.json
new file mode 100644
index 00000000000..e1ed8169450
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/283.json
@@ -0,0 +1 @@
+{"CASES": [104, 506, 168], "DRUG": ["CLOPIDOGREL", "PLAVIX", "BRILIQUE"], "FATAL": [16, 45, 6], "PATHOLOGY": "coronary angioplasty", "RECOVERED": [26, 137, 68]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/284.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/284.json
new file mode 100644
index 00000000000..eb59a8cdc5a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/284.json
@@ -0,0 +1 @@
+{"CASES": [255, 331, 160, 252, 150, 1862], "DRUG": ["CLOPIDOGREL HYDROGEN SULFATE", "CLOPIDOGREL", "TICAGRELOR", "INTEGRILIN", "BRILIQUE", "PLAVIX"], "FATAL": [37, 33, 14, 18, 10, 76], "PATHOLOGY": "coronary arterial stent insertion", "RECOVERED": [74, 92, 16, 11, 52, 388]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/285.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/285.json
new file mode 100644
index 00000000000..88a8ec3e4c9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/285.json
@@ -0,0 +1 @@
+{"CASES": [372], "DRUG": ["PLAVIX"], "FATAL": [15], "PATHOLOGY": "coronary artery bypass", "RECOVERED": [104]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/286.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/286.json
new file mode 100644
index 00000000000..20fc446545b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/286.json
@@ -0,0 +1 @@
+{"CASES": [1804, 164, 2413, 295, 1179, 137, 495], "DRUG": ["CLOPIDOGREL HYDROGEN SULFATE", "ELIQUIS", "PLAVIX", "BRILIQUE", "CLOPIDOGREL", "RANEXA", "TICAGRELOR"], "FATAL": [211, 17, 145, 16, 43, 1, 2], "PATHOLOGY": "coronary artery disease", "RECOVERED": [381, 48, 582, 100, 396, 76, 110]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/287.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/287.json
new file mode 100644
index 00000000000..f9878535b13
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/287.json
@@ -0,0 +1 @@
+{"CASES": [145, 163, 192, 434, 831, 695], "DRUG": ["ROACTEMRA", "REMDESIVIR", "TOCILIZUMAB", "KALETRA 200 MG/50 MG FILM-COATED TABLETS", "KALETRA", "COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)"], "FATAL": [28, 28, 29, 12, 17, 1], "PATHOLOGY": "coronavirus infection", "RECOVERED": [23, 48, 29, 279, 190, 172]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/288.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/288.json
new file mode 100644
index 00000000000..01c266814ff
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/288.json
@@ -0,0 +1 @@
+{"CASES": [133, 482], "DRUG": ["TRELEGY ELLIPTA", "LEVOFLOXACIN"], "FATAL": [2, 2], "PATHOLOGY": "cough", "RECOVERED": [15, 90]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/289.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/289.json
new file mode 100644
index 00000000000..0850ab34087
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/289.json
@@ -0,0 +1 @@
+{"CASES": [1090, 1388, 3029, 3501, 945, 1339, 176, 137, 728, 111, 1196, 707, 3564, 1397, 632, 845993, 2279869, 5677, 1368, 4867, 524137, 889, 280338, 587, 5838, 212, 544255, 602, 51435, 417, 560, 2122], "DRUG": ["ROACTEMRA", "DEXAMETHASONE", "REMDESIVIR", "VEKLURY", "TOCILIZUMAB", "KALETRA", "ENOXAPARIN SODIUM", "LEVOFLOXACIN", "EVUSHELD", "COMIRNATY 30 MICROGRAMS/DOSE DISPERSION FOR INJECTION", "LOPINAVIR, RITONAVIR", "COMIRNATY ORIGINAL/OMICRON BA.1", "COMIRNATY CONCENTRATE FOR DISPERSION FOR INJECTION", "COVID-19 VACCINE JANSSEN (AD26.COV2.S)", "JCOVDEN", "SPIKEVAX", "COMIRNATY", "COMIRNATY COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED)", "COMIRNATY COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED) CONCENTRATE FOR DISPERSION FOR INJECTION", "COMIRNATY ORIGINAL/OMICRON BA.4-5", "TOZINAMERAN", "ELASOMERAN", "VAXZEVRIA", "COMIRNATY 30 MICROGRAMS/DOSE", "COMIRNATY CONCENTRATE FOR DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED)", "COMIRNATY OMICRON XBB.1.5", "COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)", "COMIRNATY 30 MICROGRAMS/DOSE DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED)", "COVID-19 MRNA VACCINE MODERNA (CX-024414)", "SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.1", "SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5", "SPIKEVAX COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED)"], "FATAL": [290, 337, 666, 583, 113, 95, 11, 8, 37, 3, 30, 14, 70, 18, 8, 9836, 21866, 51, 11, 35, 3589, 6, 1733, 3, 28, 1, 1911, 2, 151, 1, 1, 3], "PATHOLOGY": "covid-19", "RECOVERED": [128, 221, 636, 878, 175, 385, 46, 61, 202, 20, 230, 203, 1877, 215, 156, 284831, 763204, 1782, 652, 758, 114182, 367, 134715, 156, 1171, 33, 235322, 77, 17287, 182, 84, 803]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/29.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/29.json
new file mode 100644
index 00000000000..ccebd415c16
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/29.json
@@ -0,0 +1 @@
+{"CASES": [480, 557, 165, 192], "DRUG": ["CAPECITABINE", "DOCETAXEL", "XELODA", "HERCEPTIN"], "FATAL": [55, 37, 8, 7], "PATHOLOGY": "adenocarcinoma gastric", "RECOVERED": [137, 159, 30, 13]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/290.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/290.json
new file mode 100644
index 00000000000..491d7076874
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/290.json
@@ -0,0 +1 @@
+{"CASES": [2628, 701, 981, 791277, 981, 569, 2259395, 4830, 524020, 273491, 190, 587, 210, 4546, 5565, 581, 536086, 51024, 857, 1900], "DRUG": ["COMIRNATY CONCENTRATE FOR DISPERSION FOR INJECTION", "COMIRNATY ORIGINAL/OMICRON BA.1", "COVID-19 VACCINE JANSSEN (AD26.COV2.S)", "SPIKEVAX", "COMIRNATY COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED) CONCENTRATE FOR DISPERSION FOR INJECTION", "JCOVDEN", "COMIRNATY", "COMIRNATY ORIGINAL/OMICRON BA.4-5", "TOZINAMERAN", "VAXZEVRIA", "SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.1", "COMIRNATY 30 MICROGRAMS/DOSE", "COMIRNATY OMICRON XBB.1.5", "COMIRNATY COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED)", "COMIRNATY CONCENTRATE FOR DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED)", "COMIRNATY 30 MICROGRAMS/DOSE DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED)", "COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)", "COVID-19 MRNA VACCINE MODERNA (CX-024414)", "ELASOMERAN", "SPIKEVAX COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED)"], "FATAL": [63, 14, 17, 8945, 11, 6, 21674, 35, 3589, 1601, 1, 3, 1, 21, 25, 2, 1848, 151, 2, 3], "PATHOLOGY": "covid-19 immunisation", "RECOVERED": [1493, 203, 172, 273333, 452, 152, 754185, 756, 114165, 132559, 62, 156, 31, 1419, 971, 77, 232017, 17181, 360, 699]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/291.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/291.json
new file mode 100644
index 00000000000..477cb08ac4a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/291.json
@@ -0,0 +1 @@
+{"CASES": [348, 535, 327, 600, 285, 416, 420], "DRUG": ["ROACTEMRA", "REMDESIVIR", "DEXAMETHASONE", "VEKLURY", "TOCILIZUMAB", "KALETRA", "LOPINAVIR, RITONAVIR"], "FATAL": [128, 123, 69, 88, 19, 8, 2], "PATHOLOGY": "covid-19 pneumonia", "RECOVERED": [56, 116, 54, 158, 40, 145, 64]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/292.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/292.json
new file mode 100644
index 00000000000..a5e919072de
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/292.json
@@ -0,0 +1 @@
+{"CASES": [498, 3380, 495, 53484, 264, 14756, 4768, 669, 416], "DRUG": ["EVUSHELD", "VAXZEVRIA", "COMIRNATY COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED)", "SPIKEVAX", "COMIRNATY CONCENTRATE FOR DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED)", "COMIRNATY", "COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)", "COMIRNATY CONCENTRATE FOR DISPERSION FOR INJECTION", "COVID-19 VACCINE JANSSEN (AD26.COV2.S)"], "FATAL": [29, 74, 10, 879, 3, 159, 42, 2, 1], "PATHOLOGY": "covid-19 prophylaxis", "RECOVERED": [132, 1097, 98, 11136, 194, 6917, 1969, 237, 43]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/293.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/293.json
new file mode 100644
index 00000000000..81485c45d3c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/293.json
@@ -0,0 +1 @@
+{"CASES": [236, 951, 299, 280, 135, 1109, 117, 1922, 789, 301, 3007, 11830, 1459, 23346, 580, 298, 11537, 840, 943, 762, 5204, 542, 640, 26562], "DRUG": ["CICLOSPORIN", "MERCAPTOPURINE", "METHOTREXATE", "ENTYVIO 300 MG", "STELARA 90 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "AZATHIOPRINE", "HUMIRA 40 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "INFLIXIMAB", "VEDOLIZUMAB", "UPADACITINIB", "REMICADE", "CIMZIA", "RINVOQ", "STELARA", "SKYRIZI", "ENTYVIO 300 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "ENTYVIO", "SIMPONI", "BUDESONIDE", "INFLECTRA", "HUMIRA", "USTEKINUMAB", "XELJANZ", "ADALIMUMAB"], "FATAL": [28, 89, 15, 13, 6, 42, 4, 59, 17, 6, 55, 165, 20, 283, 4, 2, 62, 4, 3, 2, 11, 1, 1, 35], "PATHOLOGY": "crohn's disease", "RECOVERED": [15, 231, 63, 76, 40, 103, 21, 412, 140, 41, 772, 2648, 241, 3204, 98, 113, 1863, 88, 181, 95, 1000, 177, 32, 1862]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/294.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/294.json
new file mode 100644
index 00000000000..157356cbd4d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/294.json
@@ -0,0 +1 @@
+{"CASES": [223, 567, 212], "DRUG": ["PASIREOTIDE", "SIGNIFOR", "ISTURISA"], "FATAL": [5, 12, 1], "PATHOLOGY": "cushing's syndrome", "RECOVERED": [63, 161, 33]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/295.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/295.json
new file mode 100644
index 00000000000..ea1dae26d7f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/295.json
@@ -0,0 +1 @@
+{"CASES": [824, 127, 113], "DRUG": ["POTELIGEO", "PEGASYS", "CAELYX"], "FATAL": [39, 4, 2], "PATHOLOGY": "cutaneous t-cell lymphoma", "RECOVERED": [174, 34, 46]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/296.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/296.json
new file mode 100644
index 00000000000..0c0f6630acd
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/296.json
@@ -0,0 +1 @@
+{"CASES": [197, 355, 12725, 3512, 6863, 212, 108, 230, 886], "DRUG": ["COLOBREATHE", "TOBI PODHALER", "KAFTRIO", "KALYDECO", "ORKAMBI", "IVACAFTOR", "QUINSAIR", "TOBRAMYCIN", "KAFTRIO 75 MG/50 MG/100 MG FILM-COATED TABLETS"], "FATAL": [10, 8, 229, 59, 69, 2, 1, 2, 3], "PATHOLOGY": "cystic fibrosis", "RECOVERED": [21, 89, 2666, 588, 1412, 98, 55, 88, 343]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/297.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/297.json
new file mode 100644
index 00000000000..631ba61dca3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/297.json
@@ -0,0 +1 @@
+{"CASES": [245, 899], "DRUG": ["ELMIRON", "LEVOFLOXACIN"], "FATAL": [5, 4], "PATHOLOGY": "cystitis", "RECOVERED": [47, 248]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/298.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/298.json
new file mode 100644
index 00000000000..2ff034eaee3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/298.json
@@ -0,0 +1 @@
+{"CASES": [237], "DRUG": ["ELMIRON"], "FATAL": [5], "PATHOLOGY": "cystitis interstitial", "RECOVERED": [47]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/299.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/299.json
new file mode 100644
index 00000000000..ee75e18f1de
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/299.json
@@ -0,0 +1 @@
+{"CASES": [113], "DRUG": ["EYLEA"], "FATAL": [2], "PATHOLOGY": "cystoid macular oedema", "RECOVERED": [25]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/3.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/3.json
new file mode 100644
index 00000000000..6d99f1ce5fb
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/3.json
@@ -0,0 +1 @@
+{"CASES": [387], "DRUG": ["METHOTREXATE"], "FATAL": [19], "PATHOLOGY": "abortion", "RECOVERED": [40]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/30.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/30.json
new file mode 100644
index 00000000000..39646cbb7f3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/30.json
@@ -0,0 +1 @@
+{"CASES": [102, 166, 203, 148, 880, 290, 1190, 792, 231, 368, 748, 371, 290, 337, 195], "DRUG": ["STIVARGA 40 MG FILM-COATED TABLETS", "AFLIBERCEPT", "CETUXIMAB", "KEYTRUDA", "STIVARGA", "PANITUMUMAB", "BEVACIZUMAB", "AVASTIN", "LONSURF", "ERBITUX", "CAPECITABINE", "IRINOTECAN", "XELODA", "AVASTIN 25 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION", "MVASI"], "FATAL": [16, 19, 16, 10, 54, 15, 53, 34, 9, 13, 26, 6, 3, 2, 1], "PATHOLOGY": "adenocarcinoma of colon", "RECOVERED": [44, 55, 40, 18, 136, 45, 153, 207, 86, 56, 196, 106, 69, 53, 30]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/300.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/300.json
new file mode 100644
index 00000000000..52c82b54cbb
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/300.json
@@ -0,0 +1 @@
+{"CASES": [113, 183], "DRUG": ["ROACTEMRA", "TOCILIZUMAB"], "FATAL": [17, 8], "PATHOLOGY": "cytokine release syndrome", "RECOVERED": [62, 23]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/301.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/301.json
new file mode 100644
index 00000000000..446626b07e3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/301.json
@@ -0,0 +1 @@
+{"CASES": [646], "DRUG": ["GANCICLOVIR"], "FATAL": [65], "PATHOLOGY": "cytomegalovirus chorioretinitis", "RECOVERED": [118]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/302.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/302.json
new file mode 100644
index 00000000000..de29b1a366f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/302.json
@@ -0,0 +1 @@
+{"CASES": [176], "DRUG": ["GANCICLOVIR"], "FATAL": [51], "PATHOLOGY": "cytomegalovirus colitis", "RECOVERED": [28]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/303.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/303.json
new file mode 100644
index 00000000000..2df5a070854
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/303.json
@@ -0,0 +1 @@
+{"CASES": [178, 265, 2749], "DRUG": ["LIVTENCITY", "CIDOFOVIR", "GANCICLOVIR"], "FATAL": [20, 28, 278], "PATHOLOGY": "cytomegalovirus infection", "RECOVERED": [3, 57, 615]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/304.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/304.json
new file mode 100644
index 00000000000..15a6434fe90
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/304.json
@@ -0,0 +1 @@
+{"CASES": [249], "DRUG": ["GANCICLOVIR"], "FATAL": [15], "PATHOLOGY": "cytomegalovirus infection reactivation", "RECOVERED": [76]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/305.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/305.json
new file mode 100644
index 00000000000..f738ac3a724
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/305.json
@@ -0,0 +1 @@
+{"CASES": [671], "DRUG": ["GANCICLOVIR"], "FATAL": [44], "PATHOLOGY": "cytomegalovirus viraemia", "RECOVERED": [106]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/306.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/306.json
new file mode 100644
index 00000000000..db3b5582345
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/306.json
@@ -0,0 +1 @@
+{"CASES": [190, 274, 1072, 1058, 223, 241, 122, 7686, 368, 197, 252], "DRUG": ["ARIXTRA", "XARELTO 20 MG", "ENOXAPARIN SODIUM", "XARELTO", "XARELTO 15 MG", "ELIQUIS 5 MG FILM-COATED TABLETS", "RIVAROXABAN", "ELIQUIS", "LIXIANA", "PLAVIX", "APIXABAN"], "FATAL": [72, 49, 62, 57, 12, 11, 5, 282, 11, 5, 5], "PATHOLOGY": "deep vein thrombosis", "RECOVERED": [38, 37, 355, 200, 30, 90, 46, 913, 107, 29, 179]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/307.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/307.json
new file mode 100644
index 00000000000..b3c6736fde8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/307.json
@@ -0,0 +1 @@
+{"CASES": [854], "DRUG": ["ELIQUIS"], "FATAL": [25], "PATHOLOGY": "deep vein thrombosis, pulmonary embolism", "RECOVERED": [86]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/308.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/308.json
new file mode 100644
index 00000000000..3b647952e19
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/308.json
@@ -0,0 +1 @@
+{"CASES": [238, 191], "DRUG": ["ZYPREXA", "OLANZAPINE"], "FATAL": [57, 13], "PATHOLOGY": "delirium", "RECOVERED": [51, 51]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/309.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/309.json
new file mode 100644
index 00000000000..2c40ce3f173
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/309.json
@@ -0,0 +1 @@
+{"CASES": [130, 825, 577], "DRUG": ["ABILIFY", "ZYPREXA", "OLANZAPINE"], "FATAL": [26, 30, 5], "PATHOLOGY": "delusion", "RECOVERED": [29, 187, 236]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/31.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/31.json
new file mode 100644
index 00000000000..b2b12cba5c4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/31.json
@@ -0,0 +1 @@
+{"CASES": [114, 629], "DRUG": ["ABRAXANE", "IRINOTECAN"], "FATAL": [10, 31], "PATHOLOGY": "adenocarcinoma pancreas", "RECOVERED": [3, 217]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/310.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/310.json
new file mode 100644
index 00000000000..12b9adf3e9e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/310.json
@@ -0,0 +1 @@
+{"CASES": [134, 126], "DRUG": ["ZYPREXA", "OLANZAPINE"], "FATAL": [7, 2], "PATHOLOGY": "delusional disorder, unspecified type", "RECOVERED": [53, 34]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/311.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/311.json
new file mode 100644
index 00000000000..f8c4d315b81
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/311.json
@@ -0,0 +1 @@
+{"CASES": [1784, 141, 118, 1060, 192, 652, 722, 1104, 402], "DRUG": ["MEMANTINE HYDROCHLORIDE", "AXURA", "RIVASTIGMINE", "EXELON", "EBIXA 10 MG FILM-COATED TABLETS", "EBIXA FILM-COATED TABLETS", "ZYPREXA", "EBIXA", "OLANZAPINE"], "FATAL": [182, 14, 11, 90, 16, 53, 52, 34, 8], "PATHOLOGY": "dementia", "RECOVERED": [599, 64, 32, 368, 122, 259, 204, 504, 153]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/312.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/312.json
new file mode 100644
index 00000000000..53061daa83c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/312.json
@@ -0,0 +1 @@
+{"CASES": [1129, 489, 164, 882, 245, 877, 171], "DRUG": ["MEMANTINE HYDROCHLORIDE", "EBIXA FILM-COATED TABLETS", "EBIXA 10 MG FILM-COATED TABLETS", "EXELON", "ZYPREXA", "EBIXA", "OLANZAPINE"], "FATAL": [114, 48, 14, 60, 14, 25, 1], "PATHOLOGY": "dementia alzheimer's type", "RECOVERED": [353, 187, 103, 300, 91, 383, 68]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/313.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/313.json
new file mode 100644
index 00000000000..8934c46912f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/313.json
@@ -0,0 +1 @@
+{"CASES": [129], "DRUG": ["PRIVIGEN"], "FATAL": [1], "PATHOLOGY": "demyelinating polyneuropathy", "RECOVERED": [79]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/314.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/314.json
new file mode 100644
index 00000000000..05085bae219
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/314.json
@@ -0,0 +1 @@
+{"CASES": [5554, 19193, 9548, 204, 1726, 386, 1736], "DRUG": ["BUPRENORPHINE", "SUBOXONE", "SUBOXONE SUBLINGUAL FILM", "SUBOXONE SUBLINGUAL TABLETS", "BUPRENORPHINE, NALOXONE", "BUVIDAL", "CHAMPIX"], "FATAL": [354, 751, 213, 4, 30, 6, 24], "PATHOLOGY": "dependence", "RECOVERED": [3052, 8893, 4765, 149, 568, 136, 765]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/315.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/315.json
new file mode 100644
index 00000000000..8492f66b3fd
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/315.json
@@ -0,0 +1 @@
+{"CASES": [293], "DRUG": ["CYMBALTA"], "FATAL": [3], "PATHOLOGY": "depressed mood", "RECOVERED": [60]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/316.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/316.json
new file mode 100644
index 00000000000..79ff506042e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/316.json
@@ -0,0 +1 @@
+{"CASES": [258, 223, 402, 902, 124, 3418, 404, 300, 186, 2939, 4614, 626, 677, 491, 1945, 1224, 44487, 446, 12151, 540, 165, 365, 1285, 1863, 679], "DRUG": ["MIDAZOLAM", "LYRICA", "VALDOXAN 25 MG", "DULOXETINE HYDROCHLORIDE", "PREGABALIN", "OLANZAPINE", "ZYPREXA COATED TABLETS", "VALDOXAN", "NOT AVAILABLE", "ABILIFY", "ZYPREXA", "VORTIOXETINE", "CYMBALTA 30 MG HARD GASTRO-RESISTANT CAPSULES", "RISPERIDONE", "ARIPIPRAZOLE", "LATUDA", "CYMBALTA", "CYMBALTA 60 MG", "BRINTELLIX", "CYMBALTA 60 MG HARD GASTRO-RESISTANT CAPSULES", "SERTRALINE HCL", "CYMBALTA 30 MG", "BRINTELLIX 10 MG FILM-COATED TABLETS", "DULOXETINE", "BRINTELLIX 5 MG FILM-COATED TABLETS"], "FATAL": [112, 22, 32, 66, 9, 181, 20, 14, 7, 94, 142, 12, 12, 8, 31, 18, 605, 5, 135, 4, 1, 2, 5, 7, 2], "PATHOLOGY": "depression", "RECOVERED": [72, 32, 226, 279, 30, 1154, 49, 121, 50, 592, 1135, 202, 281, 132, 280, 225, 8065, 31, 3509, 263, 54, 64, 471, 878, 224]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/317.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/317.json
new file mode 100644
index 00000000000..c10928605bb
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/317.json
@@ -0,0 +1 @@
+{"CASES": [125, 134], "DRUG": ["CYMBALTA", "BRINTELLIX"], "FATAL": [27, 4], "PATHOLOGY": "depressive symptom", "RECOVERED": [35, 22]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/318.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/318.json
new file mode 100644
index 00000000000..82ffdf84441
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/318.json
@@ -0,0 +1 @@
+{"CASES": [800, 269, 108, 496, 1469, 3662], "DRUG": ["CICLOSPORIN", "DUPILUMAB", "PROTOPIC", "UPADACITINIB", "DUPIXENT", "RINVOQ"], "FATAL": [13, 3, 1, 4, 11, 12], "PATHOLOGY": "dermatitis", "RECOVERED": [170, 39, 18, 50, 105, 678]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/319.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/319.json
new file mode 100644
index 00000000000..c715f3431a5
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/319.json
@@ -0,0 +1 @@
+{"CASES": [664, 264, 103, 1332, 490, 3636], "DRUG": ["CICLOSPORIN", "DUPILUMAB", "PROTOPIC", "DUPIXENT", "UPADACITINIB", "RINVOQ"], "FATAL": [8, 3, 1, 11, 4, 12], "PATHOLOGY": "dermatitis atopic", "RECOVERED": [135, 39, 17, 104, 49, 676]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/32.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/32.json
new file mode 100644
index 00000000000..ceaf8109683
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/32.json
@@ -0,0 +1 @@
+{"CASES": [333], "DRUG": ["CIDOFOVIR"], "FATAL": [28], "PATHOLOGY": "adenovirus infection", "RECOVERED": [68]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/320.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/320.json
new file mode 100644
index 00000000000..263a8a3e8da
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/320.json
@@ -0,0 +1 @@
+{"CASES": [105, 108, 548, 169, 213, 156, 374], "DRUG": ["TACROLIMUS", "AZATHIOPRINE", "CICLOSPORIN", "HUMAN NORMAL IMMUNOGLOBULIN", "XELJANZ", "RITUXIMAB", "PRIVIGEN"], "FATAL": [34, 15, 72, 19, 4, 2, 1], "PATHOLOGY": "dermatomyositis", "RECOVERED": [7, 3, 117, 13, 6, 42, 159]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/321.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/321.json
new file mode 100644
index 00000000000..ca89e18caed
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/321.json
@@ -0,0 +1 @@
+{"CASES": [213], "DRUG": ["IRINOTECAN"], "FATAL": [7], "PATHOLOGY": "desmoplastic small round cell tumour", "RECOVERED": [16]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/322.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/322.json
new file mode 100644
index 00000000000..b713b2e513c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/322.json
@@ -0,0 +1 @@
+{"CASES": [508, 415], "DRUG": ["CUBICIN", "DAPTOMYCIN"], "FATAL": [77, 1], "PATHOLOGY": "device related infection", "RECOVERED": [148, 12]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/323.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/323.json
new file mode 100644
index 00000000000..a1b39c5d536
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/323.json
@@ -0,0 +1 @@
+{"CASES": [165, 330, 137, 459, 124, 1100, 59196, 3159, 256, 3104, 798, 5974, 594, 852, 28047, 3060, 511, 181, 29605, 31306, 2291, 185, 677, 451, 3299, 10810, 130, 2319, 111, 168, 925, 265, 118, 239, 1080, 363, 1905, 206, 4270, 3155, 403, 2999, 1192, 82616, 317, 402, 15239, 1190, 781, 2559, 135, 271, 137, 5230, 16438, 613, 143, 1083, 2019, 3830, 257, 3325, 938, 41326, 334, 111, 117, 603, 447, 1922, 7449, 17791, 464, 8323, 4290, 1985, 143, 3951, 7437, 376, 225, 19851, 231, 1311, 945, 1304, 176, 7127, 573, 3621, 582, 294, 7331, 205, 5403, 218, 4695, 226, 228, 232, 701, 60285, 1196, 2437, 1389, 4746, 561, 32248, 878, 3420, 905, 152, 615, 158, 502, 170, 693, 348, 360, 181, 547, 183, 373, 197, 7720, 225, 228, 230, 4703, 8622, 2378, 409, 496, 490, 3436], "DRUG": ["EUCREAS 50 MG/850 MG FILM-COATED TABLETS", "LANTUS 100 IU/ML SOLUTION FOR INJECTION IN A CARTRIDGE", "VELMETIA 50 MG/1000 MG", "EUCREAS 50 MG/1000 MG FILM-COATED TABLETS", "INSULIN LISPRO SANOFI", "ROSIGLITAZONE MALEATE", "AVANDIA", "INSULIN ASPART", "JANUVIA 25 MG FILM-COATED TABLETS", "AVANDIA FILM-COATED TABLETS", "INSULATARD", "GALVUS", "ONGLYZA 5 MG FILM-COATED TABLETS", "MIXTARD 30", "BYETTA", "ONGLYZA", "BYETTA SOLUTION FOR INJECTION, PREFILLED PEN", "PRANDIN", "JANUMET", "JANUVIA", "ACTRAPID", "JANUMET 50 MG/850 MG FILM-COATED TABLETS", "AVANDAMET FILM-COATED TABLETS", "JANUMET 50 MG/1000 MG", "ACTOS", "AVANDAMET", "ACTOS 15 MG TABLETS", "GLIBENCLAMIDE", "ACTOS 30 MG TABLETS", "JANUMET 50 MG/850 MG", "VELMETIA", "SAXAGLIPTIN", "PROTAPHANE", "VELMETIA 50 MG/1000 MG FILM-COATED TABLETS", "ACTRAPID PENFILL", "INSULIN GLULISINE", "JANUVIA 50 MG FILM-COATED TABLETS", "AVANDIA 4 MG FILM-COATED TABLETS", "METFORMIN HYDROCHLORIDE, VILDAGLIPTIN", "EUCREAS", "ABASAGLAR 100 UNITS/ML SOLUTION FOR INJECTION IN A PRE-FILLED PEN", "NOVONORM", "VILDAGLIPTIN", "LANTUS", "EXUBERA", "RYBELSUS 14 MG", "VICTOZA", "OZEMPIC", "VICTOZA 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN", "TRESIBA", "EFFICIB", "INSUMAN BASAL", "BYETTA 10 MICROGRAMS SOLUTION FOR INJECTION, PREFILLED PEN", "LEVEMIR FLEXPEN", "FORXIGA", "LEVEMIR SOLUTION FOR INJECTION", "COMPETACT", "JARDIANCE 10 MG", "HUMALOG MIX50", "EMPAGLIFLOZIN", "ALBIGLUTIDE", "INSULIN HUMAN", "RYBELSUS 3 MG", "JARDIANCE", "JANUMET 50 MG/1000 MG FILM-COATED TABLETS", "DRUG USED IN DIABETES", "GLUCAGON", "MIXTARD 30 PENFILL", "INSULIN DETEMIR", "JARDIANCE FILM-COATED TABLETS", "INSULIN GLARGINE", "BYDUREON", "RYBELSUS 7 MG", "HUMALOG MIX25", "NOVORAPID FLEXPEN", "JARDIANCE 10 MG FILM-COATED TABLETS", "JANUMET 50 MG/1,000 MG FILM-COATED TABLETS", "LEVEMIR FLEXTOUCH", "LEVEMIR", "PIOGLITAZONE", "NOVOMIX 30", "APIDRA", "INSULIN HUMAN ISOPHANE (RDNA)", "FORXIGA 10 MG FILM-COATED TABLETS", "INSULIN DEGLUDEC", "DAPAGLIFLOZIN", "XELEVIA", "TRULICITY", "JARDIANCE 25 MG FILM-COATED TABLETS", "ABASAGLAR", "TRESIBA 100 UNITS/ML", "INSULIN HUMAN (RDNA)", "NOVORAPID", "LANTUS 100 IU/ML", "TOUJEO", "SEMGLEE", "INSULIN LISPRO", "LINAGLIPTIN", "NOVOMIX 30 FLEXPEN", "INSULATARD PENFILL", "CANAGLIFLOZIN", "HUMALOG", "LEVEMIR PENFILL", "DULAGLUTIDE", "RYBELSUS", "INVOKANA", "GALVUS 50 MG TABLETS", "LANTUS SOLOSTAR", "REPAGLINIDE", "NOVORAPID PENFILL", "JANUVIA 100 MG FILM-COATED TABLETS", "RYBELSUS 7 MG TABLETS", "LYUMJEV", "TRESIBA 100 UNITS/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN", "INSULATARD FLEXPEN", "TRAJENTA", "LIRAGLUTIDE", "EXENATIDE", "SAXENDA", "BYDUREON 2 MG", "SITAGLIPTIN", "PROTAPHANE PENFILL", "LANTUS 100 UNITS/ML SOLUTION FOR INJECTION IN A PRE-FILLED PEN", "INSUMAN RAPID", "TRULICITY 1.5 MG", "INSUMAN COMB 25", "BYDUREON 2 MG POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION", "TRULICITY 4.5 MG", "APIDRA SOLOSTAR", "NOVORAPID PUMPCART", "TOUJEO SOLOSTAR", "LIPROLOG", "HUMALOG 100 U/ML SOLUTION FOR INJECTION IN VIAL", "TRULICITY 3 MG", "FIASP"], "FATAL": [51, 74, 27, 61, 12, 91, 4738, 242, 19, 211, 51, 378, 35, 50, 1461, 159, 26, 9, 1404, 1469, 102, 8, 29, 19, 135, 436, 5, 88, 4, 6, 32, 9, 4, 8, 35, 11, 56, 6, 123, 87, 11, 82, 32, 2106, 8, 10, 374, 29, 19, 60, 3, 6, 3, 113, 353, 13, 3, 22, 41, 75, 5, 64, 18, 754, 6, 2, 2, 10, 7, 30, 116, 269, 7, 120, 61, 28, 2, 54, 100, 5, 3, 263, 3, 17, 11, 15, 2, 80, 6, 38, 6, 3, 74, 2, 50, 2, 42, 2, 2, 2, 6, 460, 9, 18, 10, 34, 4, 223, 6, 23, 6, 1, 4, 1, 3, 1, 4, 2, 2, 1, 3, 1, 2, 1, 36, 1, 1, 1, 14, 26, 7, 1, 1, 1, 3], "PATHOLOGY": "diabetes mellitus", "RECOVERED": [55, 121, 33, 246, 26, 53, 2630, 1079, 68, 61, 347, 1568, 203, 324, 5608, 534, 99, 84, 4787, 5066, 1082, 57, 10, 90, 1084, 153, 55, 880, 35, 28, 378, 152, 61, 132, 368, 162, 570, 68, 1003, 1097, 175, 1307, 354, 26231, 134, 139, 6343, 296, 396, 857, 53, 116, 80, 2279, 5586, 341, 38, 398, 293, 1383, 36, 874, 374, 15230, 172, 31, 43, 292, 233, 654, 2524, 3332, 178, 1409, 1565, 963, 65, 1105, 2939, 116, 101, 6755, 59, 582, 271, 414, 81, 2227, 243, 786, 186, 93, 2584, 106, 1070, 31, 1049, 66, 112, 81, 307, 13101, 474, 521, 468, 1126, 271, 3518, 427, 1077, 542, 43, 196, 75, 213, 54, 204, 125, 116, 63, 276, 82, 246, 113, 1597, 72, 59, 40, 1221, 1715, 396, 63, 99, 104, 1009]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/324.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/324.json
new file mode 100644
index 00000000000..d8d5f1324f7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/324.json
@@ -0,0 +1 @@
+{"CASES": [174, 115, 131, 469], "DRUG": ["JANUVIA", "JANUMET", "VICTOZA", "HUMALOG"], "FATAL": [11, 3, 1, 3], "PATHOLOGY": "diabetes mellitus inadequate control", "RECOVERED": [34, 12, 43, 82]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/325.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/325.json
new file mode 100644
index 00000000000..fcca00a91f7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/325.json
@@ -0,0 +1 @@
+{"CASES": [148, 166, 253], "DRUG": ["JANUMET", "JARDIANCE", "LANTUS"], "FATAL": [7, 6, 2], "PATHOLOGY": "diabetes mellitus management", "RECOVERED": [17, 60, 55]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/326.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/326.json
new file mode 100644
index 00000000000..c123fbb0215
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/326.json
@@ -0,0 +1 @@
+{"CASES": [100], "DRUG": ["CUBICIN"], "FATAL": [6], "PATHOLOGY": "diabetic foot", "RECOVERED": [20]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/327.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/327.json
new file mode 100644
index 00000000000..9ea9dd30fe0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/327.json
@@ -0,0 +1 @@
+{"CASES": [1992, 1333], "DRUG": ["CYMBALTA", "LYRICA"], "FATAL": [23, 8], "PATHOLOGY": "diabetic neuropathy", "RECOVERED": [559, 266]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/328.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/328.json
new file mode 100644
index 00000000000..163fe17d93c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/328.json
@@ -0,0 +1 @@
+{"CASES": [2291], "DRUG": ["EYLEA"], "FATAL": [72], "PATHOLOGY": "diabetic retinal oedema", "RECOVERED": [624]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/329.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/329.json
new file mode 100644
index 00000000000..f0f142517f2
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/329.json
@@ -0,0 +1 @@
+{"CASES": [580], "DRUG": ["EYLEA"], "FATAL": [19], "PATHOLOGY": "diabetic retinopathy", "RECOVERED": [134]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/33.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/33.json
new file mode 100644
index 00000000000..7df02bb2ee0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/33.json
@@ -0,0 +1 @@
+{"CASES": [255, 149], "DRUG": ["MITOTANE", "ABILIFY"], "FATAL": [8, 1], "PATHOLOGY": "adjuvant therapy", "RECOVERED": [105, 18]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/330.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/330.json
new file mode 100644
index 00000000000..682f879b66d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/330.json
@@ -0,0 +1 @@
+{"CASES": [1204], "DRUG": ["ARANESP"], "FATAL": [42], "PATHOLOGY": "dialysis", "RECOVERED": [205]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/331.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/331.json
new file mode 100644
index 00000000000..8fdcd584fec
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/331.json
@@ -0,0 +1 @@
+{"CASES": [119], "DRUG": ["OCTREOTIDE"], "FATAL": [21], "PATHOLOGY": "diarrhoea", "RECOVERED": [25]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/332.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/332.json
new file mode 100644
index 00000000000..c0f7df533fd
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/332.json
@@ -0,0 +1 @@
+{"CASES": [162, 225, 173, 7741, 297, 1244, 111, 176, 691, 632, 7097, 2983, 1095, 7399, 4479, 179, 2072, 1855, 456, 200, 329, 600, 379, 121, 228, 365, 255, 493, 1184], "DRUG": ["BUSULFAN", "IBRUTINIB", "YESCARTA 0.4 \u00c3\u00a2\u00c2\u20ac\u00c2\u201c 2 X 10E8 CELLS DISPERSION FOR INFUSION", "KYMRIAH", "TISAGENLECLEUCEL", "CARMUSTINE", "PEMBROLIZUMAB", "GAZYVARO", "EPCORITAMAB", "METHOTREXATE", "YESCARTA", "DOXORUBICIN HYDROCHLORIDE", "AXICABTAGENE CILOLEUCEL", "RITUXIMAB", "CYTARABINE", "IMBRUVICA", "MABTHERA", "DEXAMETHASONE", "BREYANZI", "POLIVY", "KYMRIAH 1.2 X 10^6 \u00c3\u00a2\u00c2\u20ac\u00c2\u201c 6 X 10^8 CELLS DISPERSION FOR INFUSION", "LENALIDOMIDE", "POLATUZUMAB VEDOTIN", "AVASTIN", "OBINUTUZUMAB", "BRUKINSA", "FILGRASTIM", "DOXORUBICIN HYDROCHLORIDE, LIPOSOMAL", "CAELYX"], "FATAL": [27, 31, 22, 934, 35, 142, 12, 18, 69, 63, 694, 274, 96, 646, 344, 12, 138, 105, 24, 10, 14, 23, 14, 4, 7, 8, 5, 8, 15], "PATHOLOGY": "diffuse large b-cell lymphoma", "RECOVERED": [19, 16, 116, 1493, 90, 175, 5, 13, 266, 179, 2237, 616, 497, 1713, 378, 33, 609, 147, 136, 15, 257, 186, 42, 103, 33, 20, 29, 73, 161]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/333.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/333.json
new file mode 100644
index 00000000000..b2937e8aaa2
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/333.json
@@ -0,0 +1 @@
+{"CASES": [197, 889, 220], "DRUG": ["CYTARABINE", "KYMRIAH", "YESCARTA"], "FATAL": [23, 93, 8], "PATHOLOGY": "diffuse large b-cell lymphoma recurrent", "RECOVERED": [9, 248, 86]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/334.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/334.json
new file mode 100644
index 00000000000..9a9aca60880
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/334.json
@@ -0,0 +1 @@
+{"CASES": [636, 122, 518, 120], "DRUG": ["KYMRIAH", "KYMRIAH 1.2 X 10^6 \u00c3\u00a2\u00c2\u20ac\u00c2\u201c 6 X 10^8 CELLS DISPERSION FOR INFUSION", "YESCARTA", "AXICABTAGENE CILOLEUCEL"], "FATAL": [96, 14, 58, 7], "PATHOLOGY": "diffuse large b-cell lymphoma refractory", "RECOVERED": [148, 82, 256, 50]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/335.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/335.json
new file mode 100644
index 00000000000..8fd9758a9d8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/335.json
@@ -0,0 +1 @@
+{"CASES": [124, 411], "DRUG": ["CYTARABINE", "RITUXIMAB"], "FATAL": [12, 26], "PATHOLOGY": "diffuse large b-cell lymphoma stage ii", "RECOVERED": [26, 128]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/336.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/336.json
new file mode 100644
index 00000000000..25a4ad8da5d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/336.json
@@ -0,0 +1 @@
+{"CASES": [211], "DRUG": ["RITUXIMAB"], "FATAL": [16], "PATHOLOGY": "diffuse large b-cell lymphoma stage iii", "RECOVERED": [63]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/337.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/337.json
new file mode 100644
index 00000000000..f00fb067942
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/337.json
@@ -0,0 +1 @@
+{"CASES": [165, 161, 781, 126, 118, 406, 154, 163], "DRUG": ["AXICABTAGENE CILOLEUCEL", "KYMRIAH", "RITUXIMAB", "DOXORUBICIN HYDROCHLORIDE", "YESCARTA", "CYTARABINE", "MABTHERA", "EPCORITAMAB"], "FATAL": [69, 23, 86, 13, 7, 23, 6, 6], "PATHOLOGY": "diffuse large b-cell lymphoma stage iv", "RECOVERED": [55, 22, 259, 43, 25, 68, 46, 67]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/338.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/338.json
new file mode 100644
index 00000000000..18a7c1fb530
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/338.json
@@ -0,0 +1 @@
+{"CASES": [620], "DRUG": ["ENTRESTO"], "FATAL": [26], "PATHOLOGY": "dilated cardiomyopathy", "RECOVERED": [122]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/339.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/339.json
new file mode 100644
index 00000000000..e82708e99e0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/339.json
@@ -0,0 +1 @@
+{"CASES": [132], "DRUG": ["NOVOSEVEN"], "FATAL": [94], "PATHOLOGY": "disseminated intravascular coagulation", "RECOVERED": [6]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/34.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/34.json
new file mode 100644
index 00000000000..47f15428c33
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/34.json
@@ -0,0 +1 @@
+{"CASES": [134], "DRUG": ["LYSODREN"], "FATAL": [2], "PATHOLOGY": "adrenal gland cancer", "RECOVERED": [30]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/340.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/340.json
new file mode 100644
index 00000000000..f6252b1cac9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/340.json
@@ -0,0 +1 @@
+{"CASES": [151, 309], "DRUG": ["BEDAQUILINE", "LEVOFLOXACIN"], "FATAL": [31, 6], "PATHOLOGY": "disseminated tuberculosis", "RECOVERED": [12, 44]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/341.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/341.json
new file mode 100644
index 00000000000..87b0decbc36
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/341.json
@@ -0,0 +1 @@
+{"CASES": [135], "DRUG": ["SPIRONOLACTONE"], "FATAL": [8], "PATHOLOGY": "diuretic therapy", "RECOVERED": [26]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/342.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/342.json
new file mode 100644
index 00000000000..145746622ac
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/342.json
@@ -0,0 +1 @@
+{"CASES": [297, 137, 200, 284], "DRUG": ["FENTANYL", "OLANZAPINE", "BUPRENORPHINE", "SUBOXONE"], "FATAL": [75, 18, 16, 15], "PATHOLOGY": "drug abuse", "RECOVERED": [41, 15, 84, 82]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/343.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/343.json
new file mode 100644
index 00000000000..0b6143cce79
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/343.json
@@ -0,0 +1 @@
+{"CASES": [5532, 19111, 9548, 200, 1679, 370], "DRUG": ["BUPRENORPHINE", "SUBOXONE", "SUBOXONE SUBLINGUAL FILM", "SUBOXONE SUBLINGUAL TABLETS", "BUPRENORPHINE, NALOXONE", "BUVIDAL"], "FATAL": [349, 743, 213, 4, 30, 6], "PATHOLOGY": "drug dependence", "RECOVERED": [3041, 8862, 4765, 149, 568, 136]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/344.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/344.json
new file mode 100644
index 00000000000..cdaad60a75b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/344.json
@@ -0,0 +1 @@
+{"CASES": [153, 778, 286, 700, 4044, 1154, 230, 2745, 1096, 384, 823, 109, 277, 124, 534, 108], "DRUG": ["SIROLIMUS", "TACROLIMUS", "EVEROLIMUS", "AZATHIOPRINE", "CICLOSPORIN", "BASILIXIMAB", "BUSULFAN", "MYCOPHENOLATE MOFETIL", "CELLCEPT", "RAPAMUNE", "ALEMTUZUMAB", "CARMUSTINE", "BUDESONIDE", "METHOTREXATE", "ADALIMUMAB", "RITUXIMAB"], "FATAL": [49, 169, 52, 102, 548, 149, 26, 294, 114, 38, 79, 10, 12, 4, 12, 1], "PATHOLOGY": "drug therapy", "RECOVERED": [17, 251, 44, 101, 1138, 343, 29, 833, 293, 84, 241, 60, 156, 38, 56, 43]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/345.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/345.json
new file mode 100644
index 00000000000..92a6ce5bb13
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/345.json
@@ -0,0 +1 @@
+{"CASES": [192, 845, 910, 569], "DRUG": ["BUVIDAL", "BUPRENORPHINE", "SUBOXONE", "BUPRENORPHINE, NALOXONE"], "FATAL": [26, 90, 35, 10], "PATHOLOGY": "drug use disorder", "RECOVERED": [63, 279, 346, 218]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/346.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/346.json
new file mode 100644
index 00000000000..b82a605c3d1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/346.json
@@ -0,0 +1 @@
+{"CASES": [303, 156], "DRUG": ["BUPRENORPHINE", "SUBOXONE"], "FATAL": [13, 5], "PATHOLOGY": "drug withdrawal maintenance therapy", "RECOVERED": [77, 84]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/347.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/347.json
new file mode 100644
index 00000000000..b3089abde84
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/347.json
@@ -0,0 +1 @@
+{"CASES": [231], "DRUG": ["SUBOXONE"], "FATAL": [10], "PATHOLOGY": "drug withdrawal syndrome", "RECOVERED": [65]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/348.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/348.json
new file mode 100644
index 00000000000..a68a9a030ee
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/348.json
@@ -0,0 +1 @@
+{"CASES": [299], "DRUG": ["IRINOTECAN"], "FATAL": [21], "PATHOLOGY": "ductal adenocarcinoma of pancreas", "RECOVERED": [38]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/349.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/349.json
new file mode 100644
index 00000000000..6a7f016869d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/349.json
@@ -0,0 +1 @@
+{"CASES": [251, 284], "DRUG": ["COLLAGENASE CLOSTRIDIUM HISTOLYTICUM", "XIAPEX"], "FATAL": [5, 2], "PATHOLOGY": "dupuytren's contracture", "RECOVERED": [130, 85]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/35.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/35.json
new file mode 100644
index 00000000000..2b5c97e28ef
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/35.json
@@ -0,0 +1 @@
+{"CASES": [566], "DRUG": ["HYDROCORTISONE"], "FATAL": [24], "PATHOLOGY": "adrenal insufficiency", "RECOVERED": [91]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/350.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/350.json
new file mode 100644
index 00000000000..82dc3cf6961
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/350.json
@@ -0,0 +1 @@
+{"CASES": [107, 187, 377, 394], "DRUG": ["AVAMYS", "INCRUSE ELLIPTA", "REVATIO", "TRELEGY ELLIPTA"], "FATAL": [10, 16, 24, 11], "PATHOLOGY": "dyspnoea", "RECOVERED": [27, 19, 59, 10]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/351.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/351.json
new file mode 100644
index 00000000000..9b072e01693
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/351.json
@@ -0,0 +1 @@
+{"CASES": [195], "DRUG": ["TOVIAZ"], "FATAL": [6], "PATHOLOGY": "dysuria", "RECOVERED": [36]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/352.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/352.json
new file mode 100644
index 00000000000..ac10d8aa521
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/352.json
@@ -0,0 +1 @@
+{"CASES": [122], "DRUG": ["RINVOQ"], "FATAL": [2], "PATHOLOGY": "eczema", "RECOVERED": [30]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/353.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/353.json
new file mode 100644
index 00000000000..5f17b041df6
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/353.json
@@ -0,0 +1 @@
+{"CASES": [128, 672, 221, 232], "DRUG": ["GEFITINIB", "TAGRISSO", "OSIMERTINIB", "IRESSA"], "FATAL": [10, 47, 14, 12], "PATHOLOGY": "egfr gene mutation", "RECOVERED": [46, 64, 46, 21]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/354.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/354.json
new file mode 100644
index 00000000000..3c6ea04e1dc
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/354.json
@@ -0,0 +1 @@
+{"CASES": [254, 128, 852, 163, 174, 243, 221, 961, 7683, 454, 453], "DRUG": ["XARELTO 20 MG", "PRADAXA", "ENOXAPARIN SODIUM", "XARELTO 15 MG", "PLAVIX", "APIXABAN", "ARIXTRA", "XARELTO", "ELIQUIS", "ELIQUIS 5 MG FILM-COATED TABLETS", "LIXIANA"], "FATAL": [32, 16, 84, 15, 14, 19, 13, 55, 352, 16, 13], "PATHOLOGY": "embolism", "RECOVERED": [36, 12, 279, 30, 54, 76, 61, 177, 899, 156, 111]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/355.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/355.json
new file mode 100644
index 00000000000..b641b913333
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/355.json
@@ -0,0 +1 @@
+{"CASES": [2390, 568], "DRUG": ["ELIQUIS", "XARELTO"], "FATAL": [119, 20], "PATHOLOGY": "embolism venous", "RECOVERED": [239, 112]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/356.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/356.json
new file mode 100644
index 00000000000..1fd07553dba
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/356.json
@@ -0,0 +1 @@
+{"CASES": [105, 659], "DRUG": ["AVAMYS", "TRELEGY ELLIPTA"], "FATAL": [10, 7], "PATHOLOGY": "emphysema", "RECOVERED": [25, 63]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/357.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/357.json
new file mode 100644
index 00000000000..83e0cee4042
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/357.json
@@ -0,0 +1 @@
+{"CASES": [372, 251, 124, 105, 220, 242, 131], "DRUG": ["GANCICLOVIR", "HUMAN NORMAL IMMUNOGLOBULIN", "HUMAN NORMAL IMMUNOGLOBULIN (IV)", "LEVETIRACETAM", "PRIVIGEN", "RITUXIMAB", "KEPPRA"], "FATAL": [52, 32, 10, 5, 6, 4, 2], "PATHOLOGY": "encephalitis", "RECOVERED": [172, 25, 24, 18, 95, 143, 36]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/358.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/358.json
new file mode 100644
index 00000000000..bd292a2d45d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/358.json
@@ -0,0 +1 @@
+{"CASES": [169, 227], "DRUG": ["HUMAN NORMAL IMMUNOGLOBULIN", "RITUXIMAB"], "FATAL": [16, 4], "PATHOLOGY": "encephalitis autoimmune", "RECOVERED": [7, 141]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/359.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/359.json
new file mode 100644
index 00000000000..2cb5168334f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/359.json
@@ -0,0 +1 @@
+{"CASES": [162], "DRUG": ["LEVETIRACETAM"], "FATAL": [4], "PATHOLOGY": "encephalopathy", "RECOVERED": [28]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/36.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/36.json
new file mode 100644
index 00000000000..bac0889dd69
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/36.json
@@ -0,0 +1 @@
+{"CASES": [492, 663, 107], "DRUG": ["MITOTANE", "LYSODREN", "LYSODREN 500 MG TABLETS"], "FATAL": [29, 13, 2], "PATHOLOGY": "adrenocortical carcinoma", "RECOVERED": [159, 188, 39]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/360.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/360.json
new file mode 100644
index 00000000000..67630f3f87f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/360.json
@@ -0,0 +1 @@
+{"CASES": [228, 102], "DRUG": ["ARANESP", "MIRCERA"], "FATAL": [9, 4], "PATHOLOGY": "end stage renal disease", "RECOVERED": [6, 63]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/361.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/361.json
new file mode 100644
index 00000000000..db23b66d733
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/361.json
@@ -0,0 +1 @@
+{"CASES": [1346, 150, 198], "DRUG": ["CUBICIN", "CUBICIN 350 MG", "DAPTOMYCIN"], "FATAL": [206, 22, 24], "PATHOLOGY": "endocarditis", "RECOVERED": [370, 16, 95]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/362.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/362.json
new file mode 100644
index 00000000000..14967fd5534
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/362.json
@@ -0,0 +1 @@
+{"CASES": [521], "DRUG": ["CUBICIN"], "FATAL": [78], "PATHOLOGY": "endocarditis staphylococcal", "RECOVERED": [94]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/363.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/363.json
new file mode 100644
index 00000000000..2764e3addfc
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/363.json
@@ -0,0 +1 @@
+{"CASES": [123, 1105], "DRUG": ["PEMBROLIZUMAB", "KEYTRUDA"], "FATAL": [5, 36], "PATHOLOGY": "endometrial adenocarcinoma", "RECOVERED": [43, 260]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/364.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/364.json
new file mode 100644
index 00000000000..5e14ccd1164
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/364.json
@@ -0,0 +1 @@
+{"CASES": [134, 1461, 8813, 101, 1048], "DRUG": ["RUBRACA", "LENVIMA", "KEYTRUDA", "IBRANCE", "PEMBROLIZUMAB"], "FATAL": [6, 52, 309, 3, 27], "PATHOLOGY": "endometrial cancer", "RECOVERED": [20, 350, 2236, 8, 226]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/365.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/365.json
new file mode 100644
index 00000000000..909eb921123
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/365.json
@@ -0,0 +1 @@
+{"CASES": [360], "DRUG": ["KEYTRUDA"], "FATAL": [13], "PATHOLOGY": "endometrial cancer metastatic", "RECOVERED": [58]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/366.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/366.json
new file mode 100644
index 00000000000..c1f59b7cd98
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/366.json
@@ -0,0 +1 @@
+{"CASES": [609], "DRUG": ["KEYTRUDA"], "FATAL": [30], "PATHOLOGY": "endometrial cancer recurrent", "RECOVERED": [204]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/367.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/367.json
new file mode 100644
index 00000000000..8d57a92bebb
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/367.json
@@ -0,0 +1 @@
+{"CASES": [467], "DRUG": ["KEYTRUDA"], "FATAL": [18], "PATHOLOGY": "endometrial cancer stage iv", "RECOVERED": [135]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/368.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/368.json
new file mode 100644
index 00000000000..1521a60956e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/368.json
@@ -0,0 +1 @@
+{"CASES": [136], "DRUG": ["VORICONAZOLE"], "FATAL": [1], "PATHOLOGY": "endophthalmitis", "RECOVERED": [35]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/369.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/369.json
new file mode 100644
index 00000000000..56bf3bbec73
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/369.json
@@ -0,0 +1 @@
+{"CASES": [241], "DRUG": ["FENTANYL"], "FATAL": [8], "PATHOLOGY": "endotracheal intubation", "RECOVERED": [63]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/37.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/37.json
new file mode 100644
index 00000000000..0ee7635fcef
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/37.json
@@ -0,0 +1 @@
+{"CASES": [367], "DRUG": ["POTELIGEO"], "FATAL": [68], "PATHOLOGY": "adult t-cell lymphoma/leukaemia", "RECOVERED": [107]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/370.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/370.json
new file mode 100644
index 00000000000..cbfb28ae354
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/370.json
@@ -0,0 +1 @@
+{"CASES": [334], "DRUG": ["LEVOFLOXACIN"], "FATAL": [12], "PATHOLOGY": "enteritis", "RECOVERED": [157]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/371.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/371.json
new file mode 100644
index 00000000000..b3d995f2659
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/371.json
@@ -0,0 +1 @@
+{"CASES": [434], "DRUG": ["CUBICIN"], "FATAL": [114], "PATHOLOGY": "enterococcal infection", "RECOVERED": [47]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/372.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/372.json
new file mode 100644
index 00000000000..4fdf39b5358
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/372.json
@@ -0,0 +1 @@
+{"CASES": [160, 196], "DRUG": ["FASENRA", "MEPOLIZUMAB"], "FATAL": [14, 2], "PATHOLOGY": "eosinophilia", "RECOVERED": [14, 10]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/373.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/373.json
new file mode 100644
index 00000000000..711d34e6b4b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/373.json
@@ -0,0 +1 @@
+{"CASES": [1049, 482], "DRUG": ["NUCALA", "MEPOLIZUMAB"], "FATAL": [50, 21], "PATHOLOGY": "eosinophilic granulomatosis with polyangiitis", "RECOVERED": [215, 118]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/374.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/374.json
new file mode 100644
index 00000000000..7ee31e76dde
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/374.json
@@ -0,0 +1 @@
+{"CASES": [235, 407, 554], "DRUG": ["BUPIVACAINE", "FENTANYL", "FENTANYL CITRATE"], "FATAL": [5, 6, 4], "PATHOLOGY": "epidural anaesthesia", "RECOVERED": [80, 172, 19]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/375.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/375.json
new file mode 100644
index 00000000000..349c531310b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/375.json
@@ -0,0 +1 @@
+{"CASES": [106], "DRUG": ["BUPIVACAINE"], "FATAL": [4], "PATHOLOGY": "epidural analgesia", "RECOVERED": [51]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/376.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/376.json
new file mode 100644
index 00000000000..95850da686e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/376.json
@@ -0,0 +1 @@
+{"CASES": [495, 183, 121, 280, 573, 285, 5908, 501, 12748, 1802, 186, 28976, 110, 2604, 152, 230, 3644, 2574, 347, 1157, 187, 417, 844, 231, 367], "DRUG": ["PREGABALIN", "MIDAZOLAM", "ZONEGRAN", "CANNABIDIOL", "KEPPRA 1000 MG FILM-COATED TABLETS", "KEPPRA 100 MG/ML ORAL SOLUTION", "VIMPAT", "VIGABATRIN", "LEVETIRACETAM", "KEPPRA 500 MG FILM-COATED TABLETS", "INOVELON", "KEPPRA", "VIMPAT 200 MG FILM-COATED TABLETS", "FYCOMPA", "VIMPAT 100 MG FILM-COATED TABLETS", "VIMPAT 50 MG FILM-COATED TABLETS", "LACOSAMIDE", "BRIVIACT", "EPIDYOLEX", "BRIVARACETAM", "LYRICA", "ZONISAMIDE", "KEPPRA 250 MG FILM-COATED TABLETS", "DIACOMIT", "PERAMPANEL"], "FATAL": [294, 52, 14, 27, 37, 16, 249, 21, 528, 65, 6, 830, 3, 55, 3, 4, 57, 39, 3, 8, 1, 2, 4, 1, 1], "PATHOLOGY": "epilepsy", "RECOVERED": [41, 27, 36, 27, 205, 110, 1829, 118, 3151, 804, 48, 7791, 38, 1036, 67, 82, 833, 362, 105, 153, 51, 141, 260, 50, 104]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/377.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/377.json
new file mode 100644
index 00000000000..f7beb0e90b5
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/377.json
@@ -0,0 +1 @@
+{"CASES": [263, 129], "DRUG": ["LACOSAMIDE", "VIMPAT"], "FATAL": [8, 1], "PATHOLOGY": "epilepsy, partial seizures", "RECOVERED": [108, 53]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/378.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/378.json
new file mode 100644
index 00000000000..5d1497fd906
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/378.json
@@ -0,0 +1 @@
+{"CASES": [189], "DRUG": ["KEPPRA"], "FATAL": [2], "PATHOLOGY": "epilepsy, seizure", "RECOVERED": [48]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/379.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/379.json
new file mode 100644
index 00000000000..7fdeca1d3ef
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/379.json
@@ -0,0 +1 @@
+{"CASES": [136], "DRUG": ["LEVETIRACETAM"], "FATAL": [4], "PATHOLOGY": "epileptic encephalopathy", "RECOVERED": [20]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/38.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/38.json
new file mode 100644
index 00000000000..79cccd2eba3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/38.json
@@ -0,0 +1 @@
+{"CASES": [126], "DRUG": ["MIDOSTAURIN"], "FATAL": [5], "PATHOLOGY": "advanced systemic mastocytosis", "RECOVERED": [19]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/380.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/380.json
new file mode 100644
index 00000000000..d816659bc95
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/380.json
@@ -0,0 +1 @@
+{"CASES": [152, 148], "DRUG": ["GANCICLOVIR", "CICLOSPORIN"], "FATAL": [71, 57], "PATHOLOGY": "epstein-barr virus infection", "RECOVERED": [22, 10]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/381.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/381.json
new file mode 100644
index 00000000000..374dd96557b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/381.json
@@ -0,0 +1 @@
+{"CASES": [187, 3638, 15490, 1139, 278, 118, 570], "DRUG": ["TADALAFIL", "CIALIS", "VIAGRA", "SILDENAFIL", "LEVITRA", "VIAGRA 50 MG", "SILDENAFIL CITRATE"], "FATAL": [15, 206, 483, 35, 6, 2, 3], "PATHOLOGY": "erectile dysfunction", "RECOVERED": [41, 559, 2538, 354, 45, 40, 142]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/382.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/382.json
new file mode 100644
index 00000000000..272f03417ba
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/382.json
@@ -0,0 +1 @@
+{"CASES": [1823, 637, 708, 242, 4518, 1432, 584, 147, 629, 21266, 2981], "DRUG": ["ANAKINRA", "CICLOSPORIN", "AZATHIOPRINE", "MYCOPHENOLATE MOFETIL", "BENLYSTA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "CELLCEPT", "BENLYSTA 400 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "THALIDOMIDE", "BENLYSTA SOLUTION FOR INJECTION IN PRE-FILLED PEN", "BENLYSTA", "BELIMUMAB"], "FATAL": [899, 74, 35, 11, 172, 42, 9, 2, 8, 260, 33], "PATHOLOGY": "erythema", "RECOVERED": [706, 156, 131, 35, 710, 283, 161, 44, 81, 5259, 1138]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/383.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/383.json
new file mode 100644
index 00000000000..cb6fe404eef
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/383.json
@@ -0,0 +1 @@
+{"CASES": [116], "DRUG": ["STELARA"], "FATAL": [10], "PATHOLOGY": "erythrodermic psoriasis", "RECOVERED": [12]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/384.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/384.json
new file mode 100644
index 00000000000..6a466e58395
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/384.json
@@ -0,0 +1 @@
+{"CASES": [149, 504], "DRUG": ["IRBESARTAN", "MICARDIS"], "FATAL": [2, 5], "PATHOLOGY": "essential hypertension", "RECOVERED": [81, 182]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/385.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/385.json
new file mode 100644
index 00000000000..6e889188406
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/385.json
@@ -0,0 +1 @@
+{"CASES": [116, 371, 661], "DRUG": ["ANAGRELIDE", "JAKAVI", "PEGASYS"], "FATAL": [12, 10, 14], "PATHOLOGY": "essential thrombocythaemia", "RECOVERED": [3, 19, 128]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/386.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/386.json
new file mode 100644
index 00000000000..64992528827
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/386.json
@@ -0,0 +1 @@
+{"CASES": [121, 240, 149], "DRUG": ["BUSULFAN", "DOXORUBICIN HYDROCHLORIDE", "IRINOTECAN"], "FATAL": [12, 13, 6], "PATHOLOGY": "ewing's sarcoma", "RECOVERED": [24, 96, 13]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/387.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/387.json
new file mode 100644
index 00000000000..f918714a4f1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/387.json
@@ -0,0 +1 @@
+{"CASES": [140, 2164], "DRUG": ["CHAMPIX FILM-COATED TABLETS", "CHAMPIX"], "FATAL": [2, 20], "PATHOLOGY": "ex-tobacco user", "RECOVERED": [44, 938]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/388.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/388.json
new file mode 100644
index 00000000000..d1304831fa8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/388.json
@@ -0,0 +1 @@
+{"CASES": [129, 103, 138, 271, 451, 298, 336, 198, 514, 171, 128, 132], "DRUG": ["COMBIVIR", "ATOSIBAN", "XOLAIR", "SUBOXONE", "DEXAMETHASONE", "IBUPROFEN", "FENTANYL", "BUPRENORPHINE", "KEPPRA", "ABILIFY", "IRON", "LAMIVUDINE"], "FATAL": [42, 22, 9, 12, 16, 9, 9, 4, 9, 3, 2, 2], "PATHOLOGY": "exposure during pregnancy", "RECOVERED": [14, 18, 9, 131, 42, 37, 30, 89, 35, 64, 35, 28]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/389.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/389.json
new file mode 100644
index 00000000000..120c35e86c7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/389.json
@@ -0,0 +1 @@
+{"CASES": [140], "DRUG": ["BEDAQUILINE"], "FATAL": [1], "PATHOLOGY": "extrapulmonary tuberculosis", "RECOVERED": [23]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/39.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/39.json
new file mode 100644
index 00000000000..d38f08cca5a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/39.json
@@ -0,0 +1 @@
+{"CASES": [516], "DRUG": ["VAXZEVRIA"], "FATAL": [2], "PATHOLOGY": "adverse drug reaction", "RECOVERED": [78]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/390.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/390.json
new file mode 100644
index 00000000000..03abc44113d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/390.json
@@ -0,0 +1 @@
+{"CASES": [130], "DRUG": ["SIFROL"], "FATAL": [90], "PATHOLOGY": "extrapyramidal disorder", "RECOVERED": [15]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/391.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/391.json
new file mode 100644
index 00000000000..5c37709ad94
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/391.json
@@ -0,0 +1 @@
+{"CASES": [266, 3112], "DRUG": ["FABRAZYME", "GALAFOLD"], "FATAL": [15, 51], "PATHOLOGY": "fabry's disease", "RECOVERED": [39, 663]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/392.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/392.json
new file mode 100644
index 00000000000..219d578c9a1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/392.json
@@ -0,0 +1 @@
+{"CASES": [366], "DRUG": ["NOVOSEVEN"], "FATAL": [40], "PATHOLOGY": "factor vii deficiency", "RECOVERED": [94]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/393.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/393.json
new file mode 100644
index 00000000000..706a1d713f0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/393.json
@@ -0,0 +1 @@
+{"CASES": [256, 108, 1159, 304, 2432, 100, 250, 421], "DRUG": ["NOVOSEVEN", "ADVATE 1000 IU", "ADVATE", "ELOCTA", "HEMLIBRA", "ADVATE 250 IU", "EMICIZUMAB", "KOVALTRY"], "FATAL": [41, 10, 44, 8, 55, 1, 2, 2], "PATHOLOGY": "factor viii deficiency", "RECOVERED": [104, 44, 342, 85, 398, 33, 40, 82]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/394.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/394.json
new file mode 100644
index 00000000000..9c95b6f590e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/394.json
@@ -0,0 +1 @@
+{"CASES": [569], "DRUG": ["BUPIVACAINE"], "FATAL": [1], "PATHOLOGY": "failed back surgery syndrome", "RECOVERED": [72]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/395.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/395.json
new file mode 100644
index 00000000000..3f2c68c3801
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/395.json
@@ -0,0 +1 @@
+{"CASES": [215, 570], "DRUG": ["LYNPARZA", "RUBRACA"], "FATAL": [9, 16], "PATHOLOGY": "fallopian tube cancer", "RECOVERED": [22, 110]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/396.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/396.json
new file mode 100644
index 00000000000..684b8564455
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/396.json
@@ -0,0 +1 @@
+{"CASES": [107, 552, 224, 184], "DRUG": ["VFEND", "CANCIDAS 50 MG POWDER FOR SOLUTION FOR INFUSION", "FILGRASTIM", "AMIKACIN"], "FATAL": [18, 80, 29, 6], "PATHOLOGY": "febrile neutropenia", "RECOVERED": [45, 218, 91, 124]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/397.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/397.json
new file mode 100644
index 00000000000..b4dd960b1b0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/397.json
@@ -0,0 +1 @@
+{"CASES": [157, 111, 4512, 5772], "DRUG": ["PREGABALIN", "XELJANZ", "LYRICA", "CYMBALTA"], "FATAL": [8, 1, 26, 11], "PATHOLOGY": "fibromyalgia", "RECOVERED": [14, 11, 704, 1010]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/398.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/398.json
new file mode 100644
index 00000000000..505d3a127ce
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/398.json
@@ -0,0 +1 @@
+{"CASES": [122, 498, 554, 287], "DRUG": ["LACOSAMIDE", "LEVETIRACETAM", "KEPPRA", "VIMPAT"], "FATAL": [3, 10, 7, 1], "PATHOLOGY": "focal dyscognitive seizures", "RECOVERED": [29, 173, 197, 92]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/399.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/399.json
new file mode 100644
index 00000000000..d51732d2954
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/399.json
@@ -0,0 +1 @@
+{"CASES": [478], "DRUG": ["CICLOSPORIN"], "FATAL": [63], "PATHOLOGY": "focal segmental glomerulosclerosis", "RECOVERED": [120]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/4.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/4.json
new file mode 100644
index 00000000000..fbe7c4e980f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/4.json
@@ -0,0 +1 @@
+{"CASES": [320], "DRUG": ["METHOTREXATE"], "FATAL": [19], "PATHOLOGY": "abortion induced", "RECOVERED": [27]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/40.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/40.json
new file mode 100644
index 00000000000..dba837ac71f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/40.json
@@ -0,0 +1 @@
+{"CASES": [283, 132, 1668, 438, 3003, 409, 1726, 868, 1254, 847, 425], "DRUG": ["ZYPREXA COATED TABLETS", "INVEGA", "OLANZAPINE", "CYMBALTA", "ZYPREXA", "RISPERIDONE", "ARIPIPRAZOLE", "ABILIFY", "LATUDA", "ABILIFY MAINTENA", "ZYPADHERA"], "FATAL": [13, 5, 52, 12, 67, 9, 32, 13, 12, 7, 1], "PATHOLOGY": "affective disorder", "RECOVERED": [28, 20, 512, 52, 695, 110, 199, 243, 261, 48, 281]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/400.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/400.json
new file mode 100644
index 00000000000..824880d65d8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/400.json
@@ -0,0 +1 @@
+{"CASES": [126, 100, 138, 388, 298, 145, 330, 514, 118], "DRUG": ["COMBIVIR", "ATOSIBAN", "XOLAIR", "DEXAMETHASONE", "IBUPROFEN", "BUPRENORPHINE", "FENTANYL", "KEPPRA", "IRON"], "FATAL": [42, 22, 9, 12, 9, 4, 9, 9, 2], "PATHOLOGY": "foetal exposure during pregnancy", "RECOVERED": [14, 15, 9, 20, 37, 83, 30, 35, 35]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/401.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/401.json
new file mode 100644
index 00000000000..5a81ed757a0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/401.json
@@ -0,0 +1 @@
+{"CASES": [112, 322, 1265, 279, 102, 360, 575, 198, 1140, 814, 277, 570, 131, 819, 278, 102], "DRUG": ["ZEVALIN", "DEXAMETHASONE", "RITUXIMAB", "CARMUSTINE", "METHOTREXATE", "YESCARTA", "MABTHERA", "LENALIDOMIDE", "OBINUTUZUMAB", "GAZYVARO", "KYMRIAH", "CYTARABINE", "RIXATHON", "DOXORUBICIN HYDROCHLORIDE", "EPCORITAMAB", "GAZYVARO 1,000 MG CONCENTRATE FOR SOLUTION FOR INFUSION"], "FATAL": [21, 43, 129, 27, 8, 28, 38, 11, 60, 36, 12, 24, 5, 27, 5, 1], "PATHOLOGY": "follicular lymphoma", "RECOVERED": [40, 64, 241, 72, 5, 137, 131, 25, 334, 181, 74, 57, 99, 171, 156, 40]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/402.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/402.json
new file mode 100644
index 00000000000..c114baef80b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/402.json
@@ -0,0 +1 @@
+{"CASES": [274, 281], "DRUG": ["NEXAVAR", "LENVIMA"], "FATAL": [14, 13], "PATHOLOGY": "follicular thyroid cancer", "RECOVERED": [30, 46]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/403.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/403.json
new file mode 100644
index 00000000000..b431236af17
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/403.json
@@ -0,0 +1 @@
+{"CASES": [108, 360, 134, 132, 157, 2725], "DRUG": ["PROTELOS", "EVENITY", "FORSTEO 20MICROGRAMS/80 MICROLITERS SOLUTION FOR INJECTION IN PRE-FILLED PEN", "BONVIVA", "TERIPARATIDE", "FORSTEO"], "FATAL": [5, 15, 2, 1, 1, 12], "PATHOLOGY": "fracture", "RECOVERED": [61, 72, 52, 54, 37, 471]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/404.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/404.json
new file mode 100644
index 00000000000..700afeb3863
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/404.json
@@ -0,0 +1 @@
+{"CASES": [143], "DRUG": ["LEVETIRACETAM"], "FATAL": [6], "PATHOLOGY": "frontal lobe epilepsy", "RECOVERED": [34]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/405.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/405.json
new file mode 100644
index 00000000000..305ec170ffa
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/405.json
@@ -0,0 +1 @@
+{"CASES": [291, 191, 372, 213, 117, 598, 898, 241, 2688, 147], "DRUG": ["CASPOFUNGIN ACETATE", "MYCAMINE", "CANCIDAS", "POSACONAZOLE", "VFEND POWDER FOR SOLUTION FOR INFUSION", "NOXAFIL", "VORICONAZOLE", "CASPOFUNGIN", "VFEND", "CRESEMBA"], "FATAL": [109, 42, 62, 31, 15, 72, 105, 27, 215, 7], "PATHOLOGY": "fungal infection", "RECOVERED": [23, 60, 76, 10, 34, 117, 204, 68, 759, 17]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/406.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/406.json
new file mode 100644
index 00000000000..77f0e34e26c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/406.json
@@ -0,0 +1 @@
+{"CASES": [137], "DRUG": ["VORICONAZOLE"], "FATAL": [17], "PATHOLOGY": "fusarium infection", "RECOVERED": [27]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/407.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/407.json
new file mode 100644
index 00000000000..3eb79fbcd62
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/407.json
@@ -0,0 +1 @@
+{"CASES": [6826, 471], "DRUG": ["FAMPYRA", "FAMPRIDINE"], "FATAL": [123, 1], "PATHOLOGY": "gait disturbance", "RECOVERED": [1782, 84]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/408.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/408.json
new file mode 100644
index 00000000000..19e8947542c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/408.json
@@ -0,0 +1 @@
+{"CASES": [184], "DRUG": ["KEYTRUDA"], "FATAL": [17], "PATHOLOGY": "gallbladder cancer", "RECOVERED": [10]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/409.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/409.json
new file mode 100644
index 00000000000..460ea79bc9c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/409.json
@@ -0,0 +1 @@
+{"CASES": [190, 337, 437, 162, 673, 314, 268, 581, 211, 1115, 1437, 796, 215, 292, 258, 1104, 109, 864], "DRUG": ["METHOTREXATE", "NIVOLUMAB", "PACLITAXEL", "CYRAMZA", "KEYTRUDA", "TAXOTERE", "SUTENT", "HERCEPTIN", "IRINOTECAN", "DOCETAXEL", "OPDIVO", "XELODA", "AVASTIN", "LONSURF", "TEGAFUR, GIMERACIL, OTERACIL", "CAPECITABINE", "TRASTUZUMAB", "TEGAFUR, GIMERACIL, OTERACIL POTASSIUM"], "FATAL": [74, 58, 49, 16, 63, 26, 22, 40, 13, 62, 78, 43, 11, 14, 9, 33, 3, 9], "PATHOLOGY": "gastric cancer", "RECOVERED": [59, 60, 61, 39, 61, 129, 20, 179, 26, 292, 237, 165, 129, 136, 21, 268, 14, 127]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/41.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/41.json
new file mode 100644
index 00000000000..84b7aa711f5
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/41.json
@@ -0,0 +1 @@
+{"CASES": [10696, 175, 146, 528, 882, 5368], "DRUG": ["EYLEA", "EYLEA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "EYLEA 40 MG/ML SOLUTION FOR INJECTION IN A VIAL", "AVASTIN", "BROLUCIZUMAB", "BEOVU"], "FATAL": [217, 2, 1, 1, 1, 5], "PATHOLOGY": "age-related macular degeneration", "RECOVERED": [3077, 23, 52, 84, 134, 1246]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/410.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/410.json
new file mode 100644
index 00000000000..ccd03e459d6
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/410.json
@@ -0,0 +1 @@
+{"CASES": [111], "DRUG": ["KEYTRUDA"], "FATAL": [7], "PATHOLOGY": "gastric cancer stage iv", "RECOVERED": [23]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/411.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/411.json
new file mode 100644
index 00000000000..f8300216ae3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/411.json
@@ -0,0 +1 @@
+{"CASES": [473], "DRUG": ["PANTOPRAZOLE"], "FATAL": [1], "PATHOLOGY": "gastritis", "RECOVERED": [167]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/412.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/412.json
new file mode 100644
index 00000000000..07af6e13716
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/412.json
@@ -0,0 +1 @@
+{"CASES": [245], "DRUG": ["LEVOFLOXACIN"], "FATAL": [2], "PATHOLOGY": "gastroenteritis", "RECOVERED": [125]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/413.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/413.json
new file mode 100644
index 00000000000..8d06efaff65
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/413.json
@@ -0,0 +1 @@
+{"CASES": [167], "DRUG": ["LUTATHERA"], "FATAL": [9], "PATHOLOGY": "gastroenteropancreatic neuroendocrine tumour disease", "RECOVERED": [28]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/414.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/414.json
new file mode 100644
index 00000000000..77e380b9b62
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/414.json
@@ -0,0 +1 @@
+{"CASES": [144], "DRUG": ["SUTENT"], "FATAL": [6], "PATHOLOGY": "gastrointestinal cancer metastatic", "RECOVERED": [4]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/415.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/415.json
new file mode 100644
index 00000000000..6e5bea7974a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/415.json
@@ -0,0 +1 @@
+{"CASES": [426, 192], "DRUG": ["SUTENT", "STIVARGA"], "FATAL": [54, 8], "PATHOLOGY": "gastrointestinal carcinoma", "RECOVERED": [16, 14]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/416.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/416.json
new file mode 100644
index 00000000000..4a2dded9870
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/416.json
@@ -0,0 +1 @@
+{"CASES": [193], "DRUG": ["PANTOPRAZOLE"], "FATAL": [38], "PATHOLOGY": "gastrointestinal disorder", "RECOVERED": [44]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/417.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/417.json
new file mode 100644
index 00000000000..8611a87c691
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/417.json
@@ -0,0 +1 @@
+{"CASES": [161], "DRUG": ["PANTOPRAZOLE"], "FATAL": [6], "PATHOLOGY": "gastrointestinal haemorrhage", "RECOVERED": [109]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/418.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/418.json
new file mode 100644
index 00000000000..2723d60938b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/418.json
@@ -0,0 +1 @@
+{"CASES": [276, 16667, 106, 280, 1821, 187, 1020, 1673, 120, 305, 717, 192], "DRUG": ["TASIGNA", "SUTENT", "GLIVEC FILM-COATED TABLETS", "NEXAVAR", "GLIVEC", "REGORAFENIB", "IMATINIB", "STIVARGA", "SUNITINIB", "IMATINIB MESILATE", "SUTENT 12.5 MG", "AVAPRITINIB"], "FATAL": [68, 3544, 18, 34, 215, 15, 74, 76, 5, 12, 28, 6], "PATHOLOGY": "gastrointestinal stromal tumour", "RECOVERED": [49, 2119, 3, 21, 182, 38, 79, 314, 26, 3, 144, 13]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/419.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/419.json
new file mode 100644
index 00000000000..d0d7e283065
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/419.json
@@ -0,0 +1 @@
+{"CASES": [659, 1435, 228], "DRUG": ["ESOMEPRAZOLE", "PANTOPRAZOLE", "ESOMEPRAZOLE MAGNESIUM"], "FATAL": [12, 13, 2], "PATHOLOGY": "gastrooesophageal reflux disease", "RECOVERED": [196, 428, 1]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/42.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/42.json
new file mode 100644
index 00000000000..c040e42efa1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/42.json
@@ -0,0 +1 @@
+{"CASES": [341, 208], "DRUG": ["OLANZAPINE", "ZYPREXA"], "FATAL": [13, 4], "PATHOLOGY": "aggression", "RECOVERED": [104, 39]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/420.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/420.json
new file mode 100644
index 00000000000..2fe2f49a953
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/420.json
@@ -0,0 +1 @@
+{"CASES": [151, 191], "DRUG": ["CEREZYME", "ZAVESCA"], "FATAL": [22, 9], "PATHOLOGY": "gaucher's disease", "RECOVERED": [24, 16]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/421.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/421.json
new file mode 100644
index 00000000000..a909074fa3e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/421.json
@@ -0,0 +1 @@
+{"CASES": [172, 128, 737, 231, 387, 244, 263, 294, 477, 257, 188], "DRUG": ["LUMYKRAS", "GEFITINIB", "TAGRISSO", "OSIMERTINIB", "RUBRACA", "IRESSA", "SOTORASIB", "LYNPARZA", "MEKINIST", "BRAFTOVI", "DABRAFENIB"], "FATAL": [25, 10, 56, 15, 23, 14, 15, 11, 16, 6, 3], "PATHOLOGY": "gene mutation", "RECOVERED": [20, 46, 68, 46, 80, 22, 59, 39, 149, 59, 43]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/422.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/422.json
new file mode 100644
index 00000000000..fa7ae9d0438
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/422.json
@@ -0,0 +1 @@
+{"CASES": [659, 659, 113, 2080, 1402, 277], "DRUG": ["MIDAZOLAM", "FENTANYL CITRATE", "DEXMEDETOMIDINE", "FENTANYL", "SUFENTANIL", "DEXAMETHASONE"], "FATAL": [41, 29, 4, 61, 26, 2], "PATHOLOGY": "general anaesthesia", "RECOVERED": [407, 233, 56, 1003, 1064, 232]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/423.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/423.json
new file mode 100644
index 00000000000..bd27ca07474
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/423.json
@@ -0,0 +1 @@
+{"CASES": [302], "DRUG": ["CYMBALTA"], "FATAL": [5], "PATHOLOGY": "generalised anxiety disorder", "RECOVERED": [70]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/424.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/424.json
new file mode 100644
index 00000000000..86cd519716d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/424.json
@@ -0,0 +1 @@
+{"CASES": [126, 1669, 233, 366, 787, 2104], "DRUG": ["BRIVIACT", "KEPPRA", "VIMPAT", "MIDAZOLAM", "LACOSAMIDE", "LEVETIRACETAM"], "FATAL": [3, 38, 5, 6, 12, 19], "PATHOLOGY": "generalised tonic-clonic seizure", "RECOVERED": [7, 415, 62, 68, 104, 638]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/425.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/425.json
new file mode 100644
index 00000000000..a3116ec4511
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/425.json
@@ -0,0 +1 @@
+{"CASES": [299, 867, 126, 294, 119, 725], "DRUG": ["INSULATARD", "LEVEMIR FLEXPEN", "LANTUS", "NOVORAPID FLEXPEN", "HUMALOG MIX25", "HUMALOG"], "FATAL": [12, 14, 2, 4, 1, 4], "PATHOLOGY": "gestational diabetes", "RECOVERED": [126, 584, 50, 151, 75, 273]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/426.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/426.json
new file mode 100644
index 00000000000..d66d91ba25a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/426.json
@@ -0,0 +1 @@
+{"CASES": [300], "DRUG": ["METHOTREXATE"], "FATAL": [13], "PATHOLOGY": "gestational trophoblastic tumour", "RECOVERED": [51]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/427.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/427.json
new file mode 100644
index 00000000000..3b3892b6833
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/427.json
@@ -0,0 +1 @@
+{"CASES": [239, 2246], "DRUG": ["TOCILIZUMAB", "ROACTEMRA"], "FATAL": [17, 50], "PATHOLOGY": "giant cell arteritis", "RECOVERED": [44, 380]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/428.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/428.json
new file mode 100644
index 00000000000..94cae47bf45
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/428.json
@@ -0,0 +1 @@
+{"CASES": [157], "DRUG": ["KEYTRUDA"], "FATAL": [9], "PATHOLOGY": "gingival cancer", "RECOVERED": [43]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/429.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/429.json
new file mode 100644
index 00000000000..fb15de696f1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/429.json
@@ -0,0 +1 @@
+{"CASES": [346, 794, 215, 192], "DRUG": ["BRIMONIDINE TARTRATE", "AZOPT", "AZARGA", "LUMIGAN"], "FATAL": [56, 37, 7, 2], "PATHOLOGY": "glaucoma", "RECOVERED": [70, 546, 149, 44]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/43.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/43.json
new file mode 100644
index 00000000000..7da4ce3f761
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/43.json
@@ -0,0 +1 @@
+{"CASES": [657, 269, 923], "DRUG": ["ZYPREXA", "MIDAZOLAM", "OLANZAPINE"], "FATAL": [74, 29, 64], "PATHOLOGY": "agitation", "RECOVERED": [172, 135, 308]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/430.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/430.json
new file mode 100644
index 00000000000..e6907d4d515
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/430.json
@@ -0,0 +1 @@
+{"CASES": [2989, 104, 513, 2319, 192, 417, 141, 223], "DRUG": ["TEMODAL", "KEYTRUDA", "BEVACIZUMAB", "TEMOZOLOMIDE", "DEXAMETHASONE", "AVASTIN", "RADIATION THERAPY", "STIVARGA"], "FATAL": [570, 19, 68, 287, 20, 42, 14, 6], "PATHOLOGY": "glioblastoma", "RECOVERED": [606, 7, 57, 410, 32, 55, 9, 38]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/431.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/431.json
new file mode 100644
index 00000000000..f989b2e3597
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/431.json
@@ -0,0 +1 @@
+{"CASES": [1240, 121, 207, 104, 852, 134], "DRUG": ["TEMODAL", "DEXAMETHASONE", "BEVACIZUMAB", "RADIATION THERAPY", "TEMOZOLOMIDE", "AVASTIN"], "FATAL": [220, 20, 33, 11, 85, 8], "PATHOLOGY": "glioblastoma multiforme", "RECOVERED": [250, 18, 28, 4, 180, 7]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/432.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/432.json
new file mode 100644
index 00000000000..42fc70eddec
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/432.json
@@ -0,0 +1 @@
+{"CASES": [611, 884, 325, 786], "DRUG": ["TEMOZOLOMIDE", "TEMODAL", "AVASTIN", "BEVACIZUMAB"], "FATAL": [58, 68, 20, 41], "PATHOLOGY": "glioma", "RECOVERED": [67, 210, 30, 10]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/433.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/433.json
new file mode 100644
index 00000000000..29178f8a9a7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/433.json
@@ -0,0 +1 @@
+{"CASES": [173, 311, 147, 456], "DRUG": ["RITUXIMAB", "SOLIRIS 300 MG", "CELLCEPT", "CICLOSPORIN"], "FATAL": [6, 9, 3, 8], "PATHOLOGY": "glomerulonephritis", "RECOVERED": [63, 74, 45, 127]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/434.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/434.json
new file mode 100644
index 00000000000..ef378303596
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/434.json
@@ -0,0 +1 @@
+{"CASES": [216], "DRUG": ["SOLIRIS 300 MG"], "FATAL": [5], "PATHOLOGY": "glomerulonephritis membranoproliferative", "RECOVERED": [63]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/435.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/435.json
new file mode 100644
index 00000000000..172a5c1b7b5
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/435.json
@@ -0,0 +1 @@
+{"CASES": [192], "DRUG": ["CICLOSPORIN"], "FATAL": [6], "PATHOLOGY": "glomerulonephritis membranous", "RECOVERED": [60]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/436.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/436.json
new file mode 100644
index 00000000000..e72f78ffbed
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/436.json
@@ -0,0 +1 @@
+{"CASES": [119, 117, 205], "DRUG": ["JANUVIA", "JARDIANCE", "VICTOZA"], "FATAL": [4, 2, 1], "PATHOLOGY": "glucose tolerance impaired", "RECOVERED": [23, 38, 72]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/437.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/437.json
new file mode 100644
index 00000000000..e94af68a232
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/437.json
@@ -0,0 +1 @@
+{"CASES": [1928, 1212, 303], "DRUG": ["FEBUXOSTAT", "ADENURIC", "ADENURIC 80 MG FILM-COATED TABLETS"], "FATAL": [170, 53, 5], "PATHOLOGY": "gout", "RECOVERED": [582, 522, 181]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/438.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/438.json
new file mode 100644
index 00000000000..81fa17be817
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/438.json
@@ -0,0 +1 @@
+{"CASES": [1304, 1099, 9355, 1529, 117, 384, 106, 1477, 1648, 184, 1274, 250, 327, 117, 195, 775, 956, 302], "DRUG": ["BUDESONIDE", "ALEMTUZUMAB", "CICLOSPORIN", "CELLCEPT", "DEXAMETHASONE", "BASILIXIMAB", "JAKAVI TABLETS", "JAKAVI", "METHOTREXATE", "SIROLIMUS", "MYCOPHENOLATE MOFETIL", "ABATACEPT", "TACROLIMUS", "IMATINIB", "RAPAMUNE", "BUSULFAN", "RUXOLITINIB", "AZATHIOPRINE"], "FATAL": [425, 358, 1718, 272, 19, 53, 14, 177, 183, 20, 136, 23, 29, 10, 13, 44, 49, 15], "PATHOLOGY": "graft versus host disease", "RECOVERED": [155, 107, 1666, 200, 2, 44, 22, 99, 367, 57, 224, 82, 79, 16, 29, 224, 133, 26]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/439.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/439.json
new file mode 100644
index 00000000000..d41efd6b858
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/439.json
@@ -0,0 +1 @@
+{"CASES": [358, 249], "DRUG": ["BUDESONIDE", "CICLOSPORIN"], "FATAL": [290, 159], "PATHOLOGY": "graft versus host disease in gastrointestinal tract", "RECOVERED": [21, 33]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/44.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/44.json
new file mode 100644
index 00000000000..15f4e47ee37
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/44.json
@@ -0,0 +1 @@
+{"CASES": [192], "DRUG": ["FILGRASTIM"], "FATAL": [9], "PATHOLOGY": "agranulocytosis", "RECOVERED": [45]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/440.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/440.json
new file mode 100644
index 00000000000..c024f44623c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/440.json
@@ -0,0 +1 @@
+{"CASES": [108, 138, 163, 130], "DRUG": ["BASILIXIMAB", "CICLOSPORIN", "RUXOLITINIB", "MYCOPHENOLATE MOFETIL"], "FATAL": [12, 12, 3, 2], "PATHOLOGY": "graft versus host disease in skin", "RECOVERED": [24, 22, 11, 1]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/441.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/441.json
new file mode 100644
index 00000000000..c770349b0b2
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/441.json
@@ -0,0 +1 @@
+{"CASES": [102, 131, 1062, 482, 118, 403], "DRUG": ["CICLOSPORIN", "METHOTREXATE", "NUCALA", "MEPOLIZUMAB", "AZATHIOPRINE", "RITUXIMAB"], "FATAL": [18, 10, 50, 21, 2, 6], "PATHOLOGY": "granulomatosis with polyangiitis", "RECOVERED": [32, 14, 215, 118, 5, 71]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/442.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/442.json
new file mode 100644
index 00000000000..4e5fbd8c838
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/442.json
@@ -0,0 +1 @@
+{"CASES": [1788, 340, 486], "DRUG": ["SOMATROPIN", "NUTROPIN AQ 5 MG/ML", "OMNITROPE"], "FATAL": [24, 4, 2], "PATHOLOGY": "growth hormone deficiency", "RECOVERED": [394, 66, 122]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/443.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/443.json
new file mode 100644
index 00000000000..c1f3ecc07e3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/443.json
@@ -0,0 +1 @@
+{"CASES": [166], "DRUG": ["SOMATROPIN"], "FATAL": [8], "PATHOLOGY": "growth retardation", "RECOVERED": [35]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/444.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/444.json
new file mode 100644
index 00000000000..f8d5f3b6e2c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/444.json
@@ -0,0 +1 @@
+{"CASES": [471, 253, 646, 135], "DRUG": ["HUMAN NORMAL IMMUNOGLOBULIN", "HUMAN NORMAL IMMUNOGLOBULIN (IV)", "PRIVIGEN", "KIOVIG"], "FATAL": [52, 26, 17, 1], "PATHOLOGY": "guillain-barre syndrome", "RECOVERED": [88, 105, 297, 100]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/445.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/445.json
new file mode 100644
index 00000000000..49a5cb08065
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/445.json
@@ -0,0 +1 @@
+{"CASES": [179, 1585], "DRUG": ["OSELTAMIVIR", "TAMIFLU"], "FATAL": [47, 293], "PATHOLOGY": "h1n1 influenza", "RECOVERED": [25, 299]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/446.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/446.json
new file mode 100644
index 00000000000..b001e2f674d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/446.json
@@ -0,0 +1 @@
+{"CASES": [394, 782], "DRUG": ["PROPRANOLOL HYDROCHLORIDE", "HEMANGIOL"], "FATAL": [8, 4], "PATHOLOGY": "haemangioma", "RECOVERED": [192, 364]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/447.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/447.json
new file mode 100644
index 00000000000..6eb3cf3d493
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/447.json
@@ -0,0 +1 @@
+{"CASES": [203], "DRUG": ["FENTANYL"], "FATAL": [113], "PATHOLOGY": "haematoma", "RECOVERED": [75]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/448.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/448.json
new file mode 100644
index 00000000000..90b0fb92a31
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/448.json
@@ -0,0 +1 @@
+{"CASES": [353], "DRUG": ["FILGRASTIM"], "FATAL": [19], "PATHOLOGY": "haematopoietic stem cell mobilisation", "RECOVERED": [111]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/449.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/449.json
new file mode 100644
index 00000000000..45625c233d4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/449.json
@@ -0,0 +1 @@
+{"CASES": [1782], "DRUG": ["EXJADE"], "FATAL": [259], "PATHOLOGY": "haemochromatosis", "RECOVERED": [331]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/45.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/45.json
new file mode 100644
index 00000000000..8bce8c3081b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/45.json
@@ -0,0 +1 @@
+{"CASES": [151], "DRUG": ["SELINCRO"], "FATAL": [5], "PATHOLOGY": "alcoholism", "RECOVERED": [95]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/450.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/450.json
new file mode 100644
index 00000000000..138ff897b85
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/450.json
@@ -0,0 +1 @@
+{"CASES": [196], "DRUG": ["ARANESP"], "FATAL": [4], "PATHOLOGY": "haemoglobin decreased", "RECOVERED": [27]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/451.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/451.json
new file mode 100644
index 00000000000..afde2bc8911
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/451.json
@@ -0,0 +1 @@
+{"CASES": [133, 148, 167, 281], "DRUG": ["CICLOSPORIN", "SOLIRIS 300 MG", "RITUXIMAB", "EXJADE"], "FATAL": [35, 26, 17, 18], "PATHOLOGY": "haemolytic anaemia", "RECOVERED": [19, 15, 15, 30]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/452.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/452.json
new file mode 100644
index 00000000000..46376586849
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/452.json
@@ -0,0 +1 @@
+{"CASES": [277, 1131, 14066, 174], "DRUG": ["SOLIRIS 300 MG CONCENTRATE FOR SOLUTION FOR INFUSION", "SOLIRIS", "SOLIRIS 300 MG", "ECULIZUMAB"], "FATAL": [76, 131, 1303, 11], "PATHOLOGY": "haemolytic uraemic syndrome", "RECOVERED": [35, 237, 2033, 75]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/453.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/453.json
new file mode 100644
index 00000000000..933de925694
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/453.json
@@ -0,0 +1 @@
+{"CASES": [514, 340, 444, 1375], "DRUG": ["ALEMTUZUMAB", "ANAKINRA", "DEXAMETHASONE", "CICLOSPORIN"], "FATAL": [205, 96, 87, 255], "PATHOLOGY": "haemophagocytic lymphohistiocytosis", "RECOVERED": [69, 6, 90, 246]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/454.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/454.json
new file mode 100644
index 00000000000..8647436eb46
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/454.json
@@ -0,0 +1 @@
+{"CASES": [765, 110, 1214, 343], "DRUG": ["NOVOSEVEN", "EMICIZUMAB", "HEMLIBRA", "ADVATE"], "FATAL": [206, 7, 53, 15], "PATHOLOGY": "haemophilia", "RECOVERED": [222, 18, 289, 74]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/455.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/455.json
new file mode 100644
index 00000000000..097e2e17b9c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/455.json
@@ -0,0 +1 @@
+{"CASES": [255, 334], "DRUG": ["NOVOSEVEN", "HEMLIBRA"], "FATAL": [26, 10], "PATHOLOGY": "haemophilia a with anti factor viii", "RECOVERED": [130, 102]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/456.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/456.json
new file mode 100644
index 00000000000..d784635476b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/456.json
@@ -0,0 +1 @@
+{"CASES": [449], "DRUG": ["HEMLIBRA"], "FATAL": [20], "PATHOLOGY": "haemophilia a without inhibitors", "RECOVERED": [126]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/457.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/457.json
new file mode 100644
index 00000000000..77b931a2d80
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/457.json
@@ -0,0 +1 @@
+{"CASES": [241, 2103, 118, 112, 180, 124, 103], "DRUG": ["PRAXBIND", "NOVOSEVEN", "OCTREOTIDE", "PLAVIX", "PANTOPRAZOLE", "ADVATE", "ELIQUIS"], "FATAL": [141, 965, 27, 6, 8, 2, 1], "PATHOLOGY": "haemorrhage", "RECOVERED": [25, 387, 29, 14, 115, 27, 21]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/458.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/458.json
new file mode 100644
index 00000000000..25d560b92c8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/458.json
@@ -0,0 +1 @@
+{"CASES": [1127], "DRUG": ["EXJADE"], "FATAL": [143], "PATHOLOGY": "haemosiderosis", "RECOVERED": [300]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/459.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/459.json
new file mode 100644
index 00000000000..8a46a331978
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/459.json
@@ -0,0 +1 @@
+{"CASES": [748, 244, 217], "DRUG": ["CLADRIBINE", "LITAK", "RITUXIMAB"], "FATAL": [70, 10, 4], "PATHOLOGY": "hairy cell leukaemia", "RECOVERED": [147, 153, 91]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/46.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/46.json
new file mode 100644
index 00000000000..dd5a4ac56d9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/46.json
@@ -0,0 +1 @@
+{"CASES": [191, 241], "DRUG": ["BUSULFAN", "CICLOSPORIN"], "FATAL": [46, 51], "PATHOLOGY": "allogenic bone marrow transplantation therapy", "RECOVERED": [33, 42]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/460.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/460.json
new file mode 100644
index 00000000000..e430aea0448
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/460.json
@@ -0,0 +1 @@
+{"CASES": [459, 494], "DRUG": ["ZYPREXA", "OLANZAPINE"], "FATAL": [14, 1], "PATHOLOGY": "hallucination", "RECOVERED": [146, 140]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/461.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/461.json
new file mode 100644
index 00000000000..0581bc6e488
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/461.json
@@ -0,0 +1 @@
+{"CASES": [118, 1178, 164, 198, 112], "DRUG": ["DOCETAXEL", "KEYTRUDA", "OPDIVO", "ERBITUX", "PEMBROLIZUMAB"], "FATAL": [26, 101, 14, 9, 3], "PATHOLOGY": "head and neck cancer", "RECOVERED": [15, 253, 39, 60, 11]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/462.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/462.json
new file mode 100644
index 00000000000..cbfd80779d8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/462.json
@@ -0,0 +1 @@
+{"CASES": [898, 1116], "DRUG": ["AIMOVIG", "IBUPROFEN"], "FATAL": [14, 8], "PATHOLOGY": "headache", "RECOVERED": [112, 262]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/463.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/463.json
new file mode 100644
index 00000000000..350e97ec673
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/463.json
@@ -0,0 +1 @@
+{"CASES": [378], "DRUG": ["SYNAGIS"], "FATAL": [35], "PATHOLOGY": "heart disease congenital", "RECOVERED": [74]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/464.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/464.json
new file mode 100644
index 00000000000..d44a8e8f034
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/464.json
@@ -0,0 +1 @@
+{"CASES": [150], "DRUG": ["ENTRESTO"], "FATAL": [6], "PATHOLOGY": "heart failure with preserved ejection fraction", "RECOVERED": [34]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/465.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/465.json
new file mode 100644
index 00000000000..a80db38e89c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/465.json
@@ -0,0 +1 @@
+{"CASES": [3817, 149, 173, 246], "DRUG": ["ENTRESTO", "FORXIGA", "VALSARTAN, SACUBITRIL", "JARDIANCE"], "FATAL": [305, 10, 11, 2], "PATHOLOGY": "heart failure with reduced ejection fraction", "RECOVERED": [837, 40, 18, 115]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/466.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/466.json
new file mode 100644
index 00000000000..5d84e5cdc86
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/466.json
@@ -0,0 +1 @@
+{"CASES": [361, 2518, 266, 684, 1049, 130], "DRUG": ["AZATHIOPRINE", "CICLOSPORIN", "MYCOPHENOLATE MOFETIL", "RAPAMUNE", "CELLCEPT", "BASILIXIMAB"], "FATAL": [85, 332, 27, 61, 54, 5], "PATHOLOGY": "heart transplant", "RECOVERED": [95, 923, 61, 88, 287, 96]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/467.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/467.json
new file mode 100644
index 00000000000..0cc135e830a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/467.json
@@ -0,0 +1 @@
+{"CASES": [458], "DRUG": ["ESMYA"], "FATAL": [6], "PATHOLOGY": "heavy menstrual bleeding", "RECOVERED": [201]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/468.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/468.json
new file mode 100644
index 00000000000..4b353d8f571
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/468.json
@@ -0,0 +1 @@
+{"CASES": [104, 130, 542, 100, 5940, 311, 306, 727, 1759, 178, 309], "DRUG": ["VOTRIENT FILM-COATED TABLETS", "SORAFENIB", "SUTENT", "CAPECITABINE", "NEXAVAR", "KEYTRUDA", "NEXAVAR 200 MG FILM-COATED TABLETS", "LENVIMA", "STIVARGA", "CABOMETYX", "AFINITOR"], "FATAL": [14, 13, 44, 8, 442, 17, 8, 18, 40, 4, 6], "PATHOLOGY": "hepatic cancer", "RECOVERED": [16, 30, 117, 25, 894, 18, 141, 125, 251, 43, 14]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/469.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/469.json
new file mode 100644
index 00000000000..82e5e9ff0b6
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/469.json
@@ -0,0 +1 @@
+{"CASES": [118, 492], "DRUG": ["STIVARGA", "NEXAVAR"], "FATAL": [24, 58], "PATHOLOGY": "hepatic cancer metastatic", "RECOVERED": [10, 74]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/47.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/47.json
new file mode 100644
index 00000000000..578c2c2a1a7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/47.json
@@ -0,0 +1 @@
+{"CASES": [158, 2721, 243, 3090, 212, 810], "DRUG": ["CELLCEPT", "CICLOSPORIN", "THIOTEPA", "BUSULFAN", "MELPHALAN", "ALEMTUZUMAB"], "FATAL": [33, 417, 24, 301, 17, 29], "PATHOLOGY": "allogenic stem cell transplantation", "RECOVERED": [12, 681, 67, 815, 53, 310]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/470.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/470.json
new file mode 100644
index 00000000000..e65950e51c6
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/470.json
@@ -0,0 +1 @@
+{"CASES": [565, 500, 434, 108, 295, 494, 209, 435, 447, 264, 473, 246], "DRUG": ["EPCLUSA", "HARVONI", "EXVIERA", "BARACLUDE", "SOVALDI", "PEGASYS", "REBETOL", "INCIVO", "PEGINTRON", "RIBAVIRIN", "OLYSIO", "HEPSERA"], "FATAL": [100, 64, 51, 11, 24, 35, 11, 20, 17, 9, 12, 4], "PATHOLOGY": "hepatic cirrhosis", "RECOVERED": [92, 123, 78, 12, 54, 118, 24, 74, 48, 59, 48, 29]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/471.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/471.json
new file mode 100644
index 00000000000..81d49335b49
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/471.json
@@ -0,0 +1 @@
+{"CASES": [304], "DRUG": ["EPCLUSA"], "FATAL": [59], "PATHOLOGY": "hepatic cirrhosis, hepatitis c", "RECOVERED": [44]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/472.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/472.json
new file mode 100644
index 00000000000..d8ca22b76a1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/472.json
@@ -0,0 +1 @@
+{"CASES": [456], "DRUG": ["NEXAVAR"], "FATAL": [16], "PATHOLOGY": "hepatic neoplasm", "RECOVERED": [108]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/473.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/473.json
new file mode 100644
index 00000000000..1a7171af6ca
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/473.json
@@ -0,0 +1 @@
+{"CASES": [126, 121, 707, 183, 104, 279, 175, 281, 854, 335, 1334, 903, 780, 3006, 104, 383, 8551, 4189, 307, 637, 498, 203, 6747, 3854, 1324, 2550, 14476, 7217, 2611, 1348, 2664, 3359, 2493, 416, 784, 6025, 189, 196, 234, 276, 227, 16513, 18553, 124, 3442, 10168, 141910, 1190, 142, 290, 150, 200, 71196, 14518, 149, 832, 458, 4724, 401, 104, 2367, 6205, 1914, 619, 644, 682], "DRUG": ["GANCICLOVIR", "PEGINTRON 120 MICROGRAMS POWDER AND SOLVENT FOR SOLUTION FOR INJECTION", "OLYSIO 150 MG HARD CAPSULES", "AZATHIOPRINE", "INTRONA 3 MILLION IU", "LAMIVUDINE", "VIRAFERONPEG", "DAKLINZA 60 MG FILM-COATED TABLETS", "EXVIERA 250 MG FILM-COATED TABLETS", "PEGASYS 180 MICROGRAMS SOLUTION FOR INJECTION", "TENOFOVIR DISOPROXIL FUMARATE", "HARVONI 90 MG/400 MG FILM-COATED TABLETS", "PEGASYS 180 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "BARACLUDE", "NEXAVAR", "VICTRELIS", "SOVALDI", "EXVIERA", "PEGASYS 135 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "SOFOSBUVIR", "BARACLUDE 0.5 MG FILM-COATED TABLETS", "CELLCEPT", "EPCLUSA", "DAKLINZA", "SIMEPREVIR", "ENTECAVIR", "HARVONI", "OLYSIO", "INCIVO 375 MG FILM-COATED TABLETS", "VEMLIDY", "ZEPATIER", "DACLATASVIR", "BOCEPREVIR", "EPCLUSA 400 MG/100 MG FILM-COATED TABLETS", "SOFOSBUVIR, VELPATASVIR", "REBETOL", "MAVIRET", "PEGASYS 180 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED PEN", "LEDIPASVIR, SOFOSBUVIR", "DASABUVIR", "PEGINTRON 100 MICROGRAMS POWDER AND SOLVENT FOR SOLUTION FOR INJECTION", "INCIVO", "RIBAVIRIN", "PEGINTRON 100 MICROGRAMS POWDER AND SOLVENT FOR SOLUTION FOR INJECTION IN PRE-FILLED PEN", "VIREAD", "PEGINTERFERON ALFA-2B", "PEGASYS", "INTERFERON ALFA-2B", "VIEKIRAX", "SOVALDI 400 MG FILM-COATED TABLETS", "VIREAD 245 MG FILM-COATED TABLETS", "TENOFOVIR DISOPROXIL", "PEGINTRON", "PEGINTERFERON ALFA-2A", "PEGINTRON 50 MICROGRAMS POWDER AND SOLVENT FOR SOLUTION FOR INJECTION", "INFERGEN", "STRIBILD", "HEPSERA", "TELAPREVIR", "BARACLUDE FILM-COATED TABLETS", "TRUVADA", "INTRONA", "ATRIPLA", "HEPSERA TABLETS", "ADEFOVIR DIPIVOXIL", "INTERFERON ALFACON-1"], "FATAL": [48, 21, 122, 23, 13, 34, 20, 27, 81, 31, 115, 75, 62, 237, 8, 27, 593, 262, 19, 36, 28, 11, 358, 200, 67, 124, 694, 345, 124, 64, 121, 143, 98, 15, 27, 199, 6, 6, 7, 8, 6, 413, 458, 3, 83, 244, 3252, 27, 3, 6, 3, 4, 1379, 252, 2, 11, 5, 48, 4, 1, 21, 51, 10, 3, 1, 1], "PATHOLOGY": "hepatitis", "RECOVERED": [8, 64, 156, 29, 61, 52, 36, 91, 238, 126, 326, 231, 318, 431, 2, 62, 1712, 1120, 129, 82, 93, 37, 1235, 532, 198, 459, 2220, 1488, 1119, 231, 479, 477, 608, 97, 135, 1465, 51, 54, 23, 72, 111, 4700, 2975, 63, 521, 2440, 27651, 285, 60, 116, 43, 86, 12342, 4618, 79, 218, 52, 827, 124, 18, 149, 345, 90, 66, 106, 94]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/474.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/474.json
new file mode 100644
index 00000000000..89045ba99a6
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/474.json
@@ -0,0 +1 @@
+{"CASES": [253, 1330, 2880, 477, 1310, 2404, 3368, 187, 148, 3944, 243, 458, 4661, 102, 2343, 1789, 580, 644], "DRUG": ["LAMIVUDINE", "TENOFOVIR DISOPROXIL FUMARATE", "BARACLUDE", "BARACLUDE 0.5 MG FILM-COATED TABLETS", "VEMLIDY", "ENTECAVIR", "VIREAD", "TENOFOVIR DISOPROXIL", "VIREAD 245 MG FILM-COATED TABLETS", "PEGASYS", "PEGINTRON", "STRIBILD", "HEPSERA", "BARACLUDE FILM-COATED TABLETS", "TRUVADA", "ATRIPLA", "HEPSERA TABLETS", "ADEFOVIR DIPIVOXIL"], "FATAL": [34, 115, 232, 28, 64, 91, 79, 4, 3, 70, 4, 5, 48, 1, 21, 10, 3, 1], "PATHOLOGY": "hepatitis b", "RECOVERED": [31, 325, 414, 80, 224, 428, 518, 77, 43, 947, 39, 52, 808, 18, 149, 88, 60, 106]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/475.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/475.json
new file mode 100644
index 00000000000..a41408b9f8d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/475.json
@@ -0,0 +1 @@
+{"CASES": [683, 121, 159, 306, 281, 851, 639, 899, 383, 8499, 4156, 259, 629, 6714, 3842, 1314, 14390, 7199, 2601, 2601, 3339, 2487, 410, 784, 5793, 209, 189, 196, 276, 16357, 9962, 18168, 1150, 135985, 142, 290, 69316, 14332, 821, 401, 6093, 668], "DRUG": ["OLYSIO 150 MG HARD CAPSULES", "PEGINTRON 120 MICROGRAMS POWDER AND SOLVENT FOR SOLUTION FOR INJECTION", "VIRAFERONPEG", "PEGASYS 180 MICROGRAMS SOLUTION FOR INJECTION", "DAKLINZA 60 MG FILM-COATED TABLETS", "EXVIERA 250 MG FILM-COATED TABLETS", "PEGASYS 180 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "HARVONI 90 MG/400 MG FILM-COATED TABLETS", "VICTRELIS", "SOVALDI", "EXVIERA", "PEGASYS 135 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "SOFOSBUVIR", "EPCLUSA", "DAKLINZA", "SIMEPREVIR", "HARVONI", "OLYSIO", "INCIVO 375 MG FILM-COATED TABLETS", "ZEPATIER", "DACLATASVIR", "BOCEPREVIR", "EPCLUSA 400 MG/100 MG FILM-COATED TABLETS", "SOFOSBUVIR, VELPATASVIR", "REBETOL", "LEDIPASVIR, SOFOSBUVIR", "MAVIRET", "PEGASYS 180 MICROGRAMS SOLUTION FOR INJECTION IN PRE-FILLED PEN", "DASABUVIR", "INCIVO", "PEGINTERFERON ALFA-2B", "RIBAVIRIN", "INTERFERON ALFA-2B", "PEGASYS", "VIEKIRAX", "SOVALDI 400 MG FILM-COATED TABLETS", "PEGINTRON", "PEGINTERFERON ALFA-2A", "INFERGEN", "TELAPREVIR", "INTRONA", "INTERFERON ALFACON-1"], "FATAL": [122, 21, 19, 31, 27, 81, 57, 75, 27, 591, 262, 15, 34, 356, 200, 67, 693, 345, 124, 114, 137, 98, 15, 27, 199, 7, 6, 6, 8, 413, 244, 444, 27, 3108, 3, 6, 1363, 252, 11, 4, 50, 1], "PATHOLOGY": "hepatitis c", "RECOVERED": [152, 64, 25, 112, 91, 238, 234, 228, 62, 1703, 1112, 95, 81, 1227, 528, 198, 2205, 1485, 1118, 473, 477, 607, 95, 135, 1409, 22, 51, 54, 72, 4677, 2343, 2859, 277, 26135, 60, 116, 11928, 4594, 218, 124, 337, 85]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/476.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/476.json
new file mode 100644
index 00000000000..a23ae70393e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/476.json
@@ -0,0 +1 @@
+{"CASES": [189, 203, 136, 116, 167, 17597, 390, 276], "DRUG": ["EPCLUSA", "PEGINTRON", "DAKLINZA", "SOVALDI", "HARVONI", "PEGASYS", "RIBAVIRIN", "PEGINTERFERON ALFA-2A"], "FATAL": [15, 9, 4, 3, 4, 156, 3, 1], "PATHOLOGY": "hepatitis c virus test", "RECOVERED": [39, 17, 2, 38, 39, 2844, 68, 58]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/477.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/477.json
new file mode 100644
index 00000000000..792223389f2
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/477.json
@@ -0,0 +1 @@
+{"CASES": [186, 166, 429, 340], "DRUG": ["EPCLUSA", "HARVONI", "PEGASYS", "RIBAVIRIN"], "FATAL": [15, 4, 6, 1], "PATHOLOGY": "hepatitis c virus test positive", "RECOVERED": [39, 39, 190, 52]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/478.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/478.json
new file mode 100644
index 00000000000..cd9f4e1412e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/478.json
@@ -0,0 +1 @@
+{"CASES": [470, 103, 185], "DRUG": ["PEGASYS", "PEGINTRON 100 MICROGRAMS POWDER AND SOLVENT FOR SOLUTION FOR INJECTION", "PEGINTRON"], "FATAL": [30, 6, 2], "PATHOLOGY": "hepatitis viral", "RECOVERED": [172, 55, 18]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/479.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/479.json
new file mode 100644
index 00000000000..844af3c68b0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/479.json
@@ -0,0 +1 @@
+{"CASES": [194], "DRUG": ["CUPRIOR"], "FATAL": [2], "PATHOLOGY": "hepato-lenticular degeneration", "RECOVERED": [49]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/48.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/48.json
new file mode 100644
index 00000000000..b8703d54341
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/48.json
@@ -0,0 +1 @@
+{"CASES": [1040, 274], "DRUG": ["BUSULFAN", "ALEMTUZUMAB"], "FATAL": [93, 16], "PATHOLOGY": "allogenic stem cell transplantation, bone marrow conditioning regimen", "RECOVERED": [137, 180]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/480.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/480.json
new file mode 100644
index 00000000000..493d91f01e9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/480.json
@@ -0,0 +1 @@
+{"CASES": [103, 126, 40359, 164, 112, 134, 5018, 1407, 2103, 196, 937, 225, 2708, 165, 226, 176], "DRUG": ["IPILIMUMAB", "NEXAVAR 200 MG", "NEXAVAR", "AVASTIN", "LENVATINIB", "PEMBROLIZUMAB", "LENVIMA", "SORAFENIB", "CABOMETYX", "ATEZOLIZUMAB", "NEXAVAR 200 MG FILM-COATED TABLETS", "KEYTRUDA", "STIVARGA", "BEVACIZUMAB", "REGORAFENIB", "STIVARGA 40 MG FILM-COATED TABLETS"], "FATAL": [14, 16, 4880, 17, 11, 10, 362, 98, 136, 12, 51, 11, 128, 7, 4, 2], "PATHOLOGY": "hepatocellular carcinoma", "RECOVERED": [1, 14, 7546, 38, 12, 17, 1883, 258, 324, 40, 366, 17, 404, 17, 57, 54]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/481.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/481.json
new file mode 100644
index 00000000000..33d0cfd5665
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/481.json
@@ -0,0 +1 @@
+{"CASES": [130, 590, 239, 416, 372, 369], "DRUG": ["TRODELVY", "RIBOCICLIB", "ALPELISIB", "IBRANCE", "KISQALI", "FULVESTRANT"], "FATAL": [6, 24, 6, 9, 4, 4], "PATHOLOGY": "her2 negative breast cancer", "RECOVERED": [24, 94, 30, 43, 68, 78]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/482.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/482.json
new file mode 100644
index 00000000000..76050cf288d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/482.json
@@ -0,0 +1 @@
+{"CASES": [245, 1733, 119, 202, 319, 2047, 255, 521, 165], "DRUG": ["PACLITAXEL", "DOCETAXEL", "DENOSUMAB", "CAPECITABINE", "PERTUZUMAB", "HERCEPTIN", "NERLYNX", "PERJETA", "KADCYLA"], "FATAL": [25, 101, 6, 9, 12, 51, 6, 11, 2], "PATHOLOGY": "her2 positive breast cancer", "RECOVERED": [73, 487, 97, 46, 61, 431, 54, 105, 3]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/483.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/483.json
new file mode 100644
index 00000000000..3df538a187b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/483.json
@@ -0,0 +1 @@
+{"CASES": [661, 2848, 4228], "DRUG": ["C1 ESTERASE INHIBITOR (HUMAN)", "CINRYZE", "RUCONEST"], "FATAL": [13, 55, 16], "PATHOLOGY": "hereditary angioedema", "RECOVERED": [108, 1042, 391]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/484.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/484.json
new file mode 100644
index 00000000000..a8ba3aea4ed
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/484.json
@@ -0,0 +1 @@
+{"CASES": [144], "DRUG": ["C1 ESTERASE INHIBITOR (HUMAN)"], "FATAL": [1], "PATHOLOGY": "hereditary angioedema with c1 esterase inhibitor deficiency", "RECOVERED": [26]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/485.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/485.json
new file mode 100644
index 00000000000..9709289154e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/485.json
@@ -0,0 +1 @@
+{"CASES": [256], "DRUG": ["C1 ESTERASE INHIBITOR (HUMAN)"], "FATAL": [10], "PATHOLOGY": "hereditary angioedema, prophylaxis", "RECOVERED": [63]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/486.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/486.json
new file mode 100644
index 00000000000..4dceb69b643
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/486.json
@@ -0,0 +1 @@
+{"CASES": [522, 1889], "DRUG": ["ZOSTAVAX", "SHINGRIX"], "FATAL": [4, 5], "PATHOLOGY": "herpes zoster", "RECOVERED": [90, 817]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/487.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/487.json
new file mode 100644
index 00000000000..4f399c36479
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/487.json
@@ -0,0 +1 @@
+{"CASES": [1643], "DRUG": ["SHINGRIX"], "FATAL": [5], "PATHOLOGY": "herpes zoster immunisation", "RECOVERED": [735]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/488.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/488.json
new file mode 100644
index 00000000000..6b60557b3a7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/488.json
@@ -0,0 +1 @@
+{"CASES": [114], "DRUG": ["STELARA"], "FATAL": [2], "PATHOLOGY": "hidradenitis", "RECOVERED": [8]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/489.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/489.json
new file mode 100644
index 00000000000..004ff685dfb
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/489.json
@@ -0,0 +1 @@
+{"CASES": [146, 167], "DRUG": ["RITUXIMAB", "YESCARTA"], "FATAL": [15, 12], "PATHOLOGY": "high-grade b-cell lymphoma", "RECOVERED": [69, 58]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/49.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/49.json
new file mode 100644
index 00000000000..dd266674a4a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/49.json
@@ -0,0 +1 @@
+{"CASES": [621], "DRUG": ["XELJANZ"], "FATAL": [1], "PATHOLOGY": "alopecia", "RECOVERED": [32]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/490.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/490.json
new file mode 100644
index 00000000000..36a27d52e3d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/490.json
@@ -0,0 +1 @@
+{"CASES": [104], "DRUG": ["XARELTO"], "FATAL": [12], "PATHOLOGY": "hip arthroplasty", "RECOVERED": [21]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/491.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/491.json
new file mode 100644
index 00000000000..c666cb9d553
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/491.json
@@ -0,0 +1 @@
+{"CASES": [125, 121, 174, 131, 217, 1750, 638, 671, 1176, 5473, 6981, 435, 106, 6686, 352, 220, 165, 365, 1440, 549, 1684, 136, 446, 1592, 150, 230, 2533, 797, 3180, 14583, 198, 157, 4309, 5477, 290, 2013, 398, 598, 1077, 2626, 790, 6334, 10952, 239, 667, 1548, 123, 1606, 9256, 371, 2296, 318, 621, 226, 954, 3286, 1044, 156, 554, 1582, 485, 165, 314, 137, 734, 922, 412, 12050, 523, 107, 4511, 10242, 168, 691, 318, 2545, 197, 399, 881, 371, 745, 528, 2564, 463, 991, 172, 2208, 297, 903, 3116, 2075, 811, 192422, 194, 966, 57084, 354411], "DRUG": ["VIRAMUNE 200 MG TABLETS", "VIREAD 245 MG FILM-COATED TABLETS", "EPIVIR 150 MG FILM-COATED TABLETS", "KALETRA SOFT CAPSULES", "CRIXIVAN 400 MG HARD CAPSULES", "VIRAMUNE", "ENFUVIRTIDE", "SUSTIVA", "EMTRIVA", "ISENTRESS", "EFAVIRENZ", "FORTOVASE", "PEGASYS", "LAMIVUDINE", "SAQUINAVIR", "RALTEGRAVIR", "ETRAVIRINE", "STAVUDINE", "INTELENCE", "PREZISTA", "NEVIRAPINE", "KALETRA ORAL SOLUTION", "ABACAVIR, LAMIVUDINE", "KIVEXA", "EMTRICITABINE/TENOFOVIR DISOPROXIL MYLAN", "FOSAMPRENAVIR", "DOLUTEGRAVIR", "KALETRA 200 MG/50 MG FILM-COATED TABLETS", "DARUNAVIR", "KALETRA", "INDINAVIR SULFATE", "VIRACEPT", "CRIXIVAN", "EPIVIR", "COBICISTAT", "TIVICAY", "VIRAMUNE TABLETS", "TIVICAY FILM-COATED TABLETS", "INDINAVIR", "DESCOVY", "TIVICAY FILM-COATED TABLET", "ATAZANAVIR", "COMBIVIR", "STRIBILD 150 MG/150 MG/200 MG/245 MG FILM-COATED TABLETS", "TRIUMEQ FILM-COATED TABLETS", "LOPINAVIR, RITONAVIR", "TRIZIVIR", "INVIRASE", "ABACAVIR", "AMPRENAVIR", "EMTRICITABINE", "ZIDOVUDINE, LAMIVUDINE", "RITONAVIR", "TENOFOVIR DISOPROXIL", "TENOFOVIR DISOPROXIL FUMARATE", "ATAZANAVIR SULFATE", "CELSENTRI", "NORVIR 100MG SOFT CAPSULE", "ATRIPLA 600 MG/200 MG/245 MG FILM-COATED TABLETS", "EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE", "STOCRIN", "EMTRICITABINE, EFAVIRENZ, TENOFOVIR DISOPROXIL FUMARATE", "FUZEON", "EMTRICITABINE, TENOFOVIR ALAFENAMIDE", "SYMTUZA", "TRIUMEQ FILM-COATED TABLET", "REKAMBYS", "BIKTARVY", "ISENTRESS 400 MG FILM-COATED TABLETS", "REKAMBYS 900 MG PROLONGED-RELEASE SUSPENSION FOR INJECTION", "NORVIR", "VIREAD", "KIVEXA 600 MG/300 MG FILM-COATED TABLETS", "TRUVADA 200 MG/245 MG FILM-COATED TABLETS", "AGENERASE", "GENVOYA", "COMBIVIR 150 MG/300 MG FILM-COATED TABLETS", "EPIVIR FILM-COATED TABLETS", "ABACAVIR SULFATE, LAMIVUDINE", "EVIPLERA", "EDURANT", "TRIUMEQ 50 MG/600 MG/300 MG FILM-COATED TABLETS", "REYATAZ", "ZERIT", "CABOTEGRAVIR", "MARAVIROC", "ABACAVIR SULFATE", "EMTRICITABINE, TENOFOVIR DISOPROXIL", "DOVATO", "ZIAGEN", "TRIUMEQ", "APTIVUS", "TRUVADA", "REYATAZ HARD CAPSULES", "BIKTARVY 50 MG/200 MG/25 MG FILM-COATED TABLETS", "STRIBILD", "ATRIPLA"], "FATAL": [33, 27, 35, 26, 36, 252, 78, 81, 133, 566, 614, 36, 8, 497, 26, 16, 12, 26, 100, 37, 107, 8, 26, 87, 8, 12, 130, 40, 151, 682, 9, 7, 188, 227, 12, 83, 16, 24, 43, 100, 29, 229, 388, 8, 22, 51, 4, 49, 275, 11, 67, 9, 17, 6, 25, 86, 27, 4, 14, 40, 12, 4, 7, 3, 16, 18, 8, 234, 10, 2, 84, 189, 3, 12, 5, 39, 3, 6, 12, 5, 10, 7, 34, 6, 12, 2, 24, 3, 9, 28, 17, 6, 1043, 1, 4, 220, 1186], "PATHOLOGY": "hiv infection", "RECOVERED": [57, 33, 96, 61, 149, 472, 37, 125, 393, 1546, 1418, 23, 11, 1452, 13, 71, 44, 57, 321, 131, 469, 31, 64, 417, 69, 66, 520, 244, 773, 2973, 62, 53, 1142, 1127, 82, 530, 198, 175, 205, 506, 205, 1467, 2064, 71, 187, 422, 32, 401, 1793, 70, 651, 60, 150, 34, 242, 975, 318, 72, 237, 459, 208, 59, 76, 53, 148, 299, 173, 2342, 238, 68, 1320, 1130, 78, 297, 61, 651, 106, 31, 126, 110, 213, 237, 623, 111, 199, 66, 305, 88, 50, 512, 716, 312, 10114, 89, 399, 3196, 19803]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/492.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/492.json
new file mode 100644
index 00000000000..b317a724dff
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/492.json
@@ -0,0 +1 @@
+{"CASES": [405, 1176, 1636], "DRUG": ["STRIBILD", "TRUVADA", "ATRIPLA"], "FATAL": [5, 9, 10], "PATHOLOGY": "hiv infection, hepatitis b", "RECOVERED": [45, 67, 67]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/493.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/493.json
new file mode 100644
index 00000000000..37f0e69c40a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/493.json
@@ -0,0 +1 @@
+{"CASES": [704], "DRUG": ["TRUVADA"], "FATAL": [4], "PATHOLOGY": "hiv infection, prophylaxis against hiv infection", "RECOVERED": [32]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/494.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/494.json
new file mode 100644
index 00000000000..60fbe2333ff
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/494.json
@@ -0,0 +1 @@
+{"CASES": [111, 241, 106, 376, 240, 117, 296, 117, 127, 159, 147], "DRUG": ["LAMIVUDINE", "KALETRA", "GENVOYA", "COMBIVIR", "NORVIR", "EFAVIRENZ", "CRIXIVAN", "EPIVIR", "STRIBILD", "TRUVADA", "REKAMBYS"], "FATAL": [22, 23, 9, 22, 13, 6, 12, 2, 2, 2, 1], "PATHOLOGY": "hiv test positive", "RECOVERED": [41, 66, 33, 34, 106, 27, 129, 42, 26, 71, 84]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/495.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/495.json
new file mode 100644
index 00000000000..432277ff3d1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/495.json
@@ -0,0 +1 @@
+{"CASES": [341, 714, 519, 135, 1983, 284, 358, 391, 166, 124, 134, 103, 163], "DRUG": ["CYTARABINE", "DOXORUBICIN HYDROCHLORIDE", "CHLORMETHINE", "RITUXIMAB", "ADCETRIS", "CARMUSTINE", "KEYTRUDA", "BRENTUXIMAB VEDOTIN", "DEXAMETHASONE", "METHOTREXATE", "CAELYX", "FILGRASTIM", "PEMBROLIZUMAB"], "FATAL": [111, 133, 74, 15, 178, 20, 17, 18, 6, 4, 4, 3, 1], "PATHOLOGY": "hodgkin's disease", "RECOVERED": [59, 208, 76, 22, 569, 73, 77, 70, 74, 13, 63, 89, 41]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/496.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/496.json
new file mode 100644
index 00000000000..75ffb03d1d0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/496.json
@@ -0,0 +1 @@
+{"CASES": [103, 113, 165, 562], "DRUG": ["FULVESTRANT", "RIBOCICLIB", "DOCETAXEL", "IBRANCE"], "FATAL": [25, 5, 2, 4], "PATHOLOGY": "hormone receptor positive breast cancer", "RECOVERED": [17, 16, 34, 40]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/497.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/497.json
new file mode 100644
index 00000000000..e693ed6276a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/497.json
@@ -0,0 +1 @@
+{"CASES": [100, 441, 239, 216, 304, 228], "DRUG": ["TRODELVY", "RIBOCICLIB", "IBRANCE", "ALPELISIB", "KISQALI", "FULVESTRANT"], "FATAL": [4, 17, 8, 6, 4, 2], "PATHOLOGY": "hormone receptor positive her2 negative breast cancer", "RECOVERED": [18, 60, 24, 23, 53, 38]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/498.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/498.json
new file mode 100644
index 00000000000..da228284be3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/498.json
@@ -0,0 +1 @@
+{"CASES": [156], "DRUG": ["FASLODEX"], "FATAL": [15], "PATHOLOGY": "hormone suppression therapy", "RECOVERED": [9]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/499.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/499.json
new file mode 100644
index 00000000000..effa94c306a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/499.json
@@ -0,0 +1 @@
+{"CASES": [167], "DRUG": ["DEXAMETHASONE"], "FATAL": [27], "PATHOLOGY": "hormone therapy", "RECOVERED": [2]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/5.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/5.json
new file mode 100644
index 00000000000..f5334542e62
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/5.json
@@ -0,0 +1 @@
+{"CASES": [319, 276, 701, 197], "DRUG": ["CUBICIN", "LEVOFLOXACIN", "AMIKACIN", "TIGECYCLINE"], "FATAL": [44, 16, 8, 1], "PATHOLOGY": "abscess", "RECOVERED": [95, 145, 166, 25]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/50.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/50.json
new file mode 100644
index 00000000000..92ab963778e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/50.json
@@ -0,0 +1 @@
+{"CASES": [191], "DRUG": ["IRINOTECAN"], "FATAL": [44], "PATHOLOGY": "alveolar rhabdomyosarcoma", "RECOVERED": [24]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/500.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/500.json
new file mode 100644
index 00000000000..db1b6de10e1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/500.json
@@ -0,0 +1 @@
+{"CASES": [122, 623, 310], "DRUG": ["NUBEQA 300 MG", "ERLEADA", "XTANDI"], "FATAL": [6, 20, 5], "PATHOLOGY": "hormone-dependent prostate cancer", "RECOVERED": [16, 131, 50]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/501.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/501.json
new file mode 100644
index 00000000000..7e64956a53e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/501.json
@@ -0,0 +1 @@
+{"CASES": [2354, 9796, 117, 2800, 303, 294, 464, 796, 688, 504, 340, 191, 157], "DRUG": ["JEVTANA", "XTANDI", "OLAPARIB", "XOFIGO", "PLUVICTO", "LYNPARZA", "NUBEQA 300 MG", "ERLEADA", "ENZALUTAMIDE", "CABAZITAXEL", "DOCETAXEL", "KEYTRUDA", "ABIRATERONE ACETATE"], "FATAL": [366, 1188, 13, 300, 22, 21, 27, 37, 29, 16, 8, 2, 1], "PATHOLOGY": "hormone-refractory prostate cancer", "RECOVERED": [562, 1703, 12, 245, 13, 41, 71, 255, 130, 41, 18, 17, 9]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/502.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/502.json
new file mode 100644
index 00000000000..7c73307bad7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/502.json
@@ -0,0 +1 @@
+{"CASES": [1079], "DRUG": ["XOFIGO"], "FATAL": [134], "PATHOLOGY": "hormone-refractory prostate cancer, metastases to bone", "RECOVERED": [114]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/503.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/503.json
new file mode 100644
index 00000000000..222e37b9eba
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/503.json
@@ -0,0 +1 @@
+{"CASES": [168, 356], "DRUG": ["PRIVIGEN", "HIZENTRA"], "FATAL": [7, 4], "PATHOLOGY": "humoral immune defect", "RECOVERED": [65, 81]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/504.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/504.json
new file mode 100644
index 00000000000..70a443d0036
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/504.json
@@ -0,0 +1 @@
+{"CASES": [230, 185, 229, 366], "DRUG": ["CINACALCET HYDROCHLORIDE", "ZOMETA", "CINACALCET", "MIMPARA"], "FATAL": [47, 33, 15, 6], "PATHOLOGY": "hypercalcaemia", "RECOVERED": [63, 48, 72, 90]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/505.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/505.json
new file mode 100644
index 00000000000..c19cbe947a0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/505.json
@@ -0,0 +1 @@
+{"CASES": [117], "DRUG": ["CINACALCET HYDROCHLORIDE"], "FATAL": [45], "PATHOLOGY": "hypercalcaemia of malignancy", "RECOVERED": [40]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/506.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/506.json
new file mode 100644
index 00000000000..5f4ba614e14
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/506.json
@@ -0,0 +1 @@
+{"CASES": [206], "DRUG": ["NUCALA"], "FATAL": [3], "PATHOLOGY": "hypereosinophilic syndrome", "RECOVERED": [9]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/507.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/507.json
new file mode 100644
index 00000000000..d462acb6135
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/507.json
@@ -0,0 +1 @@
+{"CASES": [285, 211, 110, 100, 127, 318], "DRUG": ["LANTUS", "JARDIANCE", "INSULIN GLARGINE", "ACTRAPID", "APIDRA", "HUMALOG"], "FATAL": [14, 10, 3, 2, 2, 2], "PATHOLOGY": "hyperglycaemia", "RECOVERED": [99, 80, 28, 18, 14, 83]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/508.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/508.json
new file mode 100644
index 00000000000..c7c90fc1d91
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/508.json
@@ -0,0 +1 @@
+{"CASES": [7599], "DRUG": ["VELTASSA"], "FATAL": [740], "PATHOLOGY": "hyperkalaemia", "RECOVERED": [989]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/509.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/509.json
new file mode 100644
index 00000000000..af329643277
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/509.json
@@ -0,0 +1 @@
+{"CASES": [170], "DRUG": ["REPATHA"], "FATAL": [12], "PATHOLOGY": "hyperlipidaemia", "RECOVERED": [57]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/51.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/51.json
new file mode 100644
index 00000000000..924b1d2d061
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/51.json
@@ -0,0 +1 @@
+{"CASES": [208], "DRUG": ["SUTENT"], "FATAL": [4], "PATHOLOGY": "alveolar soft part sarcoma", "RECOVERED": [46]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/510.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/510.json
new file mode 100644
index 00000000000..1c6d1025bde
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/510.json
@@ -0,0 +1 @@
+{"CASES": [289, 3255, 437, 222], "DRUG": ["CINACALCET", "MIMPARA", "MIMPARA 30 MG FILM-COATED TABLETS", "CINACALCET HYDROCHLORIDE"], "FATAL": [17, 143, 4, 2], "PATHOLOGY": "hyperparathyroidism", "RECOVERED": [74, 756, 251, 54]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/511.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/511.json
new file mode 100644
index 00000000000..909f7062557
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/511.json
@@ -0,0 +1 @@
+{"CASES": [672], "DRUG": ["MIMPARA"], "FATAL": [4], "PATHOLOGY": "hyperparathyroidism primary", "RECOVERED": [130]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/512.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/512.json
new file mode 100644
index 00000000000..e16a74b93c9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/512.json
@@ -0,0 +1 @@
+{"CASES": [2140, 180], "DRUG": ["MIMPARA", "MIMPARA 30 MG FILM-COATED TABLETS"], "FATAL": [120, 4], "PATHOLOGY": "hyperparathyroidism secondary", "RECOVERED": [488, 108]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/513.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/513.json
new file mode 100644
index 00000000000..b36a8778301
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/513.json
@@ -0,0 +1 @@
+{"CASES": [178, 313, 918], "DRUG": ["OFEV", "XOLAIR", "AERIUS"], "FATAL": [13, 2, 4], "PATHOLOGY": "hypersensitivity", "RECOVERED": [64, 66, 320]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/514.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/514.json
new file mode 100644
index 00000000000..8fac3c5c90e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/514.json
@@ -0,0 +1 @@
+{"CASES": [197, 227, 32737, 11309, 1677, 133, 1617, 115, 167, 48692, 119, 126, 2060, 917, 164, 624, 3932, 181, 694, 122, 3216, 322, 1888, 228, 359, 120, 1913, 332, 155, 142, 533, 2214, 619, 12532, 716, 6279, 122, 149, 2522, 675, 260, 110, 2745, 8722, 550, 252, 2962, 4145, 650, 191, 102, 106, 165, 4249, 767, 802, 563, 296, 1060, 162, 109, 331, 695, 237, 125, 376, 266, 343, 1660, 376, 863, 981], "DRUG": ["CLOPIDOGREL", "ESBRIET", "TRACLEER", "REVATIO", "BOSENTAN", "REVATIO 20 MG", "SILDENAFIL CITRATE", "TOCOPHEROL", "APROVEL 75 MG TABLETS", "OPSUMIT", "COAPROVEL TABLETS", "TADALAFIL", "SILDENAFIL", "VIAGRA", "BUMETANIDE", "APROVEL 150 MG TABLETS", "ADCIRCA", "EXFORGE 5 MG/80 MG FILM-COATED TABLETS", "COAPROVEL 300 MG/12.5 MG TABLETS", "VALSARTAN, AMLODIPINE, HYDROCHLOROTHIAZIDE", "APROVEL", "PROPRANOLOL HYDROCHLORIDE", "MACITENTAN", "MICARDISPLUS TABLETS", "ILOPROST", "ELIQUIS", "ADEMPAS", "MICARDIS 40 MG TABLETS", "MICARDIS 80 MG TABLETS", "VOLIBRIS", "APROVEL 300 MG TABLETS", "AMBRISENTAN", "ADCIRCA 20 MG", "EXFORGE", "UPTRAVI", "RASILEZ", "ANTIHYPERTENSIVES", "APROVEL 300 MG FILM-COATED TABLETS", "TELMISARTAN", "COAPROVEL 150 MG/12.5 MG TABLETS", "EXFORGE 5 MG/160 MG FILM-COATED TABLETS", "COPALIA", "MICARDIS TABLETS", "MICARDIS", "HYDROCHLOROTHIAZIDE, TELMISARTAN", "RASILEZ HCT", "EXFORGE HCT", "COAPROVEL", "VALSARTAN, AMLODIPINE", "PLAVIX", "RIOCIGUAT", "IRBESARTAN TEVA", "MICARDISPLUS 80 MG/12.5 MG TABLETS", "IRBESARTAN", "VALSARTAN, SACUBITRIL", "VALSARTAN, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE", "MICARDISPLUS", "ENALAPRIL MALEATE", "SPIRONOLACTONE", "CLOPIDOGREL HYDROGEN SULFATE", "AMLODIPINE, ALISKIREN", "OFEV", "COAPROVEL 300 MG/25 MG FILM-COATED TABLETS", "COAPROVEL 300 MG/12.5 MG FILM-COATED TABLETS", "APROVEL TABLETS", "TWYNSTA", "TREPROSTINIL", "MICARDIS 80 MG", "ALISKIREN", "TEKTURNA", "ENTRESTO", "HYDROCHLOROTHIAZIDE, IRBESARTAN"], "FATAL": [60, 53, 7062, 2249, 327, 25, 283, 15, 21, 5994, 14, 14, 222, 96, 17, 63, 376, 17, 58, 10, 249, 23, 121, 14, 22, 7, 111, 18, 8, 7, 26, 104, 29, 561, 32, 270, 5, 6, 96, 21, 8, 3, 74, 229, 14, 6, 70, 96, 14, 4, 2, 2, 3, 77, 13, 12, 8, 4, 14, 2, 1, 3, 6, 2, 1, 3, 2, 2, 9, 2, 2, 2], "PATHOLOGY": "hypertension", "RECOVERED": [47, 6, 4766, 1502, 140, 12, 183, 5, 103, 6330, 42, 37, 396, 163, 24, 267, 815, 54, 373, 29, 1199, 82, 226, 106, 62, 16, 319, 157, 70, 15, 256, 285, 227, 3191, 123, 2033, 36, 45, 944, 417, 138, 25, 1238, 3129, 194, 38, 834, 1577, 114, 73, 30, 57, 128, 1919, 95, 220, 219, 61, 284, 86, 15, 35, 395, 105, 49, 149, 54, 108, 392, 120, 178, 339]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/515.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/515.json
new file mode 100644
index 00000000000..dc064e79012
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/515.json
@@ -0,0 +1 @@
+{"CASES": [323, 255], "DRUG": ["DEXAMETHASONE", "PROPRANOLOL HYDROCHLORIDE"], "FATAL": [20, 6], "PATHOLOGY": "hyperthyroidism", "RECOVERED": [37, 136]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/516.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/516.json
new file mode 100644
index 00000000000..0873ce978ca
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/516.json
@@ -0,0 +1 @@
+{"CASES": [2232, 630, 316, 4129], "DRUG": ["BETMIGA", "TOVIAZ 4 MG", "OXYBUTYNIN", "TOVIAZ"], "FATAL": [18, 2, 1, 10], "PATHOLOGY": "hypertonic bladder", "RECOVERED": [847, 316, 95, 1096]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/517.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/517.json
new file mode 100644
index 00000000000..f50806502db
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/517.json
@@ -0,0 +1 @@
+{"CASES": [154, 1303, 1249, 325], "DRUG": ["FASTURTEC", "FEBUXOSTAT", "ADENURIC", "ADENURIC 80 MG FILM-COATED TABLETS"], "FATAL": [22, 72, 18, 4], "PATHOLOGY": "hyperuricaemia", "RECOVERED": [77, 572, 542, 199]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/518.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/518.json
new file mode 100644
index 00000000000..f987bb096fa
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/518.json
@@ -0,0 +1 @@
+{"CASES": [333], "DRUG": ["LYRICA"], "FATAL": [1], "PATHOLOGY": "hypoaesthesia", "RECOVERED": [148]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/519.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/519.json
new file mode 100644
index 00000000000..c302bafb4c8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/519.json
@@ -0,0 +1 @@
+{"CASES": [305, 211, 619, 3009, 126, 1518], "DRUG": ["HUMAN NORMAL IMMUNOGLOBULIN", "HYQVIA", "KIOVIG", "HIZENTRA", "KIOVIG 100 MG/ML SOLUTION FOR INFUSION", "PRIVIGEN"], "FATAL": [16, 7, 16, 53, 2, 17], "PATHOLOGY": "hypogammaglobulinaemia", "RECOVERED": [106, 67, 398, 770, 95, 926]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/52.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/52.json
new file mode 100644
index 00000000000..f194c548b5e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/52.json
@@ -0,0 +1 @@
+{"CASES": [175, 318, 311, 163, 502], "DRUG": ["VYNDAQEL", "BORTEZOMIB", "DEXAMETHASONE", "TAFAMIDIS MEGLUMINE", "DARZALEX"], "FATAL": [34, 44, 28, 13, 21], "PATHOLOGY": "amyloidosis", "RECOVERED": [17, 107, 40, 102, 88]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/520.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/520.json
new file mode 100644
index 00000000000..264d6580188
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/520.json
@@ -0,0 +1 @@
+{"CASES": [177], "DRUG": ["HIZENTRA"], "FATAL": [1], "PATHOLOGY": "hypoglobulinaemia", "RECOVERED": [40]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/521.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/521.json
new file mode 100644
index 00000000000..87f1cd695e0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/521.json
@@ -0,0 +1 @@
+{"CASES": [527, 236], "DRUG": ["GLUCAGON", "BAQSIMI"], "FATAL": [5, 1], "PATHOLOGY": "hypoglycaemia", "RECOVERED": [147, 86]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/522.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/522.json
new file mode 100644
index 00000000000..87ce668bb19
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/522.json
@@ -0,0 +1 @@
+{"CASES": [212], "DRUG": ["TESTOSTERONE"], "FATAL": [13], "PATHOLOGY": "hypogonadism", "RECOVERED": [45]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/523.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/523.json
new file mode 100644
index 00000000000..c756388913f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/523.json
@@ -0,0 +1 @@
+{"CASES": [180], "DRUG": ["ZYPREXA"], "FATAL": [2], "PATHOLOGY": "hypomania", "RECOVERED": [78]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/524.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/524.json
new file mode 100644
index 00000000000..a1edb73a05c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/524.json
@@ -0,0 +1 @@
+{"CASES": [245, 110], "DRUG": ["KEYTRUDA", "ERBITUX 5 MG/ML"], "FATAL": [18, 3], "PATHOLOGY": "hypopharyngeal cancer", "RECOVERED": [75, 47]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/525.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/525.json
new file mode 100644
index 00000000000..affe19c2e16
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/525.json
@@ -0,0 +1 @@
+{"CASES": [129, 126], "DRUG": ["HYDROCORTISONE", "SOMATROPIN"], "FATAL": [18, 10], "PATHOLOGY": "hypopituitarism", "RECOVERED": [57, 19]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/526.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/526.json
new file mode 100644
index 00000000000..e728d495956
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/526.json
@@ -0,0 +1 @@
+{"CASES": [21760, 1202, 12485, 117, 360, 106, 283], "DRUG": ["ESBRIET", "PIRFENIDONE", "OFEV", "NINTEDANIB", "ESBRIET 267 MG HARD CAPSULES", "ESBRIET 801 MG FILM-COATED TABLETS", "OFEV 150 MG SOFT CAPSULES"], "FATAL": [4086, 90, 891, 6, 7, 2, 5], "PATHOLOGY": "idiopathic pulmonary fibrosis", "RECOVERED": [2334, 228, 2667, 10, 161, 33, 146]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/527.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/527.json
new file mode 100644
index 00000000000..c7013d0ba5e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/527.json
@@ -0,0 +1 @@
+{"CASES": [599, 217], "DRUG": ["OFEV", "ESBRIET"], "FATAL": [23, 7], "PATHOLOGY": "idiopathic pulmonary fibrosis, interstitial lung disease", "RECOVERED": [115, 25]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/528.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/528.json
new file mode 100644
index 00000000000..779c4022b25
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/528.json
@@ -0,0 +1 @@
+{"CASES": [1501], "DRUG": ["XOLAIR"], "FATAL": [23], "PATHOLOGY": "idiopathic urticaria", "RECOVERED": [195]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/529.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/529.json
new file mode 100644
index 00000000000..1d499e50a13
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/529.json
@@ -0,0 +1 @@
+{"CASES": [136, 274, 381, 141, 146, 129, 132, 964, 101, 109, 179, 1157, 173, 1357], "DRUG": ["VFEND", "ALL OTHER THERAPEUTIC PRODUCTS", "NOT AVAILABLE", "SILDENAFIL", "OLANZAPINE", "IBUPROFEN", "CLOPIDOGREL", "VIAGRA", "KEPPRA", "ALL OTHER NON-THERAPEUTIC PRODUCTS", "APIXABAN", "PEGINTRON", "OSELTAMIVIR", "COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)"], "FATAL": [18, 27, 35, 12, 12, 7, 7, 40, 3, 3, 2, 12, 1, 2], "PATHOLOGY": "ill-defined disorder", "RECOVERED": [23, 48, 57, 19, 3, 56, 33, 131, 8, 16, 64, 35, 41, 477]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/53.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/53.json
new file mode 100644
index 00000000000..f589981639e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/53.json
@@ -0,0 +1 @@
+{"CASES": [634, 372], "DRUG": ["RILUTEK", "RILUZOLE"], "FATAL": [91, 40], "PATHOLOGY": "amyotrophic lateral sclerosis", "RECOVERED": [198, 134]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/530.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/530.json
new file mode 100644
index 00000000000..ededb4e29db
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/530.json
@@ -0,0 +1 @@
+{"CASES": [729], "DRUG": ["TAMIFLU"], "FATAL": [52], "PATHOLOGY": "illness", "RECOVERED": [227]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/531.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/531.json
new file mode 100644
index 00000000000..39436ca99a2
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/531.json
@@ -0,0 +1 @@
+{"CASES": [1275], "DRUG": ["OPTIMARK"], "FATAL": [98], "PATHOLOGY": "imaging procedure", "RECOVERED": [3]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/532.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/532.json
new file mode 100644
index 00000000000..d55931db869
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/532.json
@@ -0,0 +1 @@
+{"CASES": [14772, 205, 257, 302, 1157, 621], "DRUG": ["NPLATE", "DEXAMETHASONE", "HUMAN NORMAL IMMUNOGLOBULIN (IV)", "CICLOSPORIN", "PRIVIGEN", "HUMAN NORMAL IMMUNOGLOBULIN"], "FATAL": [1766, 18, 21, 18, 40, 18], "PATHOLOGY": "immune thrombocytopenia", "RECOVERED": [1384, 25, 48, 50, 652, 140]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/533.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/533.json
new file mode 100644
index 00000000000..5bbb3ab1818
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/533.json
@@ -0,0 +1 @@
+{"CASES": [205, 2240, 1418, 2953, 959, 2600, 974, 7992, 2657, 731, 109, 1505, 135, 2603, 2857155, 1100931, 643, 3409, 413, 281, 4996, 524286, 1432, 447848, 341, 338, 198, 611, 1619, 4837, 592662, 6312, 10661, 4748, 1740, 293, 27976, 300, 51044, 2073, 892, 1929, 7638, 17236], "DRUG": ["SYNFLORIX", "INFANRIX HEXA", "HEXYON", "PREVENAR 13", "PREVENAR", "BEXSERO", "GARDASIL SUSPENSION FOR INJECTION IN A PRE-FILLED SYRINGE", "COMIRNATY COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED) CONCENTRATE FOR DISPERSION FOR INJECTION", "COMIRNATY CONCENTRATE FOR DISPERSION FOR INJECTION", "COMIRNATY ORIGINAL/OMICRON BA.1", "INFANRIX HEXA POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION", "COVID-19 VACCINE JANSSEN (AD26.COV2.S)", "COMIRNATY COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED) DISPERSION FOR INJECTION", "COMIRNATY 30 MICROGRAMS/DOSE DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED)", "COMIRNATY", "SPIKEVAX", "NOT AVAILABLE", "ZOSTAVAX", "M-M-RVAXPRO POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE", "CERVARIX", "COMIRNATY ORIGINAL/OMICRON BA.4-5", "TOZINAMERAN", "M-M-RVAXPRO POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION", "VAXZEVRIA", "GARDASIL 9", "ROTASHIELD", "SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.1", "COMIRNATY 30 MICROGRAMS/DOSE", "SPIKEVAX DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED)", "COMIRNATY COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED)", "COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)", "COMIRNATY CONCENTRATE FOR DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED)", "SHINGRIX", "MENVEO", "JCOVDEN", "COMIRNATY OMICRON XBB.1.5", "M-M-RVAXPRO", "HEXACIMA", "COVID-19 MRNA VACCINE MODERNA (CX-024414)", "FLUCELVAX TETRA", "ELASOMERAN", "SPIKEVAX COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED)", "M-M-RVAXPRO MEASLES, MUMPS AND RUBELLA VACCINE (LIVE) POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION", "NIMENRIX"], "FATAL": [34, 78, 49, 94, 28, 74, 25, 205, 63, 14, 2, 26, 2, 26, 24771, 9471, 5, 26, 3, 2, 35, 3589, 9, 2789, 2, 2, 1, 3, 7, 21, 2475, 25, 39, 17, 6, 1, 93, 1, 151, 5, 2, 3, 8, 8], "PATHOLOGY": "immunisation", "RECOVERED": [100, 1203, 481, 1201, 451, 1134, 504, 4923, 1517, 204, 84, 255, 39, 990, 934155, 375411, 428, 821, 291, 79, 780, 114225, 785, 205694, 138, 170, 63, 158, 605, 1622, 255247, 1480, 4624, 2633, 473, 60, 14923, 143, 17183, 630, 371, 714, 2473, 6979]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/534.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/534.json
new file mode 100644
index 00000000000..f1c213e504e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/534.json
@@ -0,0 +1 @@
+{"CASES": [149, 120, 310, 467, 452, 306, 337, 160, 194, 710, 1377, 103, 499, 226, 727, 150, 342, 3017, 589, 11069, 1865, 936, 662, 723, 2216, 132, 168, 167, 191, 19536], "DRUG": ["ALEMTUZUMAB", "STOCRIN", "INVIRASE", "CRIXIVAN", "LAMIVUDINE", "ABACAVIR", "HUMAN NORMAL IMMUNOGLOBULIN (IV)", "BUSULFAN", "NORVIR", "KALETRA", "HYQVIA", "ISENTRESS", "EFAVIRENZ", "BIKTARVY", "VIRAMUNE", "INDINAVIR", "VIREAD", "PRIVIGEN", "COMBIVIR", "HIZENTRA", "HUMAN NORMAL IMMUNOGLOBULIN", "KIOVIG", "EPIVIR", "STRIBILD", "TRUVADA", "TRIUMEQ", "ATAZANAVIR", "KIOVIG 100 MG/ML SOLUTION FOR INFUSION", "NEVIRAPINE", "ATRIPLA"], "FATAL": [67, 24, 35, 44, 32, 21, 20, 9, 10, 36, 56, 4, 18, 8, 25, 5, 11, 82, 14, 253, 42, 17, 9, 6, 18, 1, 1, 1, 1, 2], "PATHOLOGY": "immunodeficiency", "RECOVERED": [23, 22, 12, 180, 117, 21, 45, 55, 47, 180, 261, 25, 209, 30, 321, 59, 38, 1601, 83, 2402, 269, 600, 96, 26, 120, 36, 11, 141, 24, 625]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/535.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/535.json
new file mode 100644
index 00000000000..d380cc8f8bd
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/535.json
@@ -0,0 +1 @@
+{"CASES": [474, 422, 8305, 1488, 889, 136], "DRUG": ["HUMAN NORMAL IMMUNOGLOBULIN", "KIOVIG", "HIZENTRA", "PRIVIGEN", "HYQVIA", "HUMAN NORMAL IMMUNOGLOBULIN (IV)"], "FATAL": [19, 14, 156, 28, 16, 1], "PATHOLOGY": "immunodeficiency common variable", "RECOVERED": [66, 244, 1772, 680, 150, 28]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/536.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/536.json
new file mode 100644
index 00000000000..12f790c045d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/536.json
@@ -0,0 +1 @@
+{"CASES": [153, 778, 286, 700, 4044, 1149, 222, 2736, 1088, 381, 820, 109, 138, 259, 122, 108], "DRUG": ["SIROLIMUS", "TACROLIMUS", "EVEROLIMUS", "AZATHIOPRINE", "CICLOSPORIN", "BASILIXIMAB", "BUSULFAN", "MYCOPHENOLATE MOFETIL", "CELLCEPT", "RAPAMUNE", "ALEMTUZUMAB", "CARMUSTINE", "ADALIMUMAB", "BUDESONIDE", "METHOTREXATE", "RITUXIMAB"], "FATAL": [49, 169, 52, 102, 548, 146, 25, 294, 112, 38, 79, 10, 12, 12, 4, 1], "PATHOLOGY": "immunosuppressant drug therapy", "RECOVERED": [17, 251, 44, 101, 1138, 343, 23, 824, 293, 84, 241, 60, 56, 151, 38, 43]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/537.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/537.json
new file mode 100644
index 00000000000..c2e9ee2698b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/537.json
@@ -0,0 +1 @@
+{"CASES": [173, 198, 1948, 5722, 1300, 1095, 183, 100, 872, 754, 158, 2017, 480], "DRUG": ["BUDESONIDE", "BUSULFAN", "MYCOPHENOLATE MOFETIL", "CICLOSPORIN", "BASILIXIMAB", "AZATHIOPRINE", "DEXAMETHASONE", "METHOTREXATE", "TACROLIMUS", "ALEMTUZUMAB", "EVEROLIMUS", "CELLCEPT", "RAPAMUNE"], "FATAL": [70, 33, 318, 770, 155, 112, 18, 7, 59, 47, 9, 108, 20], "PATHOLOGY": "immunosuppression", "RECOVERED": [22, 17, 559, 1422, 244, 271, 17, 37, 209, 269, 39, 547, 127]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/538.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/538.json
new file mode 100644
index 00000000000..7d2444815a5
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/538.json
@@ -0,0 +1 @@
+{"CASES": [141, 342, 700], "DRUG": ["ORGALUTRAN", "PUREGON", "OVITRELLE"], "FATAL": [3, 2, 3], "PATHOLOGY": "in vitro fertilisation", "RECOVERED": [62, 28, 421]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/539.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/539.json
new file mode 100644
index 00000000000..55b60bf37e1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/539.json
@@ -0,0 +1 @@
+{"CASES": [420, 1187, 173, 2874], "DRUG": ["OXYBUTYNIN", "BETMIGA", "OXYBUTYNIN HYDROCHLORIDE", "TOVIAZ"], "FATAL": [21, 55, 2, 10], "PATHOLOGY": "incontinence", "RECOVERED": [119, 400, 77, 554]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/54.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/54.json
new file mode 100644
index 00000000000..929383241fd
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/54.json
@@ -0,0 +1 @@
+{"CASES": [28873, 855, 202, 3520, 234, 195, 3481, 136, 233, 170, 188, 588, 5570, 123, 542, 368, 700, 1309, 575, 240, 102], "DRUG": ["ARANESP", "DARBEPOETIN ALFA", "BUSULFAN", "CICLOSPORIN", "EVRENZO", "ENTRESTO", "EXJADE", "REBLOZYL", "SOLIRIS 300 MG", "RITUXIMAB", "REVOLADE", "NEORECORMON", "MIRCERA", "FILGRASTIM", "REVOLADE FILM-COATED TABLETS", "RETACRIT", "IRON", "EPOETIN ALFA", "BINOCRIT", "ELTROMBOPAG", "BINOCRIT 30,000 IU/0.75 ML SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE"], "FATAL": [21757, 606, 67, 618, 38, 26, 451, 16, 27, 17, 18, 53, 501, 11, 42, 23, 36, 49, 19, 7, 2], "PATHOLOGY": "anaemia", "RECOVERED": [1267, 37, 21, 646, 78, 117, 526, 27, 26, 15, 19, 140, 2454, 57, 128, 168, 114, 167, 179, 34, 74]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/540.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/540.json
new file mode 100644
index 00000000000..c698f7b4790
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/540.json
@@ -0,0 +1 @@
+{"CASES": [143], "DRUG": ["FENTANYL"], "FATAL": [5], "PATHOLOGY": "induction and maintenance of anaesthesia", "RECOVERED": [93]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/541.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/541.json
new file mode 100644
index 00000000000..b8e3140af2d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/541.json
@@ -0,0 +1 @@
+{"CASES": [858, 2953, 717, 687, 299], "DRUG": ["SUFENTANIL", "FENTANYL", "FENTANYL CITRATE", "MIDAZOLAM", "DEXAMETHASONE"], "FATAL": [39, 126, 21, 11, 3], "PATHOLOGY": "induction of anaesthesia", "RECOVERED": [602, 1552, 261, 363, 208]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/542.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/542.json
new file mode 100644
index 00000000000..31caa158b17
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/542.json
@@ -0,0 +1 @@
+{"CASES": [190, 574], "DRUG": ["PROPRANOLOL HYDROCHLORIDE", "HEMANGIOL"], "FATAL": [6, 2], "PATHOLOGY": "infantile haemangioma", "RECOVERED": [77, 253]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/543.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/543.json
new file mode 100644
index 00000000000..e5f3f59bb19
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/543.json
@@ -0,0 +1 @@
+{"CASES": [445], "DRUG": ["VIGABATRIN"], "FATAL": [22], "PATHOLOGY": "infantile spasms", "RECOVERED": [115]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/544.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/544.json
new file mode 100644
index 00000000000..162d0a539b7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/544.json
@@ -0,0 +1 @@
+{"CASES": [104, 129, 105, 110, 105, 381, 209, 4073, 706, 7148, 490, 2533, 398, 725, 1112, 3087, 250], "DRUG": ["RAPILYSIN", "RAPILYSIN 10 U", "METALYSE", "RETEPLASE", "LIXIANA", "INTEGRILIN", "PLAVIX 75 MG FILM-COATED TABLETS", "BRILIQUE", "EFIENT", "PLAVIX", "ELIQUIS", "CLOPIDOGREL", "ENOXAPARIN SODIUM", "BRILIQUE 90 MG FILM-COATED TABLETS", "TICAGRELOR", "CLOPIDOGREL HYDROGEN SULFATE", "ENTRESTO"], "FATAL": [43, 41, 33, 26, 20, 50, 21, 408, 61, 585, 36, 168, 22, 36, 53, 124, 1], "PATHOLOGY": "infarction", "RECOVERED": [25, 15, 35, 24, 20, 81, 95, 987, 248, 2122, 65, 790, 96, 373, 286, 761, 24]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/545.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/545.json
new file mode 100644
index 00000000000..466a281012a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/545.json
@@ -0,0 +1 @@
+{"CASES": [385, 106, 225, 1006, 178, 163, 144, 1358, 189, 125, 121, 293, 117, 611, 714, 174, 131, 200, 145, 232, 201, 105, 3729, 220, 274, 1022, 503, 4070, 152, 198, 1765, 186, 3489, 638, 1540, 671, 1195, 178, 1033, 340, 3216, 5494, 139, 230, 386, 1314, 1112, 9226, 496, 643, 7043, 436, 277, 6789, 356, 165, 365, 171, 115, 216, 1440, 233, 770, 551, 950, 231, 1687, 449, 191, 144, 1592, 150, 2603, 230, 3295, 15565, 198, 314, 157, 407, 136, 4349, 1231, 5496, 2013, 292, 2694, 599, 1077, 202, 790, 633, 6353, 11122, 239, 668, 123, 1607, 434, 1643, 371, 9323, 2333, 330, 954, 3294, 1044, 233, 156, 554, 1586, 165, 532, 137, 734, 326, 196, 922, 412, 12096, 523, 107, 4517, 10274, 168, 691, 119, 318, 16310, 2545, 2218, 197, 265, 399, 564, 2583, 881, 371, 746, 529, 465, 991, 301, 903, 3123, 118, 2088, 812, 192472, 194, 199, 966, 57088, 354447, 345, 716], "DRUG": ["ANIDULAFUNGIN", "CANCIDAS 50 MG", "MICAFUNGIN", "CASPOFUNGIN ACETATE", "CICLOSPORIN", "CANCIDAS 50 MG POWDER FOR SOLUTION FOR INFUSION", "VFEND 50 MG", "CASPOFUNGIN", "HUMAN NORMAL IMMUNOGLOBULIN", "VIRAMUNE 200 MG TABLETS", "VIREAD 245 MG FILM-COATED TABLETS", "SYNAGIS POWDER AND SOLVENT FOR SOLUTION FOR INJECTION", "VISTIDE", "MYCAMINE", "TIGECYCLINE", "EPIVIR 150 MG FILM-COATED TABLETS", "KALETRA SOFT CAPSULES", "DEXAMETHASONE", "ROACTEMRA", "VFEND POWDER FOR SOLUTION FOR INFUSION", "REMDESIVIR", "CANCIDAS 50 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "GANCICLOVIR", "CRIXIVAN 400 MG HARD CAPSULES", "AZTREONAM", "CRESEMBA", "POSACONAZOLE", "VORICONAZOLE", "TYGACIL", "TOCILIZUMAB", "VIRAMUNE", "VFEND 200 MG", "CUBICIN", "ENFUVIRTIDE", "CANCIDAS", "SUSTIVA", "EMTRIVA", "LIVTENCITY", "DAPTOMYCIN", "CUBICIN 350 MG", "AMIKACIN", "ISENTRESS", "DIFICLIR 200 MG FILM-COATED TABLETS", "INVANZ", "RIBAVIRIN", "NOXAFIL", "TOBRAMYCIN", "VFEND", "FIDAXOMICIN", "CIDOFOVIR", "EFAVIRENZ", "FORTOVASE", "COLISTIMETHATE SODIUM", "LAMIVUDINE", "SAQUINAVIR", "ETRAVIRINE", "STAVUDINE", "ERTAPENEM", "VFEND 200 MG POWDER FOR SOLUTION FOR INFUSION", "NOT AVAILABLE", "INTELENCE", "RALTEGRAVIR", "DIFICLIR", "PREZISTA", "SYNAGIS", "PRIVIGEN", "NEVIRAPINE", "ABACAVIR, LAMIVUDINE", "MARAVIROC", "KALETRA ORAL SOLUTION", "KIVEXA", "EMTRICITABINE/TENOFOVIR DISOPROXIL MYLAN", "DOLUTEGRAVIR", "FOSAMPRENAVIR", "DARUNAVIR", "KALETRA", "INDINAVIR SULFATE", "CEFUROXIME SODIUM", "VIRACEPT", "VIRAMUNE TABLETS", "VFEND FILM-COATED TABLETS", "CRIXIVAN", "KALETRA 200 MG/50 MG FILM-COATED TABLETS", "EPIVIR", "TIVICAY", "COBICISTAT", "DESCOVY", "TIVICAY FILM-COATED TABLETS", "INDINAVIR", "PEGASYS", "TIVICAY FILM-COATED TABLET", "RITONAVIR", "ATAZANAVIR", "COMBIVIR", "STRIBILD 150 MG/150 MG/200 MG/245 MG FILM-COATED TABLETS", "TRIUMEQ FILM-COATED TABLETS", "TRIZIVIR", "LOPINAVIR, RITONAVIR", "ANTIBIOTICS", "INVIRASE", "AMPRENAVIR", "ABACAVIR", "EMTRICITABINE", "ZIDOVUDINE, LAMIVUDINE", "TENOFOVIR DISOPROXIL FUMARATE", "ATAZANAVIR SULFATE", "CELSENTRI", "TENOFOVIR DISOPROXIL", "NORVIR 100MG SOFT CAPSULE", "ATRIPLA 600 MG/200 MG/245 MG FILM-COATED TABLETS", "EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE", "EMTRICITABINE, EFAVIRENZ, TENOFOVIR DISOPROXIL FUMARATE", "STOCRIN", "EMTRICITABINE, TENOFOVIR ALAFENAMIDE", "SYMTUZA", "FUZEON", "BUDESONIDE", "TRIUMEQ FILM-COATED TABLET", "REKAMBYS", "BIKTARVY", "ISENTRESS 400 MG FILM-COATED TABLETS", "REKAMBYS 900 MG PROLONGED-RELEASE SUSPENSION FOR INJECTION", "NORVIR", "VIREAD", "KIVEXA 600 MG/300 MG FILM-COATED TABLETS", "TRUVADA 200 MG/245 MG FILM-COATED TABLETS", "BUSULFAN", "AGENERASE", "LEVOFLOXACIN", "GENVOYA", "ABACAVIR SULFATE", "COMBIVIR 150 MG/300 MG FILM-COATED TABLETS", "VFEND 200 MG FILM-COATED TABLETS", "EPIVIR FILM-COATED TABLETS", "TAMIFLU", "REYATAZ", "ABACAVIR SULFATE, LAMIVUDINE", "EVIPLERA", "EDURANT", "TRIUMEQ 50 MG/600 MG/300 MG FILM-COATED TABLETS", "ZERIT", "CABOTEGRAVIR", "EMTRICITABINE, TENOFOVIR DISOPROXIL", "DOVATO", "ZIAGEN", "HIZENTRA", "TRIUMEQ", "APTIVUS", "TRUVADA", "REYATAZ HARD CAPSULES", "BEDAQUILINE", "BIKTARVY 50 MG/200 MG/25 MG FILM-COATED TABLETS", "STRIBILD", "ATRIPLA", "KETOCONAZOLE", "COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)"], "FATAL": [168, 40, 80, 340, 57, 50, 44, 399, 53, 33, 27, 65, 25, 128, 147, 35, 26, 39, 28, 44, 35, 18, 613, 36, 44, 159, 77, 618, 23, 29, 252, 26, 461, 78, 187, 81, 136, 20, 114, 36, 337, 566, 14, 23, 38, 122, 101, 824, 44, 57, 614, 36, 21, 506, 26, 12, 26, 12, 8, 15, 100, 16, 52, 37, 63, 15, 107, 26, 11, 8, 87, 8, 138, 12, 154, 714, 9, 14, 7, 18, 6, 188, 52, 227, 83, 12, 109, 24, 43, 8, 29, 23, 229, 388, 8, 22, 4, 52, 13, 49, 11, 275, 67, 9, 25, 86, 27, 6, 4, 14, 40, 4, 12, 3, 16, 7, 4, 18, 8, 234, 10, 2, 84, 189, 3, 12, 2, 5, 256, 39, 34, 3, 4, 6, 8, 36, 12, 5, 10, 7, 6, 12, 3, 9, 29, 1, 17, 6, 1043, 1, 1, 4, 220, 1186, 1, 1], "PATHOLOGY": "infection", "RECOVERED": [40, 46, 10, 147, 18, 32, 30, 242, 21, 57, 33, 85, 25, 155, 144, 96, 61, 45, 23, 62, 48, 49, 865, 149, 47, 158, 60, 1021, 38, 29, 478, 30, 859, 37, 457, 125, 396, 3, 119, 117, 557, 1561, 40, 52, 95, 311, 287, 2508, 85, 114, 1461, 23, 107, 1456, 14, 44, 57, 81, 56, 78, 321, 71, 153, 131, 175, 141, 470, 64, 66, 31, 417, 69, 527, 66, 773, 3202, 62, 162, 53, 203, 58, 1169, 523, 1144, 530, 82, 513, 176, 205, 28, 205, 152, 1467, 2078, 71, 187, 32, 436, 237, 404, 70, 1793, 656, 60, 242, 975, 318, 34, 72, 237, 460, 59, 218, 53, 148, 76, 85, 299, 173, 2356, 238, 68, 1323, 1151, 78, 297, 32, 61, 8595, 651, 305, 106, 147, 31, 159, 631, 126, 110, 214, 238, 111, 199, 88, 50, 512, 54, 728, 313, 10124, 89, 64, 399, 3200, 19817, 10, 180]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/546.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/546.json
new file mode 100644
index 00000000000..49d2965e272
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/546.json
@@ -0,0 +1 @@
+{"CASES": [135, 101, 154], "DRUG": ["CEFUROXIME SODIUM", "NOXAFIL", "VFEND"], "FATAL": [12, 6, 5], "PATHOLOGY": "infection prophylaxis", "RECOVERED": [86, 34, 39]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/547.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/547.json
new file mode 100644
index 00000000000..8ff7f1d79d4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/547.json
@@ -0,0 +1 @@
+{"CASES": [328], "DRUG": ["GONAL-F"], "FATAL": [4], "PATHOLOGY": "infertility", "RECOVERED": [132]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/548.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/548.json
new file mode 100644
index 00000000000..cf0f49b539e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/548.json
@@ -0,0 +1 @@
+{"CASES": [104, 272, 148], "DRUG": ["LEVOFLOXACIN", "DEXAMETHASONE", "IBUPROFEN"], "FATAL": [5, 13, 1], "PATHOLOGY": "inflammation", "RECOVERED": [35, 192, 51]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/549.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/549.json
new file mode 100644
index 00000000000..8556b24075b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/549.json
@@ -0,0 +1 @@
+{"CASES": [321, 551, 436], "DRUG": ["ADALIMUMAB", "STELARA", "ENTYVIO"], "FATAL": [9, 2, 1], "PATHOLOGY": "inflammatory bowel disease", "RECOVERED": [46, 107, 77]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/55.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/55.json
new file mode 100644
index 00000000000..b67b7c89b53
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/55.json
@@ -0,0 +1 @@
+{"CASES": [922], "DRUG": ["ARANESP"], "FATAL": [114], "PATHOLOGY": "anaemia of malignant disease", "RECOVERED": [170]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/550.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/550.json
new file mode 100644
index 00000000000..2ebbbb3a6a2
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/550.json
@@ -0,0 +1 @@
+{"CASES": [731, 21650, 667, 149, 1779], "DRUG": ["OSELTAMIVIR", "TAMIFLU", "TAMIFLU 75 MG HARD CAPSULE", "LEVOFLOXACIN", "FLUCELVAX TETRA"], "FATAL": [80, 1790, 9, 2, 3], "PATHOLOGY": "influenza", "RECOVERED": [201, 8238, 404, 54, 495]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/551.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/551.json
new file mode 100644
index 00000000000..c290e37d74e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/551.json
@@ -0,0 +1 @@
+{"CASES": [1772], "DRUG": ["FLUCELVAX TETRA"], "FATAL": [3], "PATHOLOGY": "influenza immunisation", "RECOVERED": [494]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/552.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/552.json
new file mode 100644
index 00000000000..d1c74f4ba88
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/552.json
@@ -0,0 +1 @@
+{"CASES": [715], "DRUG": ["TAMIFLU"], "FATAL": [50], "PATHOLOGY": "influenza like illness", "RECOVERED": [217]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/553.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/553.json
new file mode 100644
index 00000000000..9edfd5f3d6c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/553.json
@@ -0,0 +1 @@
+{"CASES": [173], "DRUG": ["MELATONIN"], "FATAL": [1], "PATHOLOGY": "initial insomnia", "RECOVERED": [25]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/554.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/554.json
new file mode 100644
index 00000000000..3753f522ccb
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/554.json
@@ -0,0 +1 @@
+{"CASES": [250, 634, 353, 1456, 403], "DRUG": ["OLANZAPINE", "CIRCADIN", "ZYPREXA", "MELATONIN", "XYREM"], "FATAL": [34, 13, 2, 7, 1], "PATHOLOGY": "insomnia", "RECOVERED": [69, 283, 100, 491, 107]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/555.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/555.json
new file mode 100644
index 00000000000..9132e15773f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/555.json
@@ -0,0 +1 @@
+{"CASES": [143, 469, 203, 281, 225, 338, 305], "DRUG": ["JANUMET", "LANTUS", "NOVORAPID FLEXPEN", "BYETTA", "LEVEMIR", "LEVEMIR FLEXPEN", "HUMALOG"], "FATAL": [9, 21, 9, 12, 7, 5, 2], "PATHOLOGY": "insulin-requiring type 2 diabetes mellitus", "RECOVERED": [43, 332, 111, 89, 141, 193, 166]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/556.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/556.json
new file mode 100644
index 00000000000..00f81291648
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/556.json
@@ -0,0 +1 @@
+{"CASES": [241, 313], "DRUG": ["IBUPROFEN", "OLANZAPINE"], "FATAL": [34, 37], "PATHOLOGY": "intentional overdose", "RECOVERED": [125, 131]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/557.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/557.json
new file mode 100644
index 00000000000..0526e9ed49a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/557.json
@@ -0,0 +1 @@
+{"CASES": [117], "DRUG": ["FENTANYL"], "FATAL": [71], "PATHOLOGY": "intentional product misuse", "RECOVERED": [8]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/558.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/558.json
new file mode 100644
index 00000000000..22af79a56e9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/558.json
@@ -0,0 +1 @@
+{"CASES": [185], "DRUG": ["KIOVIG"], "FATAL": [2], "PATHOLOGY": "intentional product use issue", "RECOVERED": [109]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/559.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/559.json
new file mode 100644
index 00000000000..57ccbe74993
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/559.json
@@ -0,0 +1 @@
+{"CASES": [116, 600, 686, 160, 3130, 168, 234], "DRUG": ["PIRFENIDONE", "CICLOSPORIN", "ESBRIET", "MYCOPHENOLATE MOFETIL", "OFEV", "RITUXIMAB", "CELLCEPT"], "FATAL": [40, 205, 114, 16, 122, 6, 7], "PATHOLOGY": "interstitial lung disease", "RECOVERED": [12, 77, 73, 7, 719, 39, 40]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/56.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/56.json
new file mode 100644
index 00000000000..9577d930390
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/56.json
@@ -0,0 +1 @@
+{"CASES": [10417, 2800, 128, 3365, 4364, 1227, 2524, 370, 116, 448], "DRUG": ["FENTANYL", "MIDAZOLAM", "BUPIVACAINE HCL", "FENTANYL CITRATE", "SUFENTANIL", "DEXAMETHASONE", "BUPIVACAINE", "DEXMEDETOMIDINE", "SUGAMMADEX", "BRIDION"], "FATAL": [439, 106, 4, 93, 110, 21, 42, 4, 1, 2], "PATHOLOGY": "anaesthesia", "RECOVERED": [5087, 1507, 46, 1219, 3112, 805, 1011, 174, 64, 316]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/560.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/560.json
new file mode 100644
index 00000000000..cb3702f2775
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/560.json
@@ -0,0 +1 @@
+{"CASES": [107], "DRUG": ["CUBICIN"], "FATAL": [29], "PATHOLOGY": "intervertebral discitis", "RECOVERED": [28]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/561.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/561.json
new file mode 100644
index 00000000000..d9098b902d4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/561.json
@@ -0,0 +1 @@
+{"CASES": [234, 292], "DRUG": ["ESOMEPRAZOLE", "PANTOPRAZOLE"], "FATAL": [17, 6], "PATHOLOGY": "intestinal ulcer", "RECOVERED": [107, 116]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/562.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/562.json
new file mode 100644
index 00000000000..9bd8c8ea183
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/562.json
@@ -0,0 +1 @@
+{"CASES": [150, 109, 845], "DRUG": ["PACLITAXEL", "ATEZOLIZUMAB", "DOCETAXEL"], "FATAL": [4, 2, 11], "PATHOLOGY": "invasive breast carcinoma", "RECOVERED": [27, 33, 203]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/563.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/563.json
new file mode 100644
index 00000000000..61e0f87a6f5
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/563.json
@@ -0,0 +1 @@
+{"CASES": [165, 159, 1342, 212, 561, 467, 147, 224, 158, 246], "DRUG": ["FASLODEX", "BEVACIZUMAB", "DOCETAXEL", "IBRANCE", "HERCEPTIN", "CAPECITABINE", "KISQALI", "FULVESTRANT", "AFINITOR", "PACLITAXEL"], "FATAL": [11, 5, 42, 5, 11, 7, 2, 3, 2, 1], "PATHOLOGY": "invasive ductal breast carcinoma", "RECOVERED": [30, 1, 291, 5, 118, 19, 33, 37, 24, 61]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/564.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/564.json
new file mode 100644
index 00000000000..fbd26e565b9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/564.json
@@ -0,0 +1 @@
+{"CASES": [124, 228], "DRUG": ["RIBOCICLIB", "IBRANCE"], "FATAL": [3, 1], "PATHOLOGY": "invasive lobular breast carcinoma", "RECOVERED": [14, 29]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/565.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/565.json
new file mode 100644
index 00000000000..83ebfb19e77
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/565.json
@@ -0,0 +1 @@
+{"CASES": [1022], "DRUG": ["EXJADE"], "FATAL": [150], "PATHOLOGY": "iron metabolism disorder", "RECOVERED": [97]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/566.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/566.json
new file mode 100644
index 00000000000..6d09ed2da89
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/566.json
@@ -0,0 +1 @@
+{"CASES": [13281], "DRUG": ["EXJADE"], "FATAL": [1826], "PATHOLOGY": "iron overload", "RECOVERED": [2447]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/567.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/567.json
new file mode 100644
index 00000000000..89b205012d9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/567.json
@@ -0,0 +1 @@
+{"CASES": [283], "DRUG": ["ENTRESTO"], "FATAL": [3], "PATHOLOGY": "ischaemic cardiomyopathy", "RECOVERED": [73]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/568.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/568.json
new file mode 100644
index 00000000000..221010ba919
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/568.json
@@ -0,0 +1 @@
+{"CASES": [136, 144, 288], "DRUG": ["BRILIQUE", "CLOPIDOGREL", "PLAVIX"], "FATAL": [14, 10, 10], "PATHOLOGY": "ischaemic heart disease prophylaxis", "RECOVERED": [34, 46, 43]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/569.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/569.json
new file mode 100644
index 00000000000..4a36b548087
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/569.json
@@ -0,0 +1 @@
+{"CASES": [166, 230], "DRUG": ["PLAVIX", "CLOPIDOGREL"], "FATAL": [25, 9], "PATHOLOGY": "ischaemic stroke", "RECOVERED": [54, 72]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/57.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/57.json
new file mode 100644
index 00000000000..de9512f414d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/57.json
@@ -0,0 +1 @@
+{"CASES": [645, 198], "DRUG": ["FENTANYL", "FENTANYL CITRATE"], "FATAL": [35, 8], "PATHOLOGY": "anaesthesia procedure", "RECOVERED": [233, 110]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/570.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/570.json
new file mode 100644
index 00000000000..f922542e796
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/570.json
@@ -0,0 +1 @@
+{"CASES": [309, 1468, 227, 203, 839, 222, 401, 243, 1280, 250], "DRUG": ["CICLOSPORIN", "ANAKINRA", "METHOTREXATE", "ARAVA", "ENBREL", "TOCILIZUMAB", "SIMPONI", "XELJANZ", "ROACTEMRA", "CIMZIA"], "FATAL": [33, 133, 16, 13, 27, 6, 8, 4, 18, 2], "PATHOLOGY": "juvenile idiopathic arthritis", "RECOVERED": [69, 6, 61, 90, 42, 81, 56, 52, 527, 25]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/571.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/571.json
new file mode 100644
index 00000000000..2f9a3001da3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/571.json
@@ -0,0 +1 @@
+{"CASES": [526], "DRUG": ["KEPPRA"], "FATAL": [2], "PATHOLOGY": "juvenile myoclonic epilepsy", "RECOVERED": [104]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/572.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/572.json
new file mode 100644
index 00000000000..baee426f83c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/572.json
@@ -0,0 +1 @@
+{"CASES": [160], "DRUG": ["CAELYX"], "FATAL": [1], "PATHOLOGY": "kaposi's sarcoma", "RECOVERED": [60]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/573.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/573.json
new file mode 100644
index 00000000000..e7e00066ce2
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/573.json
@@ -0,0 +1 @@
+{"CASES": [161, 475], "DRUG": ["HUMAN NORMAL IMMUNOGLOBULIN (IV)", "HUMAN NORMAL IMMUNOGLOBULIN"], "FATAL": [8, 9], "PATHOLOGY": "kawasaki's disease", "RECOVERED": [46, 87]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/574.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/574.json
new file mode 100644
index 00000000000..a3e8af384c3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/574.json
@@ -0,0 +1 @@
+{"CASES": [145], "DRUG": ["VORICONAZOLE"], "FATAL": [3], "PATHOLOGY": "keratitis", "RECOVERED": [39]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/575.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/575.json
new file mode 100644
index 00000000000..f0589e2024d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/575.json
@@ -0,0 +1 @@
+{"CASES": [187], "DRUG": ["CELLCEPT"], "FATAL": [16], "PATHOLOGY": "kidney transplant rejection", "RECOVERED": [29]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/576.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/576.json
new file mode 100644
index 00000000000..ed7753ccbd2
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/576.json
@@ -0,0 +1 @@
+{"CASES": [150, 113], "DRUG": ["TIGECYCLINE", "AMIKACIN"], "FATAL": [47, 1], "PATHOLOGY": "klebsiella infection", "RECOVERED": [57, 41]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/577.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/577.json
new file mode 100644
index 00000000000..5f90cd0a5ab
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/577.json
@@ -0,0 +1 @@
+{"CASES": [123], "DRUG": ["XARELTO"], "FATAL": [3], "PATHOLOGY": "knee arthroplasty", "RECOVERED": [36]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/578.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/578.json
new file mode 100644
index 00000000000..049d5b6d712
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/578.json
@@ -0,0 +1 @@
+{"CASES": [124], "DRUG": ["PLAVIX"], "FATAL": [6], "PATHOLOGY": "lacunar infarction", "RECOVERED": [35]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/579.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/579.json
new file mode 100644
index 00000000000..9d13a507595
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/579.json
@@ -0,0 +1 @@
+{"CASES": [113, 465], "DRUG": ["CYTARABINE", "CLADRIBINE"], "FATAL": [20, 42], "PATHOLOGY": "langerhans' cell histiocytosis", "RECOVERED": [4, 88]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/58.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/58.json
new file mode 100644
index 00000000000..8e3198a8144
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/58.json
@@ -0,0 +1 @@
+{"CASES": [168, 188, 1712, 484, 285, 256], "DRUG": ["MIDAZOLAM", "SUFENTANIL", "FENTANYL", "BUPRENORPHINE", "FENTANYL CITRATE", "BUPIVACAINE"], "FATAL": [18, 19, 126, 18, 6, 2], "PATHOLOGY": "analgesic therapy", "RECOVERED": [82, 106, 789, 156, 135, 103]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/580.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/580.json
new file mode 100644
index 00000000000..9a317cbef16
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/580.json
@@ -0,0 +1 @@
+{"CASES": [189], "DRUG": ["KEYTRUDA"], "FATAL": [8], "PATHOLOGY": "laryngeal cancer", "RECOVERED": [27]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/581.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/581.json
new file mode 100644
index 00000000000..f046d9aa612
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/581.json
@@ -0,0 +1 @@
+{"CASES": [198], "DRUG": ["JARDIANCE"], "FATAL": [6], "PATHOLOGY": "latent autoimmune diabetes in adults", "RECOVERED": [72]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/582.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/582.json
new file mode 100644
index 00000000000..11f0c007ef2
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/582.json
@@ -0,0 +1 @@
+{"CASES": [1108], "DRUG": ["ENTRESTO"], "FATAL": [62], "PATHOLOGY": "left ventricular failure", "RECOVERED": [266]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/583.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/583.json
new file mode 100644
index 00000000000..5bef8db7f96
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/583.json
@@ -0,0 +1 @@
+{"CASES": [2398], "DRUG": ["ESMYA"], "FATAL": [12], "PATHOLOGY": "leiomyoma", "RECOVERED": [940]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/584.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/584.json
new file mode 100644
index 00000000000..dcbf920c9a4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/584.json
@@ -0,0 +1 @@
+{"CASES": [142, 572, 137, 297, 616, 181, 152, 113], "DRUG": ["PEMBROLIZUMAB", "YONDELIS", "TRABECTEDIN", "PAZOPANIB", "VOTRIENT", "VOTRIENT FILM-COATED TABLETS", "HALAVEN", "DOCETAXEL"], "FATAL": [126, 90, 9, 19, 36, 10, 8, 4], "PATHOLOGY": "leiomyosarcoma", "RECOVERED": [4, 140, 30, 48, 139, 47, 51, 1]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/585.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/585.json
new file mode 100644
index 00000000000..dc291b507d6
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/585.json
@@ -0,0 +1 @@
+{"CASES": [180, 117, 132], "DRUG": ["YONDELIS", "PAZOPANIB", "VOTRIENT"], "FATAL": [20, 8, 2], "PATHOLOGY": "leiomyosarcoma metastatic", "RECOVERED": [44, 17, 36]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/586.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/586.json
new file mode 100644
index 00000000000..741a9e2196b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/586.json
@@ -0,0 +1 @@
+{"CASES": [345], "DRUG": ["EPIDYOLEX"], "FATAL": [7], "PATHOLOGY": "lennox-gastaut syndrome", "RECOVERED": [130]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/587.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/587.json
new file mode 100644
index 00000000000..1ef57d8f305
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/587.json
@@ -0,0 +1 @@
+{"CASES": [513, 489, 360, 1123, 17137, 192, 216, 142, 483, 1668, 1931, 375, 418, 841, 631, 570, 4119, 907, 133, 1871, 12221, 6275, 774, 3858, 335, 6102, 107, 908, 314, 150, 1529, 327, 3113, 20387, 462, 164, 967, 184, 540, 1853, 553, 352, 2293, 326, 3233, 1610, 317, 383, 7131, 722, 668, 173, 119, 191, 1053, 1507, 380, 140, 24640, 2079, 291, 933, 389, 604, 135, 465, 19690, 193, 122, 266, 136, 1140, 3056, 2787, 434, 156, 4074, 2974, 309, 641, 448, 8609, 2552, 4901, 265, 460, 1443, 2736, 240, 169, 109, 113, 597, 378], "DRUG": ["CICLOSPORIN", "EVOLTRA", "VFEND", "EXJADE", "ASPARAGINASE", "CAELYX", "MABCAMPATH 10 MG/ML", "THIOTEPA", "MABCAMPATH", "ALEMTUZUMAB", "CLOFARABINE", "POTELIGEO", "VIDAZA", "NEXAVAR", "PONATINIB", "RYDAPT", "DEXAMETHASONE", "ARZERRA", "NOXAFIL", "CLADRIBINE", "ICLUSIG", "AZACITIDINE", "DOXORUBICIN HYDROCHLORIDE", "VENCLYXTO", "FILGRASTIM", "VENETOCLAX", "RUXOLITINIB", "VYXEOS LIPOSOMAL", "DARZALEX", "ICLUSIG 15 MG FILM-COATED TABLETS", "RITUXIMAB", "OFATUMUMAB", "BUSULFAN", "CYTARABINE", "MABTHERA", "BOSULIF 100 MG FILM-COATED TABLETS", "IBRUTINIB", "GAZYVARO 1,000 MG CONCENTRATE FOR SOLUTION FOR INFUSION", "MIDOSTAURIN", "BLINATUMOMAB", "DECITABINE", "JAKAVI", "METHOTREXATE", "ARSENIC TRIOXIDE", "GLIVEC", "BLINCYTO", "SORAFENIB", "BUSILVEX", "KYMRIAH", "TISAGENLECLEUCEL", "BORTEZOMIB", "CELLCEPT", "GILTERITINIB", "ONCASPAR 750 U/ML SOLUTION FOR INJECTION/INFUSION", "SPRYCEL FILM-COATED TABLETS", "OBINUTUZUMAB", "PRIVIGEN", "CARFILZOMIB", "TASIGNA", "IMATINIB", "INOTUZUMAB OZOGAMICIN", "TRISENOX", "SPRYCEL 70 MG FILM-COATED TABLETS", "SPRYCEL 50 MG FILM-COATED TABLETS", "ICLUSIG 45 MG FILM-COATED TABLETS", "BRUKINSA", "SPRYCEL", "KIOVIG", "SPRYCEL 20 MG FILM-COATED TABLETS", "LITAK", "TRISENOX 1 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION", "PEGASPARGASE", "GAZYVARO", "TASIGNA HARD CAPSULES", "BOSULIF 100 MG", "RIXATHON", "NILOTINIB", "DASATINIB", "TASIGNA 200 MG HARD CAPSULES", "SCEMBLIX", "DACOGEN", "BOSULIF", "IMBRUVICA", "ONCASPAR", "GLIVEC FILM-COATED TABLETS", "KYMRIAH 1.2 X 10^6 \u00c3\u00a2\u00c2\u20ac\u00c2\u201c 6 X 10^8 CELLS DISPERSION FOR INFUSION", "BOSUTINIB", "MERCAPTOPURINE", "SPRYCEL 100 MG FILM-COATED TABLETS", "CARMUSTINE", "CALQUENCE", "HIZENTRA", "IMATINIB MESILATE", "TASIGNA 150 MG HARD CAPSULES"], "FATAL": [203, 140, 97, 290, 4272, 44, 45, 29, 96, 323, 364, 68, 68, 126, 92, 83, 577, 123, 18, 245, 1549, 763, 94, 455, 39, 686, 12, 100, 34, 16, 155, 31, 295, 1909, 41, 14, 79, 15, 44, 150, 44, 28, 177, 25, 247, 122, 24, 29, 513, 51, 47, 12, 8, 12, 66, 92, 22, 8, 1387, 115, 15, 47, 18, 27, 6, 20, 838, 8, 5, 10, 5, 42, 106, 93, 14, 5, 123, 87, 9, 18, 12, 227, 66, 126, 5, 8, 25, 47, 4, 2, 1, 1, 5, 2], "PATHOLOGY": "leukaemia", "RECOVERED": [49, 103, 31, 131, 4395, 21, 70, 10, 136, 371, 359, 107, 102, 104, 125, 89, 1099, 226, 18, 308, 2155, 909, 69, 632, 67, 1000, 8, 251, 53, 61, 341, 95, 803, 4847, 125, 74, 194, 86, 100, 445, 68, 22, 739, 88, 795, 409, 45, 58, 1553, 408, 218, 17, 18, 98, 167, 378, 227, 30, 3423, 302, 79, 347, 126, 179, 86, 33, 2361, 121, 32, 160, 61, 412, 1123, 649, 133, 67, 530, 420, 130, 132, 120, 1249, 433, 2988, 51, 392, 147, 788, 86, 63, 22, 48, 57, 125]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/588.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/588.json
new file mode 100644
index 00000000000..171b4b433db
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/588.json
@@ -0,0 +1 @@
+{"CASES": [108], "DRUG": ["FILGRASTIM"], "FATAL": [10], "PATHOLOGY": "leukopenia", "RECOVERED": [17]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/589.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/589.json
new file mode 100644
index 00000000000..c99569a796c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/589.json
@@ -0,0 +1 @@
+{"CASES": [290], "DRUG": ["KEYTRUDA"], "FATAL": [23], "PATHOLOGY": "lip and/or oral cavity cancer", "RECOVERED": [58]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/59.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/59.json
new file mode 100644
index 00000000000..cf2b18d6361
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/59.json
@@ -0,0 +1 @@
+{"CASES": [100], "DRUG": ["CYTARABINE"], "FATAL": [55], "PATHOLOGY": "anaplastic large cell lymphoma t- and null-cell types", "RECOVERED": [11]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/590.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/590.json
new file mode 100644
index 00000000000..08cac138a3c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/590.json
@@ -0,0 +1 @@
+{"CASES": [422, 130, 214], "DRUG": ["YONDELIS", "HALAVEN", "IBRANCE"], "FATAL": [52, 8, 5], "PATHOLOGY": "liposarcoma", "RECOVERED": [126, 58, 22]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/591.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/591.json
new file mode 100644
index 00000000000..11570306de9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/591.json
@@ -0,0 +1 @@
+{"CASES": [407, 413, 2658, 194, 1205, 1131, 198, 202], "DRUG": ["AZATHIOPRINE", "TACROLIMUS", "CICLOSPORIN", "BASILIXIMAB", "CELLCEPT", "RAPAMUNE", "MYCOPHENOLATE MOFETIL", "ADVAGRAF"], "FATAL": [172, 94, 491, 32, 81, 66, 11, 9], "PATHOLOGY": "liver transplant", "RECOVERED": [36, 76, 763, 19, 312, 161, 120, 25]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/592.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/592.json
new file mode 100644
index 00000000000..e3523d54558
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/592.json
@@ -0,0 +1 @@
+{"CASES": [221], "DRUG": ["BUPIVACAINE"], "FATAL": [1], "PATHOLOGY": "local anaesthesia", "RECOVERED": [151]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/593.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/593.json
new file mode 100644
index 00000000000..b768be910c7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/593.json
@@ -0,0 +1 @@
+{"CASES": [491], "DRUG": ["LEVOFLOXACIN"], "FATAL": [3], "PATHOLOGY": "lower respiratory tract infection", "RECOVERED": [112]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/594.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/594.json
new file mode 100644
index 00000000000..97b978cc20e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/594.json
@@ -0,0 +1 @@
+{"CASES": [139, 171, 4455, 774, 444, 428, 332, 8540, 6180, 1328, 1398, 567, 630, 176, 216, 263, 221, 674, 2867, 2061, 393, 181, 199, 580, 859, 247, 105, 106, 339], "DRUG": ["TARCEVA", "GIOTRIF", "IRESSA", "OSIMERTINIB", "AVASTIN", "DOCETAXEL", "KEYTRUDA 50 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "KEYTRUDA", "ALIMTA", "XALKORI", "GEFITINIB", "ALIMTA 500 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "MEKINIST", "CRIZOTINIB", "TAGRISSO 80 MG FILM-COATED TABLETS", "DABRAFENIB", "ERLOTINIB", "BEVACIZUMAB", "PEMBROLIZUMAB", "PEMETREXED", "OPDIVO", "KEYTRUDA 25 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION", "ATEZOLIZUMAB", "PEMETREXED DISODIUM", "TAGRISSO", "AFATINIB", "ALECTINIB", "PACLITAXEL", "IPILIMUMAB"], "FATAL": [27, 28, 681, 90, 45, 40, 30, 772, 547, 117, 105, 42, 45, 12, 14, 17, 14, 40, 152, 87, 16, 7, 6, 16, 22, 6, 1, 1, 3], "PATHOLOGY": "lung adenocarcinoma", "RECOVERED": [31, 40, 1032, 99, 111, 53, 135, 1992, 1750, 302, 126, 269, 130, 6, 64, 34, 21, 64, 557, 389, 82, 59, 26, 132, 141, 19, 4, 24, 34]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/595.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/595.json
new file mode 100644
index 00000000000..b27743d05fa
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/595.json
@@ -0,0 +1 @@
+{"CASES": [132, 360, 152], "DRUG": ["IRESSA", "ALIMTA", "KEYTRUDA"], "FATAL": [27, 37, 15], "PATHOLOGY": "lung adenocarcinoma recurrent", "RECOVERED": [41, 96, 34]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/596.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/596.json
new file mode 100644
index 00000000000..56e80204889
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/596.json
@@ -0,0 +1 @@
+{"CASES": [103, 109, 409, 290], "DRUG": ["IRESSA", "PEMETREXED", "KEYTRUDA", "ALIMTA"], "FATAL": [37, 18, 37, 19], "PATHOLOGY": "lung adenocarcinoma stage iii", "RECOVERED": [16, 32, 123, 95]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/597.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/597.json
new file mode 100644
index 00000000000..942fd26c5de
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/597.json
@@ -0,0 +1 @@
+{"CASES": [218, 302, 2470, 1563, 301, 163, 366, 973, 589, 214, 123], "DRUG": ["OSIMERTINIB", "IRESSA", "KEYTRUDA", "ALIMTA", "XALKORI", "BEVACIZUMAB", "GEFITINIB", "PEMBROLIZUMAB", "PEMETREXED", "MEKINIST", "PEMETREXED DISODIUM"], "FATAL": [49, 62, 259, 158, 20, 5, 11, 23, 13, 4, 1], "PATHOLOGY": "lung adenocarcinoma stage iv", "RECOVERED": [30, 68, 570, 447, 63, 8, 45, 164, 105, 54, 25]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/598.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/598.json
new file mode 100644
index 00000000000..ffe8a23a7ef
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/598.json
@@ -0,0 +1 @@
+{"CASES": [153, 1233, 409, 182, 1817, 241, 1154, 592, 193, 832, 190, 221, 214, 150], "DRUG": ["IPILIMUMAB", "XALKORI", "PEMETREXED", "OSIMERTINIB", "KEYTRUDA", "IRESSA", "ALIMTA", "TAGRISSO", "DOCETAXEL", "PEMBROLIZUMAB", "OPDIVO", "SUTENT", "ATEZOLIZUMAB", "GEFITINIB"], "FATAL": [23, 163, 54, 19, 173, 22, 100, 44, 14, 51, 11, 12, 7, 4], "PATHOLOGY": "lung cancer metastatic", "RECOVERED": [22, 179, 113, 31, 261, 41, 243, 76, 33, 182, 22, 44, 54, 9]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/599.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/599.json
new file mode 100644
index 00000000000..7342957d286
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/599.json
@@ -0,0 +1 @@
+{"CASES": [108, 148, 390], "DRUG": ["MEKINIST", "IRESSA", "TAGRISSO"], "FATAL": [8, 7, 16], "PATHOLOGY": "lung carcinoma cell type unspecified stage 0", "RECOVERED": [4, 10, 10]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/6.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/6.json
new file mode 100644
index 00000000000..7e7f5a4ffd2
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/6.json
@@ -0,0 +1 @@
+{"CASES": [270], "DRUG": ["SUBOXONE"], "FATAL": [26], "PATHOLOGY": "accidental exposure to product", "RECOVERED": [200]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/60.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/60.json
new file mode 100644
index 00000000000..d92757f4543
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/60.json
@@ -0,0 +1 @@
+{"CASES": [167, 544], "DRUG": ["MEKINIST", "LENVIMA"], "FATAL": [22, 66], "PATHOLOGY": "anaplastic thyroid cancer", "RECOVERED": [28, 170]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/600.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/600.json
new file mode 100644
index 00000000000..29102a3e4ba
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/600.json
@@ -0,0 +1 @@
+{"CASES": [662, 303, 105, 249, 499], "DRUG": ["KEYTRUDA", "ALIMTA", "IRESSA", "XALKORI", "TAGRISSO"], "FATAL": [80, 36, 10, 17, 24], "PATHOLOGY": "lung carcinoma cell type unspecified stage iv", "RECOVERED": [106, 48, 2, 42, 37]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/601.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/601.json
new file mode 100644
index 00000000000..f89f9793bff
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/601.json
@@ -0,0 +1 @@
+{"CASES": [158, 298, 227], "DRUG": ["VFEND", "REVATIO", "SYNAGIS"], "FATAL": [34, 59, 8], "PATHOLOGY": "lung disorder", "RECOVERED": [51, 32, 69]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/602.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/602.json
new file mode 100644
index 00000000000..c68b52aa2d8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/602.json
@@ -0,0 +1 @@
+{"CASES": [4207, 209, 229, 224, 452, 146, 110, 256, 2857, 707, 3211, 4931, 576, 167, 319, 1221, 201, 128, 903, 119, 2960, 137, 210, 139, 359, 124, 302, 494, 158, 165, 126, 130, 748, 117, 922], "DRUG": ["XALKORI", "HYCAMTIN", "VOTRIENT FILM-COATED TABLETS", "DOCETAXEL", "OPDIVO", "KEYTRUDA 50 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "AFINITOR", "VOTRIENT", "ALIMTA", "PEMETREXED", "IRESSA", "KEYTRUDA", "SUTENT", "TARCEVA", "OSIMERTINIB", "MEKINIST", "ALIMTA 500 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "PACLITAXEL", "PEMBROLIZUMAB", "ALIMTA 500 MG", "TAGRISSO", "CABOMETYX", "XALKORI 250 MG", "IBRANCE", "GEFITINIB", "NEXAVAR", "GAVRETO", "AVASTIN", "SOTORASIB", "IPILIMUMAB", "INLYTA", "TAGRISSO 80 MG FILM-COATED TABLETS", "PEMETREXED DISODIUM", "CRIZOTINIB", "BEVACIZUMAB"], "FATAL": [1147, 43, 40, 34, 59, 19, 13, 28, 262, 64, 284, 412, 48, 11, 21, 79, 12, 7, 46, 6, 147, 6, 9, 5, 12, 4, 9, 13, 4, 3, 2, 2, 10, 1, 5], "PATHOLOGY": "lung neoplasm", "RECOVERED": [495, 38, 18, 44, 52, 46, 14, 10, 622, 151, 503, 638, 94, 32, 31, 218, 66, 40, 143, 31, 250, 25, 48, 14, 69, 8, 26, 105, 10, 22, 13, 39, 86, 29, 394]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/603.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/603.json
new file mode 100644
index 00000000000..acf730214ab
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/603.json
@@ -0,0 +1 @@
+{"CASES": [4157, 206, 229, 224, 452, 103, 234, 120, 2744, 687, 3192, 532, 4843, 170, 161, 314, 1213, 116, 116, 838, 2910, 137, 206, 128, 351, 124, 302, 493, 158, 156, 110, 128, 729, 116, 874], "DRUG": ["XALKORI", "HYCAMTIN", "VOTRIENT FILM-COATED TABLETS", "DOCETAXEL", "OPDIVO", "AFINITOR", "VOTRIENT", "KEYTRUDA 50 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "ALIMTA", "PEMETREXED", "IRESSA", "SUTENT", "KEYTRUDA", "ALIMTA 500 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "TARCEVA", "OSIMERTINIB", "MEKINIST", "PACLITAXEL", "ALIMTA 500 MG", "PEMBROLIZUMAB", "TAGRISSO", "CABOMETYX", "XALKORI 250 MG", "IBRANCE", "GEFITINIB", "NEXAVAR", "GAVRETO", "AVASTIN", "SOTORASIB", "IPILIMUMAB", "INLYTA", "TAGRISSO 80 MG FILM-COATED TABLETS", "PEMETREXED DISODIUM", "CRIZOTINIB", "BEVACIZUMAB"], "FATAL": [1140, 41, 40, 34, 59, 13, 28, 13, 259, 64, 282, 46, 409, 12, 11, 21, 77, 7, 6, 43, 146, 6, 9, 5, 12, 4, 9, 13, 4, 3, 2, 2, 10, 1, 5], "PATHOLOGY": "lung neoplasm malignant", "RECOVERED": [484, 38, 18, 44, 52, 10, 10, 33, 561, 141, 496, 88, 621, 50, 32, 31, 218, 33, 29, 129, 240, 25, 48, 11, 69, 8, 26, 105, 10, 20, 13, 39, 78, 29, 390]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/604.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/604.json
new file mode 100644
index 00000000000..21cc7bd88d4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/604.json
@@ -0,0 +1 @@
+{"CASES": [198], "DRUG": ["KEYTRUDA"], "FATAL": [20], "PATHOLOGY": "lung squamous cell carcinoma metastatic", "RECOVERED": [32]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/605.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/605.json
new file mode 100644
index 00000000000..b09a9915dad
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/605.json
@@ -0,0 +1 @@
+{"CASES": [295, 108], "DRUG": ["KEYTRUDA", "PEMBROLIZUMAB"], "FATAL": [20, 5], "PATHOLOGY": "lung squamous cell carcinoma stage iii", "RECOVERED": [86, 27]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/606.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/606.json
new file mode 100644
index 00000000000..ab5ad74e9d8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/606.json
@@ -0,0 +1 @@
+{"CASES": [155, 1144], "DRUG": ["PEMBROLIZUMAB", "KEYTRUDA"], "FATAL": [33, 131], "PATHOLOGY": "lung squamous cell carcinoma stage iv", "RECOVERED": [28, 284]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/607.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/607.json
new file mode 100644
index 00000000000..69aa16ebd70
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/607.json
@@ -0,0 +1 @@
+{"CASES": [134, 1199, 127, 498, 203], "DRUG": ["AZATHIOPRINE", "CICLOSPORIN", "MYCOPHENOLATE MOFETIL", "CELLCEPT", "RAPAMUNE"], "FATAL": [46, 305, 26, 82, 24], "PATHOLOGY": "lung transplant", "RECOVERED": [41, 292, 17, 88, 31]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/608.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/608.json
new file mode 100644
index 00000000000..e8a99231900
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/608.json
@@ -0,0 +1 @@
+{"CASES": [1131, 1695, 203], "DRUG": ["CELLCEPT", "LUPKYNIS", "CICLOSPORIN"], "FATAL": [23, 26, 1], "PATHOLOGY": "lupus nephritis", "RECOVERED": [270, 103, 67]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/609.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/609.json
new file mode 100644
index 00000000000..12d2168a7fc
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/609.json
@@ -0,0 +1 @@
+{"CASES": [335, 134, 201, 13846, 401, 1257, 323, 459, 191, 256, 3005, 441, 717, 3502, 897, 2293, 1230, 603, 257, 546, 2760, 327, 430, 172, 1091, 203, 9936, 956, 147, 2395, 632, 6390, 1691, 1494, 277, 214, 130, 331, 460, 862, 130, 1203, 3046, 183, 2521, 3954, 447, 2068, 107, 112, 262], "DRUG": ["CICLOSPORIN", "CLADRIBINE", "PONATINIB", "ASPARAGINASE", "TASIGNA", "ALEMTUZUMAB", "EXJADE", "MABCAMPATH", "MABCAMPATH 10 MG/ML", "EVOLTRA", "DEXAMETHASONE", "GLIVEC", "CLOFARABINE", "ICLUSIG", "ARZERRA", "VENCLYXTO", "RITUXIMAB", "DOXORUBICIN HYDROCHLORIDE", "IMATINIB", "BUSULFAN", "VENETOCLAX", "OFATUMUMAB", "MABTHERA", "GAZYVARO 1,000 MG CONCENTRATE FOR SOLUTION FOR INFUSION", "BLINCYTO", "FILGRASTIM", "CYTARABINE", "IBRUTINIB", "ONCASPAR 750 U/ML SOLUTION FOR INJECTION/INFUSION", "SPRYCEL", "TISAGENLECLEUCEL", "KYMRIAH", "METHOTREXATE", "OBINUTUZUMAB", "INOTUZUMAB OZOGAMICIN", "BUSILVEX", "KIOVIG", "PRIVIGEN", "BRUKINSA", "PEGASPARGASE", "RIXATHON", "BLINATUMOMAB", "GAZYVARO", "BOSULIF", "IMBRUVICA", "ONCASPAR", "DASATINIB", "MERCAPTOPURINE", "CALQUENCE", "HIZENTRA", "KYMRIAH 1.2 X 10^6 \u00c3\u00a2\u00c2\u20ac\u00c2\u201c 6 X 10^8 CELLS DISPERSION FOR INFUSION"], "FATAL": [177, 47, 65, 3954, 99, 260, 63, 89, 37, 46, 464, 66, 104, 486, 123, 278, 149, 70, 29, 55, 270, 31, 38, 15, 92, 17, 824, 79, 12, 190, 47, 451, 111, 92, 14, 10, 6, 15, 20, 36, 5, 45, 105, 6, 65, 88, 7, 27, 1, 1, 2], "PATHOLOGY": "lymphocytic leukaemia", "RECOVERED": [17, 12, 28, 3398, 55, 221, 69, 124, 64, 66, 797, 147, 130, 525, 219, 444, 224, 30, 62, 78, 558, 95, 119, 84, 197, 30, 2344, 191, 76, 272, 363, 1364, 571, 370, 77, 41, 93, 203, 33, 299, 45, 286, 1121, 37, 430, 2426, 100, 539, 22, 47, 234]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/61.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/61.json
new file mode 100644
index 00000000000..627579e1d5a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/61.json
@@ -0,0 +1 @@
+{"CASES": [627], "DRUG": ["TESTOSTERONE"], "FATAL": [12], "PATHOLOGY": "androgen replacement therapy", "RECOVERED": [49]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/610.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/610.json
new file mode 100644
index 00000000000..872474f7682
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/610.json
@@ -0,0 +1 @@
+{"CASES": [121, 666, 109, 494, 146, 790, 588, 424, 253, 3104, 357, 480, 139, 1775, 299, 189, 529, 250, 164, 8614, 10872, 192, 348, 316, 4618, 9339, 270, 2286, 14649, 405, 1273, 1016, 1535, 6827, 333, 113, 6266, 1335, 123, 813, 233, 131, 267, 216, 1852, 572, 130, 197, 136, 251, 2009, 913, 1019, 397, 899, 131, 161, 487, 280, 147, 164, 413, 125, 837, 143, 232, 272, 176, 211, 106, 1038, 225], "DRUG": ["OFATUMUMAB", "BUSULFAN", "EXJADE", "ALEMTUZUMAB", "XALKORI", "FILGRASTIM", "IBRUTINIB", "ZEVALIN", "MELPHALAN", "CARMUSTINE", "CLADRIBINE", "TORISEL", "MOGAMULIZUMAB", "ASPARAGINASE", "VENCLYXTO", "BRENTUXIMAB VEDOTIN", "BORTEZOMIB", "CICLOSPORIN", "YTTRIUM-90", "KYMRIAH", "CYTARABINE", "THIOTEPA", "TISAGENLECLEUCEL", "VENETOCLAX", "DEXAMETHASONE", "YESCARTA", "YESCARTA 0.4 \u00c3\u00a2\u00c2\u20ac\u00c2\u201c 2 X 10E8 CELLS DISPERSION FOR INFUSION", "METHOTREXATE", "RITUXIMAB", "KEYTRUDA", "POTELIGEO", "EPCORITAMAB", "AXICABTAGENE CILOLEUCEL", "DOXORUBICIN HYDROCHLORIDE", "PEMBROLIZUMAB", "BEAM", "MABTHERA", "GAZYVARO", "MABCAMPATH", "IMBRUVICA", "REVLIMID", "NOT AVAILABLE", "NEULASTA", "AZACITIDINE", "OBINUTUZUMAB", "BREYANZI", "CARFILZOMIB", "PRIVIGEN", "TRUXIMA", "POLIVY", "CAELYX", "BRUKINSA", "LENALIDOMIDE", "POLATUZUMAB VEDOTIN", "PEGFILGRASTIM", "AVASTIN", "PEGASYS", "KYMRIAH 1.2 X 10^6 \u00c3\u00a2\u00c2\u20ac\u00c2\u201c 6 X 10^8 CELLS DISPERSION FOR INFUSION", "PEGASPARGASE", "IDELALISIB", "AFINITOR", "ADCETRIS", "CALQUENCE", "RIXATHON", "ARZERRA", "BLINATUMOMAB", "ONCASPAR", "GAZYVARO 1,000 MG CONCENTRATE FOR SOLUTION FOR INFUSION", "MERCAPTOPURINE", "ACALABRUTINIB", "DOXORUBICIN HYDROCHLORIDE, LIPOSOMAL", "EPIRUBICIN HCL"], "FATAL": [39, 181, 27, 121, 30, 154, 96, 67, 39, 474, 54, 72, 19, 239, 40, 25, 69, 31, 20, 1021, 1230, 21, 38, 31, 451, 904, 26, 213, 1347, 37, 108, 79, 118, 524, 24, 8, 440, 88, 8, 47, 13, 7, 14, 11, 91, 28, 6, 9, 6, 11, 87, 39, 43, 16, 36, 5, 6, 18, 10, 5, 5, 10, 3, 18, 3, 4, 4, 2, 2, 1, 8, 1], "PATHOLOGY": "lymphoma", "RECOVERED": [6, 129, 11, 93, 11, 140, 53, 184, 84, 543, 97, 110, 23, 360, 31, 29, 47, 47, 18, 1812, 1500, 53, 104, 32, 568, 3064, 192, 661, 3580, 43, 303, 444, 694, 1537, 15, 23, 1848, 294, 22, 142, 48, 31, 84, 14, 482, 168, 5, 104, 64, 15, 283, 71, 256, 44, 506, 103, 50, 381, 54, 43, 13, 79, 16, 514, 28, 90, 148, 88, 108, 12, 192, 41]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/611.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/611.json
new file mode 100644
index 00000000000..8d8b9b38a55
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/611.json
@@ -0,0 +1 @@
+{"CASES": [131, 291], "DRUG": ["EXJADE", "RITUXIMAB"], "FATAL": [45, 52], "PATHOLOGY": "lymphoproliferative disorder", "RECOVERED": [8, 11]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/612.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/612.json
new file mode 100644
index 00000000000..9ab18bb123d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/612.json
@@ -0,0 +1 @@
+{"CASES": [11901, 690, 179, 184, 344, 893, 5457], "DRUG": ["EYLEA", "AVASTIN", "EYLEA 40 MG/ML SOLUTION FOR INJECTION IN A VIAL", "EYLEA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "LUCENTIS", "BROLUCIZUMAB", "BEOVU"], "FATAL": [259, 10, 2, 2, 3, 1, 5], "PATHOLOGY": "macular degeneration", "RECOVERED": [3332, 116, 68, 26, 104, 134, 1259]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/613.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/613.json
new file mode 100644
index 00000000000..13dbeb070e3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/613.json
@@ -0,0 +1 @@
+{"CASES": [911], "DRUG": ["EYLEA"], "FATAL": [15], "PATHOLOGY": "macular oedema", "RECOVERED": [241]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/614.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/614.json
new file mode 100644
index 00000000000..62ec736fbd5
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/614.json
@@ -0,0 +1 @@
+{"CASES": [295], "DRUG": ["EYLEA"], "FATAL": [10], "PATHOLOGY": "macular oedema, retinal vein occlusion", "RECOVERED": [91]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/615.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/615.json
new file mode 100644
index 00000000000..adea8436021
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/615.json
@@ -0,0 +1 @@
+{"CASES": [20003, 758], "DRUG": ["OPTIMARK", "CONTRAST MEDIA"], "FATAL": [1342, 10], "PATHOLOGY": "magnetic resonance imaging", "RECOVERED": [245, 7]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/616.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/616.json
new file mode 100644
index 00000000000..69a8340511a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/616.json
@@ -0,0 +1 @@
+{"CASES": [482], "DRUG": ["OPTIMARK"], "FATAL": [4], "PATHOLOGY": "magnetic resonance imaging abdominal", "RECOVERED": [6]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/617.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/617.json
new file mode 100644
index 00000000000..7cd5cee6d80
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/617.json
@@ -0,0 +1 @@
+{"CASES": [1399], "DRUG": ["OPTIMARK"], "FATAL": [30], "PATHOLOGY": "magnetic resonance imaging head", "RECOVERED": [82]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/618.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/618.json
new file mode 100644
index 00000000000..9431d0e5ea3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/618.json
@@ -0,0 +1 @@
+{"CASES": [625, 118], "DRUG": ["FENTANYL", "FENTANYL CITRATE"], "FATAL": [16, 3], "PATHOLOGY": "maintenance of anaesthesia", "RECOVERED": [315, 59]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/619.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/619.json
new file mode 100644
index 00000000000..8730fa2d1f8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/619.json
@@ -0,0 +1 @@
+{"CASES": [243, 1106, 2850, 116, 905, 616, 1536, 513], "DRUG": ["LATUDA", "ZYPREXA", "CYMBALTA", "VORTIOXETINE", "OLANZAPINE", "ABILIFY", "BRINTELLIX", "ARIPIPRAZOLE"], "FATAL": [10, 35, 85, 3, 23, 13, 30, 6], "PATHOLOGY": "major depression", "RECOVERED": [48, 356, 799, 35, 271, 111, 637, 108]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/62.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/62.json
new file mode 100644
index 00000000000..9e8bc8cf1b4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/62.json
@@ -0,0 +1 @@
+{"CASES": [115, 465, 377, 118], "DRUG": ["CYTARABINE", "CLADRIBINE", "AFINITOR", "SUTENT"], "FATAL": [20, 42, 25, 2], "PATHOLOGY": "anger", "RECOVERED": [4, 88, 6, 2]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/620.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/620.json
new file mode 100644
index 00000000000..e97287580a2
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/620.json
@@ -0,0 +1 @@
+{"CASES": [113, 566], "DRUG": ["VOTRIENT FILM-COATED TABLETS", "VOTRIENT"], "FATAL": [26, 106], "PATHOLOGY": "malignant connective tissue neoplasm", "RECOVERED": [3, 16]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/621.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/621.json
new file mode 100644
index 00000000000..54379e1182e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/621.json
@@ -0,0 +1 @@
+{"CASES": [274], "DRUG": ["VOTRIENT"], "FATAL": [22], "PATHOLOGY": "malignant connective tissue neoplasm, soft tissue sarcoma", "RECOVERED": [12]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/622.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/622.json
new file mode 100644
index 00000000000..69a1d65ca58
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/622.json
@@ -0,0 +1 @@
+{"CASES": [114, 276], "DRUG": ["AVASTIN", "TEMODAL"], "FATAL": [17, 10], "PATHOLOGY": "malignant glioma", "RECOVERED": [15, 85]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/623.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/623.json
new file mode 100644
index 00000000000..27adee78811
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/623.json
@@ -0,0 +1 @@
+{"CASES": [838, 200, 106, 672, 6736, 240, 1623, 131, 313, 15695, 103, 9621, 5629, 282, 5012, 3569, 6728, 101, 8063, 3053, 331, 1197, 10162, 919, 813, 161, 1871, 712, 262, 122, 1234, 287, 957, 178], "DRUG": ["MEKINIST FILM-COATED TABLETS", "TEMOZOLOMIDE", "IMIQUIMOD", "NIVOLUMAB", "YERVOY", "TEMODAL", "TAFINLAR", "INTERFERON ALFA-2B", "YERVOY 5 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION", "MEKINIST", "KEYTRUDA 25 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION", "KEYTRUDA", "ZELBORAF", "NEXAVAR", "COTELLIC", "DABRAFENIB", "BRAFTOVI", "CARMUSTINE", "OPDIVO", "PEMBROLIZUMAB", "TRAMETINIB", "VEMURAFENIB", "IPILIMUMAB", "BINIMETINIB", "OPDIVO 10 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION", "IMLYGIC", "COBIMETINIB", "KEYTRUDA 50 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "ZELBORAF 240 MG FILM-COATED TABLETS", "PEGINTRON 150 MICROGRAMS", "COTELLIC 20 MG FILM-COATED TABLETS", "BRAFTOVI 75 MG HARD CAPSULES", "MEKINIST 2.0 MG FILM-COATED TABLETS", "INTRONA"], "FATAL": [198, 42, 16, 86, 736, 24, 161, 12, 27, 1233, 8, 679, 384, 18, 318, 217, 408, 6, 453, 168, 16, 57, 436, 37, 27, 5, 51, 18, 6, 2, 18, 4, 13, 2], "PATHOLOGY": "malignant melanoma", "RECOVERED": [65, 34, 26, 108, 1037, 60, 442, 10, 115, 3045, 34, 1557, 1369, 42, 1389, 753, 1486, 7, 1413, 553, 40, 316, 1409, 255, 394, 3, 652, 243, 145, 68, 798, 125, 498, 21]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/624.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/624.json
new file mode 100644
index 00000000000..3bae02d231b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/624.json
@@ -0,0 +1 @@
+{"CASES": [478, 168, 442, 122], "DRUG": ["MEKINIST", "PEMBROLIZUMAB", "KEYTRUDA", "DABRAFENIB"], "FATAL": [48, 5, 11, 3], "PATHOLOGY": "malignant melanoma stage iii", "RECOVERED": [112, 43, 53, 12]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/625.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/625.json
new file mode 100644
index 00000000000..42ccd788b6d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/625.json
@@ -0,0 +1 @@
+{"CASES": [509, 162, 498, 116, 248, 182], "DRUG": ["MEKINIST", "DABRAFENIB", "KEYTRUDA", "COTELLIC", "PEMBROLIZUMAB", "IPILIMUMAB"], "FATAL": [80, 18, 33, 6, 6, 2], "PATHOLOGY": "malignant melanoma stage iv", "RECOVERED": [72, 29, 69, 59, 28, 47]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/626.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/626.json
new file mode 100644
index 00000000000..e025865d591
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/626.json
@@ -0,0 +1 @@
+{"CASES": [365, 118], "DRUG": ["AFINITOR", "SUTENT"], "FATAL": [18, 2], "PATHOLOGY": "malignant neoplasm of islets of langerhans", "RECOVERED": [6, 2]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/627.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/627.json
new file mode 100644
index 00000000000..070abdffc6b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/627.json
@@ -0,0 +1 @@
+{"CASES": [120, 179, 138], "DRUG": ["VOTRIENT", "KEYTRUDA", "SUTENT"], "FATAL": [34, 13, 8], "PATHOLOGY": "malignant neoplasm of renal pelvis", "RECOVERED": [12, 33, 10]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/628.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/628.json
new file mode 100644
index 00000000000..3d79722f83c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/628.json
@@ -0,0 +1 @@
+{"CASES": [113, 170, 278], "DRUG": ["KEYTRUDA", "LENVIMA", "SUTENT"], "FATAL": [9, 3, 4], "PATHOLOGY": "malignant neoplasm of thymus", "RECOVERED": [12, 82, 52]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/629.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/629.json
new file mode 100644
index 00000000000..d926d8ee398
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/629.json
@@ -0,0 +1 @@
+{"CASES": [113], "DRUG": ["KEYTRUDA"], "FATAL": [10], "PATHOLOGY": "malignant neoplasm progression", "RECOVERED": [6]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/63.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/63.json
new file mode 100644
index 00000000000..be1783a30a1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/63.json
@@ -0,0 +1 @@
+{"CASES": [226, 890, 1788, 195, 229, 1740], "DRUG": ["EFIENT", "PLAVIX", "RANOLAZINE", "CLOPIDOGREL", "CLOPIDOGREL HYDROGEN SULFATE", "RANEXA"], "FATAL": [28, 108, 195, 12, 12, 69], "PATHOLOGY": "angina pectoris", "RECOVERED": [109, 357, 413, 84, 66, 685]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/630.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/630.json
new file mode 100644
index 00000000000..38ab15a6049
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/630.json
@@ -0,0 +1 @@
+{"CASES": [192, 614], "DRUG": ["LYNPARZA", "RUBRACA"], "FATAL": [17, 20], "PATHOLOGY": "malignant peritoneal neoplasm", "RECOVERED": [56, 66]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/631.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/631.json
new file mode 100644
index 00000000000..71bc19da5bb
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/631.json
@@ -0,0 +1 @@
+{"CASES": [226, 184, 130, 292], "DRUG": ["VOTRIENT", "AFINITOR", "VOTRIENT FILM-COATED TABLETS", "SUTENT"], "FATAL": [62, 34, 22, 30], "PATHOLOGY": "malignant urinary tract neoplasm", "RECOVERED": [36, 6, 2, 28]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/632.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/632.json
new file mode 100644
index 00000000000..54d1d8e6c93
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/632.json
@@ -0,0 +1 @@
+{"CASES": [1628, 732, 132, 205, 385], "DRUG": ["OLANZAPINE", "ZYPREXA", "ABILIFY", "SYCREST", "ARIPIPRAZOLE"], "FATAL": [86, 17, 2, 2, 2], "PATHOLOGY": "mania", "RECOVERED": [638, 241, 24, 109, 169]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/633.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/633.json
new file mode 100644
index 00000000000..2b49d0d8a59
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/633.json
@@ -0,0 +1 @@
+{"CASES": [151, 234, 145, 432, 159, 463, 117, 220, 386, 789, 169, 342, 184], "DRUG": ["BORTEZOMIB", "DEXAMETHASONE", "VENCLYXTO", "TORISEL", "IBRUTINIB", "RITUXIMAB", "VENETOCLAX", "BRUKINSA", "CARMUSTINE", "CYTARABINE", "CAELYX", "IMBRUVICA", "MABTHERA"], "FATAL": [44, 39, 23, 66, 24, 62, 15, 19, 33, 59, 11, 22, 11], "PATHOLOGY": "mantle cell lymphoma", "RECOVERED": [19, 40, 19, 96, 22, 85, 10, 14, 117, 156, 6, 40, 32]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/634.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/634.json
new file mode 100644
index 00000000000..7184a21980e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/634.json
@@ -0,0 +1 @@
+{"CASES": [119, 153], "DRUG": ["CARMUSTINE", "CYTARABINE"], "FATAL": [21, 14], "PATHOLOGY": "mantle cell lymphoma stage iv", "RECOVERED": [46, 23]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/635.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/635.json
new file mode 100644
index 00000000000..05f849f54ed
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/635.json
@@ -0,0 +1 @@
+{"CASES": [131], "DRUG": ["RITUXIMAB"], "FATAL": [23], "PATHOLOGY": "marginal zone lymphoma", "RECOVERED": [26]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/636.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/636.json
new file mode 100644
index 00000000000..2d8b8ac5a56
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/636.json
@@ -0,0 +1 @@
+{"CASES": [240, 112, 257, 144], "DRUG": ["RYDAPT", "CLADRIBINE", "MIDOSTAURIN", "AYVAKYT"], "FATAL": [27, 10, 19, 7], "PATHOLOGY": "mastocytosis", "RECOVERED": [23, 17, 26, 12]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/637.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/637.json
new file mode 100644
index 00000000000..c9a7ec39353
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/637.json
@@ -0,0 +1 @@
+{"CASES": [190, 705, 570], "DRUG": ["NORVIR", "COMBIVIR", "KALETRA"], "FATAL": [55, 171, 52], "PATHOLOGY": "maternal exposure timing unspecified", "RECOVERED": [12, 74, 72]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/638.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/638.json
new file mode 100644
index 00000000000..9bdfb59cf61
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/638.json
@@ -0,0 +1 @@
+{"CASES": [231], "DRUG": ["DEXAMETHASONE"], "FATAL": [3], "PATHOLOGY": "maternal therapy to enhance foetal lung maturity", "RECOVERED": [64]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/639.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/639.json
new file mode 100644
index 00000000000..1b0d946b365
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/639.json
@@ -0,0 +1 @@
+{"CASES": [637, 297], "DRUG": ["CAPRELSA", "VANDETANIB"], "FATAL": [54, 12], "PATHOLOGY": "medullary thyroid cancer", "RECOVERED": [139, 67]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/64.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/64.json
new file mode 100644
index 00000000000..3596db4e836
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/64.json
@@ -0,0 +1 @@
+{"CASES": [505, 310, 119, 136], "DRUG": ["PLAVIX", "BRILIQUE", "CLOPIDOGREL", "CLOPIDOGREL HYDROGEN SULFATE"], "FATAL": [81, 34, 4, 3], "PATHOLOGY": "angina unstable", "RECOVERED": [195, 60, 69, 39]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/640.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/640.json
new file mode 100644
index 00000000000..8fa77699124
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/640.json
@@ -0,0 +1 @@
+{"CASES": [240, 103, 147], "DRUG": ["THIOTEPA", "BEVACIZUMAB", "METHOTREXATE"], "FATAL": [82, 13, 15], "PATHOLOGY": "medulloblastoma", "RECOVERED": [45, 7, 23]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/641.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/641.json
new file mode 100644
index 00000000000..f8c0052e8b7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/641.json
@@ -0,0 +1 @@
+{"CASES": [280], "DRUG": ["SUTENT"], "FATAL": [6], "PATHOLOGY": "meningioma", "RECOVERED": [56]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/642.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/642.json
new file mode 100644
index 00000000000..8f7a014db64
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/642.json
@@ -0,0 +1 @@
+{"CASES": [322, 188, 125, 225, 186], "DRUG": ["DEXAMETHASONE", "VORICONAZOLE", "LEVOFLOXACIN", "VFEND", "AMIKACIN"], "FATAL": [73, 22, 14, 8, 6], "PATHOLOGY": "meningitis", "RECOVERED": [127, 36, 23, 57, 72]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/643.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/643.json
new file mode 100644
index 00000000000..99a4d7006c2
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/643.json
@@ -0,0 +1 @@
+{"CASES": [154, 176], "DRUG": ["DEXAMETHASONE", "AMIKACIN"], "FATAL": [13, 4], "PATHOLOGY": "meningitis tuberculous", "RECOVERED": [86, 72]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/644.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/644.json
new file mode 100644
index 00000000000..9a96c90758a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/644.json
@@ -0,0 +1 @@
+{"CASES": [176], "DRUG": ["BEXSERO"], "FATAL": [9], "PATHOLOGY": "meningococcal immunisation", "RECOVERED": [130]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/645.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/645.json
new file mode 100644
index 00000000000..42439245d70
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/645.json
@@ -0,0 +1 @@
+{"CASES": [191, 733, 466, 120], "DRUG": ["ARIPIPRAZOLE", "OLANZAPINE", "ZYPREXA", "CYMBALTA"], "FATAL": [49, 49, 21, 5], "PATHOLOGY": "mental disorder", "RECOVERED": [35, 118, 134, 18]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/646.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/646.json
new file mode 100644
index 00000000000..395ecd29c81
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/646.json
@@ -0,0 +1 @@
+{"CASES": [400, 880, 134, 1863, 106, 1268, 786, 116, 227], "DRUG": ["KEYTRUDA", "PEMETREXED", "PEMETREXED DISODIUM", "ALIMTA", "PEMBROLIZUMAB", "OPDIVO", "IPILIMUMAB", "ALIMTA 500 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "BEVACIZUMAB"], "FATAL": [41, 81, 11, 137, 7, 62, 36, 2, 3], "PATHOLOGY": "mesothelioma", "RECOVERED": [28, 143, 21, 463, 13, 223, 88, 63, 17]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/647.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/647.json
new file mode 100644
index 00000000000..f2f6ed037f0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/647.json
@@ -0,0 +1 @@
+{"CASES": [532, 879, 139, 357, 869, 189], "DRUG": ["PEMETREXED", "ALIMTA", "KEYTRUDA", "IPILIMUMAB", "OPDIVO", "BEVACIZUMAB"], "FATAL": [67, 73, 11, 26, 48, 2], "PATHOLOGY": "mesothelioma malignant", "RECOVERED": [75, 227, 17, 25, 177, 3]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/648.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/648.json
new file mode 100644
index 00000000000..8c78da79bec
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/648.json
@@ -0,0 +1 @@
+{"CASES": [117, 932, 238, 365, 2614, 217, 670, 108, 115, 168, 139, 221, 489, 330, 330, 110, 522], "DRUG": ["IRINOTECAN", "ZOMETA", "ZOLEDRONIC ACID", "NEXAVAR", "XOFIGO", "XGEVA", "XTANDI", "KEYTRUDA", "CAPECITABINE", "RIBOCICLIB", "BEVACIZUMAB", "KISQALI", "DENOSUMAB", "FULVESTRANT", "FASLODEX", "ENZALUTAMIDE", "IBRANCE"], "FATAL": [17, 92, 22, 32, 226, 17, 41, 4, 3, 4, 3, 4, 7, 4, 4, 1, 4], "PATHOLOGY": "metastases to bone", "RECOVERED": [4, 88, 59, 38, 244, 37, 82, 11, 7, 36, 11, 37, 142, 37, 40, 25, 40]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/649.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/649.json
new file mode 100644
index 00000000000..497fa4b8192
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/649.json
@@ -0,0 +1 @@
+{"CASES": [195, 253, 124], "DRUG": ["MEKINIST", "KEYTRUDA", "TAGRISSO"], "FATAL": [22, 26, 11], "PATHOLOGY": "metastases to central nervous system", "RECOVERED": [12, 33, 2]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/65.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/65.json
new file mode 100644
index 00000000000..d34ab5a85d2
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/65.json
@@ -0,0 +1 @@
+{"CASES": [142, 375], "DRUG": ["DEXAMETHASONE", "ASPARAGINASE"], "FATAL": [38, 69], "PATHOLOGY": "angiocentric lymphoma", "RECOVERED": [18, 59]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/650.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/650.json
new file mode 100644
index 00000000000..35e7c9c5b55
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/650.json
@@ -0,0 +1 @@
+{"CASES": [318, 1040, 135, 665, 165, 544, 102, 121, 226, 376], "DRUG": ["AFINITOR", "STIVARGA", "FULVESTRANT", "BEVACIZUMAB", "KEYTRUDA", "IRINOTECAN", "NEXAVAR", "CETUXIMAB", "CAPECITABINE", "AVASTIN"], "FATAL": [48, 78, 10, 35, 7, 23, 4, 3, 5, 1], "PATHOLOGY": "metastases to liver", "RECOVERED": [21, 86, 2, 89, 15, 121, 8, 22, 67, 27]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/651.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/651.json
new file mode 100644
index 00000000000..7e588aee10e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/651.json
@@ -0,0 +1 @@
+{"CASES": [307, 124, 114, 138, 402, 109, 646, 164, 343, 103, 1037, 757, 426, 115, 125, 173, 135], "DRUG": ["BEVACIZUMAB", "OPDIVO", "PEMBROLIZUMAB", "MEKINIST", "VOTRIENT", "INLYTA", "STIVARGA", "DOCETAXEL", "KEYTRUDA", "CAPECITABINE", "NEXAVAR", "SUTENT", "CABOMETYX", "AXITINIB", "AVASTIN", "AFINITOR", "IRINOTECAN"], "FATAL": [40, 14, 10, 12, 34, 8, 46, 11, 19, 5, 48, 25, 13, 3, 3, 4, 2], "PATHOLOGY": "metastases to lung", "RECOVERED": [36, 28, 11, 22, 34, 13, 52, 17, 49, 21, 235, 135, 67, 21, 16, 35, 45]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/652.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/652.json
new file mode 100644
index 00000000000..affc3682745
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/652.json
@@ -0,0 +1 @@
+{"CASES": [100, 112, 147, 191, 138, 137, 124], "DRUG": ["STIVARGA", "IRINOTECAN", "DOCETAXEL", "KEYTRUDA", "NEXAVAR", "PEMBROLIZUMAB", "CABOMETYX"], "FATAL": [12, 12, 15, 14, 6, 5, 3], "PATHOLOGY": "metastases to lymph nodes", "RECOVERED": [8, 24, 17, 18, 56, 15, 16]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/653.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/653.json
new file mode 100644
index 00000000000..c079d7dd9f8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/653.json
@@ -0,0 +1 @@
+{"CASES": [134], "DRUG": ["STIVARGA"], "FATAL": [14], "PATHOLOGY": "metastases to peritoneum", "RECOVERED": [10]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/654.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/654.json
new file mode 100644
index 00000000000..ef738261e88
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/654.json
@@ -0,0 +1 @@
+{"CASES": [129, 164, 152, 110, 101, 218, 122, 156], "DRUG": ["XOFIGO", "BRAFTOVI", "MEKINIST", "VOTRIENT", "KEYTRUDA", "SUTENT", "CABOMETYX", "NEXAVAR"], "FATAL": [23, 26, 18, 10, 7, 12, 5, 4], "PATHOLOGY": "metastasis", "RECOVERED": [5, 18, 24, 16, 16, 36, 10, 4]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/655.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/655.json
new file mode 100644
index 00000000000..badff8e73d3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/655.json
@@ -0,0 +1 @@
+{"CASES": [150], "DRUG": ["AFINITOR"], "FATAL": [7], "PATHOLOGY": "metastatic carcinoid tumour", "RECOVERED": [8]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/656.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/656.json
new file mode 100644
index 00000000000..01ee626e792
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/656.json
@@ -0,0 +1 @@
+{"CASES": [117], "DRUG": ["HERCEPTIN"], "FATAL": [17], "PATHOLOGY": "metastatic gastric cancer", "RECOVERED": [26]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/657.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/657.json
new file mode 100644
index 00000000000..777ff8a1a59
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/657.json
@@ -0,0 +1 @@
+{"CASES": [290, 203, 2753, 929, 1212, 3596, 4936, 1720, 2209, 153, 251, 2823, 4300, 2525, 793, 1902, 1071, 469, 369, 709, 204, 352, 265], "DRUG": ["NIVOLUMAB", "MEKINIST FILM-COATED TABLETS", "YERVOY", "TAFINLAR", "PEMBROLIZUMAB", "KEYTRUDA", "MEKINIST", "DABRAFENIB", "OPDIVO", "YERVOY 5 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION", "KEYTRUDA 50 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "ZELBORAF", "IPILIMUMAB", "COTELLIC", "VEMURAFENIB", "BRAFTOVI", "COBIMETINIB", "MEKINIST 2.0 MG FILM-COATED TABLETS", "BINIMETINIB", "COTELLIC 20 MG FILM-COATED TABLETS", "BRAFTOVI 75 MG HARD CAPSULES", "OPDIVO 10 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION", "TRAMETINIB"], "FATAL": [47, 31, 366, 88, 110, 262, 359, 118, 145, 10, 15, 168, 220, 126, 37, 69, 33, 13, 10, 18, 4, 6, 2], "PATHOLOGY": "metastatic malignant melanoma", "RECOVERED": [51, 24, 509, 258, 238, 564, 999, 348, 321, 66, 97, 754, 641, 866, 204, 505, 372, 227, 107, 479, 95, 149, 29]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/658.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/658.json
new file mode 100644
index 00000000000..bf19d6be3ec
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/658.json
@@ -0,0 +1 @@
+{"CASES": [201, 103], "DRUG": ["SUTENT", "KEYTRUDA"], "FATAL": [27, 10], "PATHOLOGY": "metastatic neoplasm", "RECOVERED": [26, 14]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/659.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/659.json
new file mode 100644
index 00000000000..bf37e31c74a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/659.json
@@ -0,0 +1 @@
+{"CASES": [142, 255, 2713, 1081, 104, 4615, 235, 56076, 105, 138, 292, 1745, 1927, 175, 382, 516, 3077, 4986, 692, 495, 240, 450, 699, 1357, 123], "DRUG": ["NIVOLUMAB", "EVEROLIMUS", "AFINITOR", "TORISEL", "TEMSIROLIMUS", "INLYTA", "AFINITOR TABLETS", "SUTENT", "PEMBROLIZUMAB", "BAVENCIO", "AVASTIN", "CABOMETYX", "NEXAVAR", "SORAFENIB", "AVELUMAB", "KEYTRUDA", "VOTRIENT", "OPDIVO", "SUTENT 12.5 MG", "IPILIMUMAB", "VOTRIENT FILM-COATED TABLETS", "SUNITINIB", "PAZOPANIB", "AXITINIB", "CABOZANTINIB"], "FATAL": [49, 44, 360, 131, 11, 458, 22, 4557, 8, 10, 21, 118, 127, 11, 24, 32, 190, 292, 34, 22, 10, 18, 24, 46, 3], "PATHOLOGY": "metastatic renal cell carcinoma", "RECOVERED": [39, 29, 332, 248, 25, 794, 38, 9641, 19, 27, 24, 208, 363, 51, 83, 82, 551, 1051, 196, 64, 30, 111, 77, 228, 12]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/66.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/66.json
new file mode 100644
index 00000000000..801dbe9a20b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/66.json
@@ -0,0 +1 @@
+{"CASES": [180, 113, 2912, 713, 4304], "DRUG": ["HYDROCORTISONE", "ICATIBANT", "CINRYZE", "C1 ESTERASE INHIBITOR (HUMAN)", "RUCONEST"], "FATAL": [168, 6, 55, 13, 16], "PATHOLOGY": "angioedema", "RECOVERED": [6, 22, 1068, 138, 391]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/660.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/660.json
new file mode 100644
index 00000000000..8cfc91df043
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/660.json
@@ -0,0 +1 @@
+{"CASES": [440, 395], "DRUG": ["TOVIAZ", "BETMIGA"], "FATAL": [4, 1], "PATHOLOGY": "micturition urgency", "RECOVERED": [98, 111]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/661.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/661.json
new file mode 100644
index 00000000000..55ef79ea18b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/661.json
@@ -0,0 +1 @@
+{"CASES": [46898, 729, 2781], "DRUG": ["AIMOVIG", "PROPRANOLOL HYDROCHLORIDE", "ERENUMAB"], "FATAL": [1662, 17, 4], "PATHOLOGY": "migraine", "RECOVERED": [5650, 137, 242]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/662.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/662.json
new file mode 100644
index 00000000000..57b5951f8fd
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/662.json
@@ -0,0 +1 @@
+{"CASES": [5656], "DRUG": ["AIMOVIG"], "FATAL": [20], "PATHOLOGY": "migraine prophylaxis", "RECOVERED": [1078]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/663.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/663.json
new file mode 100644
index 00000000000..5a4594fe2b3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/663.json
@@ -0,0 +1 @@
+{"CASES": [516], "DRUG": ["AIMOVIG"], "FATAL": [2], "PATHOLOGY": "migraine without aura", "RECOVERED": [146]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/664.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/664.json
new file mode 100644
index 00000000000..adbd7d08626
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/664.json
@@ -0,0 +1 @@
+{"CASES": [201, 146], "DRUG": ["CYMBALTA", "BRINTELLIX 10 MG FILM-COATED TABLETS"], "FATAL": [6, 4], "PATHOLOGY": "mixed anxiety and depressive disorder", "RECOVERED": [54, 62]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/665.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/665.json
new file mode 100644
index 00000000000..9821124d16e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/665.json
@@ -0,0 +1 @@
+{"CASES": [210], "DRUG": ["RILUTEK"], "FATAL": [51], "PATHOLOGY": "motor neurone disease", "RECOVERED": [30]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/666.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/666.json
new file mode 100644
index 00000000000..5f918a8de66
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/666.json
@@ -0,0 +1 @@
+{"CASES": [548, 7164], "DRUG": ["NAGLAZYME 1.0 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION", "NAGLAZYME"], "FATAL": [76, 294], "PATHOLOGY": "mucopolysaccharidosis vi", "RECOVERED": [156, 1959]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/667.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/667.json
new file mode 100644
index 00000000000..ac1f078e8c4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/667.json
@@ -0,0 +1 @@
+{"CASES": [330, 167, 505, 317], "DRUG": ["POSACONAZOLE", "CASPOFUNGIN", "CRESEMBA", "NOXAFIL"], "FATAL": [110, 45, 82, 34], "PATHOLOGY": "mucormycosis", "RECOVERED": [37, 29, 58, 43]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/668.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/668.json
new file mode 100644
index 00000000000..85afe4da45c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/668.json
@@ -0,0 +1 @@
+{"CASES": [317], "DRUG": ["PRIVIGEN"], "FATAL": [2], "PATHOLOGY": "multifocal motor neuropathy", "RECOVERED": [158]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/669.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/669.json
new file mode 100644
index 00000000000..b30813b1668
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/669.json
@@ -0,0 +1 @@
+{"CASES": [1573, 422, 1561, 162, 1285, 7136, 1518, 876, 358, 13627, 8371, 154, 1032, 1084, 39943, 6871, 119, 7576, 2984, 501, 6225, 4320, 746, 4903, 1672, 363], "DRUG": ["REBIF", "CLADRIBINE", "GILENYA", "MAVENCLAD 10 MG TABLETS", "ZINBRYTA", "FAMPYRA", "AVONEX", "TYSABRI", "FAMPYRA 10 MG PROLONGED-RELEASE TABLETS", "LEMTRADA", "BETAFERON", "BETAFERON 250 MICROGRAMS/ML POWDER AND SOLVENT FOR SOLUTION FOR INJECTION", "TECFIDERA", "AUBAGIO 14 MG FILM-COATED TABLETS", "AUBAGIO", "ALEMTUZUMAB", "CELLCEPT", "PLEGRIDY", "OCRELIZUMAB", "KESIMPTA 20 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN", "MAVENCLAD", "PLEGRIDY SOLUTION FOR INJECTION IN PRE-FILLED PEN", "OCREVUS", "KESIMPTA", "TERIFLUNOMIDE", "FAMPRIDINE"], "FATAL": [119, 24, 57, 4, 31, 146, 31, 15, 6, 224, 127, 2, 13, 12, 429, 67, 1, 55, 18, 3, 34, 18, 3, 15, 5, 1], "PATHOLOGY": "multiple sclerosis", "RECOVERED": [433, 73, 274, 34, 330, 1419, 456, 147, 157, 3437, 2498, 51, 178, 315, 4432, 1436, 24, 1978, 376, 177, 1108, 864, 145, 1385, 353, 113]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/67.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/67.json
new file mode 100644
index 00000000000..6646ce991a1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/67.json
@@ -0,0 +1 @@
+{"CASES": [10014, 463], "DRUG": ["OPTIMARK", "CONTRAST MEDIA"], "FATAL": [520, 2], "PATHOLOGY": "angiogram", "RECOVERED": [103, 6]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/670.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/670.json
new file mode 100644
index 00000000000..77cc1955886
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/670.json
@@ -0,0 +1 @@
+{"CASES": [178, 126, 162], "DRUG": ["AUBAGIO", "BETAFERON", "LEMTRADA"], "FATAL": [99, 8, 2], "PATHOLOGY": "multiple sclerosis relapse", "RECOVERED": [22, 9, 63]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/671.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/671.json
new file mode 100644
index 00000000000..cbbb5b8c601
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/671.json
@@ -0,0 +1 @@
+{"CASES": [184], "DRUG": ["KESIMPTA"], "FATAL": [1], "PATHOLOGY": "multiple sclerosis, relapsing-remitting multiple sclerosis", "RECOVERED": [60]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/672.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/672.json
new file mode 100644
index 00000000000..91eb737badc
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/672.json
@@ -0,0 +1 @@
+{"CASES": [178, 165, 372, 121, 4532, 5878], "DRUG": ["METHOTREXATE", "PREGABALIN", "ROACTEMRA", "XELJANZ", "LYRICA", "CYMBALTA"], "FATAL": [106, 8, 12, 1, 26, 11], "PATHOLOGY": "myalgia", "RECOVERED": [12, 16, 75, 16, 711, 1040]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/673.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/673.json
new file mode 100644
index 00000000000..2bd37d899e8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/673.json
@@ -0,0 +1 @@
+{"CASES": [195, 103, 234, 183, 150, 356, 2170, 782, 511, 171], "DRUG": ["AZATHIOPRINE", "MYCOPHENOLATE MOFETIL", "SOLIRIS", "CICLOSPORIN", "HUMAN NORMAL IMMUNOGLOBULIN (IV)", "HUMAN NORMAL IMMUNOGLOBULIN", "SOLIRIS 300 MG", "PRIVIGEN", "CELLCEPT", "KIOVIG"], "FATAL": [90, 6, 9, 7, 5, 11, 50, 15, 9, 1], "PATHOLOGY": "myasthenia gravis", "RECOVERED": [14, 14, 18, 40, 29, 47, 238, 353, 69, 69]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/674.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/674.json
new file mode 100644
index 00000000000..c5b67fabc13
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/674.json
@@ -0,0 +1 @@
+{"CASES": [8280, 1737, 179], "DRUG": ["FIRDAPSE", "FIRDAPSE 10 MG", "AMIFAMPRIDINE"], "FATAL": [354, 48, 2], "PATHOLOGY": "myasthenic syndrome", "RECOVERED": [1624, 340, 24]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/675.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/675.json
new file mode 100644
index 00000000000..e443843b3e0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/675.json
@@ -0,0 +1 @@
+{"CASES": [388, 224], "DRUG": ["AMIKACIN", "LEVOFLOXACIN"], "FATAL": [23, 3], "PATHOLOGY": "mycobacterial infection", "RECOVERED": [70, 42]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/676.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/676.json
new file mode 100644
index 00000000000..28a7a8ba936
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/676.json
@@ -0,0 +1 @@
+{"CASES": [562, 193], "DRUG": ["AMIKACIN", "TIGECYCLINE"], "FATAL": [8, 1], "PATHOLOGY": "mycobacterium abscessus infection", "RECOVERED": [82, 25]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/677.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/677.json
new file mode 100644
index 00000000000..f193b438346
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/677.json
@@ -0,0 +1 @@
+{"CASES": [670, 120], "DRUG": ["AMIKACIN", "LEVOFLOXACIN"], "FATAL": [15, 1], "PATHOLOGY": "mycobacterium avium complex infection", "RECOVERED": [72, 25]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/678.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/678.json
new file mode 100644
index 00000000000..5ea3dbe6213
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/678.json
@@ -0,0 +1 @@
+{"CASES": [5662, 203, 191, 228, 104, 765, 193, 968, 132, 314, 186, 165, 337, 157, 299], "DRUG": ["EXJADE", "NPLATE", "DECITABINE", "JAKAVI", "LENALIDOMIDE", "ARANESP", "VIDAZA", "AZACITIDINE", "THALIDOMIDE", "CICLOSPORIN", "VENETOCLAX", "BUSULFAN", "REBLOZYL", "TRISENOX", "REVLIMID"], "FATAL": [1480, 37, 31, 33, 15, 107, 27, 112, 12, 26, 14, 8, 12, 5, 8], "PATHOLOGY": "myelodysplastic syndrome", "RECOVERED": [445, 7, 1, 26, 6, 78, 49, 298, 8, 62, 27, 35, 57, 50, 78]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/679.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/679.json
new file mode 100644
index 00000000000..21b474652ed
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/679.json
@@ -0,0 +1 @@
+{"CASES": [527, 2704, 15021, 2817, 177, 127, 156, 279], "DRUG": ["EXJADE", "JAKAVI TABLETS", "JAKAVI", "RUXOLITINIB", "JAKAVI 20 MG TABLETS", "JAKAVI 15 MG TABLETS", "BUSULFAN", "PEGASYS"], "FATAL": [114, 455, 1585, 248, 14, 7, 2, 2], "PATHOLOGY": "myelofibrosis", "RECOVERED": [68, 401, 1529, 267, 54, 60, 20, 26]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/68.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/68.json
new file mode 100644
index 00000000000..711e37b18f1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/68.json
@@ -0,0 +1 @@
+{"CASES": [237, 103], "DRUG": ["AFINITOR", "AFINITOR TABLETS"], "FATAL": [4, 1], "PATHOLOGY": "angiomyolipoma", "RECOVERED": [100, 28]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/680.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/680.json
new file mode 100644
index 00000000000..bb36e0eeec4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/680.json
@@ -0,0 +1 @@
+{"CASES": [168, 170, 638, 929, 136, 407, 751, 548, 121, 3110, 126, 871, 156, 8310, 5666, 1398, 358, 885, 5790, 152, 2343, 486, 114, 295, 2674, 150, 506, 416, 23890, 955, 559, 112, 1748, 281, 16602, 261, 2339, 340, 2738, 427, 623, 423, 3921, 8073, 253, 1389, 207, 152, 374, 540], "DRUG": ["EVOLTRA", "VFEND", "EXJADE", "CLOFARABINE", "CICLOSPORIN", "VIDAZA", "NEXAVAR", "RYDAPT", "ICLUSIG 15 MG FILM-COATED TABLETS", "VENETOCLAX", "TRISENOX", "CLADRIBINE", "BUSILVEX", "ICLUSIG", "AZACITIDINE", "VENCLYXTO", "ALEMTUZUMAB", "VYXEOS LIPOSOMAL", "CYTARABINE", "BOSULIF 100 MG FILM-COATED TABLETS", "BUSULFAN", "DECITABINE", "GILTERITINIB", "SORAFENIB", "GLIVEC", "CELLCEPT", "MIDOSTAURIN", "PONATINIB", "TASIGNA", "SPRYCEL FILM-COATED TABLETS", "SPRYCEL 50 MG FILM-COATED TABLETS", "SPRYCEL 20 MG FILM-COATED TABLETS", "IMATINIB", "ASPARAGINASE", "SPRYCEL", "TASIGNA 200 MG HARD CAPSULES", "DASATINIB", "SPRYCEL 70 MG FILM-COATED TABLETS", "TASIGNA HARD CAPSULES", "BOSULIF 100 MG", "SCEMBLIX", "DACOGEN", "NILOTINIB", "BOSULIF", "GLIVEC FILM-COATED TABLETS", "BOSUTINIB", "SPRYCEL 100 MG FILM-COATED TABLETS", "DEXAMETHASONE", "TASIGNA 150 MG HARD CAPSULES", "IMATINIB MESILATE"], "FATAL": [71, 55, 195, 238, 26, 68, 118, 82, 16, 403, 16, 110, 19, 1003, 672, 164, 41, 99, 608, 14, 209, 38, 8, 20, 180, 10, 31, 24, 1268, 48, 26, 5, 75, 12, 599, 9, 76, 11, 84, 13, 18, 12, 111, 209, 4, 21, 3, 2, 2, 1], "PATHOLOGY": "myeloid leukaemia", "RECOVERED": [23, 8, 54, 142, 28, 99, 70, 89, 43, 432, 41, 107, 10, 1571, 862, 171, 136, 248, 1632, 65, 674, 61, 18, 44, 599, 2, 95, 96, 3332, 147, 166, 31, 231, 89, 2018, 106, 300, 111, 648, 131, 126, 118, 514, 1156, 50, 143, 75, 41, 124, 36]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/681.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/681.json
new file mode 100644
index 00000000000..309a4986368
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/681.json
@@ -0,0 +1 @@
+{"CASES": [159, 534], "DRUG": ["RUXOLITINIB", "JAKAVI"], "FATAL": [17, 36], "PATHOLOGY": "myeloproliferative neoplasm", "RECOVERED": [25, 39]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/682.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/682.json
new file mode 100644
index 00000000000..17c0f471ba1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/682.json
@@ -0,0 +1 @@
+{"CASES": [104, 129, 105, 110, 381, 179, 4513, 3945, 1189, 693, 2062, 310, 346, 694, 1079, 236], "DRUG": ["RAPILYSIN", "RAPILYSIN 10 U", "METALYSE", "RETEPLASE", "INTEGRILIN", "PLAVIX 75 MG FILM-COATED TABLETS", "PLAVIX", "BRILIQUE", "CLOPIDOGREL HYDROGEN SULFATE", "EFIENT", "CLOPIDOGREL", "ENOXAPARIN SODIUM", "ELIQUIS", "BRILIQUE 90 MG FILM-COATED TABLETS", "TICAGRELOR", "ENTRESTO"], "FATAL": [43, 41, 33, 26, 50, 21, 466, 406, 101, 58, 162, 22, 24, 36, 53, 1], "PATHOLOGY": "myocardial infarction", "RECOVERED": [25, 15, 35, 24, 81, 79, 1221, 959, 376, 245, 665, 86, 29, 359, 281, 24]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/683.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/683.json
new file mode 100644
index 00000000000..e496bb5a7fe
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/683.json
@@ -0,0 +1 @@
+{"CASES": [446], "DRUG": ["BRILIQUE"], "FATAL": [48], "PATHOLOGY": "myocardial infarction, stent placement", "RECOVERED": [36]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/684.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/684.json
new file mode 100644
index 00000000000..8e76a84bb3f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/684.json
@@ -0,0 +1 @@
+{"CASES": [145, 119, 723, 111, 489, 112], "DRUG": ["PLAVIX 75 MG FILM-COATED TABLETS", "BRILIQUE 90 MG FILM-COATED TABLETS", "PLAVIX", "CLOPIDOGREL HYDROGEN SULFATE", "CLOPIDOGREL", "RANEXA"], "FATAL": [19, 14, 53, 6, 18, 1], "PATHOLOGY": "myocardial ischaemia", "RECOVERED": [74, 59, 255, 41, 235, 58]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/685.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/685.json
new file mode 100644
index 00000000000..1421e6e430e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/685.json
@@ -0,0 +1 @@
+{"CASES": [736, 149, 992], "DRUG": ["LEVETIRACETAM", "EPIDYOLEX", "KEPPRA"], "FATAL": [42, 3, 8], "PATHOLOGY": "myoclonic epilepsy", "RECOVERED": [194, 35, 223]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/686.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/686.json
new file mode 100644
index 00000000000..d015fe12e20
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/686.json
@@ -0,0 +1 @@
+{"CASES": [205, 313], "DRUG": ["KEPPRA", "LEVETIRACETAM"], "FATAL": [14, 15], "PATHOLOGY": "myoclonus", "RECOVERED": [31, 73]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/687.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/687.json
new file mode 100644
index 00000000000..1f9d244060c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/687.json
@@ -0,0 +1 @@
+{"CASES": [111, 647, 124, 339, 182, 813, 167, 105, 222, 113, 228, 123, 404, 417], "DRUG": ["TACROLIMUS", "CICLOSPORIN", "HUMAN NORMAL IMMUNOGLOBULIN (IV)", "HUMAN NORMAL IMMUNOGLOBULIN", "AZATHIOPRINE", "PRIVIGEN", "MYCOPHENOLATE MOFETIL", "KIOVIG", "XELJANZ", "HIZENTRA", "FLEBOGAMMA DIF", "METHOTREXATE", "CELLCEPT", "RITUXIMAB"], "FATAL": [34, 85, 15, 41, 22, 59, 11, 5, 4, 2, 4, 2, 5, 2], "PATHOLOGY": "myositis", "RECOVERED": [7, 147, 7, 28, 6, 342, 5, 37, 6, 16, 124, 34, 82, 53]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/688.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/688.json
new file mode 100644
index 00000000000..c4643e3993a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/688.json
@@ -0,0 +1 @@
+{"CASES": [4094], "DRUG": ["XYREM"], "FATAL": [6], "PATHOLOGY": "narcolepsy", "RECOVERED": [724]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/689.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/689.json
new file mode 100644
index 00000000000..60c1273f920
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/689.json
@@ -0,0 +1 @@
+{"CASES": [376], "DRUG": ["NUCALA"], "FATAL": [1], "PATHOLOGY": "nasal polyps", "RECOVERED": [75]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/69.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/69.json
new file mode 100644
index 00000000000..16feb32f0bd
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/69.json
@@ -0,0 +1 @@
+{"CASES": [241], "DRUG": ["SOLIRIS 300 MG"], "FATAL": [23], "PATHOLOGY": "angiopathy", "RECOVERED": [18]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/690.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/690.json
new file mode 100644
index 00000000000..c265eaea70c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/690.json
@@ -0,0 +1 @@
+{"CASES": [196, 133], "DRUG": ["DOCETAXEL", "KEYTRUDA"], "FATAL": [20, 8], "PATHOLOGY": "nasopharyngeal cancer", "RECOVERED": [27, 19]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/691.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/691.json
new file mode 100644
index 00000000000..9a012977c9a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/691.json
@@ -0,0 +1 @@
+{"CASES": [313, 110], "DRUG": ["LEVOFLOXACIN", "BC SINUS COLD-PHENYLPROPANOLAMINE"], "FATAL": [11, 2], "PATHOLOGY": "nasopharyngitis", "RECOVERED": [88, 36]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/692.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/692.json
new file mode 100644
index 00000000000..73f3290fcb1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/692.json
@@ -0,0 +1 @@
+{"CASES": [279, 2432, 258, 514, 1018], "DRUG": ["OLANZAPINE", "EMEND", "APREPITANT", "ALOXI", "DEXAMETHASONE"], "FATAL": [186, 154, 15, 19, 18], "PATHOLOGY": "nausea", "RECOVERED": [36, 1058, 113, 162, 439]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/693.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/693.json
new file mode 100644
index 00000000000..e5b946cfbeb
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/693.json
@@ -0,0 +1 @@
+{"CASES": [189], "DRUG": ["OLANZAPINE"], "FATAL": [184], "PATHOLOGY": "nausea, vomiting", "RECOVERED": [1]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/694.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/694.json
new file mode 100644
index 00000000000..46b9d00389a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/694.json
@@ -0,0 +1 @@
+{"CASES": [224, 731, 192, 4626, 122, 506, 124, 148, 961, 2867, 120, 100, 1080, 650, 741, 148, 267, 181, 206, 170, 256, 491, 170, 166, 1155, 3125, 105, 6197, 148, 288, 854, 215, 7293, 179, 2405, 3369, 227, 706, 665, 2526, 1108, 254, 576, 226, 1274, 379, 342, 134, 740, 119, 1378, 102, 3260, 255, 215, 632, 1668, 1146, 199, 145, 737, 600, 2453, 880, 227, 517, 314, 141, 107, 165, 174, 275, 143, 392, 205, 293, 418, 588, 419, 151, 798, 170, 192, 115, 395], "DRUG": ["TORISEL", "EXJADE", "LONSURF", "XALKORI", "JEVTANA", "HYCAMTIN", "MEKINIST FILM-COATED TABLETS", "COTELLIC", "XTANDI", "VOTRIENT", "ZELBORAF", "EVEROLIMUS", "VOTRIENT FILM-COATED TABLETS", "OPDIVO", "BRAFTOVI", "HALAVEN", "XELODA", "PAZOPANIB", "SPRYCEL", "KEYTRUDA 50 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "TAXOTERE", "CAELYX", "AXITINIB", "RUXOLITINIB", "INLYTA", "ALIMTA", "TOPOTECAN", "SUTENT", "TRODELVY", "TEMOZOLOMIDE", "PEMETREXED", "TARCEVA", "KEYTRUDA", "DABRAFENIB", "MEKINIST", "IRESSA", "METHOTREXATE", "TEMODAL", "CAPECITABINE", "AFINITOR", "DOCETAXEL", "RADIATION THERAPY", "JAKAVI", "HERCEPTIN", "NEXAVAR", "OSIMERTINIB", "PACLITAXEL", "ALIMTA 500 MG", "LYNPARZA", "NIVOLUMAB", "PEMBROLIZUMAB", "ABEMACICLIB", "TAGRISSO", "ALIMTA 500 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "XALKORI 250 MG", "FASLODEX", "BEVACIZUMAB", "AVASTIN", "ERBITUX", "DEXAMETHASONE", "CABOMETYX", "STIVARGA", "IBRANCE", "RUBRACA", "CYTARABINE", "GEFITINIB", "GAVRETO", "TAGRISSO 80 MG FILM-COATED TABLETS", "ABRAXANE", "SOTORASIB", "KISQALI", "FULVESTRANT", "CRIZOTINIB", "IPILIMUMAB", "CHEMOTHERAPY", "IRINOTECAN", "RITUXIMAB", "DOXORUBICIN HYDROCHLORIDE", "LENVIMA", "TOPOTECAN HYDROCHLORIDE", "PEMETREXED DISODIUM", "OLAPARIB", "ATEZOLIZUMAB", "MVASI", "PEGASYS"], "FATAL": [74, 232, 58, 1303, 28, 116, 26, 31, 201, 572, 22, 17, 176, 92, 103, 20, 35, 22, 25, 20, 29, 55, 19, 17, 117, 312, 10, 588, 14, 27, 80, 20, 657, 16, 213, 290, 19, 53, 46, 174, 75, 17, 38, 14, 76, 21, 18, 7, 38, 6, 69, 5, 156, 12, 10, 24, 61, 41, 7, 5, 25, 20, 80, 28, 7, 15, 9, 4, 3, 4, 4, 6, 3, 8, 4, 5, 7, 9, 6, 2, 10, 2, 2, 1, 2], "PATHOLOGY": "neoplasm", "RECOVERED": [22, 32, 26, 524, 48, 144, 13, 15, 50, 262, 15, 12, 59, 61, 107, 51, 57, 30, 9, 62, 83, 225, 36, 25, 94, 654, 34, 935, 38, 43, 158, 34, 916, 35, 274, 529, 31, 159, 102, 210, 200, 22, 39, 56, 226, 37, 92, 35, 112, 19, 204, 9, 267, 90, 48, 115, 504, 194, 36, 29, 191, 72, 254, 118, 56, 77, 26, 40, 37, 14, 44, 60, 38, 99, 44, 90, 148, 287, 116, 6, 89, 16, 39, 23, 45]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/695.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/695.json
new file mode 100644
index 00000000000..fa90875edc1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/695.json
@@ -0,0 +1 @@
+{"CASES": [113], "DRUG": ["KEYTRUDA"], "FATAL": [10], "PATHOLOGY": "neoplasm progression", "RECOVERED": [6]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/696.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/696.json
new file mode 100644
index 00000000000..485dc3bf5e0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/696.json
@@ -0,0 +1 @@
+{"CASES": [408], "DRUG": ["XTANDI"], "FATAL": [124], "PATHOLOGY": "neoplasm prostate", "RECOVERED": [27]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/697.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/697.json
new file mode 100644
index 00000000000..23f80d5c6de
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/697.json
@@ -0,0 +1 @@
+{"CASES": [6811, 160, 418, 566, 4154], "DRUG": ["EYLEA", "EYLEA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "AVASTIN", "BROLUCIZUMAB", "BEOVU"], "FATAL": [128, 1, 1, 1, 5], "PATHOLOGY": "neovascular age-related macular degeneration", "RECOVERED": [2020, 21, 69, 93, 945]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/698.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/698.json
new file mode 100644
index 00000000000..2d2020c4b4d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/698.json
@@ -0,0 +1 @@
+{"CASES": [3679, 232, 151, 4335, 169, 293, 295], "DRUG": ["ARANESP", "EVRENZO", "RETACRIT", "MIRCERA", "BINOCRIT", "NEORECORMON", "EPOETIN ALFA"], "FATAL": [956, 37, 18, 420, 13, 18, 10], "PATHOLOGY": "nephrogenic anaemia", "RECOVERED": [498, 77, 79, 1802, 35, 66, 74]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/699.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/699.json
new file mode 100644
index 00000000000..7492f465481
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/699.json
@@ -0,0 +1 @@
+{"CASES": [126], "DRUG": ["CELLCEPT"], "FATAL": [12], "PATHOLOGY": "nephropathy", "RECOVERED": [45]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/7.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/7.json
new file mode 100644
index 00000000000..90294805efb
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/7.json
@@ -0,0 +1 @@
+{"CASES": [136], "DRUG": ["SUBOXONE"], "FATAL": [26], "PATHOLOGY": "accidental exposure to product by child", "RECOVERED": [84]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/70.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/70.json
new file mode 100644
index 00000000000..a82fd574f21
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/70.json
@@ -0,0 +1 @@
+{"CASES": [171, 1028, 299], "DRUG": ["CLOPIDOGREL", "PLAVIX", "BRILIQUE"], "FATAL": [23, 63, 14], "PATHOLOGY": "angioplasty", "RECOVERED": [46, 329, 140]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/700.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/700.json
new file mode 100644
index 00000000000..1bfa0db1c17
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/700.json
@@ -0,0 +1 @@
+{"CASES": [1681, 417], "DRUG": ["CICLOSPORIN", "CELLCEPT"], "FATAL": [77, 11], "PATHOLOGY": "nephrotic syndrome", "RECOVERED": [433, 100]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/701.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/701.json
new file mode 100644
index 00000000000..ad57336ef8f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/701.json
@@ -0,0 +1 @@
+{"CASES": [633], "DRUG": ["BUPIVACAINE"], "FATAL": [20], "PATHOLOGY": "nerve block", "RECOVERED": [272]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/702.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/702.json
new file mode 100644
index 00000000000..5c6af6d048b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/702.json
@@ -0,0 +1 @@
+{"CASES": [114, 435, 132, 410, 4123, 654, 2316, 164, 1704], "DRUG": ["PREGABALIN MYLAN 25 MG HARD CAPSULES", "FENTANYL", "DULOXETINE HYDROCHLORIDE", "DULOXETINE", "LYRICA", "PREGABALIN", "CYMBALTA", "BUPRENORPHINE", "QUTENZA"], "FATAL": [15, 23, 2, 5, 35, 5, 16, 1, 8], "PATHOLOGY": "neuralgia", "RECOVERED": [46, 151, 42, 93, 948, 151, 658, 41, 808]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/703.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/703.json
new file mode 100644
index 00000000000..8972fb313ef
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/703.json
@@ -0,0 +1 @@
+{"CASES": [320, 418, 342, 233, 1758, 478, 398, 193, 225], "DRUG": ["MELPHALAN", "IRINOTECAN", "BUSULFAN", "TOPOTECAN HYDROCHLORIDE", "QARZIBA", "DINUTUXIMAB", "TOPOTECAN", "DOXORUBICIN HYDROCHLORIDE", "UNITUXIN"], "FATAL": [38, 37, 22, 14, 96, 26, 19, 8, 6], "PATHOLOGY": "neuroblastoma", "RECOVERED": [39, 159, 36, 47, 706, 67, 109, 42, 39]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/704.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/704.json
new file mode 100644
index 00000000000..697cc655458
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/704.json
@@ -0,0 +1 @@
+{"CASES": [124, 117], "DRUG": ["QARZIBA", "TOPOTECAN HYDROCHLORIDE"], "FATAL": [12, 11], "PATHOLOGY": "neuroblastoma recurrent", "RECOVERED": [52, 26]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/705.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/705.json
new file mode 100644
index 00000000000..833519d92a3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/705.json
@@ -0,0 +1 @@
+{"CASES": [621, 359, 165, 420, 607], "DRUG": ["AFINITOR", "BAVENCIO", "AVELUMAB", "KEYTRUDA", "SUTENT"], "FATAL": [98, 47, 12, 23, 26], "PATHOLOGY": "neuroendocrine carcinoma", "RECOVERED": [31, 77, 34, 44, 90]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/706.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/706.json
new file mode 100644
index 00000000000..957b5dbabf8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/706.json
@@ -0,0 +1 @@
+{"CASES": [230, 216], "DRUG": ["AFINITOR", "SUTENT"], "FATAL": [19, 6], "PATHOLOGY": "neuroendocrine carcinoma metastatic", "RECOVERED": [8, 34]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/707.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/707.json
new file mode 100644
index 00000000000..05aedd47b95
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/707.json
@@ -0,0 +1 @@
+{"CASES": [359, 162, 330], "DRUG": ["BAVENCIO", "AVELUMAB", "KEYTRUDA"], "FATAL": [47, 12, 19], "PATHOLOGY": "neuroendocrine carcinoma of the skin", "RECOVERED": [77, 31, 28]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/708.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/708.json
new file mode 100644
index 00000000000..c3475ac70e5
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/708.json
@@ -0,0 +1 @@
+{"CASES": [6630, 1516, 2109, 940, 4793, 206, 121, 748, 173, 242], "DRUG": ["AFINITOR", "LUTATHERA", "AFINITOR TABLETS", "EVEROLIMUS", "SUTENT", "LUTETIUM (177LU) OXODOTREOTIDE", "AFINITOR 10 MG TABLETS", "CAPECITABINE", "OCTREOTIDE", "SUTENT 12.5 MG"], "FATAL": [890, 121, 158, 69, 340, 14, 6, 20, 3, 4], "PATHOLOGY": "neuroendocrine tumour", "RECOVERED": [1252, 247, 448, 373, 741, 18, 56, 57, 22, 56]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/709.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/709.json
new file mode 100644
index 00000000000..7e87f6c9c86
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/709.json
@@ -0,0 +1 @@
+{"CASES": [327], "DRUG": ["AFINITOR"], "FATAL": [2], "PATHOLOGY": "neuroendocrine tumour of the lung", "RECOVERED": [8]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/71.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/71.json
new file mode 100644
index 00000000000..1b5680bd543
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/71.json
@@ -0,0 +1 @@
+{"CASES": [236, 202, 195, 146], "DRUG": ["VOTRIENT", "VOTRIENT FILM-COATED TABLETS", "PAZOPANIB", "SUTENT"], "FATAL": [59, 20, 18, 6], "PATHOLOGY": "angiosarcoma", "RECOVERED": [52, 26, 31, 36]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/710.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/710.json
new file mode 100644
index 00000000000..e3c80605703
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/710.json
@@ -0,0 +1 @@
+{"CASES": [1612, 5367, 274], "DRUG": ["BRIDION 100 MG/ML SOLUTION FOR INJECTION", "BRIDION", "SUGAMMADEX"], "FATAL": [55, 119, 5], "PATHOLOGY": "neuromuscular blockade", "RECOVERED": [1047, 3410, 171]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/711.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/711.json
new file mode 100644
index 00000000000..fe0a551ee0f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/711.json
@@ -0,0 +1 @@
+{"CASES": [1608, 218, 5329], "DRUG": ["BRIDION 100 MG/ML SOLUTION FOR INJECTION", "SUGAMMADEX", "BRIDION"], "FATAL": [55, 5, 119], "PATHOLOGY": "neuromuscular blockade reversal", "RECOVERED": [1043, 132, 3380]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/712.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/712.json
new file mode 100644
index 00000000000..d9f0d11ced4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/712.json
@@ -0,0 +1 @@
+{"CASES": [388, 525, 187], "DRUG": ["RITUXIMAB", "SOLIRIS 300 MG", "CELLCEPT"], "FATAL": [80, 34, 1], "PATHOLOGY": "neuromyelitis optica spectrum disorder", "RECOVERED": [180, 58, 19]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/713.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/713.json
new file mode 100644
index 00000000000..fdd72ffd342
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/713.json
@@ -0,0 +1 @@
+{"CASES": [134, 1763, 2414], "DRUG": ["PREGABALIN", "CYMBALTA", "LYRICA"], "FATAL": [21, 13, 10], "PATHOLOGY": "neuropathy peripheral", "RECOVERED": [13, 365, 355]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/714.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/714.json
new file mode 100644
index 00000000000..bb79b2dac92
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/714.json
@@ -0,0 +1 @@
+{"CASES": [184, 113, 552, 150, 1372, 188, 260, 2516, 476, 241, 104], "DRUG": ["CICLOSPORIN", "VFEND", "CANCIDAS 50 MG POWDER FOR SOLUTION FOR INFUSION", "TEVAGRASTIM", "FILGRASTIM", "AMIKACIN", "PEGFILGRASTIM", "NEULASTA", "ZARZIO", "ZARZIO 30 MU/0.5 ML SOLUTION FOR INJECTION OR INFUSION IN PRE-FILLED SYRINGE", "ACCOFIL"], "FATAL": [143, 24, 80, 20, 74, 10, 13, 124, 8, 3, 1], "PATHOLOGY": "neutropenia", "RECOVERED": [6, 45, 218, 93, 445, 124, 121, 495, 285, 169, 81]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/715.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/715.json
new file mode 100644
index 00000000000..904a9e7386a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/715.json
@@ -0,0 +1 @@
+{"CASES": [1724], "DRUG": ["CHAMPIX"], "FATAL": [22], "PATHOLOGY": "nicotine dependence", "RECOVERED": [765]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/716.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/716.json
new file mode 100644
index 00000000000..53a4211f683
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/716.json
@@ -0,0 +1 @@
+{"CASES": [880], "DRUG": ["ZAVESCA"], "FATAL": [187], "PATHOLOGY": "niemann-pick disease", "RECOVERED": [120]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/717.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/717.json
new file mode 100644
index 00000000000..fceef59124c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/717.json
@@ -0,0 +1 @@
+{"CASES": [445, 399, 1052, 154, 208, 197, 1752, 206, 1534, 1094, 612, 326, 113, 163], "DRUG": ["CARMUSTINE", "YESCARTA", "CYTARABINE", "YTTRIUM-90", "KYMRIAH", "OBINUTUZUMAB", "RITUXIMAB", "METHOTREXATE", "MABTHERA", "DOXORUBICIN HYDROCHLORIDE", "DEXAMETHASONE", "ASPARAGINASE", "PRIVIGEN", "CAELYX"], "FATAL": [103, 60, 138, 20, 26, 20, 150, 17, 119, 57, 29, 15, 4, 2], "PATHOLOGY": "non-hodgkin's lymphoma", "RECOVERED": [71, 161, 241, 16, 82, 32, 509, 77, 530, 259, 107, 64, 61, 27]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/718.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/718.json
new file mode 100644
index 00000000000..eae7d7bb656
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/718.json
@@ -0,0 +1 @@
+{"CASES": [896, 3380, 128, 188, 383, 479, 1561, 670, 391, 291, 6393, 155, 15780, 200, 162, 7711, 303, 881, 886, 1622, 385, 470, 141, 9078, 9036, 193, 956, 138, 140, 102, 139, 2910, 351, 209], "DRUG": ["ATEZOLIZUMAB", "XALKORI", "TARCEVA", "PEMETREXED DISODIUM", "BEVACIZUMAB", "ABRAXANE", "PEMETREXED", "DOCETAXEL", "IMFINZI", "AVASTIN", "IRESSA", "ALECTINIB", "KEYTRUDA", "LUMYKRAS", "DABRAFENIB", "ALIMTA", "CRIZOTINIB", "IPILIMUMAB", "OSIMERTINIB", "MEKINIST", "PACLITAXEL", "SOTORASIB", "NIVOLUMAB", "TAGRISSO", "OPDIVO", "TAXOTERE", "GEFITINIB", "GIOTRIF", "XALKORI 250 MG", "TAGRISSO 80 MG FILM-COATED TABLETS", "ALECENSA", "PEMBROLIZUMAB", "ERLOTINIB", "GAVRETO"], "FATAL": [205, 476, 16, 23, 43, 53, 161, 67, 39, 29, 634, 15, 1508, 19, 15, 676, 26, 69, 69, 126, 28, 34, 10, 631, 621, 13, 59, 8, 7, 5, 6, 124, 14, 4], "PATHOLOGY": "non-small cell lung cancer", "RECOVERED": [213, 572, 22, 65, 37, 156, 395, 104, 55, 72, 945, 13, 3311, 19, 17, 1651, 99, 104, 130, 336, 80, 92, 27, 1655, 1502, 79, 83, 36, 63, 39, 69, 485, 29, 26]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/719.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/719.json
new file mode 100644
index 00000000000..6cc7a8585e7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/719.json
@@ -0,0 +1 @@
+{"CASES": [117, 675, 315, 131, 969, 696, 118, 362, 178, 649, 130, 196, 136], "DRUG": ["IPILIMUMAB", "XALKORI", "PEMETREXED", "OSIMERTINIB", "KEYTRUDA", "ALIMTA", "IRESSA", "TAGRISSO", "DOCETAXEL", "PEMBROLIZUMAB", "OPDIVO", "ATEZOLIZUMAB", "GEFITINIB"], "FATAL": [22, 108, 47, 15, 95, 66, 11, 31, 14, 32, 5, 7, 3], "PATHOLOGY": "non-small cell lung cancer metastatic", "RECOVERED": [15, 96, 92, 27, 171, 116, 22, 36, 30, 150, 7, 50, 9]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/72.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/72.json
new file mode 100644
index 00000000000..d442b42c726
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/72.json
@@ -0,0 +1 @@
+{"CASES": [136, 104, 9949, 958, 222, 13674, 343, 1159, 4925, 1297], "DRUG": ["METHOTREXATE", "RINVOQ 15 MG PROLONGED-RELEASE TABLETS", "SIMPONI", "RINVOQ", "STELARA", "COSENTYX", "REMICADE", "HUMIRA", "CIMZIA", "ENBREL"], "FATAL": [12, 6, 129, 10, 2, 91, 2, 4, 14, 1], "PATHOLOGY": "ankylosing spondylitis", "RECOVERED": [16, 32, 1388, 174, 44, 1467, 79, 194, 611, 151]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/720.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/720.json
new file mode 100644
index 00000000000..21248f7a155
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/720.json
@@ -0,0 +1 @@
+{"CASES": [102, 140, 4927, 501], "DRUG": ["IRESSA", "KEYTRUDA", "OPDIVO", "ALIMTA"], "FATAL": [13, 17, 337, 32], "PATHOLOGY": "non-small cell lung cancer recurrent", "RECOVERED": [29, 18, 1063, 137]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/721.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/721.json
new file mode 100644
index 00000000000..3455225e629
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/721.json
@@ -0,0 +1 @@
+{"CASES": [162, 138, 754, 2864, 456, 366, 172, 440, 189], "DRUG": ["IRESSA", "OSIMERTINIB", "ALIMTA", "KEYTRUDA", "TAGRISSO", "XALKORI", "PEMETREXED", "PEMBROLIZUMAB", "GEFITINIB"], "FATAL": [31, 18, 73, 223, 35, 20, 8, 13, 4], "PATHOLOGY": "non-small cell lung cancer stage iv", "RECOVERED": [21, 13, 163, 702, 46, 71, 56, 74, 19]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/722.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/722.json
new file mode 100644
index 00000000000..9944d9f9849
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/722.json
@@ -0,0 +1 @@
+{"CASES": [109, 331, 108, 175, 4951, 502, 102], "DRUG": ["BYETTA", "VICTOZA", "SEMAGLUTIDE", "XENICAL", "SAXENDA", "SAXENDA 6 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED PEN", "LIRAGLUTIDE"], "FATAL": [5, 12, 3, 3, 52, 5, 1], "PATHOLOGY": "obesity", "RECOVERED": [28, 99, 85, 51, 2025, 163, 27]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/723.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/723.json
new file mode 100644
index 00000000000..9267d482518
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/723.json
@@ -0,0 +1 @@
+{"CASES": [268, 327], "DRUG": ["OLANZAPINE", "ZYPREXA"], "FATAL": [58, 3], "PATHOLOGY": "obsessive-compulsive disorder", "RECOVERED": [83, 73]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/724.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/724.json
new file mode 100644
index 00000000000..6d71cdf1142
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/724.json
@@ -0,0 +1 @@
+{"CASES": [205, 164, 485, 359, 101, 113, 3314, 2912, 713, 4304], "DRUG": ["HYDROCORTISONE", "MANNITOL", "DEXAMETHASONE", "SPIRONOLACTONE", "BUMETANIDE", "ICATIBANT", "EYLEA", "CINRYZE", "C1 ESTERASE INHIBITOR (HUMAN)", "RUCONEST"], "FATAL": [168, 31, 66, 39, 8, 6, 89, 55, 13, 16], "PATHOLOGY": "oedema", "RECOVERED": [6, 26, 147, 105, 50, 22, 884, 1068, 138, 391]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/725.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/725.json
new file mode 100644
index 00000000000..8c9fafbcd65
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/725.json
@@ -0,0 +1 @@
+{"CASES": [206, 173, 421], "DRUG": ["CAPECITABINE", "KEYTRUDA", "DOCETAXEL"], "FATAL": [20, 8, 3], "PATHOLOGY": "oesophageal adenocarcinoma", "RECOVERED": [36, 19, 146]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/726.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/726.json
new file mode 100644
index 00000000000..eee62153324
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/726.json
@@ -0,0 +1 @@
+{"CASES": [147], "DRUG": ["KEYTRUDA"], "FATAL": [3], "PATHOLOGY": "oesophageal cancer metastatic", "RECOVERED": [26]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/727.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/727.json
new file mode 100644
index 00000000000..a496f377602
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/727.json
@@ -0,0 +1 @@
+{"CASES": [1119, 513, 2303, 145, 152], "DRUG": ["OPDIVO", "DOCETAXEL", "KEYTRUDA", "PEMBROLIZUMAB", "CAPECITABINE"], "FATAL": [137, 55, 175, 8, 3], "PATHOLOGY": "oesophageal carcinoma", "RECOVERED": [96, 128, 428, 11, 18]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/728.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/728.json
new file mode 100644
index 00000000000..51f5d0235e4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/728.json
@@ -0,0 +1 @@
+{"CASES": [111, 199], "DRUG": ["KEYTRUDA", "OPDIVO"], "FATAL": [15, 14], "PATHOLOGY": "oesophageal carcinoma recurrent", "RECOVERED": [26, 11]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/729.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/729.json
new file mode 100644
index 00000000000..0748f42da13
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/729.json
@@ -0,0 +1 @@
+{"CASES": [149, 661, 130], "DRUG": ["PEMBROLIZUMAB", "KEYTRUDA", "DOCETAXEL"], "FATAL": [32, 39, 5], "PATHOLOGY": "oesophageal squamous cell carcinoma", "RECOVERED": [9, 84, 37]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/73.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/73.json
new file mode 100644
index 00000000000..675fbe96d5c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/73.json
@@ -0,0 +1 @@
+{"CASES": [358], "DRUG": ["ALDARA 5% CREAM"], "FATAL": [1], "PATHOLOGY": "anogenital warts", "RECOVERED": [148]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/730.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/730.json
new file mode 100644
index 00000000000..52c99963b62
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/730.json
@@ -0,0 +1 @@
+{"CASES": [377], "DRUG": ["KEYTRUDA"], "FATAL": [23], "PATHOLOGY": "oesophageal squamous cell carcinoma stage iv", "RECOVERED": [53]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/731.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/731.json
new file mode 100644
index 00000000000..ecec3422fbf
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/731.json
@@ -0,0 +1 @@
+{"CASES": [110, 115, 244, 1753, 102, 883, 118, 729, 292, 472, 1726, 103, 535, 209, 327, 212, 123, 413, 1732], "DRUG": ["NOVOSEVEN", "CARFILZOMIB", "LONSURF", "SOLIRIS 300 MG", "CELLCEPT", "LEVETIRACETAM", "SOLIRIS", "LACOSAMIDE", "EVENITY", "CUBICIN", "KEPPRA", "BUSULFAN", "VIMPAT", "CABOMETYX", "BRIVIACT", "REAGILA", "HUMAN NORMAL IMMUNOGLOBULIN (IV)", "BRIVARACETAM", "CIMZIA"], "FATAL": [26, 21, 43, 254, 10, 69, 9, 55, 16, 25, 91, 5, 23, 5, 7, 3, 1, 1, 3], "PATHOLOGY": "off label use", "RECOVERED": [12, 15, 69, 154, 18, 148, 20, 87, 26, 172, 386, 19, 88, 33, 39, 68, 32, 53, 100]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/732.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/732.json
new file mode 100644
index 00000000000..2fe7de8b36a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/732.json
@@ -0,0 +1 @@
+{"CASES": [102, 107, 232], "DRUG": ["KEPPRA", "LEVETIRACETAM", "LACOSAMIDE"], "FATAL": [8, 7, 4], "PATHOLOGY": "off label use, status epilepticus", "RECOVERED": [29, 10, 37]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/733.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/733.json
new file mode 100644
index 00000000000..04555dc0910
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/733.json
@@ -0,0 +1 @@
+{"CASES": [184, 300, 604], "DRUG": ["TEMOZOLOMIDE", "TEMODAL", "BEVACIZUMAB"], "FATAL": [18, 22, 9], "PATHOLOGY": "oligodendroglioma", "RECOVERED": [31, 58, 2]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/734.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/734.json
new file mode 100644
index 00000000000..c5acb5e82cd
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/734.json
@@ -0,0 +1 @@
+{"CASES": [103], "DRUG": ["CELLCEPT"], "FATAL": [2], "PATHOLOGY": "organ transplant", "RECOVERED": [38]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/735.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/735.json
new file mode 100644
index 00000000000..3d7f0fdba3c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/735.json
@@ -0,0 +1 @@
+{"CASES": [210], "DRUG": ["KEYTRUDA"], "FATAL": [17], "PATHOLOGY": "oropharyngeal cancer", "RECOVERED": [51]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/736.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/736.json
new file mode 100644
index 00000000000..01f28b14791
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/736.json
@@ -0,0 +1 @@
+{"CASES": [152, 273, 126, 229, 707, 241], "DRUG": ["SIMPONI", "CELECOXIB", "LYRICA", "ARAVA", "XELJANZ", "CIMZIA"], "FATAL": [4, 5, 2, 2, 6, 1], "PATHOLOGY": "osteoarthritis", "RECOVERED": [18, 151, 38, 16, 88, 38]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/737.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/737.json
new file mode 100644
index 00000000000..96c8ccbafd8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/737.json
@@ -0,0 +1 @@
+{"CASES": [317], "DRUG": ["XELJANZ"], "FATAL": [1], "PATHOLOGY": "osteoarthritis, rheumatoid arthritis", "RECOVERED": [36]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/738.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/738.json
new file mode 100644
index 00000000000..c033fdc0970
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/738.json
@@ -0,0 +1 @@
+{"CASES": [700], "DRUG": ["CUBICIN"], "FATAL": [52], "PATHOLOGY": "osteomyelitis", "RECOVERED": [201]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/739.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/739.json
new file mode 100644
index 00000000000..10bd501c736
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/739.json
@@ -0,0 +1 @@
+{"CASES": [750], "DRUG": ["EVISTA"], "FATAL": [5], "PATHOLOGY": "osteopenia", "RECOVERED": [150]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/74.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/74.json
new file mode 100644
index 00000000000..ea56063801a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/74.json
@@ -0,0 +1 @@
+{"CASES": [102, 129, 274, 1322], "DRUG": ["GANCICLOVIR", "TIGECYCLINE", "VORICONAZOLE", "LEVOFLOXACIN"], "FATAL": [56, 16, 2, 4], "PATHOLOGY": "anti-infective therapy", "RECOVERED": [10, 8, 49, 315]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/740.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/740.json
new file mode 100644
index 00000000000..34e3c9351e5
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/740.json
@@ -0,0 +1 @@
+{"CASES": [2334, 8061, 1700, 1048, 122, 30779, 287, 181, 1524, 472, 6495, 250, 515, 7129, 169, 287, 124, 1539, 782, 1334, 1182], "DRUG": ["FORSTEO 20MICROGRAMS/80 MICROLITERS SOLUTION FOR INJECTION IN PRE-FILLED PEN", "EVENITY", "TERIPARATIDE", "PROTELOS 2G", "EVISTA 60 MG FILM-COATED TABLETS", "FORSTEO", "PREOTACT", "STRONTIUM RANELATE", "PROTELOS", "FORSTEO SOLUTION FOR INJECTION IN PRE-FILLED PEN", "BONVIVA", "DENOSUMAB", "PROTELOS 2G GRANULES FOR ORAL SUSPENSION", "EVISTA", "PREOTACT 100 MICROGRAMS POWDER AND SOLVENT FOR SOLUTION FOR INJECTION", "BONVIVA 150 MG FILM-COATED TABLETS", "OSSEOR", "ACLASTA", "TERROSA", "PROLIA", "MOVYMIA"], "FATAL": [115, 388, 64, 39, 4, 972, 9, 4, 32, 8, 105, 4, 8, 107, 2, 3, 1, 6, 3, 3, 1], "PATHOLOGY": "osteoporosis", "RECOVERED": [706, 1751, 299, 414, 70, 5769, 88, 59, 745, 124, 2278, 48, 292, 1986, 73, 128, 73, 266, 232, 175, 554]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/741.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/741.json
new file mode 100644
index 00000000000..81e903761c7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/741.json
@@ -0,0 +1 @@
+{"CASES": [524, 264, 321, 1432, 290], "DRUG": ["FORSTEO", "PROTELOS", "EVISTA", "EVENITY", "BONVIVA"], "FATAL": [22, 7, 6, 25, 4], "PATHOLOGY": "osteoporosis postmenopausal", "RECOVERED": [142, 127, 141, 117, 113]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/742.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/742.json
new file mode 100644
index 00000000000..fa9ab1f0fe8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/742.json
@@ -0,0 +1 @@
+{"CASES": [515], "DRUG": ["EVISTA"], "FATAL": [5], "PATHOLOGY": "osteoporosis prophylaxis", "RECOVERED": [169]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/743.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/743.json
new file mode 100644
index 00000000000..2cf9b0bcd4a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/743.json
@@ -0,0 +1 @@
+{"CASES": [885], "DRUG": ["FORSTEO"], "FATAL": [8], "PATHOLOGY": "osteoporotic fracture", "RECOVERED": [233]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/744.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/744.json
new file mode 100644
index 00000000000..da14155a350
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/744.json
@@ -0,0 +1 @@
+{"CASES": [116, 154, 219, 246], "DRUG": ["PAZOPANIB", "CABOMETYX", "METHOTREXATE", "STIVARGA"], "FATAL": [12, 10, 4, 4], "PATHOLOGY": "osteosarcoma", "RECOVERED": [8, 14, 96, 22]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/745.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/745.json
new file mode 100644
index 00000000000..6af833101cf
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/745.json
@@ -0,0 +1 @@
+{"CASES": [173], "DRUG": ["IBUPROFEN"], "FATAL": [80], "PATHOLOGY": "otitis media", "RECOVERED": [19]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/746.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/746.json
new file mode 100644
index 00000000000..d55a466e1f1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/746.json
@@ -0,0 +1 @@
+{"CASES": [118, 217, 138, 158, 584, 136, 333, 562, 239, 2903, 1518, 761, 1470, 119, 459, 8950, 228, 8707, 190, 201, 109], "DRUG": ["VOTRIENT", "YONDELIS", "ALIMTA", "TOPOTECAN HYDROCHLORIDE", "BEVACIZUMAB", "DOXORUBICIN HYDROCHLORIDE", "TOPOTECAN", "KEYTRUDA", "PACLITAXEL", "CAELYX", "HYCAMTIN", "AVASTIN", "OLAPARIB", "SUTENT", "CAELYX 2 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION", "LYNPARZA", "IBRANCE", "RUBRACA", "MEKINIST", "MVASI", "LYNPARZA 150 MG FILM-COATED TABLETS"], "FATAL": [20, 27, 14, 14, 43, 10, 20, 31, 13, 149, 66, 33, 59, 4, 15, 248, 6, 222, 3, 2, 1], "PATHOLOGY": "ovarian cancer", "RECOVERED": [30, 71, 26, 69, 121, 29, 70, 33, 80, 1203, 739, 199, 313, 29, 282, 1809, 10, 1260, 17, 32, 34]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/747.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/747.json
new file mode 100644
index 00000000000..38711f989c3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/747.json
@@ -0,0 +1 @@
+{"CASES": [187, 154, 121], "DRUG": ["CAELYX", "RUBRACA", "LYNPARZA"], "FATAL": [13, 4, 2], "PATHOLOGY": "ovarian cancer metastatic", "RECOVERED": [82, 22, 17]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/748.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/748.json
new file mode 100644
index 00000000000..cb754b32d3d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/748.json
@@ -0,0 +1 @@
+{"CASES": [138, 370, 1285, 863, 510], "DRUG": ["TOPOTECAN HYDROCHLORIDE", "CAELYX", "LYNPARZA", "HYCAMTIN", "RUBRACA"], "FATAL": [13, 21, 53, 16, 6], "PATHOLOGY": "ovarian cancer recurrent", "RECOVERED": [59, 145, 260, 455, 81]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/749.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/749.json
new file mode 100644
index 00000000000..2505a14f123
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/749.json
@@ -0,0 +1 @@
+{"CASES": [182], "DRUG": ["LYNPARZA"], "FATAL": [10], "PATHOLOGY": "ovarian cancer stage iii", "RECOVERED": [25]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/75.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/75.json
new file mode 100644
index 00000000000..a6839761cf6
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/75.json
@@ -0,0 +1 @@
+{"CASES": [473], "DRUG": ["LEVOFLOXACIN"], "FATAL": [70], "PATHOLOGY": "antibiotic prophylaxis", "RECOVERED": [205]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/750.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/750.json
new file mode 100644
index 00000000000..b1973fde7cf
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/750.json
@@ -0,0 +1 @@
+{"CASES": [290], "DRUG": ["LYNPARZA"], "FATAL": [130], "PATHOLOGY": "ovarian epithelial cancer", "RECOVERED": [23]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/751.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/751.json
new file mode 100644
index 00000000000..9f954153181
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/751.json
@@ -0,0 +1 @@
+{"CASES": [119], "DRUG": ["CAELYX"], "FATAL": [38], "PATHOLOGY": "ovarian neoplasm", "RECOVERED": [49]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/752.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/752.json
new file mode 100644
index 00000000000..3187304f023
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/752.json
@@ -0,0 +1 @@
+{"CASES": [373, 515, 391], "DRUG": ["IBUPROFEN", "OLANZAPINE", "NALOXONE"], "FATAL": [47, 46, 5], "PATHOLOGY": "overdose", "RECOVERED": [171, 223, 316]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/753.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/753.json
new file mode 100644
index 00000000000..491b24127ab
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/753.json
@@ -0,0 +1 @@
+{"CASES": [1376], "DRUG": ["SAXENDA"], "FATAL": [2], "PATHOLOGY": "overweight", "RECOVERED": [480]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/754.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/754.json
new file mode 100644
index 00000000000..fb2c1bb895a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/754.json
@@ -0,0 +1 @@
+{"CASES": [399, 455, 1295, 475, 167, 6311, 122, 5549, 121, 3722, 4329, 349, 123, 937, 1434, 8019, 1030, 2828, 208, 166, 349, 1467, 592, 404, 1936], "DRUG": ["CANNABIDIOL", "PRIALT", "PREGABALIN", "DEXAMETHASONE", "PLAVIX", "FENTANYL", "ZALVISO", "IBUPROFEN", "PANTOPRAZOLE", "BUPRENORPHINE", "LYRICA", "DULOXETINE HYDROCHLORIDE", "NOT AVAILABLE", "FENTANYL CITRATE", "BUPIVACAINE", "CYMBALTA", "SUBOXONE SUBLINGUAL FILM", "SUBOXONE", "LEVOFLOXACIN", "CLOPIDOGREL", "SUFENTANIL", "DULOXETINE", "QUTENZA", "XELJANZ", "CELECOXIB"], "FATAL": [144, 56, 146, 50, 12, 372, 6, 259, 5, 134, 119, 7, 2, 14, 21, 104, 12, 33, 2, 1, 2, 7, 2, 1, 4], "PATHOLOGY": "pain", "RECOVERED": [115, 113, 297, 110, 44, 1329, 77, 1152, 62, 782, 868, 97, 53, 276, 202, 1484, 384, 827, 63, 105, 91, 168, 220, 86, 104]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/755.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/755.json
new file mode 100644
index 00000000000..2da4cccc301
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/755.json
@@ -0,0 +1 @@
+{"CASES": [408, 174], "DRUG": ["LYRICA", "CYMBALTA"], "FATAL": [10, 1], "PATHOLOGY": "pain in extremity", "RECOVERED": [93, 27]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/756.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/756.json
new file mode 100644
index 00000000000..2b65a76fd18
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/756.json
@@ -0,0 +1 @@
+{"CASES": [197], "DRUG": ["FENTANYL"], "FATAL": [9], "PATHOLOGY": "pain management", "RECOVERED": [60]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/757.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/757.json
new file mode 100644
index 00000000000..d503cd3db43
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/757.json
@@ -0,0 +1 @@
+{"CASES": [151, 171], "DRUG": ["CICLOSPORIN", "RAPAMUNE"], "FATAL": [21, 8], "PATHOLOGY": "pancreas transplant", "RECOVERED": [65, 15]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/758.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/758.json
new file mode 100644
index 00000000000..74b48e2d44b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/758.json
@@ -0,0 +1 @@
+{"CASES": [225, 114, 216, 279, 856, 2453, 679, 374, 287, 126], "DRUG": ["KEYTRUDA", "BEVACIZUMAB", "ONIVYDE", "LYNPARZA", "SUTENT", "IRINOTECAN", "ABRAXANE", "AFINITOR", "CAPECITABINE", "PACLITAXEL"], "FATAL": [28, 14, 22, 26, 78, 130, 35, 17, 11, 3], "PATHOLOGY": "pancreatic carcinoma", "RECOVERED": [24, 3, 100, 44, 98, 644, 108, 18, 40, 23]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/759.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/759.json
new file mode 100644
index 00000000000..f64104e4c33
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/759.json
@@ -0,0 +1 @@
+{"CASES": [120, 376, 754], "DRUG": ["SUTENT", "ABRAXANE", "IRINOTECAN"], "FATAL": [8, 25, 29], "PATHOLOGY": "pancreatic carcinoma metastatic", "RECOVERED": [16, 29, 201]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/76.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/76.json
new file mode 100644
index 00000000000..87b27ae6aad
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/76.json
@@ -0,0 +1 @@
+{"CASES": [288, 197, 533, 417, 404], "DRUG": ["TOBRAMYCIN", "DAPTOMYCIN", "LEVOFLOXACIN", "AMIKACIN", "CASPOFUNGIN ACETATE"], "FATAL": [109, 49, 66, 3, 2], "PATHOLOGY": "antibiotic therapy", "RECOVERED": [50, 25, 147, 231, 14]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/760.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/760.json
new file mode 100644
index 00000000000..f19ceae8bec
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/760.json
@@ -0,0 +1 @@
+{"CASES": [237], "DRUG": ["IRINOTECAN"], "FATAL": [30], "PATHOLOGY": "pancreatic carcinoma stage iv", "RECOVERED": [16]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/761.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/761.json
new file mode 100644
index 00000000000..2185a5fd323
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/761.json
@@ -0,0 +1 @@
+{"CASES": [4374, 675, 1071, 528, 4138, 536, 242], "DRUG": ["AFINITOR", "EVEROLIMUS", "AFINITOR TABLETS", "LUTATHERA", "SUTENT", "CAPECITABINE", "SUTENT 12.5 MG"], "FATAL": [438, 59, 81, 37, 278, 13, 4], "PATHOLOGY": "pancreatic neuroendocrine tumour", "RECOVERED": [1085, 363, 244, 77, 658, 43, 56]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/762.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/762.json
new file mode 100644
index 00000000000..e68e9d06fc4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/762.json
@@ -0,0 +1 @@
+{"CASES": [1458, 135, 466, 114, 1324, 135], "DRUG": ["AFINITOR", "LUTATHERA", "EVEROLIMUS", "AFINITOR TABLETS", "SUTENT", "CAPECITABINE"], "FATAL": [254, 11, 34, 7, 34, 2], "PATHOLOGY": "pancreatic neuroendocrine tumour metastatic", "RECOVERED": [661, 16, 356, 23, 168, 7]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/763.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/763.json
new file mode 100644
index 00000000000..20ec0d92f35
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/763.json
@@ -0,0 +1 @@
+{"CASES": [140], "DRUG": ["FILGRASTIM"], "FATAL": [14], "PATHOLOGY": "pancytopenia", "RECOVERED": [36]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/764.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/764.json
new file mode 100644
index 00000000000..7dfa5f68123
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/764.json
@@ -0,0 +1 @@
+{"CASES": [262, 156], "DRUG": ["CABOMETYX", "SUTENT"], "FATAL": [13, 6], "PATHOLOGY": "papillary renal cell carcinoma", "RECOVERED": [26, 4]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/765.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/765.json
new file mode 100644
index 00000000000..ce700245ae6
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/765.json
@@ -0,0 +1 @@
+{"CASES": [107, 636, 102, 721], "DRUG": ["MEKINIST", "NEXAVAR", "SORAFENIB", "LENVIMA"], "FATAL": [32, 36, 5, 34], "PATHOLOGY": "papillary thyroid cancer", "RECOVERED": [19, 176, 13, 183]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/766.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/766.json
new file mode 100644
index 00000000000..7cdf3c2bb36
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/766.json
@@ -0,0 +1 @@
+{"CASES": [246], "DRUG": ["SUTENT"], "FATAL": [2], "PATHOLOGY": "paraganglion neoplasm", "RECOVERED": [64]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/767.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/767.json
new file mode 100644
index 00000000000..ea7e2f9a3dc
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/767.json
@@ -0,0 +1 @@
+{"CASES": [353], "DRUG": ["ZYPREXA"], "FATAL": [18], "PATHOLOGY": "paranoia", "RECOVERED": [128]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/768.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/768.json
new file mode 100644
index 00000000000..9649a019614
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/768.json
@@ -0,0 +1 @@
+{"CASES": [337, 371, 139, 633, 5334, 5536, 2492, 204, 111, 312, 2268, 225, 2585, 2515, 518, 1702], "DRUG": ["RASAGILINE", "NEUPRO", "TASMAR", "COMTESS", "STALEVO", "COMTAN", "CARBIDOPA, LEVODOPA", "CARBIDOPA, ENTACAPONE, LEVODOPA", "MIRAPEXIN", "AZILECT 1 MG TABLETS", "ENTACAPONE", "INBRIJA", "SIFROL", "LEVODOPA", "STALEVO FILM-COATED TABLETS", "AZILECT"], "FATAL": [87, 35, 11, 38, 286, 283, 115, 6, 3, 8, 55, 4, 30, 27, 2, 3], "PATHOLOGY": "parkinson's disease", "RECOVERED": [92, 58, 32, 222, 1172, 1393, 435, 56, 15, 163, 488, 22, 699, 538, 83, 290]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/769.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/769.json
new file mode 100644
index 00000000000..f1980c09a9f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/769.json
@@ -0,0 +1 @@
+{"CASES": [222, 190, 137, 507, 333], "DRUG": ["ENTACAPONE", "SIFROL", "STALEVO", "COMTAN", "LEVODOPA"], "FATAL": [11, 3, 2, 6, 3], "PATHOLOGY": "parkinsonism", "RECOVERED": [4, 42, 33, 115, 87]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/77.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/77.json
new file mode 100644
index 00000000000..62504ccf438
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/77.json
@@ -0,0 +1 @@
+{"CASES": [257, 150, 241, 2183, 1242, 321, 161, 269, 311, 308, 143, 3659, 1934, 103, 966], "DRUG": ["RIVAROXABAN", "TICAGRELOR", "PRADAXA", "ENOXAPARIN SODIUM", "PLAVIX", "XARELTO", "ELIQUIS 5 MG FILM-COATED TABLETS", "BRILIQUE", "APIXABAN", "LIXIANA", "ARIXTRA", "CLOPIDOGREL", "ELIQUIS", "BIVALIRUDIN", "CLOPIDOGREL HYDROGEN SULFATE"], "FATAL": [19, 11, 17, 129, 68, 15, 5, 8, 9, 8, 3, 76, 38, 2, 14], "PATHOLOGY": "anticoagulant therapy", "RECOVERED": [34, 31, 46, 655, 267, 78, 64, 88, 33, 76, 29, 321, 361, 10, 129]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/770.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/770.json
new file mode 100644
index 00000000000..16976b00a06
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/770.json
@@ -0,0 +1 @@
+{"CASES": [197, 14139, 3173, 745, 168], "DRUG": ["SOLIRIS 300 MG CONCENTRATE FOR SOLUTION FOR INFUSION", "SOLIRIS 300 MG", "SOLIRIS", "SOLIRIS CONCENTRATE FOR SOLUTION FOR INFUSION", "ECULIZUMAB"], "FATAL": [21, 695, 150, 23, 5], "PATHOLOGY": "paroxysmal nocturnal haemoglobinuria", "RECOVERED": [55, 2739, 664, 272, 41]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/771.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/771.json
new file mode 100644
index 00000000000..3b64bc3c050
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/771.json
@@ -0,0 +1 @@
+{"CASES": [1124, 1869, 2709, 169, 1108, 770], "DRUG": ["LACOSAMIDE", "LEVETIRACETAM", "KEPPRA", "KEPPRA 500 MG FILM-COATED TABLETS", "VIMPAT", "FYCOMPA"], "FATAL": [58, 68, 83, 4, 19, 6], "PATHOLOGY": "partial seizures", "RECOVERED": [272, 607, 851, 86, 324, 291]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/772.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/772.json
new file mode 100644
index 00000000000..18ba4f2a2c5
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/772.json
@@ -0,0 +1 @@
+{"CASES": [133], "DRUG": ["KEPPRA"], "FATAL": [18], "PATHOLOGY": "partial seizures with secondary generalisation", "RECOVERED": [26]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/773.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/773.json
new file mode 100644
index 00000000000..76097f03e6e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/773.json
@@ -0,0 +1 @@
+{"CASES": [108, 152], "DRUG": ["CICLOSPORIN", "CELLCEPT"], "FATAL": [12, 2], "PATHOLOGY": "pemphigoid", "RECOVERED": [20, 17]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/774.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/774.json
new file mode 100644
index 00000000000..f27cecadaf7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/774.json
@@ -0,0 +1 @@
+{"CASES": [170, 275], "DRUG": ["CICLOSPORIN", "CELLCEPT"], "FATAL": [16, 4], "PATHOLOGY": "pemphigus", "RECOVERED": [27, 28]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/775.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/775.json
new file mode 100644
index 00000000000..5f7114d39a4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/775.json
@@ -0,0 +1 @@
+{"CASES": [231, 479, 792, 104, 269, 197, 203], "DRUG": ["CLOPIDOGREL HYDROGEN SULFATE", "PLAVIX", "ANGIOX", "INTEGRILIN", "BRILIQUE", "CLOPIDOGREL", "EFIENT"], "FATAL": [48, 84, 127, 13, 24, 12, 11], "PATHOLOGY": "percutaneous coronary intervention", "RECOVERED": [33, 147, 160, 27, 112, 82, 80]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/776.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/776.json
new file mode 100644
index 00000000000..5284a4059ea
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/776.json
@@ -0,0 +1 @@
+{"CASES": [119], "DRUG": ["IBUPROFEN"], "FATAL": [5], "PATHOLOGY": "pericarditis", "RECOVERED": [41]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/777.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/777.json
new file mode 100644
index 00000000000..f09a4cb3acc
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/777.json
@@ -0,0 +1 @@
+{"CASES": [822, 303], "DRUG": ["PLAVIX", "CLOPIDOGREL"], "FATAL": [68, 15], "PATHOLOGY": "peripheral arterial occlusive disease", "RECOVERED": [196, 181]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/778.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/778.json
new file mode 100644
index 00000000000..dd7335d9b0c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/778.json
@@ -0,0 +1 @@
+{"CASES": [260], "DRUG": ["PLAVIX"], "FATAL": [16], "PATHOLOGY": "peripheral vascular disorder", "RECOVERED": [68]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/779.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/779.json
new file mode 100644
index 00000000000..924ee2e94cf
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/779.json
@@ -0,0 +1 @@
+{"CASES": [105], "DRUG": ["LEVOFLOXACIN"], "FATAL": [1], "PATHOLOGY": "peritonitis", "RECOVERED": [26]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/78.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/78.json
new file mode 100644
index 00000000000..5efadc23b2e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/78.json
@@ -0,0 +1 @@
+{"CASES": [212, 359], "DRUG": ["BRINTELLIX", "CYMBALTA"], "FATAL": [2, 2], "PATHOLOGY": "antidepressant therapy", "RECOVERED": [9, 213]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/780.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/780.json
new file mode 100644
index 00000000000..34ffdc1c0c3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/780.json
@@ -0,0 +1 @@
+{"CASES": [425, 279, 146], "DRUG": ["ZYPREXA", "OLANZAPINE", "ABILIFY"], "FATAL": [43, 2, 1], "PATHOLOGY": "personality disorder", "RECOVERED": [125, 89, 78]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/781.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/781.json
new file mode 100644
index 00000000000..a24d4abcec3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/781.json
@@ -0,0 +1 @@
+{"CASES": [100, 318], "DRUG": ["LACOSAMIDE", "KEPPRA"], "FATAL": [3, 3], "PATHOLOGY": "petit mal epilepsy", "RECOVERED": [2, 99]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/782.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/782.json
new file mode 100644
index 00000000000..0737fd34df8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/782.json
@@ -0,0 +1 @@
+{"CASES": [148], "DRUG": ["SUTENT"], "FATAL": [26], "PATHOLOGY": "phaeochromocytoma", "RECOVERED": [26]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/783.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/783.json
new file mode 100644
index 00000000000..7d5406ae6db
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/783.json
@@ -0,0 +1 @@
+{"CASES": [575, 110, 267], "DRUG": ["LEVOFLOXACIN", "BC SINUS COLD-PHENYLPROPANOLAMINE", "IBUPROFEN"], "FATAL": [13, 2, 2], "PATHOLOGY": "pharyngitis", "RECOVERED": [164, 36, 132]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/784.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/784.json
new file mode 100644
index 00000000000..2366e1b1b27
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/784.json
@@ -0,0 +1 @@
+{"CASES": [1399], "DRUG": ["KUVAN"], "FATAL": [32], "PATHOLOGY": "phenylketonuria", "RECOVERED": [487]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/785.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/785.json
new file mode 100644
index 00000000000..fadf29cf2cf
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/785.json
@@ -0,0 +1 @@
+{"CASES": [104, 1318, 209, 244, 103, 356], "DRUG": ["PONATINIB", "ICLUSIG", "DEXAMETHASONE", "SPRYCEL", "BLINATUMOMAB", "CYTARABINE"], "FATAL": [46, 166, 15, 12, 4, 5], "PATHOLOGY": "philadelphia positive acute lymphocytic leukaemia", "RECOVERED": [6, 231, 41, 32, 22, 64]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/786.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/786.json
new file mode 100644
index 00000000000..59059c02fcd
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/786.json
@@ -0,0 +1 @@
+{"CASES": [257, 184], "DRUG": ["ICLUSIG", "BOSULIF"], "FATAL": [8, 1], "PATHOLOGY": "philadelphia positive chronic myeloid leukaemia", "RECOVERED": [44, 8]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/787.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/787.json
new file mode 100644
index 00000000000..1f033678832
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/787.json
@@ -0,0 +1 @@
+{"CASES": [235], "DRUG": ["ELIQUIS"], "FATAL": [5], "PATHOLOGY": "phlebitis", "RECOVERED": [50]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/788.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/788.json
new file mode 100644
index 00000000000..4cc7af2931f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/788.json
@@ -0,0 +1 @@
+{"CASES": [151], "DRUG": ["TEMOZOLOMIDE"], "FATAL": [23], "PATHOLOGY": "pituitary tumour", "RECOVERED": [10]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/789.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/789.json
new file mode 100644
index 00000000000..1f8d800a3bc
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/789.json
@@ -0,0 +1 @@
+{"CASES": [382, 165, 174], "DRUG": ["SIGNIFOR", "ISTURISA", "PASIREOTIDE"], "FATAL": [9, 1, 1], "PATHOLOGY": "pituitary-dependent cushing's syndrome", "RECOVERED": [124, 14, 52]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/79.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/79.json
new file mode 100644
index 00000000000..ca6615a2ed6
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/79.json
@@ -0,0 +1 @@
+{"CASES": [124, 343], "DRUG": ["EMEND", "DEXAMETHASONE"], "FATAL": [21, 18], "PATHOLOGY": "antiemetic supportive care", "RECOVERED": [78, 128]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/790.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/790.json
new file mode 100644
index 00000000000..999b3c0c809
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/790.json
@@ -0,0 +1 @@
+{"CASES": [139, 455], "DRUG": ["DARZALEX", "BORTEZOMIB"], "FATAL": [23, 29], "PATHOLOGY": "plasma cell leukaemia", "RECOVERED": [11, 147]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/791.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/791.json
new file mode 100644
index 00000000000..a3e195bf1b8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/791.json
@@ -0,0 +1 @@
+{"CASES": [124, 126, 160, 323, 6495, 192, 1691, 130, 3112, 951, 938, 6585, 10347, 1469, 1073, 256, 170, 6379, 5641, 5524, 159, 1827, 11332, 607, 539, 129, 300, 213, 100, 535, 131], "DRUG": ["AUTOTRANSPLANTATION OF BONE MARROW", "EXJADE", "CARMUSTINE", "CAELYX", "BORTEZOMIB", "TRISENOX", "POMALIDOMIDE", "VENETOCLAX", "THALIDOMIDE", "IMNOVID", "THALIDOMIDE CELGENE", "REVLIMID", "DEXAMETHASONE", "VELCADE", "MELPHALAN", "KYPROLIS 60 MG POWDER FOR SOLUTION FOR INFUSION", "IMNOVID 4 MG HARD CAPSULES", "KYPROLIS", "CARFILZOMIB", "NINLARO", "DOXORUBICIN HYDROCHLORIDE", "DARATUMUMAB", "DARZALEX", "LENALIDOMIDE", "DARZALEX 20 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION", "PRIVIGEN", "EMPLICITI", "BELANTAMAB MAFODOTIN", "ISATUXIMAB", "ZOMETA", "DARZALEX 1800 MG SOLUTION FOR INJECTION"], "FATAL": [73, 59, 27, 48, 890, 24, 201, 13, 308, 94, 88, 581, 897, 124, 87, 20, 12, 434, 376, 353, 9, 103, 591, 30, 26, 6, 8, 5, 2, 5, 1], "PATHOLOGY": "plasma cell myeloma", "RECOVERED": [10, 4, 35, 62, 1104, 59, 315, 6, 687, 238, 294, 1043, 2270, 501, 311, 113, 75, 1386, 793, 393, 35, 497, 2696, 94, 356, 95, 77, 31, 26, 71, 65]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/792.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/792.json
new file mode 100644
index 00000000000..0cdd9616494
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/792.json
@@ -0,0 +1 @@
+{"CASES": [100], "DRUG": ["NINLARO"], "FATAL": [2], "PATHOLOGY": "plasma cell myeloma in remission", "RECOVERED": [6]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/793.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/793.json
new file mode 100644
index 00000000000..396f69305d6
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/793.json
@@ -0,0 +1 @@
+{"CASES": [361, 151, 230, 410], "DRUG": ["DEXAMETHASONE", "DARZALEX", "BORTEZOMIB", "CARFILZOMIB"], "FATAL": [34, 11, 12, 15], "PATHOLOGY": "plasma cell myeloma refractory", "RECOVERED": [73, 37, 22, 69]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/794.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/794.json
new file mode 100644
index 00000000000..05529c06822
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/794.json
@@ -0,0 +1 @@
+{"CASES": [148], "DRUG": ["BORTEZOMIB"], "FATAL": [8], "PATHOLOGY": "plasmablastic lymphoma", "RECOVERED": [15]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/795.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/795.json
new file mode 100644
index 00000000000..705e11f1e1b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/795.json
@@ -0,0 +1 @@
+{"CASES": [650, 255, 141, 211, 874], "DRUG": ["PLAVIX", "TICAGRELOR", "CLOPIDOGREL", "BRILIQUE", "CLOPIDOGREL HYDROGEN SULFATE"], "FATAL": [75, 12, 2, 2, 8], "PATHOLOGY": "platelet aggregation inhibition", "RECOVERED": [95, 48, 35, 87, 119]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/796.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/796.json
new file mode 100644
index 00000000000..23e36152bf1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/796.json
@@ -0,0 +1 @@
+{"CASES": [104], "DRUG": ["PLAVIX"], "FATAL": [3], "PATHOLOGY": "platelet aggregation test", "RECOVERED": [31]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/797.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/797.json
new file mode 100644
index 00000000000..e45f5884814
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/797.json
@@ -0,0 +1 @@
+{"CASES": [497, 932, 990, 482], "DRUG": ["PEMETREXED", "ALIMTA", "OPDIVO", "IPILIMUMAB"], "FATAL": [44, 80, 54, 26], "PATHOLOGY": "pleural mesothelioma", "RECOVERED": [60, 252, 192, 39]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/798.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/798.json
new file mode 100644
index 00000000000..35a50beaebe
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/798.json
@@ -0,0 +1 @@
+{"CASES": [356, 562, 294, 827], "DRUG": ["PEMETREXED", "ALIMTA", "IPILIMUMAB", "OPDIVO"], "FATAL": [40, 49, 24, 47], "PATHOLOGY": "pleural mesothelioma malignant", "RECOVERED": [38, 157, 23, 176]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/799.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/799.json
new file mode 100644
index 00000000000..503c8c47bb7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/799.json
@@ -0,0 +1 @@
+{"CASES": [290, 408, 554, 379, 119, 152, 130, 249, 281, 161, 636, 467, 5993, 258, 469, 310, 235, 2779, 175, 1028, 121, 227, 440], "DRUG": ["GANCICLOVIR", "ROACTEMRA", "REMDESIVIR", "DEXAMETHASONE", "INVANZ", "CASPOFUNGIN ACETATE", "CEFTAZIDIME, AVIBACTAM", "TIGECYCLINE", "NOXAFIL", "TOBRAMYCIN", "VEKLURY", "AMIKACIN", "LEVOFLOXACIN", "CASPOFUNGIN", "KALETRA", "TOCILIZUMAB", "CANCIDAS", "VFEND", "KALETRA 200 MG/50 MG FILM-COATED TABLETS", "VORICONAZOLE", "OSELTAMIVIR", "TAMIFLU", "LOPINAVIR, RITONAVIR"], "FATAL": [107, 136, 124, 75, 23, 27, 22, 40, 42, 23, 89, 48, 559, 20, 36, 23, 16, 148, 6, 28, 3, 4, 2], "PATHOLOGY": "pneumonia", "RECOVERED": [30, 62, 121, 68, 26, 14, 17, 66, 43, 67, 165, 129, 1870, 66, 157, 42, 37, 728, 98, 231, 46, 75, 64]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/8.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/8.json
new file mode 100644
index 00000000000..a00cfc9d942
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/8.json
@@ -0,0 +1 @@
+{"CASES": [109], "DRUG": ["TIGECYCLINE"], "FATAL": [50], "PATHOLOGY": "acinetobacter infection", "RECOVERED": [12]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/80.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/80.json
new file mode 100644
index 00000000000..db8423be4b7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/80.json
@@ -0,0 +1 @@
+{"CASES": [141, 306, 172, 101, 435, 1004, 451, 218, 399], "DRUG": ["CANCIDAS", "CASPOFUNGIN", "CASPOFUNGIN ACETATE", "MICAFUNGIN", "POSACONAZOLE", "NOXAFIL", "VORICONAZOLE", "NOXAFIL 100 MG", "VFEND"], "FATAL": [100, 147, 63, 13, 54, 112, 43, 18, 13], "PATHOLOGY": "antifungal prophylaxis", "RECOVERED": [9, 14, 14, 1, 96, 344, 109, 66, 140]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/800.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/800.json
new file mode 100644
index 00000000000..4c94e369f34
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/800.json
@@ -0,0 +1 @@
+{"CASES": [230], "DRUG": ["LEVOFLOXACIN"], "FATAL": [12], "PATHOLOGY": "pneumonia aspiration", "RECOVERED": [23]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/801.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/801.json
new file mode 100644
index 00000000000..795301ba37c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/801.json
@@ -0,0 +1 @@
+{"CASES": [191, 103], "DRUG": ["LEVOFLOXACIN", "AMIKACIN"], "FATAL": [4, 2], "PATHOLOGY": "pneumonia bacterial", "RECOVERED": [75, 22]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/802.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/802.json
new file mode 100644
index 00000000000..2ff7ad48e1b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/802.json
@@ -0,0 +1 @@
+{"CASES": [183, 1463, 439], "DRUG": ["NOXAFIL", "VFEND", "VORICONAZOLE"], "FATAL": [28, 82, 11], "PATHOLOGY": "pneumonia fungal", "RECOVERED": [21, 374, 126]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/803.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/803.json
new file mode 100644
index 00000000000..8a54fc28980
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/803.json
@@ -0,0 +1 @@
+{"CASES": [160], "DRUG": ["LEVOFLOXACIN"], "FATAL": [12], "PATHOLOGY": "pneumonia legionella", "RECOVERED": [86]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/804.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/804.json
new file mode 100644
index 00000000000..1b71763b03a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/804.json
@@ -0,0 +1 @@
+{"CASES": [182, 332], "DRUG": ["OFEV", "LEVOFLOXACIN"], "FATAL": [14, 10], "PATHOLOGY": "pneumonitis", "RECOVERED": [63, 137]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/805.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/805.json
new file mode 100644
index 00000000000..5c5b1dcb764
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/805.json
@@ -0,0 +1 @@
+{"CASES": [193, 748, 152, 325], "DRUG": ["TOVIAZ 4 MG", "TOVIAZ", "MIRABEGRON", "BETMIGA"], "FATAL": [8, 6, 1, 1], "PATHOLOGY": "pollakiuria", "RECOVERED": [66, 195, 40, 103]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/806.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/806.json
new file mode 100644
index 00000000000..16fbadb4215
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/806.json
@@ -0,0 +1 @@
+{"CASES": [466, 225, 315, 352, 275], "DRUG": ["ARAVA", "ENBREL", "ADALIMUMAB", "ROACTEMRA", "SIMPONI"], "FATAL": [39, 9, 8, 8, 4], "PATHOLOGY": "polyarthritis", "RECOVERED": [156, 31, 5, 124, 18]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/807.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/807.json
new file mode 100644
index 00000000000..8d1ae9078c1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/807.json
@@ -0,0 +1 @@
+{"CASES": [641, 475, 4019, 780], "DRUG": ["JAKAVI TABLETS", "RUXOLITINIB", "JAKAVI", "PEGASYS"], "FATAL": [58, 9, 75, 2], "PATHOLOGY": "polycythaemia", "RECOVERED": [116, 66, 512, 212]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/808.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/808.json
new file mode 100644
index 00000000000..ca0c4c46312
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/808.json
@@ -0,0 +1 @@
+{"CASES": [641, 463, 3935, 728], "DRUG": ["JAKAVI TABLETS", "RUXOLITINIB", "JAKAVI", "PEGASYS"], "FATAL": [58, 9, 73, 2], "PATHOLOGY": "polycythaemia vera", "RECOVERED": [116, 63, 500, 178]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/809.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/809.json
new file mode 100644
index 00000000000..ee605df53c7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/809.json
@@ -0,0 +1 @@
+{"CASES": [178, 348], "DRUG": ["METHOTREXATE", "ROACTEMRA"], "FATAL": [106, 12], "PATHOLOGY": "polymyalgia rheumatica", "RECOVERED": [12, 73]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/81.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/81.json
new file mode 100644
index 00000000000..27a68e5cfa0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/81.json
@@ -0,0 +1 @@
+{"CASES": [160, 344, 137, 147, 184, 701, 568], "DRUG": ["CASPOFUNGIN ACETATE", "CASPOFUNGIN", "ANIDULAFUNGIN", "CANCIDAS", "NOXAFIL", "VORICONAZOLE", "VFEND"], "FATAL": [69, 99, 33, 31, 26, 51, 30], "PATHOLOGY": "antifungal treatment", "RECOVERED": [12, 34, 2, 15, 23, 134, 122]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/810.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/810.json
new file mode 100644
index 00000000000..00d66437f4b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/810.json
@@ -0,0 +1 @@
+{"CASES": [252], "DRUG": ["PRIVIGEN"], "FATAL": [57], "PATHOLOGY": "polymyositis", "RECOVERED": [79]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/811.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/811.json
new file mode 100644
index 00000000000..ad266bf284e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/811.json
@@ -0,0 +1 @@
+{"CASES": [140, 168, 487], "DRUG": ["FLEBOGAMMA DIF", "LYRICA", "PRIVIGEN"], "FATAL": [26, 10, 2], "PATHOLOGY": "polyneuropathy", "RECOVERED": [94, 19, 262]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/812.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/812.json
new file mode 100644
index 00000000000..1daec7be044
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/812.json
@@ -0,0 +1 @@
+{"CASES": [286], "DRUG": ["EYLEA"], "FATAL": [2], "PATHOLOGY": "polypoidal choroidal vasculopathy", "RECOVERED": [49]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/813.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/813.json
new file mode 100644
index 00000000000..38730eff533
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/813.json
@@ -0,0 +1 @@
+{"CASES": [380, 146], "DRUG": ["OPSUMIT", "TRACLEER"], "FATAL": [81, 9], "PATHOLOGY": "portopulmonary hypertension", "RECOVERED": [38, 38]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/814.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/814.json
new file mode 100644
index 00000000000..b4c6e899761
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/814.json
@@ -0,0 +1 @@
+{"CASES": [4399], "DRUG": ["ELLAONE"], "FATAL": [6], "PATHOLOGY": "post coital contraception", "RECOVERED": [1167]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/815.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/815.json
new file mode 100644
index 00000000000..260386a5bbf
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/815.json
@@ -0,0 +1 @@
+{"CASES": [663], "DRUG": ["LYRICA"], "FATAL": [11], "PATHOLOGY": "post herpetic neuralgia", "RECOVERED": [209]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/816.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/816.json
new file mode 100644
index 00000000000..4b0ab4b0fb8
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/816.json
@@ -0,0 +1 @@
+{"CASES": [265], "DRUG": ["NOVOSEVEN"], "FATAL": [136], "PATHOLOGY": "post procedural haemorrhage", "RECOVERED": [30]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/817.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/817.json
new file mode 100644
index 00000000000..a3daa74b678
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/817.json
@@ -0,0 +1 @@
+{"CASES": [168], "DRUG": ["RITUXIMAB"], "FATAL": [32], "PATHOLOGY": "post transplant lymphoproliferative disorder", "RECOVERED": [9]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/818.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/818.json
new file mode 100644
index 00000000000..1a4b8026531
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/818.json
@@ -0,0 +1 @@
+{"CASES": [126], "DRUG": ["KEPPRA"], "FATAL": [4], "PATHOLOGY": "post-traumatic epilepsy", "RECOVERED": [65]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/819.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/819.json
new file mode 100644
index 00000000000..13960c53008
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/819.json
@@ -0,0 +1 @@
+{"CASES": [102, 181], "DRUG": ["CYMBALTA", "ZYPREXA"], "FATAL": [3, 4], "PATHOLOGY": "post-traumatic stress disorder", "RECOVERED": [46, 23]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/82.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/82.json
new file mode 100644
index 00000000000..c72e5a040e4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/82.json
@@ -0,0 +1 @@
+{"CASES": [177], "DRUG": ["SOLIRIS 300 MG"], "FATAL": [16], "PATHOLOGY": "antiphospholipid syndrome", "RECOVERED": [32]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/820.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/820.json
new file mode 100644
index 00000000000..de4289788bb
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/820.json
@@ -0,0 +1 @@
+{"CASES": [157], "DRUG": ["FENTANYL"], "FATAL": [4], "PATHOLOGY": "postoperative analgesia", "RECOVERED": [63]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/821.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/821.json
new file mode 100644
index 00000000000..f704e87ccea
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/821.json
@@ -0,0 +1 @@
+{"CASES": [594], "DRUG": ["NEVANAC"], "FATAL": [2], "PATHOLOGY": "postoperative care", "RECOVERED": [125]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/822.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/822.json
new file mode 100644
index 00000000000..f0ab23fe51c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/822.json
@@ -0,0 +1 @@
+{"CASES": [105], "DRUG": ["CUBICIN"], "FATAL": [3], "PATHOLOGY": "postoperative wound infection", "RECOVERED": [45]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/823.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/823.json
new file mode 100644
index 00000000000..246e3e61cea
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/823.json
@@ -0,0 +1 @@
+{"CASES": [145], "DRUG": ["NOVOSEVEN"], "FATAL": [6], "PATHOLOGY": "postpartum haemorrhage", "RECOVERED": [87]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/824.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/824.json
new file mode 100644
index 00000000000..cc45b144499
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/824.json
@@ -0,0 +1 @@
+{"CASES": [425], "DRUG": ["SOMATROPIN"], "FATAL": [18], "PATHOLOGY": "prader-willi syndrome", "RECOVERED": [62]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/825.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/825.json
new file mode 100644
index 00000000000..2c4fe5d64c4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/825.json
@@ -0,0 +1 @@
+{"CASES": [422, 145], "DRUG": ["CYTARABINE", "ASPARAGINASE"], "FATAL": [76, 7], "PATHOLOGY": "precursor b-lymphoblastic lymphoma", "RECOVERED": [53, 12]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/826.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/826.json
new file mode 100644
index 00000000000..01f4b1f175a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/826.json
@@ -0,0 +1 @@
+{"CASES": [399, 103], "DRUG": ["ASPARAGINASE", "CYTARABINE"], "FATAL": [57, 1], "PATHOLOGY": "precursor t-lymphoblastic lymphoma/leukaemia", "RECOVERED": [84, 29]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/827.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/827.json
new file mode 100644
index 00000000000..0f9e1f3d499
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/827.json
@@ -0,0 +1 @@
+{"CASES": [129, 189, 138, 271, 490, 298, 336, 210, 514, 171, 132, 148], "DRUG": ["COMBIVIR", "ATOSIBAN", "XOLAIR", "SUBOXONE", "DEXAMETHASONE", "IBUPROFEN", "FENTANYL", "BUPRENORPHINE", "KEPPRA", "ABILIFY", "LAMIVUDINE", "IRON"], "FATAL": [42, 22, 9, 12, 16, 9, 9, 4, 9, 3, 2, 2], "PATHOLOGY": "pregnancy", "RECOVERED": [14, 42, 9, 131, 52, 37, 30, 101, 35, 64, 28, 41]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/828.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/828.json
new file mode 100644
index 00000000000..d2cda348561
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/828.json
@@ -0,0 +1 @@
+{"CASES": [124, 2413], "DRUG": ["SYNAGIS POWDER AND SOLVENT FOR SOLUTION FOR INJECTION", "SYNAGIS"], "FATAL": [20, 42], "PATHOLOGY": "premature baby", "RECOVERED": [50, 456]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/829.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/829.json
new file mode 100644
index 00000000000..a16e7dd0282
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/829.json
@@ -0,0 +1 @@
+{"CASES": [321], "DRUG": ["TRACTOCILE"], "FATAL": [17], "PATHOLOGY": "premature labour", "RECOVERED": [259]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/83.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/83.json
new file mode 100644
index 00000000000..2bedae7476d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/83.json
@@ -0,0 +1 @@
+{"CASES": [3054, 2077, 268, 4118, 1164], "DRUG": ["CLOPIDOGREL", "PLAVIX", "BRILIQUE", "CLOPIDOGREL HYDROGEN SULFATE", "TICAGRELOR"], "FATAL": [156, 96, 7, 98, 19], "PATHOLOGY": "antiplatelet therapy", "RECOVERED": [1118, 559, 62, 938, 260]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/830.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/830.json
new file mode 100644
index 00000000000..225b8774ea4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/830.json
@@ -0,0 +1 @@
+{"CASES": [117, 147, 354, 912, 354], "DRUG": ["MELPHALAN", "EMEND", "MIDAZOLAM", "DEXAMETHASONE", "HYDROCORTISONE"], "FATAL": [32, 8, 16, 26, 6], "PATHOLOGY": "premedication", "RECOVERED": [17, 94, 236, 406, 258]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/831.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/831.json
new file mode 100644
index 00000000000..ebd18a14ef3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/831.json
@@ -0,0 +1 @@
+{"CASES": [153], "DRUG": ["DARZALEX"], "FATAL": [9], "PATHOLOGY": "primary amyloidosis", "RECOVERED": [30]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/832.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/832.json
new file mode 100644
index 00000000000..a48eba059e7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/832.json
@@ -0,0 +1 @@
+{"CASES": [5442, 489], "DRUG": ["OCALIVA", "OBETICHOLIC ACID"], "FATAL": [307, 15], "PATHOLOGY": "primary biliary cholangitis", "RECOVERED": [842, 46]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/833.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/833.json
new file mode 100644
index 00000000000..3803f7ba4e9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/833.json
@@ -0,0 +1 @@
+{"CASES": [222, 1277, 305, 918], "DRUG": ["HYQVIA", "HIZENTRA", "PRIVIGEN", "HUMAN NORMAL IMMUNOGLOBULIN"], "FATAL": [17, 33, 4, 3], "PATHOLOGY": "primary immunodeficiency syndrome", "RECOVERED": [44, 340, 147, 59]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/834.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/834.json
new file mode 100644
index 00000000000..c288fe58578
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/834.json
@@ -0,0 +1 @@
+{"CASES": [118, 110, 309, 136, 289, 110], "DRUG": ["CYTARABINE", "KEYTRUDA", "YESCARTA", "RITUXIMAB", "DOXORUBICIN HYDROCHLORIDE", "PEMBROLIZUMAB"], "FATAL": [16, 10, 26, 7, 5, 1], "PATHOLOGY": "primary mediastinal large b-cell lymphoma", "RECOVERED": [5, 20, 112, 36, 111, 3]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/835.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/835.json
new file mode 100644
index 00000000000..cde7019c69e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/835.json
@@ -0,0 +1 @@
+{"CASES": [690, 690, 2146], "DRUG": ["JAKAVI TABLETS", "RUXOLITINIB", "JAKAVI"], "FATAL": [138, 63, 174], "PATHOLOGY": "primary myelofibrosis", "RECOVERED": [86, 83, 211]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/836.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/836.json
new file mode 100644
index 00000000000..ec527beb200
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/836.json
@@ -0,0 +1 @@
+{"CASES": [151], "DRUG": ["OCRELIZUMAB"], "FATAL": [18], "PATHOLOGY": "primary progressive multiple sclerosis", "RECOVERED": [24]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/837.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/837.json
new file mode 100644
index 00000000000..b61db7e58e4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/837.json
@@ -0,0 +1 @@
+{"CASES": [111, 116], "DRUG": ["ZALVISO", "QUTENZA"], "FATAL": [6, 1], "PATHOLOGY": "procedural pain", "RECOVERED": [72, 36]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/838.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/838.json
new file mode 100644
index 00000000000..e3e47b0078c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/838.json
@@ -0,0 +1 @@
+{"CASES": [864], "DRUG": ["PRAXBIND"], "FATAL": [428], "PATHOLOGY": "procoagulant therapy", "RECOVERED": [95]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/839.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/839.json
new file mode 100644
index 00000000000..64cb043396c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/839.json
@@ -0,0 +1 @@
+{"CASES": [195, 243, 139, 1186, 264, 376, 219, 105, 361, 264, 7167, 2099, 753, 511, 647, 252, 668, 665, 646, 1296, 1483, 128, 111, 1549, 313, 458, 1893, 232, 2997, 1822, 132, 180, 504, 1014, 234, 10514, 1352, 806, 434, 341, 256, 212, 1778, 1194, 192, 1780, 61498, 3844, 370, 543, 4580, 198, 571, 255, 217, 119, 2186, 122, 654, 1068, 553, 168, 467, 229, 718, 1213, 188, 138, 3185, 119, 1283, 153, 1395, 136, 1155, 151, 157, 357, 723, 140, 3790, 481, 495, 102, 318, 110, 113, 54251, 121, 683, 188, 767, 141, 2010, 163, 328, 264, 19368, 915, 440, 331, 74661, 628, 125, 289, 443, 748, 327, 7767, 10419, 2133, 579, 397, 202, 575, 4936, 5810, 310, 669, 1352, 46082, 15191, 434, 2358, 15773, 1009, 3327], "DRUG": ["ANIDULAFUNGIN", "RASBURICASE", "ENVARSUS", "GANCICLOVIR", "CANCIDAS", "CASPOFUNGIN", "CASPOFUNGIN ACETATE", "TOBRAMYCIN", "AZATHIOPRINE", "ADVAGRAF", "CICLOSPORIN", "CLOPIDOGREL", "FILGRASTIM", "TACROLIMUS", "LEVETIRACETAM", "INTEGRILIN", "BASILIXIMAB", "VORICONAZOLE", "POSACONAZOLE", "ALEMTUZUMAB", "NOXAFIL", "MICAFUNGIN", "ENTECAVIR", "METHOTREXATE", "CYTARABINE", "PLAVIX 75 MG FILM-COATED TABLETS", "MYCOPHENOLATE MOFETIL", "PRADAXA", "SYNAGIS POWDER AND SOLVENT FOR SOLUTION FOR INJECTION", "NEULASTA", "CRESEMBA", "MYCAMINE", "XARELTO 20 MG", "XARELTO", "APREPITANT", "CELLCEPT", "BUSULFAN", "VFEND", "ARIXTRA", "LAMIVUDINE", "NOXAFIL 100 MG", "NOVOSEVEN", "RAPAMUNE", "LEVOFLOXACIN", "CEFUROXIME SODIUM", "TAMIFLU", "ELIQUIS", "SYNAGIS", "ALOXI", "EVUSHELD", "PLAVIX", "CINRYZE", "ELIQUIS 5 MG FILM-COATED TABLETS", "INHIXA", "XARELTO 15 MG", "VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED)", "EMEND", "HYDROCORTISONE", "ESOMEPRAZOLE", "BRILIQUE", "COMBIVIR", "VIMPAT", "BRILIQUE 90 MG FILM-COATED TABLETS", "EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE", "PANTOPRAZOLE", "CLOPIDOGREL HYDROGEN SULFATE", "ABATACEPT", "INHIXA 10,000 IU (100 MG)/1 ML SOLUTION FOR INJECTION", "ENOXAPARIN SODIUM", "NEVIRAPINE", "DEXAMETHASONE", "EFIENT", "PREVENAR 13", "RITUXIMAB", "KEPPRA", "NOXAFIL 100 MG GASTRO-RESISTANT TABLETS", "HEXYON", "INFANRIX HEXA POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION", "LIXIANA", "EVEROLIMUS", "VAXZEVRIA", "C1 ESTERASE INHIBITOR (HUMAN)", "COMIRNATY COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED)", "ISCOVER", "CELLCEPT 500 MG TABLETS", "BIKTARVY", "PRIVIGEN", "SPIKEVAX", "MERCK STERILE DILUENT", "CERVARIX", "ADVATE", "SYNFLORIX", "POLIOMYELITIS VACCINE ORAL BIVALENT T1 T3", "INFANRIX HEXA", "ELIQUIS 2.5 MG FILM-COATED TABLETS", "PEGFILGRASTIM", "COMIRNATY CONCENTRATE FOR DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED)", "COMIRNATY", "NOT AVAILABLE", "TICAGRELOR", "CRIXIVAN", "ZOSTAVAX", "EVISTA", "OSELTAMIVIR", "DESCOVY", "PREVENAR", "ROTARIX", "COVID-19 MRNA VACCINE MODERNA (CX-024414)", "COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)", "GARDASIL 9", "BEXSERO", "SILGARD", "PROQUAD", "EMEND 125 MG HARD CAPSULE", "KALETRA", "M-M-RVAXPRO", "AIMOVIG", "ISENTRESS", "COMIRNATY CONCENTRATE FOR DISPERSION FOR INJECTION", "MENVEO", "SHINGRIX", "APIXABAN", "COVID-19 VACCINE JANSSEN (AD26.COV2.S)", "NIMENRIX", "TRUVADA", "MENVEO POWDER AND SOLUTION FOR SOLUTION FOR INJECTION", "GARDASIL SUSPENSION FOR INJECTION IN A PRE-FILLED SYRINGE"], "FATAL": [158, 140, 66, 494, 108, 150, 75, 33, 90, 57, 1365, 325, 114, 74, 91, 35, 92, 91, 87, 173, 194, 16, 13, 179, 35, 50, 196, 24, 305, 181, 12, 16, 43, 86, 19, 830, 104, 62, 31, 24, 18, 14, 113, 75, 12, 108, 3712, 229, 22, 32, 255, 11, 31, 13, 11, 6, 109, 6, 31, 50, 24, 7, 19, 9, 28, 47, 7, 5, 112, 4, 43, 5, 45, 4, 33, 4, 4, 9, 17, 3, 80, 10, 10, 2, 6, 2, 2, 897, 2, 11, 3, 11, 2, 26, 2, 4, 3, 210, 9, 4, 3, 648, 5, 1, 2, 3, 5, 2, 46, 58, 12, 3, 2, 1, 2, 17, 20, 1, 2, 4, 134, 40, 1, 4, 19, 1, 3], "PATHOLOGY": "prophylaxis", "RECOVERED": [24, 44, 7, 155, 47, 25, 18, 22, 62, 53, 1544, 707, 118, 130, 220, 24, 153, 164, 135, 174, 451, 11, 47, 391, 33, 233, 471, 81, 856, 359, 31, 55, 86, 280, 105, 2541, 319, 242, 135, 87, 78, 23, 326, 569, 109, 630, 8806, 1116, 165, 141, 1241, 81, 219, 86, 42, 16, 963, 74, 263, 340, 101, 44, 172, 60, 290, 295, 82, 51, 1060, 24, 676, 50, 711, 96, 365, 89, 48, 147, 260, 21, 1225, 96, 98, 52, 165, 26, 62, 11328, 8, 163, 59, 405, 116, 1107, 50, 104, 194, 8490, 124, 104, 106, 3973, 198, 22, 51, 156, 471, 58, 3023, 2589, 986, 284, 102, 170, 211, 2302, 1085, 133, 237, 552, 14552, 5910, 47, 1097, 915, 407, 843]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/84.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/84.json
new file mode 100644
index 00000000000..5a12a0bac57
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/84.json
@@ -0,0 +1 @@
+{"CASES": [419], "DRUG": ["OLANZAPINE"], "FATAL": [156], "PATHOLOGY": "antipsychotic therapy", "RECOVERED": [136]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/840.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/840.json
new file mode 100644
index 00000000000..fba6b9b3f5f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/840.json
@@ -0,0 +1 @@
+{"CASES": [231, 289], "DRUG": ["ESOMEPRAZOLE", "PANTOPRAZOLE"], "FATAL": [14, 6], "PATHOLOGY": "prophylaxis against gastrointestinal ulcer", "RECOVERED": [107, 116]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/841.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/841.json
new file mode 100644
index 00000000000..7c5fb4ab96e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/841.json
@@ -0,0 +1 @@
+{"CASES": [696, 6226, 924, 1423, 755, 148, 688, 186], "DRUG": ["ALEMTUZUMAB", "CICLOSPORIN", "CELLCEPT", "METHOTREXATE", "MYCOPHENOLATE MOFETIL", "TACROLIMUS", "BUSULFAN", "ABATACEPT"], "FATAL": [136, 1197, 115, 165, 83, 12, 41, 7], "PATHOLOGY": "prophylaxis against graft versus host disease", "RECOVERED": [82, 1299, 142, 348, 163, 36, 202, 82]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/842.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/842.json
new file mode 100644
index 00000000000..be54d3fdbaa
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/842.json
@@ -0,0 +1 @@
+{"CASES": [224, 107, 196, 106, 251, 287, 15584], "DRUG": ["EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE", "NEVIRAPINE", "COMBIVIR", "BIKTARVY", "ISENTRESS", "DESCOVY", "TRUVADA"], "FATAL": [9, 4, 6, 2, 1, 1, 19], "PATHOLOGY": "prophylaxis against hiv infection", "RECOVERED": [59, 21, 52, 26, 108, 50, 907]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/843.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/843.json
new file mode 100644
index 00000000000..29d25e11973
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/843.json
@@ -0,0 +1 @@
+{"CASES": [136, 349, 263, 842, 326, 616, 546, 1077, 9313, 1741, 565, 129, 299], "DRUG": ["ENVARSUS", "AZATHIOPRINE", "ADVAGRAF", "CICLOSPORIN", "TACROLIMUS", "BASILIXIMAB", "BUSULFAN", "MYCOPHENOLATE MOFETIL", "CELLCEPT", "RAPAMUNE", "ALEMTUZUMAB", "EVEROLIMUS", "CELLCEPT 500 MG TABLETS"], "FATAL": [66, 81, 57, 158, 60, 88, 61, 112, 709, 107, 25, 3, 5], "PATHOLOGY": "prophylaxis against transplant rejection", "RECOVERED": [7, 62, 53, 229, 86, 138, 117, 296, 2352, 317, 85, 21, 157]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/844.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/844.json
new file mode 100644
index 00000000000..379669d8824
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/844.json
@@ -0,0 +1 @@
+{"CASES": [185, 323, 2062, 634], "DRUG": ["APREPITANT", "ALOXI", "EMEND", "DEXAMETHASONE"], "FATAL": [15, 19, 105, 12], "PATHOLOGY": "prophylaxis of nausea and vomiting", "RECOVERED": [91, 135, 925, 303]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/845.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/845.json
new file mode 100644
index 00000000000..31d6ca49187
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/845.json
@@ -0,0 +1 @@
+{"CASES": [3198], "DRUG": ["ZOSTAVAX"], "FATAL": [43], "PATHOLOGY": "prophylaxis, routine health maintenance", "RECOVERED": [90]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/846.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/846.json
new file mode 100644
index 00000000000..c0830e17585
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/846.json
@@ -0,0 +1 @@
+{"CASES": [150, 7496, 224, 46586, 721, 518, 118, 4563, 146, 423, 185, 553, 158, 547, 497, 132, 993, 967, 952, 5320, 455, 174, 267, 180, 1895, 3959, 121, 401, 126, 173, 171, 321], "DRUG": ["JEVTANA 60 MG CONCENTRATE AND SOLVENT FOR SOLUTION FOR INFUSION", "JEVTANA", "DENOSUMAB", "XTANDI", "PLUVICTO", "RUBRACA", "SUTENT", "XOFIGO", "ZOMETA", "OLAPARIB", "TAXOTERE", "ZYTIGA", "DEXAMETHASONE", "KEYTRUDA", "XTANDI 40 MG SOFT CAPSULES", "DEGARELIX", "NUBEQA 300 MG", "LYNPARZA", "DOCETAXEL", "ERLEADA", "APALUTAMIDE", "FIRMAGON", "ERLEADA 60 MG FILM-COATED TABLETS", "XGEVA", "CABAZITAXEL", "ENZALUTAMIDE", "CABOMETYX", "ABIRATERONE ACETATE", "LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN", "LEUPRORELIN", "NUBEQA", "PROVENGE"], "FATAL": [30, 1262, 30, 5688, 84, 56, 12, 456, 13, 35, 14, 41, 10, 34, 30, 7, 49, 47, 43, 204, 16, 6, 9, 6, 60, 117, 3, 9, 2, 1, 1, 1], "PATHOLOGY": "prostate cancer", "RECOVERED": [70, 2076, 33, 5376, 35, 26, 18, 371, 56, 43, 59, 163, 8, 51, 128, 14, 183, 134, 141, 1272, 80, 22, 86, 24, 288, 812, 11, 61, 12, 96, 32, 114]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/847.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/847.json
new file mode 100644
index 00000000000..af7d6979d4a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/847.json
@@ -0,0 +1 @@
+{"CASES": [1283, 187, 4030, 722, 165, 1154, 193, 122, 774, 522, 196, 197, 140, 117, 207], "DRUG": ["JEVTANA", "PLUVICTO", "XTANDI", "XOFIGO", "OLAPARIB", "ERLEADA", "DOCETAXEL", "FIRMAGON", "ENZALUTAMIDE", "CABAZITAXEL", "ZYTIGA", "ABIRATERONE ACETATE", "XTANDI 40 MG SOFT CAPSULES", "ZOMETA", "PROVENGE"], "FATAL": [330, 24, 422, 66, 12, 50, 8, 5, 28, 18, 6, 6, 2, 1, 1], "PATHOLOGY": "prostate cancer metastatic", "RECOVERED": [348, 8, 606, 53, 12, 276, 36, 3, 192, 73, 67, 27, 47, 56, 88]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/848.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/848.json
new file mode 100644
index 00000000000..dae1273c8c4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/848.json
@@ -0,0 +1 @@
+{"CASES": [132, 160], "DRUG": ["XOFIGO", "XTANDI"], "FATAL": [21, 14], "PATHOLOGY": "prostate cancer stage iv", "RECOVERED": [12, 25]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/849.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/849.json
new file mode 100644
index 00000000000..b3508e0875c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/849.json
@@ -0,0 +1 @@
+{"CASES": [723], "DRUG": ["LEVOFLOXACIN"], "FATAL": [1], "PATHOLOGY": "prostatitis", "RECOVERED": [132]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/85.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/85.json
new file mode 100644
index 00000000000..ebdb0d23595
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/85.json
@@ -0,0 +1 @@
+{"CASES": [116, 314, 900, 1159, 296, 152, 464, 233, 206, 1293, 278, 442], "DRUG": ["REYATAZ", "ATAZANAVIR SULFATE", "LAMIVUDINE", "EFAVIRENZ", "NEVIRAPINE", "TRUVADA", "ATAZANAVIR", "KALETRA", "ISENTRESS", "ABACAVIR", "EMTRICITABINE", "COMBIVIR"], "FATAL": [18, 36, 97, 73, 12, 6, 18, 8, 6, 16, 2, 3], "PATHOLOGY": "antiretroviral therapy", "RECOVERED": [20, 31, 179, 410, 148, 36, 161, 76, 62, 483, 42, 72]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/850.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/850.json
new file mode 100644
index 00000000000..eec83a5623f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/850.json
@@ -0,0 +1 @@
+{"CASES": [103, 213], "DRUG": ["DESLORATADINE", "AERIUS"], "FATAL": [8, 2], "PATHOLOGY": "pruritus", "RECOVERED": [37, 89]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/851.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/851.json
new file mode 100644
index 00000000000..7ba6e7fda33
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/851.json
@@ -0,0 +1 @@
+{"CASES": [119, 131, 394], "DRUG": ["AMIKACIN", "LEVOFLOXACIN", "TOBRAMYCIN"], "FATAL": [12, 9, 8], "PATHOLOGY": "pseudomonas infection", "RECOVERED": [57, 28, 76]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/852.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/852.json
new file mode 100644
index 00000000000..b036f2c3168
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/852.json
@@ -0,0 +1 @@
+{"CASES": [101, 124, 111, 281, 1343, 158, 119, 326, 513, 4084, 277, 24644, 423, 131, 637, 23959, 791, 116, 2086, 2377, 159, 8663, 520, 3217, 1390, 323, 328, 3305], "DRUG": ["RAPTIVA", "HUMIRA 40 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "HUMIRA 40 MG/0.8 ML", "REMICADE", "METHOTREXATE", "RINVOQ", "TALTZ", "OTEZLA", "USTEKINUMAB", "CICLOSPORIN", "RISANKIZUMAB", "STELARA", "STELARA 90 MG SOLUTION FOR INJECTION", "ETANERCEPT", "STELARA 45 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "COSENTYX", "STELARA 45 MG SOLUTION FOR INJECTION", "INFLIXIMAB", "ENBREL", "HUMIRA", "COSENTYX 150 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "TREMFYA", "SIMPONI", "SKYRIZI", "ADALIMUMAB", "XELJANZ", "GUSELKUMAB", "CIMZIA"], "FATAL": [15, 12, 9, 17, 80, 6, 4, 10, 14, 104, 7, 600, 10, 3, 14, 518, 14, 2, 29, 33, 2, 104, 6, 33, 6, 1, 1, 10], "PATHOLOGY": "psoriasis", "RECOVERED": [21, 23, 28, 73, 196, 28, 37, 69, 120, 843, 40, 4950, 109, 43, 138, 3494, 297, 11, 573, 505, 14, 1222, 92, 529, 140, 33, 109, 360]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/853.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/853.json
new file mode 100644
index 00000000000..e5aef45e276
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/853.json
@@ -0,0 +1 @@
+{"CASES": [3429, 854], "DRUG": ["COSENTYX", "CIMZIA"], "FATAL": [73, 1], "PATHOLOGY": "psoriasis, psoriatic arthropathy", "RECOVERED": [373, 80]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/854.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/854.json
new file mode 100644
index 00000000000..6db7e2e2fcd
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/854.json
@@ -0,0 +1 @@
+{"CASES": [35469, 23900, 174, 898, 1338, 2069, 1908, 120, 259, 7529, 3566, 241, 2407, 1518, 269, 4185, 6073], "DRUG": ["ADALIMUMAB", "COSENTYX", "ROACTEMRA", "METHOTREXATE", "ARAVA", "ENBREL", "HUMIRA", "STELARA 45 MG SOLUTION FOR INJECTION", "LEFLUNOMIDE", "SIMPONI", "STELARA", "OTEZLA", "TREMFYA", "RINVOQ", "INFLIXIMAB", "XELJANZ", "CIMZIA"], "FATAL": [29222, 1996, 12, 48, 43, 45, 32, 2, 4, 84, 36, 2, 18, 8, 1, 12, 16], "PATHOLOGY": "psoriatic arthropathy", "RECOVERED": [96, 2651, 62, 163, 334, 369, 391, 32, 143, 1021, 524, 69, 165, 328, 159, 417, 655]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/855.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/855.json
new file mode 100644
index 00000000000..b88b1704e61
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/855.json
@@ -0,0 +1 @@
+{"CASES": [1214, 14173, 467, 504], "DRUG": ["COSENTYX", "ADALIMUMAB", "XELJANZ", "CIMZIA"], "FATAL": [1139, 11510, 3, 1], "PATHOLOGY": "psoriatic arthropathy, rheumatoid arthritis", "RECOVERED": [15, 3, 34, 23]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/856.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/856.json
new file mode 100644
index 00000000000..f0c2d1bf100
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/856.json
@@ -0,0 +1 @@
+{"CASES": [248], "DRUG": ["OLANZAPINE"], "FATAL": [2], "PATHOLOGY": "psychiatric symptom", "RECOVERED": [60]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/857.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/857.json
new file mode 100644
index 00000000000..84b9d558bd1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/857.json
@@ -0,0 +1 @@
+{"CASES": [100], "DRUG": ["MIDAZOLAM"], "FATAL": [4], "PATHOLOGY": "psychomotor hyperactivity", "RECOVERED": [54]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/858.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/858.json
new file mode 100644
index 00000000000..15d1f927976
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/858.json
@@ -0,0 +1 @@
+{"CASES": [429, 181, 314, 120, 4018, 484, 1261, 4268, 783, 1338, 141, 312], "DRUG": ["LATUDA", "ZYPREXA COATED TABLETS", "RISPERIDONE", "ZYPREXA VELOTAB", "ZYPREXA", "ABILIFY MAINTENA", "ABILIFY", "OLANZAPINE", "ZYPADHERA", "ARIPIPRAZOLE", "ZYPREXA 10 MG", "INVEGA"], "FATAL": [27, 11, 14, 4, 124, 13, 29, 83, 9, 10, 1, 2], "PATHOLOGY": "psychotic disorder", "RECOVERED": [107, 43, 165, 55, 1200, 368, 804, 1372, 441, 318, 23, 24]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/859.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/859.json
new file mode 100644
index 00000000000..35a9b64115d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/859.json
@@ -0,0 +1 @@
+{"CASES": [346], "DRUG": ["OLANZAPINE"], "FATAL": [4], "PATHOLOGY": "psychotic symptom", "RECOVERED": [65]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/86.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/86.json
new file mode 100644
index 00000000000..2299887fd65
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/86.json
@@ -0,0 +1 @@
+{"CASES": [913, 145, 2916, 209, 1461, 3555, 1035], "DRUG": ["GANCICLOVIR", "LAMIVUDINE", "SYNAGIS POWDER AND SOLVENT FOR SOLUTION FOR INJECTION", "COMBIVIR", "TAMIFLU", "SYNAGIS", "SHINGRIX"], "FATAL": [438, 22, 303, 18, 96, 209, 34], "PATHOLOGY": "antiviral prophylaxis", "RECOVERED": [106, 22, 809, 21, 516, 971, 362]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/860.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/860.json
new file mode 100644
index 00000000000..c52ae565af6
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/860.json
@@ -0,0 +1 @@
+{"CASES": [150, 23308, 1348, 4306, 994, 40098, 1278, 3507, 1467, 285, 1448, 1297, 333, 106, 594, 600, 290], "DRUG": ["ESBRIET", "TRACLEER", "BOSENTAN", "REVATIO", "SILDENAFIL CITRATE", "OPSUMIT", "SILDENAFIL", "ADCIRCA", "MACITENTAN", "VIAGRA", "ADEMPAS", "AMBRISENTAN", "ILOPROST", "VOLIBRIS", "ADCIRCA 20 MG", "UPTRAVI", "OFEV"], "FATAL": [38, 5509, 272, 744, 162, 5155, 156, 340, 113, 21, 95, 81, 20, 5, 28, 20, 2], "PATHOLOGY": "pulmonary arterial hypertension", "RECOVERED": [1, 3246, 109, 567, 102, 5325, 196, 710, 168, 62, 277, 118, 57, 10, 224, 96, 29]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/861.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/861.json
new file mode 100644
index 00000000000..ca9a4217767
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/861.json
@@ -0,0 +1 @@
+{"CASES": [143, 186], "DRUG": ["REVATIO", "OPSUMIT"], "FATAL": [6, 5], "PATHOLOGY": "pulmonary arterial hypertension, pulmonary hypertension", "RECOVERED": [8, 22]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/862.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/862.json
new file mode 100644
index 00000000000..74085f14e5c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/862.json
@@ -0,0 +1 @@
+{"CASES": [242, 353, 716, 148, 148, 126, 5202, 426, 372], "DRUG": ["XARELTO 20 MG", "XARELTO", "ENOXAPARIN SODIUM", "XARELTO 15 MG", "ARIXTRA", "APIXABAN", "ELIQUIS", "ELIQUIS 5 MG FILM-COATED TABLETS", "LIXIANA"], "FATAL": [30, 35, 68, 14, 12, 6, 229, 16, 10], "PATHOLOGY": "pulmonary embolism", "RECOVERED": [36, 65, 231, 29, 37, 30, 625, 146, 94]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/863.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/863.json
new file mode 100644
index 00000000000..10a2f952e0f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/863.json
@@ -0,0 +1 @@
+{"CASES": [109, 23155, 1437, 13892, 145, 366, 122, 430], "DRUG": ["REVATIO", "ESBRIET", "PIRFENIDONE", "OFEV", "NINTEDANIB", "OFEV 150 MG SOFT CAPSULES", "ESBRIET 801 MG FILM-COATED TABLETS", "ESBRIET 267 MG HARD CAPSULES"], "FATAL": [28, 4361, 153, 961, 10, 7, 2, 7], "PATHOLOGY": "pulmonary fibrosis", "RECOVERED": [17, 2535, 252, 2931, 17, 177, 37, 192]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/864.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/864.json
new file mode 100644
index 00000000000..a29a1af5da0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/864.json
@@ -0,0 +1 @@
+{"CASES": [6961, 610, 326, 101, 9418, 570, 436, 123, 8791, 749, 435, 465, 991], "DRUG": ["REVATIO", "SILDENAFIL CITRATE", "BOSENTAN", "REVATIO 20 MG", "TRACLEER", "VIAGRA", "ADCIRCA", "UPTRAVI", "OPSUMIT", "SILDENAFIL", "MACITENTAN", "ADEMPAS", "AMBRISENTAN"], "FATAL": [1503, 116, 55, 17, 1553, 69, 43, 12, 846, 66, 28, 16, 24], "PATHOLOGY": "pulmonary hypertension", "RECOVERED": [909, 77, 29, 10, 1520, 101, 107, 28, 1028, 196, 58, 42, 170]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/865.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/865.json
new file mode 100644
index 00000000000..35a6f761032
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/865.json
@@ -0,0 +1 @@
+{"CASES": [134], "DRUG": ["SUTENT"], "FATAL": [3], "PATHOLOGY": "pulmonary mass", "RECOVERED": [30]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/866.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/866.json
new file mode 100644
index 00000000000..e82a483561e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/866.json
@@ -0,0 +1 @@
+{"CASES": [121, 1473, 4636, 964, 329, 1143, 320, 399], "DRUG": ["PRETOMANID", "AMINOSALICYLIC ACID", "BEDAQUILINE", "DELAMANID", "SIRTURO", "LEVOFLOXACIN", "AMIKACIN", "DELTYBA"], "FATAL": [25, 250, 499, 88, 27, 59, 10, 10], "PATHOLOGY": "pulmonary tuberculosis", "RECOVERED": [6, 264, 558, 182, 41, 294, 36, 88]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/867.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/867.json
new file mode 100644
index 00000000000..de4c1c3924a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/867.json
@@ -0,0 +1 @@
+{"CASES": [712, 103, 438, 166], "DRUG": ["COSENTYX", "ADALIMUMAB", "CICLOSPORIN", "STELARA"], "FATAL": [73, 5, 18, 4], "PATHOLOGY": "pustular psoriasis", "RECOVERED": [130, 15, 88, 36]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/868.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/868.json
new file mode 100644
index 00000000000..4b8ae334a8f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/868.json
@@ -0,0 +1 @@
+{"CASES": [249], "DRUG": ["LEVOFLOXACIN"], "FATAL": [18], "PATHOLOGY": "pyelonephritis", "RECOVERED": [102]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/869.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/869.json
new file mode 100644
index 00000000000..a8912907256
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/869.json
@@ -0,0 +1 @@
+{"CASES": [704], "DRUG": ["CICLOSPORIN"], "FATAL": [140], "PATHOLOGY": "pyoderma gangrenosum", "RECOVERED": [91]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/87.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/87.json
new file mode 100644
index 00000000000..789769b08b4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/87.json
@@ -0,0 +1 @@
+{"CASES": [234, 141, 209, 113], "DRUG": ["COMBIVIR", "INCIVO", "GANCICLOVIR", "OSELTAMIVIR"], "FATAL": [36, 12, 10, 2], "PATHOLOGY": "antiviral treatment", "RECOVERED": [42, 88, 15, 33]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/870.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/870.json
new file mode 100644
index 00000000000..7f893a02428
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/870.json
@@ -0,0 +1 @@
+{"CASES": [415, 1189, 651, 136], "DRUG": ["AMIKACIN", "IBUPROFEN", "LEVOFLOXACIN", "TAMIFLU"], "FATAL": [115, 126, 32, 2], "PATHOLOGY": "pyrexia", "RECOVERED": [91, 325, 218, 56]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/871.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/871.json
new file mode 100644
index 00000000000..b44614d6dcc
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/871.json
@@ -0,0 +1 @@
+{"CASES": [168], "DRUG": ["DEXAMETHASONE"], "FATAL": [32], "PATHOLOGY": "radiotherapy", "RECOVERED": [28]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/872.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/872.json
new file mode 100644
index 00000000000..3d6ce032f7c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/872.json
@@ -0,0 +1 @@
+{"CASES": [130], "DRUG": ["REVATIO"], "FATAL": [4], "PATHOLOGY": "raynaud's phenomenon", "RECOVERED": [23]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/873.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/873.json
new file mode 100644
index 00000000000..e6da4c8571a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/873.json
@@ -0,0 +1 @@
+{"CASES": [783, 348, 393, 127, 522, 197, 590], "DRUG": ["BEVACIZUMAB", "STIVARGA", "IRINOTECAN", "ERBITUX", "AVASTIN", "CETUXIMAB", "CAPECITABINE"], "FATAL": [58, 24, 25, 8, 16, 6, 12], "PATHOLOGY": "rectal adenocarcinoma", "RECOVERED": [154, 60, 106, 28, 118, 48, 193]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/874.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/874.json
new file mode 100644
index 00000000000..2dfc0a34cab
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/874.json
@@ -0,0 +1 @@
+{"CASES": [363, 780, 103, 212, 12484, 4709, 6661, 123, 123, 1204, 108, 1373, 6732, 1554, 531, 1825, 893, 169, 121, 441, 269, 1753, 1716, 488, 120], "DRUG": ["ERBITUX 5 MG/ML", "CETUXIMAB", "IRINOTECAN HCL", "AVASTIN 25 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION", "STIVARGA", "LONSURF", "AVASTIN", "ZALTRAP", "MVASI", "ERBITUX", "ATEZOLIZUMAB", "BRAFTOVI", "BEVACIZUMAB", "XELODA", "KEYTRUDA", "VECTIBIX", "PANITUMUMAB", "STIVARGA 40 MG FILM-COATED TABLETS", "OPDIVO", "REGORAFENIB", "PEMBROLIZUMAB", "IRINOTECAN", "CAPECITABINE", "AFLIBERCEPT", "LONSURF 20 MG/8.19 MG"], "FATAL": [52, 69, 9, 18, 1059, 388, 549, 10, 10, 94, 8, 90, 430, 99, 32, 102, 45, 8, 5, 17, 9, 55, 51, 9, 2], "PATHOLOGY": "rectal cancer", "RECOVERED": [96, 212, 46, 113, 2274, 1307, 1850, 59, 10, 265, 72, 256, 1652, 440, 80, 316, 171, 58, 16, 126, 69, 490, 397, 164, 48]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/875.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/875.json
new file mode 100644
index 00000000000..b287db12f80
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/875.json
@@ -0,0 +1 @@
+{"CASES": [111, 396, 194, 590, 100, 3447, 4702, 786, 2860, 318, 3622, 531, 349, 193, 1032, 1021, 110, 378], "DRUG": ["AVASTIN 25 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION", "CETUXIMAB", "XELODA", "ERBITUX", "ATEZOLIZUMAB", "AVASTIN", "STIVARGA", "BRAFTOVI", "LONSURF", "REGORAFENIB", "BEVACIZUMAB", "PANITUMUMAB", "CAPECITABINE", "PEMBROLIZUMAB", "IRINOTECAN", "VECTIBIX", "LONSURF 20 MG/8.19 MG", "AFLIBERCEPT"], "FATAL": [15, 39, 19, 57, 8, 253, 305, 50, 149, 14, 146, 20, 12, 6, 27, 23, 2, 5], "PATHOLOGY": "rectal cancer metastatic", "RECOVERED": [58, 85, 72, 163, 66, 944, 654, 184, 1103, 79, 809, 82, 58, 59, 283, 165, 48, 112]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/876.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/876.json
new file mode 100644
index 00000000000..c97326f8adf
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/876.json
@@ -0,0 +1 @@
+{"CASES": [862, 423, 109], "DRUG": ["STIVARGA", "AVASTIN", "BEVACIZUMAB"], "FATAL": [142, 46, 6], "PATHOLOGY": "rectal cancer recurrent", "RECOVERED": [184, 155, 43]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/877.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/877.json
new file mode 100644
index 00000000000..3c26508a5a1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/877.json
@@ -0,0 +1 @@
+{"CASES": [122], "DRUG": ["CAPECITABINE"], "FATAL": [18], "PATHOLOGY": "rectal cancer stage iii", "RECOVERED": [53]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/878.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/878.json
new file mode 100644
index 00000000000..321f4b8377b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/878.json
@@ -0,0 +1 @@
+{"CASES": [108, 110, 222, 338], "DRUG": ["VECTIBIX", "LONSURF", "BEVACIZUMAB", "STIVARGA"], "FATAL": [30, 10, 20, 18], "PATHOLOGY": "rectal cancer stage iv", "RECOVERED": [18, 4, 53, 30]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/879.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/879.json
new file mode 100644
index 00000000000..64faf7a37d0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/879.json
@@ -0,0 +1 @@
+{"CASES": [116, 512, 184], "DRUG": ["AVASTIN", "LONSURF", "STIVARGA"], "FATAL": [16, 32, 6], "PATHOLOGY": "rectosigmoid cancer", "RECOVERED": [41, 99, 44]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/88.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/88.json
new file mode 100644
index 00000000000..4ba41d6cfa5
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/88.json
@@ -0,0 +1 @@
+{"CASES": [392, 214, 1466, 150, 182, 121, 416, 153, 1153, 260, 469, 857, 583, 7940, 597, 2383], "DRUG": ["PREGABALIN", "MIDAZOLAM", "OLANZAPINE", "CYMBALTA 60 MG HARD GASTRO-RESISTANT CAPSULES", "ZYPREXA COATED TABLETS", "CYMBALTA 30 MG HARD GASTRO-RESISTANT CAPSULES", "ARIPIPRAZOLE", "VORTIOXETINE", "ZYPREXA", "PROPRANOLOL HYDROCHLORIDE", "BRINTELLIX 10 MG FILM-COATED TABLETS", "ABILIFY", "LYRICA", "CYMBALTA", "LATUDA", "BRINTELLIX"], "FATAL": [140, 49, 274, 5, 6, 3, 10, 3, 17, 3, 4, 6, 4, 48, 2, 6], "PATHOLOGY": "anxiety", "RECOVERED": [74, 81, 267, 49, 21, 48, 108, 34, 204, 51, 173, 203, 123, 1377, 98, 572]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/880.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/880.json
new file mode 100644
index 00000000000..ca12dd4460c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/880.json
@@ -0,0 +1 @@
+{"CASES": [143, 139, 559], "DRUG": ["AUBAGIO", "LEMTRADA", "KESIMPTA"], "FATAL": [3, 1, 2], "PATHOLOGY": "relapsing multiple sclerosis", "RECOVERED": [16, 17, 159]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/881.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/881.json
new file mode 100644
index 00000000000..aae7e5fc5d0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/881.json
@@ -0,0 +1 @@
+{"CASES": [127, 309, 684, 209, 3220, 2858, 325, 4332, 386, 1032, 1029, 1206, 874], "DRUG": ["REBIF", "GILENYA", "ZINBRYTA", "AVONEX", "LEMTRADA", "AUBAGIO", "TERIFLUNOMIDE", "ALEMTUZUMAB", "OCREVUS", "MAVENCLAD", "BETAFERON", "KESIMPTA", "PLEGRIDY"], "FATAL": [7, 14, 25, 4, 60, 40, 3, 35, 3, 6, 6, 6, 1], "PATHOLOGY": "relapsing-remitting multiple sclerosis", "RECOVERED": [27, 81, 169, 60, 982, 769, 105, 902, 57, 197, 284, 335, 359]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/882.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/882.json
new file mode 100644
index 00000000000..f94b46ccfbc
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/882.json
@@ -0,0 +1 @@
+{"CASES": [120], "DRUG": ["CICLOSPORIN"], "FATAL": [21], "PATHOLOGY": "renal and pancreas transplant", "RECOVERED": [58]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/883.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/883.json
new file mode 100644
index 00000000000..3385c197a89
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/883.json
@@ -0,0 +1 @@
+{"CASES": [243, 843, 2500, 517, 9241, 101, 634, 6993, 270, 162, 35762, 184, 138, 5502, 2376, 575, 129, 1013, 4060, 804, 209, 329, 159, 106, 652, 126, 169, 274, 210, 129, 232, 220, 273], "DRUG": ["VOTRIENT 200 MG FILM-COATED TABLETS", "TORISEL", "VOTRIENT FILM-COATED TABLETS", "SUTENT 50 MG HARD CAPSULES", "VOTRIENT", "SUTENT 25 MG HARD CAPSULES", "OPDIVO", "INLYTA", "SUNITINIB", "SUTENT 37.5 MG HARD CAPSULES", "SUTENT", "AFINITOR TABLETS", "EVEROLIMUS", "AFINITOR", "NEXAVAR", "SUTENT 12.5 MG", "OPDIVO 10 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION", "AXITINIB", "CABOMETYX", "KEYTRUDA", "AVELUMAB", "IPILIMUMAB", "NEXAVAR 200 MG FILM-COATED TABLETS", "CABOMETYX 20 MG FILM-COATED TABLETS", "PAZOPANIB", "PEMBROLIZUMAB", "CABOMETYX 60 MG FILM-COATED TABLETS", "VOTRIENT 400 MG FILM-COATED TABLETS", "BAVENCIO", "INLYTA 1 MG FILM-COATED TABLETS", "LENVIMA", "CABOMETYX 40 MG FILM-COATED TABLETS", "INLYTA 5 MG FILM-COATED TABLETS"], "FATAL": [35, 111, 297, 59, 1047, 10, 58, 625, 21, 12, 2565, 13, 9, 350, 147, 34, 7, 50, 190, 28, 7, 11, 5, 3, 17, 3, 4, 6, 4, 2, 3, 2, 2], "PATHOLOGY": "renal cancer", "RECOVERED": [84, 204, 195, 194, 1377, 36, 87, 946, 69, 36, 7296, 31, 6, 784, 546, 170, 57, 170, 611, 106, 86, 55, 92, 30, 97, 25, 76, 127, 66, 57, 23, 84, 125]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/884.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/884.json
new file mode 100644
index 00000000000..ce400f78a80
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/884.json
@@ -0,0 +1 @@
+{"CASES": [142, 105, 604, 128, 436, 1678, 1120, 155, 146, 577, 503, 13358, 403, 220, 126], "DRUG": ["SUTENT 50 MG HARD CAPSULES", "SUNITINIB", "AFINITOR", "OPDIVO", "TORISEL", "VOTRIENT", "INLYTA", "SUTENT 12.5 MG", "PAZOPANIB", "CABOMETYX", "NEXAVAR", "SUTENT", "AXITINIB", "VOTRIENT FILM-COATED TABLETS", "VOTRIENT 200 MG FILM-COATED TABLETS"], "FATAL": [30, 12, 58, 12, 38, 146, 91, 12, 10, 36, 29, 744, 12, 6, 2], "PATHOLOGY": "renal cancer metastatic", "RECOVERED": [46, 25, 104, 18, 106, 374, 223, 38, 14, 103, 80, 2912, 76, 30, 24]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/885.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/885.json
new file mode 100644
index 00000000000..2b568b422ff
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/885.json
@@ -0,0 +1 @@
+{"CASES": [105, 100, 342, 122, 4400], "DRUG": ["VOTRIENT", "NEXAVAR", "INLYTA", "CABOMETYX", "SUTENT"], "FATAL": [8, 6, 13, 4, 102], "PATHOLOGY": "renal cancer stage iv", "RECOVERED": [16, 26, 95, 30, 1106]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/886.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/886.json
new file mode 100644
index 00000000000..ff9a5208ee0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/886.json
@@ -0,0 +1 @@
+{"CASES": [341, 150, 8238, 96470, 3805, 246, 800, 811, 11544, 406, 265, 9216, 402, 870, 10057, 1405, 617, 929, 7700, 736, 650, 1258, 102, 2154, 11958, 1586, 4220, 7966, 257, 230, 134, 2334], "DRUG": ["NIVOLUMAB", "NEXAVAR 200 MG", "AFINITOR", "SUTENT", "TORISEL", "TEMSIROLIMUS", "AFINITOR TABLETS", "EVEROLIMUS", "INLYTA", "AVASTIN", "SUTENT 50 MG HARD CAPSULES", "NEXAVAR", "SORAFENIB", "SUNITINIB", "VOTRIENT", "VOTRIENT FILM-COATED TABLETS", "PEMBROLIZUMAB", "AVELUMAB", "OPDIVO", "BAVENCIO", "LENVIMA", "FOTIVDA", "BEVACIZUMAB", "SUTENT 12.5 MG", "CABOMETYX", "IPILIMUMAB", "AXITINIB", "KEYTRUDA", "CABOZANTINIB", "INLYTA 5 MG", "FOTIVDA HARD CAPSULES", "PAZOPANIB"], "FATAL": [57, 22, 1057, 12340, 419, 24, 76, 76, 1030, 34, 22, 754, 32, 65, 740, 92, 39, 55, 455, 42, 37, 62, 5, 96, 510, 63, 158, 264, 8, 7, 4, 65], "PATHOLOGY": "renal cell carcinoma", "RECOVERED": [67, 26, 1060, 16457, 959, 68, 122, 91, 1979, 35, 85, 1996, 97, 193, 1697, 247, 98, 216, 1463, 188, 146, 104, 16, 585, 1908, 209, 900, 2357, 41, 69, 26, 272]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/887.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/887.json
new file mode 100644
index 00000000000..a1d287a74c3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/887.json
@@ -0,0 +1 @@
+{"CASES": [149], "DRUG": ["KEYTRUDA"], "FATAL": [1], "PATHOLOGY": "renal cell carcinoma stage iii", "RECOVERED": [59]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/888.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/888.json
new file mode 100644
index 00000000000..05425b82d07
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/888.json
@@ -0,0 +1 @@
+{"CASES": [138, 530, 118, 374, 226, 2391, 1374], "DRUG": ["VOTRIENT", "INLYTA", "NEXAVAR", "AXITINIB", "CABOMETYX", "KEYTRUDA", "SUTENT"], "FATAL": [28, 48, 6, 18, 10, 66, 24], "PATHOLOGY": "renal cell carcinoma stage iv", "RECOVERED": [16, 130, 18, 124, 66, 876, 278]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/889.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/889.json
new file mode 100644
index 00000000000..bd3778128d9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/889.json
@@ -0,0 +1 @@
+{"CASES": [117], "DRUG": ["ARANESP"], "FATAL": [6], "PATHOLOGY": "renal disorder", "RECOVERED": [1]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/89.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/89.json
new file mode 100644
index 00000000000..e1e2d26a186
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/89.json
@@ -0,0 +1 @@
+{"CASES": [146, 174, 334, 1180], "DRUG": ["ABILIFY", "OLANZAPINE", "BRINTELLIX", "CYMBALTA"], "FATAL": [6, 4, 2, 6], "PATHOLOGY": "anxiety disorder", "RECOVERED": [61, 53, 98, 283]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/890.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/890.json
new file mode 100644
index 00000000000..f69157cdc28
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/890.json
@@ -0,0 +1 @@
+{"CASES": [157, 192], "DRUG": ["FORXIGA", "ARANESP"], "FATAL": [4, 4], "PATHOLOGY": "renal failure", "RECOVERED": [45, 17]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/891.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/891.json
new file mode 100644
index 00000000000..a1facdbc14b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/891.json
@@ -0,0 +1 @@
+{"CASES": [120], "DRUG": ["AZATHIOPRINE"], "FATAL": [72], "PATHOLOGY": "renal impairment", "RECOVERED": [24]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/892.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/892.json
new file mode 100644
index 00000000000..02a642ec2ca
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/892.json
@@ -0,0 +1 @@
+{"CASES": [156, 324, 298, 156, 1132], "DRUG": ["NEXAVAR", "VOTRIENT", "AFINITOR", "INLYTA", "SUTENT"], "FATAL": [18, 32, 29, 8, 42], "PATHOLOGY": "renal neoplasm", "RECOVERED": [30, 78, 46, 27, 214]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/893.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/893.json
new file mode 100644
index 00000000000..b12321795bd
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/893.json
@@ -0,0 +1 @@
+{"CASES": [132, 974, 1030, 9821, 334, 229, 169, 725, 136, 5953, 292, 1372, 318, 185, 154], "DRUG": ["ENVARSUS", "AZATHIOPRINE", "MYCOPHENOLATE MOFETIL", "CICLOSPORIN", "SIMULECT", "CELLCEPT 500 MG TABLETS", "ALEMTUZUMAB", "BASILIXIMAB", "NOT AVAILABLE", "CELLCEPT", "TACROLIMUS", "RAPAMUNE", "ADVAGRAF", "EVEROLIMUS", "ARANESP"], "FATAL": [64, 266, 136, 1208, 37, 21, 15, 54, 9, 388, 15, 63, 14, 4, 3], "PATHOLOGY": "renal transplant", "RECOVERED": [14, 356, 300, 3164, 95, 122, 51, 226, 90, 2095, 110, 324, 93, 33, 20]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/894.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/894.json
new file mode 100644
index 00000000000..00ac4daa917
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/894.json
@@ -0,0 +1 @@
+{"CASES": [291, 911], "DRUG": ["SYNAGIS POWDER AND SOLVENT FOR SOLUTION FOR INJECTION", "SYNAGIS"], "FATAL": [64, 61], "PATHOLOGY": "respiratory syncytial virus infection", "RECOVERED": [85, 169]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/895.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/895.json
new file mode 100644
index 00000000000..ae2aec2ce06
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/895.json
@@ -0,0 +1 @@
+{"CASES": [1820, 156, 101], "DRUG": ["LEVOFLOXACIN", "VFEND", "RIBAVIRIN"], "FATAL": [28, 2, 1], "PATHOLOGY": "respiratory tract infection", "RECOVERED": [610, 42, 17]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/896.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/896.json
new file mode 100644
index 00000000000..f523e56d99d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/896.json
@@ -0,0 +1 @@
+{"CASES": [1523, 233], "DRUG": ["SIFROL", "NEUPRO"], "FATAL": [17, 2], "PATHOLOGY": "restless legs syndrome", "RECOVERED": [400, 34]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/897.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/897.json
new file mode 100644
index 00000000000..e0017176121
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/897.json
@@ -0,0 +1 @@
+{"CASES": [1475], "DRUG": ["EYLEA"], "FATAL": [36], "PATHOLOGY": "retinal vein occlusion", "RECOVERED": [465]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/898.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/898.json
new file mode 100644
index 00000000000..69d0c212d64
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/898.json
@@ -0,0 +1 @@
+{"CASES": [172], "DRUG": ["THIOTEPA"], "FATAL": [13], "PATHOLOGY": "retinoblastoma", "RECOVERED": [3]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/899.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/899.json
new file mode 100644
index 00000000000..3bb04f5ebe6
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/899.json
@@ -0,0 +1 @@
+{"CASES": [342], "DRUG": ["IRINOTECAN"], "FATAL": [50], "PATHOLOGY": "rhabdomyosarcoma", "RECOVERED": [33]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/9.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/9.json
new file mode 100644
index 00000000000..8c440ff99c4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/9.json
@@ -0,0 +1 @@
+{"CASES": [346, 257], "DRUG": ["NOVOSEVEN", "HEMLIBRA"], "FATAL": [142, 20], "PATHOLOGY": "acquired haemophilia", "RECOVERED": [52, 29]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/90.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/90.json
new file mode 100644
index 00000000000..e06064fbfdc
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/90.json
@@ -0,0 +1 @@
+{"CASES": [346], "DRUG": ["CYMBALTA"], "FATAL": [6], "PATHOLOGY": "anxiety, depression", "RECOVERED": [11]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/900.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/900.json
new file mode 100644
index 00000000000..49fad6afdbe
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/900.json
@@ -0,0 +1 @@
+{"CASES": [304, 228, 459], "DRUG": ["ARAVA", "COSENTYX", "SIMPONI"], "FATAL": [7, 5, 8], "PATHOLOGY": "rheumatic disorder", "RECOVERED": [144, 19, 68]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/901.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/901.json
new file mode 100644
index 00000000000..fd157feea0e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/901.json
@@ -0,0 +1 @@
+{"CASES": [2600, 47718, 194654, 176, 676, 208, 407, 126, 1087, 105, 756, 306, 12018, 10580, 613, 266, 1939, 487, 151, 16883, 102, 632, 245029, 1085, 13279, 1802, 276, 608, 926, 576, 764, 2283, 134, 206, 26657, 48776, 265, 914, 10225, 2794, 10998, 1103, 127, 69836, 177, 43034, 100, 346, 266, 288, 738, 292], "DRUG": ["COSENTYX", "ABATACEPT", "ADALIMUMAB", "HYDROCORTISONE", "CERTOLIZUMAB PEGOL", "MYCOPHENOLATE MOFETIL", "KEVZARA", "RINVOQ 15 MG", "CELECOXIB", "IBUPROFEN", "INFLIXIMAB", "TOFACITINIB", "ANAKINRA", "RITUXIMAB", "ARAVA 20 MG FILM-COATED TABLETS", "ARAVA 10 MG FILM-COATED TABLETS", "REMICADE", "GOLIMUMAB", "TACROLIMUS", "ROACTEMRA", "HUMIRA 40 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN", "MABTHERA", "ARAVA", "ETANERCEPT", "METHOTREXATE", "TOCILIZUMAB", "RIXATHON", "ROACTEMRA 162 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "ROACTEMRA 20 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION", "HUMIRA 40 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "XELJANZ 5 MG", "CICLOSPORIN", "SIMPONI 50 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN", "XELJANZ 5 MG FILM-COATED TABLETS", "SIMPONI", "ENBREL", "CELLCEPT", "AZATHIOPRINE", "HUMIRA", "LEFLUNOMIDE", "RINVOQ", "ORENCIA", "ROACTEMRA 162 MG", "XELJANZ", "OLUMIANT", "CIMZIA", "ARAVA 10 MG", "UPADACITINIB", "CIMZIA 200 MG SOLUTION FOR INJECTION", "ENBREL SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE", "ERELZI", "INFLECTRA"], "FATAL": [1691, 26023, 90058, 73, 279, 77, 105, 30, 191, 18, 103, 40, 1173, 1018, 44, 18, 130, 31, 8, 892, 5, 30, 10838, 47, 570, 73, 11, 24, 34, 21, 27, 75, 4, 6, 675, 1223, 6, 20, 216, 54, 194, 19, 2, 884, 2, 473, 1, 3, 2, 2, 5, 2], "PATHOLOGY": "rheumatoid arthritis", "RECOVERED": [49, 462, 1164, 22, 118, 2, 30, 24, 112, 16, 107, 64, 2517, 715, 228, 97, 493, 155, 35, 5124, 33, 169, 9185, 146, 1987, 543, 136, 238, 411, 189, 171, 524, 32, 90, 3535, 3117, 26, 137, 997, 274, 1872, 132, 56, 8912, 32, 5096, 34, 49, 110, 110, 88, 50]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/902.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/902.json
new file mode 100644
index 00000000000..3c0616f9134
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/902.json
@@ -0,0 +1 @@
+{"CASES": [1823], "DRUG": ["ANAKINRA"], "FATAL": [899], "PATHOLOGY": "rheumatoid arthritis, systemic lupus erythematosus", "RECOVERED": [706]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/903.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/903.json
new file mode 100644
index 00000000000..669b0b1ff87
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/903.json
@@ -0,0 +1 @@
+{"CASES": [1434], "DRUG": ["AVAMYS"], "FATAL": [14], "PATHOLOGY": "rhinitis", "RECOVERED": [357]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/904.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/904.json
new file mode 100644
index 00000000000..eb73ec15161
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/904.json
@@ -0,0 +1 @@
+{"CASES": [813], "DRUG": ["AVAMYS"], "FATAL": [4], "PATHOLOGY": "rhinitis allergic", "RECOVERED": [221]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/905.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/905.json
new file mode 100644
index 00000000000..eaed5983222
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/905.json
@@ -0,0 +1 @@
+{"CASES": [365], "DRUG": ["AVAMYS"], "FATAL": [10], "PATHOLOGY": "rhinorrhoea", "RECOVERED": [53]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/906.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/906.json
new file mode 100644
index 00000000000..6060e76e73f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/906.json
@@ -0,0 +1 @@
+{"CASES": [120, 100], "DRUG": ["RITUXIMAB", "CYTARABINE"], "FATAL": [12, 2], "PATHOLOGY": "richter's syndrome", "RECOVERED": [20, 3]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/907.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/907.json
new file mode 100644
index 00000000000..90322c1f37d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/907.json
@@ -0,0 +1 @@
+{"CASES": [3278], "DRUG": ["ZOSTAVAX"], "FATAL": [43], "PATHOLOGY": "routine health maintenance", "RECOVERED": [90]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/908.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/908.json
new file mode 100644
index 00000000000..021a4e6a09a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/908.json
@@ -0,0 +1 @@
+{"CASES": [111], "DRUG": ["KEYTRUDA"], "FATAL": [7], "PATHOLOGY": "salivary gland cancer", "RECOVERED": [11]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/909.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/909.json
new file mode 100644
index 00000000000..47e5c9fa5f9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/909.json
@@ -0,0 +1 @@
+{"CASES": [148], "DRUG": ["METHOTREXATE"], "FATAL": [19], "PATHOLOGY": "sarcoidosis", "RECOVERED": [6]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/91.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/91.json
new file mode 100644
index 00000000000..f9b532b1987
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/91.json
@@ -0,0 +1 @@
+{"CASES": [336], "DRUG": ["CICLOSPORIN"], "FATAL": [48], "PATHOLOGY": "aplasia pure red cell", "RECOVERED": [73]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/910.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/910.json
new file mode 100644
index 00000000000..25c39cdd8c7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/910.json
@@ -0,0 +1 @@
+{"CASES": [220, 117, 152, 5246, 2056, 121, 165, 170, 1382, 530, 342, 487, 109, 1345, 153, 1721, 310, 516, 521, 652, 352, 407, 489, 362, 464, 216, 167, 176], "DRUG": ["PEMBROLIZUMAB", "YONDELIS 1 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "BEVACIZUMAB", "VOTRIENT", "YONDELIS", "TEMOZOLOMIDE", "TOPOTECAN", "BUSULFAN", "VOTRIENT FILM-COATED TABLETS", "IRINOTECAN", "DOCETAXEL", "TRABECTEDIN", "MELPHALAN", "SUTENT", "OPDIVO", "PAZOPANIB", "METHOTREXATE", "KEYTRUDA", "HALAVEN", "DOXORUBICIN HYDROCHLORIDE", "NEXAVAR", "IBRANCE", "CABOMETYX", "STIVARGA", "CAELYX", "VOTRIENT 400 MG FILM-COATED TABLETS", "MEKINIST", "IPILIMUMAB"], "FATAL": [129, 39, 34, 907, 352, 19, 25, 21, 156, 57, 35, 49, 10, 109, 12, 128, 22, 33, 32, 36, 18, 19, 19, 8, 9, 4, 2, 2], "PATHOLOGY": "sarcoma", "RECOVERED": [16, 29, 36, 757, 500, 21, 11, 29, 269, 52, 32, 97, 31, 186, 13, 187, 121, 57, 202, 206, 24, 30, 59, 26, 130, 82, 9, 43]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/911.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/911.json
new file mode 100644
index 00000000000..df18b0a9aae
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/911.json
@@ -0,0 +1 @@
+{"CASES": [388, 123, 241, 366, 146, 116, 534, 116], "DRUG": ["YONDELIS", "TRABECTEDIN", "SUTENT", "PAZOPANIB", "VOTRIENT FILM-COATED TABLETS", "CABOMETYX", "VOTRIENT", "STIVARGA"], "FATAL": [57, 15, 29, 40, 10, 7, 32, 2], "PATHOLOGY": "sarcoma metastatic", "RECOVERED": [99, 23, 20, 26, 20, 16, 136, 4]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/912.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/912.json
new file mode 100644
index 00000000000..ba2c1c88f03
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/912.json
@@ -0,0 +1 @@
+{"CASES": [261, 249, 438], "DRUG": ["REGADENOSON", "RAPISCAN 400 MICROGRAM SOLUTION FOR INJECTION", "RAPISCAN"], "FATAL": [6, 4, 4], "PATHOLOGY": "scan", "RECOVERED": [123, 210, 354]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/913.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/913.json
new file mode 100644
index 00000000000..66e3185406a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/913.json
@@ -0,0 +1 @@
+{"CASES": [253, 243, 412], "DRUG": ["REGADENOSON", "RAPISCAN 400 MICROGRAM SOLUTION FOR INJECTION", "RAPISCAN"], "FATAL": [6, 4, 4], "PATHOLOGY": "scan myocardial perfusion", "RECOVERED": [121, 206, 348]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/914.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/914.json
new file mode 100644
index 00000000000..722156c43dc
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/914.json
@@ -0,0 +1 @@
+{"CASES": [134], "DRUG": ["VORICONAZOLE"], "FATAL": [44], "PATHOLOGY": "scedosporium infection", "RECOVERED": [31]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/915.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/915.json
new file mode 100644
index 00000000000..fd19bf8a8fb
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/915.json
@@ -0,0 +1 @@
+{"CASES": [179, 273, 109, 1343, 2440, 1395, 766, 805, 647, 421], "DRUG": ["RISPERIDONE", "ZYPREXA COATED TABLETS", "INVEGA", "OLANZAPINE", "ZYPREXA", "ARIPIPRAZOLE", "LATUDA", "ABILIFY MAINTENA", "ABILIFY", "ZYPADHERA"], "FATAL": [9, 13, 5, 45, 58, 32, 10, 7, 5, 1], "PATHOLOGY": "schizoaffective disorder", "RECOVERED": [31, 27, 11, 409, 540, 157, 133, 40, 205, 277]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/916.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/916.json
new file mode 100644
index 00000000000..5851eb5bf29
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/916.json
@@ -0,0 +1 @@
+{"CASES": [12316, 533, 538, 202, 754, 251, 235, 964, 9591, 3887, 398, 14301, 464, 177, 2719, 4476, 8300, 538, 739], "DRUG": ["ARIPIPRAZOLE", "RISPERIDONE", "XEPLION", "ZYPREXA 10 MG", "INVEGA", "LOXAPINE", "PALIPERIDONE", "ZYPREXA COATED TABLETS", "OLANZAPINE", "ABILIFY MAINTENA", "ZYPREXA VELOTAB", "ZYPREXA", "SYCREST", "ABILIFY TABLETS", "LATUDA", "ZYPADHERA", "ABILIFY", "REAGILA", "ZYPADHERA 405 MG"], "FATAL": [2285, 98, 67, 25, 66, 21, 13, 53, 396, 158, 16, 543, 16, 6, 58, 83, 125, 4, 3], "PATHOLOGY": "schizophrenia", "RECOVERED": [966, 158, 170, 57, 121, 8, 62, 239, 3230, 81, 134, 3932, 137, 59, 661, 2958, 684, 170, 369]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/917.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/917.json
new file mode 100644
index 00000000000..39bf409fed1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/917.json
@@ -0,0 +1 @@
+{"CASES": [158], "DRUG": ["LYRICA"], "FATAL": [3], "PATHOLOGY": "sciatica", "RECOVERED": [48]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/918.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/918.json
new file mode 100644
index 00000000000..982e474f49f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/918.json
@@ -0,0 +1 @@
+{"CASES": [134, 618, 124, 330, 151, 227], "DRUG": ["OPSUMIT", "TRACLEER", "ROACTEMRA", "CELLCEPT", "BOSENTAN", "OFEV"], "FATAL": [34, 93, 14, 24, 3, 4], "PATHOLOGY": "scleroderma", "RECOVERED": [24, 214, 24, 47, 18, 35]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/919.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/919.json
new file mode 100644
index 00000000000..35ad877ebb4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/919.json
@@ -0,0 +1 @@
+{"CASES": [385], "DRUG": ["TRACLEER"], "FATAL": [46], "PATHOLOGY": "scleroderma associated digital ulcer", "RECOVERED": [142]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/92.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/92.json
new file mode 100644
index 00000000000..6d42812898a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/92.json
@@ -0,0 +1 @@
+{"CASES": [167, 3379, 1431, 102, 188, 542, 240], "DRUG": ["BUSULFAN", "CICLOSPORIN", "EXJADE", "FILGRASTIM", "REVOLADE", "REVOLADE FILM-COATED TABLETS", "ELTROMBOPAG"], "FATAL": [67, 583, 242, 11, 18, 42, 7], "PATHOLOGY": "aplastic anaemia", "RECOVERED": [9, 627, 206, 38, 19, 128, 34]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/920.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/920.json
new file mode 100644
index 00000000000..340e8caf4fd
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/920.json
@@ -0,0 +1 @@
+{"CASES": [289, 476, 100, 347], "DRUG": ["HIZENTRA", "PRIVIGEN", "KIOVIG", "HUMAN NORMAL IMMUNOGLOBULIN"], "FATAL": [16, 20, 1, 2], "PATHOLOGY": "secondary immunodeficiency", "RECOVERED": [61, 323, 79, 74]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/921.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/921.json
new file mode 100644
index 00000000000..7569fe81795
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/921.json
@@ -0,0 +1 @@
+{"CASES": [115, 202, 102, 267], "DRUG": ["GILENYA", "FAMPYRA", "MAVENCLAD", "BETAFERON"], "FATAL": [24, 24, 2, 2], "PATHOLOGY": "secondary progressive multiple sclerosis", "RECOVERED": [24, 62, 6, 62]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/922.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/922.json
new file mode 100644
index 00000000000..ea73de7382f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/922.json
@@ -0,0 +1 @@
+{"CASES": [1714, 400, 347, 2326, 203], "DRUG": ["FENTANYL", "DEXMEDETOMIDINE", "DEXDOR", "MIDAZOLAM", "FENTANYL CITRATE"], "FATAL": [157, 32, 17, 107, 2], "PATHOLOGY": "sedation", "RECOVERED": [601, 201, 243, 1183, 97]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/923.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/923.json
new file mode 100644
index 00000000000..d15d21b6635
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/923.json
@@ -0,0 +1 @@
+{"CASES": [425, 780, 555], "DRUG": ["DEXMEDETOMIDINE", "MIDAZOLAM", "FENTANYL"], "FATAL": [81, 120, 24], "PATHOLOGY": "sedative therapy", "RECOVERED": [174, 307, 343]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/924.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/924.json
new file mode 100644
index 00000000000..898e2b28efb
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/924.json
@@ -0,0 +1 @@
+{"CASES": [1562, 120, 122, 1359, 279, 24882, 13446, 211, 381, 4378, 381, 139, 4963, 229, 1999], "DRUG": ["MIDAZOLAM", "ESLICARBAZEPINE ACETATE", "DEXAMETHASONE", "FYCOMPA", "ZONISAMIDE", "KEPPRA", "LEVETIRACETAM", "LYRICA", "VIGABATRIN", "LACOSAMIDE", "KEPPRA 500 MG FILM-COATED TABLETS", "PREGABALIN", "VIMPAT", "PERAMPANEL", "BRIVIACT"], "FATAL": [363, 20, 11, 96, 15, 1020, 525, 8, 13, 142, 12, 3, 100, 3, 7], "PATHOLOGY": "seizure", "RECOVERED": [296, 10, 3, 494, 98, 5932, 3644, 55, 96, 1070, 159, 46, 1275, 123, 247]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/925.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/925.json
new file mode 100644
index 00000000000..66a060733bb
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/925.json
@@ -0,0 +1 @@
+{"CASES": [444, 139, 700], "DRUG": ["LEVETIRACETAM", "VIMPAT", "KEPPRA"], "FATAL": [73, 7, 12], "PATHOLOGY": "seizure prophylaxis", "RECOVERED": [139, 27, 241]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/926.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/926.json
new file mode 100644
index 00000000000..b48d885d123
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/926.json
@@ -0,0 +1 @@
+{"CASES": [156, 486], "DRUG": ["PRIVIGEN", "HIZENTRA"], "FATAL": [2, 6], "PATHOLOGY": "selective igg subclass deficiency", "RECOVERED": [73, 113]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/927.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/927.json
new file mode 100644
index 00000000000..7b09c4312ab
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/927.json
@@ -0,0 +1 @@
+{"CASES": [497, 101, 289, 127, 168, 122, 147], "DRUG": ["CUBICIN", "MYCAMINE", "LEVOFLOXACIN", "XIGRIS", "AMIKACIN", "CANCIDAS", "VFEND"], "FATAL": [123, 21, 43, 18, 21, 12, 11], "PATHOLOGY": "sepsis", "RECOVERED": [149, 12, 82, 20, 62, 34, 39]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/928.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/928.json
new file mode 100644
index 00000000000..a95f6597f06
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/928.json
@@ -0,0 +1 @@
+{"CASES": [707], "DRUG": ["EXJADE"], "FATAL": [51], "PATHOLOGY": "serum ferritin increased", "RECOVERED": [108]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/929.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/929.json
new file mode 100644
index 00000000000..3609dbbb612
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/929.json
@@ -0,0 +1 @@
+{"CASES": [146], "DRUG": ["EPIDYOLEX"], "FATAL": [3], "PATHOLOGY": "severe myoclonic epilepsy of infancy", "RECOVERED": [35]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/93.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/93.json
new file mode 100644
index 00000000000..503e7414640
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/93.json
@@ -0,0 +1 @@
+{"CASES": [107], "DRUG": ["LONSURF"], "FATAL": [19], "PATHOLOGY": "appendix cancer", "RECOVERED": [6]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/930.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/930.json
new file mode 100644
index 00000000000..a72f9779544
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/930.json
@@ -0,0 +1 @@
+{"CASES": [719], "DRUG": ["VIAGRA"], "FATAL": [4], "PATHOLOGY": "sexual dysfunction", "RECOVERED": [140]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/931.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/931.json
new file mode 100644
index 00000000000..da90004b794
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/931.json
@@ -0,0 +1 @@
+{"CASES": [272], "DRUG": ["SOMATROPIN"], "FATAL": [2], "PATHOLOGY": "short stature", "RECOVERED": [87]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/932.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/932.json
new file mode 100644
index 00000000000..09db01c1651
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/932.json
@@ -0,0 +1 @@
+{"CASES": [725, 791], "DRUG": ["REVESTIVE", "TEDUGLUTIDE"], "FATAL": [26, 3], "PATHOLOGY": "short-bowel syndrome", "RECOVERED": [165, 35]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/933.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/933.json
new file mode 100644
index 00000000000..5ca96bcceb3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/933.json
@@ -0,0 +1 @@
+{"CASES": [991], "DRUG": ["EXJADE"], "FATAL": [100], "PATHOLOGY": "sickle cell anaemia", "RECOVERED": [175]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/934.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/934.json
new file mode 100644
index 00000000000..99c5cf256bf
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/934.json
@@ -0,0 +1 @@
+{"CASES": [1744], "DRUG": ["EXJADE"], "FATAL": [97], "PATHOLOGY": "sickle cell disease", "RECOVERED": [214]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/935.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/935.json
new file mode 100644
index 00000000000..fb216ba9ca1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/935.json
@@ -0,0 +1 @@
+{"CASES": [132, 152, 972, 213, 760], "DRUG": ["VFEND", "DUPIXENT", "LEVOFLOXACIN", "NUCALA", "AVAMYS"], "FATAL": [6, 1, 6, 1, 2], "PATHOLOGY": "sinusitis", "RECOVERED": [41, 55, 276, 52, 155]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/936.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/936.json
new file mode 100644
index 00000000000..62983e3d94c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/936.json
@@ -0,0 +1 @@
+{"CASES": [119], "DRUG": ["MEKINIST"], "FATAL": [16], "PATHOLOGY": "skin cancer", "RECOVERED": [4]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/937.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/937.json
new file mode 100644
index 00000000000..a9739276213
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/937.json
@@ -0,0 +1 @@
+{"CASES": [930], "DRUG": ["TRACLEER"], "FATAL": [100], "PATHOLOGY": "skin ulcer", "RECOVERED": [217]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/938.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/938.json
new file mode 100644
index 00000000000..c94d42eae5d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/938.json
@@ -0,0 +1 @@
+{"CASES": [528], "DRUG": ["MELATONIN"], "FATAL": [488], "PATHOLOGY": "sleep disorder therapy", "RECOVERED": [11]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/939.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/939.json
new file mode 100644
index 00000000000..36a31dce944
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/939.json
@@ -0,0 +1 @@
+{"CASES": [993, 383, 519, 3439, 924, 188, 131, 388, 483, 414, 1575, 702, 291, 6435, 155, 200, 16059, 7789, 304, 179, 1622, 902, 470, 999, 9252, 966, 9177, 195, 154, 129, 138, 140, 106, 2999, 140, 352, 115, 209], "DRUG": ["ATEZOLIZUMAB", "TOPOTECAN", "ABRAXANE", "XALKORI", "HYCAMTIN", "PEMETREXED DISODIUM", "TARCEVA", "BEVACIZUMAB", "IMFINZI", "PACLITAXEL", "PEMETREXED", "DOCETAXEL", "AVASTIN", "IRESSA", "ALECTINIB", "LUMYKRAS", "KEYTRUDA", "ALIMTA", "CRIZOTINIB", "DABRAFENIB", "MEKINIST", "OSIMERTINIB", "SOTORASIB", "IPILIMUMAB", "OPDIVO", "GEFITINIB", "TAGRISSO", "TAXOTERE", "NIVOLUMAB", "SUTENT", "GIOTRIF", "XALKORI 250 MG", "TAGRISSO 80 MG FILM-COATED TABLETS", "PEMBROLIZUMAB", "ALECENSA", "ERLOTINIB", "TOPOTECAN HYDROCHLORIDE", "GAVRETO"], "FATAL": [206, 68, 75, 485, 121, 23, 16, 43, 53, 44, 164, 71, 29, 635, 15, 19, 1526, 677, 26, 15, 126, 70, 34, 72, 665, 69, 642, 13, 10, 8, 8, 7, 5, 129, 6, 14, 4, 4], "PATHOLOGY": "small cell lung cancer", "RECOVERED": [270, 142, 158, 577, 244, 65, 22, 38, 76, 83, 396, 105, 72, 949, 13, 19, 3357, 1663, 99, 17, 336, 131, 92, 122, 1512, 83, 1664, 81, 29, 26, 36, 63, 40, 497, 69, 29, 55, 26]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/94.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/94.json
new file mode 100644
index 00000000000..7fbcacc085c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/94.json
@@ -0,0 +1 @@
+{"CASES": [240, 469, 256, 105, 636], "DRUG": ["PRADAXA", "ELIQUIS", "LIXIANA", "ELIQUIS 5 MG FILM-COATED TABLETS", "MULTAQ"], "FATAL": [35, 27, 12, 2, 10], "PATHOLOGY": "arrhythmia", "RECOVERED": [24, 96, 36, 32, 201]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/940.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/940.json
new file mode 100644
index 00000000000..95e26058c28
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/940.json
@@ -0,0 +1 @@
+{"CASES": [104], "DRUG": ["SUTENT"], "FATAL": [4], "PATHOLOGY": "small intestine carcinoma", "RECOVERED": [8]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/941.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/941.json
new file mode 100644
index 00000000000..c5c0543ec3d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/941.json
@@ -0,0 +1 @@
+{"CASES": [49204, 182, 590, 491, 1085, 973, 1153], "DRUG": ["CHAMPIX", "CHAMPIX 0.5 MG", "CHAMPIX 0.5 MG FILM-COATED TABLETS", "VARENICLINE TARTRATE", "CHAMPIX FILM-COATED TABLETS", "VARENICLINE", "CHAMPIX 1 MG FILM-COATED TABLETS"], "FATAL": [593, 2, 6, 4, 6, 2, 2], "PATHOLOGY": "smoking cessation therapy", "RECOVERED": [20499, 96, 223, 149, 396, 206, 461]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/942.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/942.json
new file mode 100644
index 00000000000..54965b308bd
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/942.json
@@ -0,0 +1 @@
+{"CASES": [1740, 425, 134, 320, 264, 119, 116, 136], "DRUG": ["VOTRIENT", "VOTRIENT FILM-COATED TABLETS", "YONDELIS", "SUTENT", "PAZOPANIB", "HALAVEN", "IBRANCE", "MEKINIST"], "FATAL": [351, 72, 21, 22, 17, 4, 3, 2], "PATHOLOGY": "soft tissue sarcoma", "RECOVERED": [204, 104, 29, 14, 41, 57, 7, 9]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/943.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/943.json
new file mode 100644
index 00000000000..204cdb52d06
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/943.json
@@ -0,0 +1 @@
+{"CASES": [165, 298, 1308, 727], "DRUG": ["FENTANYL CITRATE", "SUFENTANIL", "BUPIVACAINE", "FENTANYL"], "FATAL": [20, 9, 18, 5], "PATHOLOGY": "spinal anaesthesia", "RECOVERED": [56, 162, 475, 304]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/944.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/944.json
new file mode 100644
index 00000000000..007d407b9d3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/944.json
@@ -0,0 +1 @@
+{"CASES": [242], "DRUG": ["FORSTEO"], "FATAL": [2], "PATHOLOGY": "spinal compression fracture", "RECOVERED": [28]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/945.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/945.json
new file mode 100644
index 00000000000..bade7cb2cf2
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/945.json
@@ -0,0 +1 @@
+{"CASES": [216, 12204], "DRUG": ["NUSINERSEN", "SPINRAZA"], "FATAL": [25, 956], "PATHOLOGY": "spinal muscular atrophy", "RECOVERED": [76, 3090]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/946.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/946.json
new file mode 100644
index 00000000000..0acc1fbf826
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/946.json
@@ -0,0 +1 @@
+{"CASES": [134], "DRUG": ["CIMZIA"], "FATAL": [1], "PATHOLOGY": "spinal osteoarthritis", "RECOVERED": [5]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/947.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/947.json
new file mode 100644
index 00000000000..1e1a1658c04
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/947.json
@@ -0,0 +1 @@
+{"CASES": [210], "DRUG": ["JAKAVI"], "FATAL": [8], "PATHOLOGY": "splenomegaly", "RECOVERED": [32]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/948.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/948.json
new file mode 100644
index 00000000000..5ae8d449e92
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/948.json
@@ -0,0 +1 @@
+{"CASES": [181, 149, 10680, 1184, 116, 300, 14158, 353, 1220, 5324, 1332], "DRUG": ["METHOTREXATE", "RINVOQ 15 MG PROLONGED-RELEASE TABLETS", "SIMPONI", "RINVOQ", "GOLIMUMAB", "STELARA", "COSENTYX", "REMICADE", "HUMIRA", "CIMZIA", "ENBREL"], "FATAL": [12, 8, 135, 12, 1, 2, 94, 2, 4, 15, 1], "PATHOLOGY": "spondylitis", "RECOVERED": [18, 50, 1575, 210, 29, 56, 1595, 88, 205, 704, 153]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/949.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/949.json
new file mode 100644
index 00000000000..b0b16c5d07b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/949.json
@@ -0,0 +1 @@
+{"CASES": [150, 430, 220, 1061, 274, 262, 477, 5673, 1390, 238, 410, 177, 132, 169], "DRUG": ["TAXOTERE", "IRESSA", "CETUXIMAB", "LIBTAYO", "ABRAXANE", "OPDIVO", "DOCETAXEL", "KEYTRUDA", "PEMBROLIZUMAB", "ERBITUX", "PACLITAXEL", "IPILIMUMAB", "CAPECITABINE", "ERBITUX 5 MG/ML"], "FATAL": [47, 115, 52, 156, 38, 28, 49, 509, 116, 16, 22, 6, 3, 2], "PATHOLOGY": "squamous cell carcinoma", "RECOVERED": [43, 75, 47, 191, 60, 17, 121, 1237, 222, 97, 106, 33, 14, 73]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/95.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/95.json
new file mode 100644
index 00000000000..f58564d8232
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/95.json
@@ -0,0 +1 @@
+{"CASES": [116], "DRUG": ["PLAVIX"], "FATAL": [10], "PATHOLOGY": "arterial disorder", "RECOVERED": [54]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/950.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/950.json
new file mode 100644
index 00000000000..fa5d4ee9e36
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/950.json
@@ -0,0 +1 @@
+{"CASES": [343, 235, 169], "DRUG": ["KEYTRUDA", "PEMBROLIZUMAB", "ERBITUX 5 MG/ML"], "FATAL": [26, 10, 2], "PATHOLOGY": "squamous cell carcinoma of head and neck", "RECOVERED": [37, 38, 73]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/951.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/951.json
new file mode 100644
index 00000000000..f5d49161ade
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/951.json
@@ -0,0 +1 @@
+{"CASES": [265, 1843, 214, 100, 123], "DRUG": ["IRESSA", "KEYTRUDA", "PEMBROLIZUMAB", "ABRAXANE", "OPDIVO"], "FATAL": [73, 169, 19, 7, 8], "PATHOLOGY": "squamous cell carcinoma of lung", "RECOVERED": [54, 495, 23, 26, 9]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/952.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/952.json
new file mode 100644
index 00000000000..07606eb91a0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/952.json
@@ -0,0 +1 @@
+{"CASES": [446, 109], "DRUG": ["LIBTAYO", "KEYTRUDA"], "FATAL": [69, 3], "PATHOLOGY": "squamous cell carcinoma of skin", "RECOVERED": [75, 19]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/953.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/953.json
new file mode 100644
index 00000000000..f0af47f285d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/953.json
@@ -0,0 +1 @@
+{"CASES": [150], "DRUG": ["KEYTRUDA"], "FATAL": [13], "PATHOLOGY": "squamous cell carcinoma of the cervix", "RECOVERED": [31]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/954.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/954.json
new file mode 100644
index 00000000000..3f560eaa705
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/954.json
@@ -0,0 +1 @@
+{"CASES": [441], "DRUG": ["CUBICIN"], "FATAL": [54], "PATHOLOGY": "staphylococcal bacteraemia", "RECOVERED": [85]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/955.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/955.json
new file mode 100644
index 00000000000..a43d3dbaf01
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/955.json
@@ -0,0 +1 @@
+{"CASES": [309, 150, 970, 156], "DRUG": ["DAPTOMYCIN", "CUBICIN 350 MG", "CUBICIN", "LEVOFLOXACIN"], "FATAL": [54, 20, 103, 10], "PATHOLOGY": "staphylococcal infection", "RECOVERED": [61, 48, 229, 46]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/956.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/956.json
new file mode 100644
index 00000000000..93719f8065b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/956.json
@@ -0,0 +1 @@
+{"CASES": [166], "DRUG": ["CUBICIN"], "FATAL": [42], "PATHOLOGY": "staphylococcal sepsis", "RECOVERED": [44]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/957.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/957.json
new file mode 100644
index 00000000000..4c723d876b2
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/957.json
@@ -0,0 +1 @@
+{"CASES": [625, 361, 972, 210, 1712, 110, 2618, 535], "DRUG": ["DEXAMETHASONE", "MIDAZOLAM", "KEPPRA", "VIMPAT", "LACOSAMIDE", "BRIVIACT", "LEVETIRACETAM", "BRIVARACETAM"], "FATAL": [422, 97, 219, 41, 109, 7, 144, 7], "PATHOLOGY": "status epilepticus", "RECOVERED": [55, 77, 184, 45, 219, 4, 423, 94]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/958.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/958.json
new file mode 100644
index 00000000000..5035f638aa4
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/958.json
@@ -0,0 +1 @@
+{"CASES": [280, 6015, 156, 1833, 6552, 582, 555, 175, 143, 707, 170], "DRUG": ["CELLCEPT", "CICLOSPORIN", "FILGRASTIM", "ALEMTUZUMAB", "BUSULFAN", "BUSILVEX", "MELPHALAN", "CYTARABINE", "METHOTREXATE", "THIOTEPA", "CARMUSTINE"], "FATAL": [61, 1246, 26, 284, 978, 84, 59, 18, 12, 51, 10], "PATHOLOGY": "stem cell transplant", "RECOVERED": [49, 1664, 8, 527, 1569, 131, 107, 39, 46, 256, 49]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/959.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/959.json
new file mode 100644
index 00000000000..e0ed28b437c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/959.json
@@ -0,0 +1 @@
+{"CASES": [533, 357, 131, 1324, 5302, 289], "DRUG": ["CLOPIDOGREL", "EFIENT", "BRILIQUE 90 MG FILM-COATED TABLETS", "BRILIQUE", "PLAVIX", "CLOPIDOGREL HYDROGEN SULFATE"], "FATAL": [47, 24, 8, 72, 257, 8], "PATHOLOGY": "stent placement", "RECOVERED": [174, 109, 72, 185, 966, 81]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/96.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/96.json
new file mode 100644
index 00000000000..a1c816aabae
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/96.json
@@ -0,0 +1 @@
+{"CASES": [1133, 305], "DRUG": ["PLAVIX", "CLOPIDOGREL"], "FATAL": [81, 15], "PATHOLOGY": "arterial occlusive disease", "RECOVERED": [258, 181]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/960.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/960.json
new file mode 100644
index 00000000000..ea9e65af75e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/960.json
@@ -0,0 +1 @@
+{"CASES": [161, 118, 574, 276, 196, 894, 1123], "DRUG": ["METHOTREXATE", "KINERET", "ANAKINRA", "CICLOSPORIN", "ADALIMUMAB", "ROACTEMRA", "ILARIS"], "FATAL": [11, 8, 24, 11, 2, 8, 1], "PATHOLOGY": "still's disease", "RECOVERED": [56, 7, 83, 72, 30, 351, 372]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/961.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/961.json
new file mode 100644
index 00000000000..a88e3fbc37e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/961.json
@@ -0,0 +1 @@
+{"CASES": [221, 198, 177], "DRUG": ["ZYPREXA", "RAPISCAN", "CYMBALTA"], "FATAL": [9, 8, 4], "PATHOLOGY": "stress", "RECOVERED": [38, 138, 55]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/962.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/962.json
new file mode 100644
index 00000000000..b0cdeae5ada
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/962.json
@@ -0,0 +1 @@
+{"CASES": [182], "DRUG": ["SUBSTANCE PSYCHOACTIVE"], "FATAL": [3], "PATHOLOGY": "substance abuse", "RECOVERED": [68]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/963.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/963.json
new file mode 100644
index 00000000000..cce08df7bfb
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/963.json
@@ -0,0 +1 @@
+{"CASES": [120, 934, 123, 115, 122, 245, 409, 242], "DRUG": ["LACOSAMIDE", "IBUPROFEN", "PREGABALIN", "KEPPRA", "INSULIN GLARGINE", "PROPRANOLOL HYDROCHLORIDE", "OLANZAPINE", "LANTUS"], "FATAL": [48, 312, 36, 27, 20, 36, 55, 12], "PATHOLOGY": "suicide attempt", "RECOVERED": [17, 220, 29, 10, 46, 123, 142, 143]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/964.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/964.json
new file mode 100644
index 00000000000..a5700e4e575
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/964.json
@@ -0,0 +1 @@
+{"CASES": [124, 597], "DRUG": ["EMEND", "DEXAMETHASONE"], "FATAL": [21, 18], "PATHOLOGY": "supportive care", "RECOVERED": [78, 349]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/965.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/965.json
new file mode 100644
index 00000000000..dead1fb4a18
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/965.json
@@ -0,0 +1 @@
+{"CASES": [193, 241, 278, 123, 177, 721], "DRUG": ["CICLOSPORIN", "FENTANYL", "DEXAMETHASONE", "PLAVIX", "BRIDION", "BUPIVACAINE"], "FATAL": [39, 30, 15, 4, 2, 3], "PATHOLOGY": "surgery", "RECOVERED": [86, 98, 117, 26, 70, 94]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/966.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/966.json
new file mode 100644
index 00000000000..7bfb72d241b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/966.json
@@ -0,0 +1 @@
+{"CASES": [378], "DRUG": ["BUSULFAN"], "FATAL": [8], "PATHOLOGY": "surgical preconditioning", "RECOVERED": [45]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/967.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/967.json
new file mode 100644
index 00000000000..6129f8ff5df
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/967.json
@@ -0,0 +1 @@
+{"CASES": [187, 322], "DRUG": ["YONDELIS", "VOTRIENT"], "FATAL": [37, 4], "PATHOLOGY": "synovial sarcoma", "RECOVERED": [41, 50]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/968.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/968.json
new file mode 100644
index 00000000000..8ae0b5e428a
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/968.json
@@ -0,0 +1 @@
+{"CASES": [238, 139], "DRUG": ["CANCIDAS 50 MG POWDER FOR SOLUTION FOR INFUSION", "CANCIDAS"], "FATAL": [92, 43], "PATHOLOGY": "systemic candida", "RECOVERED": [86, 22]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/969.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/969.json
new file mode 100644
index 00000000000..7c609167265
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/969.json
@@ -0,0 +1 @@
+{"CASES": [1823, 565, 671, 238, 4479, 1402, 579, 611, 21167, 2942], "DRUG": ["ANAKINRA", "CICLOSPORIN", "AZATHIOPRINE", "MYCOPHENOLATE MOFETIL", "BENLYSTA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "CELLCEPT", "BENLYSTA 400 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION", "BENLYSTA SOLUTION FOR INJECTION IN PRE-FILLED PEN", "BENLYSTA", "BELIMUMAB"], "FATAL": [899, 71, 35, 11, 172, 42, 9, 8, 259, 33], "PATHOLOGY": "systemic lupus erythematosus", "RECOVERED": [706, 153, 129, 35, 710, 279, 161, 78, 5224, 1122]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/97.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/97.json
new file mode 100644
index 00000000000..9cc4a5eaa36
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/97.json
@@ -0,0 +1 @@
+{"CASES": [127, 506, 518], "DRUG": ["CLOPIDOGREL", "PLAVIX", "CLOPIDOGREL HYDROGEN SULFATE"], "FATAL": [8, 20, 1], "PATHOLOGY": "arteriosclerosis", "RECOVERED": [39, 162, 84]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/970.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/970.json
new file mode 100644
index 00000000000..d3a379c82b7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/970.json
@@ -0,0 +1 @@
+{"CASES": [197, 249, 144], "DRUG": ["RYDAPT", "MIDOSTAURIN", "AYVAKYT"], "FATAL": [16, 17, 7], "PATHOLOGY": "systemic mastocytosis", "RECOVERED": [23, 26, 12]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/971.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/971.json
new file mode 100644
index 00000000000..ddbbadbf261
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/971.json
@@ -0,0 +1 @@
+{"CASES": [148], "DRUG": ["VFEND"], "FATAL": [14], "PATHOLOGY": "systemic mycosis", "RECOVERED": [60]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/972.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/972.json
new file mode 100644
index 00000000000..5741619aa3d
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/972.json
@@ -0,0 +1 @@
+{"CASES": [118, 125, 135, 119, 170], "DRUG": ["OPSUMIT", "TRACLEER", "CELLCEPT", "BOSENTAN", "OFEV"], "FATAL": [34, 18, 8, 3, 3], "PATHOLOGY": "systemic scleroderma", "RECOVERED": [12, 34, 23, 13, 23]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/973.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/973.json
new file mode 100644
index 00000000000..04dea908866
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/973.json
@@ -0,0 +1 @@
+{"CASES": [282, 108, 317, 118, 259, 117, 132, 467, 256, 164, 1270, 145, 116], "DRUG": ["ALEMTUZUMAB", "CICLOSPORIN", "DEXAMETHASONE", "CARMUSTINE", "ASPARAGINASE", "METHOTREXATE", "MOGAMULIZUMAB", "CYTARABINE", "DOXORUBICIN HYDROCHLORIDE", "CAELYX", "POTELIGEO", "PEGASYS", "ADCETRIS"], "FATAL": [81, 28, 69, 25, 52, 17, 19, 67, 26, 14, 108, 6, 4], "PATHOLOGY": "t-cell lymphoma", "RECOVERED": [37, 15, 30, 7, 50, 38, 21, 66, 52, 62, 301, 46, 28]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/974.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/974.json
new file mode 100644
index 00000000000..8d4c16c6e53
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/974.json
@@ -0,0 +1 @@
+{"CASES": [302], "DRUG": ["ALEMTUZUMAB"], "FATAL": [53], "PATHOLOGY": "t-cell prolymphocytic leukaemia", "RECOVERED": [48]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/975.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/975.json
new file mode 100644
index 00000000000..af8e6f02e48
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/975.json
@@ -0,0 +1 @@
+{"CASES": [395, 646, 163, 114, 108], "DRUG": ["CYTARABINE", "ASPARAGINASE", "DEXAMETHASONE", "ONCASPAR", "METHOTREXATE"], "FATAL": [122, 125, 27, 8, 3], "PATHOLOGY": "t-cell type acute leukaemia", "RECOVERED": [71, 145, 40, 70, 44]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/976.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/976.json
new file mode 100644
index 00000000000..c4b0618ea2f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/976.json
@@ -0,0 +1 @@
+{"CASES": [129, 117, 180], "DRUG": ["IVABRADINE", "ELIQUIS", "PROPRANOLOL HYDROCHLORIDE"], "FATAL": [7, 2, 3], "PATHOLOGY": "tachycardia", "RECOVERED": [8, 15, 39]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/977.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/977.json
new file mode 100644
index 00000000000..d0292299304
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/977.json
@@ -0,0 +1 @@
+{"CASES": [100], "DRUG": ["NEXAVAR"], "FATAL": [2], "PATHOLOGY": "targeted cancer therapy", "RECOVERED": [10]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/978.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/978.json
new file mode 100644
index 00000000000..63f5a66c2ca
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/978.json
@@ -0,0 +1 @@
+{"CASES": [485, 115, 176, 644], "DRUG": ["KEPPRA", "FYCOMPA", "VIMPAT", "LEVETIRACETAM"], "FATAL": [26, 3, 4, 8], "PATHOLOGY": "temporal lobe epilepsy", "RECOVERED": [131, 26, 25, 74]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/979.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/979.json
new file mode 100644
index 00000000000..af873c77e3e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/979.json
@@ -0,0 +1 @@
+{"CASES": [2356, 215], "DRUG": ["EXJADE", "REBLOZYL"], "FATAL": [102, 3], "PATHOLOGY": "thalassaemia", "RECOVERED": [551, 31]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/98.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/98.json
new file mode 100644
index 00000000000..1d145fc3b13
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/98.json
@@ -0,0 +1 @@
+{"CASES": [305], "DRUG": ["PLAVIX"], "FATAL": [4], "PATHOLOGY": "arteriosclerosis coronary artery", "RECOVERED": [76]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/980.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/980.json
new file mode 100644
index 00000000000..c4f829499c1
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/980.json
@@ -0,0 +1 @@
+{"CASES": [612, 172], "DRUG": ["EXJADE", "REBLOZYL"], "FATAL": [30, 3], "PATHOLOGY": "thalassaemia beta", "RECOVERED": [154, 18]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/981.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/981.json
new file mode 100644
index 00000000000..ca4350cc647
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/981.json
@@ -0,0 +1 @@
+{"CASES": [245], "DRUG": ["NEXOBRID"], "FATAL": [6], "PATHOLOGY": "thermal burn", "RECOVERED": [55]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/982.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/982.json
new file mode 100644
index 00000000000..393d3165b60
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/982.json
@@ -0,0 +1 @@
+{"CASES": [15543, 219, 352, 317, 1410, 749, 233, 334], "DRUG": ["NPLATE", "DEXAMETHASONE", "HUMAN NORMAL IMMUNOGLOBULIN (IV)", "CICLOSPORIN", "PRIVIGEN", "HUMAN NORMAL IMMUNOGLOBULIN", "ELTROMBOPAG", "REVOLADE"], "FATAL": [1885, 18, 28, 18, 74, 24, 3, 1], "PATHOLOGY": "thrombocytopenia", "RECOVERED": [1467, 31, 69, 52, 780, 177, 64, 40]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/983.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/983.json
new file mode 100644
index 00000000000..25f6b852a84
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/983.json
@@ -0,0 +1 @@
+{"CASES": [1393, 623, 108, 301, 216, 650, 1882, 242, 758, 271, 4282, 720, 902, 15326, 558, 150, 214, 3009, 822, 163, 250, 168, 1100, 156, 127], "DRUG": ["CLOPIDOGREL", "ARIXTRA", "LIXIANA 30 MG", "INTEGRILIN", "PLAVIX 75 MG FILM-COATED TABLETS", "XARELTO 20 MG", "XARELTO", "RIVAROXABAN", "ELIQUIS 5 MG FILM-COATED TABLETS", "INHIXA", "ENOXAPARIN SODIUM", "APIXABAN", "BRILIQUE", "ELIQUIS", "XARELTO 15 MG", "EFIENT", "TICAGRELOR", "PLAVIX", "CLOPIDOGREL HYDROGEN SULFATE", "INHIXA 10,000 IU (100 MG)/1 ML SOLUTION FOR INJECTION", "BRILIQUE 90 MG FILM-COATED TABLETS", "PRADAXA", "LIXIANA", "ELIQUIS 2.5 MG FILM-COATED TABLETS", "LIXIANA 60 MG FILM-COATED TABLETS"], "FATAL": [258, 106, 15, 39, 25, 71, 122, 15, 44, 15, 197, 32, 40, 660, 24, 6, 8, 96, 26, 5, 7, 4, 25, 3, 1], "PATHOLOGY": "thrombosis", "RECOVERED": [473, 179, 28, 30, 117, 105, 412, 84, 243, 82, 1350, 370, 297, 2204, 78, 46, 45, 814, 267, 60, 102, 45, 263, 44, 36]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/984.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/984.json
new file mode 100644
index 00000000000..fcb205dfecc
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/984.json
@@ -0,0 +1 @@
+{"CASES": [1002, 246, 188, 632, 358, 285, 358, 227, 5696, 430, 346, 123, 771, 110, 111, 1962, 2266, 151, 405, 232, 140, 114], "DRUG": ["CLOPIDOGREL", "INTEGRILIN", "PLAVIX 75 MG FILM-COATED TABLETS", "XARELTO", "ARIXTRA", "XARELTO 20 MG", "APIXABAN", "INHIXA", "ELIQUIS", "CLOPIDOGREL HYDROGEN SULFATE", "ELIQUIS 5 MG FILM-COATED TABLETS", "INHIXA 10,000 IU (100 MG)/1 ML SOLUTION FOR INJECTION", "BRILIQUE", "EFIENT", "PRADAXA", "PLAVIX", "ENOXAPARIN SODIUM", "XARELTO 15 MG", "LIXIANA", "BRILIQUE 90 MG FILM-COATED TABLETS", "TICAGRELOR", "ELIQUIS 2.5 MG FILM-COATED TABLETS"], "FATAL": [232, 35, 22, 60, 29, 21, 23, 13, 296, 21, 15, 5, 30, 4, 4, 69, 79, 5, 13, 7, 4, 2], "PATHOLOGY": "thrombosis prophylaxis", "RECOVERED": [331, 22, 107, 187, 123, 51, 152, 75, 1051, 101, 121, 46, 237, 35, 35, 574, 790, 24, 85, 88, 34, 35]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/985.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/985.json
new file mode 100644
index 00000000000..192568ef54b
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/985.json
@@ -0,0 +1 @@
+{"CASES": [227], "DRUG": ["SOLIRIS 300 MG"], "FATAL": [22], "PATHOLOGY": "thrombotic microangiopathy", "RECOVERED": [18]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/986.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/986.json
new file mode 100644
index 00000000000..081afbbedd7
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/986.json
@@ -0,0 +1 @@
+{"CASES": [232], "DRUG": ["SUTENT"], "FATAL": [6], "PATHOLOGY": "thymoma", "RECOVERED": [56]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/987.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/987.json
new file mode 100644
index 00000000000..500b5555828
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/987.json
@@ -0,0 +1 @@
+{"CASES": [857, 350, 118, 891, 188, 263, 3844, 3190, 189, 1912, 612, 414, 459, 143], "DRUG": ["MEKINIST", "VOTRIENT", "VOTRIENT FILM-COATED TABLETS", "SUTENT", "BRAFTOVI", "SORAFENIB", "LENVIMA", "NEXAVAR", "KEYTRUDA", "CAPRELSA", "DABRAFENIB", "VANDETANIB", "CABOMETYX", "GAVRETO"], "FATAL": [97, 38, 12, 80, 16, 19, 264, 180, 10, 86, 27, 16, 8, 2], "PATHOLOGY": "thyroid cancer", "RECOVERED": [101, 54, 6, 158, 6, 23, 1158, 601, 8, 238, 12, 107, 38, 13]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/988.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/988.json
new file mode 100644
index 00000000000..61cd1189929
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/988.json
@@ -0,0 +1 @@
+{"CASES": [103, 334, 134, 416], "DRUG": ["LENVIMA", "SUTENT", "MEKINIST", "NEXAVAR"], "FATAL": [7, 18, 4, 6], "PATHOLOGY": "thyroid cancer metastatic", "RECOVERED": [35, 68, 6, 66]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/989.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/989.json
new file mode 100644
index 00000000000..96d04f8f69e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/989.json
@@ -0,0 +1 @@
+{"CASES": [116, 140, 3117, 305], "DRUG": ["CHAMPIX 0.5 MG FILM-COATED TABLETS", "CHAMPIX FILM-COATED TABLETS", "CHAMPIX", "CHAMPIX 1 MG FILM-COATED TABLETS"], "FATAL": [2, 2, 31, 2], "PATHOLOGY": "tobacco user", "RECOVERED": [93, 44, 1368, 94]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/99.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/99.json
new file mode 100644
index 00000000000..6ce6558cc38
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/99.json
@@ -0,0 +1 @@
+{"CASES": [108, 167, 952, 218, 608], "DRUG": ["PREGABALIN", "CELECOXIB", "IBUPROFEN", "BUPRENORPHINE", "CYMBALTA"], "FATAL": [35, 6, 21, 3, 3], "PATHOLOGY": "arthralgia", "RECOVERED": [12, 47, 361, 55, 94]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/990.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/990.json
new file mode 100644
index 00000000000..0bffd9d6ef3
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/990.json
@@ -0,0 +1 @@
+{"CASES": [181, 398], "DRUG": ["TRACTOCILE", "ATOSIBAN"], "FATAL": [8, 14], "PATHOLOGY": "tocolysis", "RECOVERED": [34, 73]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/991.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/991.json
new file mode 100644
index 00000000000..13070180f43
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/991.json
@@ -0,0 +1 @@
+{"CASES": [150], "DRUG": ["KEYTRUDA"], "FATAL": [14], "PATHOLOGY": "tongue neoplasm malignant stage unspecified", "RECOVERED": [14]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/992.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/992.json
new file mode 100644
index 00000000000..a832bab62ef
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/992.json
@@ -0,0 +1 @@
+{"CASES": [120], "DRUG": ["HYDROCORTISONE"], "FATAL": [10], "PATHOLOGY": "toxic epidermal necrolysis", "RECOVERED": [20]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/993.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/993.json
new file mode 100644
index 00000000000..c9b22571a52
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/993.json
@@ -0,0 +1 @@
+{"CASES": [251], "DRUG": ["NALOXONE"], "FATAL": [158], "PATHOLOGY": "toxicity to various agents", "RECOVERED": [3]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/994.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/994.json
new file mode 100644
index 00000000000..9be3ebcfc2c
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/994.json
@@ -0,0 +1 @@
+{"CASES": [333, 103, 106, 1517, 674], "DRUG": ["CLOPIDOGREL HYDROGEN SULFATE", "PLAVIX 75 MG FILM-COATED TABLETS", "ELIQUIS", "PLAVIX", "CLOPIDOGREL"], "FATAL": [45, 8, 5, 69, 11], "PATHOLOGY": "transient ischaemic attack", "RECOVERED": [52, 60, 21, 355, 196]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/995.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/995.json
new file mode 100644
index 00000000000..cf581d6211e
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/995.json
@@ -0,0 +1 @@
+{"CASES": [344], "DRUG": ["KEYTRUDA"], "FATAL": [34], "PATHOLOGY": "transitional cell cancer of the renal pelvis and ureter", "RECOVERED": [79]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/996.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/996.json
new file mode 100644
index 00000000000..bb738315ba6
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/996.json
@@ -0,0 +1 @@
+{"CASES": [518, 4038, 374, 306, 119, 482, 142, 243], "DRUG": ["BAVENCIO", "KEYTRUDA", "ATEZOLIZUMAB", "AVELUMAB", "PADCEV", "PEMBROLIZUMAB", "METHOTREXATE", "OPDIVO"], "FATAL": [51, 397, 31, 25, 9, 22, 3, 1], "PATHOLOGY": "transitional cell carcinoma", "RECOVERED": [116, 852, 114, 59, 22, 114, 29, 4]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/997.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/997.json
new file mode 100644
index 00000000000..088c3b2288f
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/997.json
@@ -0,0 +1 @@
+{"CASES": [116], "DRUG": ["KEYTRUDA"], "FATAL": [12], "PATHOLOGY": "transitional cell carcinoma metastatic", "RECOVERED": [6]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/998.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/998.json
new file mode 100644
index 00000000000..2b1228674b9
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/998.json
@@ -0,0 +1 @@
+{"CASES": [175, 159, 200, 2214, 225, 28870, 8664, 261, 898, 1828, 455, 1090, 3065, 3098, 382, 101, 1339, 875, 399, 147, 721, 20523, 508, 442, 140, 5537, 215, 878, 187, 416, 120, 185, 546], "DRUG": ["ENVARSUS", "HUMAN NORMAL IMMUNOGLOBULIN", "FILGRASTIM", "AZATHIOPRINE", "SOLIRIS 300 MG", "CICLOSPORIN", "BUSULFAN", "VFEND", "MELPHALAN", "BASILIXIMAB", "SIMULECT", "BUSILVEX", "ALEMTUZUMAB", "MYCOPHENOLATE MOFETIL", "RITUXIMAB", "HUMAN NORMAL IMMUNOGLOBULIN (IV)", "TACROLIMUS", "ADVAGRAF", "METHOTREXATE", "CELLCEPT 250 MG CAPSULES", "CELLCEPT 500 MG TABLETS", "CELLCEPT", "CYTARABINE", "PRIVIGEN", "NOT AVAILABLE", "RAPAMUNE", "CARMUSTINE", "THIOTEPA", "BORTEZOMIB", "EVEROLIMUS", "BELATACEPT", "ARANESP", "DACLIZUMAB"], "FATAL": [70, 54, 56, 581, 39, 4689, 1305, 37, 126, 245, 57, 132, 363, 355, 40, 10, 130, 80, 36, 12, 58, 1541, 38, 33, 9, 347, 13, 51, 9, 15, 4, 3, 4], "PATHOLOGY": "transplant", "RECOVERED": [22, 21, 11, 616, 26, 8689, 1920, 40, 143, 502, 157, 272, 825, 849, 107, 19, 387, 202, 102, 68, 361, 5461, 116, 217, 94, 1003, 63, 330, 38, 69, 44, 24, 14]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/999.json b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/999.json
new file mode 100644
index 00000000000..a2fd57a9fc0
--- /dev/null
+++ b/docs/DrugsForPathologies/data/DrugDescriptionsForPathologies/999.json
@@ -0,0 +1 @@
+{"CASES": [138, 129, 383, 276, 909, 392, 646, 546, 1287, 300, 9917, 2073, 754, 148, 303, 163], "DRUG": ["ENVARSUS", "HUMAN NORMAL IMMUNOGLOBULIN", "AZATHIOPRINE", "ADVAGRAF", "CICLOSPORIN", "TACROLIMUS", "BASILIXIMAB", "BUSULFAN", "MYCOPHENOLATE MOFETIL", "PRIVIGEN", "CELLCEPT", "RAPAMUNE", "ALEMTUZUMAB", "EVEROLIMUS", "CELLCEPT 500 MG TABLETS", "RITUXIMAB"], "FATAL": [66, 48, 81, 57, 158, 62, 96, 61, 142, 31, 733, 122, 32, 3, 5, 2], "PATHOLOGY": "transplant rejection", "RECOVERED": [8, 16, 70, 59, 243, 106, 147, 117, 327, 136, 2443, 374, 113, 23, 157, 78]}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/index.html b/docs/DrugsForPathologies/index.html
index 0058175ddbe..bf2c1eeac5d 100644
--- a/docs/DrugsForPathologies/index.html
+++ b/docs/DrugsForPathologies/index.html
@@ -32,10 +32,19 @@
   <script crossorigin="anonymous"
     integrity="sha512-EFlschXPq/G5zunGPRSYqazR1CMKj0cQc8v6eMrQwybxgIbhsfoO5NAMQX3xFDQIbFlViv53o7Hy+yCWw6iZxA=="
     referrerpolicy="no-referrer" src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.10/vfs_fonts.min.js"></script>
+  <script src="./js/PageInitializer.js"></script>
+  <script src="./js/DrugsChartView.js"></script>
+  <script src="../Select2.js"></script>
   <script>
     document.addEventListener(
       "DOMContentLoaded",
       event => {
+        PageInitializer.initializePage(
+          {
+            pathologySelectElement: $('#pathologySelect'),
+            drugsChartViewElement: document.querySelector("#drugsChartView")
+          }
+        );
       });
   </script>
 </head>
@@ -60,7 +69,7 @@
           </div>
           <div class="clearfix"></div>
           <div class="row">
-            <div class="col-xs-12 col-sm-6">
+            <div class="col">
               <div class="x_panel">
                 <div class="x_title">
                   <h3 id="subheading">Associated Drugs</h3>
@@ -71,16 +80,1051 @@
                     <label>Select Pathology:</label>
                     <select id="pathologySelect" name="pathology">
                       <option disabled="" hidden="" selected="" value="">Select Pathology</option>
+                      <option value="1">abdominal discomfort</option>
+                      <option value="2">abdominal pain</option>
+                      <option value="3">abortion</option>
+                      <option value="4">abortion induced</option>
+                      <option value="5">abscess</option>
+                      <option value="6">accidental exposure to product</option>
+                      <option value="7">accidental exposure to product by child</option>
+                      <option value="8">acinetobacter infection</option>
+                      <option value="9">acquired haemophilia</option>
+                      <option value="10">acquired immunodeficiency syndrome</option>
+                      <option value="11">acquired immunodeficiency syndrome, hiv infection</option>
+                      <option value="12">acromegaly</option>
+                      <option value="13">actinic keratosis</option>
+                      <option value="14">acute coronary syndrome</option>
+                      <option value="15">acute graft versus host disease</option>
+                      <option value="16">acute leukaemia</option>
+                      <option value="17">acute lymphocytic leukaemia</option>
+                      <option value="18">acute lymphocytic leukaemia recurrent</option>
+                      <option value="19">acute lymphocytic leukaemia refractory</option>
+                      <option value="20">acute monocytic leukaemia</option>
+                      <option value="21">acute myeloid leukaemia</option>
+                      <option value="22">acute myeloid leukaemia recurrent</option>
+                      <option value="23">acute myeloid leukaemia refractory</option>
+                      <option value="24">acute myocardial infarction</option>
+                      <option value="25">acute promyelocytic leukaemia</option>
+                      <option value="26">acute psychosis</option>
+                      <option value="27">acute sinusitis</option>
+                      <option value="28">adenocarcinoma</option>
+                      <option value="29">adenocarcinoma gastric</option>
+                      <option value="30">adenocarcinoma of colon</option>
+                      <option value="31">adenocarcinoma pancreas</option>
+                      <option value="32">adenovirus infection</option>
+                      <option value="33">adjuvant therapy</option>
+                      <option value="34">adrenal gland cancer</option>
+                      <option value="35">adrenal insufficiency</option>
+                      <option value="36">adrenocortical carcinoma</option>
+                      <option value="37">adult t-cell lymphoma/leukaemia</option>
+                      <option value="38">advanced systemic mastocytosis</option>
+                      <option value="39">adverse drug reaction</option>
+                      <option value="40">affective disorder</option>
+                      <option value="41">age-related macular degeneration</option>
+                      <option value="42">aggression</option>
+                      <option value="43">agitation</option>
+                      <option value="44">agranulocytosis</option>
+                      <option value="45">alcoholism</option>
+                      <option value="46">allogenic bone marrow transplantation therapy</option>
+                      <option value="47">allogenic stem cell transplantation</option>
+                      <option value="48">allogenic stem cell transplantation, bone marrow conditioning regimen</option>
+                      <option value="49">alopecia</option>
+                      <option value="50">alveolar rhabdomyosarcoma</option>
+                      <option value="51">alveolar soft part sarcoma</option>
+                      <option value="52">amyloidosis</option>
+                      <option value="53">amyotrophic lateral sclerosis</option>
+                      <option value="54">anaemia</option>
+                      <option value="55">anaemia of malignant disease</option>
+                      <option value="56">anaesthesia</option>
+                      <option value="57">anaesthesia procedure</option>
+                      <option value="58">analgesic therapy</option>
+                      <option value="59">anaplastic large cell lymphoma t- and null-cell types</option>
+                      <option value="60">anaplastic thyroid cancer</option>
+                      <option value="61">androgen replacement therapy</option>
+                      <option value="62">anger</option>
+                      <option value="63">angina pectoris</option>
+                      <option value="64">angina unstable</option>
+                      <option value="65">angiocentric lymphoma</option>
+                      <option value="66">angioedema</option>
+                      <option value="67">angiogram</option>
+                      <option value="68">angiomyolipoma</option>
+                      <option value="69">angiopathy</option>
+                      <option value="70">angioplasty</option>
+                      <option value="71">angiosarcoma</option>
+                      <option value="72">ankylosing spondylitis</option>
+                      <option value="73">anogenital warts</option>
+                      <option value="74">anti-infective therapy</option>
+                      <option value="75">antibiotic prophylaxis</option>
+                      <option value="76">antibiotic therapy</option>
+                      <option value="77">anticoagulant therapy</option>
+                      <option value="78">antidepressant therapy</option>
+                      <option value="79">antiemetic supportive care</option>
+                      <option value="80">antifungal prophylaxis</option>
+                      <option value="81">antifungal treatment</option>
+                      <option value="82">antiphospholipid syndrome</option>
+                      <option value="83">antiplatelet therapy</option>
+                      <option value="84">antipsychotic therapy</option>
+                      <option value="85">antiretroviral therapy</option>
+                      <option value="86">antiviral prophylaxis</option>
+                      <option value="87">antiviral treatment</option>
+                      <option value="88">anxiety</option>
+                      <option value="89">anxiety disorder</option>
+                      <option value="90">anxiety, depression</option>
+                      <option value="91">aplasia pure red cell</option>
+                      <option value="92">aplastic anaemia</option>
+                      <option value="93">appendix cancer</option>
+                      <option value="94">arrhythmia</option>
+                      <option value="95">arterial disorder</option>
+                      <option value="96">arterial occlusive disease</option>
+                      <option value="97">arteriosclerosis</option>
+                      <option value="98">arteriosclerosis coronary artery</option>
+                      <option value="99">arthralgia</option>
+                      <option value="100">arthritis</option>
+                      <option value="101">arthritis bacterial</option>
+                      <option value="102">arthritis infective</option>
+                      <option value="103">arthritis, rheumatoid arthritis</option>
+                      <option value="104">arthropathy</option>
+                      <option value="105">aspergilloma</option>
+                      <option value="106">aspergillus infection</option>
+                      <option value="107">assisted reproductive technology</option>
+                      <option value="108">asthenia</option>
+                      <option value="109">asthma</option>
+                      <option value="110">asthma, chronic obstructive pulmonary disease</option>
+                      <option value="111">asthma, eosinophilic granulomatosis with polyangiitis</option>
+                      <option value="112">astrocytoma</option>
+                      <option value="113">astrocytoma malignant</option>
+                      <option value="114">astrocytoma, low grade</option>
+                      <option value="115">atrial fibrillation</option>
+                      <option value="116">atrial fibrillation, cerebrovascular accident prophylaxis, thrombosis
+                        prophylaxis</option>
+                      <option value="117">atrial flutter</option>
+                      <option value="118">atypical haemolytic uraemic syndrome</option>
+                      <option value="119">atypical mycobacterial infection</option>
+                      <option value="120">autism spectrum disorder</option>
+                      <option value="121">autoimmune disorder</option>
+                      <option value="122">autoimmune haemolytic anaemia</option>
+                      <option value="123">autoimmune hepatitis</option>
+                      <option value="124">autologous haematopoietic stem cell transplant</option>
+                      <option value="125">axial spondyloarthritis</option>
+                      <option value="126">b precursor type acute leukaemia</option>
+                      <option value="127">b-cell lymphoma</option>
+                      <option value="128">b-cell small lymphocytic lymphoma</option>
+                      <option value="129">b-cell type acute leukaemia</option>
+                      <option value="130">back pain</option>
+                      <option value="131">bacteraemia</option>
+                      <option value="132">bacterial infection</option>
+                      <option value="133">basal cell carcinoma</option>
+                      <option value="134">behaviour disorder</option>
+                      <option value="135">behcet's syndrome</option>
+                      <option value="136">benign prostatic hyperplasia</option>
+                      <option value="137">bile duct cancer</option>
+                      <option value="138">bipolar disorder</option>
+                      <option value="139">bipolar i disorder</option>
+                      <option value="140">bipolar ii disorder</option>
+                      <option value="141">bladder cancer</option>
+                      <option value="142">bladder disorder</option>
+                      <option value="143">bladder transitional cell carcinoma</option>
+                      <option value="144">blast crisis in myelogenous leukaemia</option>
+                      <option value="145">blood disorder</option>
+                      <option value="146">blood glucose</option>
+                      <option value="147">blood glucose abnormal</option>
+                      <option value="148">blood glucose decreased</option>
+                      <option value="149">blood glucose increased</option>
+                      <option value="150">blood iron increased</option>
+                      <option value="151">blood potassium increased</option>
+                      <option value="152">blood pressure abnormal</option>
+                      <option value="153">blood pressure increased</option>
+                      <option value="154">blood pressure measurement</option>
+                      <option value="155">blood testosterone decreased</option>
+                      <option value="156">blood uric acid increased</option>
+                      <option value="157">bone cancer</option>
+                      <option value="158">bone disorder</option>
+                      <option value="159">bone marrow conditioning regimen</option>
+                      <option value="160">bone marrow transplant</option>
+                      <option value="161">bone pain</option>
+                      <option value="162">borderline personality disorder</option>
+                      <option value="163">bradycardia</option>
+                      <option value="164">braf gene mutation</option>
+                      <option value="165">brain neoplasm</option>
+                      <option value="166">brain neoplasm malignant</option>
+                      <option value="167">brain oedema</option>
+                      <option value="168">breakthrough pain</option>
+                      <option value="169">breast cancer</option>
+                      <option value="170">breast cancer female</option>
+                      <option value="171">breast cancer female, breast cancer metastatic</option>
+                      <option value="172">breast cancer male</option>
+                      <option value="173">breast cancer metastatic</option>
+                      <option value="174">breast cancer recurrent</option>
+                      <option value="175">breast cancer stage i</option>
+                      <option value="176">breast cancer stage ii</option>
+                      <option value="177">breast cancer stage iii</option>
+                      <option value="178">breast cancer stage iv</option>
+                      <option value="179">breast neoplasm</option>
+                      <option value="180">bronchial carcinoma</option>
+                      <option value="181">bronchitis</option>
+                      <option value="182">bronchitis chronic</option>
+                      <option value="183">bronchopulmonary aspergillosis</option>
+                      <option value="184">bronchopulmonary aspergillosis allergic</option>
+                      <option value="185">bronchopulmonary dysplasia</option>
+                      <option value="186">burkitt's lymphoma</option>
+                      <option value="187">c3 glomerulopathy</option>
+                      <option value="188">cancer pain</option>
+                      <option value="189">candida infection</option>
+                      <option value="190">carcinoid syndrome</option>
+                      <option value="191">carcinoid tumour</option>
+                      <option value="192">carcinoid tumour pulmonary</option>
+                      <option value="193">cardiac amyloidosis</option>
+                      <option value="194">cardiac disorder</option>
+                      <option value="195">cardiac failure</option>
+                      <option value="196">cardiac failure chronic</option>
+                      <option value="197">cardiac failure congestive</option>
+                      <option value="198">cardiac failure, diabetes mellitus</option>
+                      <option value="199">cardiac failure, type 2 diabetes mellitus</option>
+                      <option value="200">cardiac operation</option>
+                      <option value="201">cardiac pacemaker insertion</option>
+                      <option value="202">cardiac stress test</option>
+                      <option value="203">cardiac ventricular thrombosis</option>
+                      <option value="204">cardiomyopathy</option>
+                      <option value="205">cardiovascular disorder</option>
+                      <option value="206">cardiovascular event prophylaxis</option>
+                      <option value="207">carotid artery occlusion</option>
+                      <option value="208">carotid artery stenosis</option>
+                      <option value="209">castleman's disease</option>
+                      <option value="210">cataplexy</option>
+                      <option value="211">cataract</option>
+                      <option value="212">cataract operation</option>
+                      <option value="213">catatonia</option>
+                      <option value="214">catheterisation cardiac</option>
+                      <option value="215">cellulitis</option>
+                      <option value="216">central nervous system lymphoma</option>
+                      <option value="217">cerebral infarction</option>
+                      <option value="218">cerebral ischaemia</option>
+                      <option value="219">cerebrovascular accident</option>
+                      <option value="220">cerebrovascular accident prophylaxis</option>
+                      <option value="221">cerebrovascular disorder</option>
+                      <option value="222">cervix carcinoma</option>
+                      <option value="223">cervix carcinoma stage iv</option>
+                      <option value="224">chelation therapy</option>
+                      <option value="225">chemotherapy</option>
+                      <option value="226">chest pain</option>
+                      <option value="227">cholangitis</option>
+                      <option value="228">choriocarcinoma</option>
+                      <option value="229">choroid melanoma</option>
+                      <option value="230">choroidal neovascularisation</option>
+                      <option value="231">choroidal neovascularisation, neovascular age-related macular degeneration
+                      </option>
+                      <option value="232">chronic graft versus host disease</option>
+                      <option value="233">chronic hepatitis</option>
+                      <option value="234">chronic hepatitis b</option>
+                      <option value="235">chronic hepatitis c</option>
+                      <option value="236">chronic inflammatory demyelinating polyradiculoneuropathy</option>
+                      <option value="237">chronic kidney disease</option>
+                      <option value="238">chronic kidney disease, type 2 diabetes mellitus</option>
+                      <option value="239">chronic lymphocytic leukaemia</option>
+                      <option value="240">chronic lymphocytic leukaemia recurrent</option>
+                      <option value="241">chronic lymphocytic leukaemia refractory</option>
+                      <option value="242">chronic myeloid leukaemia</option>
+                      <option value="243">chronic myeloid leukaemia transformation</option>
+                      <option value="244">chronic myelomonocytic leukaemia</option>
+                      <option value="245">chronic obstructive pulmonary disease</option>
+                      <option value="246">chronic obstructive pulmonary disease, emphysema</option>
+                      <option value="247">chronic rhinosinusitis with nasal polyps</option>
+                      <option value="248">chronic sinusitis</option>
+                      <option value="249">chronic spontaneous urticaria</option>
+                      <option value="250">chronic spontaneous urticaria, urticaria</option>
+                      <option value="251">clear cell renal cell carcinoma</option>
+                      <option value="252">clostridium difficile colitis</option>
+                      <option value="253">clostridium difficile infection</option>
+                      <option value="254">cluster headache</option>
+                      <option value="255">coagulopathy</option>
+                      <option value="256">colitis</option>
+                      <option value="257">colitis microscopic</option>
+                      <option value="258">colitis ulcerative</option>
+                      <option value="259">colitis ulcerative, crohn's disease</option>
+                      <option value="260">colitis ulcerative, rheumatoid arthritis</option>
+                      <option value="261">colon cancer</option>
+                      <option value="262">colon cancer metastatic</option>
+                      <option value="263">colon cancer recurrent</option>
+                      <option value="264">colon cancer stage iii</option>
+                      <option value="265">colon cancer stage iv</option>
+                      <option value="266">colon cancer, metastases to liver</option>
+                      <option value="267">colorectal adenocarcinoma</option>
+                      <option value="268">colorectal cancer</option>
+                      <option value="269">colorectal cancer metastatic</option>
+                      <option value="270">colorectal cancer recurrent</option>
+                      <option value="271">colorectal cancer stage iv</option>
+                      <option value="272">combined immunodeficiency</option>
+                      <option value="273">complex regional pain syndrome</option>
+                      <option value="274">complications of transplant surgery</option>
+                      <option value="275">computerised tomogram</option>
+                      <option value="276">congenital aplastic anaemia</option>
+                      <option value="277">congenital cytomegalovirus infection</option>
+                      <option value="278">connective tissue disorder</option>
+                      <option value="279">contraception</option>
+                      <option value="280">controlled ovarian stimulation</option>
+                      <option value="281">cor pulmonale chronic</option>
+                      <option value="282">cord blood transplant therapy</option>
+                      <option value="283">coronary angioplasty</option>
+                      <option value="284">coronary arterial stent insertion</option>
+                      <option value="285">coronary artery bypass</option>
+                      <option value="286">coronary artery disease</option>
+                      <option value="287">coronavirus infection</option>
+                      <option value="288">cough</option>
+                      <option value="289">covid-19</option>
+                      <option value="290">covid-19 immunisation</option>
+                      <option value="291">covid-19 pneumonia</option>
+                      <option value="292">covid-19 prophylaxis</option>
+                      <option value="293">crohn's disease</option>
+                      <option value="294">cushing's syndrome</option>
+                      <option value="295">cutaneous t-cell lymphoma</option>
+                      <option value="296">cystic fibrosis</option>
+                      <option value="297">cystitis</option>
+                      <option value="298">cystitis interstitial</option>
+                      <option value="299">cystoid macular oedema</option>
+                      <option value="300">cytokine release syndrome</option>
+                      <option value="301">cytomegalovirus chorioretinitis</option>
+                      <option value="302">cytomegalovirus colitis</option>
+                      <option value="303">cytomegalovirus infection</option>
+                      <option value="304">cytomegalovirus infection reactivation</option>
+                      <option value="305">cytomegalovirus viraemia</option>
+                      <option value="306">deep vein thrombosis</option>
+                      <option value="307">deep vein thrombosis, pulmonary embolism</option>
+                      <option value="308">delirium</option>
+                      <option value="309">delusion</option>
+                      <option value="310">delusional disorder, unspecified type</option>
+                      <option value="311">dementia</option>
+                      <option value="312">dementia alzheimer's type</option>
+                      <option value="313">demyelinating polyneuropathy</option>
+                      <option value="314">dependence</option>
+                      <option value="315">depressed mood</option>
+                      <option value="316">depression</option>
+                      <option value="317">depressive symptom</option>
+                      <option value="318">dermatitis</option>
+                      <option value="319">dermatitis atopic</option>
+                      <option value="320">dermatomyositis</option>
+                      <option value="321">desmoplastic small round cell tumour</option>
+                      <option value="322">device related infection</option>
+                      <option value="323">diabetes mellitus</option>
+                      <option value="324">diabetes mellitus inadequate control</option>
+                      <option value="325">diabetes mellitus management</option>
+                      <option value="326">diabetic foot</option>
+                      <option value="327">diabetic neuropathy</option>
+                      <option value="328">diabetic retinal oedema</option>
+                      <option value="329">diabetic retinopathy</option>
+                      <option value="330">dialysis</option>
+                      <option value="331">diarrhoea</option>
+                      <option value="332">diffuse large b-cell lymphoma</option>
+                      <option value="333">diffuse large b-cell lymphoma recurrent</option>
+                      <option value="334">diffuse large b-cell lymphoma refractory</option>
+                      <option value="335">diffuse large b-cell lymphoma stage ii</option>
+                      <option value="336">diffuse large b-cell lymphoma stage iii</option>
+                      <option value="337">diffuse large b-cell lymphoma stage iv</option>
+                      <option value="338">dilated cardiomyopathy</option>
+                      <option value="339">disseminated intravascular coagulation</option>
+                      <option value="340">disseminated tuberculosis</option>
+                      <option value="341">diuretic therapy</option>
+                      <option value="342">drug abuse</option>
+                      <option value="343">drug dependence</option>
+                      <option value="344">drug therapy</option>
+                      <option value="345">drug use disorder</option>
+                      <option value="346">drug withdrawal maintenance therapy</option>
+                      <option value="347">drug withdrawal syndrome</option>
+                      <option value="348">ductal adenocarcinoma of pancreas</option>
+                      <option value="349">dupuytren's contracture</option>
+                      <option value="350">dyspnoea</option>
+                      <option value="351">dysuria</option>
+                      <option value="352">eczema</option>
+                      <option value="353">egfr gene mutation</option>
+                      <option value="354">embolism</option>
+                      <option value="355">embolism venous</option>
+                      <option value="356">emphysema</option>
+                      <option value="357">encephalitis</option>
+                      <option value="358">encephalitis autoimmune</option>
+                      <option value="359">encephalopathy</option>
+                      <option value="360">end stage renal disease</option>
+                      <option value="361">endocarditis</option>
+                      <option value="362">endocarditis staphylococcal</option>
+                      <option value="363">endometrial adenocarcinoma</option>
+                      <option value="364">endometrial cancer</option>
+                      <option value="365">endometrial cancer metastatic</option>
+                      <option value="366">endometrial cancer recurrent</option>
+                      <option value="367">endometrial cancer stage iv</option>
+                      <option value="368">endophthalmitis</option>
+                      <option value="369">endotracheal intubation</option>
+                      <option value="370">enteritis</option>
+                      <option value="371">enterococcal infection</option>
+                      <option value="372">eosinophilia</option>
+                      <option value="373">eosinophilic granulomatosis with polyangiitis</option>
+                      <option value="374">epidural anaesthesia</option>
+                      <option value="375">epidural analgesia</option>
+                      <option value="376">epilepsy</option>
+                      <option value="377">epilepsy, partial seizures</option>
+                      <option value="378">epilepsy, seizure</option>
+                      <option value="379">epileptic encephalopathy</option>
+                      <option value="380">epstein-barr virus infection</option>
+                      <option value="381">erectile dysfunction</option>
+                      <option value="382">erythema</option>
+                      <option value="383">erythrodermic psoriasis</option>
+                      <option value="384">essential hypertension</option>
+                      <option value="385">essential thrombocythaemia</option>
+                      <option value="386">ewing's sarcoma</option>
+                      <option value="387">ex-tobacco user</option>
+                      <option value="388">exposure during pregnancy</option>
+                      <option value="389">extrapulmonary tuberculosis</option>
+                      <option value="390">extrapyramidal disorder</option>
+                      <option value="391">fabry's disease</option>
+                      <option value="392">factor vii deficiency</option>
+                      <option value="393">factor viii deficiency</option>
+                      <option value="394">failed back surgery syndrome</option>
+                      <option value="395">fallopian tube cancer</option>
+                      <option value="396">febrile neutropenia</option>
+                      <option value="397">fibromyalgia</option>
+                      <option value="398">focal dyscognitive seizures</option>
+                      <option value="399">focal segmental glomerulosclerosis</option>
+                      <option value="400">foetal exposure during pregnancy</option>
+                      <option value="401">follicular lymphoma</option>
+                      <option value="402">follicular thyroid cancer</option>
+                      <option value="403">fracture</option>
+                      <option value="404">frontal lobe epilepsy</option>
+                      <option value="405">fungal infection</option>
+                      <option value="406">fusarium infection</option>
+                      <option value="407">gait disturbance</option>
+                      <option value="408">gallbladder cancer</option>
+                      <option value="409">gastric cancer</option>
+                      <option value="410">gastric cancer stage iv</option>
+                      <option value="411">gastritis</option>
+                      <option value="412">gastroenteritis</option>
+                      <option value="413">gastroenteropancreatic neuroendocrine tumour disease</option>
+                      <option value="414">gastrointestinal cancer metastatic</option>
+                      <option value="415">gastrointestinal carcinoma</option>
+                      <option value="416">gastrointestinal disorder</option>
+                      <option value="417">gastrointestinal haemorrhage</option>
+                      <option value="418">gastrointestinal stromal tumour</option>
+                      <option value="419">gastrooesophageal reflux disease</option>
+                      <option value="420">gaucher's disease</option>
+                      <option value="421">gene mutation</option>
+                      <option value="422">general anaesthesia</option>
+                      <option value="423">generalised anxiety disorder</option>
+                      <option value="424">generalised tonic-clonic seizure</option>
+                      <option value="425">gestational diabetes</option>
+                      <option value="426">gestational trophoblastic tumour</option>
+                      <option value="427">giant cell arteritis</option>
+                      <option value="428">gingival cancer</option>
+                      <option value="429">glaucoma</option>
+                      <option value="430">glioblastoma</option>
+                      <option value="431">glioblastoma multiforme</option>
+                      <option value="432">glioma</option>
+                      <option value="433">glomerulonephritis</option>
+                      <option value="434">glomerulonephritis membranoproliferative</option>
+                      <option value="435">glomerulonephritis membranous</option>
+                      <option value="436">glucose tolerance impaired</option>
+                      <option value="437">gout</option>
+                      <option value="438">graft versus host disease</option>
+                      <option value="439">graft versus host disease in gastrointestinal tract</option>
+                      <option value="440">graft versus host disease in skin</option>
+                      <option value="441">granulomatosis with polyangiitis</option>
+                      <option value="442">growth hormone deficiency</option>
+                      <option value="443">growth retardation</option>
+                      <option value="444">guillain-barre syndrome</option>
+                      <option value="445">h1n1 influenza</option>
+                      <option value="446">haemangioma</option>
+                      <option value="447">haematoma</option>
+                      <option value="448">haematopoietic stem cell mobilisation</option>
+                      <option value="449">haemochromatosis</option>
+                      <option value="450">haemoglobin decreased</option>
+                      <option value="451">haemolytic anaemia</option>
+                      <option value="452">haemolytic uraemic syndrome</option>
+                      <option value="453">haemophagocytic lymphohistiocytosis</option>
+                      <option value="454">haemophilia</option>
+                      <option value="455">haemophilia a with anti factor viii</option>
+                      <option value="456">haemophilia a without inhibitors</option>
+                      <option value="457">haemorrhage</option>
+                      <option value="458">haemosiderosis</option>
+                      <option value="459">hairy cell leukaemia</option>
+                      <option value="460">hallucination</option>
+                      <option value="461">head and neck cancer</option>
+                      <option value="462">headache</option>
+                      <option value="463">heart disease congenital</option>
+                      <option value="464">heart failure with preserved ejection fraction</option>
+                      <option value="465">heart failure with reduced ejection fraction</option>
+                      <option value="466">heart transplant</option>
+                      <option value="467">heavy menstrual bleeding</option>
+                      <option value="468">hepatic cancer</option>
+                      <option value="469">hepatic cancer metastatic</option>
+                      <option value="470">hepatic cirrhosis</option>
+                      <option value="471">hepatic cirrhosis, hepatitis c</option>
+                      <option value="472">hepatic neoplasm</option>
+                      <option value="473">hepatitis</option>
+                      <option value="474">hepatitis b</option>
+                      <option value="475">hepatitis c</option>
+                      <option value="476">hepatitis c virus test</option>
+                      <option value="477">hepatitis c virus test positive</option>
+                      <option value="478">hepatitis viral</option>
+                      <option value="479">hepato-lenticular degeneration</option>
+                      <option value="480">hepatocellular carcinoma</option>
+                      <option value="481">her2 negative breast cancer</option>
+                      <option value="482">her2 positive breast cancer</option>
+                      <option value="483">hereditary angioedema</option>
+                      <option value="484">hereditary angioedema with c1 esterase inhibitor deficiency</option>
+                      <option value="485">hereditary angioedema, prophylaxis</option>
+                      <option value="486">herpes zoster</option>
+                      <option value="487">herpes zoster immunisation</option>
+                      <option value="488">hidradenitis</option>
+                      <option value="489">high-grade b-cell lymphoma</option>
+                      <option value="490">hip arthroplasty</option>
+                      <option value="491">hiv infection</option>
+                      <option value="492">hiv infection, hepatitis b</option>
+                      <option value="493">hiv infection, prophylaxis against hiv infection</option>
+                      <option value="494">hiv test positive</option>
+                      <option value="495">hodgkin's disease</option>
+                      <option value="496">hormone receptor positive breast cancer</option>
+                      <option value="497">hormone receptor positive her2 negative breast cancer</option>
+                      <option value="498">hormone suppression therapy</option>
+                      <option value="499">hormone therapy</option>
+                      <option value="500">hormone-dependent prostate cancer</option>
+                      <option value="501">hormone-refractory prostate cancer</option>
+                      <option value="502">hormone-refractory prostate cancer, metastases to bone</option>
+                      <option value="503">humoral immune defect</option>
+                      <option value="504">hypercalcaemia</option>
+                      <option value="505">hypercalcaemia of malignancy</option>
+                      <option value="506">hypereosinophilic syndrome</option>
+                      <option value="507">hyperglycaemia</option>
+                      <option value="508">hyperkalaemia</option>
+                      <option value="509">hyperlipidaemia</option>
+                      <option value="510">hyperparathyroidism</option>
+                      <option value="511">hyperparathyroidism primary</option>
+                      <option value="512">hyperparathyroidism secondary</option>
+                      <option value="513">hypersensitivity</option>
+                      <option value="514">hypertension</option>
+                      <option value="515">hyperthyroidism</option>
+                      <option value="516">hypertonic bladder</option>
+                      <option value="517">hyperuricaemia</option>
+                      <option value="518">hypoaesthesia</option>
+                      <option value="519">hypogammaglobulinaemia</option>
+                      <option value="520">hypoglobulinaemia</option>
+                      <option value="521">hypoglycaemia</option>
+                      <option value="522">hypogonadism</option>
+                      <option value="523">hypomania</option>
+                      <option value="524">hypopharyngeal cancer</option>
+                      <option value="525">hypopituitarism</option>
+                      <option value="526">idiopathic pulmonary fibrosis</option>
+                      <option value="527">idiopathic pulmonary fibrosis, interstitial lung disease</option>
+                      <option value="528">idiopathic urticaria</option>
+                      <option value="529">ill-defined disorder</option>
+                      <option value="530">illness</option>
+                      <option value="531">imaging procedure</option>
+                      <option value="532">immune thrombocytopenia</option>
+                      <option value="533">immunisation</option>
+                      <option value="534">immunodeficiency</option>
+                      <option value="535">immunodeficiency common variable</option>
+                      <option value="536">immunosuppressant drug therapy</option>
+                      <option value="537">immunosuppression</option>
+                      <option value="538">in vitro fertilisation</option>
+                      <option value="539">incontinence</option>
+                      <option value="540">induction and maintenance of anaesthesia</option>
+                      <option value="541">induction of anaesthesia</option>
+                      <option value="542">infantile haemangioma</option>
+                      <option value="543">infantile spasms</option>
+                      <option value="544">infarction</option>
+                      <option value="545">infection</option>
+                      <option value="546">infection prophylaxis</option>
+                      <option value="547">infertility</option>
+                      <option value="548">inflammation</option>
+                      <option value="549">inflammatory bowel disease</option>
+                      <option value="550">influenza</option>
+                      <option value="551">influenza immunisation</option>
+                      <option value="552">influenza like illness</option>
+                      <option value="553">initial insomnia</option>
+                      <option value="554">insomnia</option>
+                      <option value="555">insulin-requiring type 2 diabetes mellitus</option>
+                      <option value="556">intentional overdose</option>
+                      <option value="557">intentional product misuse</option>
+                      <option value="558">intentional product use issue</option>
+                      <option value="559">interstitial lung disease</option>
+                      <option value="560">intervertebral discitis</option>
+                      <option value="561">intestinal ulcer</option>
+                      <option value="562">invasive breast carcinoma</option>
+                      <option value="563">invasive ductal breast carcinoma</option>
+                      <option value="564">invasive lobular breast carcinoma</option>
+                      <option value="565">iron metabolism disorder</option>
+                      <option value="566">iron overload</option>
+                      <option value="567">ischaemic cardiomyopathy</option>
+                      <option value="568">ischaemic heart disease prophylaxis</option>
+                      <option value="569">ischaemic stroke</option>
+                      <option value="570">juvenile idiopathic arthritis</option>
+                      <option value="571">juvenile myoclonic epilepsy</option>
+                      <option value="572">kaposi's sarcoma</option>
+                      <option value="573">kawasaki's disease</option>
+                      <option value="574">keratitis</option>
+                      <option value="575">kidney transplant rejection</option>
+                      <option value="576">klebsiella infection</option>
+                      <option value="577">knee arthroplasty</option>
+                      <option value="578">lacunar infarction</option>
+                      <option value="579">langerhans' cell histiocytosis</option>
+                      <option value="580">laryngeal cancer</option>
+                      <option value="581">latent autoimmune diabetes in adults</option>
+                      <option value="582">left ventricular failure</option>
+                      <option value="583">leiomyoma</option>
+                      <option value="584">leiomyosarcoma</option>
+                      <option value="585">leiomyosarcoma metastatic</option>
+                      <option value="586">lennox-gastaut syndrome</option>
+                      <option value="587">leukaemia</option>
+                      <option value="588">leukopenia</option>
+                      <option value="589">lip and/or oral cavity cancer</option>
+                      <option value="590">liposarcoma</option>
+                      <option value="591">liver transplant</option>
+                      <option value="592">local anaesthesia</option>
+                      <option value="593">lower respiratory tract infection</option>
+                      <option value="594">lung adenocarcinoma</option>
+                      <option value="595">lung adenocarcinoma recurrent</option>
+                      <option value="596">lung adenocarcinoma stage iii</option>
+                      <option value="597">lung adenocarcinoma stage iv</option>
+                      <option value="598">lung cancer metastatic</option>
+                      <option value="599">lung carcinoma cell type unspecified stage 0</option>
+                      <option value="600">lung carcinoma cell type unspecified stage iv</option>
+                      <option value="601">lung disorder</option>
+                      <option value="602">lung neoplasm</option>
+                      <option value="603">lung neoplasm malignant</option>
+                      <option value="604">lung squamous cell carcinoma metastatic</option>
+                      <option value="605">lung squamous cell carcinoma stage iii</option>
+                      <option value="606">lung squamous cell carcinoma stage iv</option>
+                      <option value="607">lung transplant</option>
+                      <option value="608">lupus nephritis</option>
+                      <option value="609">lymphocytic leukaemia</option>
+                      <option value="610">lymphoma</option>
+                      <option value="611">lymphoproliferative disorder</option>
+                      <option value="612">macular degeneration</option>
+                      <option value="613">macular oedema</option>
+                      <option value="614">macular oedema, retinal vein occlusion</option>
+                      <option value="615">magnetic resonance imaging</option>
+                      <option value="616">magnetic resonance imaging abdominal</option>
+                      <option value="617">magnetic resonance imaging head</option>
+                      <option value="618">maintenance of anaesthesia</option>
+                      <option value="619">major depression</option>
+                      <option value="620">malignant connective tissue neoplasm</option>
+                      <option value="621">malignant connective tissue neoplasm, soft tissue sarcoma</option>
+                      <option value="622">malignant glioma</option>
+                      <option value="623">malignant melanoma</option>
+                      <option value="624">malignant melanoma stage iii</option>
+                      <option value="625">malignant melanoma stage iv</option>
+                      <option value="626">malignant neoplasm of islets of langerhans</option>
+                      <option value="627">malignant neoplasm of renal pelvis</option>
+                      <option value="628">malignant neoplasm of thymus</option>
+                      <option value="629">malignant neoplasm progression</option>
+                      <option value="630">malignant peritoneal neoplasm</option>
+                      <option value="631">malignant urinary tract neoplasm</option>
+                      <option value="632">mania</option>
+                      <option value="633">mantle cell lymphoma</option>
+                      <option value="634">mantle cell lymphoma stage iv</option>
+                      <option value="635">marginal zone lymphoma</option>
+                      <option value="636">mastocytosis</option>
+                      <option value="637">maternal exposure timing unspecified</option>
+                      <option value="638">maternal therapy to enhance foetal lung maturity</option>
+                      <option value="639">medullary thyroid cancer</option>
+                      <option value="640">medulloblastoma</option>
+                      <option value="641">meningioma</option>
+                      <option value="642">meningitis</option>
+                      <option value="643">meningitis tuberculous</option>
+                      <option value="644">meningococcal immunisation</option>
+                      <option value="645">mental disorder</option>
+                      <option value="646">mesothelioma</option>
+                      <option value="647">mesothelioma malignant</option>
+                      <option value="648">metastases to bone</option>
+                      <option value="649">metastases to central nervous system</option>
+                      <option value="650">metastases to liver</option>
+                      <option value="651">metastases to lung</option>
+                      <option value="652">metastases to lymph nodes</option>
+                      <option value="653">metastases to peritoneum</option>
+                      <option value="654">metastasis</option>
+                      <option value="655">metastatic carcinoid tumour</option>
+                      <option value="656">metastatic gastric cancer</option>
+                      <option value="657">metastatic malignant melanoma</option>
+                      <option value="658">metastatic neoplasm</option>
+                      <option value="659">metastatic renal cell carcinoma</option>
+                      <option value="660">micturition urgency</option>
+                      <option value="661">migraine</option>
+                      <option value="662">migraine prophylaxis</option>
+                      <option value="663">migraine without aura</option>
+                      <option value="664">mixed anxiety and depressive disorder</option>
+                      <option value="665">motor neurone disease</option>
+                      <option value="666">mucopolysaccharidosis vi</option>
+                      <option value="667">mucormycosis</option>
+                      <option value="668">multifocal motor neuropathy</option>
+                      <option value="669">multiple sclerosis</option>
+                      <option value="670">multiple sclerosis relapse</option>
+                      <option value="671">multiple sclerosis, relapsing-remitting multiple sclerosis</option>
+                      <option value="672">myalgia</option>
+                      <option value="673">myasthenia gravis</option>
+                      <option value="674">myasthenic syndrome</option>
+                      <option value="675">mycobacterial infection</option>
+                      <option value="676">mycobacterium abscessus infection</option>
+                      <option value="677">mycobacterium avium complex infection</option>
+                      <option value="678">myelodysplastic syndrome</option>
+                      <option value="679">myelofibrosis</option>
+                      <option value="680">myeloid leukaemia</option>
+                      <option value="681">myeloproliferative neoplasm</option>
+                      <option value="682">myocardial infarction</option>
+                      <option value="683">myocardial infarction, stent placement</option>
+                      <option value="684">myocardial ischaemia</option>
+                      <option value="685">myoclonic epilepsy</option>
+                      <option value="686">myoclonus</option>
+                      <option value="687">myositis</option>
+                      <option value="688">narcolepsy</option>
+                      <option value="689">nasal polyps</option>
+                      <option value="690">nasopharyngeal cancer</option>
+                      <option value="691">nasopharyngitis</option>
+                      <option value="692">nausea</option>
+                      <option value="693">nausea, vomiting</option>
+                      <option value="694">neoplasm</option>
+                      <option value="695">neoplasm progression</option>
+                      <option value="696">neoplasm prostate</option>
+                      <option value="697">neovascular age-related macular degeneration</option>
+                      <option value="698">nephrogenic anaemia</option>
+                      <option value="699">nephropathy</option>
+                      <option value="700">nephrotic syndrome</option>
+                      <option value="701">nerve block</option>
+                      <option value="702">neuralgia</option>
+                      <option value="703">neuroblastoma</option>
+                      <option value="704">neuroblastoma recurrent</option>
+                      <option value="705">neuroendocrine carcinoma</option>
+                      <option value="706">neuroendocrine carcinoma metastatic</option>
+                      <option value="707">neuroendocrine carcinoma of the skin</option>
+                      <option value="708">neuroendocrine tumour</option>
+                      <option value="709">neuroendocrine tumour of the lung</option>
+                      <option value="710">neuromuscular blockade</option>
+                      <option value="711">neuromuscular blockade reversal</option>
+                      <option value="712">neuromyelitis optica spectrum disorder</option>
+                      <option value="713">neuropathy peripheral</option>
+                      <option value="714">neutropenia</option>
+                      <option value="715">nicotine dependence</option>
+                      <option value="716">niemann-pick disease</option>
+                      <option value="717">non-hodgkin's lymphoma</option>
+                      <option value="718">non-small cell lung cancer</option>
+                      <option value="719">non-small cell lung cancer metastatic</option>
+                      <option value="720">non-small cell lung cancer recurrent</option>
+                      <option value="721">non-small cell lung cancer stage iv</option>
+                      <option value="722">obesity</option>
+                      <option value="723">obsessive-compulsive disorder</option>
+                      <option value="724">oedema</option>
+                      <option value="725">oesophageal adenocarcinoma</option>
+                      <option value="726">oesophageal cancer metastatic</option>
+                      <option value="727">oesophageal carcinoma</option>
+                      <option value="728">oesophageal carcinoma recurrent</option>
+                      <option value="729">oesophageal squamous cell carcinoma</option>
+                      <option value="730">oesophageal squamous cell carcinoma stage iv</option>
+                      <option value="731">off label use</option>
+                      <option value="732">off label use, status epilepticus</option>
+                      <option value="733">oligodendroglioma</option>
+                      <option value="734">organ transplant</option>
+                      <option value="735">oropharyngeal cancer</option>
+                      <option value="736">osteoarthritis</option>
+                      <option value="737">osteoarthritis, rheumatoid arthritis</option>
+                      <option value="738">osteomyelitis</option>
+                      <option value="739">osteopenia</option>
+                      <option value="740">osteoporosis</option>
+                      <option value="741">osteoporosis postmenopausal</option>
+                      <option value="742">osteoporosis prophylaxis</option>
+                      <option value="743">osteoporotic fracture</option>
+                      <option value="744">osteosarcoma</option>
+                      <option value="745">otitis media</option>
+                      <option value="746">ovarian cancer</option>
+                      <option value="747">ovarian cancer metastatic</option>
+                      <option value="748">ovarian cancer recurrent</option>
+                      <option value="749">ovarian cancer stage iii</option>
+                      <option value="750">ovarian epithelial cancer</option>
+                      <option value="751">ovarian neoplasm</option>
+                      <option value="752">overdose</option>
+                      <option value="753">overweight</option>
+                      <option value="754">pain</option>
+                      <option value="755">pain in extremity</option>
+                      <option value="756">pain management</option>
+                      <option value="757">pancreas transplant</option>
+                      <option value="758">pancreatic carcinoma</option>
+                      <option value="759">pancreatic carcinoma metastatic</option>
+                      <option value="760">pancreatic carcinoma stage iv</option>
+                      <option value="761">pancreatic neuroendocrine tumour</option>
+                      <option value="762">pancreatic neuroendocrine tumour metastatic</option>
+                      <option value="763">pancytopenia</option>
+                      <option value="764">papillary renal cell carcinoma</option>
+                      <option value="765">papillary thyroid cancer</option>
+                      <option value="766">paraganglion neoplasm</option>
+                      <option value="767">paranoia</option>
+                      <option value="768">parkinson's disease</option>
+                      <option value="769">parkinsonism</option>
+                      <option value="770">paroxysmal nocturnal haemoglobinuria</option>
+                      <option value="771">partial seizures</option>
+                      <option value="772">partial seizures with secondary generalisation</option>
+                      <option value="773">pemphigoid</option>
+                      <option value="774">pemphigus</option>
+                      <option value="775">percutaneous coronary intervention</option>
+                      <option value="776">pericarditis</option>
+                      <option value="777">peripheral arterial occlusive disease</option>
+                      <option value="778">peripheral vascular disorder</option>
+                      <option value="779">peritonitis</option>
+                      <option value="780">personality disorder</option>
+                      <option value="781">petit mal epilepsy</option>
+                      <option value="782">phaeochromocytoma</option>
+                      <option value="783">pharyngitis</option>
+                      <option value="784">phenylketonuria</option>
+                      <option value="785">philadelphia positive acute lymphocytic leukaemia</option>
+                      <option value="786">philadelphia positive chronic myeloid leukaemia</option>
+                      <option value="787">phlebitis</option>
+                      <option value="788">pituitary tumour</option>
+                      <option value="789">pituitary-dependent cushing's syndrome</option>
+                      <option value="790">plasma cell leukaemia</option>
+                      <option value="791">plasma cell myeloma</option>
+                      <option value="792">plasma cell myeloma in remission</option>
+                      <option value="793">plasma cell myeloma refractory</option>
+                      <option value="794">plasmablastic lymphoma</option>
+                      <option value="795">platelet aggregation inhibition</option>
+                      <option value="796">platelet aggregation test</option>
+                      <option value="797">pleural mesothelioma</option>
+                      <option value="798">pleural mesothelioma malignant</option>
+                      <option value="799">pneumonia</option>
+                      <option value="800">pneumonia aspiration</option>
+                      <option value="801">pneumonia bacterial</option>
+                      <option value="802">pneumonia fungal</option>
+                      <option value="803">pneumonia legionella</option>
+                      <option value="804">pneumonitis</option>
+                      <option value="805">pollakiuria</option>
+                      <option value="806">polyarthritis</option>
+                      <option value="807">polycythaemia</option>
+                      <option value="808">polycythaemia vera</option>
+                      <option value="809">polymyalgia rheumatica</option>
+                      <option value="810">polymyositis</option>
+                      <option value="811">polyneuropathy</option>
+                      <option value="812">polypoidal choroidal vasculopathy</option>
+                      <option value="813">portopulmonary hypertension</option>
+                      <option value="814">post coital contraception</option>
+                      <option value="815">post herpetic neuralgia</option>
+                      <option value="816">post procedural haemorrhage</option>
+                      <option value="817">post transplant lymphoproliferative disorder</option>
+                      <option value="818">post-traumatic epilepsy</option>
+                      <option value="819">post-traumatic stress disorder</option>
+                      <option value="820">postoperative analgesia</option>
+                      <option value="821">postoperative care</option>
+                      <option value="822">postoperative wound infection</option>
+                      <option value="823">postpartum haemorrhage</option>
+                      <option value="824">prader-willi syndrome</option>
+                      <option value="825">precursor b-lymphoblastic lymphoma</option>
+                      <option value="826">precursor t-lymphoblastic lymphoma/leukaemia</option>
+                      <option value="827">pregnancy</option>
+                      <option value="828">premature baby</option>
+                      <option value="829">premature labour</option>
+                      <option value="830">premedication</option>
+                      <option value="831">primary amyloidosis</option>
+                      <option value="832">primary biliary cholangitis</option>
+                      <option value="833">primary immunodeficiency syndrome</option>
+                      <option value="834">primary mediastinal large b-cell lymphoma</option>
+                      <option value="835">primary myelofibrosis</option>
+                      <option value="836">primary progressive multiple sclerosis</option>
+                      <option value="837">procedural pain</option>
+                      <option value="838">procoagulant therapy</option>
+                      <option value="839">prophylaxis</option>
+                      <option value="840">prophylaxis against gastrointestinal ulcer</option>
+                      <option value="841">prophylaxis against graft versus host disease</option>
+                      <option value="842">prophylaxis against hiv infection</option>
+                      <option value="843">prophylaxis against transplant rejection</option>
+                      <option value="844">prophylaxis of nausea and vomiting</option>
+                      <option value="845">prophylaxis, routine health maintenance</option>
+                      <option value="846">prostate cancer</option>
+                      <option value="847">prostate cancer metastatic</option>
+                      <option value="848">prostate cancer stage iv</option>
+                      <option value="849">prostatitis</option>
+                      <option value="850">pruritus</option>
+                      <option value="851">pseudomonas infection</option>
+                      <option value="852">psoriasis</option>
+                      <option value="853">psoriasis, psoriatic arthropathy</option>
+                      <option value="854">psoriatic arthropathy</option>
+                      <option value="855">psoriatic arthropathy, rheumatoid arthritis</option>
+                      <option value="856">psychiatric symptom</option>
+                      <option value="857">psychomotor hyperactivity</option>
+                      <option value="858">psychotic disorder</option>
+                      <option value="859">psychotic symptom</option>
+                      <option value="860">pulmonary arterial hypertension</option>
+                      <option value="861">pulmonary arterial hypertension, pulmonary hypertension</option>
+                      <option value="862">pulmonary embolism</option>
+                      <option value="863">pulmonary fibrosis</option>
+                      <option value="864">pulmonary hypertension</option>
+                      <option value="865">pulmonary mass</option>
+                      <option value="866">pulmonary tuberculosis</option>
+                      <option value="867">pustular psoriasis</option>
+                      <option value="868">pyelonephritis</option>
+                      <option value="869">pyoderma gangrenosum</option>
+                      <option value="870">pyrexia</option>
+                      <option value="871">radiotherapy</option>
+                      <option value="872">raynaud's phenomenon</option>
+                      <option value="873">rectal adenocarcinoma</option>
+                      <option value="874">rectal cancer</option>
+                      <option value="875">rectal cancer metastatic</option>
+                      <option value="876">rectal cancer recurrent</option>
+                      <option value="877">rectal cancer stage iii</option>
+                      <option value="878">rectal cancer stage iv</option>
+                      <option value="879">rectosigmoid cancer</option>
+                      <option value="880">relapsing multiple sclerosis</option>
+                      <option value="881">relapsing-remitting multiple sclerosis</option>
+                      <option value="882">renal and pancreas transplant</option>
+                      <option value="883">renal cancer</option>
+                      <option value="884">renal cancer metastatic</option>
+                      <option value="885">renal cancer stage iv</option>
+                      <option value="886">renal cell carcinoma</option>
+                      <option value="887">renal cell carcinoma stage iii</option>
+                      <option value="888">renal cell carcinoma stage iv</option>
+                      <option value="889">renal disorder</option>
+                      <option value="890">renal failure</option>
+                      <option value="891">renal impairment</option>
+                      <option value="892">renal neoplasm</option>
+                      <option value="893">renal transplant</option>
+                      <option value="894">respiratory syncytial virus infection</option>
+                      <option value="895">respiratory tract infection</option>
+                      <option value="896">restless legs syndrome</option>
+                      <option value="897">retinal vein occlusion</option>
+                      <option value="898">retinoblastoma</option>
+                      <option value="899">rhabdomyosarcoma</option>
+                      <option value="900">rheumatic disorder</option>
+                      <option value="901">rheumatoid arthritis</option>
+                      <option value="902">rheumatoid arthritis, systemic lupus erythematosus</option>
+                      <option value="903">rhinitis</option>
+                      <option value="904">rhinitis allergic</option>
+                      <option value="905">rhinorrhoea</option>
+                      <option value="906">richter's syndrome</option>
+                      <option value="907">routine health maintenance</option>
+                      <option value="908">salivary gland cancer</option>
+                      <option value="909">sarcoidosis</option>
+                      <option value="910">sarcoma</option>
+                      <option value="911">sarcoma metastatic</option>
+                      <option value="912">scan</option>
+                      <option value="913">scan myocardial perfusion</option>
+                      <option value="914">scedosporium infection</option>
+                      <option value="915">schizoaffective disorder</option>
+                      <option value="916">schizophrenia</option>
+                      <option value="917">sciatica</option>
+                      <option value="918">scleroderma</option>
+                      <option value="919">scleroderma associated digital ulcer</option>
+                      <option value="920">secondary immunodeficiency</option>
+                      <option value="921">secondary progressive multiple sclerosis</option>
+                      <option value="922">sedation</option>
+                      <option value="923">sedative therapy</option>
+                      <option value="924">seizure</option>
+                      <option value="925">seizure prophylaxis</option>
+                      <option value="926">selective igg subclass deficiency</option>
+                      <option value="927">sepsis</option>
+                      <option value="928">serum ferritin increased</option>
+                      <option value="929">severe myoclonic epilepsy of infancy</option>
+                      <option value="930">sexual dysfunction</option>
+                      <option value="931">short stature</option>
+                      <option value="932">short-bowel syndrome</option>
+                      <option value="933">sickle cell anaemia</option>
+                      <option value="934">sickle cell disease</option>
+                      <option value="935">sinusitis</option>
+                      <option value="936">skin cancer</option>
+                      <option value="937">skin ulcer</option>
+                      <option value="938">sleep disorder therapy</option>
+                      <option value="939">small cell lung cancer</option>
+                      <option value="940">small intestine carcinoma</option>
+                      <option value="941">smoking cessation therapy</option>
+                      <option value="942">soft tissue sarcoma</option>
+                      <option value="943">spinal anaesthesia</option>
+                      <option value="944">spinal compression fracture</option>
+                      <option value="945">spinal muscular atrophy</option>
+                      <option value="946">spinal osteoarthritis</option>
+                      <option value="947">splenomegaly</option>
+                      <option value="948">spondylitis</option>
+                      <option value="949">squamous cell carcinoma</option>
+                      <option value="950">squamous cell carcinoma of head and neck</option>
+                      <option value="951">squamous cell carcinoma of lung</option>
+                      <option value="952">squamous cell carcinoma of skin</option>
+                      <option value="953">squamous cell carcinoma of the cervix</option>
+                      <option value="954">staphylococcal bacteraemia</option>
+                      <option value="955">staphylococcal infection</option>
+                      <option value="956">staphylococcal sepsis</option>
+                      <option value="957">status epilepticus</option>
+                      <option value="958">stem cell transplant</option>
+                      <option value="959">stent placement</option>
+                      <option value="960">still's disease</option>
+                      <option value="961">stress</option>
+                      <option value="962">substance abuse</option>
+                      <option value="963">suicide attempt</option>
+                      <option value="964">supportive care</option>
+                      <option value="965">surgery</option>
+                      <option value="966">surgical preconditioning</option>
+                      <option value="967">synovial sarcoma</option>
+                      <option value="968">systemic candida</option>
+                      <option value="969">systemic lupus erythematosus</option>
+                      <option value="970">systemic mastocytosis</option>
+                      <option value="971">systemic mycosis</option>
+                      <option value="972">systemic scleroderma</option>
+                      <option value="973">t-cell lymphoma</option>
+                      <option value="974">t-cell prolymphocytic leukaemia</option>
+                      <option value="975">t-cell type acute leukaemia</option>
+                      <option value="976">tachycardia</option>
+                      <option value="977">targeted cancer therapy</option>
+                      <option value="978">temporal lobe epilepsy</option>
+                      <option value="979">thalassaemia</option>
+                      <option value="980">thalassaemia beta</option>
+                      <option value="981">thermal burn</option>
+                      <option value="982">thrombocytopenia</option>
+                      <option value="983">thrombosis</option>
+                      <option value="984">thrombosis prophylaxis</option>
+                      <option value="985">thrombotic microangiopathy</option>
+                      <option value="986">thymoma</option>
+                      <option value="987">thyroid cancer</option>
+                      <option value="988">thyroid cancer metastatic</option>
+                      <option value="989">tobacco user</option>
+                      <option value="990">tocolysis</option>
+                      <option value="991">tongue neoplasm malignant stage unspecified</option>
+                      <option value="992">toxic epidermal necrolysis</option>
+                      <option value="993">toxicity to various agents</option>
+                      <option value="994">transient ischaemic attack</option>
+                      <option value="995">transitional cell cancer of the renal pelvis and ureter</option>
+                      <option value="996">transitional cell carcinoma</option>
+                      <option value="997">transitional cell carcinoma metastatic</option>
+                      <option value="998">transplant</option>
+                      <option value="999">transplant rejection</option>
+                      <option value="1000">tremor</option>
+                      <option value="1001">trigeminal neuralgia</option>
+                      <option value="1002">triple negative breast cancer</option>
+                      <option value="1003">tuberculosis</option>
+                      <option value="1004">tumour lysis syndrome</option>
+                      <option value="1005">turner's syndrome</option>
+                      <option value="1006">type 1 diabetes mellitus</option>
+                      <option value="1007">type 2 diabetes mellitus</option>
+                      <option value="1008">type 2 lepra reaction</option>
+                      <option value="1009">ulcer</option>
+                      <option value="1010">upper respiratory tract infection</option>
+                      <option value="1011">ureteric cancer</option>
+                      <option value="1012">urge incontinence</option>
+                      <option value="1013">urinary incontinence</option>
+                      <option value="1014">urinary tract infection</option>
+                      <option value="1015">urticaria</option>
+                      <option value="1016">urticaria chronic</option>
+                      <option value="1017">uterine cancer</option>
+                      <option value="1018">uterine leiomyoma</option>
+                      <option value="1019">uterine leiomyosarcoma</option>
+                      <option value="1020">uveitis</option>
+                      <option value="1021">vascular graft</option>
+                      <option value="1022">vasculitis</option>
+                      <option value="1023">venoocclusive disease</option>
+                      <option value="1024">venoocclusive liver disease</option>
+                      <option value="1025">venous thrombosis</option>
+                      <option value="1026">viral infection</option>
+                      <option value="1027">vitreous adhesions</option>
+                      <option value="1028">vomiting</option>
+                      <option value="1029">von willebrand's disease</option>
+                      <option value="1030">waldenstrom's macroglobulinaemia</option>
+                      <option value="1031">weight control</option>
+                      <option value="1032">weight decreased</option>
+                      <option value="1033">wheezing</option>
+                      <option value="1034">white blood cell count decreased</option>
+                      <option value="1035">withdrawal syndrome</option>
+                      <option value="1036">wound</option>
+                      <option value="1037">wound infection</option>
+                      <option value="1038">wrong product administered</option>
                     </select>
                   </div>
-                  <table class="display" id="prrByVaccineTable">
-                    <thead>
-                      <tr>
-                        <th>Drug</th>
-                        <th>Lower Confidence Limit of Proportional Reporting Ratio</th>
-                      </tr>
-                    </thead>
-                  </table>
+                  <div>
+                    <canvas id="drugsChartView"></canvas>
+                  </div>
                 </div>
               </div>
             </div>
diff --git a/docs/DrugsForPathologies/js/DrugsChartView.js b/docs/DrugsForPathologies/js/DrugsChartView.js
new file mode 100644
index 00000000000..f76eb060273
--- /dev/null
+++ b/docs/DrugsForPathologies/js/DrugsChartView.js
@@ -0,0 +1,71 @@
+class DrugsChartView {
+
+    #canvas;
+    #chart;
+
+    constructor(canvas) {
+        this.#canvas = canvas;
+    }
+
+    displayChart(drugDescr) {
+        if (this.#chart != null) {
+            this.#chart.destroy();
+        }
+        this.#chart = new Chart(
+            this.#canvas,
+            {
+                type: 'bar',
+                plugins: [ChartDataLabels],
+                data: this.#getData(drugDescr),
+                options: this.#getOptions()
+            });
+    }
+
+    setData(histoDescr) {
+        const data = this.#getData(histoDescr);
+        this.#chart.config.data = data;
+        this.#chart.update();
+    }
+
+    #getData(drugDescr) {
+        return {
+            labels: drugDescr['DRUG'],
+            datasets: [{
+                label: 'FATAL',
+                data: drugDescr['FATAL'],
+                backgroundColor: '#FF0000'
+            },
+            {
+                label: 'RECOVERED',
+                data: drugDescr['RECOVERED'],
+                backgroundColor: '#00FF00'
+            }]
+        };
+    }
+
+    #getOptions() {
+        return {
+            plugins: {
+                datalabels: {
+                    anchor: 'end',
+                    align: 'top'
+                }
+            },
+            title: {
+                display: true,
+                position: 'top'
+            },
+            scales: {
+                y: {
+                    ticks: {
+                        precision: 0
+                    },
+                    title: {
+                        display: true,
+                        text: 'Frequency'
+                    }
+                }
+            }
+        };
+    }
+}
\ No newline at end of file
diff --git a/docs/DrugsForPathologies/js/PageInitializer.js b/docs/DrugsForPathologies/js/PageInitializer.js
new file mode 100644
index 00000000000..e53b7bd8496
--- /dev/null
+++ b/docs/DrugsForPathologies/js/PageInitializer.js
@@ -0,0 +1,21 @@
+class PageInitializer {
+
+    static initializePage({ pathologySelectElement, drugsChartViewElement }) {
+        PageInitializer.#configurePathologySelect(pathologySelectElement, drugsChartViewElement);
+    }
+
+    static #configurePathologySelect(pathologySelectElement, drugsChartViewElement) {
+        const drugsChartView = new DrugsChartView(drugsChartViewElement);
+        Select2.initializeSelectElement(
+            {
+                selectElement: pathologySelectElement,
+                minimumInputLength: 0,
+                textOfOption2Select: null,
+                onSelectOptionHavingValueAndText: (id, text) => {
+                    fetch(`data/DrugDescriptionsForPathologies/${id}.json`)
+                        .then(response => response.json())
+                        .then(drugDescr => drugsChartView.displayChart(drugDescr));
+                }
+            });
+    }
+}
diff --git a/src/HowBadIsMyBatch.ipynb b/src/HowBadIsMyBatch.ipynb
index ac8d62b672d..1463a1f15a7 100644
--- a/src/HowBadIsMyBatch.ipynb
+++ b/src/HowBadIsMyBatch.ipynb
@@ -692,7 +692,7 @@
    "metadata": {},
    "outputs": [],
    "source": [
-    "drugDescrByPathology['bone cancer']"
+    "drugDescrByPathology['abdominal pain']"
    ]
   },
   {
@@ -702,7 +702,7 @@
    "metadata": {},
    "outputs": [],
    "source": [
-    "drugs4Pathologies[drugs4Pathologies['PATHOLOGY'] == 'bone cancer']"
+    "drugs4Pathologies[drugs4Pathologies['PATHOLOGY'] == 'abdominal pain']"
    ]
   },
   {
@@ -713,7 +713,7 @@
    "outputs": [],
    "source": [
     "saveDrugDescriptionsForPathologiesAndUpdateHtmlFile(\n",
-    "    drugDescrByPathology = drugDescrByPathology[:2],\n",
+    "    drugDescrByPathology = drugDescrByPathology,\n",
     "    webAppBaseDir = os.path.normpath(os.getcwd() + '/../docs/DrugsForPathologies'))"
    ]
   }

From 9d003eccf60a61ae7d322588238ed062fe20bf5b Mon Sep 17 00:00:00 2001
From: Frank Knoll <Knoll_Frank@web.de>
Date: Sat, 27 Jul 2024 23:25:21 +0200
Subject: [PATCH 08/16] displaying fatal and recovered as fractions

---
 docs/DrugsForPathologies/index.html           |  1 +
 docs/DrugsForPathologies/js/DrugsChartView.js | 14 ++++++++++----
 2 files changed, 11 insertions(+), 4 deletions(-)

diff --git a/docs/DrugsForPathologies/index.html b/docs/DrugsForPathologies/index.html
index bf2c1eeac5d..8e51ca6c746 100644
--- a/docs/DrugsForPathologies/index.html
+++ b/docs/DrugsForPathologies/index.html
@@ -34,6 +34,7 @@
     referrerpolicy="no-referrer" src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.10/vfs_fonts.min.js"></script>
   <script src="./js/PageInitializer.js"></script>
   <script src="./js/DrugsChartView.js"></script>
+  <script src="../Utils.js"></script>
   <script src="../Select2.js"></script>
   <script>
     document.addEventListener(
diff --git a/docs/DrugsForPathologies/js/DrugsChartView.js b/docs/DrugsForPathologies/js/DrugsChartView.js
index f76eb060273..7824e403cdc 100644
--- a/docs/DrugsForPathologies/js/DrugsChartView.js
+++ b/docs/DrugsForPathologies/js/DrugsChartView.js
@@ -31,18 +31,24 @@ class DrugsChartView {
         return {
             labels: drugDescr['DRUG'],
             datasets: [{
-                label: 'FATAL',
-                data: drugDescr['FATAL'],
+                label: 'Fatal',
+                data: this.#divide(drugDescr['FATAL'], drugDescr['CASES']),
                 backgroundColor: '#FF0000'
             },
             {
-                label: 'RECOVERED',
-                data: drugDescr['RECOVERED'],
+                label: 'Recovered',
+                data: this.#divide(drugDescr['RECOVERED'], drugDescr['CASES']),
                 backgroundColor: '#00FF00'
             }]
         };
     }
 
+    #divide(dividends, divisors) {
+        return Utils
+            .zip([dividends, divisors])
+            .map(([dividend, divisor]) => dividend / divisor);
+    }
+
     #getOptions() {
         return {
             plugins: {

From 763d0a366bbbe28bb8f21271727a781a7dc54333 Mon Sep 17 00:00:00 2001
From: Frank Knoll <Knoll_Frank@web.de>
Date: Sun, 28 Jul 2024 10:04:23 +0200
Subject: [PATCH 09/16] styling chart

---
 docs/DrugsForPathologies/index.html           |  4 +-
 docs/DrugsForPathologies/js/DrugsChartView.js | 47 +++++++++----------
 2 files changed, 24 insertions(+), 27 deletions(-)

diff --git a/docs/DrugsForPathologies/index.html b/docs/DrugsForPathologies/index.html
index 8e51ca6c746..d04a74cf80a 100644
--- a/docs/DrugsForPathologies/index.html
+++ b/docs/DrugsForPathologies/index.html
@@ -1180,11 +1180,11 @@
   <script src="../gentelella/vendors/bootstrap/dist/js/bootstrap.min.js"></script>
   <link href="https://cdn.jsdelivr.net/npm/select2@4.1.0-rc.0/dist/css/select2.min.css" rel="stylesheet" />
   <script src="https://cdn.jsdelivr.net/npm/select2@4.1.0-rc.0/dist/js/select2.min.js"></script>
-  <script src="https://cdn.jsdelivr.net/npm/chart.js@4.2.0/dist/chart.umd.min.js"></script>
+  <script src="https://cdn.jsdelivr.net/npm/chart.js@4.4.3/dist/chart.umd.min.js"></script>
   <script charset="utf8" src="https://cdn.datatables.net/1.13.1/js/jquery.dataTables.min.js"
     type="text/javascript"></script>
   <script
-    src=" https://cdn.jsdelivr.net/npm/chartjs-plugin-datalabels@2.2.0/dist/chartjs-plugin-datalabels.min.js "></script>
+    src="https://cdn.jsdelivr.net/npm/chartjs-plugin-datalabels@2.2.0/dist/chartjs-plugin-datalabels.min.js"></script>
   <!-- FastClick -->
   <script src="../gentelella/vendors/fastclick/lib/fastclick.js"></script>
   <!-- Custom Theme Scripts -->
diff --git a/docs/DrugsForPathologies/js/DrugsChartView.js b/docs/DrugsForPathologies/js/DrugsChartView.js
index 7824e403cdc..1d0acb6c8c7 100644
--- a/docs/DrugsForPathologies/js/DrugsChartView.js
+++ b/docs/DrugsForPathologies/js/DrugsChartView.js
@@ -15,31 +15,26 @@ class DrugsChartView {
             this.#canvas,
             {
                 type: 'bar',
-                plugins: [ChartDataLabels],
                 data: this.#getData(drugDescr),
                 options: this.#getOptions()
             });
     }
 
-    setData(histoDescr) {
-        const data = this.#getData(histoDescr);
-        this.#chart.config.data = data;
-        this.#chart.update();
-    }
-
     #getData(drugDescr) {
         return {
             labels: drugDescr['DRUG'],
-            datasets: [{
-                label: 'Fatal',
-                data: this.#divide(drugDescr['FATAL'], drugDescr['CASES']),
-                backgroundColor: '#FF0000'
-            },
-            {
-                label: 'Recovered',
-                data: this.#divide(drugDescr['RECOVERED'], drugDescr['CASES']),
-                backgroundColor: '#00FF00'
-            }]
+            datasets: [
+                {
+                    label: 'Recovered',
+                    data: this.#divide(drugDescr['RECOVERED'], drugDescr['CASES']),
+                    backgroundColor: '#00FF00'
+                },
+                {
+                    label: 'Fatal',
+                    data: this.#divide(drugDescr['FATAL'], drugDescr['CASES']),
+                    backgroundColor: '#FF0000'
+                }
+            ]
         };
     }
 
@@ -51,24 +46,26 @@ class DrugsChartView {
 
     #getOptions() {
         return {
-            plugins: {
-                datalabels: {
-                    anchor: 'end',
-                    align: 'top'
-                }
-            },
             title: {
                 display: true,
                 position: 'top'
             },
             scales: {
+                x: {
+                    title: {
+                        display: true,
+                        text: 'Drug'
+                    }
+                },
                 y: {
                     ticks: {
-                        precision: 0
+                        format: {
+                            style: 'percent'
+                        }
                     },
                     title: {
                         display: true,
-                        text: 'Frequency'
+                        text: 'percentage of reports'
                     }
                 }
             }

From 6eb922079f82812b167b736d1eb4c62c9ee1ca69 Mon Sep 17 00:00:00 2001
From: Frank Knoll <Knoll_Frank@web.de>
Date: Sun, 28 Jul 2024 10:40:20 +0200
Subject: [PATCH 10/16] addNumberOfReports2EachDrug()

---
 docs/DrugsForPathologies/js/DrugsChartView.js | 10 ++++++++--
 1 file changed, 8 insertions(+), 2 deletions(-)

diff --git a/docs/DrugsForPathologies/js/DrugsChartView.js b/docs/DrugsForPathologies/js/DrugsChartView.js
index 1d0acb6c8c7..92d1dec49c3 100644
--- a/docs/DrugsForPathologies/js/DrugsChartView.js
+++ b/docs/DrugsForPathologies/js/DrugsChartView.js
@@ -22,7 +22,7 @@ class DrugsChartView {
 
     #getData(drugDescr) {
         return {
-            labels: drugDescr['DRUG'],
+            labels: this.#addNumberOfReports2EachDrug(drugDescr['DRUG'], drugDescr['CASES']),
             datasets: [
                 {
                     label: 'Recovered',
@@ -38,6 +38,12 @@ class DrugsChartView {
         };
     }
 
+    #addNumberOfReports2EachDrug(drugList, numberOfReportsList) {
+        return Utils
+            .zip([drugList, numberOfReportsList])
+            .map(([drug, numberOfReports]) => `${drug} (${numberOfReports} reports)`);
+    }
+
     #divide(dividends, divisors) {
         return Utils
             .zip([dividends, divisors])
@@ -65,7 +71,7 @@ class DrugsChartView {
                     },
                     title: {
                         display: true,
-                        text: 'percentage of reports'
+                        text: 'Percentage of reports'
                     }
                 }
             }

From 7efc392e74954aa58dc3055bd9f5921f5cf8ed8e Mon Sep 17 00:00:00 2001
From: Frank Knoll <Knoll_Frank@web.de>
Date: Sun, 28 Jul 2024 10:46:49 +0200
Subject: [PATCH 11/16] removing PDF button

---
 docs/DrugsForPathologies/index.html | 7 -------
 1 file changed, 7 deletions(-)

diff --git a/docs/DrugsForPathologies/index.html b/docs/DrugsForPathologies/index.html
index d04a74cf80a..233bacddfa9 100644
--- a/docs/DrugsForPathologies/index.html
+++ b/docs/DrugsForPathologies/index.html
@@ -26,12 +26,6 @@
   <!-- Custom Theme Style -->
   <link href="../gentelella/build/css/custom.css" rel="stylesheet" />
   <link href="../forkMeOnGitHub.css" rel="stylesheet" type="text/css" />
-  <script crossorigin="anonymous"
-    integrity="sha512-w61kvDEdEhJPJLSAJpuL+RWp1+zTBUUpgPaP+6pcqCk78wQkOaExjnGWrVbovojeisWGQS7XZKz+gr3L+GPYLg=="
-    referrerpolicy="no-referrer" src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.10/pdfmake.min.js"></script>
-  <script crossorigin="anonymous"
-    integrity="sha512-EFlschXPq/G5zunGPRSYqazR1CMKj0cQc8v6eMrQwybxgIbhsfoO5NAMQX3xFDQIbFlViv53o7Hy+yCWw6iZxA=="
-    referrerpolicy="no-referrer" src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.10/vfs_fonts.min.js"></script>
   <script src="./js/PageInitializer.js"></script>
   <script src="./js/DrugsChartView.js"></script>
   <script src="../Utils.js"></script>
@@ -1145,7 +1139,6 @@
         <a class="a2a_button_whatsapp"></a>
         <a class="a2a_button_telegram"></a>
         <a class="a2a_button_email"></a>
-        <button class="btn" id="PDF">PDF</button>
       </div>
       <script>
         var a2a_config = a2a_config || {};

From 169a60c3b899798820bee05e238ce54243c7a77f Mon Sep 17 00:00:00 2001
From: Frank Knoll <Knoll_Frank@web.de>
Date: Sun, 28 Jul 2024 10:56:04 +0200
Subject: [PATCH 12/16] styling

---
 docs/DrugsForPathologies/index.html | 6 +-----
 1 file changed, 1 insertion(+), 5 deletions(-)

diff --git a/docs/DrugsForPathologies/index.html b/docs/DrugsForPathologies/index.html
index 233bacddfa9..b8dfc055efe 100644
--- a/docs/DrugsForPathologies/index.html
+++ b/docs/DrugsForPathologies/index.html
@@ -56,7 +56,7 @@
         <div>
           <div class="page-title">
             <div class="title_left">
-              <h1 id="heading">Drugs for Pathologies</h1>
+              <h1 id="heading">Drugs for Treatment of Pathologies</h1>
               <p>
                 By Craig Paardekooper
               </p>
@@ -66,10 +66,6 @@
           <div class="row">
             <div class="col">
               <div class="x_panel">
-                <div class="x_title">
-                  <h3 id="subheading">Associated Drugs</h3>
-                  <div class="clearfix"></div>
-                </div>
                 <div class="x_content">
                   <div style="margin-bottom: 20px;">
                     <label>Select Pathology:</label>

From 9e6be5c6eae035ed3b67674bdcba5d007838f54a Mon Sep 17 00:00:00 2001
From: Frank Knoll <Knoll_Frank@web.de>
Date: Sun, 28 Jul 2024 11:13:40 +0200
Subject: [PATCH 13/16] adding URLSearchParam

---
 docs/DrugsForPathologies/index.html           | 22 +++++++++----------
 .../DrugsForPathologies/js/PageInitializer.js | 13 ++++++-----
 2 files changed, 19 insertions(+), 16 deletions(-)

diff --git a/docs/DrugsForPathologies/index.html b/docs/DrugsForPathologies/index.html
index b8dfc055efe..1dcde84881a 100644
--- a/docs/DrugsForPathologies/index.html
+++ b/docs/DrugsForPathologies/index.html
@@ -7,17 +7,16 @@
   <meta charset="utf-8" />
   <meta content="IE=edge" http-equiv="X-UA-Compatible" />
   <meta content="width=device-width, initial-scale=1.0" name="viewport" />
-  <title>Drugs for Pathologies</title>
-  <!-- FK-TODO: reactivate GA: -->
+  <title>Drugs for the Treatment of Pathologies</title>
   <!-- Google tag (gtag.js) -->
-  <!-- <script async="" src="https://www.googletagmanager.com/gtag/js?id=G-ERHYDH4P64"></script>
+  <script async="" src="https://www.googletagmanager.com/gtag/js?id=G-ERHYDH4P64"></script>
   <script>
     window.dataLayer = window.dataLayer || [];
     function gtag() { dataLayer.push(arguments); }
     gtag('js', new Date());
 
     gtag('config', 'G-ERHYDH4P64');
-  </script> -->
+  </script>
   <!-- Bootstrap -->
   <link href="../gentelella/vendors/bootstrap/dist/css/bootstrap.min.css" rel="stylesheet" />
   <link href="https://cdn.datatables.net/1.13.1/css/jquery.dataTables.css" rel="stylesheet" type="text/css" />
@@ -29,6 +28,8 @@
   <script src="./js/PageInitializer.js"></script>
   <script src="./js/DrugsChartView.js"></script>
   <script src="../Utils.js"></script>
+  <script src="../UrlUtils.js"></script>
+  <script src="../URLSearchParam.js"></script>
   <script src="../Select2.js"></script>
   <script>
     document.addEventListener(
@@ -37,7 +38,8 @@
         PageInitializer.initializePage(
           {
             pathologySelectElement: $('#pathologySelect'),
-            drugsChartViewElement: document.querySelector("#drugsChartView")
+            drugsChartViewElement: document.querySelector("#drugsChartView"),
+            urlSearchParam: new URLSearchParam('pathology'),
           }
         );
       });
@@ -56,10 +58,8 @@
         <div>
           <div class="page-title">
             <div class="title_left">
-              <h1 id="heading">Drugs for Treatment of Pathologies</h1>
-              <p>
-                By Craig Paardekooper
-              </p>
+              <h1 id="heading">Drugs for the Treatment of Pathologies</h1>
+              <h2 >By Craig Paardekooper</h2>
             </div>
           </div>
           <div class="clearfix"></div>
@@ -68,7 +68,7 @@
               <div class="x_panel">
                 <div class="x_content">
                   <div style="margin-bottom: 20px;">
-                    <label>Select Pathology:</label>
+                    <label>Select a Pathology:</label>
                     <select id="pathologySelect" name="pathology">
                       <option disabled="" hidden="" selected="" value="">Select Pathology</option>
                       <option value="1">abdominal discomfort</option>
@@ -1128,7 +1128,7 @@
     <!-- footer content -->
     <footer>
       <!-- AddToAny BEGIN -->
-      <div class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-title="EU Safety Signal (All drugs)">
+      <div class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-title="Drugs for the Treatment of Pathologies">
         <a class="a2a_dd" href="https://www.addtoany.com/share"></a>
         <a class="a2a_button_facebook"></a>
         <a class="a2a_button_twitter"></a>
diff --git a/docs/DrugsForPathologies/js/PageInitializer.js b/docs/DrugsForPathologies/js/PageInitializer.js
index e53b7bd8496..7211bf87c5a 100644
--- a/docs/DrugsForPathologies/js/PageInitializer.js
+++ b/docs/DrugsForPathologies/js/PageInitializer.js
@@ -1,20 +1,23 @@
 class PageInitializer {
 
-    static initializePage({ pathologySelectElement, drugsChartViewElement }) {
-        PageInitializer.#configurePathologySelect(pathologySelectElement, drugsChartViewElement);
+    static initializePage({ pathologySelectElement, drugsChartViewElement, urlSearchParam }) {
+        PageInitializer.#configurePathologySelect(pathologySelectElement, drugsChartViewElement, urlSearchParam);
     }
 
-    static #configurePathologySelect(pathologySelectElement, drugsChartViewElement) {
+    static #configurePathologySelect(pathologySelectElement, drugsChartViewElement, urlSearchParam) {
         const drugsChartView = new DrugsChartView(drugsChartViewElement);
         Select2.initializeSelectElement(
             {
                 selectElement: pathologySelectElement,
                 minimumInputLength: 0,
-                textOfOption2Select: null,
+                textOfOption2Select: urlSearchParam.get(),
                 onSelectOptionHavingValueAndText: (id, text) => {
                     fetch(`data/DrugDescriptionsForPathologies/${id}.json`)
                         .then(response => response.json())
-                        .then(drugDescr => drugsChartView.displayChart(drugDescr));
+                        .then(drugDescr => {
+                            drugsChartView.displayChart(drugDescr);
+                            urlSearchParam.set(text);
+                        });
                 }
             });
     }

From 03533a8a938b7e6f53e475c0951427070856aa29 Mon Sep 17 00:00:00 2001
From: Frank Knoll <Knoll_Frank@web.de>
Date: Sun, 28 Jul 2024 11:21:22 +0200
Subject: [PATCH 14/16] refactoring

---
 docs/DrugsForPathologies/index.html | 4 ----
 1 file changed, 4 deletions(-)

diff --git a/docs/DrugsForPathologies/index.html b/docs/DrugsForPathologies/index.html
index 1dcde84881a..1e46c84f330 100644
--- a/docs/DrugsForPathologies/index.html
+++ b/docs/DrugsForPathologies/index.html
@@ -1170,10 +1170,6 @@
   <link href="https://cdn.jsdelivr.net/npm/select2@4.1.0-rc.0/dist/css/select2.min.css" rel="stylesheet" />
   <script src="https://cdn.jsdelivr.net/npm/select2@4.1.0-rc.0/dist/js/select2.min.js"></script>
   <script src="https://cdn.jsdelivr.net/npm/chart.js@4.4.3/dist/chart.umd.min.js"></script>
-  <script charset="utf8" src="https://cdn.datatables.net/1.13.1/js/jquery.dataTables.min.js"
-    type="text/javascript"></script>
-  <script
-    src="https://cdn.jsdelivr.net/npm/chartjs-plugin-datalabels@2.2.0/dist/chartjs-plugin-datalabels.min.js"></script>
   <!-- FastClick -->
   <script src="../gentelella/vendors/fastclick/lib/fastclick.js"></script>
   <!-- Custom Theme Scripts -->

From 02feabce8e629ebbb7e5d4ccbccbbff87c6b3aaa Mon Sep 17 00:00:00 2001
From: Frank Knoll <Knoll_Frank@web.de>
Date: Sun, 28 Jul 2024 11:33:12 +0200
Subject: [PATCH 15/16] refactoring

---
 docs/DrugsForPathologies/js/PageInitializer.js | 18 +++++++++++++-----
 1 file changed, 13 insertions(+), 5 deletions(-)

diff --git a/docs/DrugsForPathologies/js/PageInitializer.js b/docs/DrugsForPathologies/js/PageInitializer.js
index 7211bf87c5a..ee7a1540959 100644
--- a/docs/DrugsForPathologies/js/PageInitializer.js
+++ b/docs/DrugsForPathologies/js/PageInitializer.js
@@ -1,19 +1,23 @@
 class PageInitializer {
 
     static initializePage({ pathologySelectElement, drugsChartViewElement, urlSearchParam }) {
-        PageInitializer.#configurePathologySelect(pathologySelectElement, drugsChartViewElement, urlSearchParam);
+        PageInitializer.#configurePathologySelect(
+            {
+                pathologySelectElement: pathologySelectElement,
+                drugsChartView: new DrugsChartView(drugsChartViewElement),
+                urlSearchParam: urlSearchParam
+            });
     }
 
-    static #configurePathologySelect(pathologySelectElement, drugsChartViewElement, urlSearchParam) {
-        const drugsChartView = new DrugsChartView(drugsChartViewElement);
+    static #configurePathologySelect({ pathologySelectElement, drugsChartView, urlSearchParam }) {
         Select2.initializeSelectElement(
             {
                 selectElement: pathologySelectElement,
                 minimumInputLength: 0,
                 textOfOption2Select: urlSearchParam.get(),
                 onSelectOptionHavingValueAndText: (id, text) => {
-                    fetch(`data/DrugDescriptionsForPathologies/${id}.json`)
-                        .then(response => response.json())
+                    PageInitializer
+                        .#loadDrugDescr(id)
                         .then(drugDescr => {
                             drugsChartView.displayChart(drugDescr);
                             urlSearchParam.set(text);
@@ -21,4 +25,8 @@ class PageInitializer {
                 }
             });
     }
+
+    static #loadDrugDescr(id) {
+        return fetch(`data/DrugDescriptionsForPathologies/${id}.json`).then(response => response.json());
+    }
 }

From bf267f42d4c9b23506d9b52e70c2b9401052550d Mon Sep 17 00:00:00 2001
From: Frank Knoll <Knoll_Frank@web.de>
Date: Sun, 28 Jul 2024 11:35:54 +0200
Subject: [PATCH 16/16] refactoring

---
 docs/DrugsForPathologies/index.html |  2 +-
 src/HowBadIsMyBatch.ipynb           | 20 --------------------
 2 files changed, 1 insertion(+), 21 deletions(-)

diff --git a/docs/DrugsForPathologies/index.html b/docs/DrugsForPathologies/index.html
index 1e46c84f330..71781df31f5 100644
--- a/docs/DrugsForPathologies/index.html
+++ b/docs/DrugsForPathologies/index.html
@@ -59,7 +59,7 @@
           <div class="page-title">
             <div class="title_left">
               <h1 id="heading">Drugs for the Treatment of Pathologies</h1>
-              <h2 >By Craig Paardekooper</h2>
+              <h2>By Craig Paardekooper</h2>
             </div>
           </div>
           <div class="clearfix"></div>
diff --git a/src/HowBadIsMyBatch.ipynb b/src/HowBadIsMyBatch.ipynb
index 1463a1f15a7..3911a940004 100644
--- a/src/HowBadIsMyBatch.ipynb
+++ b/src/HowBadIsMyBatch.ipynb
@@ -685,26 +685,6 @@
     "drugDescrByPathology"
    ]
   },
-  {
-   "cell_type": "code",
-   "execution_count": null,
-   "id": "f7e83e81",
-   "metadata": {},
-   "outputs": [],
-   "source": [
-    "drugDescrByPathology['abdominal pain']"
-   ]
-  },
-  {
-   "cell_type": "code",
-   "execution_count": null,
-   "id": "0d0b6909",
-   "metadata": {},
-   "outputs": [],
-   "source": [
-    "drugs4Pathologies[drugs4Pathologies['PATHOLOGY'] == 'abdominal pain']"
-   ]
-  },
   {
    "cell_type": "code",
    "execution_count": null,